data_2yuj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2yuj _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.8 t80 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.843 0.354 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.9 p -151.63 102.11 2.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -165.61 171.61 12.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.86 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -96.56 156.91 16.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -145.49 148.13 32.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.25 112.11 14.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 73.0 m -77.61 128.99 35.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -135.41 172.21 13.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.08 163.39 24.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.9 m -81.1 -31.9 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.192 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.8 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 180.0 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.824 0.345 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.76 -31.2 70.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.902 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.0 mttp -82.65 60.3 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.91 -168.71 41.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.426 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.82 59.8 0.52 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.524 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.82 140.01 50.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.817 0.341 . . . . 0.0 110.853 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.8 pt -126.91 -179.97 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.8 mt -130.49 118.64 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 58.8 mtp -107.89 152.46 41.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.861 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.86 151.87 24.95 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.573 2.182 . . . . 0.0 112.253 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.27 -29.6 58.14 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.576 2.184 . . . . 0.0 112.311 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.1 p -59.76 -30.71 69.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.993 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.51 -39.1 82.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.164 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.4 HD11 ' CD2' ' A' ' 82' ' ' PHE . 12.5 tp -63.9 -43.78 94.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.25 -40.6 94.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.957 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -54.52 27.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.3 mt -57.68 -30.17 65.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.0 t -68.5 -29.76 68.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -92.56 -21.21 20.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.164 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.42 -3.34 39.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.513 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.45 31.61 10.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.908 0.385 . . . . 0.0 110.912 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.9 mt -98.79 127.95 50.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.06 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.31 178.01 4.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.428 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.3 t80 -66.99 139.89 95.79 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.748 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.428 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.6 166.66 82.13 Favored 'Cis proline' 0 C--N 1.348 0.524 0 C-N-CA 123.517 -1.451 . . . . 0.0 112.411 -0.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 16.1 mtt -134.17 80.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.845 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.41 152.94 19.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -114.5 159.31 20.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -112.4 95.62 5.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.894 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.4 mt -80.7 101.87 9.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -100.75 106.03 17.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -76.56 122.89 25.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -98.79 31.27 3.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.86 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.77 -37.08 4.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.803 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.28 25.92 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.016 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t70 56.2 36.82 28.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.114 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.77 153.59 21.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.4 ttp -144.19 131.96 21.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.6 t -150.89 131.89 14.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -107.89 115.59 30.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.5 p -115.88 176.61 5.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.35 135.81 8.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.456 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.1 p -72.34 146.02 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.366 . . . . 0.0 111.102 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.5 tp -118.18 -63.53 1.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -113.68 138.8 49.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.4 ' CD2' HD11 ' A' ' 50' ' ' LEU . 42.5 m-85 -103.51 72.96 1.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.6 m -148.64 73.36 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.046 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.13 175.12 9.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.07 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -85.01 160.46 20.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.824 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -70.64 132.75 45.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.27 25.61 69.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.657 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.1 mt -148.66 82.24 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 111.149 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.53 130.52 35.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -94.89 125.06 39.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.58 156.13 80.44 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.918 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.37 -176.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.547 2.165 . . . . 0.0 112.34 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.13 -33.88 12.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.418 ' CH2' ' HE3' ' A' ' 95' ' ' MET . 66.3 p-90 -63.93 -33.19 75.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.418 ' HE3' ' CH2' ' A' ' 94' ' ' TRP . 17.2 ttm -71.66 -31.29 66.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.21 -47.18 45.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.955 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -64.16 -41.45 97.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -62.69 -42.47 99.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.1 mt -83.46 -16.89 43.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.193 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.6 mt 61.09 34.45 19.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.816 0.341 . . . . 0.0 110.833 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.9 mt -84.05 -178.77 7.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.891 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -126.66 169.29 13.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -60.08 111.94 1.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.67 36.0 8.9 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.554 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.09 125.97 8.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.415 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.5 mt -77.81 129.24 35.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.9 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.2 135.01 58.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.041 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -60.43 121.93 13.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.11 135.81 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -139.17 132.13 29.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.21 96.42 5.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.8 m -109.72 146.16 15.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.18 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -108.58 110.04 21.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 mt -105.71 179.97 4.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.61 171.34 10.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.6 m -59.69 162.06 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.035 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -102.84 148.56 25.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 80.5 p -104.7 -31.51 9.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.795 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -140.48 111.24 6.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.843 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.1 m -121.65 120.42 34.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.932 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.5 ttmm -101.72 137.53 39.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.418 ' CG ' HD22 ' A' ' 139' ' ' LEU . 28.4 m-85 -121.17 152.0 39.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.932 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -137.71 93.6 12.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.922 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.65 119.13 4.34 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.556 2.17 . . . . 0.0 112.459 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 40.6 mm-40 -73.64 -33.01 64.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.3 t -104.4 147.38 34.28 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.19 -17.76 31.03 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.58 2.187 . . . . 0.0 112.503 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.04 -45.0 79.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.006 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -69.33 -45.05 70.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.5 mt -59.79 -31.31 69.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.72 -25.91 66.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.986 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.443 HD12 HG21 ' A' ' 132' ' ' ILE . 52.2 mt -59.97 136.54 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.013 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.0 t -69.34 -32.92 72.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.963 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -125.1 79.02 66.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.968 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.91 -27.94 20.35 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.569 2.18 . . . . 0.0 112.346 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -65.91 -44.93 83.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.56 -38.78 92.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.123 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 26.8 t -72.04 -40.9 67.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.418 HD22 ' CG ' ' A' ' 122' ' ' PHE . 3.8 tp -72.81 -33.86 66.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.007 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -76.27 -30.23 57.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.986 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -75.37 -30.61 60.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.08 -34.41 17.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.169 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.2 mt -59.53 -27.97 66.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.963 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -57.01 -29.15 63.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.071 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -78.73 -36.63 43.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.976 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.42 ' CZ ' ' HB ' ' A' ' 155' ' ' ILE . 61.3 m-85 -67.48 143.23 56.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.952 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -110.01 -25.34 10.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.178 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 12.2 t -137.46 159.26 42.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.984 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.2 mt -151.32 139.0 19.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.2 m -123.3 160.24 27.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.984 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.8 m -72.97 103.22 3.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 97.83 36.77 4.65 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.54 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -104.5 108.28 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.352 . . . . 0.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 32.6 t -69.59 86.35 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.061 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.42 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 8.2 pt -93.41 131.41 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.136 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -100.06 142.49 31.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.163 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 40.5 pt -127.83 152.74 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -144.19 136.45 26.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.406 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 3.6 p90 -150.71 -50.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -96.78 44.35 1.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 60.29 31.24 20.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -145.12 137.64 26.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.82 105.71 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.147 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -91.97 119.38 31.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.02 125.23 28.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.974 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.9 mt -134.14 128.91 35.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.812 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -122.44 133.73 54.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.942 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 19.9 t -78.26 139.73 18.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.032 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 56.3 mmm -100.67 -48.3 4.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.987 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.05 153.51 46.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.022 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.83 158.18 43.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.805 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -138.1 153.94 73.72 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.04 -34.11 3.55 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 123.204 -1.582 . . . . 0.0 112.448 0.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.52 178.41 4.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -47.67 84.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -99.02 130.55 45.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.0 m -134.3 161.58 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.205 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.3 t -119.38 94.57 4.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.8 pt -81.17 83.4 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 35.1 mt -116.01 84.98 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.075 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.37 87.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -159.76 176.56 11.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.802 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.22 107.14 13.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -126.41 179.24 5.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -117.12 121.77 42.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.16 122.12 50.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.137 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.76 179.88 4.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.903 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -130.54 157.92 41.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -144.34 87.43 1.88 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.025 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.6 t80 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.741 0.305 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.2 p -137.75 94.97 2.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.91 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.6 t -156.85 174.93 14.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.914 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -102.61 152.79 20.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.945 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -146.98 147.22 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.6 mtt85 -74.68 135.45 41.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.973 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 76.2 m -97.24 132.35 43.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.411 ' CD2' HG21 ' A' ' 88' ' ' ILE . 31.5 m-85 -145.45 157.89 43.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -81.03 161.9 24.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.937 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.6 m -65.41 -31.41 53.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.188 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.7 m . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.746 0.308 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.85 -34.95 51.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.947 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -81.59 100.62 9.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.5 -147.77 19.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.505 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.37 52.69 0.58 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.475 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.76 160.73 20.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.804 0.335 . . . . 0.0 110.917 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.0 pt -145.48 177.51 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.058 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.5 mt -122.81 137.86 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.123 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -131.22 160.04 68.87 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.844 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.59 162.68 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.567 2.178 . . . . 0.0 112.321 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.26 -33.48 24.11 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.606 2.204 . . . . 0.0 112.277 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.9 p -60.34 -34.55 73.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.34 -39.62 87.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.413 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 39.3 tp -64.24 -42.84 96.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.977 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.3 -30.64 60.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -79.32 -41.77 27.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.059 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.0 mt -53.52 -49.63 67.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.0 t -72.31 -28.51 63.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.887 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.37 -21.23 62.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.3 mt -94.07 20.19 8.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.327 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 59.52 30.88 20.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.02 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.1 mt -93.07 124.31 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.126 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 50.0 m -111.63 162.11 15.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.981 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.457 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -59.51 144.15 84.92 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.79 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.457 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 75.5 Cg_endo -77.23 167.45 79.54 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.539 -1.442 . . . . 0.0 112.409 0.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 63.9 mtt -129.33 66.98 1.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.818 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mt -91.07 148.68 22.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.921 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -113.57 135.64 53.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.804 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -83.49 89.65 7.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.893 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.6 mt -69.99 76.35 0.48 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -87.36 109.4 19.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.908 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -84.79 117.62 23.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -98.57 33.94 2.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.84 -44.21 1.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.936 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.8 m -120.25 20.99 11.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.175 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.7 t0 53.6 60.0 3.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.944 0.402 . . . . 0.0 111.117 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -112.11 164.35 13.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.945 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.3 ttp -159.49 130.61 6.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.0 t -158.38 170.77 21.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -138.18 117.01 12.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.923 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 9.4 p -122.36 153.48 38.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.818 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -116.98 127.85 7.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.507 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.42 HG22 ' CE2' ' A' ' 82' ' ' PHE . 10.6 p -66.71 130.6 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 0.0 111.064 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.9 tp -106.91 -56.33 2.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -106.77 155.69 19.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CE2' HG22 ' A' ' 79' ' ' VAL . 87.1 m-85 -130.43 82.9 2.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.1 m -157.39 31.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.169 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.58 167.86 14.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.11 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.38 159.35 33.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -66.06 107.29 1.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.26 28.32 30.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.426 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.411 HG21 ' CD2' ' A' ' 23' ' ' PHE . 27.7 mt -145.81 98.16 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.843 0.354 . . . . 0.0 111.112 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 94.6 m -94.27 132.54 38.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -95.06 127.27 40.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 mt -126.27 153.08 74.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.862 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.41 -173.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.587 2.191 . . . . 0.0 112.244 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -92.57 -40.32 10.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -66.76 -45.43 78.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -33.41 75.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.932 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -39.21 80.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -78.41 -33.98 48.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -60.32 -39.88 88.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.773 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.1 mt -87.8 -13.92 40.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.276 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.7 mt 61.93 37.14 15.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.814 0.34 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.3 mt -80.35 -178.53 6.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -130.04 167.85 17.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.86 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -62.73 84.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.944 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.33 33.96 1.4 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.463 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.32 131.73 10.87 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.474 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.1 mt -85.81 129.81 34.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.834 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.28 149.03 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.208 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -64.9 120.44 12.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.47 88.43 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.13 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -102.44 140.98 36.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.98 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.2 p -96.97 106.85 19.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.3 m -118.3 160.78 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -120.9 120.14 34.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.8 mt -114.49 177.2 4.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.859 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -122.98 170.44 10.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.901 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.15 133.73 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.162 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.91 162.24 28.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.9 p -120.49 -41.42 2.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.946 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -122.02 91.96 3.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.8 m -108.03 120.65 42.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.2 156.26 17.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.964 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.408 ' CE2' HG21 ' A' ' 168' ' ' VAL . 69.9 m-85 -141.56 155.52 45.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -136.76 89.3 17.87 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -51.43 114.59 1.63 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.531 2.154 . . . . 0.0 112.314 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -69.93 -32.01 70.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.0 t -98.85 144.44 28.18 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.59 -19.77 21.2 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.572 2.181 . . . . 0.0 112.484 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -55.13 -36.53 65.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.093 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -71.13 -42.16 69.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 64.3 mt -63.41 -31.46 72.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.12 -23.32 65.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.05 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 132' ' ' ILE . 57.4 mt -59.99 141.59 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.056 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.3 m -67.23 -42.56 83.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.975 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -125.84 74.91 71.05 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.001 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -57.09 -31.49 90.47 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.613 2.209 . . . . 0.0 112.235 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -43.26 99.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.957 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.66 84.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.19 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.8 t -67.73 -45.12 85.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.413 HD21 ' CZ ' ' A' ' 188' ' ' PHE . 21.0 tp -59.96 -31.25 69.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.016 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -87.24 -30.74 20.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.01 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.52 -31.3 71.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.947 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.26 -33.06 17.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.3 mt -59.3 -25.42 64.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -56.25 -33.64 65.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.031 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -77.73 -34.4 52.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.405 ' CE2' HG21 ' A' ' 155' ' ' ILE . 37.5 m-85 -69.13 137.61 53.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -102.4 -28.07 12.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.191 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 12.9 t -141.61 159.23 42.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.6 mt -141.39 119.58 12.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.7 m -111.17 138.45 47.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.9 m -62.4 123.05 17.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 94.4 49.82 2.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.472 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.35 132.63 35.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.816 0.341 . . . . 0.0 110.825 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.78 89.24 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.405 HG21 ' CE2' ' A' ' 146' ' ' PHE . 29.7 pt -80.21 141.99 14.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.178 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -114.08 98.05 6.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.044 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.8 pt -83.52 148.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.234 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -151.03 151.36 31.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.737 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -176.43 -40.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.989 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -105.28 43.36 1.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.929 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 57.42 30.04 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.057 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -144.98 120.44 10.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.4 mp -84.65 89.65 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.056 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -70.86 120.5 16.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -74.65 134.47 42.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.43 160.33 41.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.778 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 44.6 ttt-85 -152.12 121.62 6.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.408 HG21 ' CE2' ' A' ' 122' ' ' PHE . 21.4 t -62.93 138.07 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.2 mmm -103.82 -56.42 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -137.83 158.49 44.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.978 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 71.4 p -154.51 138.9 16.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -121.73 155.77 59.66 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.71 -26.33 9.52 Favored 'Cis proline' 0 C--N 1.347 0.471 0 C-N-CA 123.324 -1.532 . . . . 0.0 112.428 -0.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -120.74 170.9 9.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -37.35 76.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.963 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -102.68 117.64 35.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.043 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.85 142.87 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 3.8 t -98.2 105.69 17.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.6 pt -95.37 87.84 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.12 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 22.0 mt -116.23 84.35 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.093 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 60.29 88.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.34 175.18 14.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.854 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.16 110.98 20.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.839 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -131.91 179.56 6.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.41 110.64 20.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.68 143.69 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.04 177.85 4.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . 0.413 ' CZ ' HD21 ' A' ' 139' ' ' LEU . 7.9 m-85 -140.04 141.65 36.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.874 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.3 106.21 14.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.926 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.051 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.41 ' CE2' HG23 ' A' ' 18' ' ' THR . 59.9 t80 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.6 p -143.41 115.97 8.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.41 HG23 ' CE2' ' A' ' 16' ' ' PHE . 9.0 t -176.41 162.15 2.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -94.6 150.35 20.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.765 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -142.47 137.93 30.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -72.92 115.05 11.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.2 p -85.37 136.18 33.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.967 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.413 ' CD2' HG23 ' A' ' 88' ' ' ILE . 84.7 m-85 -138.99 170.98 15.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.89 146.49 28.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.931 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.1 m -63.47 -26.45 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.225 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.3 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.079 179.974 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.787 0.327 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -91.73 -32.08 15.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -84.58 92.44 8.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.49 168.6 11.76 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.441 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.02 56.59 3.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.513 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.86 134.54 54.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.9 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.9 pt -128.8 175.31 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.215 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mp -128.98 117.48 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.203 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 14.7 mtp -115.93 163.88 19.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.831 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -51.78 152.89 12.43 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.517 2.145 . . . . 0.0 112.269 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.44 -27.3 40.02 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.541 2.161 . . . . 0.0 112.337 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 95.2 p -63.74 -30.81 71.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.6 -40.43 96.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.415 HD11 ' CD2' ' A' ' 82' ' ' PHE . 23.2 tp -59.7 -40.45 87.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.975 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.35 -30.03 67.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.993 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -84.95 -30.65 24.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.937 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.8 mt -59.39 -30.72 68.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.015 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.5 -30.08 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.044 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -21.95 66.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.23 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.0 mt -93.88 18.37 10.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.392 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 53.94 42.11 31.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.812 0.339 . . . . 0.0 111.167 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.0 mt -107.44 133.59 51.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.126 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.29 169.03 10.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.969 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.442 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -59.92 142.39 88.81 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.7 Cg_endo -77.02 165.82 84.05 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.457 -1.476 . . . . 0.0 112.412 -0.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 65.0 mtt -131.42 51.68 2.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.1 mt -68.13 142.08 55.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.918 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -109.57 139.06 45.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.769 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.404 ' HD3' ' CE1' ' A' ' 76' ' ' HIS . 0.9 OUTLIER -93.08 96.65 10.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 34.3 mt -80.9 81.38 7.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.978 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.65 108.48 18.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -70.36 123.96 23.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.848 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -98.52 32.19 2.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -124.95 -45.5 1.87 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.943 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.6 t -121.63 17.85 11.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.208 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 52.66 59.9 4.17 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.863 0.364 . . . . 0.0 111.073 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.44 177.66 4.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 37.4 ttp -156.22 129.44 8.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.7 m -150.82 137.46 18.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 176' ' ' ALA . 6.8 m80 -112.38 108.7 17.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 31.2 p -109.8 166.66 10.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.98 136.75 11.11 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.428 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.443 ' CG2' ' CZ ' ' A' ' 82' ' ' PHE . 11.1 p -75.84 148.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.791 0.329 . . . . 0.0 111.168 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.2 tp -122.09 -63.47 1.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.871 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -109.66 -179.46 3.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.443 ' CZ ' ' CG2' ' A' ' 79' ' ' VAL . 57.5 m-85 -150.19 79.97 1.36 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.6 m -148.71 31.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.66 167.08 13.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.143 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.06 177.68 3.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -84.82 89.7 7.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 105.74 28.19 5.45 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.519 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.413 HG23 ' CD2' ' A' ' 23' ' ' PHE . 31.8 mt -141.45 82.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.845 0.355 . . . . 0.0 111.057 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 90.6 m -82.77 131.4 35.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.987 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -98.55 145.0 27.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 17.6 mt -143.29 149.75 49.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.905 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.13 178.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.574 2.183 . . . . 0.0 112.372 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -85.74 -40.66 15.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.42 ' CH2' ' HE2' ' A' ' 95' ' ' MET . 69.3 p-90 -63.25 -35.89 81.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.846 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.42 ' HE2' ' CH2' ' A' ' 94' ' ' TRP . 37.0 ttm -70.54 -40.86 73.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 4.6 mtt -60.39 -46.58 89.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.942 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -64.64 -33.46 75.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -66.72 -40.55 88.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.825 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.3 mt -84.85 -21.57 29.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.091 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.5 mt 64.4 34.85 10.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 0.0 110.947 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.8 mt -83.87 -179.58 7.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -118.56 -178.02 3.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -71.8 85.04 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.86 30.51 2.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.549 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.58 145.53 30.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.532 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.4 mt -96.72 123.47 40.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 0.0 110.953 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.77 131.6 72.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.084 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -64.57 100.22 0.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.89 126.29 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -134.6 118.35 17.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.2 p -76.92 116.93 18.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.843 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.4 m -121.24 170.15 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.221 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.03 106.38 9.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.795 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mt -106.9 170.68 7.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -115.56 179.96 3.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.2 m -69.48 141.65 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -83.71 141.68 31.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.088 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 71.5 p -99.75 -31.11 11.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -140.36 107.61 5.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.931 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 96.4 p -120.46 118.33 30.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -103.04 160.06 14.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.42 ' CZ ' HD21 ' A' ' 143' ' ' LEU . 47.7 m-85 -141.88 153.49 44.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.91 89.57 29.28 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.008 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -50.97 111.06 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.557 2.171 . . . . 0.0 112.401 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -61.49 -31.33 71.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.9 t -98.69 143.21 25.94 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.829 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.82 -20.26 17.48 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.567 2.178 . . . . 0.0 112.395 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.49 -39.65 70.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.042 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -64.66 -44.52 90.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.7 mt -59.71 -30.99 69.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -67.88 -23.74 65.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.024 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.1 mt -59.94 136.59 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.039 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.9 m -61.65 -49.16 77.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.994 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -118.17 82.65 18.42 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.39 -32.37 10.24 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.573 2.182 . . . . 0.0 112.319 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -33.75 75.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.31 -47.56 27.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.103 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.2 t -66.77 -30.57 50.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.146 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 49.8 tp -77.99 -45.59 23.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.937 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.17 -31.31 70.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -64.75 -28.43 69.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.67 -32.42 18.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.106 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.42 HD21 ' CZ ' ' A' ' 122' ' ' PHE . 34.7 mt -59.54 -28.87 67.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.044 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -57.73 -27.16 62.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.094 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -79.0 -41.23 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.921 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.416 ' CZ ' ' HB ' ' A' ' 155' ' ' ILE . 97.0 m-85 -71.32 130.36 41.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -88.79 -33.37 17.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 15.0 t -126.42 158.9 34.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.899 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.2 mt -142.1 125.28 16.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 m -119.0 148.16 43.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 66.0 m -75.37 128.25 34.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.98 28.08 19.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.555 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -118.81 138.6 52.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.2 t -96.8 104.12 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.126 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.416 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 3.1 pt -102.28 89.73 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.153 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.17 134.33 55.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt -121.49 157.43 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.11 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -143.29 155.06 44.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -175.13 -46.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -100.82 43.14 1.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 59.21 30.22 19.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.959 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.37 122.23 9.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.817 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -81.11 88.87 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.099 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -65.79 131.85 47.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.823 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -90.05 113.11 24.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.55 140.05 51.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.812 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -131.01 134.66 46.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.78 147.36 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.4 mmt -110.12 -61.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.63 152.38 50.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.963 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 43.5 p -150.3 143.64 25.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -120.35 151.95 54.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.19 -38.34 1.8 Allowed 'Cis proline' 0 C--N 1.346 0.427 0 C-N-CA 123.376 -1.51 . . . . 0.0 112.367 0.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -108.64 175.4 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.787 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.52 -47.78 78.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.998 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.422 ' HB3' ' CD2' ' A' ' 76' ' ' HIS . . . -94.18 131.02 40.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.8 m -143.33 155.3 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.177 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 2.8 t -112.39 99.82 8.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.827 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.2 pt -88.98 85.72 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.165 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 20.8 mt -116.46 96.06 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 60.75 66.1 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 7.3 t -155.51 154.91 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.93 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -101.71 135.8 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.933 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -137.21 155.47 49.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.7 76.12 7.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.5 125.82 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.144 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.95 167.11 11.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -120.46 127.7 52.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -98.99 96.87 8.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.095 -179.981 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.9 t80 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.76 0.314 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.8 p -130.53 133.98 46.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.852 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.8 t -177.1 169.41 2.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -99.6 125.31 45.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -123.64 152.4 42.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 -84.66 130.19 34.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.9 m -93.66 130.45 39.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.97 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -133.15 171.12 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -85.12 164.34 18.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -90.47 11.67 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.473 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.9 p . . . . . 0 C--N 1.331 -0.207 0 CA-C-O 120.722 0.296 . . . . 0.0 110.824 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.8 t . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.826 0.346 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.405 ' O ' ' CD1' ' A' ' 94' ' ' TRP . 9.3 mt-10 -82.51 -30.68 29.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.073 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.2 mttm -87.39 -30.62 20.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.009 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.03 -179.93 38.39 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.575 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.12 63.04 0.48 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.528 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.91 153.09 51.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.756 0.312 . . . . 0.0 110.847 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.7 pt -136.89 177.7 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.218 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.9 mt -126.19 114.98 40.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 76.8 mtp -108.74 164.16 15.36 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.819 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.8 144.94 63.74 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.584 2.189 . . . . 0.0 112.147 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.06 -28.3 49.8 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.448 2.098 . . . . 0.0 112.338 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.0 t -65.44 -29.72 70.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.043 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.13 -48.27 80.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.15 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 82' ' ' PHE . 25.1 tp -60.49 -43.5 96.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.35 -31.4 69.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -44.58 69.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.999 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.1 mt -58.19 -30.14 66.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.009 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.3 m -73.84 -26.25 60.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -94.96 20.14 9.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.318 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -134.04 20.02 3.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.219 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 56.18 30.19 16.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.809 0.338 . . . . 0.0 111.013 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.8 mt -100.43 130.28 49.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.77 164.86 15.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.931 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.442 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.6 t80 -64.44 140.81 98.07 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.787 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 76.9 Cg_endo -77.46 164.46 86.41 Favored 'Cis proline' 0 C--N 1.348 0.511 0 C-N-CA 123.487 -1.464 . . . . 0.0 112.473 -0.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 34.2 mtt -135.04 64.65 1.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.803 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.7 165.05 23.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.984 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -132.78 126.23 31.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.419 ' HG3' ' CD2' ' A' ' 76' ' ' HIS . 15.7 ttpt -83.09 112.7 20.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.4 mt -91.71 82.88 5.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.814 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.7 m -86.16 99.6 11.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -62.22 125.18 23.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.5 33.91 2.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.36 -48.27 1.57 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.816 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.2 m -118.18 21.69 12.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.209 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 t0 54.16 35.14 21.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.833 0.349 . . . . 0.0 111.077 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -84.37 162.09 20.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.969 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.78 127.05 13.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.8 m -152.93 131.39 12.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.419 ' CD2' ' HG3' ' A' ' 65' ' ' LYS . 49.5 m80 -104.48 106.41 16.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.5 p -93.49 174.52 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.25 138.79 10.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.443 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.9 p -84.81 158.41 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.846 0.355 . . . . 0.0 111.055 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.6 tp -151.56 -58.28 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -104.88 147.36 27.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 97.2 m-85 -125.31 86.72 2.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.2 m -155.91 32.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.109 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.38 165.59 12.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -83.47 165.11 19.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -64.08 121.73 14.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.43 33.7 68.13 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.555 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 26.5 mt -148.46 95.15 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 111.095 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 98.0 m -98.12 126.93 43.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.964 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -89.9 129.45 36.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mp -136.29 155.34 77.34 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.02 -174.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.509 2.139 . . . . 0.0 112.354 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -94.55 -36.05 11.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.405 ' CD1' ' O ' ' A' ' 38' ' ' GLU . 59.1 p-90 -64.34 -37.03 86.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.898 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 56.4 ttm -71.24 -39.12 71.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 36.5 mmm -64.57 -45.2 88.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -39.44 68.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -59.61 -31.9 69.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.4 mt -98.13 -8.84 26.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.342 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.4 mt 63.03 33.6 14.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.849 0.357 . . . . 0.0 110.885 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.6 mt -92.17 130.32 37.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.831 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -84.15 179.07 7.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.79 94.35 0.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.43 41.53 1.48 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.564 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.58 119.92 6.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.569 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.8 mt -73.62 126.57 30.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.838 0.351 . . . . 0.0 110.878 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.43 143.62 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.126 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -67.33 104.65 1.55 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.35 136.32 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -141.97 148.2 38.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.3 p -104.68 115.16 29.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.4 m -131.13 173.05 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.078 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.81 100.07 4.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.0 mt -89.19 -179.95 5.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -123.91 170.23 10.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -64.36 143.96 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.15 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -83.28 156.37 23.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.181 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.2 p -117.64 -39.94 3.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.943 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -125.22 85.68 2.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.2 m -100.32 120.43 39.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -109.53 149.59 29.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.419 ' CD1' HD23 ' A' ' 139' ' ' LEU . 89.5 m-85 -134.46 164.03 28.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.84 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -148.43 90.06 5.0 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.13 126.21 19.64 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.486 2.124 . . . . 0.0 112.313 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -73.35 -32.03 64.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.6 m -105.61 148.32 36.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.5 -12.59 27.21 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.586 2.19 . . . . 0.0 112.53 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -55.18 -41.71 72.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.034 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.418 ' CE1' HD13 ' A' ' 166' ' ' LEU . 12.6 t80 -70.67 -35.37 72.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.892 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 26.5 mt -66.68 -29.71 69.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.31 -26.04 68.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.008 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 47.5 mt -63.13 138.76 22.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.986 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.4 t -66.58 -39.65 88.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.992 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -126.68 80.49 70.21 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.17 -36.1 92.39 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.542 2.161 . . . . 0.0 112.31 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -59.69 -35.7 75.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.47 -37.34 80.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.2 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.75 -31.69 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.274 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.419 HD23 ' CD1' ' A' ' 122' ' ' PHE . 32.0 tp -75.2 -39.0 60.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.52 -31.35 68.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -66.19 -31.14 71.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.96 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.08 -41.35 13.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.149 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.6 mt -59.41 -27.56 66.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.999 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -56.97 -29.94 63.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.053 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.09 -46.0 18.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.865 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -61.1 134.26 56.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -98.48 -28.63 13.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -133.65 166.72 21.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.873 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.8 mt -158.19 147.34 19.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.42 132.08 40.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.0 m -59.99 107.1 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.942 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 112.44 28.87 3.36 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.505 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -122.67 134.28 54.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.774 0.321 . . . . 0.0 110.871 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.13 114.79 29.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.106 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 7.2 pt -112.87 118.5 58.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.124 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.38 141.6 33.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.066 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.6 pt -135.04 147.27 29.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.108 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -143.06 156.46 44.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 160' ' ' ASN . 47.9 p90 -175.29 -44.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.872 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.42 ' HB2' ' CE2' ' A' ' 159' ' ' TYR . 41.0 t30 -101.5 40.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 60.29 31.15 20.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -152.03 134.85 15.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.23 105.93 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -89.47 111.52 22.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.2 138.5 57.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.418 HD13 ' CE1' ' A' ' 129' ' ' PHE . 0.5 OUTLIER -156.56 118.05 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -115.79 137.48 52.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.97 109.01 5.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.2 mmm -76.64 -47.01 23.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.13 155.94 43.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.979 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -160.06 132.9 6.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.763 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -108.88 158.16 34.92 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.69 -26.72 9.1 Favored 'Cis proline' 0 C--N 1.347 0.454 0 C-N-CA 123.31 -1.538 . . . . 0.0 112.414 -0.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -125.74 179.46 5.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -47.83 84.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -91.04 124.33 35.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.0 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.2 m -140.74 152.57 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.8 t -113.23 98.95 7.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.2 pt -88.1 85.09 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.184 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.0 mm -113.61 89.19 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.12 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 61.1 77.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.818 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 13.9 t -163.16 149.91 12.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -101.32 131.16 47.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.926 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -136.11 170.98 15.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.43 97.73 11.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 29.2 t -84.26 139.69 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.084 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.09 175.24 5.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.844 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . 0.407 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 4.1 m-85 -141.56 148.44 39.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -135.87 90.49 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.138 179.939 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.404 ' CE2' HG23 ' A' ' 18' ' ' THR . 43.7 t80 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.789 0.328 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.9 p -159.04 118.8 3.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.966 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.404 HG23 ' CE2' ' A' ' 16' ' ' PHE . 9.8 t -177.47 150.91 0.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.888 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -75.39 140.02 42.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -142.0 144.11 33.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -69.32 176.49 3.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.971 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.1 m -146.38 125.32 12.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.414 ' CD2' HG23 ' A' ' 88' ' ' ILE . 56.7 m-85 -132.64 174.41 10.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 t -93.62 146.94 23.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.28 -27.65 43.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.173 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.5 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.107 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.89 0.376 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.87 -31.03 28.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -91.21 56.19 3.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.773 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.33 149.42 6.88 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.423 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.55 72.96 2.73 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.484 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -131.28 133.67 45.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.789 0.328 . . . . 0.0 110.842 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.9 pt -120.3 163.67 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.151 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.24 118.3 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.06 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.7 mtm -110.78 164.16 15.53 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.08 148.23 49.63 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.567 2.178 . . . . 0.0 112.19 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.86 -29.69 54.3 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.513 2.142 . . . . 0.0 112.316 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.7 p -59.0 -30.94 68.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.91 74.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 82' ' ' PHE . 38.4 tp -70.9 -50.39 35.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.924 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.26 -30.85 69.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -77.12 -41.32 42.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.058 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.1 mt -58.23 -31.97 67.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.038 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -82.33 -29.79 30.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.61 -16.08 52.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.216 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mt -93.93 19.6 8.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.265 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.3 t30 55.2 30.08 13.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.0 mt -98.18 141.14 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.193 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.8 p -126.45 159.35 33.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.435 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -63.02 145.37 96.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.842 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.3 Cg_endo -77.1 152.12 94.39 Favored 'Cis proline' 0 C--N 1.348 0.501 0 C-N-CA 123.413 -1.495 . . . . 0.0 112.378 0.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 20.3 mtt -116.17 61.3 0.72 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.77 137.95 37.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.826 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.409 ' CD1' HG12 ' A' ' 109' ' ' VAL . 94.7 m-85 -100.73 171.8 7.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.33 86.51 2.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.887 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 mt -66.18 88.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 m -88.25 103.08 15.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -85.17 113.69 21.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -96.08 42.93 1.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -124.59 -44.29 1.98 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.85 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 m -128.13 25.65 5.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.085 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 55.92 39.58 30.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.039 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -89.59 157.39 18.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.962 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.7 ttp -154.72 127.38 8.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.932 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.6 t -157.43 145.22 18.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.965 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -112.14 108.06 17.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.819 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 28.6 p -107.5 147.52 30.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.08 142.47 16.17 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.438 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.418 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 11.7 p -70.3 136.12 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.876 0.37 . . . . 0.0 111.066 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.7 tp -104.59 -63.25 1.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -127.61 167.49 16.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.934 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 94.8 m-85 -123.27 93.42 3.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.9 m -156.73 37.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.188 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.91 157.65 19.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.1 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.41 148.47 46.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -59.81 124.59 20.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.86 -19.15 54.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.594 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.414 HG23 ' CD2' ' A' ' 23' ' ' PHE . 29.0 mt -108.24 132.2 56.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 111.157 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 43.6 m -128.76 126.53 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.56 145.88 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 mp -146.57 158.51 46.46 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.03 155.0 9.32 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.605 2.203 . . . . 0.0 112.278 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -69.34 -38.46 78.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.446 ' CD2' ' N ' ' A' ' 95' ' ' MET . 49.0 p-90 -64.75 -41.17 96.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.446 ' N ' ' CD2' ' A' ' 94' ' ' TRP . 3.3 ttp -66.91 -36.97 83.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.929 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.6 mtp -61.94 -35.69 79.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -77.61 -38.38 48.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -60.33 -31.96 70.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.834 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.2 mt -98.13 -14.42 20.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.257 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.7 mt 62.07 39.99 12.51 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.9 0.381 . . . . 0.0 110.88 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 mt -81.23 164.97 21.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.842 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.81 -174.39 2.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -65.01 96.11 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.27 38.12 5.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.06 110.3 3.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.3 mt -73.76 124.85 26.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.826 0.346 . . . . 0.0 110.945 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -134.34 150.42 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -66.5 136.63 55.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.888 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.409 HG12 ' CD1' ' A' ' 64' ' ' PHE . 21.4 t -123.63 92.3 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -107.79 137.6 45.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 21.7 p -88.49 114.49 25.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.3 m -119.67 131.05 73.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.142 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -82.13 112.42 19.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 mt -111.7 175.08 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -133.08 171.83 13.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.06 147.28 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.184 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -89.65 149.74 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.064 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.1 p -105.55 -28.58 10.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.824 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -134.93 90.78 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.906 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.7 p -98.24 109.03 21.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -101.22 136.46 41.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.845 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -124.49 156.71 36.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -133.64 94.45 19.21 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.97 108.58 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.52 2.147 . . . . 0.0 112.395 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -61.98 -31.82 72.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.948 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 m -113.87 146.68 36.09 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.002 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.31 -14.6 25.47 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.544 2.163 . . . . 0.0 112.567 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.68 -33.96 61.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.135 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -75.29 -31.38 60.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.9 mt -63.53 -30.72 71.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.71 -27.99 69.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.012 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 46.8 mt -60.88 135.62 25.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.049 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.6 m -71.07 -30.66 66.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -127.88 73.32 78.93 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -56.74 -37.09 98.65 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.629 2.219 . . . . 0.0 112.209 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -60.75 -46.4 90.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.046 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -59.21 -46.02 89.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.055 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.438 ' CG1' ' CE2' ' A' ' 159' ' ' TYR . 21.5 t -69.72 -37.54 74.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.4 tp -73.5 -34.08 65.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -74.16 -34.49 63.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.906 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.05 -37.07 86.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.3 -33.44 43.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 12.6 mt -60.03 -28.82 68.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.947 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -57.95 -32.76 68.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.03 -31.56 58.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.83 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -74.71 142.61 44.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -100.79 -30.67 11.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -134.56 173.31 11.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 55.0 mt -149.59 114.38 5.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.824 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.0 m -104.95 144.88 31.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.1 m -71.12 112.72 7.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 99.76 39.3 3.42 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.575 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.18 112.9 20.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 110.883 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.21 82.97 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.116 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 8.7 pt -79.98 160.52 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.062 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -121.8 112.91 18.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.3 pt -98.7 152.51 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.208 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -147.72 147.24 29.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 160' ' ' ASN . 52.8 p90 -164.49 -47.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.846 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.45 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 57.0 t-20 -98.93 43.95 1.04 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 60.15 31.02 20.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.17 132.35 19.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 mp -90.39 88.49 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.087 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -70.38 123.18 21.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -75.14 133.09 41.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.22 141.38 22.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.877 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -136.94 145.51 44.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.38 153.64 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.177 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 13.2 mmm -121.99 -54.37 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.91 140.13 34.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.7 p -144.43 135.76 25.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -113.49 153.91 45.62 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.69 -37.12 2.22 Favored 'Cis proline' 0 C--N 1.346 0.395 0 C-N-CA 123.337 -1.526 . . . . 0.0 112.4 0.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.39 173.13 6.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -56.58 -43.33 79.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -95.06 127.63 41.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.004 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 16.2 m -138.35 139.61 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.169 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 30.9 p -93.18 102.1 14.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.793 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.0 pt -96.13 88.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.271 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.5 mp -124.28 82.31 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.005 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 62.19 81.57 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 23.7 t -157.18 158.15 35.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -91.14 129.75 37.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 5.9 ptt? -152.02 174.04 14.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -108.48 117.19 33.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.813 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.91 137.98 23.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.203 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.1 146.56 52.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -105.75 148.13 27.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -114.91 85.16 2.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.931 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.163 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.416 ' CE2' ' HG ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.791 0.329 . . . . 0.0 110.875 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.3 p -159.72 99.5 1.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -160.69 162.39 32.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -96.06 130.59 43.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -126.15 143.27 51.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -78.08 143.13 37.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.2 p -104.38 130.23 52.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.437 ' CZ ' ' CA ' ' A' ' 104' ' ' GLY . 57.1 m-85 -139.86 154.56 47.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -60.23 162.44 5.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.6 m -95.55 20.09 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.331 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 120.842 0.353 . . . . 0.0 110.911 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.745 0.307 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.47 -40.99 63.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.8 mttm -66.02 79.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.47 -171.9 22.08 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.49 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.7 79.98 0.26 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.453 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -140.51 134.25 30.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.813 0.339 . . . . 0.0 110.932 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.1 pt -122.53 170.07 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.098 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mt -124.46 96.9 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.004 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.9 mmm -90.34 158.55 43.33 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.81 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.64 149.38 32.1 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.51 2.14 . . . . 0.0 112.267 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.54 -30.14 53.03 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.566 2.177 . . . . 0.0 112.276 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.93 -30.19 71.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.43 -30.05 66.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.177 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.416 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 32.2 tp -70.67 -50.6 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.962 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.29 -32.39 73.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -76.78 -44.12 34.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.06 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.416 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 8.1 mt -58.72 -37.02 75.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.953 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.4 t -83.01 -28.76 29.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.79 -19.95 59.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.171 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.6 mt -92.69 15.52 14.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.332 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.83 32.69 20.09 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.735 0.302 . . . . 0.0 111.038 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.2 mt -92.87 144.17 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.107 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.3 p -127.19 179.69 5.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.984 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.451 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 16.7 t80 -72.55 138.42 80.65 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.749 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.4 Cg_endo -77.15 156.57 97.09 Favored 'Cis proline' 0 C--N 1.348 0.537 0 C-N-CA 123.534 -1.444 . . . . 0.0 112.426 0.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 41.8 mtt -119.97 31.34 6.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.809 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -61.58 149.23 39.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -109.51 145.51 36.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.882 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -92.39 85.97 5.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.949 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.73 90.1 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -98.89 111.64 23.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.927 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -83.86 113.17 20.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.825 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -88.31 54.35 3.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -142.9 -47.48 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.885 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.7 22.5 9.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.157 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 54.52 37.02 27.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.005 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -90.56 147.93 23.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.9 ttt -138.07 142.01 40.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.809 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.5 m -159.98 148.68 17.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -124.78 114.01 18.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 26.5 p -115.06 155.89 26.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.23 131.08 9.81 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.449 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.412 HG23 ' CZ ' ' A' ' 82' ' ' PHE . 10.7 p -68.59 140.14 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 111.164 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.6 tp -129.65 -56.35 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.832 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -108.54 146.12 33.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.971 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.416 ' CD2' ' HB2' ' A' ' 50' ' ' LEU . 76.6 m-85 -120.39 58.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.1 m -125.34 31.2 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.104 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.24 179.24 7.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.076 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.69 169.08 9.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -73.02 107.97 5.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.37 28.21 33.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.493 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.0 mt -148.33 95.67 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 15.0 m -91.05 134.2 34.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -97.84 120.64 38.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.8 mt -123.34 150.23 59.96 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.935 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.3 176.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.52 2.147 . . . . 0.0 112.304 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -79.84 -47.4 15.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -59.53 -29.12 67.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.992 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 33.4 ttm -73.45 -30.94 63.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.831 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 6.4 mtp -71.61 -43.59 65.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -68.92 -40.25 79.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.854 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -60.38 -61.51 2.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.819 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 mt -62.88 -20.54 65.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.6 mt 63.25 34.25 13.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.823 0.344 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 mt -81.52 179.27 7.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.827 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -125.79 177.59 6.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -63.97 103.18 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.437 ' CA ' ' CZ ' ' A' ' 23' ' ' PHE . . . 89.41 34.87 8.29 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.521 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.18 117.83 4.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.554 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.7 mt -64.71 130.22 42.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 110.884 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.9 t -121.46 138.02 53.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -70.46 112.81 7.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.0 t -96.44 143.93 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.107 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -160.03 138.63 10.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.4 p -91.05 113.91 26.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.6 m -120.86 150.14 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.115 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.74 86.8 2.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.9 mt -83.01 168.08 17.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.801 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -110.9 175.53 5.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.838 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.14 139.59 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.2 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.39 151.02 36.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.6 t -110.57 -30.93 7.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -138.77 107.72 6.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.938 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 m -114.26 137.99 51.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -129.02 148.63 50.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -133.8 150.84 51.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -131.55 91.33 34.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -51.34 125.02 15.39 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.543 2.162 . . . . 0.0 112.34 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -71.12 -39.77 71.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.1 m -105.57 148.0 35.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.877 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.73 -11.22 29.25 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.575 2.183 . . . . 0.0 112.576 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -56.37 -39.7 73.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.766 0.317 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -72.32 -38.3 68.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 32.4 mt -65.32 -36.94 85.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.824 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.29 -25.3 67.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.405 HD13 HG23 ' A' ' 132' ' ' ILE . 52.2 mt -59.99 134.57 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.052 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.1 t -59.69 -32.65 70.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.004 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.04 81.01 33.86 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.34 -30.05 16.11 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.62 2.214 . . . . 0.0 112.318 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -63.51 -37.8 88.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.63 -56.48 17.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.7 -33.94 62.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.164 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.415 HD22 ' CZ ' ' A' ' 188' ' ' PHE . 29.7 tp -70.16 -50.92 35.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.943 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -67.27 -39.07 86.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -60.13 -30.92 69.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.858 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.08 -31.21 61.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.071 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 60.4 mt -57.95 -27.16 63.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.038 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -30.05 62.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.012 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -81.55 -36.25 29.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -77.69 147.14 35.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.962 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -107.96 -28.66 9.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.58 159.56 35.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 28.4 mt -137.44 118.71 14.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.14 140.77 46.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.86 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.4 m -66.7 125.5 26.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.22 44.69 8.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.438 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -111.01 119.46 39.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.839 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.73 81.22 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 39.9 pt -81.91 178.41 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -152.63 131.32 12.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.039 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 39.8 pt -118.56 138.02 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -136.83 146.01 45.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.403 ' CE2' ' HB2' ' A' ' 160' ' ' ASN . 52.6 p90 -173.98 -44.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.868 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.403 ' HB2' ' CE2' ' A' ' 159' ' ' TYR . 53.1 t30 -97.76 38.5 1.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 60.21 31.12 20.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.21 119.45 8.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -84.09 90.81 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.13 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -71.8 138.61 48.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -96.96 124.86 41.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.2 mt -139.33 138.28 36.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -129.85 136.57 49.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.4 t -71.78 130.19 35.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.067 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.2 mmm -91.37 -62.81 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.09 150.45 48.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 31.5 p -144.79 144.22 31.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.849 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -123.84 152.17 65.7 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.96 -38.77 1.62 Allowed 'Cis proline' 0 C--N 1.346 0.436 0 C-N-CA 123.321 -1.533 . . . . 0.0 112.368 0.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -107.63 168.82 8.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -34.87 72.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.947 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -108.39 124.02 49.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.075 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 6.4 m -135.89 160.04 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 3.7 t -108.93 91.83 3.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.0 pt -80.56 82.76 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.145 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.9 mt -115.2 82.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.089 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 60.0 79.78 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.842 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 2.0 t -156.94 153.93 28.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.85 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -90.7 118.89 30.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -135.11 176.26 8.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.839 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.01 142.06 27.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.54 86.6 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.138 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.62 175.39 10.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . 0.415 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 2.2 m-85 -134.75 145.34 48.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -141.08 105.09 4.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.092 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.78 0.324 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.6 p -158.42 102.85 1.75 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -168.25 177.82 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -105.38 122.08 45.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -117.73 151.06 38.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 mtt85 -86.4 137.16 32.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.5 p -104.16 122.93 46.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -132.05 160.29 36.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 t -77.09 152.72 34.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -64.34 -21.04 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.347 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.276 -179.956 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.749 0.309 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.68 -36.33 65.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.821 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -60.29 -33.29 72.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -110.4 -164.66 19.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.474 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.16 31.63 5.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.55 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.0 mmtt -87.66 158.57 18.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.815 0.341 . . . . 0.0 110.973 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.6 pt -135.77 -179.98 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.45 104.45 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.04 157.17 34.21 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.34 144.86 38.2 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.541 2.161 . . . . 0.0 112.261 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.66 -30.62 56.61 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.516 2.144 . . . . 0.0 112.279 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.3 p -60.65 -35.45 76.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.94 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.89 -30.98 71.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.144 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.413 ' HB2' ' CD1' ' A' ' 82' ' ' PHE . 43.3 tp -63.06 -39.38 94.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.56 -32.89 47.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -61.14 -38.79 87.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.37 -46.21 91.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -60.14 -30.98 69.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.947 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.8 mtt85 -82.1 -26.35 33.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.036 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.1 mt -86.74 6.14 32.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.428 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 t30 59.52 31.34 20.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.81 0.338 . . . . 0.0 110.966 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.1 mt -94.73 125.19 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.128 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.7 p -110.37 170.62 7.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.438 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.8 OUTLIER -64.82 141.18 98.27 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.822 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.9 Cg_endo -77.1 164.61 86.76 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.468 -1.471 . . . . 0.0 112.403 -0.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 20.1 mtt -126.65 72.9 1.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.852 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.0 mt -90.96 149.26 21.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.958 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -112.78 142.99 44.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.823 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.42 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 59.5 tttt -94.93 103.39 15.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.984 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.9 mt -91.69 76.24 5.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.94 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -78.09 97.22 5.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.931 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -66.02 116.92 7.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -92.31 49.71 1.54 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -130.4 -46.13 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.795 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.0 m -133.28 28.82 4.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.958 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 58.02 34.75 24.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.031 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -88.82 156.32 19.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.8 ttm -158.4 137.63 11.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.0 t -160.0 108.98 1.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.42 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 37.9 m80 -75.91 118.31 18.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.9 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 24.7 p -111.61 147.16 36.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.95 149.71 19.26 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.499 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -91.02 154.42 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.853 0.358 . . . . 0.0 111.084 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.0 tp -145.96 -55.99 0.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -101.89 143.96 31.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.894 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 67.4 m-85 -123.54 76.8 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.4 m -150.79 31.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.42 150.12 28.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.148 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.01 173.06 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.85 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -67.95 115.89 7.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.11 29.83 75.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 32.7 mt -142.7 91.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 0.0 111.146 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.5 t -94.66 129.43 41.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -89.01 140.96 28.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.1 mt -137.47 155.92 75.22 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.2 179.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.603 2.202 . . . . 0.0 112.293 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -87.44 -45.3 10.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -60.35 -44.89 95.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.4 tpp -60.15 -34.74 73.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -53.36 22.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -60.0 -36.3 76.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.865 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -62.2 -49.08 77.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.781 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.9 mt -75.36 -17.06 60.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.2 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.4 mt 61.21 35.22 18.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.6 mt -80.68 -178.63 6.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.826 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.02 -177.98 4.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 120.75 10.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.8 27.84 70.04 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.504 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -70.71 107.62 2.22 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.439 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.3 mt -69.52 123.52 21.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.839 0.352 . . . . 0.0 110.839 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.2 t -125.59 145.88 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.08 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -73.32 108.72 6.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.93 121.54 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.7 114.55 12.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.8 p -77.73 114.86 17.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.985 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.9 m -122.54 144.13 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.071 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.43 102.58 15.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.0 mt -99.58 168.93 9.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.63 172.34 7.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.6 m -67.96 140.76 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.122 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -81.82 148.84 28.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.062 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.7 p -109.63 -31.55 7.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -131.73 93.29 3.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 61.1 m -114.49 94.49 4.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.38 142.5 35.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.823 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.415 ' CD1' HD22 ' A' ' 139' ' ' LEU . 42.7 m-85 -124.68 150.92 45.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.014 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -128.37 93.54 38.13 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.54 104.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.557 2.171 . . . . 0.0 112.373 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -59.51 -30.88 68.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.3 146.31 35.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.821 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.69 -12.76 26.87 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.536 2.157 . . . . 0.0 112.559 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -56.82 -40.69 76.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.067 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.411 ' CD2' HD21 ' A' ' 166' ' ' LEU . 19.2 t80 -67.31 -44.24 79.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.62 -29.98 68.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.947 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -61.99 -26.31 68.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.988 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.2 mt -61.66 139.68 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.981 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.4 m -65.3 -37.38 86.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -130.01 71.12 82.28 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.409 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 39.6 Cg_exo -57.0 -29.95 84.78 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.611 2.207 . . . . 0.0 112.241 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -60.31 -49.52 77.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.043 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.45 75.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.139 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.57 -33.27 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.415 HD22 ' CD1' ' A' ' 122' ' ' PHE . 12.6 tp -71.7 -42.87 66.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.14 -37.83 72.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -65.69 -32.76 74.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.58 -31.74 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.136 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.2 mt -63.98 -27.32 69.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.038 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -57.03 -25.2 58.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.101 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -79.74 -49.24 12.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.826 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.421 ' CZ ' ' HB ' ' A' ' 155' ' ' ILE . 84.5 m-85 -60.77 146.72 45.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -100.85 -30.33 11.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.24 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.11 167.46 22.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.974 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 27.6 mt -143.01 137.53 29.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.0 m -114.09 141.64 47.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.0 m -65.83 94.28 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 108.33 30.43 3.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.548 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.03 134.17 46.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.766 0.317 . . . . 0.0 110.854 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 26.1 t -90.2 91.19 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.117 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.421 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 9.3 pt -91.65 134.03 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -102.05 125.07 48.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.12 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.0 pt -115.88 141.59 32.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.103 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -139.19 142.22 37.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -157.71 -50.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -96.77 44.18 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 60.34 31.47 20.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -148.55 126.21 11.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -85.92 95.45 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.188 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -76.66 137.43 39.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -95.46 122.96 38.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.411 HD21 ' CD2' ' A' ' 129' ' ' PHE . 3.2 mt -141.63 100.55 3.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -93.93 127.74 39.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.94 128.79 32.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.083 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.8 mmm -86.71 -64.16 1.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.014 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -123.14 155.79 36.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 58.2 p -144.98 161.01 40.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -148.12 155.4 43.47 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.825 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.29 -31.6 5.17 Favored 'Cis proline' 0 C--N 1.348 0.507 0 C-N-CA 123.309 -1.538 . . . . 0.0 112.462 0.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -113.51 176.7 4.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -60.01 -41.94 93.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -98.83 116.94 32.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.018 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 17.7 m -133.27 137.66 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.16 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 10.0 t -94.62 97.9 10.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.1 pt -89.63 85.49 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.3 mm -117.83 85.12 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.123 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 60.58 87.26 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 49.9 t -161.65 141.52 10.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.97 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -80.84 108.14 14.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -128.34 179.22 5.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -93.84 89.97 6.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.75 81.33 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.01 172.05 13.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . 0.403 ' CE1' HD21 ' A' ' 139' ' ' LEU . 11.8 m-85 -128.52 163.07 25.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.93 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -147.93 101.64 3.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.958 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.048 179.946 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.3 t80 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.889 0.376 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.9 p -118.97 105.34 11.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.831 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.0 t -168.35 160.97 11.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.952 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -95.7 148.57 22.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -139.03 148.5 43.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 -75.84 128.51 35.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.873 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 64.9 m -99.11 125.79 44.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -130.66 175.47 8.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 t -92.28 150.66 20.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.906 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.5 m -68.3 -30.8 48.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.086 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.869 0.366 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.17 -31.58 43.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -80.56 -35.17 34.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.78 167.14 26.72 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.476 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.47 40.88 2.57 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.455 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.18 162.4 13.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.356 . . . . 0.0 110.897 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.0 pt -141.1 172.55 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.102 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 mt -120.93 86.41 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.174 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.6 mtp -89.11 151.59 47.0 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.773 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.09 156.09 7.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.574 2.183 . . . . 0.0 112.251 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.73 -25.46 61.17 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.625 2.217 . . . . 0.0 112.342 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.5 p -58.87 -30.78 67.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.942 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.79 -47.96 64.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.161 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.417 HD11 ' CE2' ' A' ' 82' ' ' PHE . 56.1 tp -59.51 -39.46 83.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.68 -31.01 64.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.924 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -74.04 -32.6 63.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.6 mt -59.84 -30.38 68.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.895 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.5 t -80.91 -22.94 39.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.111 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -75.09 -30.57 60.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.018 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.5 mt -95.52 20.05 10.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.243 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 53.58 38.42 28.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.82 0.343 . . . . 0.0 111.265 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.0 mm -77.08 154.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.025 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.91 151.55 44.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.436 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.5 t80 -61.83 140.6 95.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.753 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.436 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.75 157.8 97.34 Favored 'Cis proline' 0 C--N 1.349 0.579 0 C-N-CA 123.479 -1.467 . . . . 0.0 112.409 -0.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 45.0 mtt -116.38 56.86 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.91 139.72 45.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -105.81 157.13 17.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.402 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 10.3 tttp -103.55 92.94 4.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.6 mt -75.8 80.64 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.7 m -95.21 117.8 30.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -89.36 129.46 35.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.889 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -98.69 31.11 3.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.32 -41.02 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.847 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m -134.41 21.99 3.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.5 t70 54.4 59.95 3.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.098 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -106.55 158.98 16.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.1 ttm -159.28 126.64 4.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.4 t -158.96 100.94 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.941 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.402 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 50.4 m80 -65.77 131.98 47.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.926 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.6 p -123.11 166.32 15.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.49 113.24 2.05 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.516 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.35 154.18 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.102 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.2 tp -133.33 -62.22 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -95.7 162.76 13.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.417 ' CE2' HD11 ' A' ' 50' ' ' LEU . 51.7 m-85 -140.83 74.02 1.44 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.4 m -143.56 31.44 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.42 158.26 17.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.13 169.1 18.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -73.19 120.79 19.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.82 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.19 26.08 55.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.577 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.3 mt -149.74 113.99 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.834 0.35 . . . . 0.0 111.106 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 86.4 m -117.38 131.29 56.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -97.96 135.87 39.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 mp -135.36 160.63 67.25 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.43 -176.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.582 2.188 . . . . 0.0 112.292 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -93.09 -40.92 10.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.023 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -61.85 -42.07 98.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.98 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 44.6 ttm -60.43 -44.46 95.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.22 -48.76 80.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -60.57 -36.81 79.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.898 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -65.44 -56.38 12.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.2 mt -68.14 -17.68 64.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.184 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.3 mt 62.86 32.35 15.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.844 0.354 . . . . 0.0 110.84 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.84 179.96 7.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -134.08 176.53 8.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -59.91 105.4 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.8 28.45 8.31 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.52 121.58 5.56 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.466 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.6 mt -83.14 123.55 29.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.835 0.35 . . . . 0.0 110.985 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.41 135.55 62.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.085 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -68.28 102.13 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.4 t -86.86 132.12 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -145.17 133.15 21.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.8 p -90.88 103.06 15.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.1 m -109.19 170.96 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.168 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -114.89 118.69 34.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 mt -119.12 177.31 4.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -123.06 167.53 13.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.2 m -64.85 141.96 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.064 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.53 148.85 36.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.3 p -113.29 -37.05 4.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.926 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -137.6 118.41 14.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.931 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.58 107.2 6.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.07 131.64 34.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.41 ' CE2' HG22 ' A' ' 168' ' ' VAL . 26.4 m-85 -112.29 144.5 41.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -131.57 96.97 19.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.81 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.82 119.91 5.35 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.518 2.145 . . . . 0.0 112.327 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -71.49 -32.22 67.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.033 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.98 147.48 34.56 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.957 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.65 -19.14 28.27 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.571 2.18 . . . . 0.0 112.604 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.52 -48.07 78.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.051 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.42 ' CZ ' HD11 ' A' ' 166' ' ' LEU . 13.4 t80 -61.14 -44.96 96.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.88 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.6 mt -59.37 -31.8 69.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -62.77 -26.8 68.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.976 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 29.6 mt -61.38 135.56 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.993 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.7 t -64.51 -33.39 75.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.61 81.76 46.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.86 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.12 -27.23 20.42 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.47 2.113 . . . . 0.0 112.321 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -60.14 -35.74 75.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.019 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.3 -39.27 68.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.13 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.54 -30.28 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.275 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 25.5 tp -79.75 -44.51 20.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.04 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -63.64 -31.56 72.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.94 -28.82 67.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.74 -32.63 31.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.124 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.06 -26.63 68.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.076 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -56.41 -30.1 62.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.068 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -85.86 -42.73 13.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.944 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.416 ' CE2' HD11 ' A' ' 155' ' ' ILE . 37.6 m-85 -62.49 142.42 57.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -108.03 -25.67 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.279 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -141.42 165.5 27.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.5 mt -145.83 162.55 37.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.66 143.71 30.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.959 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 89.0 m -62.98 96.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 110.0 27.47 4.55 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.468 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.93 116.15 28.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.3 t -84.62 89.0 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.069 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.416 HD11 ' CE2' ' A' ' 146' ' ' PHE . 1.1 pt -93.67 142.85 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.111 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -109.0 131.25 55.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.159 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.8 pt -117.99 154.63 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -144.72 142.06 29.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.908 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.419 ' CE1' ' CD1' ' A' ' 164' ' ' TYR . 16.4 p90 -158.5 -49.75 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.966 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -97.87 44.5 1.04 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.9 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 60.0 30.14 19.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -144.58 142.63 30.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.67 90.45 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.041 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.419 ' CD1' ' CE1' ' A' ' 159' ' ' TYR . 39.8 m-85 -74.04 120.79 20.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -77.45 139.61 39.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.991 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.42 HD11 ' CZ ' ' A' ' 129' ' ' PHE . 0.7 OUTLIER -153.28 124.78 7.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -124.16 137.67 54.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.929 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.41 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.5 t -76.18 146.96 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 24.5 mmm -106.23 -56.88 2.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -128.65 149.79 50.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.983 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 17.5 p -145.69 141.17 27.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.869 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -127.43 152.98 77.23 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.99 -28.15 7.94 Favored 'Cis proline' 0 C--N 1.346 0.397 0 C-N-CA 123.38 -1.508 . . . . 0.0 112.366 0.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -124.61 173.25 8.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -47.16 85.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.968 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -90.88 103.55 16.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.016 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.38 132.19 71.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 5.7 t -89.55 85.58 6.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.813 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.8 pt -74.17 81.55 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.213 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.9 mm -119.69 103.07 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.977 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.98 79.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.808 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -176.48 144.14 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -101.18 120.48 40.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.969 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.75 172.18 7.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.05 95.06 9.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.3 90.34 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.13 175.43 10.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -130.43 151.6 50.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -129.2 80.74 1.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.128 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.421 ' CZ ' HG22 ' A' ' 18' ' ' THR . 5.1 t80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.856 0.36 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.8 p -147.75 107.26 3.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.952 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.421 HG22 ' CZ ' ' A' ' 16' ' ' PHE . 9.4 t -156.5 178.65 10.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -107.2 163.29 13.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.861 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -157.36 142.59 17.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.982 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -81.87 118.81 23.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.2 p -84.94 133.43 34.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -138.58 174.52 10.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.21 147.08 23.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.976 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.7 m -68.27 -21.2 26.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.324 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.215 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.819 0.342 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -78.42 -31.37 48.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -71.8 86.46 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.417 ' HA2' ' CE1' ' A' ' 146' ' ' PHE . . . 139.45 -156.83 24.83 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.488 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.22 40.28 1.62 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.552 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.85 149.36 22.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.921 0.391 . . . . 0.0 110.891 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.6 pt -126.99 170.74 16.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.179 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mt -122.83 99.78 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.033 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -99.93 157.5 33.77 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -51.87 160.24 3.09 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.515 2.143 . . . . 0.0 112.282 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.09 -27.42 42.03 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.494 2.129 . . . . 0.0 112.357 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.43 -31.22 71.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.3 -39.16 89.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.088 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.417 HD11 ' CE1' ' A' ' 82' ' ' PHE . 24.1 tp -60.11 -42.3 94.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -74.27 -42.28 59.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.63 -47.14 86.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.999 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.7 mt -54.12 -26.92 29.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.122 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.96 -27.52 24.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.033 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -97.12 20.05 11.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.268 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.1 mt -126.17 20.0 7.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.721 0.296 . . . . 0.0 111.295 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 55.05 30.04 13.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.804 0.335 . . . . 0.0 111.072 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.0 mt -98.24 124.61 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.152 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 t -114.98 169.5 9.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.449 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -70.98 145.17 91.24 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.77 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.449 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.7 Cg_endo -76.88 156.24 97.63 Favored 'Cis proline' 0 C--N 1.348 0.503 0 C-N-CA 123.549 -1.438 . . . . 0.0 112.393 0.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.6 mtt -115.76 66.68 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.32 123.47 30.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -98.31 142.95 29.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.404 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 13.0 ttpt -101.03 82.72 2.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.897 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.6 mt -60.9 94.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -94.46 112.55 24.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.861 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -71.06 103.8 2.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -79.95 61.98 4.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -174.08 -41.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.854 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.24 4.59 26.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.398 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 57.83 49.06 12.66 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.905 0.384 . . . . 0.0 110.904 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -107.64 168.82 8.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.4 ttm -157.39 128.4 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.3 t -145.81 148.74 33.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.948 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.404 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 69.3 m80 -116.11 95.28 5.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.932 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.5 p -107.04 160.98 15.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -118.16 134.91 11.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.531 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.417 ' CG2' ' CZ ' ' A' ' 82' ' ' PHE . 11.7 p -73.87 151.41 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 111.09 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.6 tp -137.55 -59.13 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -102.26 145.34 29.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.417 ' CE1' HD11 ' A' ' 50' ' ' LEU . 82.4 m-85 -124.89 75.66 1.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.851 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 m -136.57 30.86 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.68 155.26 16.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.58 160.26 25.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -60.34 113.02 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.5 27.64 32.15 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.58 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 26.0 mt -148.59 98.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 111.131 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.7 t -103.19 135.12 45.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -103.77 136.78 42.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 mp -136.12 157.55 75.48 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -51.95 179.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.573 2.182 . . . . 0.0 112.321 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.71 -35.54 15.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.413 ' CZ3' HG23 ' A' ' 155' ' ' ILE . 65.3 p-90 -68.06 -43.17 79.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.41 ' CE ' ' CH2' ' A' ' 94' ' ' TRP . 31.0 ttm -66.93 -33.08 74.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.956 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.8 mmt -60.57 -39.83 89.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.811 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -79.34 -33.86 42.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.886 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -60.31 -31.1 69.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 mt -102.13 0.28 34.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.375 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.4 mt 57.87 30.78 19.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.82 0.343 . . . . 0.0 110.919 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.7 mt -82.42 -178.63 7.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -144.56 -174.19 4.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.789 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -76.82 90.78 3.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.05 50.18 0.74 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.532 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.65 141.91 17.19 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.477 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.5 mt -85.65 127.19 34.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 110.867 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.41 139.68 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -80.26 121.77 26.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.27 139.22 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.093 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -143.18 130.03 20.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.3 p -88.77 123.17 32.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.89 140.26 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.134 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -91.96 112.14 23.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.6 mt -115.76 176.86 4.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -128.01 173.96 9.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.841 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.5 m -59.71 164.67 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.056 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -96.94 160.74 14.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.103 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 58.3 p -119.58 -41.12 2.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.809 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -133.08 92.4 3.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.807 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.92 143.26 35.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.941 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -117.23 169.76 9.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.828 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.419 ' CG ' HD12 ' A' ' 139' ' ' LEU . 42.9 m-85 -153.75 139.82 18.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -128.57 86.64 57.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -51.56 125.44 16.78 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.573 2.182 . . . . 0.0 112.375 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -80.99 -31.22 34.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.5 p -101.01 146.57 32.37 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.37 -17.14 24.27 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.528 2.152 . . . . 0.0 112.51 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.22 -38.48 68.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.073 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -76.07 -38.28 57.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 21.4 mt -63.48 -32.33 73.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -67.26 -26.1 66.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.061 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.417 HD12 HG22 ' A' ' 132' ' ' ILE . 47.9 mt -64.68 124.49 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.124 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.5 m -59.96 -39.06 84.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.48 77.71 4.47 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.17 -27.79 19.57 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.574 2.183 . . . . 0.0 112.252 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -64.41 -39.77 94.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.0 -51.66 44.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.09 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.418 HG12 ' CZ ' ' A' ' 159' ' ' TYR . 21.4 t -59.73 -30.51 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.419 HD12 ' CG ' ' A' ' 122' ' ' PHE . 6.1 tp -75.98 -44.71 38.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.38 -38.35 77.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -59.63 -31.09 69.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.968 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -86.04 -31.61 21.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.049 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 28.1 mt -61.35 -28.48 69.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -57.56 -29.71 64.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.067 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -79.07 -31.24 44.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.417 ' CE1' ' HA2' ' A' ' 40' ' ' GLY . 7.4 m-85 -83.6 150.68 25.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -109.87 -29.37 8.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.173 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.4 t -141.58 158.69 43.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.6 mt -131.66 178.53 6.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.0 m -158.89 136.63 10.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.5 m -65.41 121.57 15.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.8 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.75 41.34 9.83 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.356 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.77 106.71 9.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.836 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.8 t -66.57 107.02 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.011 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.413 HG23 ' CZ3' ' A' ' 94' ' ' TRP . 4.0 pt -109.1 132.17 57.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.116 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -92.45 129.85 38.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.083 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.0 pt -115.36 140.87 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.155 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -143.01 145.21 32.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.418 ' CZ ' HG12 ' A' ' 138' ' ' VAL . 10.8 p90 -161.3 -48.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.923 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 48.0 p30 -101.66 44.93 0.99 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.976 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.77 30.79 20.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.96 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -139.36 119.04 13.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.84 83.99 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.164 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -62.95 179.97 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -132.31 130.72 41.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.888 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 20.2 mt -145.63 159.07 43.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.864 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -153.0 114.96 4.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.415 HG22 ' CE1' ' A' ' 122' ' ' PHE . 21.5 t -59.72 135.41 24.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 41.1 mmm -99.97 -46.71 5.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.942 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.38 156.18 44.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.6 p -153.06 157.24 40.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -143.12 154.9 61.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.3 -31.4 5.31 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 123.298 -1.542 . . . . 0.0 112.434 0.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -108.34 167.67 9.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -35.17 71.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.949 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -113.61 115.43 27.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.023 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.67 154.79 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.5 t -99.89 80.01 2.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.1 pt -71.28 81.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.202 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.2 mt -125.19 95.92 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.079 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 61.59 78.38 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.08 148.43 2.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.02 136.57 43.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.946 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -143.54 167.45 22.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.1 85.41 5.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.0 108.79 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.108 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.09 179.96 5.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -138.28 140.83 39.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -107.56 99.5 8.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.819 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.255 -0.878 . . . . 0.0 111.057 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.2 t80 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.813 0.34 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.8 p -158.56 85.31 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 92.7 m -148.95 160.31 43.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -103.12 121.16 42.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.877 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.25 146.87 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.96 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -69.89 169.16 13.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.6 m -131.15 112.77 13.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -122.73 162.46 21.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -83.48 154.21 24.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.5 m -65.25 -29.67 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.112 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.2 p . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.037 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.1 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.755 0.312 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -39.51 76.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.946 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -84.38 94.25 8.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.83 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.18 -134.01 7.41 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.606 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.1 52.3 0.56 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.524 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.9 154.17 26.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 0.0 110.804 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.2 pt -136.85 161.2 36.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.187 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.5 mt -110.09 102.13 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.15 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 82.7 mtp -99.55 161.4 24.64 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -55.89 159.52 11.73 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.532 2.155 . . . . 0.0 112.234 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.2 -27.78 23.96 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.625 2.217 . . . . 0.0 112.297 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 p -59.4 -31.75 69.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.23 -36.43 77.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.124 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.415 HD11 ' CZ ' ' A' ' 82' ' ' PHE . 16.1 tp -61.79 -44.27 97.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -71.9 -31.18 66.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.942 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.42 -41.5 60.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -61.55 -48.07 82.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.7 p -65.31 -30.82 71.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.876 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.58 -20.35 58.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.2 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.8 mt -94.38 20.03 8.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.295 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.9 t30 56.16 30.59 16.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 111.064 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.3 mt -97.81 141.67 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.129 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 p -134.37 172.1 13.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.439 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.5 t80 -60.6 140.62 92.55 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.855 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.439 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.6 Cg_endo -77.05 163.24 89.82 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 123.501 -1.458 . . . . 0.0 112.345 0.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.4 mtt -130.45 69.42 1.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 mt -90.13 147.56 23.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -113.5 126.75 55.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -82.81 89.09 6.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.6 mt -68.03 77.5 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.857 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -81.92 95.39 7.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -64.38 116.04 5.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.828 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -98.11 29.51 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -119.16 -40.5 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 m -124.28 21.79 8.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.098 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 54.4 37.97 28.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.036 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.9 mmp_? -93.09 171.85 8.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.963 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.1 ttp -156.08 125.42 6.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.0 m -144.52 132.25 21.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.888 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.417 ' CD2' ' HB2' ' A' ' 176' ' ' ALA . 12.0 m80 -107.35 101.0 10.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.917 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 28.8 p -108.06 172.66 6.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -134.6 137.67 9.45 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.528 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.79 150.91 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.761 0.315 . . . . 0.0 111.091 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.5 tp -133.44 -60.71 0.83 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -99.51 157.24 16.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 50' ' ' LEU . 93.6 m-85 -130.32 55.46 1.81 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.827 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.14 31.76 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.21 168.46 11.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.74 151.8 25.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.861 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -59.9 134.87 57.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.13 24.86 70.66 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.501 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 29.4 mt -145.93 92.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.85 0.357 . . . . 0.0 111.033 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 83.8 m -92.18 126.15 37.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.022 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -92.7 141.3 28.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.777 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mp -141.67 160.21 57.2 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.853 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -51.84 177.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.53 2.154 . . . . 0.0 112.365 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -84.32 -46.16 12.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -60.24 -38.49 83.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.9 ttm -61.29 -40.81 95.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -41.85 99.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.892 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -71.79 -36.76 70.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -62.25 -39.0 91.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.0 mt -87.25 -20.68 26.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.4 mt 61.74 42.83 10.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.878 0.37 . . . . 0.0 110.924 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.3 mt -87.72 170.01 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.77 179.33 3.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.905 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.92 88.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.886 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.48 47.71 1.38 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.395 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.07 107.95 3.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.457 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 32.3 mt -69.59 132.61 46.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.804 0.335 . . . . 0.0 110.941 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.32 149.52 32.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.073 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -63.26 110.18 1.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.58 120.59 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -148.84 142.59 25.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.836 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.1 p -90.15 114.66 26.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.854 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 20.4 m -116.46 152.18 18.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.129 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -108.55 119.11 38.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.1 mt -119.48 179.93 4.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.14 171.61 7.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.915 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.0 m -71.51 133.57 31.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.27 147.42 53.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.149 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.7 p -111.98 -35.53 5.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 187' ' ' ASP . 75.2 t80 -133.23 99.8 4.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.5 p -113.43 111.05 21.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -102.67 136.53 42.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.411 ' CD1' HD23 ' A' ' 139' ' ' LEU . 20.7 m-85 -120.43 155.24 33.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.923 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -133.04 94.62 20.18 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.96 120.4 6.01 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.552 2.168 . . . . 0.0 112.374 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -76.13 -31.48 58.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.965 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.44 149.4 42.1 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.974 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.23 -9.68 26.49 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.536 2.157 . . . . 0.0 112.684 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.41 ' HB3' ' CE2' ' A' ' 164' ' ' TYR . 0.3 OUTLIER -56.41 -35.39 67.74 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.08 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.415 ' CD1' HD13 ' A' ' 166' ' ' LEU . 9.2 t80 -79.61 -34.01 41.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.812 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.8 mt -66.0 -34.77 78.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.29 -26.2 68.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.068 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 39.1 mt -60.04 139.4 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.002 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.5 m -61.24 -53.35 58.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.39 80.01 29.08 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.875 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.414 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 38.9 Cg_exo -57.15 -35.1 98.83 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.54 2.16 . . . . 0.0 112.194 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -34.08 73.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.962 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.49 -39.06 74.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.114 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.43 -30.97 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.411 HD23 ' CD1' ' A' ' 122' ' ' PHE . 9.0 tp -76.71 -30.72 56.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.009 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -80.67 -31.67 36.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.944 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.66 -32.0 70.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.27 -33.5 32.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.104 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 22.7 mt -59.87 -28.93 67.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.043 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -58.29 -33.03 68.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -79.53 -31.14 42.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -71.26 145.56 49.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -108.54 -27.27 9.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.192 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.87 171.61 13.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.7 mt -155.41 136.15 13.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.22 149.78 47.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.816 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 57.0 m -69.27 100.39 1.31 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.65 28.55 4.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.501 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.89 90.08 4.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.85 0.357 . . . . 0.0 110.867 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.7 t -63.37 100.68 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.104 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 pt -109.54 161.98 7.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.11 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -127.28 99.41 5.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.11 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.2 pt -69.41 150.1 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.044 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -158.33 150.3 21.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -177.29 -37.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.087 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -103.47 38.94 1.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.944 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 60.86 29.96 19.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -145.87 108.39 4.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.784 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.0 mp -82.48 112.82 20.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.127 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 128' ' ' ASP . 32.5 m-85 -94.13 131.78 39.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.837 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -83.52 107.34 15.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.415 HD13 ' CD1' ' A' ' 129' ' ' PHE . 0.8 OUTLIER -128.68 136.4 50.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -130.61 131.85 45.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.0 t -70.14 154.41 8.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.5 mmm -121.35 -57.68 1.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -124.55 141.53 52.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.915 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.3 p -145.22 148.29 33.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -133.94 158.02 76.37 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.21 -41.64 0.92 Allowed 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.222 -1.574 . . . . 0.0 112.427 -0.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.35 178.47 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.843 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -47.49 82.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.417 ' HB2' ' CD2' ' A' ' 76' ' ' HIS . . . -99.06 129.48 45.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.03 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.55 135.92 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.201 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 8.0 t -93.04 96.9 10.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.6 pt -88.24 82.72 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.132 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.2 mt -109.89 81.02 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.104 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.26 89.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 2.8 t -162.95 166.23 24.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -106.74 121.68 44.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.896 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -134.72 172.1 13.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.951 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.12 111.8 23.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.2 t -96.03 131.77 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.146 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.415 ' HB2' ' CE1' ' A' ' 119' ' ' TYR . 10.6 t70 -114.8 167.19 10.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -127.41 141.67 51.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.974 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -122.5 81.8 1.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.04 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.1 t80 . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.878 0.37 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.7 p -141.59 129.16 21.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.1 t -176.5 160.42 2.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -77.76 149.66 34.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -155.02 145.22 21.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.917 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.2 mtt85 -76.5 148.15 37.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 64.3 m -113.52 127.7 56.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -129.01 175.89 8.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.59 156.75 17.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.9 m -67.48 -30.17 48.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.803 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.816 0.341 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -73.5 -37.32 65.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -97.57 76.17 2.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.82 159.24 7.86 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.482 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.92 92.1 1.44 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.533 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -153.38 129.26 10.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.327 . . . . 0.0 110.904 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.1 pt -123.64 179.91 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.145 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.7 mt -130.11 115.65 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.064 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 25.3 mtp -117.35 158.6 44.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.14 163.79 2.09 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.597 2.198 . . . . 0.0 112.234 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.31 -27.76 23.42 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.495 2.13 . . . . 0.0 112.234 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.1 p -59.14 -35.7 73.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.92 -32.56 72.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.8 tp -70.91 -39.51 72.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.19 -33.02 56.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -67.04 -41.55 86.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 mt -63.5 -31.6 72.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.9 t -68.88 -42.68 76.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -66.92 -32.19 73.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.4 mt -79.89 -3.26 47.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.461 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 m120 62.2 30.78 17.72 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.733 0.301 . . . . 0.0 110.909 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.5 mt -90.18 106.9 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.109 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.1 p -90.43 171.81 9.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.939 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -59.25 145.21 81.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.803 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.453 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 78.9 Cg_endo -77.41 167.63 78.81 Favored 'Cis proline' 0 C--N 1.347 0.499 0 C-N-CA 123.478 -1.468 . . . . 0.0 112.482 -0.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 4.8 mtt -128.73 62.02 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.85 158.94 22.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.948 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -131.25 126.58 35.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -82.69 106.42 14.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.9 mt -82.41 79.36 8.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.835 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -75.84 93.47 3.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.979 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -68.08 120.04 13.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -97.75 38.07 1.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -128.46 -45.65 1.34 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.8 23.24 7.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.124 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 54.75 39.26 31.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.046 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -89.32 160.43 16.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.964 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 ttm -155.95 124.83 6.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.0 m -153.8 121.38 5.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.854 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -86.01 97.15 10.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 26.4 p -85.19 159.42 20.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -118.26 128.71 7.86 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.521 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.4 p -75.45 137.44 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.76 0.314 . . . . 0.0 111.117 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.3 tp -124.85 -56.49 1.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -103.39 142.75 33.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -118.01 67.82 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.942 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.04 30.99 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.078 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.25 157.92 19.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -81.91 165.28 20.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -63.6 106.86 1.03 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.19 29.93 21.19 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.486 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 31.9 mt -144.96 117.16 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 0.0 111.132 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 61.7 m -125.29 129.52 50.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -97.82 149.4 22.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 mp -144.34 155.05 57.76 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.957 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.25 170.64 0.23 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.575 2.183 . . . . 0.0 112.307 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -78.02 -44.51 26.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -60.24 -37.28 79.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 50.1 ttm -75.05 -31.62 61.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -42.72 81.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.841 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -75.14 -40.41 59.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.839 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -60.5 -35.92 77.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 72.6 mt -83.11 -21.99 33.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.15 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 86.3 mt 61.55 38.06 15.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.4 mt -86.51 -178.26 6.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -115.92 168.36 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -65.31 81.39 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.98 41.14 1.86 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.518 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.83 135.73 13.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.555 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.4 mt -81.98 124.6 29.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 0.0 110.935 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.36 153.37 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.5 143.78 51.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.6 t -124.86 149.4 29.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -157.61 131.47 8.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.9 p -91.86 101.66 14.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.5 m -117.91 144.82 24.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.105 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -102.63 113.04 26.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.6 mt -102.68 171.89 7.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -115.84 171.89 7.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.849 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.1 m -60.41 155.68 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.061 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -89.59 156.41 18.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.077 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.33 -35.67 4.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -133.94 92.58 2.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.63 110.93 23.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.88 130.4 53.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.401 ' CZ ' HD22 ' A' ' 143' ' ' LEU . 37.6 m-85 -118.26 156.21 29.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.878 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -136.01 87.67 23.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.25 116.64 2.95 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.523 2.149 . . . . 0.0 112.363 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -68.54 -31.3 70.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.963 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -103.74 143.92 27.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.972 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.62 -17.06 20.88 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.585 2.19 . . . . 0.0 112.543 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -33.22 63.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.136 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -73.36 -48.48 33.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 70.4 mt -59.29 -30.37 68.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.919 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.85 -25.64 67.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.964 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 38.7 mt -59.96 138.96 20.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.06 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.7 m -64.0 -42.9 97.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -117.62 79.97 13.09 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.979 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.46 -28.39 21.96 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.602 2.202 . . . . 0.0 112.247 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -68.5 -38.94 81.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.948 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.77 -38.04 70.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.051 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.9 t -69.59 -35.51 66.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.019 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.5 tp -78.82 -42.75 26.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.829 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.89 -35.94 81.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -65.24 -34.39 78.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.72 -32.64 27.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.088 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.401 HD22 ' CZ ' ' A' ' 122' ' ' PHE . 12.4 mt -60.63 -30.12 69.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -58.8 -31.39 68.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -74.4 -33.69 63.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.17 149.95 45.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -110.07 -27.44 9.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.248 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 4.5 t -141.65 163.55 32.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.0 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.4 mt -137.92 165.02 27.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.781 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.8 145.44 23.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.905 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.3 m -69.34 97.44 0.96 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.19 51.76 0.86 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.472 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.46 120.66 38.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.827 0.346 . . . . 0.0 110.908 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.24 93.2 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.071 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.1 pp -101.35 138.34 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.113 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -111.9 100.32 8.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.055 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.6 pt -80.0 160.17 4.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.165 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -156.53 147.55 22.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -171.69 -46.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.932 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -96.72 40.31 1.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.92 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 59.71 31.65 20.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -148.5 129.01 13.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 mp -87.67 97.51 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.076 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -78.8 120.79 23.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.53 128.99 38.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.981 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.5 mt -145.95 136.25 23.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -136.17 126.12 25.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.16 140.03 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.094 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.6 mmm -107.41 -49.44 3.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -139.17 154.47 48.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.91 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 80.6 p -156.92 125.72 5.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -111.63 158.09 37.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.819 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.01 -40.63 1.12 Allowed 'Cis proline' 0 C--N 1.347 0.459 0 C-N-CA 123.248 -1.563 . . . . 0.0 112.347 0.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.67 174.48 5.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -58.06 -46.71 84.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.912 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -102.62 128.96 49.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.071 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 16.0 m -139.98 153.38 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.167 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.48 101.86 11.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.2 pt -85.24 84.56 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.166 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 29.6 mm -118.51 89.54 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.113 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 60.47 87.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 30.2 t -166.54 154.54 10.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.59 97.07 7.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -102.53 170.27 8.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -93.9 88.27 5.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.866 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 29.5 t -78.52 120.69 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.43 162.5 16.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.813 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -118.33 162.88 17.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -153.31 96.38 2.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.965 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.117 -179.95 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.2 t80 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.803 0.335 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.7 p -135.47 96.48 3.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.1 t -150.17 160.91 43.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -86.37 161.92 18.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.889 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -159.92 137.83 10.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -70.93 138.49 50.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 75.8 m -100.94 142.03 32.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.865 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -145.34 176.71 9.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.2 p -88.37 167.1 13.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.8 m -102.15 20.03 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.356 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.949 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.802 0.334 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -70.68 -31.73 68.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -99.57 86.75 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.88 -170.98 24.3 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.509 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.23 46.59 1.15 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.541 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -102.21 134.88 44.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.4 pt -127.63 177.15 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.5 mt -128.96 96.04 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.07 159.3 34.57 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -55.94 169.08 1.5 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.585 2.19 . . . . 0.0 112.27 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.25 -26.06 30.34 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.579 2.186 . . . . 0.0 112.369 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.28 -31.15 67.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.015 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.32 -43.86 96.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.42 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 3.3 tp -70.82 -32.3 69.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.75 -25.75 44.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.035 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.04 -30.99 13.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.965 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.8 mt -60.47 -49.62 76.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.112 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.53 -31.47 69.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.068 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -70.5 -22.82 62.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.122 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.3 mt -94.78 20.06 9.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.193 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.67 35.58 25.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.863 0.363 . . . . 0.0 110.961 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.4 HG23 HD12 ' A' ' 58' ' ' ILE . 31.1 mt -100.94 124.89 54.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.59 170.4 8.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.808 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.429 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.5 t80 -65.46 140.6 97.69 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.837 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 72.1 Cg_endo -77.15 167.15 80.51 Favored 'Cis proline' 0 C--N 1.349 0.566 0 C-N-CA 123.53 -1.446 . . . . 0.0 112.393 0.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.7 mtt -131.74 69.03 1.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -82.15 148.8 28.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -118.34 142.65 47.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.422 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 10.8 tttt -97.13 107.67 20.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.4 mt -89.65 99.71 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.0 103.02 12.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.95 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -67.7 129.27 39.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -97.66 38.26 1.3 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.61 -47.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.974 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m -106.31 13.42 28.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.296 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 53.87 30.66 11.83 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.77 0.319 . . . . 0.0 111.13 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -82.66 161.53 22.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.64 117.98 3.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.0 t -143.68 156.02 44.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.933 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.422 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 13.8 m80 -122.79 112.92 18.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 24.2 p -106.35 168.09 9.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.3 139.04 13.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.583 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.418 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 12.3 p -81.1 151.48 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 0.0 111.051 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.9 tp -129.09 -61.91 1.02 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -113.59 169.45 8.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CD2' ' HB2' ' A' ' 50' ' ' LEU . 47.6 m-85 -138.75 75.16 1.5 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.852 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 m -142.51 32.48 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.154 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.03 161.9 14.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.054 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.04 158.26 23.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -60.1 132.77 54.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.24 28.2 73.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.526 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.5 mt -147.98 127.18 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.835 0.35 . . . . 0.0 111.136 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 83.1 m -132.39 127.34 35.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -94.15 134.12 36.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.1 mp -142.0 159.96 57.19 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.86 -177.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.554 2.169 . . . . 0.0 112.326 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -97.92 -31.64 12.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.419 ' CH2' ' HE3' ' A' ' 95' ' ' MET . 45.4 p-90 -67.48 -34.8 77.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.965 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.419 ' HE3' ' CH2' ' A' ' 94' ' ' TRP . 6.4 tpp -79.1 -32.0 44.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 44.9 mmm -67.59 -31.35 71.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -37.03 22.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -59.97 -31.73 70.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.9 mt -91.62 -16.81 26.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.276 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.3 mt 65.19 33.7 9.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.827 0.346 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.7 mt -79.8 -178.52 6.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.89 175.77 8.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.901 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.9 101.13 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.85 43.03 7.4 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.564 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.85 128.96 9.19 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.54 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.3 mt -79.38 126.87 31.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.93 139.66 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -63.75 110.61 2.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.2 t -101.07 136.9 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.147 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -134.62 164.32 27.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.3 p -123.38 110.88 15.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.89 148.6 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.152 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -104.22 100.03 9.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.804 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.7 mt -96.21 178.44 5.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -120.44 169.65 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.3 m -64.02 146.15 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.033 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.87 149.59 21.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.045 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 75.4 p -114.23 -37.28 4.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -123.65 111.57 16.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.7 m -128.15 122.51 32.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -102.1 132.32 48.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.412 ' CG ' HD21 ' A' ' 139' ' ' LEU . 90.7 m-85 -119.02 161.6 19.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -150.76 93.02 3.79 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.27 117.86 3.51 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.545 2.164 . . . . 0.0 112.34 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -67.09 -33.19 74.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.908 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.73 146.31 33.46 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.61 -14.91 24.67 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.612 2.208 . . . . 0.0 112.541 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -55.05 -34.19 63.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.104 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.412 ' CE1' ' HB3' ' A' ' 135' ' ' PRO . 22.6 t80 -73.68 -36.06 65.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.0 mt -63.27 -31.77 73.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -62.73 -23.09 67.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.071 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 48.9 mt -59.94 140.06 18.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.001 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.0 t -69.7 -30.96 68.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -133.12 67.26 77.09 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.989 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.412 ' HB3' ' CE1' ' A' ' 129' ' ' PHE . 37.3 Cg_exo -57.23 -34.0 97.02 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.634 2.223 . . . . 0.0 112.22 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.81 -44.77 92.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.86 -45.03 91.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.079 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.5 t -63.87 -39.89 87.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.419 HD23 ' CZ ' ' A' ' 188' ' ' PHE . 21.5 tp -67.02 -35.91 80.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -76.78 -32.06 57.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -65.42 -33.05 75.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.27 -35.13 28.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.155 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.7 mt -60.26 -30.0 69.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -58.71 -30.48 67.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -83.04 -34.62 26.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.93 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -66.14 136.15 55.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -99.08 -29.2 13.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.153 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -138.05 164.56 28.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.964 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.6 mt -141.65 154.31 45.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 15.5 m -144.71 141.71 29.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 37.9 m -72.72 119.61 17.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 90.7 43.51 4.81 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.523 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -131.14 122.88 27.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.745 0.307 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.23 84.96 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.055 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.4 pt -77.78 110.45 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.166 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.81 139.56 37.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.083 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 37.0 pt -128.44 144.34 38.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.175 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -138.45 142.68 39.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.792 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -167.45 -48.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.044 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -95.52 41.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 58.11 30.27 19.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.932 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -148.02 122.29 9.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.904 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.7 mp -81.42 89.12 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.125 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -67.53 166.15 15.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.83 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -117.15 137.82 52.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.27 149.2 29.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -138.73 129.59 26.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.12 113.24 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.188 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.6 mmt -68.0 -59.93 2.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -144.93 166.07 26.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 77.2 p -154.49 161.12 41.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -138.56 156.8 73.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.33 -18.48 17.88 Favored 'Cis proline' 0 C--N 1.347 0.487 0 C-N-CA 123.312 -1.537 . . . . 0.0 112.589 0.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -133.38 169.88 16.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.902 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -43.48 82.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.934 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -96.55 117.67 31.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 15.7 m -139.56 151.18 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.214 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 23.3 t -105.54 92.12 4.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.829 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.3 pt -87.48 83.4 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.198 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.2 mt -112.88 96.55 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.042 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.49 81.94 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.823 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 11.0 t -169.5 149.44 3.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.843 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.99 127.85 41.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -132.97 149.43 52.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -78.03 87.87 4.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.843 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.01 136.93 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -114.14 174.11 6.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . 0.419 ' CZ ' HD23 ' A' ' 139' ' ' LEU . 15.6 m-85 -139.41 155.48 47.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.955 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -150.55 91.0 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.056 -179.948 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.864 0.364 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.1 p -121.13 109.08 14.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.0 t -174.55 162.3 3.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -91.34 150.17 21.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -145.31 136.59 24.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.6 mtt180 -68.91 141.55 54.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.0 m -101.37 134.62 44.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.416 ' CD2' HG21 ' A' ' 88' ' ' ILE . 8.8 m-85 -146.89 138.49 24.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 76.0 p -66.76 138.32 57.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.2 m -59.39 -27.18 36.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.227 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.034 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.762 0.315 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -31.99 71.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -78.31 -46.92 18.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.936 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.59 162.83 19.74 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.438 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.83 30.04 10.73 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.542 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -94.64 174.05 7.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.824 0.345 . . . . 0.0 110.891 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.2 pt -146.7 165.51 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.096 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mt -116.49 106.04 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.066 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 71.6 mtp -97.39 160.53 28.61 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.01 162.81 2.44 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.57 2.18 . . . . 0.0 112.301 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.4 -25.94 35.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.582 2.188 . . . . 0.0 112.348 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.4 t -58.86 -30.82 68.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.99 -32.79 73.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.088 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.1 tp -60.23 -33.18 71.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -89.1 -30.43 18.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.957 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -41.5 70.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.974 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.1 mt -54.11 -30.82 50.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.061 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.05 -28.62 17.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -23.17 57.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.7 mt -93.12 17.41 10.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.317 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 54.96 32.46 18.09 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.784 0.326 . . . . 0.0 111.171 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.6 mt -96.27 153.54 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.119 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.19 175.42 11.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.431 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 3.2 t80 -63.36 139.0 97.51 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.431 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.9 Cg_endo -76.6 162.1 92.43 Favored 'Cis proline' 0 C--N 1.348 0.55 0 C-N-CA 123.492 -1.462 . . . . 0.0 112.371 -0.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.1 mtt -130.48 65.17 1.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.1 mt -87.69 139.66 30.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -113.1 142.65 45.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.411 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 1.0 OUTLIER -99.01 108.38 21.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.4 mt -95.68 90.63 5.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.4 m -95.8 121.73 37.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -82.01 128.53 34.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.946 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.7 31.4 2.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -120.04 -42.08 2.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.94 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.29 22.47 7.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 54.49 39.83 31.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.093 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.7 159.0 15.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.922 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -150.61 139.69 21.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.2 t -158.03 148.24 20.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.932 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.411 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 66.5 m80 -115.29 115.41 26.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.978 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.8 p -124.74 167.09 15.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.74 165.23 13.44 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.419 HG23 ' CE1' ' A' ' 82' ' ' PHE . 12.0 p -95.2 141.72 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.859 0.361 . . . . 0.0 111.09 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.5 tp -119.25 -60.63 1.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -107.03 161.94 14.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.971 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CE1' HG23 ' A' ' 79' ' ' VAL . 90.0 m-85 -129.7 47.95 2.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.828 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 m -123.38 35.43 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.007 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.52 154.86 18.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.051 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.47 149.63 33.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.846 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -59.99 110.51 1.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.97 -22.7 36.78 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.643 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.416 HG21 ' CD2' ' A' ' 23' ' ' PHE . 25.7 mt -99.05 121.82 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 111.139 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 28.5 t -110.41 130.52 55.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -93.23 143.16 26.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.99 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 mp -144.89 156.54 55.43 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.07 -174.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.538 2.159 . . . . 0.0 112.283 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.69 -37.93 10.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.893 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 53.7 p-90 -61.36 -39.47 90.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.2 ttp -65.86 -40.01 91.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -37.98 86.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.82 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -74.06 -38.21 64.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.819 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -65.96 -42.01 90.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.2 mt -83.23 -16.87 44.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.204 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt 62.31 36.84 14.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.777 0.323 . . . . 0.0 110.9 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.7 mt -84.94 -177.42 6.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -134.42 168.63 18.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.06 91.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.84 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.411 ' HA2' ' CE2' ' A' ' 23' ' ' PHE . . . 106.68 43.74 1.4 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.487 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.08 123.62 7.88 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.531 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.9 mt -72.94 131.21 41.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.809 0.338 . . . . 0.0 110.951 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.72 150.49 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.002 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -72.11 143.37 49.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.36 108.62 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.134 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.49 123.74 34.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.922 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.5 p -81.49 121.78 26.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.4 m -125.94 155.07 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.57 100.81 9.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.776 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.8 mt -98.6 178.92 4.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -115.71 170.8 8.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 m -70.36 135.03 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.09 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.28 145.45 43.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.8 p -111.53 -31.95 6.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.914 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -129.53 110.3 11.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 93.5 p -122.58 119.0 29.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -106.17 130.87 53.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -117.86 158.81 24.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -143.05 97.93 5.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.57 110.89 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.442 2.094 . . . . 0.0 112.47 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -63.42 -31.4 72.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.1 m -114.33 149.03 41.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.94 -14.87 32.62 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.618 2.212 . . . . 0.0 112.584 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -55.59 -35.65 66.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.053 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -75.53 -42.98 51.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.916 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.07 -31.2 69.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.951 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.83 -28.19 69.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.002 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.8 mt -62.74 137.31 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.093 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.3 t -68.95 -34.28 75.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -119.51 77.31 19.5 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.86 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.38 -28.31 22.45 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.619 2.212 . . . . 0.0 112.285 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -70.35 -46.67 63.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.15 -31.19 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.157 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 26.3 t -78.78 -31.53 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.095 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.5 tp -84.5 -34.75 23.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -70.85 -30.44 66.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.976 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -73.43 -31.63 63.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.17 -31.64 64.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.118 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 82.2 mt -59.4 -30.44 68.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.5 mmp_? -62.42 -26.65 68.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -95.97 26.72 3.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.091 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -135.84 152.65 51.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.835 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.13 -34.25 6.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 6.8 t -141.78 158.91 43.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.965 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.93 137.27 36.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.876 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.67 149.4 40.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 43.8 m -69.49 104.8 2.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.82 33.3 3.57 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.552 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.35 111.8 24.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.759 0.314 . . . . 0.0 110.928 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.53 79.95 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.075 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 3.2 pt -63.79 159.07 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.152 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -125.05 93.0 3.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.085 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.0 pt -85.53 152.72 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.184 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -154.85 140.89 18.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -161.89 -47.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.97 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -93.75 45.19 1.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 55.65 29.48 13.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.086 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -149.34 122.19 8.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.868 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.3 mp -85.12 108.53 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -80.1 173.78 12.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -123.95 110.07 14.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.31 117.52 21.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.826 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -111.14 133.22 53.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.5 127.16 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.087 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 23.9 mmm -85.6 -54.71 4.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -142.73 160.19 40.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.952 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.6 p -159.08 146.47 17.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.909 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -129.07 159.86 66.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.95 -41.39 0.97 Allowed 'Cis proline' 0 C--N 1.347 0.48 0 C-N-CA 123.238 -1.567 . . . . 0.0 112.366 -0.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -106.29 172.43 6.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -57.86 -48.71 79.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.061 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -93.29 110.8 22.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.001 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 15.4 m -118.72 133.64 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.167 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 22.2 t -89.73 99.95 12.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.5 pt -94.08 87.26 2.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.249 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.2 mt -118.29 84.59 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.052 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.36 75.35 0.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 49.6 t -153.27 153.99 33.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.903 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.83 129.73 40.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 13.0 ptt? -140.21 179.23 6.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.869 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.45 112.63 25.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.81 127.52 44.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.7 171.81 7.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.878 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -134.74 141.89 46.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -111.75 83.23 1.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.121 179.971 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 t80 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.91 0.386 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.0 p -160.03 112.8 2.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.1 t -176.86 159.46 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.935 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -95.94 121.85 38.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.814 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -115.48 147.41 40.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -75.17 129.54 37.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.6 p -99.01 133.33 43.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.972 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.417 ' CD2' HG22 ' A' ' 88' ' ' ILE . 87.4 m-85 -136.3 178.45 7.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.66 146.07 27.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.1 m -58.41 -26.15 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.257 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.042 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.4 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.866 0.365 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -78.03 -31.06 50.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -78.53 -31.22 47.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.67 -178.57 20.14 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.564 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.75 53.24 0.63 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.544 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -114.74 165.04 13.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.851 0.357 . . . . 0.0 110.852 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.1 pt -133.38 174.4 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mt -125.51 98.39 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.414 ' HE2' ' CZ ' ' A' ' 64' ' ' PHE . 3.9 mtm -98.54 155.51 36.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.782 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.71 154.9 40.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.581 2.188 . . . . 0.0 112.211 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.8 -26.42 17.71 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.619 2.213 . . . . 0.0 112.566 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.6 p -58.79 -31.19 68.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.973 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.14 -30.26 69.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.261 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.417 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 33.8 tp -74.69 -30.14 61.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.998 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.18 -33.91 19.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.914 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.73 -38.88 62.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.0 mt -59.1 -32.84 70.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.043 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -86.98 -30.06 21.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -22.61 62.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.12 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.1 mt -93.93 19.19 9.31 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.244 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 55.12 30.47 14.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.871 0.367 . . . . 0.0 111.14 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.7 mt -99.03 120.81 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.098 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -109.59 168.35 9.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.965 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.441 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -60.17 144.58 87.02 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.89 158.27 96.89 Favored 'Cis proline' 0 C--N 1.348 0.5 0 C-N-CA 123.485 -1.464 . . . . 0.0 112.344 0.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 9.5 mtt -123.7 73.52 1.2 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 mt -91.26 134.9 34.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.853 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.414 ' CZ ' ' HE2' ' A' ' 45' ' ' MET . 80.8 m-85 -102.8 141.3 35.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.401 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 13.5 tttp -94.97 97.6 10.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.4 mt -76.98 76.83 3.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 m -83.16 95.55 8.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -74.79 129.44 37.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.933 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -98.14 35.58 1.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -111.63 -35.66 5.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.841 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.1 t -151.94 29.72 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.973 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 58.72 35.83 24.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.002 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -81.82 143.31 31.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.929 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -144.22 135.02 25.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 t -159.97 95.25 1.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.401 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 62.0 m80 -63.68 115.75 5.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.0 p -121.91 151.31 40.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.37 138.91 15.06 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.519 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.3 146.82 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 111.066 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.9 tp -131.29 -56.65 1.02 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -91.76 142.85 27.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.841 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.417 ' CD2' ' HB2' ' A' ' 50' ' ' LEU . 71.8 m-85 -128.3 55.62 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 m -137.07 35.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.177 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.11 161.89 13.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.109 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.62 155.53 38.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.91 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.46 127.37 31.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.948 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.35 27.69 65.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.558 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.417 HG22 ' CD2' ' A' ' 23' ' ' PHE . 29.8 mt -148.75 99.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 111.072 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 13.7 m -100.9 134.85 43.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.32 151.35 22.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.1 mp -145.29 155.59 54.17 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.894 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.28 -176.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.528 2.152 . . . . 0.0 112.355 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -87.51 -50.67 6.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.944 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -61.96 -37.53 85.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.856 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -38.26 90.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -47.22 70.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.801 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -38.08 89.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.814 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -59.55 -31.28 69.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.3 mt -98.82 -15.25 19.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.234 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.9 mt 61.7 41.25 12.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 0.0 110.872 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mt -79.33 159.04 27.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.828 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -111.13 -178.95 3.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.869 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.53 106.42 1.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.951 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.415 ' HA2' ' CZ ' ' A' ' 23' ' ' PHE . . . 85.8 33.77 14.93 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.545 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.74 136.03 17.48 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.52 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 34.5 mt -88.6 128.86 35.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.11 146.97 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.156 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -69.16 128.87 38.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.17 99.02 6.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.087 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -124.09 128.48 49.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.4 p -88.78 100.49 13.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 m -103.43 162.09 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.126 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -97.05 116.44 29.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 65.2 mt -115.4 170.78 8.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -127.4 164.56 21.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.926 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.2 m -62.65 140.47 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.63 148.11 37.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.124 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.9 p -105.0 -36.09 7.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.824 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -127.61 109.63 11.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 m -108.9 126.57 53.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -124.41 134.17 53.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.8 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -127.88 159.32 35.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -137.06 95.31 12.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.62 107.33 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.581 2.188 . . . . 0.0 112.347 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -59.27 -31.22 68.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.0 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.84 146.6 35.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.98 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.53 -16.02 27.37 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.63 2.22 . . . . 0.0 112.515 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.22 -42.6 73.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.009 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -60.21 -40.95 91.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.5 -28.33 69.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -60.68 -24.4 65.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.992 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 50.7 mt -62.72 136.9 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.986 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 31.5 m -59.06 -40.2 84.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -131.63 86.93 47.53 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.77 -28.03 25.7 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.528 2.152 . . . . 0.0 112.272 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -63.34 -31.16 72.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.3 -32.7 49.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.131 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.37 -30.83 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.179 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.417 HD23 ' CZ ' ' A' ' 188' ' ' PHE . 46.5 tp -75.16 -30.39 60.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -85.54 -38.83 18.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.014 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -65.3 -23.98 67.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.25 -33.39 61.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.291 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 23.3 mt -63.65 -22.88 67.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.163 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -29.25 40.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.123 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -87.08 -29.71 21.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.981 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -88.28 140.6 29.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -103.44 -30.37 10.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 4.4 t -131.64 163.56 27.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.8 mt -141.15 164.78 29.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.23 129.09 13.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 52.3 m -59.95 110.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 98.41 51.61 1.42 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.539 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.23 130.25 28.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 110.866 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.5 107.07 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.069 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.3 pt -105.09 106.08 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.144 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.42 127.07 32.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.088 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 36.9 pt -118.8 148.39 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.076 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -146.7 134.56 21.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -149.73 -47.42 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.907 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -100.42 44.31 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.85 30.36 19.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.88 115.93 9.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 mp -81.11 86.59 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.09 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -66.9 158.4 30.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.44 136.19 50.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.954 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.3 mt -145.6 154.22 41.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -144.22 125.21 14.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.7 104.47 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -51.5 51.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.64 164.23 37.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.97 142.17 13.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 39.4 mttt -118.55 157.48 49.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.2 -27.08 8.82 Favored 'Cis proline' 0 C--N 1.347 0.453 0 C-N-CA 123.268 -1.555 . . . . 0.0 112.355 0.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.98 174.1 8.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.852 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -57.66 -45.23 85.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.51 111.55 23.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.055 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.7 m -128.63 140.7 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 3.9 t -97.76 87.69 4.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.1 pt -83.63 82.95 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.1 mt -117.97 89.31 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.161 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.84 88.36 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.07 173.56 12.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.838 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.41 120.09 39.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -135.32 174.04 11.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.837 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -105.24 97.74 7.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.947 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.95 145.45 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.04 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -127.38 169.75 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . 0.417 ' CZ ' HD23 ' A' ' 139' ' ' LEU . 7.0 m-85 -127.42 143.14 51.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.947 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -134.94 97.73 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.916 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.137 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.799 0.333 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.7 p -151.21 110.43 3.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 t -168.55 171.05 9.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -95.7 126.65 41.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -125.09 143.05 51.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.3 mtt-85 -66.73 144.79 56.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.008 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.6 p -114.92 120.95 41.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.955 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -127.45 177.0 7.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.975 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -91.54 153.36 19.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.24 -28.3 40.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.144 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.088 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.851 0.358 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.81 20.15 10.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -118.22 -38.05 3.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.957 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.34 -154.25 26.33 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.456 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.38 87.73 0.45 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.51 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.0 149.91 31.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.791 0.329 . . . . 0.0 110.843 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.4 pt -138.14 175.52 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.189 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 mp -129.77 111.22 21.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.092 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 1.4 mtm -105.33 161.0 24.12 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.38 154.01 12.28 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.577 2.185 . . . . 0.0 112.267 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.93 -34.9 68.76 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.563 2.175 . . . . 0.0 112.278 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.81 -29.75 68.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.63 -46.57 86.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.182 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.402 ' HB2' ' CD1' ' A' ' 82' ' ' PHE . 41.3 tp -61.93 -42.65 99.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.956 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.98 -38.92 76.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -31.62 68.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.811 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.4 mt -63.6 -37.65 88.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.71 10.66 25.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.308 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.5 -25.6 9.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.713 0.292 . . . . 0.0 110.969 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.0 mt -94.48 20.15 8.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.313 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.84 40.12 19.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.889 0.375 . . . . 0.0 111.004 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.475 HG23 HD13 ' A' ' 58' ' ' ILE . 20.1 mm -95.12 127.56 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.097 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.47 158.91 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.909 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.43 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -66.37 143.04 98.08 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.43 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.9 Cg_endo -76.81 160.19 95.24 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 123.468 -1.472 . . . . 0.0 112.364 0.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.6 mtt -112.46 53.7 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.3 mt -74.68 120.73 20.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.9 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -85.57 168.62 14.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -121.75 102.08 7.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.0 mt -85.76 105.02 15.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.958 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.1 m -104.1 101.84 11.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -77.84 123.32 26.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -98.87 31.56 2.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -129.52 -45.93 1.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.2 m -113.48 15.24 19.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.257 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 53.22 32.29 13.12 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.811 0.338 . . . . 0.0 111.134 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.1 mmt-85 -86.53 151.34 23.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.96 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.3 ttt -149.13 107.46 3.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.815 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.7 t -130.29 163.61 26.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.419 ' CE1' ' HB1' ' A' ' 176' ' ' ALA . 52.0 m80 -122.14 105.46 10.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.7 p -98.27 175.59 6.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.941 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -137.68 139.27 10.3 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.488 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.6 p -82.57 149.97 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 111.03 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.4 tp -136.43 -59.08 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.953 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -92.41 160.57 15.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 96.6 m-85 -142.18 68.59 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.94 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.9 m -150.96 31.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.156 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.04 179.99 7.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -95.39 156.64 16.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -59.93 121.19 11.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.961 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.75 28.06 63.74 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 29.5 mt -146.93 107.79 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 111.165 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 89.0 m -108.35 133.03 53.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -90.67 134.35 34.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 mt -136.63 149.94 68.71 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.878 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.48 -172.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.528 2.152 . . . . 0.0 112.34 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -96.73 -41.34 8.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.942 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.444 ' CD2' ' N ' ' A' ' 95' ' ' MET . 65.2 p-90 -61.32 -44.07 97.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.924 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.444 ' N ' ' CD2' ' A' ' 94' ' ' TRP . 31.8 ttm -69.21 -38.19 78.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.982 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -31.39 72.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -85.06 -39.92 17.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -59.91 -34.21 72.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.824 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.1 mt -90.02 -12.93 37.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.219 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.5 mt 62.36 38.7 12.85 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.822 0.344 . . . . 0.0 110.873 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.4 mt -82.89 178.89 7.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -136.24 -179.94 5.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.07 127.51 33.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.84 28.25 73.23 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.532 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -84.93 131.77 10.64 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.501 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.5 mt -84.57 125.15 32.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.772 0.32 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.07 137.02 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.066 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.44 119.36 11.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.72 153.03 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -156.57 159.46 38.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.43 116.74 31.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.58 158.51 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.078 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -113.06 111.55 22.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.3 mt -106.49 170.25 8.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -126.44 167.78 15.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.1 m -57.76 159.26 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.259 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -98.96 153.03 19.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.048 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.0 t -111.08 -30.97 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -143.56 105.66 4.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.849 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 m -111.97 140.64 46.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -119.94 126.75 51.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.964 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -117.73 154.35 31.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -135.5 95.22 14.59 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.86 110.72 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.515 2.143 . . . . 0.0 112.39 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -62.98 -34.57 77.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 m -106.98 147.7 35.59 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.949 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.22 -19.14 26.22 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.572 2.181 . . . . 0.0 112.417 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -55.35 -36.21 66.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.072 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -69.66 -45.34 68.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 25.8 mt -60.59 -32.96 72.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.834 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.82 -27.72 69.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.989 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 37.0 mt -60.98 131.0 25.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.981 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.2 t -63.03 -42.15 99.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.942 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.44 78.65 3.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.884 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.39 -29.89 16.16 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.593 2.195 . . . . 0.0 112.352 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -65.52 -31.11 72.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.99 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.6 -49.86 17.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.084 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.411 HG12 ' CZ ' ' A' ' 159' ' ' TYR . 21.5 t -62.53 -31.05 50.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.089 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 42.4 tp -79.8 -37.49 35.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -80.26 -30.57 38.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -67.18 -30.76 70.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.18 -29.59 20.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 16.3 mt -58.49 -29.9 66.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.954 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -59.24 -32.62 70.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -74.74 -31.21 61.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.967 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -81.98 146.63 29.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -106.59 -29.55 9.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.083 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 3.9 t -136.98 164.97 27.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.3 mt -140.64 173.93 11.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 63.5 m -155.5 143.65 20.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.8 t -81.53 104.52 12.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.98 36.89 2.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.421 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -131.37 146.27 52.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 0.0 110.872 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.61 108.35 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.9 pt -109.41 120.89 61.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.182 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.63 138.95 38.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.2 pt -126.66 137.23 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.073 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -143.99 145.87 32.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.959 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.411 ' CZ ' HG12 ' A' ' 138' ' ' VAL . 7.3 p90 -158.01 -47.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -108.76 43.99 1.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 61.11 31.69 19.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -137.91 99.85 4.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.9 mp -76.51 96.72 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.112 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.76 128.62 34.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.871 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -81.29 131.97 35.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.37 154.0 45.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -149.17 114.58 5.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.8 151.88 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.101 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.3 mmt -118.05 -43.98 2.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.943 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -145.81 157.81 43.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.2 p -157.61 140.24 14.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -119.5 152.51 53.1 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.885 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.56 -27.63 8.37 Favored 'Cis proline' 0 C--N 1.346 0.446 0 C-N-CA 123.343 -1.524 . . . . 0.0 112.453 -0.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.68 173.62 6.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -46.39 85.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.967 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.419 ' HB1' ' CE1' ' A' ' 76' ' ' HIS . . . -98.79 121.46 40.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.066 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.38 132.42 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.065 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 24.8 p -82.17 94.83 7.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.806 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.3 pt -81.94 82.46 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.148 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 4.5 mt -114.98 83.62 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.995 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.26 85.08 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 8.0 t -165.03 142.05 5.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.58 116.26 26.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -125.01 177.77 5.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.942 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -102.2 120.06 39.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.32 129.48 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.119 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -108.43 172.05 7.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -141.62 133.86 27.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -117.07 95.52 5.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.084 179.919 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.844 0.355 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.9 p -141.08 114.95 9.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.6 t -176.93 170.13 2.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.831 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -97.25 157.0 16.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.819 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -150.62 147.61 27.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.838 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.0 mtp85 -72.47 124.34 24.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.3 p -92.72 127.21 38.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -135.44 143.37 45.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.2 t -59.75 169.23 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.969 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.5 m -96.03 20.2 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.332 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 C--N 1.331 -0.227 0 CA-C-O 120.807 0.337 . . . . 0.0 110.823 179.935 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.814 0.34 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -70.79 -36.58 73.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -95.26 82.04 3.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.97 142.8 5.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.446 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -66.15 77.76 0.12 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.513 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.68 117.87 19.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 0.0 110.832 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.3 pt -112.5 170.53 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.101 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.2 mt -119.5 120.3 63.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.052 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 85.7 mtp -112.88 154.38 44.92 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.11 153.2 16.64 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.57 2.18 . . . . 0.0 112.31 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.92 -28.74 40.69 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.466 2.111 . . . . 0.0 112.304 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.0 p -64.38 -29.11 70.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.995 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.61 -36.4 71.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.249 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.412 HD13 ' CE1' ' A' ' 82' ' ' PHE . 8.2 tp -71.08 -45.78 63.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.938 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -68.94 -31.21 69.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -73.64 -50.64 20.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.976 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.4 mt -63.45 -35.38 80.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.2 p -77.21 -29.84 54.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.978 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.49 -20.44 47.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.9 mt -94.46 19.22 9.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.283 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.1 t30 54.88 32.22 17.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.189 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.7 mt -91.87 112.91 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.15 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.8 p -99.33 169.91 9.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.939 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.439 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -65.07 143.03 98.79 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.439 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 77.1 Cg_endo -77.34 169.02 75.15 Favored 'Cis proline' 0 C--N 1.348 0.502 0 C-N-CA 123.477 -1.468 . . . . 0.0 112.462 0.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.5 mtt -130.08 38.72 3.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.912 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.15 137.12 58.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.966 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.408 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 39.9 m-85 -100.24 160.57 14.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.414 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 13.9 tttt -109.7 84.32 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.88 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.7 mt -69.62 75.18 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.783 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.76 103.39 6.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.981 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.54 118.22 13.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.915 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.96 33.58 2.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -131.62 -46.1 0.97 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 63.0 m -111.87 15.43 20.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.341 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.61 38.93 29.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.843 0.354 . . . . 0.0 111.084 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.46 163.07 12.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.0 ttp -150.13 114.1 5.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.847 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.5 m -134.9 141.64 46.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.994 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.425 ' CE1' ' CB ' ' A' ' 176' ' ' ALA . 42.9 m80 -108.67 118.53 37.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.944 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 28.2 p -128.86 145.97 51.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.928 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.96 138.92 14.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.499 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.37 148.12 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.852 0.358 . . . . 0.0 111.107 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.2 tp -113.59 -66.58 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -114.01 172.34 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.988 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.412 ' CE1' HD13 ' A' ' 50' ' ' LEU . 76.8 m-85 -133.39 66.45 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.853 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.4 m -137.2 31.75 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.165 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.64 178.63 5.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.134 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -96.58 156.46 16.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -60.9 124.19 19.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.97 28.57 62.3 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.487 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.6 mt -146.93 87.99 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 0.0 111.088 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 96.7 m -94.32 120.0 33.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -84.6 146.33 27.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.925 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.64 160.07 52.03 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.69 -174.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.568 2.179 . . . . 0.0 112.325 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -98.9 -31.46 11.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.986 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -72.31 -38.58 68.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 36.8 ttm -64.52 -35.69 81.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -61.53 -48.77 79.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.873 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -61.83 -42.69 99.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -59.98 -50.24 74.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.2 mt -76.08 -20.62 57.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.5 mt 63.23 44.03 5.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.414 . . . . 0.0 110.815 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mt -86.52 -175.75 5.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.869 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -127.25 172.37 10.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -70.0 78.8 0.49 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.1 35.96 1.07 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.441 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.66 150.17 20.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.451 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.1 mt -92.2 124.6 36.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.938 0.399 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.12 132.4 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.11 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.97 111.17 2.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.408 ' CG1' ' CD1' ' A' ' 64' ' ' PHE . 19.7 t -105.56 128.73 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.09 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -145.18 118.52 8.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.7 p -69.86 123.02 20.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.96 168.98 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -131.31 116.17 17.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.85 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 mt -115.76 179.42 3.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.85 174.63 5.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.3 m -64.88 172.36 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.102 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -105.81 153.2 22.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 38.5 p -113.48 -36.36 4.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -131.98 97.52 4.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 94.9 p -101.43 109.92 21.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -98.65 119.45 37.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -113.68 147.76 37.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.847 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.49 89.86 51.23 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -51.66 102.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.553 2.169 . . . . 0.0 112.288 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -59.48 -30.78 68.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.969 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.5 m -109.79 145.91 32.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.933 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.8 -16.3 23.53 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.588 2.192 . . . . 0.0 112.555 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -55.17 -33.45 62.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.138 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -77.11 -40.33 46.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.917 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 39.5 mt -64.89 -30.61 71.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.48 -25.13 67.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.026 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 23.1 mt -60.05 138.25 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.001 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.7 m -65.6 -34.42 78.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.066 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -128.36 72.55 80.19 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.981 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.62 -32.77 91.45 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.617 2.211 . . . . 0.0 112.275 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -60.01 -47.72 84.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.964 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.4 -45.49 90.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.06 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.66 -39.48 81.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.181 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.1 tp -70.9 -41.91 70.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.913 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -68.01 -31.07 70.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -69.14 -31.36 69.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.5 -37.8 35.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.138 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.5 -26.63 68.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.045 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -56.48 -30.37 62.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -82.74 -49.07 10.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.906 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -60.07 152.86 23.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -107.07 -29.21 9.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.138 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.6 m -146.86 167.87 22.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.953 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.1 mt -142.97 170.19 16.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 63.4 m -153.6 136.65 15.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.8 t -60.67 121.02 11.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 91.54 28.96 12.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.546 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.46 126.57 52.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.942 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.6 t -89.38 91.09 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.089 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 4.4 pt -87.55 154.63 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.136 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -129.32 102.36 6.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.6 pt -90.93 147.08 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -140.6 145.86 37.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -176.54 -38.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.999 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -99.2 40.3 1.22 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 56.82 29.28 15.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.033 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.31 110.79 2.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.6 mp -68.47 94.43 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -61.68 145.77 51.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -95.41 132.79 40.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.931 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.01 158.22 41.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -156.91 139.01 14.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.855 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.6 t -80.9 147.85 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 59.6 mmm -117.41 -40.75 3.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.7 151.38 27.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 64.3 p -151.2 149.35 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -122.22 152.87 61.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.35 -27.32 8.62 Favored 'Cis proline' 0 C--N 1.346 0.435 0 C-N-CA 123.281 -1.55 . . . . 0.0 112.389 -0.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -124.5 168.98 12.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.735 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.59 -49.18 75.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.98 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.425 ' CB ' ' CE1' ' A' ' 76' ' ' HIS . . . -92.85 110.73 22.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.033 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.5 m -128.52 148.72 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.19 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.7 95.7 8.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.2 pt -86.97 83.3 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.087 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 28.2 mm -112.73 90.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 61.17 55.29 3.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 6.1 t -135.83 143.27 45.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.19 134.48 41.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.869 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -139.65 164.52 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -78.97 76.25 5.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.785 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 28.6 t -63.3 125.82 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.091 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.32 162.22 16.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -124.17 128.98 50.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -90.97 94.21 9.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.12 179.948 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.1 t80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.819 0.342 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.7 p -154.57 124.34 6.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -175.3 179.34 1.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.952 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -107.07 155.17 20.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -155.23 152.6 29.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.6 mtt-85 -82.86 134.58 35.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.1 m -102.23 128.14 48.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -138.38 175.19 9.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.949 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.5 t -86.19 -179.98 6.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.9 m -95.62 20.08 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.347 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.172 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.78 0.324 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -80.45 -31.34 37.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -83.47 91.19 7.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.87 178.27 15.62 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.55 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.73 31.56 8.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.557 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -89.17 135.53 33.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.81 0.338 . . . . 0.0 110.782 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.8 pt -128.93 167.75 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.166 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.0 mt -120.3 140.81 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.176 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.09 158.13 76.58 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.85 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.79 161.42 3.15 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.524 2.149 . . . . 0.0 112.315 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.83 -25.81 32.82 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.648 2.232 . . . . 0.0 112.302 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.7 p -58.95 -38.4 78.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.979 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.32 -33.11 70.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.214 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.5 tp -62.01 -51.58 67.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.82 -31.19 67.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.41 -43.91 63.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.928 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 mt -58.18 -52.25 66.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -65.25 -29.74 70.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -76.58 -26.04 54.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.02 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.9 mt -94.51 20.09 8.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.227 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 m120 58.24 35.51 25.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.866 0.365 . . . . 0.0 111.058 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.4 mt -102.62 116.74 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 t -114.17 173.56 6.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.444 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -68.1 144.09 96.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.7 Cg_endo -77.08 159.56 95.53 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 123.446 -1.481 . . . . 0.0 112.327 -0.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 19.1 mtt -125.35 59.0 1.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.983 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.93 114.99 14.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.859 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.421 ' CE2' ' HB ' ' A' ' 79' ' ' VAL . 17.3 m-85 -81.68 133.37 35.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.857 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -85.66 93.23 8.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.037 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.9 mt -78.36 76.85 4.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.6 m -90.02 103.17 15.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.9 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -67.14 127.23 31.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -98.92 32.17 2.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.44 -43.84 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 73.4 m -123.56 23.07 8.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 54.43 31.33 14.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.092 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.33 157.82 23.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.826 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.92 131.91 10.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.7 t -159.95 114.3 2.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.964 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.42 ' CD2' HG23 ' A' ' 112' ' ' VAL . 12.0 m80 -79.74 122.99 27.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.0 p -117.29 150.73 38.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.949 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.86 129.36 9.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.417 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.421 ' HB ' ' CE2' ' A' ' 64' ' ' PHE . 10.8 p -69.44 147.36 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 111.094 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -130.41 -59.74 1.02 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.818 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -110.11 146.91 34.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.743 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -113.88 49.52 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.06 79.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.147 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -132.31 173.36 11.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.64 162.93 27.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -66.59 109.92 2.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.02 34.94 54.76 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.483 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 26.8 mt -144.01 91.62 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.81 0.338 . . . . 0.0 111.085 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 97.0 m -80.67 134.52 35.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -99.63 127.38 45.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.19 157.74 76.27 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.849 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.57 -172.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.591 2.194 . . . . 0.0 112.283 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -90.58 -39.02 12.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -69.61 -42.86 73.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.2 ttp -61.08 -31.31 70.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -31.5 61.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.827 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -81.55 -37.13 28.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.894 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -68.62 -45.13 72.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.7 mt -68.83 -23.87 64.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.061 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.8 mt 66.27 48.79 1.57 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.803 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.2 mt -96.36 -176.26 3.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.78 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.31 174.77 10.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -59.85 92.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.02 28.1 7.49 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -70.44 130.0 20.47 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.491 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 64.5 mt -87.82 126.95 35.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.807 0.337 . . . . 0.0 110.927 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.53 156.42 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -79.67 125.01 29.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.35 105.7 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.097 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -125.45 133.56 52.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.8 p -81.92 108.56 15.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.989 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.42 HG23 ' CD2' ' A' ' 76' ' ' HIS . 6.8 m -111.2 156.21 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -107.57 118.04 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.411 HD12 ' CD2' ' A' ' 76' ' ' HIS . 13.1 mt -118.02 157.15 27.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -109.56 169.83 8.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.7 m -64.85 139.82 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.101 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.75 149.33 31.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.3 p -107.33 -37.85 6.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -128.04 125.22 38.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.8 p -129.74 140.23 51.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.023 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -131.23 125.51 33.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.824 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.42 ' CD1' HD23 ' A' ' 139' ' ' LEU . 17.1 m-85 -113.41 147.62 37.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.982 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -131.06 92.44 33.38 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.779 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.18 116.58 2.54 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.561 2.174 . . . . 0.0 112.455 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -73.62 -31.45 63.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -106.8 146.93 34.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.27 -14.77 28.5 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.582 2.188 . . . . 0.0 112.461 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.0 -40.07 75.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.011 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -71.87 -38.44 70.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 84.9 mt -64.95 -31.84 73.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -62.42 -25.62 68.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 32.9 mt -66.01 135.38 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.089 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.2 t -66.93 -37.86 85.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -119.07 75.75 14.73 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.17 -30.27 16.28 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.631 2.221 . . . . 0.0 112.311 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -37.01 84.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.48 -44.33 67.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 29.9 t -63.03 -44.73 99.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.012 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.42 HD23 ' CD1' ' A' ' 122' ' ' PHE . 16.0 tp -69.26 -31.58 70.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.819 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.01 -31.43 62.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.914 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -78.79 -34.28 45.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.861 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.23 -35.7 66.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.8 mt -59.73 -25.73 65.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.983 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 -55.4 -30.57 60.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.09 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.24 -31.21 30.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -71.24 140.53 50.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -101.12 -29.59 12.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.105 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 18.3 t -148.76 158.36 44.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.954 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.1 mt -134.34 150.92 50.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.0 m -128.32 148.51 50.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 26.5 m -76.01 101.72 5.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 103.51 48.17 1.23 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.462 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -134.0 115.16 14.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.792 0.329 . . . . 0.0 110.931 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.3 t -72.54 99.25 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 37.3 pt -97.13 143.91 11.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.157 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -107.97 150.72 26.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.125 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.5 pt -141.15 139.55 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.125 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -127.39 156.66 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -177.43 -47.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -103.02 42.65 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.64 31.04 20.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.915 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.09 126.42 9.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.4 mp -86.9 101.12 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -79.17 123.95 27.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.86 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -87.47 131.48 34.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.5 mt -143.69 147.34 34.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.827 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -127.06 127.73 45.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.14 131.91 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 14.2 mmm -87.57 -55.57 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.28 160.02 42.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 3.0 p -160.07 119.08 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -96.83 155.77 37.27 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.96 -43.18 0.67 Allowed 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.326 -1.531 . . . . 0.0 112.444 0.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.29 174.48 5.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.935 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -59.13 -48.79 80.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.74 113.02 25.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.084 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.54 139.34 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 11.3 t -91.8 98.29 11.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.9 pt -90.91 80.35 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.5 mt -108.41 83.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.08 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 60.94 78.76 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 14.3 t -153.49 148.36 26.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.14 121.91 28.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -144.14 154.04 42.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.16 119.28 19.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.15 109.49 27.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.164 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.8 169.61 9.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -142.12 109.64 5.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -112.01 105.03 13.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.117 179.932 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.416 ' CZ ' HG22 ' A' ' 18' ' ' THR . 7.3 t80 . . . . . 0 CA--C 1.527 0.073 0 CA-C-O 120.789 0.328 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.2 p -159.99 118.4 2.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.416 HG22 ' CZ ' ' A' ' 16' ' ' PHE . 9.7 t -176.33 161.22 2.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.972 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -90.11 143.61 26.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.811 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -144.4 136.41 26.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -71.57 157.86 37.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.6 m -119.96 130.72 54.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.939 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -136.2 166.79 22.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -79.14 138.58 37.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.946 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.3 m -63.6 -19.33 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.288 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.412 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.5 t . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.907 0.384 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -71.85 -38.68 70.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.884 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -84.14 79.54 9.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.74 178.8 32.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.411 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.06 37.87 3.6 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.517 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.5 153.58 21.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.705 0.288 . . . . 0.0 110.872 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.0 pt -139.66 179.95 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.041 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mt -122.51 136.12 60.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.124 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 71.8 mtp -137.75 161.49 59.85 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.81 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.79 146.47 35.55 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.506 2.138 . . . . 0.0 112.335 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.83 -26.89 41.21 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.521 2.147 . . . . 0.0 112.384 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.0 t -58.54 -39.01 78.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.035 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.89 -31.08 70.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.102 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.408 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 58.3 tp -64.68 -51.31 63.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -72.61 -29.5 63.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -50.34 74.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.947 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 mt -56.56 -38.29 71.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.007 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.8 t -75.52 -27.5 58.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -81.54 -25.04 36.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.03 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.4 mt -95.52 19.77 10.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.18 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 53.98 44.88 28.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.86 0.362 . . . . 0.0 111.173 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.3 mt -107.35 130.37 59.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.182 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 p -113.4 170.84 7.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.433 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.3 t80 -61.15 140.35 94.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.815 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.433 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.85 171.34 68.58 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.544 -1.44 . . . . 0.0 112.368 0.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 15.9 mtt -126.31 41.71 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.9 mt -68.97 164.0 23.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.935 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -130.34 153.89 48.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -99.82 91.9 5.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.842 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.43 78.95 2.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.836 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -81.65 99.17 8.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -71.27 120.23 16.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.829 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -98.46 30.56 3.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.994 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.94 -37.43 4.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.846 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.23 23.54 4.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.128 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.01 39.31 31.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 111.113 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.31 172.46 8.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.0 ttp -157.82 124.93 5.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.834 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.0 m -140.17 155.74 46.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -129.56 108.86 10.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.1 p -116.59 149.88 38.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.87 137.68 13.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.545 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.9 p -83.79 134.88 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.782 0.325 . . . . 0.0 111.06 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.5 tp -117.94 -58.01 2.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.32 150.75 19.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.408 ' CD2' ' HB2' ' A' ' 50' ' ' LEU . 65.7 m-85 -132.99 62.83 1.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.3 m -136.15 32.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.164 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.12 158.78 15.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.071 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.54 160.31 30.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -66.98 136.12 54.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.19 28.69 73.85 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.452 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.8 mt -147.82 112.47 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 111.14 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.7 m -114.85 130.5 56.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -92.42 143.25 26.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.935 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 44.0 mt -139.28 147.67 53.9 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.52 169.93 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.57 2.18 . . . . 0.0 112.283 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.53 -38.68 77.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.834 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.405 ' CH2' ' CE ' ' A' ' 95' ' ' MET . 51.0 p-90 -72.58 -31.48 65.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.405 ' CE ' ' CH2' ' A' ' 94' ' ' TRP . 7.4 ttm -74.72 -31.16 61.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 37.7 mmm -76.39 -39.06 54.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -76.63 -38.75 54.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.858 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -59.66 -53.49 57.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.8 mt -71.21 -21.79 62.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 mt 66.99 45.6 1.74 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.892 0.377 . . . . 0.0 110.944 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.1 mt -96.83 149.24 22.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -103.47 -179.19 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.799 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.34 113.5 2.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.35 42.24 8.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.446 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.86 109.51 3.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.536 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.1 mt -73.27 131.88 42.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.01 158.83 36.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.079 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -74.67 122.5 23.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.95 86.9 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.146 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -107.5 135.2 49.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.1 p -75.72 101.49 5.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 19.2 m -113.88 149.3 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.105 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -121.84 117.21 25.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mt -107.81 174.22 5.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.45 164.06 12.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.95 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.1 m -64.69 135.05 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -77.68 152.87 33.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.076 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.3 t -109.55 -31.77 7.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -134.82 106.7 7.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.6 m -122.92 113.39 19.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.946 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -92.38 142.56 27.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.415 ' CG ' HD21 ' A' ' 139' ' ' LEU . 18.1 m-85 -130.43 150.2 51.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -131.79 95.93 21.72 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.8 109.9 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.536 2.157 . . . . 0.0 112.408 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -59.62 -31.78 69.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.998 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 72.4 p -113.38 146.81 36.11 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.958 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.88 -17.8 25.13 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.544 2.163 . . . . 0.0 112.48 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -55.14 -39.84 69.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.023 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -66.41 -46.91 74.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.7 mt -60.31 -30.67 69.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.968 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.3 -25.07 66.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 51.4 mt -62.27 136.92 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.9 m -58.28 -39.62 79.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.992 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -125.59 80.67 65.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.0 -28.63 19.05 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.585 2.19 . . . . 0.0 112.363 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.9 mtpm? -66.73 -44.95 80.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.84 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.89 93.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.038 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.3 t -64.08 -45.25 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.064 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.415 HD21 ' CG ' ' A' ' 122' ' ' PHE . 21.5 tp -67.91 -43.44 79.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.83 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -62.35 -36.37 82.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.807 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -68.82 -29.83 68.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.35 -33.19 69.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 65.9 mt -60.49 -25.77 66.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.059 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.6 mtp-105 -55.16 -30.36 59.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.05 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -89.21 -38.7 14.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -69.08 144.67 53.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -109.39 -26.15 10.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.22 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -140.25 165.14 28.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.968 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 20.8 mt -144.33 129.41 18.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.54 145.47 46.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.876 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.7 m -71.47 123.58 22.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.75 27.69 21.07 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.45 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.82 132.66 53.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.4 t -90.58 89.68 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.084 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 18.4 pt -85.16 132.31 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.081 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -108.05 140.75 40.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.3 pt -125.12 165.26 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.041 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -157.83 150.41 22.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -172.71 -48.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -97.66 41.44 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.94 29.65 19.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.954 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.59 128.12 17.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.801 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 mp -87.83 105.18 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.177 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -82.71 137.44 34.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -90.11 121.73 32.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.001 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.23 141.55 49.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.82 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 -137.24 129.05 28.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.57 132.46 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.7 mmm -94.0 -68.53 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.95 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -123.8 152.91 41.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.5 p -147.24 150.49 34.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -130.68 153.97 81.66 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.64 -31.96 4.92 Favored 'Cis proline' 0 C--N 1.348 0.522 0 C-N-CA 123.264 -1.557 . . . . 0.0 112.45 -0.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.36 171.53 7.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.835 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -40.75 76.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.022 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -102.64 124.47 48.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.081 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.58 153.71 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 23.8 t -104.7 98.01 7.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.4 pt -88.68 84.11 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.207 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.5 mm -111.65 79.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.089 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 59.14 91.0 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.99 156.16 26.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.967 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.19 103.53 15.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.827 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -126.67 170.84 11.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -94.22 113.54 25.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.39 106.85 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.176 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -87.13 159.33 18.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -133.09 133.24 42.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.885 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -121.09 97.37 5.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.087 179.969 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.6 t80 . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.893 0.378 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.0 p -155.23 110.1 2.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.2 t -176.42 168.96 2.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -103.38 146.85 27.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -146.87 147.28 30.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.91 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -84.6 132.08 34.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.9 p -84.82 142.01 30.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -147.0 149.47 33.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.85 168.51 6.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 m -95.82 20.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.374 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 55.1 m . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.019 179.955 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.791 0.329 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -77.2 -30.14 54.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -97.93 33.72 2.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.6 171.51 25.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.553 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.23 28.66 13.02 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.545 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.83 151.2 20.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.805 0.336 . . . . 0.0 110.913 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.9 pt -133.35 165.67 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mt -115.7 96.17 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.138 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 97.1 mtp -88.55 157.8 49.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.8 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -51.83 156.74 6.48 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.571 2.181 . . . . 0.0 112.336 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.71 -27.06 38.57 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.519 2.146 . . . . 0.0 112.318 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.8 p -61.65 -31.67 71.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.87 -31.67 72.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.3 tp -62.27 -34.64 76.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -86.96 -30.54 21.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.0 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.42 -47.25 70.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.5 mt -57.19 -47.48 81.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.077 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 p -64.15 -23.61 67.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.173 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.72 20.11 9.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.355 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -135.83 19.95 3.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.206 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 55.9 33.69 22.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.766 0.317 . . . . 0.0 111.029 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.403 HG21 HD12 ' A' ' 58' ' ' ILE . 31.2 mt -102.78 109.01 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.151 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.4 p -104.51 162.96 12.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.442 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -60.14 144.3 87.29 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.775 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 72.2 Cg_endo -76.71 171.29 68.84 Favored 'Cis proline' 0 C--N 1.347 0.484 0 C-N-CA 123.467 -1.472 . . . . 0.0 112.4 0.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.3 mtt -138.23 78.02 1.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mp -89.55 138.29 31.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -109.78 143.02 40.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.846 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -94.74 99.76 11.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.936 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.7 mt -84.66 78.44 9.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 53.7 m -77.93 111.59 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -74.88 113.96 12.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -88.92 53.9 2.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -145.22 -53.49 0.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.9 m -120.32 25.37 9.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.067 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 t0 55.19 30.44 14.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.112 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.0 mmt-85 -82.3 146.19 29.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.3 ttm -133.12 140.77 47.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.7 t -157.15 143.0 17.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -120.78 114.6 21.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.2 p -113.46 172.73 6.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.46 124.84 4.83 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.539 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.42 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 11.0 p -64.12 141.65 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 0.0 111.09 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.7 tp -134.9 -54.79 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.45 152.09 18.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 72.5 m-85 -135.0 73.86 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.6 m -149.93 35.23 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.164 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.69 178.77 5.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.095 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.69 166.47 12.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.804 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -65.66 90.96 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.807 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 96.73 26.17 10.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.509 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.0 mt -136.08 80.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 111.07 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 57.5 m -78.29 134.7 37.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -102.96 130.91 50.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.848 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 mp -132.69 162.19 58.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.36 -173.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.628 2.218 . . . . 0.0 112.287 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -94.18 -46.65 7.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.41 ' CH2' ' HE2' ' A' ' 95' ' ' MET . 69.7 p-90 -60.01 -39.63 86.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.41 ' HE2' ' CH2' ' A' ' 94' ' ' TRP . 37.4 ttm -62.03 -32.79 73.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.893 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -53.17 18.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -61.91 -38.35 88.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -59.96 -40.97 90.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.792 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.86 -14.46 47.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.281 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.7 mt 61.35 32.95 19.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.9 mt -82.75 162.88 21.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -108.85 173.52 6.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.898 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -60.14 112.55 1.95 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.83 42.65 10.89 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.465 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.11 119.65 5.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.478 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.9 mt -65.57 129.23 39.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.803 0.335 . . . . 0.0 110.847 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.94 149.78 33.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -75.8 124.28 27.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.29 122.87 66.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -144.2 121.87 11.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 71.4 p -72.75 129.35 38.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.4 m -137.69 139.79 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.057 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -101.06 109.37 21.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 mt -103.52 172.01 7.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -116.03 164.72 14.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.7 m -60.82 144.34 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.094 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -88.07 153.3 21.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.124 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.1 p -106.35 -31.32 8.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -133.7 112.64 11.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.9 m -123.35 122.1 37.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.23 146.46 38.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.974 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -125.94 143.94 50.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -126.59 90.24 50.26 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.958 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.81 112.08 0.75 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.583 2.189 . . . . 0.0 112.328 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -65.39 -31.25 72.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.1 p -106.57 146.47 33.12 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.931 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.59 -17.03 23.76 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.597 2.198 . . . . 0.0 112.576 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.02 -44.25 74.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.087 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.409 ' CD2' HD22 ' A' ' 166' ' ' LEU . 20.9 t80 -70.49 -44.67 67.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.869 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.3 mt -59.82 -31.81 70.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -64.4 -24.07 67.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.977 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 60.5 mt -60.02 139.94 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.924 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.0 t -59.11 -44.73 92.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.76 86.76 54.32 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.49 -28.61 21.52 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.585 2.19 . . . . 0.0 112.313 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.418 ' HG3' ' CE1' ' A' ' 188' ' ' PHE . 36.8 mttt -65.49 -35.67 81.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.93 -41.85 77.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.076 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.423 HG13 ' CE1' ' A' ' 159' ' ' TYR . 21.5 t -74.38 -36.8 43.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.075 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 tp -71.42 -37.59 71.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.22 -31.42 65.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.76 -33.02 68.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.899 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.97 -29.19 32.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.7 mt -57.9 -25.97 61.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.057 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -55.59 -30.0 60.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.034 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -80.02 -35.13 37.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.419 ' CE2' HD12 ' A' ' 155' ' ' ILE . 46.2 m-85 -73.92 132.75 42.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -103.1 -27.21 12.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 7.6 t -123.0 161.12 24.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.1 mt -143.78 113.37 7.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.3 m -117.42 136.37 53.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.08 129.35 39.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.918 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 83.4 47.43 5.72 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.53 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.57 110.85 13.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.738 0.304 . . . . 0.0 110.862 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.59 83.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.193 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.419 HD12 ' CE2' ' A' ' 146' ' ' PHE . 1.4 pt -81.67 150.58 4.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -114.59 117.4 30.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.023 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.4 pt -109.1 145.7 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.227 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -148.77 140.67 23.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.882 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 159' ' ' TYR . 1.8 p90 -149.02 -50.17 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -100.81 49.34 0.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 59.05 30.0 19.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.974 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -139.74 105.41 5.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -78.26 88.04 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.144 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -69.58 158.09 35.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.781 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -113.98 135.95 53.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.975 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.409 HD22 ' CD2' ' A' ' 129' ' ' PHE . 3.6 mp -150.4 160.56 43.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.825 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 8.5 ttt-85 -144.77 130.67 19.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.025 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.56 123.53 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.056 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.17 -61.4 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.06 148.08 44.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.991 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 16.6 p -145.92 138.87 25.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -122.19 154.48 61.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.1 -39.08 1.52 Allowed 'Cis proline' 0 C--N 1.347 0.469 0 C-N-CA 123.267 -1.555 . . . . 0.0 112.324 0.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.49 171.64 7.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.81 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.11 -48.1 82.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -93.2 123.42 36.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.062 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.78 152.91 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 4.7 t -106.45 106.5 17.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.0 pt -92.09 86.6 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.176 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 4.8 mt -116.48 81.57 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.015 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 60.36 89.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 2.8 t -162.54 153.18 17.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -80.64 119.57 23.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.5 ptt? -147.83 168.94 20.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -102.07 150.82 22.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.67 106.94 12.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.134 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.16 158.89 15.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.942 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . 0.418 ' CE1' ' HG3' ' A' ' 136' ' ' LYS . 7.2 m-85 -127.53 148.01 50.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.864 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -139.14 97.26 3.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.139 179.934 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.0 t80 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.759 0.314 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.35 122.69 22.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.415 HG23 ' CE2' ' A' ' 20' ' ' TYR . 11.2 t -177.09 163.75 2.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.913 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -86.14 153.34 22.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.415 ' CE2' HG23 ' A' ' 18' ' ' THR . 13.6 m-85 -154.99 156.74 36.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -82.36 149.8 27.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.905 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.8 m -112.36 119.28 37.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -127.65 163.11 24.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.922 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.8 m -81.22 157.55 25.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.9 m -72.57 -30.61 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.974 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.458 -0.031 0 CA-C-O 120.884 0.373 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -94.03 -31.2 14.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.826 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -97.54 95.42 7.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.888 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.94 -145.98 17.37 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.408 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.11 80.44 0.3 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.557 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.36 126.62 17.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.826 0.346 . . . . 0.0 110.872 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.1 pt -118.17 171.01 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.181 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 mp -128.9 106.7 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.94 160.56 25.7 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.962 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.93 161.35 3.32 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.535 2.156 . . . . 0.0 112.28 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.9 -26.39 26.95 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.548 2.165 . . . . 0.0 112.33 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 p -58.86 -31.24 68.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.948 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.45 -36.88 83.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.407 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 44.8 tp -64.86 -38.74 92.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.906 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -77.27 -30.99 54.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.932 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -68.93 -51.3 41.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.9 mt -59.63 -33.13 71.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.5 m -64.24 -30.27 71.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -96.64 20.23 11.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.4 mt -128.57 18.45 6.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.182 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 53.77 30.07 10.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.797 0.332 . . . . 0.0 111.157 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.1 mt -99.59 123.78 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.126 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -119.55 168.79 10.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.429 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -59.93 144.07 86.76 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.89 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 72.7 Cg_endo -77.27 149.8 90.23 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 123.422 -1.491 . . . . 0.0 112.398 0.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 4.6 mtt -115.74 74.88 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mt -88.15 160.37 17.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -127.37 148.28 50.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.837 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.401 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 24.7 tttt -104.11 93.78 5.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.71 80.75 5.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.822 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 m -87.87 95.94 10.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -62.07 123.13 17.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.845 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm -98.31 32.4 2.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -131.93 -46.07 0.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.959 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.0 m -108.66 17.69 21.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.266 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.0 t0 53.16 37.74 25.77 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.848 0.356 . . . . 0.0 111.169 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.1 mmt-85 -96.45 152.4 18.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.4 ttp -149.17 123.21 9.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.795 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 t -148.96 160.54 43.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.992 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.405 ' CD2' HD13 ' A' ' 114' ' ' LEU . 15.1 m80 -125.26 107.87 11.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 24.6 p -104.3 161.16 14.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.957 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.53 143.24 17.97 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.42 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 11.1 p -79.53 144.09 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 111.076 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.6 tp -116.89 -62.99 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.851 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -122.01 -179.65 4.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 49.6 m-85 -140.19 80.12 1.74 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.7 m -141.9 31.28 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.129 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.85 172.51 8.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.062 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.78 162.37 13.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -60.75 126.1 26.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.89 29.99 76.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.518 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 26.2 mt -148.95 99.25 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.839 0.352 . . . . 0.0 111.169 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 39.0 m -102.68 135.15 44.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -99.53 131.4 45.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 mt -131.27 157.52 77.87 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.9 -174.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.52 2.147 . . . . 0.0 112.35 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -98.36 -36.04 10.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.895 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 57.0 p-90 -64.97 -31.38 72.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -75.95 -34.16 59.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -37.68 81.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -32.7 52.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -68.58 -38.05 80.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.834 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -90.73 -21.23 21.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.0 mt 61.26 65.35 0.99 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.898 0.38 . . . . 0.0 110.938 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.1 mt -118.84 -177.21 3.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.877 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -126.5 174.59 8.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.881 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -64.85 85.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.26 38.34 1.13 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.426 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.73 134.78 12.68 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.98 123.71 29.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 0.0 110.992 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.93 139.69 51.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.106 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -69.28 102.05 1.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -87.04 142.9 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.96 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -152.95 173.68 15.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.2 p -131.02 108.87 10.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.919 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.5 m -117.9 158.31 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.211 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -110.78 111.4 22.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.405 HD13 ' CD2' ' A' ' 76' ' ' HIS . 8.5 mt -110.53 179.94 3.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.935 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.86 168.25 15.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.1 m -59.9 158.09 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.125 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.91 150.7 21.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.045 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.3 t -107.38 -31.28 8.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -132.27 90.76 2.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.2 m -103.69 104.89 14.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.835 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -94.57 146.85 23.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -134.49 152.21 51.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -137.57 93.37 12.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -51.64 121.46 8.61 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.534 2.156 . . . . 0.0 112.297 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -74.14 -31.41 62.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.984 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -107.73 147.36 35.24 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.989 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.43 -15.3 27.93 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.642 2.228 . . . . 0.0 112.52 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.32 -40.22 70.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.103 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.42 ' CE2' HD13 ' A' ' 166' ' ' LEU . 13.6 t80 -70.73 -46.15 63.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.858 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 56.5 mt -59.84 -31.5 69.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -64.53 -25.64 68.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.073 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 46.8 mt -61.98 132.68 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.086 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.1 m -61.07 -34.27 74.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.934 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.58 79.97 30.55 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.809 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.64 -30.21 18.52 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.547 2.165 . . . . 0.0 112.295 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -73.72 -31.02 63.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.77 -48.71 52.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.15 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.89 -40.37 86.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 9.7 tp -65.41 -46.98 77.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -70.62 -30.91 67.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.966 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -67.58 -27.81 67.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.089 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.5 -26.16 14.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.35 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.3 mt -57.3 -39.47 75.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.117 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -27.62 64.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.05 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -73.54 -30.28 62.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.776 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.41 ' CE2' HD12 ' A' ' 155' ' ' ILE . 25.0 m-85 -78.77 155.6 29.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -109.96 -30.51 7.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.3 m -145.37 170.77 15.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.932 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.4 mt -137.79 176.25 8.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.5 m -159.67 143.94 14.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.9 m -72.85 123.53 23.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.89 58.49 3.22 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -137.89 130.32 29.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.829 0.347 . . . . 0.0 110.859 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.58 98.52 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.056 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.41 HD12 ' CE2' ' A' ' 146' ' ' PHE . 14.6 pt -93.68 153.3 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -119.34 148.31 43.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.067 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 pp -142.13 133.1 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -133.96 141.86 47.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -152.77 -47.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -99.46 45.19 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 61.05 34.34 19.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -152.12 130.43 12.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.804 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -95.36 113.25 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.146 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -86.09 157.21 20.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.816 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.23 137.2 46.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.42 HD13 ' CE2' ' A' ' 129' ' ' PHE . 2.9 mt -154.41 134.61 13.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.829 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -126.27 131.39 51.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 27.7 t -72.37 121.1 22.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 18.2 mmm -81.51 -53.56 6.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.0 155.43 41.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.894 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 26.7 p -149.33 158.75 44.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -140.89 157.29 67.76 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.39 -42.24 0.82 Allowed 'Cis proline' 0 C--N 1.346 0.417 0 C-N-CA 123.3 -1.542 . . . . 0.0 112.437 -0.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.84 172.15 7.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.938 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.61 -44.38 89.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.956 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -102.93 119.04 38.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 16.1 m -127.78 155.68 39.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.16 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.7 t -106.77 95.11 5.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.0 pt -87.83 85.28 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.253 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.7 mm -116.51 86.52 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.102 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 61.4 80.58 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.941 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 9.1 t -159.19 151.08 20.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.811 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.23 127.0 40.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -135.46 173.16 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.83 79.46 5.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.06 138.92 21.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.063 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -137.28 172.3 13.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -134.17 133.85 41.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -117.87 90.31 3.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.069 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 m -139.22 156.85 46.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.7 p -104.51 90.71 3.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.73 -65.27 0.11 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.456 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.0 m 60.42 85.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.761 0.315 . . . . 0.0 110.854 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.56 -49.68 30.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -109.81 14.86 31.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.723 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.9 mt 56.98 73.6 0.78 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.342 . . . . 0.0 111.218 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.86 170.65 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.535 2.157 . . . . 0.0 112.29 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.86 32.43 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 m -109.38 124.01 65.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -134.53 -47.94 0.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -60.93 -177.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.954 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.14 111.79 23.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -173.16 159.82 3.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -69.65 120.34 15.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.9 p -151.63 102.11 2.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -165.61 171.61 12.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.86 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -96.56 156.91 16.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -145.49 148.13 32.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.25 112.11 14.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 73.0 m -77.61 128.99 35.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -135.41 172.21 13.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.08 163.39 24.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.9 m -81.1 -31.9 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.192 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.8 p -61.72 -30.07 70.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.8 mtt -58.28 -27.16 63.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.109 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.0 tp -57.08 156.01 7.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.96 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.05 177.3 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.084 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.78 150.09 12.08 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.534 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.56 -38.92 7.55 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.544 2.163 . . . . 0.0 112.269 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -114.04 169.18 9.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -104.11 128.96 51.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -72.86 132.32 43.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.983 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 79.6 p -107.67 -28.58 9.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.992 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -58.09 -35.1 70.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.022 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.1 t -61.31 -47.28 94.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.064 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.76 -31.2 70.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.902 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.0 mttp -82.65 60.3 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.91 -168.71 41.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.426 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.82 59.8 0.52 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.524 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.82 140.01 50.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.817 0.341 . . . . 0.0 110.853 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.8 pt -126.91 -179.97 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.8 mt -130.49 118.64 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 58.8 mtp -107.89 152.46 41.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.861 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.86 151.87 24.95 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.573 2.182 . . . . 0.0 112.253 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.27 -29.6 58.14 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.576 2.184 . . . . 0.0 112.311 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.1 p -59.76 -30.71 69.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.993 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.51 -39.1 82.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.164 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.4 HD11 ' CD2' ' A' ' 82' ' ' PHE . 12.5 tp -63.9 -43.78 94.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.25 -40.6 94.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.957 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -54.52 27.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.3 mt -57.68 -30.17 65.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.0 t -68.5 -29.76 68.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -92.56 -21.21 20.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.164 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.42 -3.34 39.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.513 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.45 31.61 10.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.908 0.385 . . . . 0.0 110.912 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.9 mt -98.79 127.95 50.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.06 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.31 178.01 4.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.428 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.3 t80 -66.99 139.89 95.79 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.748 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.428 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.6 166.66 82.13 Favored 'Cis proline' 0 C--N 1.348 0.524 0 C-N-CA 123.517 -1.451 . . . . 0.0 112.411 -0.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 16.1 mtt -134.17 80.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.845 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.41 152.94 19.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -114.5 159.31 20.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -112.4 95.62 5.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.894 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.4 mt -80.7 101.87 9.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -100.75 106.03 17.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -76.56 122.89 25.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -98.79 31.27 3.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.86 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.77 -37.08 4.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.803 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.28 25.92 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.016 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t70 56.2 36.82 28.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.114 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.77 153.59 21.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.4 ttp -144.19 131.96 21.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.6 t -150.89 131.89 14.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -107.89 115.59 30.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.5 p -115.88 176.61 5.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.35 135.81 8.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.456 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.1 p -72.34 146.02 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.366 . . . . 0.0 111.102 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.5 tp -118.18 -63.53 1.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -113.68 138.8 49.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.4 ' CD2' HD11 ' A' ' 50' ' ' LEU . 42.5 m-85 -103.51 72.96 1.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.6 m -148.64 73.36 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.046 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.13 175.12 9.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.07 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -85.01 160.46 20.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.824 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -70.64 132.75 45.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.27 25.61 69.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.657 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.1 mt -148.66 82.24 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 111.149 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.53 130.52 35.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -94.89 125.06 39.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.58 156.13 80.44 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.918 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.37 -176.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.547 2.165 . . . . 0.0 112.34 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.13 -33.88 12.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.418 ' CH2' ' HE3' ' A' ' 95' ' ' MET . 66.3 p-90 -63.93 -33.19 75.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.418 ' HE3' ' CH2' ' A' ' 94' ' ' TRP . 17.2 ttm -71.66 -31.29 66.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.21 -47.18 45.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.955 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -64.16 -41.45 97.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -62.69 -42.47 99.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.1 mt -83.46 -16.89 43.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.193 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.6 mt 61.09 34.45 19.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.816 0.341 . . . . 0.0 110.833 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.9 mt -84.05 -178.77 7.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.891 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -126.66 169.29 13.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -60.08 111.94 1.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.67 36.0 8.9 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.554 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.09 125.97 8.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.415 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.5 mt -77.81 129.24 35.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.9 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.2 135.01 58.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.041 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -60.43 121.93 13.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.11 135.81 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -139.17 132.13 29.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.21 96.42 5.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.8 m -109.72 146.16 15.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.18 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -108.58 110.04 21.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 mt -105.71 179.97 4.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.61 171.34 10.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.6 m -59.69 162.06 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.035 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -102.84 148.56 25.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 80.5 p -104.7 -31.51 9.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.795 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -140.48 111.24 6.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.843 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.1 m -121.65 120.42 34.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.932 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.5 ttmm -101.72 137.53 39.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.418 ' CG ' HD22 ' A' ' 139' ' ' LEU . 28.4 m-85 -121.17 152.0 39.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.932 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -137.71 93.6 12.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.922 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.65 119.13 4.34 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.556 2.17 . . . . 0.0 112.459 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 40.6 mm-40 -73.64 -33.01 64.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.3 t -104.4 147.38 34.28 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.19 -17.76 31.03 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.58 2.187 . . . . 0.0 112.503 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.04 -45.0 79.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.006 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -69.33 -45.05 70.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.5 mt -59.79 -31.31 69.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.72 -25.91 66.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.986 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.443 HD12 HG21 ' A' ' 132' ' ' ILE . 52.2 mt -59.97 136.54 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.013 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.0 t -69.34 -32.92 72.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.963 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -125.1 79.02 66.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.968 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.91 -27.94 20.35 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.569 2.18 . . . . 0.0 112.346 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -65.91 -44.93 83.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.56 -38.78 92.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.123 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 26.8 t -72.04 -40.9 67.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.418 HD22 ' CG ' ' A' ' 122' ' ' PHE . 3.8 tp -72.81 -33.86 66.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.007 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -76.27 -30.23 57.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.986 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -75.37 -30.61 60.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.08 -34.41 17.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.169 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.2 mt -59.53 -27.97 66.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.963 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -57.01 -29.15 63.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.071 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -78.73 -36.63 43.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.976 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.42 ' CZ ' ' HB ' ' A' ' 155' ' ' ILE . 61.3 m-85 -67.48 143.23 56.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.952 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -110.01 -25.34 10.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.178 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 12.2 t -137.46 159.26 42.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.984 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.2 mt -151.32 139.0 19.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.2 m -123.3 160.24 27.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.984 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.8 m -72.97 103.22 3.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 97.83 36.77 4.65 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.54 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -104.5 108.28 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.352 . . . . 0.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 32.6 t -69.59 86.35 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.061 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.42 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 8.2 pt -93.41 131.41 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.136 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -100.06 142.49 31.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.163 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 40.5 pt -127.83 152.74 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -144.19 136.45 26.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.406 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 3.6 p90 -150.71 -50.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -96.78 44.35 1.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 60.29 31.24 20.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -145.12 137.64 26.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.82 105.71 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.147 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -91.97 119.38 31.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.02 125.23 28.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.974 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.9 mt -134.14 128.91 35.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.812 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -122.44 133.73 54.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.942 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 19.9 t -78.26 139.73 18.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.032 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 56.3 mmm -100.67 -48.3 4.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.987 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.05 153.51 46.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.022 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.83 158.18 43.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.805 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -138.1 153.94 73.72 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.04 -34.11 3.55 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 123.204 -1.582 . . . . 0.0 112.448 0.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.52 178.41 4.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -47.67 84.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -99.02 130.55 45.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.0 m -134.3 161.58 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.205 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.3 t -119.38 94.57 4.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.8 pt -81.17 83.4 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 35.1 mt -116.01 84.98 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.075 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.37 87.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -159.76 176.56 11.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.802 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.22 107.14 13.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -126.41 179.24 5.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -117.12 121.77 42.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.16 122.12 50.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.137 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.76 179.88 4.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.903 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -130.54 157.92 41.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -144.34 87.43 1.88 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.025 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.71 175.27 8.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 0.0 110.891 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.11 -46.37 0.93 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.56 54.32 0.37 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.503 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 92.2 p -135.91 141.01 44.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 110.956 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 m -152.88 163.72 39.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 154.99 149.4 5.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.433 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.9 mt -138.75 95.75 9.71 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.575 0.226 . . . . 0.0 111.136 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.77 123.5 10.8 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.496 2.131 . . . . 0.0 112.329 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.8 ttp85 60.78 92.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.946 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.54 83.97 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.174 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 61.15 100.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 59.18 177.7 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.976 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -124.38 45.95 2.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.813 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.81 139.24 34.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.844 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -76.91 104.79 7.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.2 p -137.75 94.97 2.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.91 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.6 t -156.85 174.93 14.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.914 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -102.61 152.79 20.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.945 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -146.98 147.22 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.6 mtt85 -74.68 135.45 41.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.973 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 76.2 m -97.24 132.35 43.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.411 ' CD2' HG21 ' A' ' 88' ' ' ILE . 31.5 m-85 -145.45 157.89 43.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -81.03 161.9 24.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.937 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.6 m -65.41 -31.41 53.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.188 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.7 m -60.15 -31.69 70.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.39 -27.32 68.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.068 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.434 ' CD1' ' CE2' ' A' ' 90' ' ' TYR . 53.9 tp -56.72 -63.5 1.18 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.979 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.46 -59.79 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.44 149.82 19.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.53 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.84 -45.38 1.02 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.564 2.176 . . . . 0.0 112.282 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -134.4 127.61 31.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -142.92 114.41 7.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.938 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.1 mmm-85 60.39 168.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -112.49 30.45 7.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.946 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.57 -33.78 5.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.051 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.22 -56.68 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.202 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.85 -34.95 51.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.947 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -81.59 100.62 9.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.5 -147.77 19.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.505 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.37 52.69 0.58 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.475 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.76 160.73 20.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.804 0.335 . . . . 0.0 110.917 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.0 pt -145.48 177.51 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.058 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.5 mt -122.81 137.86 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.123 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -131.22 160.04 68.87 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.844 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.59 162.68 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.567 2.178 . . . . 0.0 112.321 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.26 -33.48 24.11 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.606 2.204 . . . . 0.0 112.277 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.9 p -60.34 -34.55 73.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.34 -39.62 87.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.413 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 39.3 tp -64.24 -42.84 96.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.977 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.3 -30.64 60.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -79.32 -41.77 27.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.059 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.0 mt -53.52 -49.63 67.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.0 t -72.31 -28.51 63.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.887 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.37 -21.23 62.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.3 mt -94.07 20.19 8.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.327 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 59.52 30.88 20.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.02 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.1 mt -93.07 124.31 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.126 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 50.0 m -111.63 162.11 15.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.981 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.457 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -59.51 144.15 84.92 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.79 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.457 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 75.5 Cg_endo -77.23 167.45 79.54 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.539 -1.442 . . . . 0.0 112.409 0.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 63.9 mtt -129.33 66.98 1.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.818 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mt -91.07 148.68 22.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.921 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -113.57 135.64 53.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.804 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -83.49 89.65 7.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.893 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.6 mt -69.99 76.35 0.48 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -87.36 109.4 19.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.908 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -84.79 117.62 23.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -98.57 33.94 2.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.84 -44.21 1.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.936 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.8 m -120.25 20.99 11.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.175 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.7 t0 53.6 60.0 3.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.944 0.402 . . . . 0.0 111.117 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -112.11 164.35 13.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.945 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.3 ttp -159.49 130.61 6.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.0 t -158.38 170.77 21.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -138.18 117.01 12.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.923 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 9.4 p -122.36 153.48 38.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.818 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -116.98 127.85 7.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.507 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.42 HG22 ' CE2' ' A' ' 82' ' ' PHE . 10.6 p -66.71 130.6 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 0.0 111.064 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.9 tp -106.91 -56.33 2.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -106.77 155.69 19.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CE2' HG22 ' A' ' 79' ' ' VAL . 87.1 m-85 -130.43 82.9 2.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.1 m -157.39 31.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.169 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.58 167.86 14.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.11 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.38 159.35 33.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -66.06 107.29 1.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.26 28.32 30.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.426 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.411 HG21 ' CD2' ' A' ' 23' ' ' PHE . 27.7 mt -145.81 98.16 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.843 0.354 . . . . 0.0 111.112 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 94.6 m -94.27 132.54 38.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.434 ' CE2' ' CD1' ' A' ' 28' ' ' LEU . 54.6 m-85 -95.06 127.27 40.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 mt -126.27 153.08 74.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.862 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.41 -173.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.587 2.191 . . . . 0.0 112.244 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -92.57 -40.32 10.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -66.76 -45.43 78.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -33.41 75.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.932 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -39.21 80.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -78.41 -33.98 48.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -60.32 -39.88 88.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.773 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.1 mt -87.8 -13.92 40.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.276 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.7 mt 61.93 37.14 15.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.814 0.34 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.3 mt -80.35 -178.53 6.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -130.04 167.85 17.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.86 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -62.73 84.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.944 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.33 33.96 1.4 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.463 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.32 131.73 10.87 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.474 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.1 mt -85.81 129.81 34.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.834 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.28 149.03 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.208 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -64.9 120.44 12.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.47 88.43 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.13 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -102.44 140.98 36.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.98 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.2 p -96.97 106.85 19.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.3 m -118.3 160.78 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -120.9 120.14 34.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.8 mt -114.49 177.2 4.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.859 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -122.98 170.44 10.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.901 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.15 133.73 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.162 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.91 162.24 28.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.9 p -120.49 -41.42 2.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.946 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -122.02 91.96 3.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.8 m -108.03 120.65 42.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.2 156.26 17.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.964 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.408 ' CE2' HG21 ' A' ' 168' ' ' VAL . 69.9 m-85 -141.56 155.52 45.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -136.76 89.3 17.87 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -51.43 114.59 1.63 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.531 2.154 . . . . 0.0 112.314 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -69.93 -32.01 70.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.0 t -98.85 144.44 28.18 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.59 -19.77 21.2 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.572 2.181 . . . . 0.0 112.484 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -55.13 -36.53 65.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.093 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -71.13 -42.16 69.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 64.3 mt -63.41 -31.46 72.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.12 -23.32 65.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.05 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 132' ' ' ILE . 57.4 mt -59.99 141.59 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.056 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.3 m -67.23 -42.56 83.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.975 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -125.84 74.91 71.05 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.001 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -57.09 -31.49 90.47 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.613 2.209 . . . . 0.0 112.235 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -43.26 99.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.957 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.66 84.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.19 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.8 t -67.73 -45.12 85.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.413 HD21 ' CZ ' ' A' ' 188' ' ' PHE . 21.0 tp -59.96 -31.25 69.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.016 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -87.24 -30.74 20.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.01 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.52 -31.3 71.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.947 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.26 -33.06 17.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.3 mt -59.3 -25.42 64.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -56.25 -33.64 65.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.031 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -77.73 -34.4 52.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.405 ' CE2' HG21 ' A' ' 155' ' ' ILE . 37.5 m-85 -69.13 137.61 53.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -102.4 -28.07 12.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.191 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 12.9 t -141.61 159.23 42.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.6 mt -141.39 119.58 12.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.7 m -111.17 138.45 47.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.9 m -62.4 123.05 17.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 94.4 49.82 2.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.472 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.35 132.63 35.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.816 0.341 . . . . 0.0 110.825 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.78 89.24 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.405 HG21 ' CE2' ' A' ' 146' ' ' PHE . 29.7 pt -80.21 141.99 14.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.178 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -114.08 98.05 6.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.044 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.8 pt -83.52 148.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.234 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -151.03 151.36 31.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.737 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -176.43 -40.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.989 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -105.28 43.36 1.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.929 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 57.42 30.04 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.057 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -144.98 120.44 10.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.4 mp -84.65 89.65 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.056 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -70.86 120.5 16.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -74.65 134.47 42.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.43 160.33 41.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.778 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 44.6 ttt-85 -152.12 121.62 6.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.408 HG21 ' CE2' ' A' ' 122' ' ' PHE . 21.4 t -62.93 138.07 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.2 mmm -103.82 -56.42 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -137.83 158.49 44.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.978 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 71.4 p -154.51 138.9 16.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -121.73 155.77 59.66 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.71 -26.33 9.52 Favored 'Cis proline' 0 C--N 1.347 0.471 0 C-N-CA 123.324 -1.532 . . . . 0.0 112.428 -0.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -120.74 170.9 9.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -37.35 76.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.963 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -102.68 117.64 35.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.043 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.85 142.87 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 3.8 t -98.2 105.69 17.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.6 pt -95.37 87.84 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.12 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 22.0 mt -116.23 84.35 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.093 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 60.29 88.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.34 175.18 14.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.854 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.16 110.98 20.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.839 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -131.91 179.56 6.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.41 110.64 20.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.68 143.69 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.04 177.85 4.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . 0.413 ' CZ ' HD21 ' A' ' 139' ' ' LEU . 7.9 m-85 -140.04 141.65 36.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.874 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.3 106.21 14.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.926 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.051 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.3 t 60.35 174.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.916 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.41 90.63 2.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.956 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.84 -164.49 24.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.553 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.4 t -106.56 86.75 2.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.323 . . . . 0.0 110.855 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.93 -31.24 7.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.64 177.2 37.82 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.462 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.6 pp -67.11 158.74 80.28 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.696 0.284 . . . . 0.0 111.149 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.01 144.09 38.15 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.551 2.167 . . . . 0.0 112.368 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.19 146.0 27.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 m -143.57 48.15 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.082 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 61.24 82.49 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.855 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.76 -46.92 0.49 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.967 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 m120 60.5 99.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.824 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -148.54 109.81 4.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.41 ' CE2' HG23 ' A' ' 18' ' ' THR . 59.9 t80 -59.86 122.52 14.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.96 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.6 p -143.41 115.97 8.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.41 HG23 ' CE2' ' A' ' 16' ' ' PHE . 9.0 t -176.41 162.15 2.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -94.6 150.35 20.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.765 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -142.47 137.93 30.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -72.92 115.05 11.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.2 p -85.37 136.18 33.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.967 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.413 ' CD2' HG23 ' A' ' 88' ' ' ILE . 84.7 m-85 -138.99 170.98 15.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.89 146.49 28.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.931 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.1 m -63.47 -26.45 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.225 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.3 t -55.91 -28.64 57.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.079 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -58.05 -27.42 63.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.002 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.3 tp -57.37 -35.52 70.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.948 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.26 -178.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 138.36 147.66 5.21 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.534 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.13 -44.25 50.38 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.623 2.215 . . . . 0.0 112.278 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -97.19 -177.82 3.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.878 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.62 162.36 32.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.09 150.55 51.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 p -115.86 -38.47 3.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -59.59 -28.65 67.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.018 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.4 t -61.61 -33.69 58.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.056 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -91.73 -32.08 15.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -84.58 92.44 8.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.49 168.6 11.76 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.441 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.02 56.59 3.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.513 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.86 134.54 54.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.9 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.9 pt -128.8 175.31 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.215 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mp -128.98 117.48 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.203 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 14.7 mtp -115.93 163.88 19.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.831 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -51.78 152.89 12.43 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.517 2.145 . . . . 0.0 112.269 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.44 -27.3 40.02 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.541 2.161 . . . . 0.0 112.337 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 95.2 p -63.74 -30.81 71.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.6 -40.43 96.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.415 HD11 ' CD2' ' A' ' 82' ' ' PHE . 23.2 tp -59.7 -40.45 87.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.975 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.35 -30.03 67.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.993 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -84.95 -30.65 24.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.937 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.8 mt -59.39 -30.72 68.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.015 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.5 -30.08 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.044 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -21.95 66.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.23 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.0 mt -93.88 18.37 10.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.392 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 53.94 42.11 31.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.812 0.339 . . . . 0.0 111.167 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.0 mt -107.44 133.59 51.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.126 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.29 169.03 10.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.969 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.442 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -59.92 142.39 88.81 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.7 Cg_endo -77.02 165.82 84.05 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.457 -1.476 . . . . 0.0 112.412 -0.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 65.0 mtt -131.42 51.68 2.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.1 mt -68.13 142.08 55.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.918 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -109.57 139.06 45.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.769 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.404 ' HD3' ' CE1' ' A' ' 76' ' ' HIS . 0.9 OUTLIER -93.08 96.65 10.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 34.3 mt -80.9 81.38 7.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.978 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.65 108.48 18.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -70.36 123.96 23.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.848 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -98.52 32.19 2.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -124.95 -45.5 1.87 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.943 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.6 t -121.63 17.85 11.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.208 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 52.66 59.9 4.17 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.863 0.364 . . . . 0.0 111.073 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.44 177.66 4.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 37.4 ttp -156.22 129.44 8.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.7 m -150.82 137.46 18.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 176' ' ' ALA . 6.8 m80 -112.38 108.7 17.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 31.2 p -109.8 166.66 10.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.98 136.75 11.11 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.428 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.443 ' CG2' ' CZ ' ' A' ' 82' ' ' PHE . 11.1 p -75.84 148.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.791 0.329 . . . . 0.0 111.168 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.2 tp -122.09 -63.47 1.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.871 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -109.66 -179.46 3.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.443 ' CZ ' ' CG2' ' A' ' 79' ' ' VAL . 57.5 m-85 -150.19 79.97 1.36 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.6 m -148.71 31.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.66 167.08 13.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.143 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.06 177.68 3.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -84.82 89.7 7.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 105.74 28.19 5.45 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.519 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.413 HG23 ' CD2' ' A' ' 23' ' ' PHE . 31.8 mt -141.45 82.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.845 0.355 . . . . 0.0 111.057 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 90.6 m -82.77 131.4 35.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.987 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -98.55 145.0 27.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 17.6 mt -143.29 149.75 49.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.905 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.13 178.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.574 2.183 . . . . 0.0 112.372 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -85.74 -40.66 15.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.42 ' CH2' ' HE2' ' A' ' 95' ' ' MET . 69.3 p-90 -63.25 -35.89 81.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.846 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.42 ' HE2' ' CH2' ' A' ' 94' ' ' TRP . 37.0 ttm -70.54 -40.86 73.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 4.6 mtt -60.39 -46.58 89.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.942 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -64.64 -33.46 75.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -66.72 -40.55 88.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.825 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.3 mt -84.85 -21.57 29.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.091 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.5 mt 64.4 34.85 10.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 0.0 110.947 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.8 mt -83.87 -179.58 7.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -118.56 -178.02 3.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -71.8 85.04 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.86 30.51 2.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.549 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.58 145.53 30.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.532 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.4 mt -96.72 123.47 40.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 0.0 110.953 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.77 131.6 72.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.084 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -64.57 100.22 0.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.89 126.29 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -134.6 118.35 17.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.2 p -76.92 116.93 18.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.843 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.4 m -121.24 170.15 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.221 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.03 106.38 9.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.795 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mt -106.9 170.68 7.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -115.56 179.96 3.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.2 m -69.48 141.65 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -83.71 141.68 31.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.088 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 71.5 p -99.75 -31.11 11.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -140.36 107.61 5.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.931 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 96.4 p -120.46 118.33 30.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -103.04 160.06 14.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.42 ' CZ ' HD21 ' A' ' 143' ' ' LEU . 47.7 m-85 -141.88 153.49 44.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.91 89.57 29.28 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.008 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -50.97 111.06 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.557 2.171 . . . . 0.0 112.401 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -61.49 -31.33 71.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.9 t -98.69 143.21 25.94 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.829 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.82 -20.26 17.48 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.567 2.178 . . . . 0.0 112.395 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.49 -39.65 70.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.042 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -64.66 -44.52 90.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.7 mt -59.71 -30.99 69.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -67.88 -23.74 65.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.024 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.1 mt -59.94 136.59 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.039 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.9 m -61.65 -49.16 77.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.994 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -118.17 82.65 18.42 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.39 -32.37 10.24 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.573 2.182 . . . . 0.0 112.319 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -33.75 75.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.31 -47.56 27.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.103 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.2 t -66.77 -30.57 50.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.146 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 49.8 tp -77.99 -45.59 23.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.937 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.17 -31.31 70.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -64.75 -28.43 69.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.67 -32.42 18.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.106 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.42 HD21 ' CZ ' ' A' ' 122' ' ' PHE . 34.7 mt -59.54 -28.87 67.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.044 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -57.73 -27.16 62.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.094 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -79.0 -41.23 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.921 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.416 ' CZ ' ' HB ' ' A' ' 155' ' ' ILE . 97.0 m-85 -71.32 130.36 41.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -88.79 -33.37 17.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 15.0 t -126.42 158.9 34.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.899 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.2 mt -142.1 125.28 16.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 m -119.0 148.16 43.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 66.0 m -75.37 128.25 34.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.98 28.08 19.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.555 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -118.81 138.6 52.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.2 t -96.8 104.12 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.126 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.416 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 3.1 pt -102.28 89.73 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.153 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.17 134.33 55.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.2 pt -121.49 157.43 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.11 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -143.29 155.06 44.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -175.13 -46.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -100.82 43.14 1.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 59.21 30.22 19.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.959 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.37 122.23 9.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.817 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -81.11 88.87 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.099 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -65.79 131.85 47.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.823 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -90.05 113.11 24.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.55 140.05 51.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.812 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -131.01 134.66 46.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.78 147.36 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.4 mmt -110.12 -61.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.63 152.38 50.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.963 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 43.5 p -150.3 143.64 25.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -120.35 151.95 54.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.19 -38.34 1.8 Allowed 'Cis proline' 0 C--N 1.346 0.427 0 C-N-CA 123.376 -1.51 . . . . 0.0 112.367 0.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -108.64 175.4 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.787 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.52 -47.78 78.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.998 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.422 ' HB3' ' CD2' ' A' ' 76' ' ' HIS . . . -94.18 131.02 40.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.8 m -143.33 155.3 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.177 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 2.8 t -112.39 99.82 8.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.827 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.2 pt -88.98 85.72 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.165 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 20.8 mt -116.46 96.06 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 60.75 66.1 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 7.3 t -155.51 154.91 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.93 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -101.71 135.8 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.933 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -137.21 155.47 49.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.7 76.12 7.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.5 125.82 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.144 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.95 167.11 11.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -120.46 127.7 52.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -98.99 96.87 8.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.095 -179.981 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -139.0 165.25 27.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.782 0.325 . . . . 0.0 110.903 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.9 105.08 5.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.85 115.68 3.95 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.451 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -90.3 107.74 19.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.3 p -103.89 105.84 16.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.17 -155.4 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.462 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.5 mt -120.19 135.95 24.77 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.62 0.247 . . . . 0.0 110.996 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.23 -167.0 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.5 2.133 . . . . 0.0 112.391 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 64.48 173.2 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.1 m -63.23 178.19 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.3 31.1 6.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.15 124.78 50.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -118.8 160.72 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -151.42 114.18 4.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.966 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -60.47 98.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.8 p -130.53 133.98 46.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.852 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.8 t -177.1 169.41 2.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -99.6 125.31 45.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -123.64 152.4 42.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 -84.66 130.19 34.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.9 m -93.66 130.45 39.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.97 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -133.15 171.12 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -85.12 164.34 18.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -90.47 11.67 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.473 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.9 p -76.46 -27.76 56.29 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.722 0.296 . . . . 0.0 110.824 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 46.1 mtp -57.89 -48.39 79.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.898 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.31 86.01 6.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.59 -178.16 3.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.1 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -172.75 -164.91 28.96 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.519 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.7 -45.97 1.43 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.593 2.196 . . . . 0.0 112.32 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -86.48 175.62 8.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.947 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -110.77 113.9 26.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.01 125.17 33.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.5 m -137.13 32.14 2.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.83 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -111.33 -29.55 7.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.998 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.8 t -62.03 -29.48 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.275 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.405 ' O ' ' CD1' ' A' ' 94' ' ' TRP . 9.3 mt-10 -82.51 -30.68 29.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.073 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.2 mttm -87.39 -30.62 20.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.009 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.03 -179.93 38.39 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.575 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.12 63.04 0.48 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.528 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.91 153.09 51.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.756 0.312 . . . . 0.0 110.847 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.7 pt -136.89 177.7 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.218 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.9 mt -126.19 114.98 40.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 76.8 mtp -108.74 164.16 15.36 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.819 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.8 144.94 63.74 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.584 2.189 . . . . 0.0 112.147 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.06 -28.3 49.8 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.448 2.098 . . . . 0.0 112.338 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.0 t -65.44 -29.72 70.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.043 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.13 -48.27 80.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.15 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 82' ' ' PHE . 25.1 tp -60.49 -43.5 96.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.35 -31.4 69.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -44.58 69.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.999 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.1 mt -58.19 -30.14 66.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.009 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.3 m -73.84 -26.25 60.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -94.96 20.14 9.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.318 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -134.04 20.02 3.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.219 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 56.18 30.19 16.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.809 0.338 . . . . 0.0 111.013 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.8 mt -100.43 130.28 49.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.77 164.86 15.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.931 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.442 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.6 t80 -64.44 140.81 98.07 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.787 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 76.9 Cg_endo -77.46 164.46 86.41 Favored 'Cis proline' 0 C--N 1.348 0.511 0 C-N-CA 123.487 -1.464 . . . . 0.0 112.473 -0.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 34.2 mtt -135.04 64.65 1.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.803 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.7 165.05 23.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.984 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -132.78 126.23 31.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.419 ' HG3' ' CD2' ' A' ' 76' ' ' HIS . 15.7 ttpt -83.09 112.7 20.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.4 mt -91.71 82.88 5.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.814 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.7 m -86.16 99.6 11.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -62.22 125.18 23.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.5 33.91 2.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.36 -48.27 1.57 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.816 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.2 m -118.18 21.69 12.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.209 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 t0 54.16 35.14 21.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.833 0.349 . . . . 0.0 111.077 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -84.37 162.09 20.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.969 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.78 127.05 13.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.8 m -152.93 131.39 12.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.419 ' CD2' ' HG3' ' A' ' 65' ' ' LYS . 49.5 m80 -104.48 106.41 16.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.5 p -93.49 174.52 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.25 138.79 10.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.443 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.9 p -84.81 158.41 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.846 0.355 . . . . 0.0 111.055 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.6 tp -151.56 -58.28 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -104.88 147.36 27.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 97.2 m-85 -125.31 86.72 2.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.2 m -155.91 32.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.109 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.38 165.59 12.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -83.47 165.11 19.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -64.08 121.73 14.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.43 33.7 68.13 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.555 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 26.5 mt -148.46 95.15 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 111.095 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 98.0 m -98.12 126.93 43.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.964 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -89.9 129.45 36.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mp -136.29 155.34 77.34 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.02 -174.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.509 2.139 . . . . 0.0 112.354 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -94.55 -36.05 11.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.405 ' CD1' ' O ' ' A' ' 38' ' ' GLU . 59.1 p-90 -64.34 -37.03 86.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.898 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 56.4 ttm -71.24 -39.12 71.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 36.5 mmm -64.57 -45.2 88.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -39.44 68.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -59.61 -31.9 69.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.4 mt -98.13 -8.84 26.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.342 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.4 mt 63.03 33.6 14.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.849 0.357 . . . . 0.0 110.885 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.6 mt -92.17 130.32 37.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.831 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -84.15 179.07 7.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.79 94.35 0.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.43 41.53 1.48 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.564 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.58 119.92 6.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.569 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.8 mt -73.62 126.57 30.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.838 0.351 . . . . 0.0 110.878 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.43 143.62 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.126 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -67.33 104.65 1.55 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.35 136.32 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -141.97 148.2 38.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.3 p -104.68 115.16 29.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.4 m -131.13 173.05 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.078 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.81 100.07 4.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.0 mt -89.19 -179.95 5.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -123.91 170.23 10.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -64.36 143.96 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.15 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -83.28 156.37 23.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.181 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.2 p -117.64 -39.94 3.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.943 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -125.22 85.68 2.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.2 m -100.32 120.43 39.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.859 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -109.53 149.59 29.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.419 ' CD1' HD23 ' A' ' 139' ' ' LEU . 89.5 m-85 -134.46 164.03 28.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.84 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -148.43 90.06 5.0 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.13 126.21 19.64 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.486 2.124 . . . . 0.0 112.313 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -73.35 -32.03 64.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.6 m -105.61 148.32 36.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.5 -12.59 27.21 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.586 2.19 . . . . 0.0 112.53 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -55.18 -41.71 72.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.034 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.418 ' CE1' HD13 ' A' ' 166' ' ' LEU . 12.6 t80 -70.67 -35.37 72.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.892 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 26.5 mt -66.68 -29.71 69.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.31 -26.04 68.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.008 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 47.5 mt -63.13 138.76 22.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.986 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.4 t -66.58 -39.65 88.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.992 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -126.68 80.49 70.21 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.17 -36.1 92.39 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.542 2.161 . . . . 0.0 112.31 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -59.69 -35.7 75.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.47 -37.34 80.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.2 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.75 -31.69 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.274 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.419 HD23 ' CD1' ' A' ' 122' ' ' PHE . 32.0 tp -75.2 -39.0 60.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.52 -31.35 68.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -66.19 -31.14 71.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.96 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.08 -41.35 13.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.149 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.6 mt -59.41 -27.56 66.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.999 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -56.97 -29.94 63.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.053 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.09 -46.0 18.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.865 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -61.1 134.26 56.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -98.48 -28.63 13.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -133.65 166.72 21.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.873 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.8 mt -158.19 147.34 19.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.42 132.08 40.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.0 m -59.99 107.1 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.942 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 112.44 28.87 3.36 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.505 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -122.67 134.28 54.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.774 0.321 . . . . 0.0 110.871 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.13 114.79 29.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.106 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 7.2 pt -112.87 118.5 58.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.124 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.38 141.6 33.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.066 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.6 pt -135.04 147.27 29.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.108 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -143.06 156.46 44.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 160' ' ' ASN . 47.9 p90 -175.29 -44.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.872 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.42 ' HB2' ' CE2' ' A' ' 159' ' ' TYR . 41.0 t30 -101.5 40.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 60.29 31.15 20.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -152.03 134.85 15.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.23 105.93 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -89.47 111.52 22.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.2 138.5 57.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.418 HD13 ' CE1' ' A' ' 129' ' ' PHE . 0.5 OUTLIER -156.56 118.05 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -115.79 137.48 52.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.97 109.01 5.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.2 mmm -76.64 -47.01 23.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.13 155.94 43.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.979 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -160.06 132.9 6.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.763 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -108.88 158.16 34.92 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.69 -26.72 9.1 Favored 'Cis proline' 0 C--N 1.347 0.454 0 C-N-CA 123.31 -1.538 . . . . 0.0 112.414 -0.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -125.74 179.46 5.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -47.83 84.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -91.04 124.33 35.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.0 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.2 m -140.74 152.57 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.8 t -113.23 98.95 7.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.2 pt -88.1 85.09 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.184 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.0 mm -113.61 89.19 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.12 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 61.1 77.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.818 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 13.9 t -163.16 149.91 12.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -101.32 131.16 47.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.926 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -136.11 170.98 15.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.43 97.73 11.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 29.2 t -84.26 139.69 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.084 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.09 175.24 5.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.844 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . 0.407 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 4.1 m-85 -141.56 148.44 39.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -135.87 90.49 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.138 179.939 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m 60.47 -173.84 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.843 0.354 . . . . 0.0 110.896 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 p -159.72 169.96 22.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.941 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.75 -132.81 1.59 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.507 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -63.0 112.76 2.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 0.0 110.863 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -159.12 164.74 35.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 150.88 -170.63 30.66 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.512 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 pt -66.93 150.91 97.55 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.736 0.303 . . . . 0.0 111.105 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.76 167.19 25.14 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.502 2.135 . . . . 0.0 112.389 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.49 118.11 4.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.28 177.4 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -60.24 108.52 0.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.808 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.5 158.85 37.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.969 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.83 116.45 4.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.855 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.39 164.97 17.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.872 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.404 ' CE2' HG23 ' A' ' 18' ' ' THR . 43.7 t80 -94.54 136.57 34.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.9 p -159.04 118.8 3.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.966 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.404 HG23 ' CE2' ' A' ' 16' ' ' PHE . 9.8 t -177.47 150.91 0.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.888 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -75.39 140.02 42.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -142.0 144.11 33.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -69.32 176.49 3.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.971 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.1 m -146.38 125.32 12.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.414 ' CD2' HG23 ' A' ' 88' ' ' ILE . 56.7 m-85 -132.64 174.41 10.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 t -93.62 146.94 23.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.28 -27.65 43.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.173 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.5 p -56.62 -28.64 60.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.107 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.7 mtt -58.75 -51.16 71.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.981 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.7 tt -89.22 151.89 21.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -161.6 163.51 29.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.101 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.16 -160.07 9.11 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.432 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.97 -28.24 29.33 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.573 2.182 . . . . 0.0 112.289 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -115.63 151.88 34.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.86 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -80.72 178.77 8.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.4 mtt-85 -167.17 125.92 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.9 t -110.84 -29.49 7.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.961 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -58.93 -29.22 66.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.014 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.9 t -59.79 -40.85 83.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.123 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.87 -31.03 28.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -91.21 56.19 3.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.773 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.33 149.42 6.88 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.423 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.55 72.96 2.73 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.484 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -131.28 133.67 45.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.789 0.328 . . . . 0.0 110.842 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.9 pt -120.3 163.67 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.151 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.24 118.3 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.06 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.7 mtm -110.78 164.16 15.53 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.08 148.23 49.63 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.567 2.178 . . . . 0.0 112.19 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.86 -29.69 54.3 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.513 2.142 . . . . 0.0 112.316 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.7 p -59.0 -30.94 68.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.91 74.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 82' ' ' PHE . 38.4 tp -70.9 -50.39 35.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.924 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.26 -30.85 69.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -77.12 -41.32 42.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.058 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.1 mt -58.23 -31.97 67.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.038 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -82.33 -29.79 30.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.61 -16.08 52.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.216 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.2 mt -93.93 19.6 8.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.265 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.3 t30 55.2 30.08 13.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.0 mt -98.18 141.14 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.193 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.8 p -126.45 159.35 33.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.435 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -63.02 145.37 96.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.842 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.3 Cg_endo -77.1 152.12 94.39 Favored 'Cis proline' 0 C--N 1.348 0.501 0 C-N-CA 123.413 -1.495 . . . . 0.0 112.378 0.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 20.3 mtt -116.17 61.3 0.72 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.77 137.95 37.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.826 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.409 ' CD1' HG12 ' A' ' 109' ' ' VAL . 94.7 m-85 -100.73 171.8 7.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.33 86.51 2.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.887 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 mt -66.18 88.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 m -88.25 103.08 15.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -85.17 113.69 21.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -96.08 42.93 1.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -124.59 -44.29 1.98 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.85 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 m -128.13 25.65 5.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.085 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 55.92 39.58 30.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.039 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -89.59 157.39 18.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.962 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.7 ttp -154.72 127.38 8.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.932 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.6 t -157.43 145.22 18.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.965 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -112.14 108.06 17.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.819 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 28.6 p -107.5 147.52 30.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.08 142.47 16.17 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.438 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.418 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 11.7 p -70.3 136.12 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.876 0.37 . . . . 0.0 111.066 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.7 tp -104.59 -63.25 1.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -127.61 167.49 16.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.934 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 94.8 m-85 -123.27 93.42 3.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.9 m -156.73 37.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.188 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.91 157.65 19.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.1 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.41 148.47 46.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -59.81 124.59 20.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.86 -19.15 54.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.594 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.414 HG23 ' CD2' ' A' ' 23' ' ' PHE . 29.0 mt -108.24 132.2 56.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 111.157 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 43.6 m -128.76 126.53 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.56 145.88 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 mp -146.57 158.51 46.46 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.03 155.0 9.32 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.605 2.203 . . . . 0.0 112.278 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -69.34 -38.46 78.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.446 ' CD2' ' N ' ' A' ' 95' ' ' MET . 49.0 p-90 -64.75 -41.17 96.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.446 ' N ' ' CD2' ' A' ' 94' ' ' TRP . 3.3 ttp -66.91 -36.97 83.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.929 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.6 mtp -61.94 -35.69 79.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -77.61 -38.38 48.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -60.33 -31.96 70.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.834 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.2 mt -98.13 -14.42 20.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.257 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.7 mt 62.07 39.99 12.51 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.9 0.381 . . . . 0.0 110.88 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 mt -81.23 164.97 21.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.842 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.81 -174.39 2.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -65.01 96.11 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.27 38.12 5.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.06 110.3 3.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.3 mt -73.76 124.85 26.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.826 0.346 . . . . 0.0 110.945 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -134.34 150.42 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -66.5 136.63 55.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.888 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.409 HG12 ' CD1' ' A' ' 64' ' ' PHE . 21.4 t -123.63 92.3 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -107.79 137.6 45.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 21.7 p -88.49 114.49 25.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.3 m -119.67 131.05 73.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.142 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -82.13 112.42 19.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 mt -111.7 175.08 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -133.08 171.83 13.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.06 147.28 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.184 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -89.65 149.74 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.064 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.1 p -105.55 -28.58 10.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.824 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -134.93 90.78 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.906 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.7 p -98.24 109.03 21.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -101.22 136.46 41.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.845 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -124.49 156.71 36.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -133.64 94.45 19.21 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.97 108.58 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.52 2.147 . . . . 0.0 112.395 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -61.98 -31.82 72.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.948 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 m -113.87 146.68 36.09 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.002 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.31 -14.6 25.47 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.544 2.163 . . . . 0.0 112.567 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.68 -33.96 61.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.135 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -75.29 -31.38 60.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.9 mt -63.53 -30.72 71.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.71 -27.99 69.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.012 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 46.8 mt -60.88 135.62 25.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.049 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.6 m -71.07 -30.66 66.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -127.88 73.32 78.93 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -56.74 -37.09 98.65 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.629 2.219 . . . . 0.0 112.209 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -60.75 -46.4 90.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.046 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -59.21 -46.02 89.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.055 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.438 ' CG1' ' CE2' ' A' ' 159' ' ' TYR . 21.5 t -69.72 -37.54 74.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.4 tp -73.5 -34.08 65.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -74.16 -34.49 63.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.906 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.05 -37.07 86.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.3 -33.44 43.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 12.6 mt -60.03 -28.82 68.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.947 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -57.95 -32.76 68.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.03 -31.56 58.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.83 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -74.71 142.61 44.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -100.79 -30.67 11.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -134.56 173.31 11.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 55.0 mt -149.59 114.38 5.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.824 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.0 m -104.95 144.88 31.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.1 m -71.12 112.72 7.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 99.76 39.3 3.42 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.575 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.18 112.9 20.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 110.883 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.21 82.97 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.116 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 8.7 pt -79.98 160.52 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.062 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -121.8 112.91 18.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.3 pt -98.7 152.51 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.208 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -147.72 147.24 29.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 160' ' ' ASN . 52.8 p90 -164.49 -47.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.846 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.45 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 57.0 t-20 -98.93 43.95 1.04 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 60.15 31.02 20.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.17 132.35 19.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.0 mp -90.39 88.49 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.087 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -70.38 123.18 21.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -75.14 133.09 41.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.22 141.38 22.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.877 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -136.94 145.51 44.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.38 153.64 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.177 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 13.2 mmm -121.99 -54.37 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.91 140.13 34.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.7 p -144.43 135.76 25.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -113.49 153.91 45.62 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.69 -37.12 2.22 Favored 'Cis proline' 0 C--N 1.346 0.395 0 C-N-CA 123.337 -1.526 . . . . 0.0 112.4 0.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.39 173.13 6.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -56.58 -43.33 79.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -95.06 127.63 41.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.004 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 16.2 m -138.35 139.61 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.169 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 30.9 p -93.18 102.1 14.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.793 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.0 pt -96.13 88.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.271 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.5 mp -124.28 82.31 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.005 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 62.19 81.57 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 23.7 t -157.18 158.15 35.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -91.14 129.75 37.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 5.9 ptt? -152.02 174.04 14.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -108.48 117.19 33.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.813 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.91 137.98 23.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.203 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.1 146.56 52.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -105.75 148.13 27.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -114.91 85.16 2.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.931 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.163 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.118 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.1 t -170.98 150.21 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.83 0.347 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.51 -38.36 14.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.816 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.8 28.5 65.82 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.492 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -120.39 97.66 5.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.32 . . . . 0.0 110.924 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.2 p -168.71 -178.4 3.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.86 -159.4 30.25 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.587 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.3 pp -139.9 154.35 70.59 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.731 0.301 . . . . 0.0 111.092 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.51 139.76 41.89 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.605 2.203 . . . . 0.0 112.344 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.5 mmt85 -99.14 30.47 3.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -158.95 40.47 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.035 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.75 -58.38 1.24 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.811 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -103.0 30.99 4.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -96.09 168.95 10.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.36 174.13 11.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.416 ' CE2' ' HG ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -68.39 119.7 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.875 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.3 p -159.72 99.5 1.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -160.69 162.39 32.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -96.06 130.59 43.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -126.15 143.27 51.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -78.08 143.13 37.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.2 p -104.38 130.23 52.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.437 ' CZ ' ' CA ' ' A' ' 104' ' ' GLY . 57.1 m-85 -139.86 154.56 47.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -60.23 162.44 5.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.6 m -95.55 20.09 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.331 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 m -88.06 -31.41 19.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.842 0.353 . . . . 0.0 110.911 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.41 -45.95 92.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.415 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 31.2 tp -86.47 63.98 8.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.53 123.27 4.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.069 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.47 -155.23 5.04 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.553 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.13 -27.91 31.26 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.616 2.21 . . . . 0.0 112.347 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -102.56 166.79 10.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -126.26 171.21 11.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.964 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -139.24 146.42 40.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.878 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 93.6 p -110.33 -25.15 10.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.026 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -54.02 -29.64 44.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.114 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.93 -54.11 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.129 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.47 -40.99 63.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.8 mttm -66.02 79.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.47 -171.9 22.08 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.49 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.7 79.98 0.26 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.453 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -140.51 134.25 30.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.813 0.339 . . . . 0.0 110.932 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.1 pt -122.53 170.07 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.098 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mt -124.46 96.9 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.004 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.9 mmm -90.34 158.55 43.33 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.81 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.64 149.38 32.1 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.51 2.14 . . . . 0.0 112.267 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.54 -30.14 53.03 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.566 2.177 . . . . 0.0 112.276 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.93 -30.19 71.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.43 -30.05 66.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.177 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.416 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 32.2 tp -70.67 -50.6 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.962 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.29 -32.39 73.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -76.78 -44.12 34.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.06 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.416 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 8.1 mt -58.72 -37.02 75.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.953 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.4 t -83.01 -28.76 29.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.79 -19.95 59.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.171 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.6 mt -92.69 15.52 14.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.332 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.83 32.69 20.09 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.735 0.302 . . . . 0.0 111.038 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.2 mt -92.87 144.17 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.107 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.3 p -127.19 179.69 5.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.984 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.451 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 16.7 t80 -72.55 138.42 80.65 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.749 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.4 Cg_endo -77.15 156.57 97.09 Favored 'Cis proline' 0 C--N 1.348 0.537 0 C-N-CA 123.534 -1.444 . . . . 0.0 112.426 0.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 41.8 mtt -119.97 31.34 6.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.809 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -61.58 149.23 39.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -109.51 145.51 36.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.882 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -92.39 85.97 5.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.949 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.73 90.1 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -98.89 111.64 23.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.927 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -83.86 113.17 20.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.825 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -88.31 54.35 3.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -142.9 -47.48 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.885 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.7 22.5 9.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.157 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 54.52 37.02 27.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.005 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -90.56 147.93 23.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.9 ttt -138.07 142.01 40.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.809 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.5 m -159.98 148.68 17.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -124.78 114.01 18.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 26.5 p -115.06 155.89 26.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.23 131.08 9.81 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.449 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.412 HG23 ' CZ ' ' A' ' 82' ' ' PHE . 10.7 p -68.59 140.14 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 111.164 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.6 tp -129.65 -56.35 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.832 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -108.54 146.12 33.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.971 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.416 ' CD2' ' HB2' ' A' ' 50' ' ' LEU . 76.6 m-85 -120.39 58.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.1 m -125.34 31.2 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.104 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.24 179.24 7.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.076 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.69 169.08 9.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -73.02 107.97 5.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.37 28.21 33.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.493 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.0 mt -148.33 95.67 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 15.0 m -91.05 134.2 34.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.415 ' CE2' ' HB2' ' A' ' 28' ' ' LEU . 34.7 m-85 -97.84 120.64 38.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.8 mt -123.34 150.23 59.96 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.935 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.3 176.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.52 2.147 . . . . 0.0 112.304 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -79.84 -47.4 15.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -59.53 -29.12 67.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.992 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 33.4 ttm -73.45 -30.94 63.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.831 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 6.4 mtp -71.61 -43.59 65.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -68.92 -40.25 79.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.854 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -60.38 -61.51 2.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.819 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 mt -62.88 -20.54 65.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.6 mt 63.25 34.25 13.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.823 0.344 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 mt -81.52 179.27 7.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.827 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -125.79 177.59 6.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -63.97 103.18 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.437 ' CA ' ' CZ ' ' A' ' 23' ' ' PHE . . . 89.41 34.87 8.29 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.521 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.18 117.83 4.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.554 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.7 mt -64.71 130.22 42.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 110.884 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.9 t -121.46 138.02 53.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -70.46 112.81 7.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.0 t -96.44 143.93 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.107 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -160.03 138.63 10.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.4 p -91.05 113.91 26.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.6 m -120.86 150.14 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.115 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.74 86.8 2.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.9 mt -83.01 168.08 17.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.801 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -110.9 175.53 5.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.838 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.14 139.59 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.2 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.39 151.02 36.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.6 t -110.57 -30.93 7.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -138.77 107.72 6.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.938 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 m -114.26 137.99 51.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -129.02 148.63 50.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -133.8 150.84 51.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -131.55 91.33 34.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -51.34 125.02 15.39 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.543 2.162 . . . . 0.0 112.34 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -71.12 -39.77 71.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.1 m -105.57 148.0 35.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.877 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.73 -11.22 29.25 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.575 2.183 . . . . 0.0 112.576 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -56.37 -39.7 73.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.766 0.317 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -72.32 -38.3 68.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 32.4 mt -65.32 -36.94 85.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.824 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.29 -25.3 67.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.405 HD13 HG23 ' A' ' 132' ' ' ILE . 52.2 mt -59.99 134.57 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.052 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.1 t -59.69 -32.65 70.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.004 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.04 81.01 33.86 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.34 -30.05 16.11 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.62 2.214 . . . . 0.0 112.318 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -63.51 -37.8 88.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.63 -56.48 17.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.7 -33.94 62.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.164 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.415 HD22 ' CZ ' ' A' ' 188' ' ' PHE . 29.7 tp -70.16 -50.92 35.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.943 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -67.27 -39.07 86.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -60.13 -30.92 69.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.858 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.08 -31.21 61.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.071 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 60.4 mt -57.95 -27.16 63.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.038 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -30.05 62.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.012 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -81.55 -36.25 29.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -77.69 147.14 35.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.962 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -107.96 -28.66 9.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.58 159.56 35.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 28.4 mt -137.44 118.71 14.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.14 140.77 46.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.86 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.4 m -66.7 125.5 26.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.22 44.69 8.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.438 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -111.01 119.46 39.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.839 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.73 81.22 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 39.9 pt -81.91 178.41 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -152.63 131.32 12.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.039 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 39.8 pt -118.56 138.02 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -136.83 146.01 45.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.403 ' CE2' ' HB2' ' A' ' 160' ' ' ASN . 52.6 p90 -173.98 -44.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.868 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.403 ' HB2' ' CE2' ' A' ' 159' ' ' TYR . 53.1 t30 -97.76 38.5 1.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 60.21 31.12 20.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.21 119.45 8.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -84.09 90.81 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.13 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -71.8 138.61 48.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -96.96 124.86 41.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.2 mt -139.33 138.28 36.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -129.85 136.57 49.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.4 t -71.78 130.19 35.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.067 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.2 mmm -91.37 -62.81 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.09 150.45 48.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 31.5 p -144.79 144.22 31.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.849 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -123.84 152.17 65.7 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.96 -38.77 1.62 Allowed 'Cis proline' 0 C--N 1.346 0.436 0 C-N-CA 123.321 -1.533 . . . . 0.0 112.368 0.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -107.63 168.82 8.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -34.87 72.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.947 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -108.39 124.02 49.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.075 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 6.4 m -135.89 160.04 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 3.7 t -108.93 91.83 3.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.0 pt -80.56 82.76 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.145 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.9 mt -115.2 82.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.089 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 60.0 79.78 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.842 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 2.0 t -156.94 153.93 28.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.85 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -90.7 118.89 30.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -135.11 176.26 8.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.839 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.01 142.06 27.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.54 86.6 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.138 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.62 175.39 10.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . 0.415 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 2.2 m-85 -134.75 145.34 48.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -141.08 105.09 4.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.092 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.14 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 m -104.25 -66.73 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 110.941 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.56 -69.22 0.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.976 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 58.31 -89.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.494 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.86 147.43 23.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 110.911 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.4 m -109.85 -30.66 7.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.32 -157.37 15.08 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.424 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.4 pt -109.5 134.42 20.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.535 0.207 . . . . 0.0 111.127 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.9 114.97 4.15 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.421 2.081 . . . . 0.0 112.328 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -128.52 101.04 6.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 m -101.34 29.52 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.16 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -113.31 30.65 7.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.805 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -133.51 153.29 51.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -153.84 -59.75 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 62.23 148.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.939 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.15 120.8 16.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.829 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.6 p -158.42 102.85 1.75 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -168.25 177.82 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -105.38 122.08 45.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -117.73 151.06 38.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 mtt85 -86.4 137.16 32.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.5 p -104.16 122.93 46.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -132.05 160.29 36.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 t -77.09 152.72 34.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -64.34 -21.04 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.347 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.4 m -61.17 -18.87 60.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.276 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.1 mtp -94.0 20.06 8.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.428 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.421 HD23 ' CE2' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -85.32 135.3 33.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.809 0.338 . . . . 0.0 110.745 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.88 134.74 52.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.161 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 140.19 166.07 10.52 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.466 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.48 -28.15 26.94 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.546 2.164 . . . . 0.0 112.278 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.48 145.34 17.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.832 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -84.41 -178.54 6.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.925 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -123.81 144.92 49.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.86 31.64 2.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.898 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -98.31 -31.34 12.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.947 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.36 -31.33 46.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.68 -36.33 65.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.821 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -60.29 -33.29 72.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -110.4 -164.66 19.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.474 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.16 31.63 5.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.55 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.0 mmtt -87.66 158.57 18.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.815 0.341 . . . . 0.0 110.973 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.6 pt -135.77 -179.98 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.45 104.45 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.04 157.17 34.21 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.34 144.86 38.2 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.541 2.161 . . . . 0.0 112.261 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.66 -30.62 56.61 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.516 2.144 . . . . 0.0 112.279 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.3 p -60.65 -35.45 76.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.94 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.89 -30.98 71.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.144 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.413 ' HB2' ' CD1' ' A' ' 82' ' ' PHE . 43.3 tp -63.06 -39.38 94.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.56 -32.89 47.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -61.14 -38.79 87.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.37 -46.21 91.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -60.14 -30.98 69.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.947 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.8 mtt85 -82.1 -26.35 33.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.036 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.1 mt -86.74 6.14 32.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.428 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 t30 59.52 31.34 20.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.81 0.338 . . . . 0.0 110.966 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 33.1 mt -94.73 125.19 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.128 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.7 p -110.37 170.62 7.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.438 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.8 OUTLIER -64.82 141.18 98.27 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.822 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.9 Cg_endo -77.1 164.61 86.76 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.468 -1.471 . . . . 0.0 112.403 -0.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 20.1 mtt -126.65 72.9 1.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.852 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.0 mt -90.96 149.26 21.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.958 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -112.78 142.99 44.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.823 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.42 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 59.5 tttt -94.93 103.39 15.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.984 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.9 mt -91.69 76.24 5.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.94 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -78.09 97.22 5.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.931 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -66.02 116.92 7.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -92.31 49.71 1.54 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -130.4 -46.13 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.795 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.0 m -133.28 28.82 4.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.958 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 58.02 34.75 24.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.031 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -88.82 156.32 19.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 13.8 ttm -158.4 137.63 11.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.0 t -160.0 108.98 1.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.42 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 37.9 m80 -75.91 118.31 18.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.9 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 24.7 p -111.61 147.16 36.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.95 149.71 19.26 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.499 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -91.02 154.42 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.853 0.358 . . . . 0.0 111.084 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.0 tp -145.96 -55.99 0.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -101.89 143.96 31.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.894 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 67.4 m-85 -123.54 76.8 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.4 m -150.79 31.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.42 150.12 28.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.148 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.01 173.06 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.85 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -67.95 115.89 7.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.11 29.83 75.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 32.7 mt -142.7 91.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 0.0 111.146 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.5 t -94.66 129.43 41.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.421 ' CE2' HD23 ' A' ' 28' ' ' LEU . 86.3 m-85 -89.01 140.96 28.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.1 mt -137.47 155.92 75.22 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.2 179.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.603 2.202 . . . . 0.0 112.293 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -87.44 -45.3 10.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -60.35 -44.89 95.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.4 tpp -60.15 -34.74 73.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -53.36 22.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -60.0 -36.3 76.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.865 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -62.2 -49.08 77.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.781 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.9 mt -75.36 -17.06 60.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.2 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.4 mt 61.21 35.22 18.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.6 mt -80.68 -178.63 6.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.826 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.02 -177.98 4.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 120.75 10.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.8 27.84 70.04 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.504 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -70.71 107.62 2.22 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.439 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.3 mt -69.52 123.52 21.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.839 0.352 . . . . 0.0 110.839 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.2 t -125.59 145.88 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.08 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -73.32 108.72 6.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.93 121.54 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.7 114.55 12.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.8 p -77.73 114.86 17.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.985 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.9 m -122.54 144.13 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.071 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.43 102.58 15.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.0 mt -99.58 168.93 9.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.63 172.34 7.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.6 m -67.96 140.76 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.122 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -81.82 148.84 28.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.062 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.7 p -109.63 -31.55 7.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -131.73 93.29 3.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 61.1 m -114.49 94.49 4.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.38 142.5 35.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.823 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.415 ' CD1' HD22 ' A' ' 139' ' ' LEU . 42.7 m-85 -124.68 150.92 45.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.014 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -128.37 93.54 38.13 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.54 104.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.557 2.171 . . . . 0.0 112.373 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -59.51 -30.88 68.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.3 146.31 35.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.821 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.69 -12.76 26.87 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.536 2.157 . . . . 0.0 112.559 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -56.82 -40.69 76.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.067 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.411 ' CD2' HD21 ' A' ' 166' ' ' LEU . 19.2 t80 -67.31 -44.24 79.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.62 -29.98 68.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.947 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -61.99 -26.31 68.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.988 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.2 mt -61.66 139.68 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.981 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.4 m -65.3 -37.38 86.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -130.01 71.12 82.28 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.409 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 39.6 Cg_exo -57.0 -29.95 84.78 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.611 2.207 . . . . 0.0 112.241 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -60.31 -49.52 77.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.043 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.45 75.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.139 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.57 -33.27 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.415 HD22 ' CD1' ' A' ' 122' ' ' PHE . 12.6 tp -71.7 -42.87 66.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.14 -37.83 72.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -65.69 -32.76 74.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.58 -31.74 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.136 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.2 mt -63.98 -27.32 69.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.038 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -57.03 -25.2 58.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.101 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -79.74 -49.24 12.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.826 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.421 ' CZ ' ' HB ' ' A' ' 155' ' ' ILE . 84.5 m-85 -60.77 146.72 45.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -100.85 -30.33 11.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.24 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.11 167.46 22.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.974 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 27.6 mt -143.01 137.53 29.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.0 m -114.09 141.64 47.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.0 m -65.83 94.28 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 108.33 30.43 3.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.548 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.03 134.17 46.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.766 0.317 . . . . 0.0 110.854 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 26.1 t -90.2 91.19 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.117 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.421 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 9.3 pt -91.65 134.03 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -102.05 125.07 48.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.12 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.0 pt -115.88 141.59 32.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.103 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -139.19 142.22 37.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -157.71 -50.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -96.77 44.18 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 60.34 31.47 20.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -148.55 126.21 11.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -85.92 95.45 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.188 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -76.66 137.43 39.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -95.46 122.96 38.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.411 HD21 ' CD2' ' A' ' 129' ' ' PHE . 3.2 mt -141.63 100.55 3.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -93.93 127.74 39.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.94 128.79 32.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.083 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.8 mmm -86.71 -64.16 1.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.014 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -123.14 155.79 36.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 58.2 p -144.98 161.01 40.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -148.12 155.4 43.47 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.825 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.29 -31.6 5.17 Favored 'Cis proline' 0 C--N 1.348 0.507 0 C-N-CA 123.309 -1.538 . . . . 0.0 112.462 0.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -113.51 176.7 4.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -60.01 -41.94 93.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -98.83 116.94 32.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.018 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 17.7 m -133.27 137.66 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.16 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 10.0 t -94.62 97.9 10.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.1 pt -89.63 85.49 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.3 mm -117.83 85.12 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.123 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 60.58 87.26 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 49.9 t -161.65 141.52 10.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.97 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -80.84 108.14 14.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -128.34 179.22 5.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -93.84 89.97 6.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.75 81.33 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.01 172.05 13.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . 0.403 ' CE1' HD21 ' A' ' 139' ' ' LEU . 11.8 m-85 -128.52 163.07 25.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.93 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -147.93 101.64 3.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.958 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.048 179.946 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.451 -0.259 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.88 158.55 20.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.921 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.25 -42.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.3 -141.16 3.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.51 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.38 -34.69 61.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 0.0 110.952 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.87 159.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.86 -154.74 29.62 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.479 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 mp -112.88 90.95 16.5 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.674 0.274 . . . . 0.0 111.152 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -51.06 91.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.584 2.189 . . . . 0.0 112.43 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.1 mtt-85 59.55 -178.46 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.977 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.7 p -155.25 113.74 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.087 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -144.37 -48.38 0.27 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.987 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -170.68 -38.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.082 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 t30 75.59 -68.05 0.22 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.013 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 63.36 135.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.946 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -62.47 89.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.947 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.9 p -118.97 105.34 11.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.831 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.0 t -168.35 160.97 11.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.952 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -95.7 148.57 22.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -139.03 148.5 43.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 -75.84 128.51 35.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.873 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 64.9 m -99.11 125.79 44.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -130.66 175.47 8.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 t -92.28 150.66 20.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.906 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.5 m -68.3 -30.8 48.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.086 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.01 -29.22 66.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -27.78 63.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.046 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.5 tp -57.4 -67.1 0.36 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.023 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -104.93 -68.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.079 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.42 -169.28 23.5 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.465 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.1 -35.74 18.98 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.616 2.211 . . . . 0.0 112.266 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -122.16 121.46 36.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.823 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -165.23 -44.44 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.953 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -131.67 147.7 52.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.4 p -130.83 31.63 4.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -122.03 -43.33 2.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 m -63.11 -32.33 55.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.09 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.17 -31.58 43.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -80.56 -35.17 34.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.78 167.14 26.72 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.476 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.47 40.88 2.57 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.455 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.18 162.4 13.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.356 . . . . 0.0 110.897 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.0 pt -141.1 172.55 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.102 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 mt -120.93 86.41 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.174 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.6 mtp -89.11 151.59 47.0 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.773 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.09 156.09 7.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.574 2.183 . . . . 0.0 112.251 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.73 -25.46 61.17 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.625 2.217 . . . . 0.0 112.342 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.5 p -58.87 -30.78 67.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.942 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.79 -47.96 64.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.161 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.417 HD11 ' CE2' ' A' ' 82' ' ' PHE . 56.1 tp -59.51 -39.46 83.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.68 -31.01 64.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.924 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -74.04 -32.6 63.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.6 mt -59.84 -30.38 68.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.895 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.5 t -80.91 -22.94 39.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.111 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -75.09 -30.57 60.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.018 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.5 mt -95.52 20.05 10.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.243 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 53.58 38.42 28.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.82 0.343 . . . . 0.0 111.265 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.0 mm -77.08 154.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.025 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.91 151.55 44.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.436 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.5 t80 -61.83 140.6 95.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.753 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.436 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.75 157.8 97.34 Favored 'Cis proline' 0 C--N 1.349 0.579 0 C-N-CA 123.479 -1.467 . . . . 0.0 112.409 -0.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 45.0 mtt -116.38 56.86 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.91 139.72 45.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -105.81 157.13 17.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.402 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 10.3 tttp -103.55 92.94 4.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.6 mt -75.8 80.64 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.7 m -95.21 117.8 30.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -89.36 129.46 35.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.889 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -98.69 31.11 3.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.32 -41.02 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.847 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m -134.41 21.99 3.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.5 t70 54.4 59.95 3.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.098 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -106.55 158.98 16.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.1 ttm -159.28 126.64 4.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.4 t -158.96 100.94 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.941 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.402 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 50.4 m80 -65.77 131.98 47.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.926 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.6 p -123.11 166.32 15.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.49 113.24 2.05 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.516 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.35 154.18 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.102 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.2 tp -133.33 -62.22 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -95.7 162.76 13.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.417 ' CE2' HD11 ' A' ' 50' ' ' LEU . 51.7 m-85 -140.83 74.02 1.44 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.4 m -143.56 31.44 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.42 158.26 17.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.13 169.1 18.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -73.19 120.79 19.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.82 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.19 26.08 55.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.577 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.3 mt -149.74 113.99 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.834 0.35 . . . . 0.0 111.106 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 86.4 m -117.38 131.29 56.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -97.96 135.87 39.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 mp -135.36 160.63 67.25 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.43 -176.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.582 2.188 . . . . 0.0 112.292 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -93.09 -40.92 10.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.023 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -61.85 -42.07 98.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.98 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 44.6 ttm -60.43 -44.46 95.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.22 -48.76 80.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -60.57 -36.81 79.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.898 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -65.44 -56.38 12.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.2 mt -68.14 -17.68 64.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.184 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.3 mt 62.86 32.35 15.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.844 0.354 . . . . 0.0 110.84 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.84 179.96 7.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -134.08 176.53 8.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -59.91 105.4 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.8 28.45 8.31 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.52 121.58 5.56 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.466 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.6 mt -83.14 123.55 29.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.835 0.35 . . . . 0.0 110.985 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.41 135.55 62.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.085 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -68.28 102.13 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.4 t -86.86 132.12 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -145.17 133.15 21.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.8 p -90.88 103.06 15.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.1 m -109.19 170.96 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.168 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -114.89 118.69 34.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.1 mt -119.12 177.31 4.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -123.06 167.53 13.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.2 m -64.85 141.96 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.064 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.53 148.85 36.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.3 p -113.29 -37.05 4.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.926 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -137.6 118.41 14.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.931 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.58 107.2 6.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.07 131.64 34.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.41 ' CE2' HG22 ' A' ' 168' ' ' VAL . 26.4 m-85 -112.29 144.5 41.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -131.57 96.97 19.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.81 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.82 119.91 5.35 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.518 2.145 . . . . 0.0 112.327 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -71.49 -32.22 67.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.033 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.98 147.48 34.56 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.957 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.65 -19.14 28.27 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.571 2.18 . . . . 0.0 112.604 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.52 -48.07 78.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.051 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.42 ' CZ ' HD11 ' A' ' 166' ' ' LEU . 13.4 t80 -61.14 -44.96 96.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.88 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.6 mt -59.37 -31.8 69.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -62.77 -26.8 68.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.976 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 29.6 mt -61.38 135.56 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.993 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.7 t -64.51 -33.39 75.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.61 81.76 46.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.86 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.12 -27.23 20.42 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.47 2.113 . . . . 0.0 112.321 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -60.14 -35.74 75.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.019 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.3 -39.27 68.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.13 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.54 -30.28 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.275 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 25.5 tp -79.75 -44.51 20.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.04 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -63.64 -31.56 72.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.94 -28.82 67.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.74 -32.63 31.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.124 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.06 -26.63 68.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.076 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -56.41 -30.1 62.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.068 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -85.86 -42.73 13.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.944 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.416 ' CE2' HD11 ' A' ' 155' ' ' ILE . 37.6 m-85 -62.49 142.42 57.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -108.03 -25.67 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.279 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -141.42 165.5 27.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.5 mt -145.83 162.55 37.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.66 143.71 30.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.959 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 89.0 m -62.98 96.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 110.0 27.47 4.55 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.468 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.93 116.15 28.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.3 t -84.62 89.0 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.069 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.416 HD11 ' CE2' ' A' ' 146' ' ' PHE . 1.1 pt -93.67 142.85 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.111 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -109.0 131.25 55.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.159 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.8 pt -117.99 154.63 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -144.72 142.06 29.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.908 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.419 ' CE1' ' CD1' ' A' ' 164' ' ' TYR . 16.4 p90 -158.5 -49.75 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.966 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -97.87 44.5 1.04 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.9 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 60.0 30.14 19.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -144.58 142.63 30.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.67 90.45 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.041 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.419 ' CD1' ' CE1' ' A' ' 159' ' ' TYR . 39.8 m-85 -74.04 120.79 20.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -77.45 139.61 39.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.991 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.42 HD11 ' CZ ' ' A' ' 129' ' ' PHE . 0.7 OUTLIER -153.28 124.78 7.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -124.16 137.67 54.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.929 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.41 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.5 t -76.18 146.96 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 24.5 mmm -106.23 -56.88 2.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -128.65 149.79 50.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.983 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 17.5 p -145.69 141.17 27.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.869 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -127.43 152.98 77.23 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.99 -28.15 7.94 Favored 'Cis proline' 0 C--N 1.346 0.397 0 C-N-CA 123.38 -1.508 . . . . 0.0 112.366 0.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -124.61 173.25 8.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -47.16 85.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.968 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -90.88 103.55 16.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.016 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 15.9 m -123.38 132.19 71.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 5.7 t -89.55 85.58 6.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.813 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.8 pt -74.17 81.55 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.213 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.9 mm -119.69 103.07 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.977 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.98 79.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.808 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -176.48 144.14 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -101.18 120.48 40.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.969 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.75 172.18 7.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.05 95.06 9.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -86.3 90.34 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.13 175.43 10.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -130.43 151.6 50.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -129.2 80.74 1.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.128 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.561 -0.215 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t -171.99 141.62 1.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.889 0.375 . . . . 0.0 110.917 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 p -118.91 131.68 56.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.94 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.74 134.91 41.11 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.488 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.7 t -167.57 96.24 0.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.857 0.361 . . . . 0.0 110.966 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -118.11 149.62 40.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.88 -162.97 37.13 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.537 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.7 tt -177.56 133.38 0.35 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.587 0.232 . . . . 0.0 111.043 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.11 144.3 38.28 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.4 2.067 . . . . 0.0 112.391 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.89 30.97 3.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.789 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.3 m -133.16 86.54 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.168 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -146.61 -56.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -126.45 155.61 41.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -129.03 172.1 11.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -137.55 109.62 7.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.421 ' CZ ' HG22 ' A' ' 18' ' ' THR . 5.1 t80 -61.36 126.9 29.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.858 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.8 p -147.75 107.26 3.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.952 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.421 HG22 ' CZ ' ' A' ' 16' ' ' PHE . 9.4 t -156.5 178.65 10.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -107.2 163.29 13.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.861 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -157.36 142.59 17.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.982 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -81.87 118.81 23.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.2 p -84.94 133.43 34.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -138.58 174.52 10.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.21 147.08 23.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.976 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.7 m -68.27 -21.2 26.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.324 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.23 -29.53 33.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.215 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 6.1 mtt -71.94 -41.49 67.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tt -121.46 83.43 2.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -172.46 -178.78 2.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.072 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.6 164.85 13.97 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.87 -45.35 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.603 2.202 . . . . 0.0 112.304 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.7 -31.32 32.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.52 118.97 37.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.45 -40.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.969 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.73 -30.38 71.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.879 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.27 -43.94 92.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.86 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -66.78 -30.93 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.134 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -78.42 -31.37 48.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -71.8 86.46 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.417 ' HA2' ' CE1' ' A' ' 146' ' ' PHE . . . 139.45 -156.83 24.83 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.488 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.22 40.28 1.62 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.552 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.85 149.36 22.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.921 0.391 . . . . 0.0 110.891 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.6 pt -126.99 170.74 16.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.179 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mt -122.83 99.78 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.033 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -99.93 157.5 33.77 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -51.87 160.24 3.09 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.515 2.143 . . . . 0.0 112.282 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.09 -27.42 42.03 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.494 2.129 . . . . 0.0 112.357 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.43 -31.22 71.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.3 -39.16 89.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.088 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.417 HD11 ' CE1' ' A' ' 82' ' ' PHE . 24.1 tp -60.11 -42.3 94.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -74.27 -42.28 59.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.63 -47.14 86.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.999 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.7 mt -54.12 -26.92 29.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.122 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.96 -27.52 24.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.033 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -97.12 20.05 11.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.268 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.1 mt -126.17 20.0 7.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.721 0.296 . . . . 0.0 111.295 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 55.05 30.04 13.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.804 0.335 . . . . 0.0 111.072 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.0 mt -98.24 124.61 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.152 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 t -114.98 169.5 9.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.449 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -70.98 145.17 91.24 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.77 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.449 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.7 Cg_endo -76.88 156.24 97.63 Favored 'Cis proline' 0 C--N 1.348 0.503 0 C-N-CA 123.549 -1.438 . . . . 0.0 112.393 0.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.6 mtt -115.76 66.68 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.32 123.47 30.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -98.31 142.95 29.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.404 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 13.0 ttpt -101.03 82.72 2.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.897 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.6 mt -60.9 94.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -94.46 112.55 24.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.861 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -71.06 103.8 2.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -79.95 61.98 4.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -174.08 -41.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.854 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.24 4.59 26.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.398 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 57.83 49.06 12.66 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.905 0.384 . . . . 0.0 110.904 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -107.64 168.82 8.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.4 ttm -157.39 128.4 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.3 t -145.81 148.74 33.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.948 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.404 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 69.3 m80 -116.11 95.28 5.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.932 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.5 p -107.04 160.98 15.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -118.16 134.91 11.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.531 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.417 ' CG2' ' CZ ' ' A' ' 82' ' ' PHE . 11.7 p -73.87 151.41 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 111.09 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.6 tp -137.55 -59.13 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -102.26 145.34 29.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.417 ' CE1' HD11 ' A' ' 50' ' ' LEU . 82.4 m-85 -124.89 75.66 1.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.851 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 m -136.57 30.86 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.68 155.26 16.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.58 160.26 25.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -60.34 113.02 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.5 27.64 32.15 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.58 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 26.0 mt -148.59 98.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 111.131 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.7 t -103.19 135.12 45.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -103.77 136.78 42.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 mp -136.12 157.55 75.48 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -51.95 179.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.573 2.182 . . . . 0.0 112.321 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.71 -35.54 15.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.413 ' CZ3' HG23 ' A' ' 155' ' ' ILE . 65.3 p-90 -68.06 -43.17 79.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.41 ' CE ' ' CH2' ' A' ' 94' ' ' TRP . 31.0 ttm -66.93 -33.08 74.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.956 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.8 mmt -60.57 -39.83 89.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.811 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -79.34 -33.86 42.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.886 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -60.31 -31.1 69.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 mt -102.13 0.28 34.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.375 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.4 mt 57.87 30.78 19.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.82 0.343 . . . . 0.0 110.919 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 38.7 mt -82.42 -178.63 7.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -144.56 -174.19 4.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.789 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -76.82 90.78 3.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.05 50.18 0.74 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.532 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.65 141.91 17.19 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.477 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.5 mt -85.65 127.19 34.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 110.867 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.41 139.68 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -80.26 121.77 26.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.27 139.22 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.093 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -143.18 130.03 20.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.3 p -88.77 123.17 32.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.89 140.26 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.134 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -91.96 112.14 23.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.6 mt -115.76 176.86 4.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -128.01 173.96 9.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.841 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.5 m -59.71 164.67 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.056 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -96.94 160.74 14.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.103 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 58.3 p -119.58 -41.12 2.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.809 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -133.08 92.4 3.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.807 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.92 143.26 35.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.941 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -117.23 169.76 9.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.828 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.419 ' CG ' HD12 ' A' ' 139' ' ' LEU . 42.9 m-85 -153.75 139.82 18.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -128.57 86.64 57.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -51.56 125.44 16.78 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.573 2.182 . . . . 0.0 112.375 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -80.99 -31.22 34.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.5 p -101.01 146.57 32.37 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.37 -17.14 24.27 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.528 2.152 . . . . 0.0 112.51 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.22 -38.48 68.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.073 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -76.07 -38.28 57.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 21.4 mt -63.48 -32.33 73.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -67.26 -26.1 66.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.061 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.417 HD12 HG22 ' A' ' 132' ' ' ILE . 47.9 mt -64.68 124.49 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.124 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.5 m -59.96 -39.06 84.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.48 77.71 4.47 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.17 -27.79 19.57 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.574 2.183 . . . . 0.0 112.252 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -64.41 -39.77 94.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.0 -51.66 44.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.09 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.418 HG12 ' CZ ' ' A' ' 159' ' ' TYR . 21.4 t -59.73 -30.51 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.419 HD12 ' CG ' ' A' ' 122' ' ' PHE . 6.1 tp -75.98 -44.71 38.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.38 -38.35 77.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -59.63 -31.09 69.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.968 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -86.04 -31.61 21.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.049 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 28.1 mt -61.35 -28.48 69.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -57.56 -29.71 64.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.067 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -79.07 -31.24 44.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.417 ' CE1' ' HA2' ' A' ' 40' ' ' GLY . 7.4 m-85 -83.6 150.68 25.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -109.87 -29.37 8.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.173 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 17.4 t -141.58 158.69 43.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.6 mt -131.66 178.53 6.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.0 m -158.89 136.63 10.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.5 m -65.41 121.57 15.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.8 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.75 41.34 9.83 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.356 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.77 106.71 9.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.836 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.8 t -66.57 107.02 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.011 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.413 HG23 ' CZ3' ' A' ' 94' ' ' TRP . 4.0 pt -109.1 132.17 57.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.116 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -92.45 129.85 38.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.083 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.0 pt -115.36 140.87 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.155 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -143.01 145.21 32.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.418 ' CZ ' HG12 ' A' ' 138' ' ' VAL . 10.8 p90 -161.3 -48.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.923 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 48.0 p30 -101.66 44.93 0.99 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.976 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.77 30.79 20.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.96 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -139.36 119.04 13.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.84 83.99 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.164 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -62.95 179.97 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -132.31 130.72 41.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.888 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 20.2 mt -145.63 159.07 43.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.864 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -153.0 114.96 4.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.415 HG22 ' CE1' ' A' ' 122' ' ' PHE . 21.5 t -59.72 135.41 24.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 41.1 mmm -99.97 -46.71 5.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.942 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.38 156.18 44.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.6 p -153.06 157.24 40.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 39.2 mttt -143.12 154.9 61.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.3 -31.4 5.31 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 123.298 -1.542 . . . . 0.0 112.434 0.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -108.34 167.67 9.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -35.17 71.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.949 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -113.61 115.43 27.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.023 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.67 154.79 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.5 t -99.89 80.01 2.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.1 pt -71.28 81.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.202 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.2 mt -125.19 95.92 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.079 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 61.59 78.38 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.08 148.43 2.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.02 136.57 43.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.946 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.1 ptt? -143.54 167.45 22.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.1 85.41 5.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.0 108.79 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.108 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.09 179.96 5.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -138.28 140.83 39.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -107.56 99.5 8.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.819 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.255 -0.878 . . . . 0.0 111.057 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 m 60.71 85.64 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.792 0.33 . . . . 0.0 110.961 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -108.11 152.04 25.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.2 65.91 0.3 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.531 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -73.05 163.48 28.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.798 0.332 . . . . 0.0 110.85 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.1 t 59.87 175.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 61.7 -98.91 0.2 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.491 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.2 mt 68.82 84.28 0.15 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.781 0.324 . . . . 0.0 111.177 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.76 148.5 28.25 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.608 2.205 . . . . 0.0 112.288 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.11 38.94 0.51 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.8 m -116.47 30.69 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.14 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.59 -46.59 65.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -90.29 87.23 6.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -66.43 -64.41 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 60.53 159.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -75.81 138.97 41.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.8 p -158.56 85.31 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 92.7 m -148.95 160.31 43.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -103.12 121.16 42.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.877 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.25 146.87 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.96 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -69.89 169.16 13.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.6 m -131.15 112.77 13.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -122.73 162.46 21.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -83.48 154.21 24.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.5 m -65.25 -29.67 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.112 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.2 p -57.98 -27.19 63.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.037 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.0 mmt -64.03 -38.05 89.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.97 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 tp -57.87 -36.12 71.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.926 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.97 176.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.138 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 140.54 136.05 3.28 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.431 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.81 -36.17 81.7 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.428 2.085 . . . . 0.0 112.209 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -116.54 120.02 37.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.843 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.73 165.95 10.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.837 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.5 148.06 30.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.09 33.59 4.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.751 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -118.15 -40.94 2.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.96 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.1 t -62.62 -45.81 97.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.084 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -39.51 76.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.946 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -84.38 94.25 8.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.83 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.18 -134.01 7.41 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.606 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.1 52.3 0.56 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.524 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.9 154.17 26.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 0.0 110.804 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.2 pt -136.85 161.2 36.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.187 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.5 mt -110.09 102.13 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.15 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 82.7 mtp -99.55 161.4 24.64 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -55.89 159.52 11.73 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.532 2.155 . . . . 0.0 112.234 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.2 -27.78 23.96 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.625 2.217 . . . . 0.0 112.297 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 p -59.4 -31.75 69.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.23 -36.43 77.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.124 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.415 HD11 ' CZ ' ' A' ' 82' ' ' PHE . 16.1 tp -61.79 -44.27 97.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -71.9 -31.18 66.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.942 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.42 -41.5 60.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -61.55 -48.07 82.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.7 p -65.31 -30.82 71.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.876 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.58 -20.35 58.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.2 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.8 mt -94.38 20.03 8.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.295 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.9 t30 56.16 30.59 16.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 111.064 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.3 mt -97.81 141.67 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.129 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 p -134.37 172.1 13.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.439 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.5 t80 -60.6 140.62 92.55 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.855 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.439 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.6 Cg_endo -77.05 163.24 89.82 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 123.501 -1.458 . . . . 0.0 112.345 0.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.4 mtt -130.45 69.42 1.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 mt -90.13 147.56 23.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -113.5 126.75 55.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -82.81 89.09 6.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.6 mt -68.03 77.5 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.857 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -81.92 95.39 7.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -64.38 116.04 5.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.828 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -98.11 29.51 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -119.16 -40.5 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 m -124.28 21.79 8.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.098 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 54.4 37.97 28.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.036 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.9 mmp_? -93.09 171.85 8.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.963 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.1 ttp -156.08 125.42 6.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.0 m -144.52 132.25 21.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.888 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.417 ' CD2' ' HB2' ' A' ' 176' ' ' ALA . 12.0 m80 -107.35 101.0 10.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.917 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 28.8 p -108.06 172.66 6.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -134.6 137.67 9.45 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.528 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.79 150.91 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.761 0.315 . . . . 0.0 111.091 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.5 tp -133.44 -60.71 0.83 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -99.51 157.24 16.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 50' ' ' LEU . 93.6 m-85 -130.32 55.46 1.81 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.827 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.14 31.76 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.21 168.46 11.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.74 151.8 25.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.861 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -59.9 134.87 57.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.13 24.86 70.66 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.501 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 29.4 mt -145.93 92.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.85 0.357 . . . . 0.0 111.033 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 83.8 m -92.18 126.15 37.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.022 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -92.7 141.3 28.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.777 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mp -141.67 160.21 57.2 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.853 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -51.84 177.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.53 2.154 . . . . 0.0 112.365 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -84.32 -46.16 12.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -60.24 -38.49 83.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.9 ttm -61.29 -40.81 95.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -41.85 99.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.892 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -71.79 -36.76 70.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -62.25 -39.0 91.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 52.0 mt -87.25 -20.68 26.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.4 mt 61.74 42.83 10.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.878 0.37 . . . . 0.0 110.924 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.3 mt -87.72 170.01 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.77 179.33 3.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.905 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.92 88.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.886 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.48 47.71 1.38 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.395 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.07 107.95 3.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.457 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 32.3 mt -69.59 132.61 46.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.804 0.335 . . . . 0.0 110.941 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.32 149.52 32.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.073 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -63.26 110.18 1.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.58 120.59 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -148.84 142.59 25.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.836 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.1 p -90.15 114.66 26.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.854 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 20.4 m -116.46 152.18 18.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.129 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -108.55 119.11 38.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.1 mt -119.48 179.93 4.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.14 171.61 7.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.915 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.0 m -71.51 133.57 31.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.27 147.42 53.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.149 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.7 p -111.98 -35.53 5.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 187' ' ' ASP . 75.2 t80 -133.23 99.8 4.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.5 p -113.43 111.05 21.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -102.67 136.53 42.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.411 ' CD1' HD23 ' A' ' 139' ' ' LEU . 20.7 m-85 -120.43 155.24 33.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.923 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -133.04 94.62 20.18 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.96 120.4 6.01 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.552 2.168 . . . . 0.0 112.374 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -76.13 -31.48 58.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.965 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.44 149.4 42.1 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.974 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.23 -9.68 26.49 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.536 2.157 . . . . 0.0 112.684 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.41 ' HB3' ' CE2' ' A' ' 164' ' ' TYR . 0.3 OUTLIER -56.41 -35.39 67.74 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.08 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.415 ' CD1' HD13 ' A' ' 166' ' ' LEU . 9.2 t80 -79.61 -34.01 41.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.812 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.8 mt -66.0 -34.77 78.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.29 -26.2 68.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.068 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 39.1 mt -60.04 139.4 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.002 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.5 m -61.24 -53.35 58.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.39 80.01 29.08 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.875 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.414 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 38.9 Cg_exo -57.15 -35.1 98.83 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.54 2.16 . . . . 0.0 112.194 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -34.08 73.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.962 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.49 -39.06 74.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.114 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.43 -30.97 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.411 HD23 ' CD1' ' A' ' 122' ' ' PHE . 9.0 tp -76.71 -30.72 56.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.009 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -80.67 -31.67 36.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.944 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.66 -32.0 70.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.27 -33.5 32.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.104 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 22.7 mt -59.87 -28.93 67.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.043 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -58.29 -33.03 68.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -79.53 -31.14 42.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -71.26 145.56 49.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -108.54 -27.27 9.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.192 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.87 171.61 13.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.7 mt -155.41 136.15 13.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.22 149.78 47.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.816 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 57.0 m -69.27 100.39 1.31 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.65 28.55 4.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.501 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.89 90.08 4.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.85 0.357 . . . . 0.0 110.867 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.7 t -63.37 100.68 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.104 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 pt -109.54 161.98 7.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.11 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -127.28 99.41 5.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.11 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.2 pt -69.41 150.1 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.044 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -158.33 150.3 21.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -177.29 -37.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.087 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -103.47 38.94 1.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.944 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 60.86 29.96 19.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -145.87 108.39 4.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.784 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.0 mp -82.48 112.82 20.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.127 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 128' ' ' ASP . 32.5 m-85 -94.13 131.78 39.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.837 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -83.52 107.34 15.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.415 HD13 ' CD1' ' A' ' 129' ' ' PHE . 0.8 OUTLIER -128.68 136.4 50.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -130.61 131.85 45.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.0 t -70.14 154.41 8.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.5 mmm -121.35 -57.68 1.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -124.55 141.53 52.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.915 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.3 p -145.22 148.29 33.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -133.94 158.02 76.37 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.21 -41.64 0.92 Allowed 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.222 -1.574 . . . . 0.0 112.427 -0.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.35 178.47 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.843 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -47.49 82.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.417 ' HB2' ' CD2' ' A' ' 76' ' ' HIS . . . -99.06 129.48 45.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.03 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.55 135.92 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.201 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 8.0 t -93.04 96.9 10.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.6 pt -88.24 82.72 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.132 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.2 mt -109.89 81.02 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.104 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.26 89.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 2.8 t -162.95 166.23 24.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -106.74 121.68 44.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.896 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -134.72 172.1 13.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.951 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.12 111.8 23.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.2 t -96.03 131.77 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.146 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.415 ' HB2' ' CE1' ' A' ' 119' ' ' TYR . 10.6 t70 -114.8 167.19 10.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -127.41 141.67 51.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.974 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -122.5 81.8 1.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.04 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.35 102.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.8 0.333 . . . . 0.0 110.866 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.4 p -104.0 36.42 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.65 122.57 6.76 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.508 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.79 -74.23 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.782 0.325 . . . . 0.0 110.899 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.0 t 61.15 35.55 18.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.985 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.02 -110.52 4.04 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.508 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.7 mt -95.69 102.44 10.22 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.646 0.26 . . . . 0.0 111.026 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.02 116.1 4.14 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.334 2.023 . . . . 0.0 112.316 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.22 172.94 12.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.8 m -99.42 29.71 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.113 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 59.88 160.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.929 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -166.7 119.13 0.99 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.814 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -109.13 132.22 54.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.044 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.8 mtm105 -148.94 136.53 20.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -91.1 117.96 30.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.826 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.7 p -141.59 129.16 21.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.1 t -176.5 160.42 2.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -77.76 149.66 34.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -155.02 145.22 21.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.917 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.2 mtt85 -76.5 148.15 37.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 64.3 m -113.52 127.7 56.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -129.01 175.89 8.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.59 156.75 17.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.9 m -67.48 -30.17 48.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -32.1 73.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.803 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.2 mmm -67.89 -18.3 64.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.194 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.2 tp -52.81 -33.2 48.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.836 0.351 . . . . 0.0 111.065 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.9 -175.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.131 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.42 149.08 13.89 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.51 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.82 -61.56 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.539 2.159 . . . . 0.0 112.301 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -66.47 169.25 7.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -144.25 175.05 10.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -138.67 150.57 46.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.919 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.0 30.56 4.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.853 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -119.43 -40.01 2.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.9 m -58.16 -37.95 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -73.5 -37.32 65.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -97.57 76.17 2.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.82 159.24 7.86 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.482 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.92 92.1 1.44 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.533 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -153.38 129.26 10.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.327 . . . . 0.0 110.904 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.1 pt -123.64 179.91 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.145 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.7 mt -130.11 115.65 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.064 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 25.3 mtp -117.35 158.6 44.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.14 163.79 2.09 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.597 2.198 . . . . 0.0 112.234 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.31 -27.76 23.42 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.495 2.13 . . . . 0.0 112.234 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.1 p -59.14 -35.7 73.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.92 -32.56 72.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.8 tp -70.91 -39.51 72.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.19 -33.02 56.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -67.04 -41.55 86.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 mt -63.5 -31.6 72.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.9 t -68.88 -42.68 76.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -66.92 -32.19 73.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.4 mt -79.89 -3.26 47.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.461 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 m120 62.2 30.78 17.72 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.733 0.301 . . . . 0.0 110.909 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.5 mt -90.18 106.9 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.109 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.1 p -90.43 171.81 9.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.939 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -59.25 145.21 81.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.803 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.453 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 78.9 Cg_endo -77.41 167.63 78.81 Favored 'Cis proline' 0 C--N 1.347 0.499 0 C-N-CA 123.478 -1.468 . . . . 0.0 112.482 -0.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 4.8 mtt -128.73 62.02 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.85 158.94 22.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.948 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -131.25 126.58 35.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -82.69 106.42 14.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.9 mt -82.41 79.36 8.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.835 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -75.84 93.47 3.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.979 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -68.08 120.04 13.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -97.75 38.07 1.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -128.46 -45.65 1.34 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.8 23.24 7.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.124 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 54.75 39.26 31.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.046 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -89.32 160.43 16.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.964 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 ttm -155.95 124.83 6.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.0 m -153.8 121.38 5.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.854 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -86.01 97.15 10.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 26.4 p -85.19 159.42 20.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -118.26 128.71 7.86 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.521 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.4 p -75.45 137.44 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.76 0.314 . . . . 0.0 111.117 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.3 tp -124.85 -56.49 1.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -103.39 142.75 33.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -118.01 67.82 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.942 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.04 30.99 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.078 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.25 157.92 19.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -81.91 165.28 20.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -63.6 106.86 1.03 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.19 29.93 21.19 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.486 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 31.9 mt -144.96 117.16 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 0.0 111.132 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 61.7 m -125.29 129.52 50.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -97.82 149.4 22.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 mp -144.34 155.05 57.76 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.957 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.25 170.64 0.23 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.575 2.183 . . . . 0.0 112.307 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -78.02 -44.51 26.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -60.24 -37.28 79.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 50.1 ttm -75.05 -31.62 61.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -42.72 81.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.841 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -75.14 -40.41 59.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.839 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -60.5 -35.92 77.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 72.6 mt -83.11 -21.99 33.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.15 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 86.3 mt 61.55 38.06 15.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.4 mt -86.51 -178.26 6.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -115.92 168.36 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -65.31 81.39 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.98 41.14 1.86 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.518 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.83 135.73 13.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.555 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.4 mt -81.98 124.6 29.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 0.0 110.935 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.36 153.37 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.5 143.78 51.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.6 t -124.86 149.4 29.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -157.61 131.47 8.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.9 p -91.86 101.66 14.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.5 m -117.91 144.82 24.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.105 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -102.63 113.04 26.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.6 mt -102.68 171.89 7.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -115.84 171.89 7.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.849 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.1 m -60.41 155.68 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.061 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -89.59 156.41 18.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.077 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.33 -35.67 4.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -133.94 92.58 2.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.63 110.93 23.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.88 130.4 53.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.401 ' CZ ' HD22 ' A' ' 143' ' ' LEU . 37.6 m-85 -118.26 156.21 29.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.878 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -136.01 87.67 23.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.25 116.64 2.95 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.523 2.149 . . . . 0.0 112.363 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -68.54 -31.3 70.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.963 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -103.74 143.92 27.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.972 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.62 -17.06 20.88 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.585 2.19 . . . . 0.0 112.543 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -33.22 63.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.136 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -73.36 -48.48 33.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 70.4 mt -59.29 -30.37 68.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.919 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.85 -25.64 67.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.964 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 38.7 mt -59.96 138.96 20.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.06 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.7 m -64.0 -42.9 97.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -117.62 79.97 13.09 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.979 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.46 -28.39 21.96 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.602 2.202 . . . . 0.0 112.247 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -68.5 -38.94 81.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.948 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.77 -38.04 70.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.051 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.9 t -69.59 -35.51 66.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.019 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.5 tp -78.82 -42.75 26.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.829 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.89 -35.94 81.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -65.24 -34.39 78.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.72 -32.64 27.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.088 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.401 HD22 ' CZ ' ' A' ' 122' ' ' PHE . 12.4 mt -60.63 -30.12 69.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -58.8 -31.39 68.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -74.4 -33.69 63.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.17 149.95 45.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -110.07 -27.44 9.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.248 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 4.5 t -141.65 163.55 32.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.0 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.4 mt -137.92 165.02 27.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.781 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.8 145.44 23.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.905 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.3 m -69.34 97.44 0.96 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.19 51.76 0.86 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.472 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.46 120.66 38.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.827 0.346 . . . . 0.0 110.908 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.24 93.2 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.071 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.1 pp -101.35 138.34 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.113 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -111.9 100.32 8.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.055 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.6 pt -80.0 160.17 4.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.165 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -156.53 147.55 22.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -171.69 -46.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.932 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -96.72 40.31 1.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.92 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 59.71 31.65 20.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -148.5 129.01 13.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 4.1 mp -87.67 97.51 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.076 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -78.8 120.79 23.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.53 128.99 38.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.981 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.5 mt -145.95 136.25 23.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -136.17 126.12 25.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.16 140.03 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.094 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.6 mmm -107.41 -49.44 3.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -139.17 154.47 48.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.91 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 80.6 p -156.92 125.72 5.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -111.63 158.09 37.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.819 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.01 -40.63 1.12 Allowed 'Cis proline' 0 C--N 1.347 0.459 0 C-N-CA 123.248 -1.563 . . . . 0.0 112.347 0.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.67 174.48 5.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -58.06 -46.71 84.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.912 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -102.62 128.96 49.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.071 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 16.0 m -139.98 153.38 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.167 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.48 101.86 11.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.2 pt -85.24 84.56 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.166 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 29.6 mm -118.51 89.54 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.113 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 60.47 87.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 30.2 t -166.54 154.54 10.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.59 97.07 7.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -102.53 170.27 8.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -93.9 88.27 5.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.866 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 29.5 t -78.52 120.69 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.43 162.5 16.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.813 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -118.33 162.88 17.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -153.31 96.38 2.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.965 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.117 -179.95 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.43 -178.46 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.937 0.398 . . . . 0.0 110.847 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.1 p -102.85 -71.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.92 174.06 44.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.509 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.9 m -105.68 -69.9 0.8 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.847 0.356 . . . . 0.0 110.936 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.62 105.28 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.54 -168.94 12.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.452 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 pt -128.45 139.03 34.35 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.625 0.25 . . . . 0.0 111.101 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.91 121.27 6.14 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.507 2.138 . . . . 0.0 112.374 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -98.58 139.0 34.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.2 m -101.46 124.28 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.094 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -76.44 -68.24 0.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -113.55 90.79 3.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.957 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.55 119.51 3.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.15 178.71 6.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -99.63 108.92 21.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.7 p -135.47 96.48 3.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.1 t -150.17 160.91 43.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -86.37 161.92 18.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.889 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -159.92 137.83 10.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -70.93 138.49 50.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 75.8 m -100.94 142.03 32.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.865 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -145.34 176.71 9.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.2 p -88.37 167.1 13.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.8 m -102.15 20.03 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.356 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.59 -29.65 9.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.949 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 1.1 mmt -58.61 -27.63 64.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.042 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.437 ' CD1' ' CE2' ' A' ' 90' ' ' TYR . 1.0 OUTLIER -57.42 157.47 6.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.937 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.73 179.86 4.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.088 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 140.67 154.44 6.24 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.475 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.09 -39.51 70.34 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.581 2.187 . . . . 0.0 112.249 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -126.11 170.01 12.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -133.88 147.48 51.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.17 147.74 27.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.944 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 p -108.2 -23.81 11.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.056 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -53.14 -29.88 33.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.107 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -60.51 -41.09 86.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.078 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -70.68 -31.73 68.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -99.57 86.75 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.88 -170.98 24.3 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.509 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.23 46.59 1.15 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.541 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -102.21 134.88 44.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.4 pt -127.63 177.15 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.5 mt -128.96 96.04 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.07 159.3 34.57 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -55.94 169.08 1.5 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.585 2.19 . . . . 0.0 112.27 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.25 -26.06 30.34 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.579 2.186 . . . . 0.0 112.369 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.28 -31.15 67.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.015 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.32 -43.86 96.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.42 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 3.3 tp -70.82 -32.3 69.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.75 -25.75 44.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.035 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.04 -30.99 13.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.965 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.8 mt -60.47 -49.62 76.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.112 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.53 -31.47 69.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.068 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -70.5 -22.82 62.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.122 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.3 mt -94.78 20.06 9.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.193 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.67 35.58 25.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.863 0.363 . . . . 0.0 110.961 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.4 HG23 HD12 ' A' ' 58' ' ' ILE . 31.1 mt -100.94 124.89 54.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.59 170.4 8.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.808 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.429 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.5 t80 -65.46 140.6 97.69 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.837 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 72.1 Cg_endo -77.15 167.15 80.51 Favored 'Cis proline' 0 C--N 1.349 0.566 0 C-N-CA 123.53 -1.446 . . . . 0.0 112.393 0.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.7 mtt -131.74 69.03 1.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -82.15 148.8 28.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -118.34 142.65 47.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.422 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 10.8 tttt -97.13 107.67 20.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.4 mt -89.65 99.71 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.0 103.02 12.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.95 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -67.7 129.27 39.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -97.66 38.26 1.3 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.61 -47.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.974 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m -106.31 13.42 28.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.296 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 53.87 30.66 11.83 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.77 0.319 . . . . 0.0 111.13 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -82.66 161.53 22.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.64 117.98 3.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.0 t -143.68 156.02 44.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.933 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.422 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 13.8 m80 -122.79 112.92 18.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 24.2 p -106.35 168.09 9.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.3 139.04 13.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.583 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.418 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 12.3 p -81.1 151.48 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 0.0 111.051 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.9 tp -129.09 -61.91 1.02 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -113.59 169.45 8.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CD2' ' HB2' ' A' ' 50' ' ' LEU . 47.6 m-85 -138.75 75.16 1.5 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.852 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 m -142.51 32.48 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.154 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.03 161.9 14.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.054 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.04 158.26 23.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -60.1 132.77 54.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.24 28.2 73.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.526 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.5 mt -147.98 127.18 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.835 0.35 . . . . 0.0 111.136 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 83.1 m -132.39 127.34 35.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.437 ' CE2' ' CD1' ' A' ' 28' ' ' LEU . 35.6 m-85 -94.15 134.12 36.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.1 mp -142.0 159.96 57.19 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.86 -177.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.554 2.169 . . . . 0.0 112.326 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -97.92 -31.64 12.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.419 ' CH2' ' HE3' ' A' ' 95' ' ' MET . 45.4 p-90 -67.48 -34.8 77.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.965 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.419 ' HE3' ' CH2' ' A' ' 94' ' ' TRP . 6.4 tpp -79.1 -32.0 44.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 44.9 mmm -67.59 -31.35 71.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -37.03 22.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -59.97 -31.73 70.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.9 mt -91.62 -16.81 26.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.276 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.3 mt 65.19 33.7 9.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.827 0.346 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.7 mt -79.8 -178.52 6.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.89 175.77 8.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.901 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.9 101.13 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.85 43.03 7.4 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.564 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.85 128.96 9.19 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.54 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.3 mt -79.38 126.87 31.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.93 139.66 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -63.75 110.61 2.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.2 t -101.07 136.9 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.147 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -134.62 164.32 27.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.3 p -123.38 110.88 15.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.89 148.6 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.152 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -104.22 100.03 9.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.804 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.7 mt -96.21 178.44 5.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -120.44 169.65 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.3 m -64.02 146.15 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.033 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.87 149.59 21.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.045 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 75.4 p -114.23 -37.28 4.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -123.65 111.57 16.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.7 m -128.15 122.51 32.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -102.1 132.32 48.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.412 ' CG ' HD21 ' A' ' 139' ' ' LEU . 90.7 m-85 -119.02 161.6 19.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -150.76 93.02 3.79 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.27 117.86 3.51 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.545 2.164 . . . . 0.0 112.34 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -67.09 -33.19 74.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.908 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.73 146.31 33.46 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.61 -14.91 24.67 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.612 2.208 . . . . 0.0 112.541 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -55.05 -34.19 63.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.104 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.412 ' CE1' ' HB3' ' A' ' 135' ' ' PRO . 22.6 t80 -73.68 -36.06 65.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.0 mt -63.27 -31.77 73.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -62.73 -23.09 67.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.071 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 48.9 mt -59.94 140.06 18.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.001 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.0 t -69.7 -30.96 68.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -133.12 67.26 77.09 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.989 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.412 ' HB3' ' CE1' ' A' ' 129' ' ' PHE . 37.3 Cg_exo -57.23 -34.0 97.02 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.634 2.223 . . . . 0.0 112.22 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.81 -44.77 92.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.86 -45.03 91.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.079 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.5 t -63.87 -39.89 87.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.419 HD23 ' CZ ' ' A' ' 188' ' ' PHE . 21.5 tp -67.02 -35.91 80.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -76.78 -32.06 57.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -65.42 -33.05 75.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.27 -35.13 28.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.155 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.7 mt -60.26 -30.0 69.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -58.71 -30.48 67.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -83.04 -34.62 26.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.93 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -66.14 136.15 55.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -99.08 -29.2 13.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.153 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -138.05 164.56 28.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.964 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.6 mt -141.65 154.31 45.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 15.5 m -144.71 141.71 29.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 37.9 m -72.72 119.61 17.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 90.7 43.51 4.81 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.523 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -131.14 122.88 27.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.745 0.307 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.23 84.96 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.055 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.4 pt -77.78 110.45 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.166 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.81 139.56 37.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.083 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 37.0 pt -128.44 144.34 38.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.175 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -138.45 142.68 39.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.792 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -167.45 -48.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.044 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -95.52 41.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 58.11 30.27 19.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.932 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -148.02 122.29 9.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.904 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.7 mp -81.42 89.12 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.125 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -67.53 166.15 15.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.83 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -117.15 137.82 52.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.27 149.2 29.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -138.73 129.59 26.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.12 113.24 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.188 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.6 mmt -68.0 -59.93 2.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -144.93 166.07 26.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 77.2 p -154.49 161.12 41.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -138.56 156.8 73.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.33 -18.48 17.88 Favored 'Cis proline' 0 C--N 1.347 0.487 0 C-N-CA 123.312 -1.537 . . . . 0.0 112.589 0.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -133.38 169.88 16.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.902 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -43.48 82.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.934 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -96.55 117.67 31.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 15.7 m -139.56 151.18 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.214 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 23.3 t -105.54 92.12 4.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.829 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.3 pt -87.48 83.4 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.198 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.2 mt -112.88 96.55 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.042 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.49 81.94 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.823 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 11.0 t -169.5 149.44 3.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.843 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.99 127.85 41.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -132.97 149.43 52.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -78.03 87.87 4.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.843 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.01 136.93 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -114.14 174.11 6.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . 0.419 ' CZ ' HD23 ' A' ' 139' ' ' LEU . 15.6 m-85 -139.41 155.48 47.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.955 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -150.55 91.0 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.056 -179.948 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.481 -0.247 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.8 m 62.14 149.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 0.0 110.972 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 m 59.8 96.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.84 -177.18 51.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.425 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 t 60.65 88.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.846 0.355 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -103.23 157.89 16.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.93 -143.97 8.28 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.455 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.1 tt -144.24 125.29 7.84 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.547 0.213 . . . . 0.0 111.02 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.76 149.55 67.01 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.355 2.037 . . . . 0.0 112.355 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.94 31.33 6.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 m -74.61 149.83 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.156 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -99.46 31.33 3.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -106.99 -60.24 1.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 60.58 178.17 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.6 mtt85 -119.9 -177.21 3.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -83.45 88.3 6.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.1 p -121.13 109.08 14.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.0 t -174.55 162.3 3.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -91.34 150.17 21.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -145.31 136.59 24.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.6 mtt180 -68.91 141.55 54.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.0 m -101.37 134.62 44.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.416 ' CD2' HG21 ' A' ' 88' ' ' ILE . 8.8 m-85 -146.89 138.49 24.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 76.0 p -66.76 138.32 57.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.2 m -59.39 -27.18 36.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.227 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.52 -27.5 57.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.034 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 32.4 mmt -57.79 -45.99 85.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.969 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.4 tp -60.92 142.61 56.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.821 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.64 174.87 5.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.14 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 144.62 146.92 4.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.419 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.54 -38.85 83.97 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.492 2.128 . . . . 0.0 112.352 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -93.34 126.16 38.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.95 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.95 -53.92 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.791 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.13 145.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.01 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.8 m -111.65 -21.15 11.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.19 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.71 -36.86 62.7 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.141 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.1 t -62.66 -39.31 84.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.016 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -31.99 71.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -78.31 -46.92 18.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.936 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.59 162.83 19.74 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.438 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.83 30.04 10.73 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.542 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -94.64 174.05 7.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.824 0.345 . . . . 0.0 110.891 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.2 pt -146.7 165.51 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.096 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mt -116.49 106.04 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.066 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 71.6 mtp -97.39 160.53 28.61 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.01 162.81 2.44 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.57 2.18 . . . . 0.0 112.301 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.4 -25.94 35.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.582 2.188 . . . . 0.0 112.348 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.4 t -58.86 -30.82 68.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.99 -32.79 73.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.088 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.1 tp -60.23 -33.18 71.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -89.1 -30.43 18.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.957 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -41.5 70.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.974 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.1 mt -54.11 -30.82 50.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.061 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.05 -28.62 17.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -23.17 57.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.7 mt -93.12 17.41 10.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.317 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 54.96 32.46 18.09 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.784 0.326 . . . . 0.0 111.171 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.6 mt -96.27 153.54 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.119 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.19 175.42 11.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.431 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 3.2 t80 -63.36 139.0 97.51 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.431 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.9 Cg_endo -76.6 162.1 92.43 Favored 'Cis proline' 0 C--N 1.348 0.55 0 C-N-CA 123.492 -1.462 . . . . 0.0 112.371 -0.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.1 mtt -130.48 65.17 1.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.1 mt -87.69 139.66 30.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -113.1 142.65 45.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.411 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 1.0 OUTLIER -99.01 108.38 21.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.4 mt -95.68 90.63 5.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.4 m -95.8 121.73 37.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -82.01 128.53 34.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.946 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.7 31.4 2.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -120.04 -42.08 2.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.94 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.29 22.47 7.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 54.49 39.83 31.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.093 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.7 159.0 15.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.922 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -150.61 139.69 21.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.2 t -158.03 148.24 20.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.932 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.411 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 66.5 m80 -115.29 115.41 26.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.978 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.8 p -124.74 167.09 15.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.74 165.23 13.44 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.419 HG23 ' CE1' ' A' ' 82' ' ' PHE . 12.0 p -95.2 141.72 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.859 0.361 . . . . 0.0 111.09 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.5 tp -119.25 -60.63 1.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -107.03 161.94 14.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.971 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CE1' HG23 ' A' ' 79' ' ' VAL . 90.0 m-85 -129.7 47.95 2.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.828 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 m -123.38 35.43 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.007 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.52 154.86 18.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.051 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.47 149.63 33.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.846 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -59.99 110.51 1.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.97 -22.7 36.78 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.643 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.416 HG21 ' CD2' ' A' ' 23' ' ' PHE . 25.7 mt -99.05 121.82 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 111.139 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 28.5 t -110.41 130.52 55.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -93.23 143.16 26.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.99 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 mp -144.89 156.54 55.43 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.07 -174.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.538 2.159 . . . . 0.0 112.283 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.69 -37.93 10.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.893 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 53.7 p-90 -61.36 -39.47 90.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.2 ttp -65.86 -40.01 91.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -37.98 86.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.82 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -74.06 -38.21 64.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.819 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -65.96 -42.01 90.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.2 mt -83.23 -16.87 44.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.204 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt 62.31 36.84 14.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.777 0.323 . . . . 0.0 110.9 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.7 mt -84.94 -177.42 6.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -134.42 168.63 18.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.06 91.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.84 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.411 ' HA2' ' CE2' ' A' ' 23' ' ' PHE . . . 106.68 43.74 1.4 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.487 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.08 123.62 7.88 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.531 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.9 mt -72.94 131.21 41.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.809 0.338 . . . . 0.0 110.951 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.72 150.49 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.002 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -72.11 143.37 49.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.36 108.62 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.134 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.49 123.74 34.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.922 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.5 p -81.49 121.78 26.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.4 m -125.94 155.07 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.57 100.81 9.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.776 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.8 mt -98.6 178.92 4.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -115.71 170.8 8.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 m -70.36 135.03 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.09 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.28 145.45 43.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.8 p -111.53 -31.95 6.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.914 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -129.53 110.3 11.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 93.5 p -122.58 119.0 29.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -106.17 130.87 53.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -117.86 158.81 24.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -143.05 97.93 5.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.57 110.89 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.442 2.094 . . . . 0.0 112.47 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -63.42 -31.4 72.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.1 m -114.33 149.03 41.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.94 -14.87 32.62 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.618 2.212 . . . . 0.0 112.584 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -55.59 -35.65 66.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.053 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -75.53 -42.98 51.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.916 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.07 -31.2 69.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.951 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.83 -28.19 69.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.002 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.8 mt -62.74 137.31 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.093 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.3 t -68.95 -34.28 75.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -119.51 77.31 19.5 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.86 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.38 -28.31 22.45 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.619 2.212 . . . . 0.0 112.285 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -70.35 -46.67 63.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.15 -31.19 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.157 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 26.3 t -78.78 -31.53 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.095 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.5 tp -84.5 -34.75 23.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -70.85 -30.44 66.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.976 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -73.43 -31.63 63.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.17 -31.64 64.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.118 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 82.2 mt -59.4 -30.44 68.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.5 mmp_? -62.42 -26.65 68.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -95.97 26.72 3.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.091 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -135.84 152.65 51.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.835 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.13 -34.25 6.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 6.8 t -141.78 158.91 43.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.965 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.93 137.27 36.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.876 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.67 149.4 40.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 43.8 m -69.49 104.8 2.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.82 33.3 3.57 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.552 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.35 111.8 24.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.759 0.314 . . . . 0.0 110.928 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.53 79.95 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.075 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 3.2 pt -63.79 159.07 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.152 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -125.05 93.0 3.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.085 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 10.0 pt -85.53 152.72 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.184 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -154.85 140.89 18.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -161.89 -47.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.97 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -93.75 45.19 1.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 55.65 29.48 13.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.086 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -149.34 122.19 8.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.868 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.3 mp -85.12 108.53 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -80.1 173.78 12.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -123.95 110.07 14.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.31 117.52 21.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.826 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -111.14 133.22 53.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.5 127.16 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.087 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 23.9 mmm -85.6 -54.71 4.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -142.73 160.19 40.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.952 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.6 p -159.08 146.47 17.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.909 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -129.07 159.86 66.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.95 -41.39 0.97 Allowed 'Cis proline' 0 C--N 1.347 0.48 0 C-N-CA 123.238 -1.567 . . . . 0.0 112.366 -0.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -106.29 172.43 6.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -57.86 -48.71 79.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.061 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -93.29 110.8 22.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.001 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 15.4 m -118.72 133.64 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.167 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 22.2 t -89.73 99.95 12.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.5 pt -94.08 87.26 2.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.249 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.2 mt -118.29 84.59 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.052 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.36 75.35 0.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 49.6 t -153.27 153.99 33.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.903 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.83 129.73 40.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 13.0 ptt? -140.21 179.23 6.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.869 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.45 112.63 25.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.81 127.52 44.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.7 171.81 7.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.878 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -134.74 141.89 46.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -111.75 83.23 1.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.121 179.971 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.9 -69.93 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.879 0.371 . . . . 0.0 110.823 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m 59.4 101.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.009 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.7 133.6 1.78 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.532 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.2 p -71.48 -50.32 32.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.828 0.347 . . . . 0.0 110.867 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.3 m 62.29 119.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.939 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.94 176.33 42.28 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.443 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.3 pt -64.77 155.67 81.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.775 0.322 . . . . 0.0 111.072 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.14 58.66 4.32 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.703 2.269 . . . . 0.0 112.507 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.1 mtt85 48.09 -168.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.299 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.3 m -132.77 176.47 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.03 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -106.16 36.44 2.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -110.56 102.37 10.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.803 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -152.19 -169.67 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.937 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 61.14 166.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -102.85 128.39 49.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.0 p -160.03 112.8 2.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.1 t -176.86 159.46 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.935 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -95.94 121.85 38.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.814 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -115.48 147.41 40.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -75.17 129.54 37.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.6 p -99.01 133.33 43.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.972 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.417 ' CD2' HG22 ' A' ' 88' ' ' ILE . 87.4 m-85 -136.3 178.45 7.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.66 146.07 27.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.1 m -58.41 -26.15 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.257 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.73 -30.06 63.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.042 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 10.5 mmm -71.44 -30.46 66.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.965 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tp -58.91 91.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.95 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.38 -76.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.093 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.88 173.68 17.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.507 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.19 -37.64 7.9 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.642 2.228 . . . . 0.0 112.328 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -107.91 129.6 55.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.918 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.67 -68.5 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.2 mmm-85 -111.24 154.96 23.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.53 28.93 5.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.38 -37.34 3.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.994 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.4 m -56.77 -40.18 68.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.238 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -78.03 -31.06 50.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -78.53 -31.22 47.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.67 -178.57 20.14 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.564 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.75 53.24 0.63 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.544 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -114.74 165.04 13.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.851 0.357 . . . . 0.0 110.852 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.1 pt -133.38 174.4 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mt -125.51 98.39 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.414 ' HE2' ' CZ ' ' A' ' 64' ' ' PHE . 3.9 mtm -98.54 155.51 36.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.782 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.71 154.9 40.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.581 2.188 . . . . 0.0 112.211 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.8 -26.42 17.71 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.619 2.213 . . . . 0.0 112.566 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.6 p -58.79 -31.19 68.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.973 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.14 -30.26 69.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.261 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.417 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 33.8 tp -74.69 -30.14 61.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.998 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.18 -33.91 19.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.914 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.73 -38.88 62.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.0 mt -59.1 -32.84 70.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.043 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -86.98 -30.06 21.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -22.61 62.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.12 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.1 mt -93.93 19.19 9.31 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.244 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 55.12 30.47 14.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.871 0.367 . . . . 0.0 111.14 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.7 mt -99.03 120.81 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.098 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -109.59 168.35 9.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.965 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.441 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -60.17 144.58 87.02 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.89 158.27 96.89 Favored 'Cis proline' 0 C--N 1.348 0.5 0 C-N-CA 123.485 -1.464 . . . . 0.0 112.344 0.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 9.5 mtt -123.7 73.52 1.2 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 mt -91.26 134.9 34.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.853 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.414 ' CZ ' ' HE2' ' A' ' 45' ' ' MET . 80.8 m-85 -102.8 141.3 35.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.401 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 13.5 tttp -94.97 97.6 10.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.4 mt -76.98 76.83 3.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 m -83.16 95.55 8.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -74.79 129.44 37.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.933 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -98.14 35.58 1.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -111.63 -35.66 5.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.841 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.1 t -151.94 29.72 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.973 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 58.72 35.83 24.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.002 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -81.82 143.31 31.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.929 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -144.22 135.02 25.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 t -159.97 95.25 1.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.401 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 62.0 m80 -63.68 115.75 5.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.0 p -121.91 151.31 40.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.37 138.91 15.06 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.519 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.3 146.82 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 111.066 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.9 tp -131.29 -56.65 1.02 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -91.76 142.85 27.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.841 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.417 ' CD2' ' HB2' ' A' ' 50' ' ' LEU . 71.8 m-85 -128.3 55.62 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 m -137.07 35.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.177 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.11 161.89 13.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.109 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.62 155.53 38.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.91 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.46 127.37 31.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.948 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.35 27.69 65.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.558 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.417 HG22 ' CD2' ' A' ' 23' ' ' PHE . 29.8 mt -148.75 99.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 111.072 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 13.7 m -100.9 134.85 43.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.32 151.35 22.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.1 mp -145.29 155.59 54.17 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.894 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.28 -176.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.528 2.152 . . . . 0.0 112.355 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -87.51 -50.67 6.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.944 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -61.96 -37.53 85.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.856 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -38.26 90.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -47.22 70.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.801 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -38.08 89.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.814 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -59.55 -31.28 69.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.3 mt -98.82 -15.25 19.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.234 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.9 mt 61.7 41.25 12.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 0.0 110.872 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mt -79.33 159.04 27.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.828 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -111.13 -178.95 3.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.869 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.53 106.42 1.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.951 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.415 ' HA2' ' CZ ' ' A' ' 23' ' ' PHE . . . 85.8 33.77 14.93 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.545 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.74 136.03 17.48 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.52 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 34.5 mt -88.6 128.86 35.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.11 146.97 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.156 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -69.16 128.87 38.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.17 99.02 6.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.087 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -124.09 128.48 49.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.4 p -88.78 100.49 13.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 m -103.43 162.09 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.126 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -97.05 116.44 29.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 65.2 mt -115.4 170.78 8.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -127.4 164.56 21.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.926 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.2 m -62.65 140.47 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.63 148.11 37.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.124 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.9 p -105.0 -36.09 7.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.824 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -127.61 109.63 11.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 m -108.9 126.57 53.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -124.41 134.17 53.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.8 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -127.88 159.32 35.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -137.06 95.31 12.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.62 107.33 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.581 2.188 . . . . 0.0 112.347 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -59.27 -31.22 68.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.0 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.84 146.6 35.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.98 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.53 -16.02 27.37 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.63 2.22 . . . . 0.0 112.515 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.22 -42.6 73.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.009 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -60.21 -40.95 91.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.5 -28.33 69.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -60.68 -24.4 65.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.992 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 50.7 mt -62.72 136.9 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.986 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 31.5 m -59.06 -40.2 84.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -131.63 86.93 47.53 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.77 -28.03 25.7 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.528 2.152 . . . . 0.0 112.272 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -63.34 -31.16 72.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.3 -32.7 49.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.131 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.37 -30.83 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.179 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.417 HD23 ' CZ ' ' A' ' 188' ' ' PHE . 46.5 tp -75.16 -30.39 60.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -85.54 -38.83 18.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.014 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -65.3 -23.98 67.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.25 -33.39 61.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.291 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 23.3 mt -63.65 -22.88 67.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.163 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -29.25 40.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.123 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -87.08 -29.71 21.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.981 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -88.28 140.6 29.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -103.44 -30.37 10.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 4.4 t -131.64 163.56 27.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.8 mt -141.15 164.78 29.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.23 129.09 13.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 52.3 m -59.95 110.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 98.41 51.61 1.42 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.539 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.23 130.25 28.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 110.866 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.5 107.07 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.069 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.3 pt -105.09 106.08 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.144 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.42 127.07 32.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.088 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 36.9 pt -118.8 148.39 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.076 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -146.7 134.56 21.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -149.73 -47.42 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.907 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -100.42 44.31 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.85 30.36 19.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.88 115.93 9.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 mp -81.11 86.59 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.09 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -66.9 158.4 30.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.44 136.19 50.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.954 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.3 mt -145.6 154.22 41.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -144.22 125.21 14.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.7 104.47 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -51.5 51.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.64 164.23 37.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.97 142.17 13.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 39.4 mttt -118.55 157.48 49.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.2 -27.08 8.82 Favored 'Cis proline' 0 C--N 1.347 0.453 0 C-N-CA 123.268 -1.555 . . . . 0.0 112.355 0.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.98 174.1 8.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.852 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -57.66 -45.23 85.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.51 111.55 23.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.055 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.7 m -128.63 140.7 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 3.9 t -97.76 87.69 4.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.1 pt -83.63 82.95 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.1 mt -117.97 89.31 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.161 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.84 88.36 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.07 173.56 12.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.838 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.41 120.09 39.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -135.32 174.04 11.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.837 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -105.24 97.74 7.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.947 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.95 145.45 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.04 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -127.38 169.75 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . 0.417 ' CZ ' HD23 ' A' ' 139' ' ' LEU . 7.0 m-85 -127.42 143.14 51.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.947 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -134.94 97.73 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.916 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.137 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.0 m 60.37 106.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 110.949 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.1 p -64.49 -69.45 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.828 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.95 -132.45 17.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.499 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.8 p -134.04 124.59 26.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.329 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.4 m -136.89 178.47 7.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.826 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.53 -169.81 19.54 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.619 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.7 pt -150.07 154.24 36.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.704 0.288 . . . . 0.0 111.097 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.27 63.01 2.08 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.587 2.191 . . . . 0.0 112.275 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.38 159.29 32.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.863 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t 55.0 29.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -98.23 139.83 33.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.844 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -177.26 -39.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.838 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -90.23 51.58 2.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.855 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.55 117.38 7.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.11 107.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.002 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.7 p -151.21 110.43 3.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 t -168.55 171.05 9.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -95.7 126.65 41.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -125.09 143.05 51.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.3 mtt-85 -66.73 144.79 56.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.008 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.6 p -114.92 120.95 41.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.955 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -127.45 177.0 7.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.975 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -91.54 153.36 19.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.24 -28.3 40.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.144 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.02 -29.37 63.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.088 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.22 -31.7 69.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.417 HD12 ' CE2' ' A' ' 90' ' ' TYR . 17.3 tp -79.94 154.66 28.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.2 168.98 11.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.51 161.27 34.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.52 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.24 -40.38 69.85 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.639 2.226 . . . . 0.0 112.259 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -156.88 -74.48 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -163.43 141.8 7.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.8 mmt85 -138.24 104.54 5.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.17 35.77 1.7 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -110.04 -30.23 7.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.9 t -77.16 -28.42 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.197 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.81 20.15 10.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -118.22 -38.05 3.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.957 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.34 -154.25 26.33 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.456 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.38 87.73 0.45 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.51 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.0 149.91 31.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.791 0.329 . . . . 0.0 110.843 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.4 pt -138.14 175.52 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.189 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 mp -129.77 111.22 21.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.092 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 1.4 mtm -105.33 161.0 24.12 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.38 154.01 12.28 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.577 2.185 . . . . 0.0 112.267 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.93 -34.9 68.76 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.563 2.175 . . . . 0.0 112.278 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.81 -29.75 68.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.63 -46.57 86.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.182 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.402 ' HB2' ' CD1' ' A' ' 82' ' ' PHE . 41.3 tp -61.93 -42.65 99.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.956 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.98 -38.92 76.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -31.62 68.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.811 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.4 mt -63.6 -37.65 88.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.71 10.66 25.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.308 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.5 -25.6 9.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.713 0.292 . . . . 0.0 110.969 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.0 mt -94.48 20.15 8.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.313 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.84 40.12 19.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.889 0.375 . . . . 0.0 111.004 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.475 HG23 HD13 ' A' ' 58' ' ' ILE . 20.1 mm -95.12 127.56 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.097 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.47 158.91 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.909 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.43 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -66.37 143.04 98.08 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.43 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.9 Cg_endo -76.81 160.19 95.24 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 123.468 -1.472 . . . . 0.0 112.364 0.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.6 mtt -112.46 53.7 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.3 mt -74.68 120.73 20.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.9 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -85.57 168.62 14.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -121.75 102.08 7.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.0 mt -85.76 105.02 15.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.958 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.1 m -104.1 101.84 11.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -77.84 123.32 26.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -98.87 31.56 2.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -129.52 -45.93 1.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.2 m -113.48 15.24 19.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.257 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 53.22 32.29 13.12 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.811 0.338 . . . . 0.0 111.134 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.1 mmt-85 -86.53 151.34 23.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.96 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.3 ttt -149.13 107.46 3.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.815 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.7 t -130.29 163.61 26.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.419 ' CE1' ' HB1' ' A' ' 176' ' ' ALA . 52.0 m80 -122.14 105.46 10.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.7 p -98.27 175.59 6.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.941 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -137.68 139.27 10.3 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.488 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.6 p -82.57 149.97 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 111.03 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.4 tp -136.43 -59.08 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.953 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -92.41 160.57 15.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.402 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 96.6 m-85 -142.18 68.59 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.94 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.9 m -150.96 31.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.156 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.04 179.99 7.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -95.39 156.64 16.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -59.93 121.19 11.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.961 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.75 28.06 63.74 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 29.5 mt -146.93 107.79 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 111.165 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 89.0 m -108.35 133.03 53.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.417 ' CE2' HD12 ' A' ' 28' ' ' LEU . 33.2 m-85 -90.67 134.35 34.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 mt -136.63 149.94 68.71 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.878 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.48 -172.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.528 2.152 . . . . 0.0 112.34 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -96.73 -41.34 8.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.942 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.444 ' CD2' ' N ' ' A' ' 95' ' ' MET . 65.2 p-90 -61.32 -44.07 97.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.924 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.444 ' N ' ' CD2' ' A' ' 94' ' ' TRP . 31.8 ttm -69.21 -38.19 78.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.982 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -31.39 72.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -85.06 -39.92 17.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -59.91 -34.21 72.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.824 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.1 mt -90.02 -12.93 37.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.219 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.5 mt 62.36 38.7 12.85 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.822 0.344 . . . . 0.0 110.873 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.4 mt -82.89 178.89 7.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -136.24 -179.94 5.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.07 127.51 33.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.84 28.25 73.23 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.532 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -84.93 131.77 10.64 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.501 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.5 mt -84.57 125.15 32.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.772 0.32 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.07 137.02 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.066 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.44 119.36 11.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.72 153.03 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -156.57 159.46 38.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.43 116.74 31.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.58 158.51 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.078 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -113.06 111.55 22.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.3 mt -106.49 170.25 8.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -126.44 167.78 15.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.1 m -57.76 159.26 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.259 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -98.96 153.03 19.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.048 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.0 t -111.08 -30.97 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -143.56 105.66 4.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.849 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 m -111.97 140.64 46.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -119.94 126.75 51.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.964 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -117.73 154.35 31.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -135.5 95.22 14.59 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.86 110.72 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.515 2.143 . . . . 0.0 112.39 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -62.98 -34.57 77.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 m -106.98 147.7 35.59 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.949 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.22 -19.14 26.22 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.572 2.181 . . . . 0.0 112.417 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -55.35 -36.21 66.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.072 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -69.66 -45.34 68.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 25.8 mt -60.59 -32.96 72.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.834 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.82 -27.72 69.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.989 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 37.0 mt -60.98 131.0 25.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.981 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.2 t -63.03 -42.15 99.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.942 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.44 78.65 3.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.884 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.39 -29.89 16.16 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.593 2.195 . . . . 0.0 112.352 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -65.52 -31.11 72.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.99 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.6 -49.86 17.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.084 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.411 HG12 ' CZ ' ' A' ' 159' ' ' TYR . 21.5 t -62.53 -31.05 50.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.089 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 42.4 tp -79.8 -37.49 35.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -80.26 -30.57 38.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -67.18 -30.76 70.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.18 -29.59 20.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 16.3 mt -58.49 -29.9 66.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.954 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -59.24 -32.62 70.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -74.74 -31.21 61.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.967 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -81.98 146.63 29.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -106.59 -29.55 9.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.083 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 3.9 t -136.98 164.97 27.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.918 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.3 mt -140.64 173.93 11.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 63.5 m -155.5 143.65 20.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.8 t -81.53 104.52 12.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.98 36.89 2.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.421 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -131.37 146.27 52.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 0.0 110.872 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.61 108.35 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.9 pt -109.41 120.89 61.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.182 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.63 138.95 38.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.2 pt -126.66 137.23 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.073 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -143.99 145.87 32.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.959 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.411 ' CZ ' HG12 ' A' ' 138' ' ' VAL . 7.3 p90 -158.01 -47.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -108.76 43.99 1.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 61.11 31.69 19.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -137.91 99.85 4.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.9 mp -76.51 96.72 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.112 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.76 128.62 34.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.871 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -81.29 131.97 35.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.37 154.0 45.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -149.17 114.58 5.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.8 151.88 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.101 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.3 mmt -118.05 -43.98 2.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.943 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -145.81 157.81 43.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.2 p -157.61 140.24 14.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -119.5 152.51 53.1 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.885 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.56 -27.63 8.37 Favored 'Cis proline' 0 C--N 1.346 0.446 0 C-N-CA 123.343 -1.524 . . . . 0.0 112.453 -0.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.68 173.62 6.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -46.39 85.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.967 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.419 ' HB1' ' CE1' ' A' ' 76' ' ' HIS . . . -98.79 121.46 40.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.066 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.38 132.42 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.065 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 24.8 p -82.17 94.83 7.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.806 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.3 pt -81.94 82.46 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.148 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 4.5 mt -114.98 83.62 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.995 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.26 85.08 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 8.0 t -165.03 142.05 5.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.58 116.26 26.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -125.01 177.77 5.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.942 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -102.2 120.06 39.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.32 129.48 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.119 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -108.43 172.05 7.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -141.62 133.86 27.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -117.07 95.52 5.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.084 179.919 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.526 -0.229 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -95.77 -33.9 12.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.835 0.35 . . . . 0.0 110.909 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 m -112.46 -69.25 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.811 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.68 28.59 5.02 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.512 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.9 p -127.49 -45.32 1.5 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.903 0.382 . . . . 0.0 110.877 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.4 m -120.61 114.47 21.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.72 -126.16 0.98 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.528 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.1 mt -126.67 75.49 74.91 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.83 109.59 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.485 2.124 . . . . 0.0 112.329 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -100.85 88.98 3.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.66 139.08 18.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.103 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -106.21 168.14 9.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.938 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.51 154.2 40.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.967 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -96.11 42.58 1.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.95 150.61 25.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.16 104.58 0.32 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.872 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.9 p -141.08 114.95 9.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.6 t -176.93 170.13 2.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.831 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -97.25 157.0 16.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.819 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -150.62 147.61 27.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.838 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.0 mtp85 -72.47 124.34 24.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.3 p -92.72 127.21 38.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -135.44 143.37 45.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.2 t -59.75 169.23 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.969 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.5 m -96.03 20.2 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.332 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.2 p -89.03 -30.92 18.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.807 0.337 . . . . 0.0 110.823 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -59.64 -39.99 86.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.815 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.8 87.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.38 -174.06 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.131 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.43 153.7 6.56 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.484 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.15 -27.54 29.25 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.59 2.193 . . . . 0.0 112.306 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.64 -47.72 3.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 62.86 120.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -76.5 143.19 40.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.869 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.0 t -118.92 33.68 5.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -110.02 -31.31 7.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.9 m -59.3 -36.61 64.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.196 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -70.79 -36.58 73.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -95.26 82.04 3.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.97 142.8 5.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.446 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -66.15 77.76 0.12 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.513 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.68 117.87 19.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 0.0 110.832 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.3 pt -112.5 170.53 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.101 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.2 mt -119.5 120.3 63.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.052 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 85.7 mtp -112.88 154.38 44.92 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.11 153.2 16.64 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.57 2.18 . . . . 0.0 112.31 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.92 -28.74 40.69 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.466 2.111 . . . . 0.0 112.304 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.0 p -64.38 -29.11 70.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.995 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.61 -36.4 71.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.249 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.412 HD13 ' CE1' ' A' ' 82' ' ' PHE . 8.2 tp -71.08 -45.78 63.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.938 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -68.94 -31.21 69.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -73.64 -50.64 20.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.976 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.4 mt -63.45 -35.38 80.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.2 p -77.21 -29.84 54.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.978 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.49 -20.44 47.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.9 mt -94.46 19.22 9.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.283 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.1 t30 54.88 32.22 17.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.189 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.7 mt -91.87 112.91 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.15 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.8 p -99.33 169.91 9.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.939 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.439 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -65.07 143.03 98.79 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.439 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 77.1 Cg_endo -77.34 169.02 75.15 Favored 'Cis proline' 0 C--N 1.348 0.502 0 C-N-CA 123.477 -1.468 . . . . 0.0 112.462 0.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.5 mtt -130.08 38.72 3.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.912 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.15 137.12 58.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.966 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.408 ' CD1' ' CG1' ' A' ' 109' ' ' VAL . 39.9 m-85 -100.24 160.57 14.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.414 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 13.9 tttt -109.7 84.32 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.88 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.7 mt -69.62 75.18 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.783 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.76 103.39 6.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.981 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.54 118.22 13.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.915 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.96 33.58 2.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -131.62 -46.1 0.97 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 63.0 m -111.87 15.43 20.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.341 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.61 38.93 29.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.843 0.354 . . . . 0.0 111.084 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.46 163.07 12.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.0 ttp -150.13 114.1 5.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.847 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.5 m -134.9 141.64 46.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.994 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.425 ' CE1' ' CB ' ' A' ' 176' ' ' ALA . 42.9 m80 -108.67 118.53 37.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.944 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 28.2 p -128.86 145.97 51.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.928 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.96 138.92 14.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.499 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.37 148.12 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.852 0.358 . . . . 0.0 111.107 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.2 tp -113.59 -66.58 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -114.01 172.34 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.988 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.412 ' CE1' HD13 ' A' ' 50' ' ' LEU . 76.8 m-85 -133.39 66.45 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.853 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.4 m -137.2 31.75 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.165 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.64 178.63 5.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.134 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -96.58 156.46 16.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -60.9 124.19 19.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.97 28.57 62.3 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.487 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.6 mt -146.93 87.99 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 0.0 111.088 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 96.7 m -94.32 120.0 33.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -84.6 146.33 27.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.925 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.64 160.07 52.03 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.69 -174.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.568 2.179 . . . . 0.0 112.325 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -98.9 -31.46 11.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.986 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -72.31 -38.58 68.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 36.8 ttm -64.52 -35.69 81.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -61.53 -48.77 79.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.873 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -61.83 -42.69 99.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -59.98 -50.24 74.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.2 mt -76.08 -20.62 57.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.5 mt 63.23 44.03 5.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.414 . . . . 0.0 110.815 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mt -86.52 -175.75 5.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.869 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -127.25 172.37 10.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -70.0 78.8 0.49 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.1 35.96 1.07 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.441 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.66 150.17 20.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.451 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.1 mt -92.2 124.6 36.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.938 0.399 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.12 132.4 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.11 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.97 111.17 2.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.408 ' CG1' ' CD1' ' A' ' 64' ' ' PHE . 19.7 t -105.56 128.73 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.09 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -145.18 118.52 8.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.7 p -69.86 123.02 20.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.96 168.98 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -131.31 116.17 17.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.85 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 mt -115.76 179.42 3.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.85 174.63 5.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.3 m -64.88 172.36 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.102 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -105.81 153.2 22.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 38.5 p -113.48 -36.36 4.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -131.98 97.52 4.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 94.9 p -101.43 109.92 21.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -98.65 119.45 37.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -113.68 147.76 37.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.847 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.49 89.86 51.23 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -51.66 102.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.553 2.169 . . . . 0.0 112.288 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -59.48 -30.78 68.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.969 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.5 m -109.79 145.91 32.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.933 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.8 -16.3 23.53 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.588 2.192 . . . . 0.0 112.555 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -55.17 -33.45 62.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.138 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -77.11 -40.33 46.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.917 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 39.5 mt -64.89 -30.61 71.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.48 -25.13 67.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.026 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 23.1 mt -60.05 138.25 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.001 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.7 m -65.6 -34.42 78.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.066 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -128.36 72.55 80.19 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.981 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.62 -32.77 91.45 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.617 2.211 . . . . 0.0 112.275 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -60.01 -47.72 84.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.964 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.4 -45.49 90.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.06 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.66 -39.48 81.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.181 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.1 tp -70.9 -41.91 70.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.913 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -68.01 -31.07 70.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -69.14 -31.36 69.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.5 -37.8 35.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.138 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 59.1 mt -61.5 -26.63 68.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.045 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -56.48 -30.37 62.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -82.74 -49.07 10.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.906 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -60.07 152.86 23.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -107.07 -29.21 9.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.138 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.6 m -146.86 167.87 22.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.953 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.1 mt -142.97 170.19 16.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 63.4 m -153.6 136.65 15.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.8 t -60.67 121.02 11.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 91.54 28.96 12.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.546 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.46 126.57 52.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.942 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.6 t -89.38 91.09 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.089 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 4.4 pt -87.55 154.63 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.136 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -129.32 102.36 6.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.6 pt -90.93 147.08 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -140.6 145.86 37.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -176.54 -38.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.999 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -99.2 40.3 1.22 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 56.82 29.28 15.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.033 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.31 110.79 2.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.6 mp -68.47 94.43 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -61.68 145.77 51.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -95.41 132.79 40.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.931 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.01 158.22 41.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -156.91 139.01 14.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.855 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.6 t -80.9 147.85 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 59.6 mmm -117.41 -40.75 3.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.7 151.38 27.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 64.3 p -151.2 149.35 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -122.22 152.87 61.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.35 -27.32 8.62 Favored 'Cis proline' 0 C--N 1.346 0.435 0 C-N-CA 123.281 -1.55 . . . . 0.0 112.389 -0.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -124.5 168.98 12.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.735 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.59 -49.18 75.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.98 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.425 ' CB ' ' CE1' ' A' ' 76' ' ' HIS . . . -92.85 110.73 22.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.033 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 11.5 m -128.52 148.72 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.19 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.7 95.7 8.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.2 pt -86.97 83.3 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.087 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 28.2 mm -112.73 90.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 61.17 55.29 3.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 6.1 t -135.83 143.27 45.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.19 134.48 41.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.869 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 2.1 ptt? -139.65 164.52 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -78.97 76.25 5.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.785 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 28.6 t -63.3 125.82 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.091 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.32 162.22 16.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -124.17 128.98 50.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -90.97 94.21 9.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.12 179.948 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m -87.26 -66.49 0.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.0 110.941 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.3 p -65.23 109.11 2.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.5 94.19 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.516 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.47 174.06 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.783 0.325 . . . . 0.0 110.912 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.78 37.9 18.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.958 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.4 146.61 17.88 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.559 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.6 tp -147.97 74.69 11.02 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.942 0.401 . . . . 0.0 111.037 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.17 148.85 63.35 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.579 2.186 . . . . 0.0 112.309 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.44 144.9 46.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.51 106.82 13.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -157.04 78.06 0.89 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.24 -37.99 3.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.931 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -138.7 166.82 23.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 61.36 113.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -87.62 129.65 35.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.7 p -154.57 124.34 6.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -175.3 179.34 1.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.952 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -107.07 155.17 20.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -155.23 152.6 29.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.6 mtt-85 -82.86 134.58 35.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.1 m -102.23 128.14 48.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -138.38 175.19 9.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.949 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.5 t -86.19 -179.98 6.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.9 m -95.62 20.08 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.347 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 m -96.69 -19.45 18.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.172 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 36.1 mtp -93.88 20.06 8.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.282 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.17 -57.03 2.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.847 0.356 . . . . 0.0 110.887 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.93 -174.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.15 174.13 18.02 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.34 -35.29 14.18 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.582 2.188 . . . . 0.0 112.301 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -126.82 122.33 34.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -106.24 150.01 26.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.29 155.46 42.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.9 p -97.89 27.6 4.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.977 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.62 11.81 38.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.161 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.72 -35.11 3.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.78 0.324 . . . . 0.0 111.078 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -80.45 -31.34 37.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -83.47 91.19 7.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.87 178.27 15.62 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.55 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.73 31.56 8.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.557 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -89.17 135.53 33.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.81 0.338 . . . . 0.0 110.782 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.8 pt -128.93 167.75 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.166 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.0 mt -120.3 140.81 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.176 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.09 158.13 76.58 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.85 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.79 161.42 3.15 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.524 2.149 . . . . 0.0 112.315 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.83 -25.81 32.82 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.648 2.232 . . . . 0.0 112.302 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.7 p -58.95 -38.4 78.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.979 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.32 -33.11 70.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.214 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.5 tp -62.01 -51.58 67.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.82 -31.19 67.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.41 -43.91 63.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.928 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 mt -58.18 -52.25 66.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -65.25 -29.74 70.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -76.58 -26.04 54.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.02 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.9 mt -94.51 20.09 8.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.227 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 m120 58.24 35.51 25.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.866 0.365 . . . . 0.0 111.058 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.4 mt -102.62 116.74 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 t -114.17 173.56 6.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.444 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -68.1 144.09 96.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.7 Cg_endo -77.08 159.56 95.53 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 123.446 -1.481 . . . . 0.0 112.327 -0.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 19.1 mtt -125.35 59.0 1.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.983 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 88.8 mt -74.93 114.99 14.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.859 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.421 ' CE2' ' HB ' ' A' ' 79' ' ' VAL . 17.3 m-85 -81.68 133.37 35.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.857 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -85.66 93.23 8.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.037 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.9 mt -78.36 76.85 4.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.6 m -90.02 103.17 15.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.9 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -67.14 127.23 31.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -98.92 32.17 2.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.44 -43.84 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 73.4 m -123.56 23.07 8.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 54.43 31.33 14.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.092 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.33 157.82 23.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.826 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.92 131.91 10.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.7 t -159.95 114.3 2.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.964 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.42 ' CD2' HG23 ' A' ' 112' ' ' VAL . 12.0 m80 -79.74 122.99 27.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.0 p -117.29 150.73 38.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.949 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.86 129.36 9.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.417 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.421 ' HB ' ' CE2' ' A' ' 64' ' ' PHE . 10.8 p -69.44 147.36 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 111.094 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -130.41 -59.74 1.02 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.818 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -110.11 146.91 34.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.743 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -113.88 49.52 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.06 79.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.147 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -132.31 173.36 11.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.64 162.93 27.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -66.59 109.92 2.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.02 34.94 54.76 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.483 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 26.8 mt -144.01 91.62 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.81 0.338 . . . . 0.0 111.085 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 97.0 m -80.67 134.52 35.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -99.63 127.38 45.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.19 157.74 76.27 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.849 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.57 -172.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.591 2.194 . . . . 0.0 112.283 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -90.58 -39.02 12.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -69.61 -42.86 73.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.2 ttp -61.08 -31.31 70.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -31.5 61.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.827 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -81.55 -37.13 28.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.894 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -68.62 -45.13 72.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.7 mt -68.83 -23.87 64.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.061 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.8 mt 66.27 48.79 1.57 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.803 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.2 mt -96.36 -176.26 3.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.78 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.31 174.77 10.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -59.85 92.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.02 28.1 7.49 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -70.44 130.0 20.47 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.491 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 64.5 mt -87.82 126.95 35.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.807 0.337 . . . . 0.0 110.927 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.53 156.42 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -79.67 125.01 29.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.35 105.7 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.097 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -125.45 133.56 52.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.8 p -81.92 108.56 15.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.989 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.42 HG23 ' CD2' ' A' ' 76' ' ' HIS . 6.8 m -111.2 156.21 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -107.57 118.04 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.411 HD12 ' CD2' ' A' ' 76' ' ' HIS . 13.1 mt -118.02 157.15 27.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -109.56 169.83 8.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.7 m -64.85 139.82 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.101 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.75 149.33 31.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.3 p -107.33 -37.85 6.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -128.04 125.22 38.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.8 p -129.74 140.23 51.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.023 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -131.23 125.51 33.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.824 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.42 ' CD1' HD23 ' A' ' 139' ' ' LEU . 17.1 m-85 -113.41 147.62 37.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.982 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -131.06 92.44 33.38 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.779 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.18 116.58 2.54 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.561 2.174 . . . . 0.0 112.455 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -73.62 -31.45 63.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -106.8 146.93 34.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.27 -14.77 28.5 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.582 2.188 . . . . 0.0 112.461 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.0 -40.07 75.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.011 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -71.87 -38.44 70.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 84.9 mt -64.95 -31.84 73.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -62.42 -25.62 68.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 32.9 mt -66.01 135.38 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.089 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.2 t -66.93 -37.86 85.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -119.07 75.75 14.73 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.17 -30.27 16.28 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.631 2.221 . . . . 0.0 112.311 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -37.01 84.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.48 -44.33 67.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 29.9 t -63.03 -44.73 99.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.012 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.42 HD23 ' CD1' ' A' ' 122' ' ' PHE . 16.0 tp -69.26 -31.58 70.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.819 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.01 -31.43 62.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.914 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -78.79 -34.28 45.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.861 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.23 -35.7 66.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.8 mt -59.73 -25.73 65.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.983 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 -55.4 -30.57 60.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.09 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.24 -31.21 30.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -71.24 140.53 50.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -101.12 -29.59 12.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.105 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 18.3 t -148.76 158.36 44.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.954 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.1 mt -134.34 150.92 50.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.0 m -128.32 148.51 50.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 26.5 m -76.01 101.72 5.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 103.51 48.17 1.23 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.462 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -134.0 115.16 14.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.792 0.329 . . . . 0.0 110.931 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.3 t -72.54 99.25 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 37.3 pt -97.13 143.91 11.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.157 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -107.97 150.72 26.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.125 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.5 pt -141.15 139.55 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.125 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -127.39 156.66 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -177.43 -47.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -103.02 42.65 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.64 31.04 20.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.915 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.09 126.42 9.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.4 mp -86.9 101.12 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -79.17 123.95 27.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.86 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -87.47 131.48 34.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.5 mt -143.69 147.34 34.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.827 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -127.06 127.73 45.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.14 131.91 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 14.2 mmm -87.57 -55.57 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.28 160.02 42.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 3.0 p -160.07 119.08 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -96.83 155.77 37.27 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.96 -43.18 0.67 Allowed 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.326 -1.531 . . . . 0.0 112.444 0.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.29 174.48 5.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.935 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -59.13 -48.79 80.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.74 113.02 25.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.084 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 28.2 m -129.54 139.34 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 11.3 t -91.8 98.29 11.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.9 pt -90.91 80.35 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.5 mt -108.41 83.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.08 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 60.94 78.76 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 14.3 t -153.49 148.36 26.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.14 121.91 28.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -144.14 154.04 42.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.16 119.28 19.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.15 109.49 27.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.164 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.8 169.61 9.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -142.12 109.64 5.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -112.01 105.03 13.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.117 179.932 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.134 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -115.22 -174.89 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 m 60.24 105.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.13 -121.8 5.73 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.473 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -71.63 178.37 3.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.323 . . . . 0.0 110.888 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.3 121.03 0.85 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.936 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.97 -149.82 51.54 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.549 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.8 pt -140.4 91.78 9.57 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.616 0.246 . . . . 0.0 111.139 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.12 127.98 16.84 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.552 2.168 . . . . 0.0 112.335 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -106.68 114.01 27.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.41 149.25 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.145 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -132.21 -46.79 0.92 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.826 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -94.17 139.47 30.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.93 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -130.55 -178.06 4.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.81 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 63.61 167.23 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.882 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.416 ' CZ ' HG22 ' A' ' 18' ' ' THR . 7.3 t80 -105.26 141.69 36.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.2 p -159.99 118.4 2.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.416 HG22 ' CZ ' ' A' ' 16' ' ' PHE . 9.7 t -176.33 161.22 2.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.972 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -90.11 143.61 26.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.811 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -144.4 136.41 26.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -71.57 157.86 37.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.6 m -119.96 130.72 54.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.939 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -136.2 166.79 22.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -79.14 138.58 37.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.946 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.3 m -63.6 -19.33 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.288 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 m -67.64 -12.49 60.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.412 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 36.4 mtt -91.79 20.13 5.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.624 0.25 . . . . 0.0 111.362 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -141.31 74.93 1.48 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.904 0.383 . . . . 0.0 110.881 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.97 -170.63 2.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.067 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.97 -156.45 26.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.505 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.22 -30.04 40.24 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.498 2.132 . . . . 0.0 112.337 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -136.75 167.92 20.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -102.21 -53.53 2.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.5 mmt-85 60.24 109.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.933 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.9 m -96.65 23.48 6.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.092 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -91.17 -29.19 17.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.844 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.5 t -59.28 -36.05 61.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.039 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -71.85 -38.68 70.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.884 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -84.14 79.54 9.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.74 178.8 32.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.411 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.06 37.87 3.6 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.517 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.5 153.58 21.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.705 0.288 . . . . 0.0 110.872 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.0 pt -139.66 179.95 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.041 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mt -122.51 136.12 60.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.124 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 71.8 mtp -137.75 161.49 59.85 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.81 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.79 146.47 35.55 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.506 2.138 . . . . 0.0 112.335 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.83 -26.89 41.21 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.521 2.147 . . . . 0.0 112.384 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.0 t -58.54 -39.01 78.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.035 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.89 -31.08 70.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.102 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.408 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 58.3 tp -64.68 -51.31 63.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -72.61 -29.5 63.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -50.34 74.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.947 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 mt -56.56 -38.29 71.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.007 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.8 t -75.52 -27.5 58.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -81.54 -25.04 36.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.03 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.4 mt -95.52 19.77 10.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.18 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 53.98 44.88 28.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.86 0.362 . . . . 0.0 111.173 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.3 mt -107.35 130.37 59.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.182 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 p -113.4 170.84 7.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.433 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.3 t80 -61.15 140.35 94.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.815 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.433 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.85 171.34 68.58 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.544 -1.44 . . . . 0.0 112.368 0.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 15.9 mtt -126.31 41.71 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.9 mt -68.97 164.0 23.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.935 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -130.34 153.89 48.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -99.82 91.9 5.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.842 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.43 78.95 2.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.836 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -81.65 99.17 8.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -71.27 120.23 16.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.829 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -98.46 30.56 3.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.994 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.94 -37.43 4.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.846 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.23 23.54 4.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.128 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.01 39.31 31.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 111.113 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.31 172.46 8.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.0 ttp -157.82 124.93 5.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.834 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.0 m -140.17 155.74 46.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -129.56 108.86 10.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.1 p -116.59 149.88 38.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.87 137.68 13.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.545 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.9 p -83.79 134.88 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.782 0.325 . . . . 0.0 111.06 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.5 tp -117.94 -58.01 2.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.32 150.75 19.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.408 ' CD2' ' HB2' ' A' ' 50' ' ' LEU . 65.7 m-85 -132.99 62.83 1.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.3 m -136.15 32.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.164 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.12 158.78 15.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.071 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.54 160.31 30.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -66.98 136.12 54.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.19 28.69 73.85 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.452 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.8 mt -147.82 112.47 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 111.14 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.7 m -114.85 130.5 56.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -92.42 143.25 26.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.935 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 44.0 mt -139.28 147.67 53.9 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.52 169.93 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.57 2.18 . . . . 0.0 112.283 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.53 -38.68 77.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.834 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.405 ' CH2' ' CE ' ' A' ' 95' ' ' MET . 51.0 p-90 -72.58 -31.48 65.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.405 ' CE ' ' CH2' ' A' ' 94' ' ' TRP . 7.4 ttm -74.72 -31.16 61.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 37.7 mmm -76.39 -39.06 54.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -76.63 -38.75 54.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.858 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -59.66 -53.49 57.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.8 mt -71.21 -21.79 62.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 mt 66.99 45.6 1.74 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.892 0.377 . . . . 0.0 110.944 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.1 mt -96.83 149.24 22.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -103.47 -179.19 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.799 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.34 113.5 2.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.35 42.24 8.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.446 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.86 109.51 3.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.536 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.1 mt -73.27 131.88 42.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.01 158.83 36.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.079 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 62.7 mm-40 -74.67 122.5 23.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.95 86.9 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.146 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -107.5 135.2 49.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.1 p -75.72 101.49 5.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 19.2 m -113.88 149.3 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.105 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -121.84 117.21 25.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.4 mt -107.81 174.22 5.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.45 164.06 12.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.95 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.1 m -64.69 135.05 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -77.68 152.87 33.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.076 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.3 t -109.55 -31.77 7.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -134.82 106.7 7.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.6 m -122.92 113.39 19.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.946 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -92.38 142.56 27.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.415 ' CG ' HD21 ' A' ' 139' ' ' LEU . 18.1 m-85 -130.43 150.2 51.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -131.79 95.93 21.72 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.8 109.9 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.536 2.157 . . . . 0.0 112.408 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -59.62 -31.78 69.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.998 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 72.4 p -113.38 146.81 36.11 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.958 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.88 -17.8 25.13 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.544 2.163 . . . . 0.0 112.48 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -55.14 -39.84 69.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.023 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -66.41 -46.91 74.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.7 mt -60.31 -30.67 69.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.968 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.3 -25.07 66.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 51.4 mt -62.27 136.92 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.9 m -58.28 -39.62 79.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.992 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -125.59 80.67 65.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.0 -28.63 19.05 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.585 2.19 . . . . 0.0 112.363 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.9 mtpm? -66.73 -44.95 80.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.84 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.89 93.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.038 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 25.3 t -64.08 -45.25 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.064 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.415 HD21 ' CG ' ' A' ' 122' ' ' PHE . 21.5 tp -67.91 -43.44 79.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.83 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -62.35 -36.37 82.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.807 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -68.82 -29.83 68.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.35 -33.19 69.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 65.9 mt -60.49 -25.77 66.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.059 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.6 mtp-105 -55.16 -30.36 59.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.05 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -89.21 -38.7 14.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -69.08 144.67 53.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -109.39 -26.15 10.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.22 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -140.25 165.14 28.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.968 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 20.8 mt -144.33 129.41 18.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.54 145.47 46.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.876 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.7 m -71.47 123.58 22.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.75 27.69 21.07 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.45 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.82 132.66 53.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.4 t -90.58 89.68 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.084 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 18.4 pt -85.16 132.31 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.081 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -108.05 140.75 40.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.3 pt -125.12 165.26 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.041 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -157.83 150.41 22.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -172.71 -48.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -97.66 41.44 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.94 29.65 19.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.954 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.59 128.12 17.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.801 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.9 mp -87.83 105.18 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.177 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -82.71 137.44 34.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -90.11 121.73 32.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.001 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.23 141.55 49.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.82 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 -137.24 129.05 28.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.57 132.46 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.7 mmm -94.0 -68.53 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.95 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -123.8 152.91 41.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.5 p -147.24 150.49 34.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -130.68 153.97 81.66 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.64 -31.96 4.92 Favored 'Cis proline' 0 C--N 1.348 0.522 0 C-N-CA 123.264 -1.557 . . . . 0.0 112.45 -0.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.36 171.53 7.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.835 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -40.75 76.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.022 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -102.64 124.47 48.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.081 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.58 153.71 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 23.8 t -104.7 98.01 7.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.4 pt -88.68 84.11 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.207 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.5 mm -111.65 79.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.089 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 59.14 91.0 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.99 156.16 26.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.967 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.19 103.53 15.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.827 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -126.67 170.84 11.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -94.22 113.54 25.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.39 106.85 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.176 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -87.13 159.33 18.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -133.09 133.24 42.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.885 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -121.09 97.37 5.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.087 179.969 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -170.26 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.811 0.339 . . . . 0.0 110.932 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.3 t 60.67 34.8 19.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.25 44.83 2.45 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.519 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.9 m 60.61 172.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.785 0.326 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 m -157.24 37.67 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.7 -166.89 13.73 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.446 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.6 pt -108.34 146.57 33.89 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.676 0.274 . . . . 0.0 111.098 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.08 123.99 9.7 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.572 2.182 . . . . 0.0 112.293 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.78 118.35 21.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.884 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.5 t -97.88 32.05 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.015 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -166.71 129.33 1.83 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.839 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.77 151.36 51.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -142.72 158.88 43.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.5 158.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.804 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -86.63 123.93 32.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.0 p -155.23 110.1 2.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.2 t -176.42 168.96 2.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -103.38 146.85 27.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -146.87 147.28 30.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.91 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -84.6 132.08 34.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.9 p -84.82 142.01 30.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -147.0 149.47 33.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.85 168.51 6.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 m -95.82 20.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.374 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 55.1 m -96.38 -25.16 15.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.019 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.7 mmt -54.97 -51.59 65.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.124 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 tp -73.63 142.39 46.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.43 154.84 20.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.06 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -154.95 156.41 26.89 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.498 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.99 -35.78 8.51 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.627 2.218 . . . . 0.0 112.325 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -102.1 -29.92 11.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.947 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 70.85 -62.63 0.44 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.1 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 66.95 133.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.889 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.4 t -104.07 -18.69 14.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.202 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -35.83 44.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.817 0.341 . . . . 0.0 111.116 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.63 -30.29 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.1 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -77.2 -30.14 54.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -97.93 33.72 2.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.6 171.51 25.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.553 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.23 28.66 13.02 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.545 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.83 151.2 20.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.805 0.336 . . . . 0.0 110.913 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.9 pt -133.35 165.67 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mt -115.7 96.17 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.138 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 97.1 mtp -88.55 157.8 49.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.8 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -51.83 156.74 6.48 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.571 2.181 . . . . 0.0 112.336 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.71 -27.06 38.57 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.519 2.146 . . . . 0.0 112.318 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.8 p -61.65 -31.67 71.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.87 -31.67 72.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.3 tp -62.27 -34.64 76.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -86.96 -30.54 21.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.0 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.42 -47.25 70.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.5 mt -57.19 -47.48 81.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.077 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 p -64.15 -23.61 67.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.173 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.72 20.11 9.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.355 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -135.83 19.95 3.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.206 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 55.9 33.69 22.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.766 0.317 . . . . 0.0 111.029 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.403 HG21 HD12 ' A' ' 58' ' ' ILE . 31.2 mt -102.78 109.01 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.151 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.4 p -104.51 162.96 12.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.442 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -60.14 144.3 87.29 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.775 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 72.2 Cg_endo -76.71 171.29 68.84 Favored 'Cis proline' 0 C--N 1.347 0.484 0 C-N-CA 123.467 -1.472 . . . . 0.0 112.4 0.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.3 mtt -138.23 78.02 1.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mp -89.55 138.29 31.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -109.78 143.02 40.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.846 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -94.74 99.76 11.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.936 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.7 mt -84.66 78.44 9.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 53.7 m -77.93 111.59 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -74.88 113.96 12.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.956 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -88.92 53.9 2.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -145.22 -53.49 0.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.9 m -120.32 25.37 9.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.067 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 t0 55.19 30.44 14.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.112 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.0 mmt-85 -82.3 146.19 29.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.3 ttm -133.12 140.77 47.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.7 t -157.15 143.0 17.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -120.78 114.6 21.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.2 p -113.46 172.73 6.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.46 124.84 4.83 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.539 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.42 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 11.0 p -64.12 141.65 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 0.0 111.09 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.7 tp -134.9 -54.79 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.45 152.09 18.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 72.5 m-85 -135.0 73.86 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.6 m -149.93 35.23 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.164 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.69 178.77 5.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.095 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.69 166.47 12.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.804 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -65.66 90.96 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.807 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 96.73 26.17 10.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.509 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.0 mt -136.08 80.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 111.07 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 57.5 m -78.29 134.7 37.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -102.96 130.91 50.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.848 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 mp -132.69 162.19 58.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.36 -173.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.628 2.218 . . . . 0.0 112.287 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -94.18 -46.65 7.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.41 ' CH2' ' HE2' ' A' ' 95' ' ' MET . 69.7 p-90 -60.01 -39.63 86.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.41 ' HE2' ' CH2' ' A' ' 94' ' ' TRP . 37.4 ttm -62.03 -32.79 73.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.893 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -53.17 18.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -61.91 -38.35 88.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -59.96 -40.97 90.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.792 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.0 mt -84.86 -14.46 47.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.281 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.7 mt 61.35 32.95 19.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.9 mt -82.75 162.88 21.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -108.85 173.52 6.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.898 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -60.14 112.55 1.95 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.83 42.65 10.89 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.465 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.11 119.65 5.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.478 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.9 mt -65.57 129.23 39.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.803 0.335 . . . . 0.0 110.847 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.94 149.78 33.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -75.8 124.28 27.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.29 122.87 66.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -144.2 121.87 11.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 71.4 p -72.75 129.35 38.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.4 m -137.69 139.79 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.057 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -101.06 109.37 21.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 mt -103.52 172.01 7.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -116.03 164.72 14.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.7 m -60.82 144.34 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.094 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -88.07 153.3 21.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.124 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.1 p -106.35 -31.32 8.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -133.7 112.64 11.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.9 m -123.35 122.1 37.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.23 146.46 38.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.974 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -125.94 143.94 50.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -126.59 90.24 50.26 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.958 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.81 112.08 0.75 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.583 2.189 . . . . 0.0 112.328 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -65.39 -31.25 72.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.1 p -106.57 146.47 33.12 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.931 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.59 -17.03 23.76 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.597 2.198 . . . . 0.0 112.576 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.02 -44.25 74.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.087 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.409 ' CD2' HD22 ' A' ' 166' ' ' LEU . 20.9 t80 -70.49 -44.67 67.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.869 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.3 mt -59.82 -31.81 70.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -64.4 -24.07 67.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.977 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 60.5 mt -60.02 139.94 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.924 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.0 t -59.11 -44.73 92.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.76 86.76 54.32 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.49 -28.61 21.52 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.585 2.19 . . . . 0.0 112.313 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.418 ' HG3' ' CE1' ' A' ' 188' ' ' PHE . 36.8 mttt -65.49 -35.67 81.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.93 -41.85 77.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.076 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.423 HG13 ' CE1' ' A' ' 159' ' ' TYR . 21.5 t -74.38 -36.8 43.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.075 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 tp -71.42 -37.59 71.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.22 -31.42 65.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.76 -33.02 68.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.899 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.97 -29.19 32.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.7 mt -57.9 -25.97 61.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.057 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -55.59 -30.0 60.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.034 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -80.02 -35.13 37.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.419 ' CE2' HD12 ' A' ' 155' ' ' ILE . 46.2 m-85 -73.92 132.75 42.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -103.1 -27.21 12.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 7.6 t -123.0 161.12 24.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.1 mt -143.78 113.37 7.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.3 m -117.42 136.37 53.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.08 129.35 39.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.918 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 83.4 47.43 5.72 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.53 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.57 110.85 13.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.738 0.304 . . . . 0.0 110.862 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.59 83.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.193 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.419 HD12 ' CE2' ' A' ' 146' ' ' PHE . 1.4 pt -81.67 150.58 4.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -114.59 117.4 30.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.023 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.4 pt -109.1 145.7 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.227 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -148.77 140.67 23.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.882 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 159' ' ' TYR . 1.8 p90 -149.02 -50.17 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -100.81 49.34 0.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 59.05 30.0 19.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.974 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -139.74 105.41 5.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -78.26 88.04 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.144 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -69.58 158.09 35.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.781 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -113.98 135.95 53.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.975 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.409 HD22 ' CD2' ' A' ' 129' ' ' PHE . 3.6 mp -150.4 160.56 43.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.825 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 8.5 ttt-85 -144.77 130.67 19.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.025 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.56 123.53 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.056 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.17 -61.4 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.06 148.08 44.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.991 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 16.6 p -145.92 138.87 25.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -122.19 154.48 61.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.1 -39.08 1.52 Allowed 'Cis proline' 0 C--N 1.347 0.469 0 C-N-CA 123.267 -1.555 . . . . 0.0 112.324 0.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.49 171.64 7.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.81 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.11 -48.1 82.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -93.2 123.42 36.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.062 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.78 152.91 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 4.7 t -106.45 106.5 17.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.0 pt -92.09 86.6 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.176 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 4.8 mt -116.48 81.57 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.015 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 60.36 89.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 2.8 t -162.54 153.18 17.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.928 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -80.64 119.57 23.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.5 ptt? -147.83 168.94 20.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -102.07 150.82 22.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.67 106.94 12.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.134 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.16 158.89 15.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.942 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . 0.418 ' CE1' ' HG3' ' A' ' 136' ' ' LYS . 7.2 m-85 -127.53 148.01 50.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.864 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -139.14 97.26 3.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.139 179.934 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 m -124.93 100.72 6.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.823 0.344 . . . . 0.0 110.898 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -98.73 137.84 36.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.87 -73.15 0.52 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.46 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 m -105.88 110.37 22.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.844 0.354 . . . . 0.0 110.92 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 p -164.66 123.88 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.86 129.16 0.73 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.51 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 mt 63.65 88.37 0.12 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.656 0.265 . . . . 0.0 111.04 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.51 152.9 70.64 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.539 2.16 . . . . 0.0 112.267 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -137.32 104.57 5.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.3 m -100.8 35.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 61.76 31.8 18.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -89.79 123.11 33.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.975 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -128.56 -66.85 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 57.99 176.11 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.971 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -94.38 103.11 15.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.35 122.69 22.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.415 HG23 ' CE2' ' A' ' 20' ' ' TYR . 11.2 t -177.09 163.75 2.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.913 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -86.14 153.34 22.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.415 ' CE2' HG23 ' A' ' 18' ' ' THR . 13.6 m-85 -154.99 156.74 36.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -82.36 149.8 27.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.905 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.8 m -112.36 119.28 37.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -127.65 163.11 24.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.922 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.8 m -81.22 157.55 25.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.9 m -72.57 -30.61 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.69 -26.92 68.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.974 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -56.2 -23.01 32.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.254 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 tp -52.18 108.9 0.33 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.84 0.353 . . . . 0.0 111.066 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.16 -20.53 65.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.432 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.6 155.29 4.02 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.728 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.06 122.14 9.21 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.578 2.185 . . . . 0.0 112.365 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 59.71 173.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -154.61 169.98 22.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.52 163.44 24.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.5 -12.55 17.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.37 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.87 20.04 8.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.678 0.275 . . . . 0.0 111.259 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.1 m -95.72 -34.84 5.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.884 0.373 . . . . 0.0 111.092 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -94.03 -31.2 14.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.826 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -97.54 95.42 7.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.888 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.94 -145.98 17.37 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.408 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.11 80.44 0.3 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.557 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.36 126.62 17.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.826 0.346 . . . . 0.0 110.872 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.1 pt -118.17 171.01 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.181 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 mp -128.9 106.7 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.94 160.56 25.7 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.962 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -52.93 161.35 3.32 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.535 2.156 . . . . 0.0 112.28 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.9 -26.39 26.95 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.548 2.165 . . . . 0.0 112.33 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 p -58.86 -31.24 68.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.948 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.45 -36.88 83.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.407 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 44.8 tp -64.86 -38.74 92.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.906 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -77.27 -30.99 54.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.932 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -68.93 -51.3 41.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.9 mt -59.63 -33.13 71.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.5 m -64.24 -30.27 71.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -96.64 20.23 11.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.4 mt -128.57 18.45 6.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.182 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 53.77 30.07 10.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.797 0.332 . . . . 0.0 111.157 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.1 mt -99.59 123.78 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.126 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -119.55 168.79 10.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.429 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -59.93 144.07 86.76 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.89 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 72.7 Cg_endo -77.27 149.8 90.23 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 123.422 -1.491 . . . . 0.0 112.398 0.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 4.6 mtt -115.74 74.88 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mt -88.15 160.37 17.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -127.37 148.28 50.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.837 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.401 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 24.7 tttt -104.11 93.78 5.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.71 80.75 5.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.822 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 m -87.87 95.94 10.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -62.07 123.13 17.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.845 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm -98.31 32.4 2.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -131.93 -46.07 0.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.959 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.0 m -108.66 17.69 21.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.266 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.0 t0 53.16 37.74 25.77 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.848 0.356 . . . . 0.0 111.169 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.1 mmt-85 -96.45 152.4 18.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.4 ttp -149.17 123.21 9.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.795 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 t -148.96 160.54 43.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.992 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.405 ' CD2' HD13 ' A' ' 114' ' ' LEU . 15.1 m80 -125.26 107.87 11.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 24.6 p -104.3 161.16 14.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.957 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.53 143.24 17.97 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.42 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 11.1 p -79.53 144.09 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 111.076 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.6 tp -116.89 -62.99 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.851 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -122.01 -179.65 4.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 49.6 m-85 -140.19 80.12 1.74 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.7 m -141.9 31.28 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.129 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.85 172.51 8.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.062 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.78 162.37 13.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -60.75 126.1 26.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.89 29.99 76.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.518 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 26.2 mt -148.95 99.25 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.839 0.352 . . . . 0.0 111.169 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 39.0 m -102.68 135.15 44.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -99.53 131.4 45.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 mt -131.27 157.52 77.87 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.9 -174.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.52 2.147 . . . . 0.0 112.35 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -98.36 -36.04 10.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.895 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 57.0 p-90 -64.97 -31.38 72.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -75.95 -34.16 59.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -37.68 81.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -32.7 52.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -68.58 -38.05 80.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.834 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mt -90.73 -21.23 21.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.0 mt 61.26 65.35 0.99 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.898 0.38 . . . . 0.0 110.938 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.1 mt -118.84 -177.21 3.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.877 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -126.5 174.59 8.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.881 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -64.85 85.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.26 38.34 1.13 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.426 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.73 134.78 12.68 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.98 123.71 29.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 0.0 110.992 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.93 139.69 51.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.106 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -69.28 102.05 1.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -87.04 142.9 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.96 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -152.95 173.68 15.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.2 p -131.02 108.87 10.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.919 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.5 m -117.9 158.31 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.211 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -110.78 111.4 22.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.405 HD13 ' CD2' ' A' ' 76' ' ' HIS . 8.5 mt -110.53 179.94 3.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.935 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.86 168.25 15.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.1 m -59.9 158.09 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.125 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.91 150.7 21.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.045 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.3 t -107.38 -31.28 8.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -132.27 90.76 2.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.2 m -103.69 104.89 14.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.835 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -94.57 146.85 23.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -134.49 152.21 51.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -137.57 93.37 12.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -51.64 121.46 8.61 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.534 2.156 . . . . 0.0 112.297 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -74.14 -31.41 62.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.984 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -107.73 147.36 35.24 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.989 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.43 -15.3 27.93 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.642 2.228 . . . . 0.0 112.52 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.32 -40.22 70.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.103 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.42 ' CE2' HD13 ' A' ' 166' ' ' LEU . 13.6 t80 -70.73 -46.15 63.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.858 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 56.5 mt -59.84 -31.5 69.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -64.53 -25.64 68.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.073 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 46.8 mt -61.98 132.68 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.086 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.1 m -61.07 -34.27 74.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.934 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.58 79.97 30.55 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.809 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.64 -30.21 18.52 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.547 2.165 . . . . 0.0 112.295 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -73.72 -31.02 63.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.77 -48.71 52.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.15 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.89 -40.37 86.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 9.7 tp -65.41 -46.98 77.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -70.62 -30.91 67.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.966 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -67.58 -27.81 67.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.089 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.5 -26.16 14.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.35 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.3 mt -57.3 -39.47 75.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.117 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -27.62 64.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.05 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -73.54 -30.28 62.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.776 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.41 ' CE2' HD12 ' A' ' 155' ' ' ILE . 25.0 m-85 -78.77 155.6 29.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -109.96 -30.51 7.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.3 m -145.37 170.77 15.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.932 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.4 mt -137.79 176.25 8.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.5 m -159.67 143.94 14.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.9 m -72.85 123.53 23.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.89 58.49 3.22 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -137.89 130.32 29.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.829 0.347 . . . . 0.0 110.859 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.58 98.52 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.056 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.41 HD12 ' CE2' ' A' ' 146' ' ' PHE . 14.6 pt -93.68 153.3 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -119.34 148.31 43.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.067 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 pp -142.13 133.1 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -133.96 141.86 47.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -152.77 -47.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -99.46 45.19 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 61.05 34.34 19.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -152.12 130.43 12.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.804 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.8 mp -95.36 113.25 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.146 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -86.09 157.21 20.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.816 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.23 137.2 46.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.42 HD13 ' CE2' ' A' ' 129' ' ' PHE . 2.9 mt -154.41 134.61 13.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.829 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -126.27 131.39 51.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 27.7 t -72.37 121.1 22.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 18.2 mmm -81.51 -53.56 6.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.0 155.43 41.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.894 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 26.7 p -149.33 158.75 44.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -140.89 157.29 67.76 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.39 -42.24 0.82 Allowed 'Cis proline' 0 C--N 1.346 0.417 0 C-N-CA 123.3 -1.542 . . . . 0.0 112.437 -0.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.84 172.15 7.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.938 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.61 -44.38 89.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.956 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -102.93 119.04 38.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 16.1 m -127.78 155.68 39.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.16 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.7 t -106.77 95.11 5.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.0 pt -87.83 85.28 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.253 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.7 mm -116.51 86.52 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.102 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 61.4 80.58 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.941 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 9.1 t -159.19 151.08 20.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.811 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.23 127.0 40.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -135.46 173.16 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.83 79.46 5.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.06 138.92 21.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.063 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -137.28 172.3 13.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -134.17 133.85 41.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -117.87 90.31 3.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.069 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.428 ' HB2' HD13 ' A' ' 56' ' ' LEU . 10.8 t80 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.843 0.354 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.9 p -151.63 102.11 2.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -165.61 171.61 12.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.86 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.643 ' HB3' HD22 ' A' ' 106' ' ' LEU . 15.8 mt-30 -96.56 156.91 16.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -145.49 148.13 32.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.25 112.11 14.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.507 ' HB3' ' HE3' ' A' ' 96' ' ' MET . 73.0 m -77.61 128.99 35.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.512 ' CD2' HG23 ' A' ' 88' ' ' ILE . 2.0 m-85 -135.41 172.21 13.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.08 163.39 24.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.9 m -81.1 -31.9 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.192 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.8 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 180.0 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.824 0.345 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.76 -31.2 70.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.902 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.0 mttp -82.65 60.3 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.91 -168.71 41.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.426 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.82 59.8 0.52 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.524 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.82 140.01 50.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.817 0.341 . . . . 0.0 110.853 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.84 HG21 HD23 ' A' ' 91' ' ' LEU . 11.8 pt -126.91 -179.97 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.8 mt -130.49 118.64 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 58.8 mtp -107.89 152.46 41.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.861 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.86 151.87 24.95 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.573 2.182 . . . . 0.0 112.253 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.27 -29.6 58.14 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.576 2.184 . . . . 0.0 112.311 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.1 p -59.76 -30.71 69.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.993 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.51 -39.1 82.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.164 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.483 HD13 ' CD2' ' A' ' 82' ' ' PHE . 12.5 tp -63.9 -43.78 94.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.25 -40.6 94.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.957 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -54.52 27.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.697 ' HA ' HD12 ' A' ' 56' ' ' LEU . 68.3 mt -57.68 -30.17 65.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.0 t -68.5 -29.76 68.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -92.56 -21.21 20.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.164 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.697 HD12 ' HA ' ' A' ' 53' ' ' LEU . 12.8 mt -77.42 -3.34 39.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.513 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.45 31.61 10.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.908 0.385 . . . . 0.0 110.912 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.9 mt -98.79 127.95 50.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.06 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -116.31 178.01 4.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.443 ' CD1' ' HA ' ' A' ' 61' ' ' PRO . 1.3 t80 -66.99 139.89 95.79 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.748 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.443 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.6 166.66 82.13 Favored 'Cis proline' 0 C--N 1.348 0.524 0 C-N-CA 123.517 -1.451 . . . . 0.0 112.411 -0.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 16.1 mtt -134.17 80.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.845 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.41 152.94 19.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.485 ' HB3' HG13 ' A' ' 109' ' ' VAL . 98.2 m-85 -114.5 159.31 20.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -112.4 95.62 5.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.894 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.4 mt -80.7 101.87 9.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -100.75 106.03 17.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.59 ' OD1' HD21 ' A' ' 101' ' ' LEU . 7.5 t30 -76.56 122.89 25.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -98.79 31.27 3.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.86 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.77 -37.08 4.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.803 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.28 25.92 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.016 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t70 56.2 36.82 28.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.114 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.77 153.59 21.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.4 ttp -144.19 131.96 21.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.485 HG21 HD11 ' A' ' 99' ' ' LEU . 2.6 t -150.89 131.89 14.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -107.89 115.59 30.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.5 p -115.88 176.61 5.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.35 135.81 8.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.456 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.1 p -72.34 146.02 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.366 . . . . 0.0 111.102 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.5 tp -118.18 -63.53 1.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -113.68 138.8 49.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.483 ' CD2' HD13 ' A' ' 50' ' ' LEU . 42.5 m-85 -103.51 72.96 1.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 83' ' ' VAL . 15.6 m -148.64 73.36 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.046 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.13 175.12 9.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.07 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -85.01 160.46 20.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.824 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -70.64 132.75 45.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.27 25.61 69.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.657 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.512 HG23 ' CD2' ' A' ' 23' ' ' PHE . 27.1 mt -148.66 82.24 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 111.149 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.53 130.52 35.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -94.89 125.06 39.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.84 HD23 HG21 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -132.58 156.13 80.44 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.918 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.789 ' HD3' HG22 ' A' ' 43' ' ' ILE . 53.5 Cg_exo -52.37 -176.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.547 2.165 . . . . 0.0 112.34 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.13 -33.88 12.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.464 ' CH2' ' HE2' ' A' ' 95' ' ' MET . 66.3 p-90 -63.93 -33.19 75.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.464 ' HE2' ' CH2' ' A' ' 94' ' ' TRP . 17.2 ttm -71.66 -31.29 66.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' MET . . . . . 0.507 ' HE3' ' HB3' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -73.21 -47.18 45.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.955 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -64.16 -41.45 97.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -62.69 -42.47 99.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.485 HD11 HG21 ' A' ' 75' ' ' THR . 17.1 mt -83.46 -16.89 43.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.193 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 100' ' ' LEU . 27.6 mt 61.09 34.45 19.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.816 0.341 . . . . 0.0 110.833 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.59 HD21 ' OD1' ' A' ' 68' ' ' ASN . 7.9 mt -84.05 -178.77 7.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.891 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -126.66 169.29 13.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -60.08 111.94 1.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.67 36.0 8.9 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.554 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.09 125.97 8.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.415 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.643 HD22 ' HB3' ' A' ' 19' ' ' GLN . 17.5 mt -77.81 129.24 35.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.9 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.2 135.01 58.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.041 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -60.43 121.93 13.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.485 HG13 ' HB3' ' A' ' 64' ' ' PHE . 21.5 t -116.11 135.81 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -139.17 132.13 29.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.21 96.42 5.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.8 m -109.72 146.16 15.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.18 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -108.58 110.04 21.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 mt -105.71 179.97 4.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.61 171.34 10.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.6 m -59.69 162.06 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.035 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.558 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -102.84 148.56 25.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 80.5 p -104.7 -31.51 9.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.795 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -140.48 111.24 6.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.843 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.1 m -121.65 120.42 34.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.932 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.488 ' O ' HG13 ' A' ' 168' ' ' VAL . 2.5 ttmm -101.72 137.53 39.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -121.17 152.0 39.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.932 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -137.71 93.6 12.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.922 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.65 119.13 4.34 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.556 2.17 . . . . 0.0 112.459 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 40.6 mm-40 -73.64 -33.01 64.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.3 t -104.4 147.38 34.28 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.667 ' HA ' HD12 ' A' ' 130' ' ' LEU . 57.9 Cg_endo -71.19 -17.76 31.03 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.58 2.187 . . . . 0.0 112.503 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.04 -45.0 79.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.006 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -69.33 -45.05 70.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.667 HD12 ' HA ' ' A' ' 127' ' ' PRO . 11.5 mt -59.79 -31.31 69.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.72 -25.91 66.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.986 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.589 HG22 ' H ' ' A' ' 134' ' ' ASN . 52.2 mt -59.97 136.54 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.013 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.0 t -69.34 -32.92 72.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.963 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.589 ' H ' HG22 ' A' ' 132' ' ' ILE . 1.9 m120 -125.1 79.02 66.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.968 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.91 -27.94 20.35 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.569 2.18 . . . . 0.0 112.346 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -65.91 -44.93 83.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.56 -38.78 92.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.123 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 134' ' ' ASN . 26.8 t -72.04 -40.9 67.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.772 HD12 HD13 ' A' ' 166' ' ' LEU . 3.8 tp -72.81 -33.86 66.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.007 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -76.27 -30.23 57.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.986 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -75.37 -30.61 60.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.08 -34.41 17.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.169 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.411 HD22 HD11 ' A' ' 149' ' ' LEU . 14.2 mt -59.53 -27.97 66.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.963 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -57.01 -29.15 63.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.071 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -78.73 -36.63 43.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.976 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.428 ' CZ ' ' HB ' ' A' ' 155' ' ' ILE . 61.3 m-85 -67.48 143.23 56.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.952 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -110.01 -25.34 10.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.178 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 12.2 t -137.46 159.26 42.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.984 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.411 HD11 HD22 ' A' ' 143' ' ' LEU . 25.2 mt -151.32 139.0 19.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.2 m -123.3 160.24 27.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.984 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.8 m -72.97 103.22 3.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 97.83 36.77 4.65 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.54 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -104.5 108.28 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.352 . . . . 0.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 32.6 t -69.59 86.35 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.061 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.428 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 8.2 pt -93.41 131.41 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.136 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -100.06 142.49 31.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.163 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 40.5 pt -127.83 152.74 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -144.19 136.45 26.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.406 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 3.6 p90 -150.71 -50.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -96.78 44.35 1.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 60.29 31.24 20.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -145.12 137.64 26.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.528 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.8 mp -93.82 105.71 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.147 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -91.97 119.38 31.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.02 125.23 28.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.974 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.772 HD13 HD12 ' A' ' 139' ' ' LEU . 1.9 mt -134.14 128.91 35.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.812 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -122.44 133.73 54.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.942 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 121' ' ' LYS . 19.9 t -78.26 139.73 18.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.032 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 56.3 mmm -100.67 -48.3 4.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.987 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.05 153.51 46.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.022 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.444 HG23 HG11 ' A' ' 168' ' ' VAL . 0.9 OUTLIER -148.83 158.18 43.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.805 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -138.1 153.94 73.72 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.04 -34.11 3.55 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 123.204 -1.582 . . . . 0.0 112.448 0.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.52 178.41 4.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -47.67 84.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -99.02 130.55 45.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.558 HG21 ' HB2' ' A' ' 117' ' ' ALA . 31.0 m -134.3 161.58 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.205 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.3 t -119.38 94.57 4.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.8 pt -81.17 83.4 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 35.1 mt -116.01 84.98 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.075 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.37 87.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -159.76 176.56 11.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.802 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.22 107.14 13.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -126.41 179.24 5.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -117.12 121.77 42.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.505 HG11 ' CD2' ' A' ' 139' ' ' LEU . 21.4 t -99.16 122.12 50.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.137 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.76 179.88 4.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.903 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -130.54 157.92 41.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -144.34 87.43 1.88 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.025 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.434 ' N ' ' HG ' ' A' ' 111' ' ' SER . 4.6 t80 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.741 0.305 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.2 p -137.75 94.97 2.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.91 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.6 t -156.85 174.93 14.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.914 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -102.61 152.79 20.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.945 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -146.98 147.22 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.6 mtt85 -74.68 135.45 41.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.973 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 76.2 m -97.24 132.35 43.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -145.45 157.89 43.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -81.03 161.9 24.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.937 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.6 m -65.41 -31.41 53.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.188 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.7 m . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.746 0.308 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.85 -34.95 51.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.947 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -81.59 100.62 9.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.5 -147.77 19.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.505 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.37 52.69 0.58 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.475 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.76 160.73 20.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.804 0.335 . . . . 0.0 110.917 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.577 HG21 HD23 ' A' ' 91' ' ' LEU . 6.0 pt -145.48 177.51 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.058 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.543 HG22 ' HB2' ' A' ' 84' ' ' ALA . 32.5 mt -122.81 137.86 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.123 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -131.22 160.04 68.87 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.844 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.59 162.68 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.567 2.178 . . . . 0.0 112.321 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.26 -33.48 24.11 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.606 2.204 . . . . 0.0 112.277 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.9 p -60.34 -34.55 73.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.34 -39.62 87.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.424 HD13 ' CE1' ' A' ' 82' ' ' PHE . 39.3 tp -64.24 -42.84 96.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.977 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.3 -30.64 60.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -79.32 -41.77 27.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.059 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.469 HD22 ' SD ' ' A' ' 62' ' ' MET . 3.0 mt -53.52 -49.63 67.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.0 t -72.31 -28.51 63.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.887 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.37 -21.23 62.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.3 mt -94.07 20.19 8.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.327 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 59.52 30.88 20.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.02 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.438 ' CD1' HD23 ' A' ' 53' ' ' LEU . 35.1 mt -93.07 124.31 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.126 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.444 HG22 ' N ' ' A' ' 60' ' ' TYR . 50.0 m -111.63 162.11 15.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.981 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.479 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -59.51 144.15 84.92 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.79 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.479 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 75.5 Cg_endo -77.23 167.45 79.54 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.539 -1.442 . . . . 0.0 112.409 0.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.469 ' SD ' HD22 ' A' ' 53' ' ' LEU . 63.9 mtt -129.33 66.98 1.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.818 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.668 HD23 ' CA ' ' A' ' 78' ' ' GLY . 2.5 mt -91.07 148.68 22.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.921 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.435 ' HZ ' HD11 ' A' ' 53' ' ' LEU . 60.2 m-85 -113.57 135.64 53.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.804 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -83.49 89.65 7.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.893 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.675 ' HB2' HG23 ' A' ' 75' ' ' THR . 15.6 mt -69.99 76.35 0.48 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -87.36 109.4 19.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.908 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -84.79 117.62 23.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -98.57 33.94 2.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.84 -44.21 1.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.936 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.8 m -120.25 20.99 11.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.175 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.7 t0 53.6 60.0 3.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.944 0.402 . . . . 0.0 111.117 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.502 ' CB ' HD23 ' A' ' 99' ' ' LEU . 4.7 mmt180 -112.11 164.35 13.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.945 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.3 ttp -159.49 130.61 6.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.689 HG21 HD11 ' A' ' 99' ' ' LEU . 5.0 t -158.38 170.77 21.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -138.18 117.01 12.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.923 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 9.4 p -122.36 153.48 38.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.818 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.668 ' CA ' HD23 ' A' ' 63' ' ' LEU . . . -116.98 127.85 7.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.507 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.524 HG21 ' CE2' ' A' ' 82' ' ' PHE . 10.6 p -66.71 130.6 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 0.0 111.064 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.9 tp -106.91 -56.33 2.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -106.77 155.69 19.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.524 ' CE2' HG21 ' A' ' 79' ' ' VAL . 87.1 m-85 -130.43 82.9 2.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 82' ' ' PHE . 16.1 m -157.39 31.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.169 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.543 ' HB2' HG22 ' A' ' 44' ' ' ILE . . . -86.58 167.86 14.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.11 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.525 ' HB3' HD12 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -73.38 159.35 33.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -66.06 107.29 1.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.26 28.32 30.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.426 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 85' ' ' ASP . 27.7 mt -145.81 98.16 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.843 0.354 . . . . 0.0 111.112 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 94.6 m -94.27 132.54 38.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -95.06 127.27 40.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.577 HD23 HG21 ' A' ' 43' ' ' ILE . 1.1 mt -126.27 153.08 74.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.862 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.419 ' HD3' HG22 ' A' ' 43' ' ' ILE . 51.1 Cg_exo -53.41 -173.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.587 2.191 . . . . 0.0 112.244 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -92.57 -40.32 10.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -66.76 -45.43 78.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -33.41 75.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.932 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -39.21 80.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -78.41 -33.98 48.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -60.32 -39.88 88.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.773 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.689 HD11 HG21 ' A' ' 75' ' ' THR . 6.1 mt -87.8 -13.92 40.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.276 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.7 mt 61.93 37.14 15.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.814 0.34 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.3 mt -80.35 -178.53 6.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -130.04 167.85 17.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.86 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -62.73 84.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.944 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.33 33.96 1.4 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.463 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.32 131.73 10.87 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.474 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.1 mt -85.81 129.81 34.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.834 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.28 149.03 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.208 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -64.9 120.44 12.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.47 88.43 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.13 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -102.44 140.98 36.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.98 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.434 ' HG ' ' N ' ' A' ' 16' ' ' PHE . 34.2 p -96.97 106.85 19.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.3 m -118.3 160.78 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -120.9 120.14 34.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.497 HD13 ' C ' ' A' ' 176' ' ' ALA . 10.8 mt -114.49 177.2 4.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.859 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -122.98 170.44 10.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.901 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.15 133.73 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.162 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.874 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -75.91 162.24 28.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.9 p -120.49 -41.42 2.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.946 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -122.02 91.96 3.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.8 m -108.03 120.65 42.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.2 156.26 17.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.964 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.463 ' CE2' HG22 ' A' ' 168' ' ' VAL . 69.9 m-85 -141.56 155.52 45.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -136.76 89.3 17.87 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -51.43 114.59 1.63 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.531 2.154 . . . . 0.0 112.314 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -69.93 -32.01 70.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.0 t -98.85 144.44 28.18 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.59 -19.77 21.2 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.572 2.181 . . . . 0.0 112.484 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -55.13 -36.53 65.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.093 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -71.13 -42.16 69.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 64.3 mt -63.41 -31.46 72.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.12 -23.32 65.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.05 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 134' ' ' ASN . 57.4 mt -59.99 141.59 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.056 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.3 m -67.23 -42.56 83.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.975 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.42 ' H ' HG22 ' A' ' 132' ' ' ILE . 2.5 m120 -125.84 74.91 71.05 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.001 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -57.09 -31.49 90.47 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.613 2.209 . . . . 0.0 112.235 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -43.26 99.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.957 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.66 84.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.19 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.403 HG21 HD13 ' A' ' 132' ' ' ILE . 27.8 t -67.73 -45.12 85.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.762 HD22 ' CZ ' ' A' ' 188' ' ' PHE . 21.0 tp -59.96 -31.25 69.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.016 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -87.24 -30.74 20.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.01 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.52 -31.3 71.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.947 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.26 -33.06 17.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.483 HD22 HD11 ' A' ' 149' ' ' LEU . 14.3 mt -59.3 -25.42 64.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -56.25 -33.64 65.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.031 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -77.73 -34.4 52.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -69.13 137.61 53.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -102.4 -28.07 12.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.191 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 12.9 t -141.61 159.23 42.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.483 HD11 HD22 ' A' ' 143' ' ' LEU . 7.6 mt -141.39 119.58 12.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.7 m -111.17 138.45 47.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.9 m -62.4 123.05 17.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 94.4 49.82 2.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.472 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.35 132.63 35.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.816 0.341 . . . . 0.0 110.825 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.78 89.24 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 29.7 pt -80.21 141.99 14.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.178 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -114.08 98.05 6.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.044 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.8 pt -83.52 148.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.234 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -151.03 151.36 31.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.737 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -176.43 -40.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.989 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -105.28 43.36 1.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.929 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 57.42 30.04 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.057 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -144.98 120.44 10.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.575 ' H ' HD12 ' A' ' 163' ' ' ILE . 4.4 mp -84.65 89.65 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.056 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -70.86 120.5 16.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -74.65 134.47 42.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.43 160.33 41.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.778 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 44.6 ttt-85 -152.12 121.62 6.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.463 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.4 t -62.93 138.07 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.2 mmm -103.82 -56.42 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -137.83 158.49 44.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.978 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 71.4 p -154.51 138.9 16.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -121.73 155.77 59.66 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.71 -26.33 9.52 Favored 'Cis proline' 0 C--N 1.347 0.471 0 C-N-CA 123.324 -1.532 . . . . 0.0 112.428 -0.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -120.74 170.9 9.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -37.35 76.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.963 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.497 ' C ' HD13 ' A' ' 114' ' ' LEU . . . -102.68 117.64 35.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.043 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.874 HG21 ' HB2' ' A' ' 117' ' ' ALA . 15.6 m -137.85 142.87 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 3.8 t -98.2 105.69 17.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.6 pt -95.37 87.84 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.12 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 22.0 mt -116.23 84.35 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.093 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 60.29 88.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.34 175.18 14.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.854 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.16 110.98 20.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.839 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -131.91 179.56 6.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -113.41 110.64 20.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.68 143.69 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.04 177.85 4.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' PHE . . . . . 0.762 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 7.9 m-85 -140.04 141.65 36.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.874 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.3 106.21 14.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.926 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.051 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.417 ' CE2' HG22 ' A' ' 18' ' ' THR . 59.9 t80 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.6 p -143.41 115.97 8.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.417 HG22 ' CE2' ' A' ' 16' ' ' PHE . 9.0 t -176.41 162.15 2.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -94.6 150.35 20.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.765 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -142.47 137.93 30.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -72.92 115.05 11.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.467 ' HB2' HD12 ' A' ' 91' ' ' LEU . 24.2 p -85.37 136.18 33.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.967 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.746 ' CD2' HG23 ' A' ' 88' ' ' ILE . 84.7 m-85 -138.99 170.98 15.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.89 146.49 28.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.931 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.1 m -63.47 -26.45 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.225 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.3 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.079 179.974 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.787 0.327 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -91.73 -32.08 15.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -84.58 92.44 8.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.49 168.6 11.76 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.441 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.02 56.59 3.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.513 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.68 ' HG2' HD13 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -115.86 134.54 54.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.9 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.632 HD13 ' SG ' ' A' ' 77' ' ' CYS . 44.9 pt -128.8 175.31 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.215 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mp -128.98 117.48 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.203 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 14.7 mtp -115.93 163.88 19.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.831 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -51.78 152.89 12.43 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.517 2.145 . . . . 0.0 112.269 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.44 -27.3 40.02 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.541 2.161 . . . . 0.0 112.337 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 95.2 p -63.74 -30.81 71.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.6 -40.43 96.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.742 HD13 ' CD2' ' A' ' 82' ' ' PHE . 23.2 tp -59.7 -40.45 87.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.975 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.35 -30.03 67.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.993 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -84.95 -30.65 24.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.937 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.8 mt -59.39 -30.72 68.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.015 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.5 -30.08 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.044 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -21.95 66.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.23 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.0 mt -93.88 18.37 10.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.392 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 53.94 42.11 31.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.812 0.339 . . . . 0.0 111.167 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.0 mt -107.44 133.59 51.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.126 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.29 169.03 10.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.969 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.47 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -59.92 142.39 88.81 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.7 Cg_endo -77.02 165.82 84.05 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.457 -1.476 . . . . 0.0 112.412 -0.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 65.0 mtt -131.42 51.68 2.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.698 HD22 ' HB2' ' A' ' 148' ' ' CYS . 16.1 mt -68.13 142.08 55.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.918 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.413 ' HB3' HG13 ' A' ' 109' ' ' VAL . 97.2 m-85 -109.57 139.06 45.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.769 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.4 ' HD3' ' CE1' ' A' ' 76' ' ' HIS . 0.9 OUTLIER -93.08 96.65 10.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 34.3 mt -80.9 81.38 7.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.978 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.65 108.48 18.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -70.36 123.96 23.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.848 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -98.52 32.19 2.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -124.95 -45.5 1.87 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.943 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.6 t -121.63 17.85 11.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.208 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 52.66 59.9 4.17 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.863 0.364 . . . . 0.0 111.073 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.44 177.66 4.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 37.4 ttp -156.22 129.44 8.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.7 m -150.82 137.46 18.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.427 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 6.8 m80 -112.38 108.7 17.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.632 ' SG ' HD13 ' A' ' 43' ' ' ILE . 31.2 p -109.8 166.66 10.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.98 136.75 11.11 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.428 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.883 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 11.1 p -75.84 148.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.791 0.329 . . . . 0.0 111.168 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.68 HD13 ' HG2' ' A' ' 42' ' ' LYS . 20.2 tp -122.09 -63.47 1.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.871 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -109.66 -179.46 3.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.883 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 57.5 m-85 -150.19 79.97 1.36 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.6 m -148.71 31.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.66 167.08 13.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.143 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.493 ' HB2' HD12 ' A' ' 88' ' ' ILE . 1.2 m-20 -71.06 177.68 3.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -84.82 89.7 7.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 105.74 28.19 5.45 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.519 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.746 HG23 ' CD2' ' A' ' 23' ' ' PHE . 31.8 mt -141.45 82.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.845 0.355 . . . . 0.0 111.057 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 90.6 m -82.77 131.4 35.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.987 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.469 ' O ' HD23 ' A' ' 91' ' ' LEU . 59.3 m-85 -98.55 145.0 27.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 90' ' ' TYR . 17.6 mt -143.29 149.75 49.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.905 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.478 ' HD3' HG22 ' A' ' 43' ' ' ILE . 53.7 Cg_exo -52.13 178.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.574 2.183 . . . . 0.0 112.372 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -85.74 -40.66 15.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 69.3 p-90 -63.25 -35.89 81.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.846 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 37.0 ttm -70.54 -40.86 73.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 4.6 mtt -60.39 -46.58 89.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.942 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -64.64 -33.46 75.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -66.72 -40.55 88.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.825 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.3 mt -84.85 -21.57 29.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.091 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.5 mt 64.4 34.85 10.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 0.0 110.947 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.8 mt -83.87 -179.58 7.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -118.56 -178.02 3.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -71.8 85.04 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.401 ' HA2' ' CZ ' ' A' ' 23' ' ' PHE . . . 112.86 30.51 2.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.549 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.58 145.53 30.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.532 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.4 mt -96.72 123.47 40.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 0.0 110.953 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.77 131.6 72.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.084 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -64.57 100.22 0.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.413 HG13 ' HB3' ' A' ' 64' ' ' PHE . 21.9 t -83.89 126.29 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -134.6 118.35 17.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.2 p -76.92 116.93 18.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.843 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.4 m -121.24 170.15 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.221 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.03 106.38 9.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.795 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mt -106.9 170.68 7.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -115.56 179.96 3.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.2 m -69.48 141.65 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.716 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -83.71 141.68 31.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.088 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 71.5 p -99.75 -31.11 11.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -140.36 107.61 5.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.931 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 96.4 p -120.46 118.33 30.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -103.04 160.06 14.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -141.88 153.49 44.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.91 89.57 29.28 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.008 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.707 ' HG3' HD21 ' A' ' 166' ' ' LEU . 68.5 Cg_exo -50.97 111.06 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.557 2.171 . . . . 0.0 112.401 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -61.49 -31.33 71.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.9 t -98.69 143.21 25.94 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.829 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.82 -20.26 17.48 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.567 2.178 . . . . 0.0 112.395 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.49 -39.65 70.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.042 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.47 ' HE2' HD11 ' A' ' 157' ' ' ILE . 11.0 t80 -64.66 -44.52 90.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.923 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.7 mt -59.71 -30.99 69.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -67.88 -23.74 65.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.024 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.1 mt -59.94 136.59 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.039 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.9 m -61.65 -49.16 77.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.994 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -118.17 82.65 18.42 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.39 -32.37 10.24 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.573 2.182 . . . . 0.0 112.319 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -33.75 75.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.31 -47.56 27.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.103 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.2 t -66.77 -30.57 50.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.146 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 49.8 tp -77.99 -45.59 23.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.937 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.17 -31.31 70.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -64.75 -28.43 69.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.67 -32.42 18.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.106 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.479 HD22 HD11 ' A' ' 149' ' ' LEU . 34.7 mt -59.54 -28.87 67.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.044 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -57.73 -27.16 62.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.094 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -79.0 -41.23 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.921 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.422 ' CZ ' ' HB ' ' A' ' 155' ' ' ILE . 97.0 m-85 -71.32 130.36 41.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -88.79 -33.37 17.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.698 ' HB2' HD22 ' A' ' 63' ' ' LEU . 15.0 t -126.42 158.9 34.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.899 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.479 HD11 HD22 ' A' ' 143' ' ' LEU . 4.2 mt -142.1 125.28 16.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 m -119.0 148.16 43.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 169' ' ' MET . 66.0 m -75.37 128.25 34.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.98 28.08 19.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.555 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -118.81 138.6 52.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.2 t -96.8 104.12 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.126 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 3.1 pt -102.28 89.73 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.153 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.17 134.33 55.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.47 HD11 ' HE2' ' A' ' 129' ' ' PHE . 3.2 pt -121.49 157.43 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.11 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -143.29 155.06 44.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -175.13 -46.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -100.82 43.14 1.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 59.21 30.22 19.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.959 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.37 122.23 9.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.817 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.509 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.8 mp -81.11 88.87 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.099 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -65.79 131.85 47.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.823 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -90.05 113.11 24.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.707 HD21 ' HG3' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -128.55 140.05 51.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.812 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -131.01 134.66 46.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.78 147.36 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.542 ' O ' HG23 ' A' ' 151' ' ' THR . 1.4 mmt -110.12 -61.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.63 152.38 50.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.963 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 43.5 p -150.3 143.64 25.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -120.35 151.95 54.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.19 -38.34 1.8 Allowed 'Cis proline' 0 C--N 1.346 0.427 0 C-N-CA 123.376 -1.51 . . . . 0.0 112.367 0.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -108.64 175.4 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.787 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.52 -47.78 78.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.998 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.427 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -94.18 131.02 40.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.716 HG21 ' HB2' ' A' ' 117' ' ' ALA . 7.8 m -143.33 155.3 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.177 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.451 ' OG ' HD11 ' A' ' 63' ' ' LEU . 2.8 t -112.39 99.82 8.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.827 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.2 pt -88.98 85.72 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.165 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 20.8 mt -116.46 96.06 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 60.75 66.1 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 7.3 t -155.51 154.91 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.93 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -101.71 135.8 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.933 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -137.21 155.47 49.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.7 76.12 7.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.5 125.82 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.144 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.95 167.11 11.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -120.46 127.7 52.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -98.99 96.87 8.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.095 -179.981 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.426 ' N ' ' HG ' ' A' ' 111' ' ' SER . 53.9 t80 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.76 0.314 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.8 p -130.53 133.98 46.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.852 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.8 t -177.1 169.41 2.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -99.6 125.31 45.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -123.64 152.4 42.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 -84.66 130.19 34.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.9 m -93.66 130.45 39.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.97 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -133.15 171.12 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -85.12 164.34 18.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.643 HG11 HG11 ' A' ' 37' ' ' VAL . 16.0 m -90.47 11.67 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.473 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.9 p . . . . . 0 C--N 1.331 -0.207 0 CA-C-O 120.722 0.296 . . . . 0.0 110.824 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.643 HG11 HG11 ' A' ' 25' ' ' VAL . 20.8 t . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.826 0.346 . . . . 0.0 111.275 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.405 ' O ' ' CD1' ' A' ' 94' ' ' TRP . 9.3 mt-10 -82.51 -30.68 29.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.073 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.2 mttm -87.39 -30.62 20.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.009 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.03 -179.93 38.39 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.575 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.12 63.04 0.48 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.528 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.91 153.09 51.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.756 0.312 . . . . 0.0 110.847 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.652 HG21 HD23 ' A' ' 91' ' ' LEU . 10.7 pt -136.89 177.7 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.218 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.9 mt -126.19 114.98 40.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 76.8 mtp -108.74 164.16 15.36 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.819 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 52.6 Cg_exo -54.8 144.94 63.74 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.584 2.189 . . . . 0.0 112.147 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 46' ' ' PRO . 50.9 Cg_exo -54.06 -28.3 49.8 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.448 2.098 . . . . 0.0 112.338 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.0 t -65.44 -29.72 70.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.043 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.13 -48.27 80.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.15 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.701 HD13 ' CE2' ' A' ' 82' ' ' PHE . 25.1 tp -60.49 -43.5 96.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.35 -31.4 69.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -44.58 69.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.999 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 50' ' ' LEU . 5.1 mt -58.19 -30.14 66.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.009 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.3 m -73.84 -26.25 60.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -94.96 20.14 9.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.318 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -134.04 20.02 3.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.219 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 56.18 30.19 16.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.809 0.338 . . . . 0.0 111.013 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.8 mt -100.43 130.28 49.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.77 164.86 15.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.931 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.451 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.6 t80 -64.44 140.81 98.07 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.787 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 76.9 Cg_endo -77.46 164.46 86.41 Favored 'Cis proline' 0 C--N 1.348 0.511 0 C-N-CA 123.487 -1.464 . . . . 0.0 112.473 -0.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 34.2 mtt -135.04 64.65 1.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.803 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.734 HD13 ' SG ' ' A' ' 148' ' ' CYS . 1.1 mt -70.7 165.05 23.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.984 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -132.78 126.23 31.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.409 ' HG3' ' CD2' ' A' ' 76' ' ' HIS . 15.7 ttpt -83.09 112.7 20.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.4 mt -91.71 82.88 5.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.814 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.7 m -86.16 99.6 11.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.481 ' HA ' HG13 ' A' ' 107' ' ' VAL . 26.0 t-20 -62.22 125.18 23.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.5 33.91 2.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.36 -48.27 1.57 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.816 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.2 m -118.18 21.69 12.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.209 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 t0 54.16 35.14 21.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.833 0.349 . . . . 0.0 111.077 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -84.37 162.09 20.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.969 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.78 127.05 13.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.477 ' OG1' HD21 ' A' ' 99' ' ' LEU . 55.8 m -152.93 131.39 12.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.616 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 49.5 m80 -104.48 106.41 16.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.5 p -93.49 174.52 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.25 138.79 10.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.443 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.574 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 10.9 p -84.81 158.41 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.846 0.355 . . . . 0.0 111.055 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.485 ' N ' HG22 ' A' ' 79' ' ' VAL . 16.6 tp -151.56 -58.28 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -104.88 147.36 27.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.701 ' CE2' HD13 ' A' ' 50' ' ' LEU . 97.2 m-85 -125.31 86.72 2.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.2 m -155.91 32.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.109 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.38 165.59 12.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -83.47 165.11 19.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -64.08 121.73 14.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.43 33.7 68.13 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.555 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 26.5 mt -148.46 95.15 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 111.095 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 98.0 m -98.12 126.93 43.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.964 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -89.9 129.45 36.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.652 HD23 HG21 ' A' ' 43' ' ' ILE . 1.4 mp -136.29 155.34 77.34 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.02 -174.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.509 2.139 . . . . 0.0 112.354 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -94.55 -36.05 11.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.608 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 59.1 p-90 -64.34 -37.03 86.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.898 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.45 ' O ' HD12 ' A' ' 99' ' ' LEU . 56.4 ttm -71.24 -39.12 71.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 36.5 mmm -64.57 -45.2 88.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -39.44 68.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -59.61 -31.9 69.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.477 HD21 ' OG1' ' A' ' 75' ' ' THR . 6.4 mt -98.13 -8.84 26.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.342 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.4 mt 63.03 33.6 14.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.849 0.357 . . . . 0.0 110.885 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.6 mt -92.17 130.32 37.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.831 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -84.15 179.07 7.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.79 94.35 0.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.43 41.53 1.48 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.564 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.58 119.92 6.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.569 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.8 mt -73.62 126.57 30.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.838 0.351 . . . . 0.0 110.878 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.481 HG13 ' HA ' ' A' ' 68' ' ' ASN . 21.6 t -127.43 143.62 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.126 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -67.33 104.65 1.55 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.35 136.32 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -141.97 148.2 38.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.426 ' HG ' ' N ' ' A' ' 16' ' ' PHE . 53.3 p -104.68 115.16 29.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.4 m -131.13 173.05 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.078 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.81 100.07 4.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.444 ' CD1' ' HB1' ' A' ' 176' ' ' ALA . 5.0 mt -89.19 -179.95 5.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -123.91 170.23 10.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -64.36 143.96 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.15 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.519 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -83.28 156.37 23.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.181 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.2 p -117.64 -39.94 3.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.943 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -125.22 85.68 2.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.42 ' OG ' HG22 ' A' ' 171' ' ' THR . 35.2 m -100.32 120.43 39.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.859 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -109.53 149.59 29.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 143' ' ' LEU . 89.5 m-85 -134.46 164.03 28.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.84 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -148.43 90.06 5.0 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.13 126.21 19.64 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.486 2.124 . . . . 0.0 112.313 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -73.35 -32.03 64.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.6 m -105.61 148.32 36.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.5 -12.59 27.21 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.586 2.19 . . . . 0.0 112.53 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -55.18 -41.71 72.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.034 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.416 ' CE1' HD11 ' A' ' 166' ' ' LEU . 12.6 t80 -70.67 -35.37 72.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.892 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 26.5 mt -66.68 -29.71 69.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.31 -26.04 68.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.008 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.755 HD13 HG21 ' A' ' 138' ' ' VAL . 47.5 mt -63.13 138.76 22.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.986 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.4 t -66.58 -39.65 88.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.992 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.472 ' H ' HG22 ' A' ' 132' ' ' ILE . 9.2 t30 -126.68 80.49 70.21 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.17 -36.1 92.39 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.542 2.161 . . . . 0.0 112.31 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -59.69 -35.7 75.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.47 -37.34 80.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.2 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.755 HG21 HD13 ' A' ' 132' ' ' ILE . 21.4 t -82.75 -31.69 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.274 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.556 HD21 ' CD1' ' A' ' 122' ' ' PHE . 32.0 tp -75.2 -39.0 60.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.52 -31.35 68.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -66.19 -31.14 71.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.96 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.08 -41.35 13.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.149 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.579 HD11 ' CZ ' ' A' ' 122' ' ' PHE . 15.6 mt -59.41 -27.56 66.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.999 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -56.97 -29.94 63.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.053 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.09 -46.0 18.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.865 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -61.1 134.26 56.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -98.48 -28.63 13.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.734 ' SG ' HD13 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -133.65 166.72 21.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.873 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.573 HD22 HG21 ' A' ' 168' ' ' VAL . 11.8 mt -158.19 147.34 19.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.42 132.08 40.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.0 m -59.99 107.1 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.942 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 112.44 28.87 3.36 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.505 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -122.67 134.28 54.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.774 0.321 . . . . 0.0 110.871 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.13 114.79 29.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.106 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.608 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 7.2 pt -112.87 118.5 58.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.38 141.6 33.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.066 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.6 pt -135.04 147.27 29.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.108 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -143.06 156.46 44.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.439 ' CE2' ' HB2' ' A' ' 160' ' ' ASN . 47.9 p90 -175.29 -44.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.872 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.439 ' HB2' ' CE2' ' A' ' 159' ' ' TYR . 41.0 t30 -101.5 40.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 60.29 31.15 20.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -152.03 134.85 15.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.567 ' H ' HD12 ' A' ' 163' ' ' ILE . 4.0 mp -85.23 105.93 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -89.47 111.52 22.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.2 138.5 57.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.416 HD11 ' CE1' ' A' ' 129' ' ' PHE . 0.5 OUTLIER -156.56 118.05 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -115.79 137.48 52.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.573 HG21 HD22 ' A' ' 149' ' ' LEU . 21.5 t -73.97 109.01 5.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.2 mmm -76.64 -47.01 23.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.13 155.94 43.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.979 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.42 HG22 ' OG ' ' A' ' 120' ' ' SER . 0.5 OUTLIER -160.06 132.9 6.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.763 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -108.88 158.16 34.92 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.69 -26.72 9.1 Favored 'Cis proline' 0 C--N 1.347 0.454 0 C-N-CA 123.31 -1.538 . . . . 0.0 112.414 -0.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -125.74 179.46 5.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -47.83 84.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.616 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -91.04 124.33 35.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.0 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 117' ' ' ALA . 9.2 m -140.74 152.57 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.8 t -113.23 98.95 7.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.2 pt -88.1 85.09 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.184 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.0 mm -113.61 89.19 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.12 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 61.1 77.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.818 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 13.9 t -163.16 149.91 12.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -101.32 131.16 47.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.926 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -136.11 170.98 15.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -91.43 97.73 11.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 29.2 t -84.26 139.69 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.084 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.09 175.24 5.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.844 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -141.56 148.44 39.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -135.87 90.49 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.138 179.939 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.469 ' CE2' HG22 ' A' ' 18' ' ' THR . 43.7 t80 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.789 0.328 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.9 p -159.04 118.8 3.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.966 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.469 HG22 ' CE2' ' A' ' 16' ' ' PHE . 9.8 t -177.47 150.91 0.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.888 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -75.39 140.02 42.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.436 ' C ' HD23 ' A' ' 106' ' ' LEU . 5.9 m-85 -142.0 144.11 33.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -69.32 176.49 3.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.971 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.1 m -146.38 125.32 12.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.651 ' CD2' HG23 ' A' ' 88' ' ' ILE . 56.7 m-85 -132.64 174.41 10.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 t -93.62 146.94 23.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.28 -27.65 43.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.173 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.5 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.107 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.89 0.376 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.87 -31.03 28.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -91.21 56.19 3.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.773 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.33 149.42 6.88 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.423 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.55 72.96 2.73 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.484 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.452 ' HE2' HD13 ' A' ' 80' ' ' LEU . 33.9 mttt -131.28 133.67 45.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.789 0.328 . . . . 0.0 110.842 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.561 HG21 HD23 ' A' ' 91' ' ' LEU . 1.9 pt -120.3 163.67 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.151 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.24 118.3 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.06 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.7 mtm -110.78 164.16 15.53 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 52.2 Cg_exo -55.08 148.23 49.63 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.567 2.178 . . . . 0.0 112.19 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 46' ' ' PRO . 50.7 Cg_exo -53.86 -29.69 54.3 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.513 2.142 . . . . 0.0 112.316 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.7 p -59.0 -30.94 68.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.91 74.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.603 HD13 ' CE2' ' A' ' 82' ' ' PHE . 38.4 tp -70.9 -50.39 35.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.924 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.26 -30.85 69.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.592 ' HG2' HD11 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -77.12 -41.32 42.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.058 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.1 mt -58.23 -31.97 67.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.038 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -82.33 -29.79 30.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.61 -16.08 52.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.216 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.592 HD11 ' HG2' ' A' ' 52' ' ' GLN . 9.2 mt -93.93 19.6 8.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.265 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.3 t30 55.2 30.08 13.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.0 mt -98.18 141.14 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.193 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.8 p -126.45 159.35 33.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.46 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -63.02 145.37 96.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.842 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.46 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.3 Cg_endo -77.1 152.12 94.39 Favored 'Cis proline' 0 C--N 1.348 0.501 0 C-N-CA 123.413 -1.495 . . . . 0.0 112.378 0.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 20.3 mtt -116.17 61.3 0.72 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.651 HD13 HD12 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -78.77 137.95 37.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.826 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.495 ' CD1' HG12 ' A' ' 109' ' ' VAL . 94.7 m-85 -100.73 171.8 7.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.451 ' NZ ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -121.33 86.51 2.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.887 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 mt -66.18 88.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.451 HG23 ' NZ ' ' A' ' 65' ' ' LYS . 3.4 m -88.25 103.08 15.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -85.17 113.69 21.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -96.08 42.93 1.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -124.59 -44.29 1.98 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.85 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 m -128.13 25.65 5.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.085 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 55.92 39.58 30.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.039 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.523 ' HB3' HD23 ' A' ' 99' ' ' LEU . 2.1 mmp_? -89.59 157.39 18.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.962 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.7 ttp -154.72 127.38 8.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.932 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.602 HG21 HD11 ' A' ' 99' ' ' LEU . 4.6 t -157.43 145.22 18.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.965 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -112.14 108.06 17.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.819 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 28.6 p -107.5 147.52 30.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.08 142.47 16.17 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.438 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.41 HG21 ' CE1' ' A' ' 82' ' ' PHE . 11.7 p -70.3 136.12 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.876 0.37 . . . . 0.0 111.066 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.452 HD13 ' HE2' ' A' ' 42' ' ' LYS . 14.7 tp -104.59 -63.25 1.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -127.61 167.49 16.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.934 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.603 ' CE2' HD13 ' A' ' 50' ' ' LEU . 94.8 m-85 -123.27 93.42 3.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 82' ' ' PHE . 22.9 m -156.73 37.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.188 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.91 157.65 19.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.1 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.498 ' HB3' HD12 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -71.41 148.47 46.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -59.81 124.59 20.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.86 -19.15 54.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.594 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.651 HG23 ' CD2' ' A' ' 23' ' ' PHE . 29.0 mt -108.24 132.2 56.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 111.157 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 43.6 m -128.76 126.53 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.56 145.88 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.561 HD23 HG21 ' A' ' 43' ' ' ILE . 4.6 mp -146.57 158.51 46.46 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.03 155.0 9.32 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.605 2.203 . . . . 0.0 112.278 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -69.34 -38.46 78.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.528 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 49.0 p-90 -64.75 -41.17 96.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.446 ' N ' ' CD2' ' A' ' 94' ' ' TRP . 3.3 ttp -66.91 -36.97 83.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.929 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.6 mtp -61.94 -35.69 79.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -77.61 -38.38 48.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -60.33 -31.96 70.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.834 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.602 HD11 HG21 ' A' ' 75' ' ' THR . 9.2 mt -98.13 -14.42 20.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.257 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.7 mt 62.07 39.99 12.51 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.9 0.381 . . . . 0.0 110.88 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 mt -81.23 164.97 21.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.842 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.81 -174.39 2.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -65.01 96.11 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.27 38.12 5.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.06 110.3 3.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.436 HD23 ' C ' ' A' ' 20' ' ' TYR . 26.3 mt -73.76 124.85 26.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.826 0.346 . . . . 0.0 110.945 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -134.34 150.42 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -66.5 136.63 55.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.888 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.495 HG12 ' CD1' ' A' ' 64' ' ' PHE . 21.4 t -123.63 92.3 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -107.79 137.6 45.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.431 ' HG ' ' N ' ' A' ' 16' ' ' PHE . 21.7 p -88.49 114.49 25.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.3 m -119.67 131.05 73.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.142 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -82.13 112.42 19.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.651 HD12 HD13 ' A' ' 63' ' ' LEU . 1.9 mt -111.7 175.08 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -133.08 171.83 13.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.06 147.28 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.184 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.589 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -89.65 149.74 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.064 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.1 p -105.55 -28.58 10.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.824 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -134.93 90.78 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.906 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.7 p -98.24 109.03 21.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -101.22 136.46 41.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.845 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.509 ' CZ ' HD21 ' A' ' 143' ' ' LEU . 64.5 m-85 -124.49 156.71 36.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -133.64 94.45 19.21 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.97 108.58 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.52 2.147 . . . . 0.0 112.395 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -61.98 -31.82 72.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.948 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 m -113.87 146.68 36.09 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.002 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.31 -14.6 25.47 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.544 2.163 . . . . 0.0 112.567 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.68 -33.96 61.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.135 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -75.29 -31.38 60.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.9 mt -63.53 -30.72 71.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.71 -27.99 69.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.012 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.648 HD13 HG21 ' A' ' 138' ' ' VAL . 46.8 mt -60.88 135.62 25.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.049 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.6 m -71.07 -30.66 66.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.598 ' H ' HG22 ' A' ' 132' ' ' ILE . 1.1 m120 -127.88 73.32 78.93 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.908 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -56.74 -37.09 98.65 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.629 2.219 . . . . 0.0 112.209 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -60.75 -46.4 90.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.046 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -59.21 -46.02 89.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.055 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.648 HG21 HD13 ' A' ' 132' ' ' ILE . 21.5 t -69.72 -37.54 74.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.485 HD21 ' CD1' ' A' ' 122' ' ' PHE . 4.4 tp -73.5 -34.08 65.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -74.16 -34.49 63.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.906 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.05 -37.07 86.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.3 -33.44 43.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.534 HD22 HD11 ' A' ' 149' ' ' LEU . 12.6 mt -60.03 -28.82 68.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.947 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -57.95 -32.76 68.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.03 -31.56 58.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.83 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -74.71 142.61 44.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -100.79 -30.67 11.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.522 ' SG ' HD13 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -134.56 173.31 11.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.534 HD11 HD22 ' A' ' 143' ' ' LEU . 55.0 mt -149.59 114.38 5.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.824 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.0 m -104.95 144.88 31.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.1 m -71.12 112.72 7.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 99.76 39.3 3.42 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.575 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.18 112.9 20.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 110.883 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.21 82.97 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.116 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.528 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 8.7 pt -79.98 160.52 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.062 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.625 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -121.8 112.91 18.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.3 pt -98.7 152.51 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.208 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -147.72 147.24 29.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 160' ' ' ASN . 52.8 p90 -164.49 -47.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.846 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.45 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 57.0 t-20 -98.93 43.95 1.04 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 60.15 31.02 20.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.17 132.35 19.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.625 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 4.0 mp -90.39 88.49 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.087 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -70.38 123.18 21.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -75.14 133.09 41.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.22 141.38 22.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.877 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -136.94 145.51 44.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.38 153.64 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.177 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 13.2 mmm -121.99 -54.37 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.91 140.13 34.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.7 p -144.43 135.76 25.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -113.49 153.91 45.62 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.69 -37.12 2.22 Favored 'Cis proline' 0 C--N 1.346 0.395 0 C-N-CA 123.337 -1.526 . . . . 0.0 112.4 0.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.39 173.13 6.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -56.58 -43.33 79.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -95.06 127.63 41.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.004 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.589 HG21 ' HB2' ' A' ' 117' ' ' ALA . 16.2 m -138.35 139.61 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.169 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.429 ' HB2' HD11 ' A' ' 180' ' ' ILE . 30.9 p -93.18 102.1 14.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.793 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.0 pt -96.13 88.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.271 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.429 HD11 ' HB2' ' A' ' 178' ' ' SER . 3.5 mp -124.28 82.31 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.005 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 62.19 81.57 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 23.7 t -157.18 158.15 35.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -91.14 129.75 37.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 5.9 ptt? -152.02 174.04 14.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -108.48 117.19 33.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.813 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.477 HG11 HD23 ' A' ' 139' ' ' LEU . 21.4 t -97.91 137.98 23.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.203 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.1 146.56 52.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -105.75 148.13 27.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -114.91 85.16 2.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.931 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.163 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.426 ' CE2' ' HG ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.791 0.329 . . . . 0.0 110.875 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.3 p -159.72 99.5 1.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -160.69 162.39 32.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.747 ' HB3' HD22 ' A' ' 106' ' ' LEU . 12.1 mt-30 -96.06 130.59 43.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.436 ' HD2' HG21 ' A' ' 109' ' ' VAL . 12.7 m-85 -126.15 143.27 51.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -78.08 143.13 37.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.2 p -104.38 130.23 52.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.568 ' CD2' HG23 ' A' ' 88' ' ' ILE . 57.1 m-85 -139.86 154.56 47.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -60.23 162.44 5.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.595 HG12 ' HB3' ' A' ' 90' ' ' TYR . 14.6 m -95.55 20.09 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.331 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 120.842 0.353 . . . . 0.0 110.911 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.745 0.307 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.525 ' OE1' HG21 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -73.47 -40.99 63.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.897 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.8 mttm -66.02 79.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.47 -171.9 22.08 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.49 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.7 79.98 0.26 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.453 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.473 ' HE2' HD13 ' A' ' 80' ' ' LEU . 17.0 mttt -140.51 134.25 30.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.813 0.339 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.604 HG21 HD23 ' A' ' 91' ' ' LEU . 24.1 pt -122.53 170.07 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.098 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 4.6 mt -124.46 96.9 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.004 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.9 mmm -90.34 158.55 43.33 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.81 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.64 149.38 32.1 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.51 2.14 . . . . 0.0 112.267 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.54 -30.14 53.03 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.566 2.177 . . . . 0.0 112.276 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.93 -30.19 71.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.43 -30.05 66.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.177 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.421 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 32.2 tp -70.67 -50.6 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.962 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.29 -32.39 73.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -76.78 -44.12 34.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.06 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.426 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 8.1 mt -58.72 -37.02 75.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.953 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.4 t -83.01 -28.76 29.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.79 -19.95 59.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.171 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.6 mt -92.69 15.52 14.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.332 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.83 32.69 20.09 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.735 0.302 . . . . 0.0 111.038 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.419 HD12 HD23 ' A' ' 53' ' ' LEU . 41.2 mt -92.87 144.17 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.107 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.3 p -127.19 179.69 5.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.984 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 16.7 t80 -72.55 138.42 80.65 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.749 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.458 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.4 Cg_endo -77.15 156.57 97.09 Favored 'Cis proline' 0 C--N 1.348 0.537 0 C-N-CA 123.534 -1.444 . . . . 0.0 112.426 0.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 41.8 mtt -119.97 31.34 6.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.809 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.543 HD22 ' HB2' ' A' ' 148' ' ' CYS . 1.3 mt -61.58 149.23 39.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.468 ' HB3' HG13 ' A' ' 109' ' ' VAL . 94.8 m-85 -109.51 145.51 36.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.882 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.57 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 16.8 tttt -92.39 85.97 5.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.949 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.514 HD11 ' SG ' ' A' ' 77' ' ' CYS . 96.2 mt -70.73 90.1 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -98.89 111.64 23.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.927 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -83.86 113.17 20.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.825 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -88.31 54.35 3.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -142.9 -47.48 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.885 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.7 22.5 9.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.157 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 54.52 37.02 27.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.005 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -90.56 147.93 23.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.9 ttt -138.07 142.01 40.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.809 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.5 m -159.98 148.68 17.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.57 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 60.3 m-70 -124.78 114.01 18.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.514 ' SG ' HD11 ' A' ' 66' ' ' LEU . 26.5 p -115.06 155.89 26.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.511 ' CA ' HD23 ' A' ' 63' ' ' LEU . . . -113.23 131.08 9.81 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.449 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.535 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 10.7 p -68.59 140.14 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 111.164 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.473 HD13 ' HE2' ' A' ' 42' ' ' LYS . 12.6 tp -129.65 -56.35 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.832 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -108.54 146.12 33.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.971 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.535 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 76.6 m-85 -120.39 58.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.1 m -125.34 31.2 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.104 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 44' ' ' ILE . . . -85.24 179.24 7.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.076 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.69 169.08 9.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -73.02 107.97 5.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.37 28.21 33.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.493 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.568 HG23 ' CD2' ' A' ' 23' ' ' PHE . 27.0 mt -148.33 95.67 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 111.12 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 15.0 m -91.05 134.2 34.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.595 ' HB3' HG12 ' A' ' 25' ' ' VAL . 34.7 m-85 -97.84 120.64 38.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.604 HD23 HG21 ' A' ' 43' ' ' ILE . 4.8 mt -123.34 150.23 59.96 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.935 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.3 176.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.52 2.147 . . . . 0.0 112.304 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -79.84 -47.4 15.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -59.53 -29.12 67.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.992 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.555 ' SD ' HD22 ' A' ' 91' ' ' LEU . 33.4 ttm -73.45 -30.94 63.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.831 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 6.4 mtp -71.61 -43.59 65.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -68.92 -40.25 79.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.854 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -60.38 -61.51 2.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.819 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 mt -62.88 -20.54 65.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.6 mt 63.25 34.25 13.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.823 0.344 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 mt -81.52 179.27 7.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.827 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -125.79 177.59 6.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -63.97 103.18 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.437 ' CA ' ' CZ ' ' A' ' 23' ' ' PHE . . . 89.41 34.87 8.29 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.521 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.18 117.83 4.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.554 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.747 HD22 ' HB3' ' A' ' 19' ' ' GLN . 12.7 mt -64.71 130.22 42.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 110.884 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.9 t -121.46 138.02 53.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -70.46 112.81 7.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 64' ' ' PHE . 27.0 t -96.44 143.93 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -160.03 138.63 10.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.4 p -91.05 113.91 26.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.6 m -120.86 150.14 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.115 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.74 86.8 2.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.422 ' CD1' ' HB1' ' A' ' 176' ' ' ALA . 4.9 mt -83.01 168.08 17.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.801 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -110.9 175.53 5.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.838 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.14 139.59 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.2 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.944 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -76.39 151.02 36.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.6 t -110.57 -30.93 7.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -138.77 107.72 6.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.938 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 m -114.26 137.99 51.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -129.02 148.63 50.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.496 ' CD1' HD21 ' A' ' 139' ' ' LEU . 67.8 m-85 -133.8 150.84 51.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -131.55 91.33 34.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -51.34 125.02 15.39 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.543 2.162 . . . . 0.0 112.34 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -71.12 -39.77 71.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.1 m -105.57 148.0 35.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.877 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.472 ' HA ' HD12 ' A' ' 130' ' ' LEU . 57.4 Cg_endo -70.73 -11.22 29.25 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.575 2.183 . . . . 0.0 112.576 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -56.37 -39.7 73.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.766 0.317 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -72.32 -38.3 68.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 127' ' ' PRO . 32.4 mt -65.32 -36.94 85.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.824 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.29 -25.3 67.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.652 HG22 ' H ' ' A' ' 134' ' ' ASN . 52.2 mt -59.99 134.57 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.052 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.1 t -59.69 -32.65 70.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.004 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.652 ' H ' HG22 ' A' ' 132' ' ' ILE . 0.5 OUTLIER -137.04 81.01 33.86 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.926 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.34 -30.05 16.11 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.62 2.214 . . . . 0.0 112.318 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -63.51 -37.8 88.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.63 -56.48 17.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.7 -33.94 62.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.164 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.496 HD21 ' CD1' ' A' ' 122' ' ' PHE . 29.7 tp -70.16 -50.92 35.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.943 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.425 ' CD ' HG21 ' A' ' 186' ' ' VAL . 2.2 mt-10 -67.27 -39.07 86.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -60.13 -30.92 69.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.858 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.08 -31.21 61.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.071 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 60.4 mt -57.95 -27.16 63.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.038 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -30.05 62.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.012 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -81.55 -36.25 29.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -77.69 147.14 35.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.962 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -107.96 -28.66 9.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.543 ' HB2' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -128.58 159.56 35.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.402 HD12 HG21 ' A' ' 179' ' ' ILE . 28.4 mt -137.44 118.71 14.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.14 140.77 46.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.86 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.4 m -66.7 125.5 26.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.22 44.69 8.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.438 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -111.01 119.46 39.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.839 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.73 81.22 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 39.9 pt -81.91 178.41 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -152.63 131.32 12.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.039 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 39.8 pt -118.56 138.02 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -136.83 146.01 45.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.425 ' CE2' ' HB2' ' A' ' 160' ' ' ASN . 52.6 p90 -173.98 -44.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.868 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.425 ' HB2' ' CE2' ' A' ' 159' ' ' TYR . 53.1 t30 -97.76 38.5 1.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 60.21 31.12 20.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.21 119.45 8.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.517 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.8 mp -84.09 90.81 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -71.8 138.61 48.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -96.96 124.86 41.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.2 mt -139.33 138.28 36.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -129.85 136.57 49.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.4 t -71.78 130.19 35.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.067 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.2 mmm -91.37 -62.81 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.09 150.45 48.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 31.5 p -144.79 144.22 31.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.849 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -123.84 152.17 65.7 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.96 -38.77 1.62 Allowed 'Cis proline' 0 C--N 1.346 0.436 0 C-N-CA 123.321 -1.533 . . . . 0.0 112.368 0.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -107.63 168.82 8.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -34.87 72.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.947 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.422 ' HB1' ' CD1' ' A' ' 114' ' ' LEU . . . -108.39 124.02 49.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.075 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.944 HG21 ' HB2' ' A' ' 117' ' ' ALA . 6.4 m -135.89 160.04 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 3.7 t -108.93 91.83 3.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.402 HG21 HD12 ' A' ' 149' ' ' LEU . 3.0 pt -80.56 82.76 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.145 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.9 mt -115.2 82.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.089 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 60.0 79.78 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.842 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 2.0 t -156.94 153.93 28.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.85 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -90.7 118.89 30.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -135.11 176.26 8.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.839 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.01 142.06 27.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.425 HG21 ' CD ' ' A' ' 140' ' ' GLU . 21.5 t -129.54 86.6 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.138 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.62 175.39 10.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -134.75 145.34 48.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -141.08 105.09 4.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.092 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.78 0.324 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.6 p -158.42 102.85 1.75 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -168.25 177.82 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.45 ' HB3' HD22 ' A' ' 106' ' ' LEU . 57.8 mt-30 -105.38 122.08 45.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -117.73 151.06 38.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 mtt85 -86.4 137.16 32.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.582 ' HB2' HD12 ' A' ' 91' ' ' LEU . 21.5 p -104.16 122.93 46.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.522 ' CD2' HG23 ' A' ' 88' ' ' ILE . 36.7 m-85 -132.05 160.29 36.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 t -77.09 152.72 34.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -64.34 -21.04 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.347 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.276 -179.956 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.749 0.309 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.68 -36.33 65.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.821 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -60.29 -33.29 72.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -110.4 -164.66 19.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.474 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.16 31.63 5.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.55 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.635 ' HE3' HD13 ' A' ' 80' ' ' LEU . 22.0 mmtt -87.66 158.57 18.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.815 0.341 . . . . 0.0 110.973 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.6 pt -135.77 -179.98 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 3.6 mp -130.45 104.45 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.04 157.17 34.21 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.54 ' N ' ' HB3' ' A' ' 84' ' ' ALA . 53.6 Cg_exo -52.34 144.86 38.2 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.541 2.161 . . . . 0.0 112.261 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 46' ' ' PRO . 50.1 Cg_exo -53.66 -30.62 56.61 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.516 2.144 . . . . 0.0 112.279 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.3 p -60.65 -35.45 76.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.94 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.89 -30.98 71.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.144 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.589 HD13 ' CD2' ' A' ' 82' ' ' PHE . 43.3 tp -63.06 -39.38 94.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.56 -32.89 47.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -61.14 -38.79 87.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.53 HD23 HD12 ' A' ' 58' ' ' ILE . 8.8 mt -61.37 -46.21 91.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -60.14 -30.98 69.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.947 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.8 mtt85 -82.1 -26.35 33.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.036 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.1 mt -86.74 6.14 32.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.428 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 t30 59.52 31.34 20.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.81 0.338 . . . . 0.0 110.966 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.53 HD12 HD23 ' A' ' 53' ' ' LEU . 33.1 mt -94.73 125.19 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.128 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.7 p -110.37 170.62 7.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.455 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.8 OUTLIER -64.82 141.18 98.27 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.822 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.9 Cg_endo -77.1 164.61 86.76 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.468 -1.471 . . . . 0.0 112.403 -0.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 20.1 mtt -126.65 72.9 1.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.852 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.665 HD21 ' HB1' ' A' ' 147' ' ' ALA . 4.0 mt -90.96 149.26 21.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.958 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.459 ' HB3' HG13 ' A' ' 109' ' ' VAL . 97.7 m-85 -112.78 142.99 44.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.823 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 59.5 tttt -94.93 103.39 15.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.984 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.5 HD12 ' SG ' ' A' ' 77' ' ' CYS . 7.9 mt -91.69 76.24 5.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.94 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -78.09 97.22 5.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.931 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -66.02 116.92 7.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -92.31 49.71 1.54 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -130.4 -46.13 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.795 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.0 m -133.28 28.82 4.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.958 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 58.02 34.75 24.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.031 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -88.82 156.32 19.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.512 ' O ' HG21 ' A' ' 150' ' ' THR . 13.8 ttm -158.4 137.63 11.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.592 ' CG2' HD11 ' A' ' 99' ' ' LEU . 7.0 t -160.0 108.98 1.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.888 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.436 ' CD2' HD11 ' A' ' 114' ' ' LEU . 37.9 m80 -75.91 118.31 18.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.9 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.5 ' SG ' HD12 ' A' ' 66' ' ' LEU . 24.7 p -111.61 147.16 36.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.95 149.71 19.26 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.499 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.539 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 9.8 p -91.02 154.42 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.853 0.358 . . . . 0.0 111.084 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.635 HD13 ' HE3' ' A' ' 42' ' ' LYS . 53.0 tp -145.96 -55.99 0.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.925 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -101.89 143.96 31.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.894 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.589 ' CD2' HD13 ' A' ' 50' ' ' LEU . 67.4 m-85 -123.54 76.8 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.4 m -150.79 31.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.54 ' HB3' ' N ' ' A' ' 46' ' ' PRO . . . -81.42 150.12 28.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.148 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.481 ' HB3' HD12 ' A' ' 88' ' ' ILE . 0.7 OUTLIER -68.01 173.06 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.85 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -67.95 115.89 7.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.11 29.83 75.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.522 HG23 ' CD2' ' A' ' 23' ' ' PHE . 32.7 mt -142.7 91.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 0.0 111.146 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.5 t -94.66 129.43 41.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -89.01 140.96 28.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 22' ' ' CYS . 4.1 mt -137.47 155.92 75.22 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.2 179.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.603 2.202 . . . . 0.0 112.293 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -87.44 -45.3 10.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.781 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 39.9 p-90 -60.35 -44.89 95.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.4 tpp -60.15 -34.74 73.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -53.36 22.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -60.0 -36.3 76.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.865 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -62.2 -49.08 77.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.781 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.592 HD11 ' CG2' ' A' ' 75' ' ' THR . 4.9 mt -75.36 -17.06 60.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.2 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.4 mt 61.21 35.22 18.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.44 HD13 ' SG ' ' A' ' 22' ' ' CYS . 25.6 mt -80.68 -178.63 6.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.826 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.02 -177.98 4.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 120.75 10.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.8 27.84 70.04 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.504 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -70.71 107.62 2.22 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.439 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' A' ' 19' ' ' GLN . 16.3 mt -69.52 123.52 21.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.839 0.352 . . . . 0.0 110.839 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.2 t -125.59 145.88 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.08 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -73.32 108.72 6.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.459 HG13 ' HB3' ' A' ' 64' ' ' PHE . 21.5 t -95.93 121.54 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.7 114.55 12.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.8 p -77.73 114.86 17.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.985 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.9 m -122.54 144.13 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.071 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.43 102.58 15.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.436 HD11 ' CD2' ' A' ' 76' ' ' HIS . 6.0 mt -99.58 168.93 9.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.63 172.34 7.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.6 m -67.96 140.76 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.122 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.592 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -81.82 148.84 28.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.062 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.7 p -109.63 -31.55 7.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -131.73 93.29 3.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 61.1 m -114.49 94.49 4.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.38 142.5 35.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.823 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.642 ' CE2' HG22 ' A' ' 168' ' ' VAL . 42.7 m-85 -124.68 150.92 45.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.014 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -128.37 93.54 38.13 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.54 104.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.557 2.171 . . . . 0.0 112.373 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -59.51 -30.88 68.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.3 146.31 35.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.821 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.69 -12.76 26.87 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.536 2.157 . . . . 0.0 112.559 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -56.82 -40.69 76.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.067 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.534 ' CD1' HD11 ' A' ' 166' ' ' LEU . 19.2 t80 -67.31 -44.24 79.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.62 -29.98 68.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.947 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -61.99 -26.31 68.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.988 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.564 HG22 ' H ' ' A' ' 134' ' ' ASN . 43.2 mt -61.66 139.68 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.981 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.4 m -65.3 -37.38 86.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.564 ' H ' HG22 ' A' ' 132' ' ' ILE . 2.0 m120 -130.01 71.12 82.28 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.407 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 39.6 Cg_exo -57.0 -29.95 84.78 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.611 2.207 . . . . 0.0 112.241 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -60.31 -49.52 77.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.043 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.45 75.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.139 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.4 HG21 HD13 ' A' ' 132' ' ' ILE . 21.5 t -75.57 -33.27 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.679 HD22 ' CE1' ' A' ' 188' ' ' PHE . 12.6 tp -71.7 -42.87 66.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.14 -37.83 72.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -65.69 -32.76 74.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.58 -31.74 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.136 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.538 HD22 HD11 ' A' ' 149' ' ' LEU . 14.2 mt -63.98 -27.32 69.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.038 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -57.03 -25.2 58.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.101 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -79.74 -49.24 12.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.826 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.431 ' CZ ' ' HB ' ' A' ' 155' ' ' ILE . 84.5 m-85 -60.77 146.72 45.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.665 ' HB1' HD21 ' A' ' 63' ' ' LEU . . . -100.85 -30.33 11.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.24 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.11 167.46 22.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.974 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.538 HD11 HD22 ' A' ' 143' ' ' LEU . 27.6 mt -143.01 137.53 29.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.512 HG21 ' O ' ' A' ' 74' ' ' MET . 2.0 m -114.09 141.64 47.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.0 m -65.83 94.28 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 108.33 30.43 3.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.548 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.03 134.17 46.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.766 0.317 . . . . 0.0 110.854 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 26.1 t -90.2 91.19 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.117 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.781 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 9.3 pt -91.65 134.03 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.494 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -102.05 125.07 48.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.12 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.433 HG12 HD12 ' A' ' 166' ' ' LEU . 5.0 pt -115.88 141.59 32.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.103 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -139.19 142.22 37.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -157.71 -50.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -96.77 44.18 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 60.34 31.47 20.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -148.55 126.21 11.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.494 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 3.8 mp -85.92 95.45 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.188 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -76.66 137.43 39.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -95.46 122.96 38.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.534 HD11 ' CD1' ' A' ' 129' ' ' PHE . 3.2 mt -141.63 100.55 3.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -93.93 127.74 39.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.642 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.2 t -68.94 128.79 32.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.083 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.8 mmm -86.71 -64.16 1.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.014 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -123.14 155.79 36.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 58.2 p -144.98 161.01 40.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.636 ' O ' HG11 ' A' ' 177' ' ' VAL . 25.9 mttt -148.12 155.4 43.47 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.825 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.29 -31.6 5.17 Favored 'Cis proline' 0 C--N 1.348 0.507 0 C-N-CA 123.309 -1.538 . . . . 0.0 112.462 0.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -113.51 176.7 4.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -60.01 -41.94 93.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -98.83 116.94 32.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.018 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.636 HG11 ' O ' ' A' ' 172' ' ' LYS . 17.7 m -133.27 137.66 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.16 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.506 ' OG ' HD11 ' A' ' 63' ' ' LEU . 10.0 t -94.62 97.9 10.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.1 pt -89.63 85.49 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.3 mm -117.83 85.12 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.123 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 60.58 87.26 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 49.9 t -161.65 141.52 10.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.97 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -80.84 108.14 14.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -128.34 179.22 5.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -93.84 89.97 6.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.75 81.33 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.01 172.05 13.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' PHE . . . . . 0.679 ' CE1' HD22 ' A' ' 139' ' ' LEU . 11.8 m-85 -128.52 163.07 25.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.93 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -147.93 101.64 3.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.958 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.048 179.946 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.3 t80 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.889 0.376 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.9 p -118.97 105.34 11.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.831 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.0 t -168.35 160.97 11.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.952 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -95.7 148.57 22.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -139.03 148.5 43.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 -75.84 128.51 35.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.873 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.463 ' HB3' HD13 ' A' ' 91' ' ' LEU . 64.9 m -99.11 125.79 44.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -130.66 175.47 8.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 t -92.28 150.66 20.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.906 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.5 m -68.3 -30.8 48.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.086 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.869 0.366 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.17 -31.58 43.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -80.56 -35.17 34.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.78 167.14 26.72 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.476 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.47 40.88 2.57 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.455 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.18 162.4 13.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.356 . . . . 0.0 110.897 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.537 HG22 ' HD3' ' A' ' 92' ' ' PRO . 43.0 pt -141.1 172.55 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.102 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 mt -120.93 86.41 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.174 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.6 mtp -89.11 151.59 47.0 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.773 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.09 156.09 7.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.574 2.183 . . . . 0.0 112.251 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.73 -25.46 61.17 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.625 2.217 . . . . 0.0 112.342 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.5 p -58.87 -30.78 67.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.942 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.79 -47.96 64.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.161 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.733 ' HA ' HD12 ' A' ' 53' ' ' LEU . 56.1 tp -59.51 -39.46 83.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.68 -31.01 64.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.924 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -74.04 -32.6 63.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.733 HD12 ' HA ' ' A' ' 50' ' ' LEU . 23.6 mt -59.84 -30.38 68.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.5 t -80.91 -22.94 39.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.111 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -75.09 -30.57 60.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.018 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.5 mt -95.52 20.05 10.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.243 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 53.58 38.42 28.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.82 0.343 . . . . 0.0 111.265 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 59' ' ' THR . 25.0 mm -77.08 154.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.025 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.408 ' N ' HG22 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -140.91 151.55 44.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.451 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.5 t80 -61.83 140.6 95.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.753 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.75 157.8 97.34 Favored 'Cis proline' 0 C--N 1.349 0.579 0 C-N-CA 123.479 -1.467 . . . . 0.0 112.409 -0.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.626 ' SD ' HD13 ' A' ' 53' ' ' LEU . 45.0 mtt -116.38 56.86 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.91 139.72 45.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.552 ' HB3' HG13 ' A' ' 109' ' ' VAL . 57.6 m-85 -105.81 157.13 17.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.421 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 10.3 tttp -103.55 92.94 4.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.6 mt -75.8 80.64 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.7 m -95.21 117.8 30.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -89.36 129.46 35.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.889 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -98.69 31.11 3.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.32 -41.02 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.847 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m -134.41 21.99 3.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.5 t70 54.4 59.95 3.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.098 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.627 ' HB3' HD23 ' A' ' 99' ' ' LEU . 5.7 mmp_? -106.55 158.98 16.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.1 ttm -159.28 126.64 4.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.712 HG22 HD21 ' A' ' 99' ' ' LEU . 4.4 t -158.96 100.94 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.941 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.421 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 50.4 m80 -65.77 131.98 47.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.926 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.6 p -123.11 166.32 15.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.49 113.24 2.05 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.516 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 80' ' ' LEU . 11.2 p -62.35 154.18 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.102 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.407 ' N ' HG22 ' A' ' 79' ' ' VAL . 23.2 tp -133.33 -62.22 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -95.7 162.76 13.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.51 ' CD2' HD22 ' A' ' 50' ' ' LEU . 51.7 m-85 -140.83 74.02 1.44 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.4 m -143.56 31.44 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.42 158.26 17.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.13 169.1 18.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -73.19 120.79 19.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.82 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.19 26.08 55.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.577 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.3 mt -149.74 113.99 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.834 0.35 . . . . 0.0 111.106 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 86.4 m -117.38 131.29 56.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -97.96 135.87 39.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.465 HD23 HG21 ' A' ' 43' ' ' ILE . 3.3 mp -135.36 160.63 67.25 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.537 ' HD3' HG22 ' A' ' 43' ' ' ILE . 53.6 Cg_exo -52.43 -176.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.582 2.188 . . . . 0.0 112.292 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -93.09 -40.92 10.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.023 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.413 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 65.1 p-90 -61.85 -42.07 98.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.98 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 44.6 ttm -60.43 -44.46 95.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.22 -48.76 80.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -60.57 -36.81 79.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.898 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -65.44 -56.38 12.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.712 HD21 HG22 ' A' ' 75' ' ' THR . 12.2 mt -68.14 -17.68 64.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.184 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.3 mt 62.86 32.35 15.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.844 0.354 . . . . 0.0 110.84 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.84 179.96 7.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -134.08 176.53 8.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -59.91 105.4 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.8 28.45 8.31 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.52 121.58 5.56 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.466 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.6 mt -83.14 123.55 29.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.835 0.35 . . . . 0.0 110.985 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.41 135.55 62.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.085 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -68.28 102.13 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 64' ' ' PHE . 25.4 t -86.86 132.12 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -145.17 133.15 21.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.8 p -90.88 103.06 15.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.1 m -109.19 170.96 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.168 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -114.89 118.69 34.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 176' ' ' ALA . 12.1 mt -119.12 177.31 4.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -123.06 167.53 13.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.2 m -64.85 141.96 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.064 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.638 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -76.53 148.85 36.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.3 p -113.29 -37.05 4.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.926 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -137.6 118.41 14.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.931 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.58 107.2 6.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.07 131.64 34.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.603 ' CG ' HD21 ' A' ' 139' ' ' LEU . 26.4 m-85 -112.29 144.5 41.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -131.57 96.97 19.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.81 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.82 119.91 5.35 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.518 2.145 . . . . 0.0 112.327 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -71.49 -32.22 67.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.033 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.98 147.48 34.56 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.957 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.65 -19.14 28.27 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.571 2.18 . . . . 0.0 112.604 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.52 -48.07 78.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.051 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.457 ' CE1' HD11 ' A' ' 166' ' ' LEU . 13.4 t80 -61.14 -44.96 96.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.88 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.6 mt -59.37 -31.8 69.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -62.77 -26.8 68.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.976 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.629 HG22 ' H ' ' A' ' 134' ' ' ASN . 29.6 mt -61.38 135.56 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.993 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.7 t -64.51 -33.39 75.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.629 ' H ' HG22 ' A' ' 132' ' ' ILE . 0.1 OUTLIER -134.61 81.76 46.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.86 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.12 -27.23 20.42 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.47 2.113 . . . . 0.0 112.321 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -60.14 -35.74 75.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.019 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.3 -39.27 68.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.13 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.54 -30.28 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.275 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.603 HD21 ' CG ' ' A' ' 122' ' ' PHE . 25.5 tp -79.75 -44.51 20.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.04 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -63.64 -31.56 72.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.94 -28.82 67.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.74 -32.63 31.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.124 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.06 -26.63 68.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.076 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -56.41 -30.1 62.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.068 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.86 -42.73 13.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.944 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.597 ' CE2' HD13 ' A' ' 155' ' ' ILE . 37.6 m-85 -62.49 142.42 57.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.547 ' HB1' HD11 ' A' ' 180' ' ' ILE . . . -108.03 -25.67 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.279 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -141.42 165.5 27.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.5 mt -145.83 162.55 37.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.66 143.71 30.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.959 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 169' ' ' MET . 89.0 m -62.98 96.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 110.0 27.47 4.55 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.468 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.93 116.15 28.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.3 t -84.62 89.0 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.069 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.597 HD13 ' CE2' ' A' ' 146' ' ' PHE . 1.1 pt -93.67 142.85 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.111 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.409 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -109.0 131.25 55.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.159 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.8 pt -117.99 154.63 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -144.72 142.06 29.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.908 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.419 ' CE1' ' CD1' ' A' ' 164' ' ' TYR . 16.4 p90 -158.5 -49.75 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.966 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -97.87 44.5 1.04 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.9 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 60.0 30.14 19.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -144.58 142.63 30.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.8 mp -93.67 90.45 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.041 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.419 ' CD1' ' CE1' ' A' ' 159' ' ' TYR . 39.8 m-85 -74.04 120.79 20.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -77.45 139.61 39.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.991 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.475 HD22 HD13 ' A' ' 139' ' ' LEU . 0.7 OUTLIER -153.28 124.78 7.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -124.16 137.67 54.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.929 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.425 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.5 t -76.18 146.96 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.443 ' O ' HG23 ' A' ' 151' ' ' THR . 24.5 mmm -106.23 -56.88 2.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -128.65 149.79 50.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.983 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 17.5 p -145.69 141.17 27.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.869 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -127.43 152.98 77.23 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.99 -28.15 7.94 Favored 'Cis proline' 0 C--N 1.346 0.397 0 C-N-CA 123.38 -1.508 . . . . 0.0 112.366 0.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -124.61 173.25 8.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -47.16 85.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.968 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.487 ' O ' HD22 ' A' ' 114' ' ' LEU . . . -90.88 103.55 16.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.016 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.638 HG21 ' HB2' ' A' ' 117' ' ' ALA . 15.9 m -123.38 132.19 71.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 5.7 t -89.55 85.58 6.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.813 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.8 pt -74.17 81.55 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.213 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.547 HD11 ' HB1' ' A' ' 147' ' ' ALA . 27.9 mm -119.69 103.07 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.977 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.98 79.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.808 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -176.48 144.14 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -101.18 120.48 40.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.969 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.75 172.18 7.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.05 95.06 9.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.414 HG13 ' CD1' ' A' ' 122' ' ' PHE . 21.5 t -86.3 90.34 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.13 175.43 10.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -130.43 151.6 50.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -129.2 80.74 1.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.128 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.1 t80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.856 0.36 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.8 p -147.75 107.26 3.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.952 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 t -156.5 178.65 10.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.482 ' HB3' HD22 ' A' ' 106' ' ' LEU . 38.6 mt-30 -107.2 163.29 13.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.861 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -157.36 142.59 17.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.982 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -81.87 118.81 23.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.2 p -84.94 133.43 34.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -138.58 174.52 10.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.21 147.08 23.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.976 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.7 m -68.27 -21.2 26.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.324 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.215 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.819 0.342 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -78.42 -31.37 48.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -71.8 86.46 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.412 ' HA2' ' CE1' ' A' ' 146' ' ' PHE . . . 139.45 -156.83 24.83 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.488 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.22 40.28 1.62 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.552 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HG2' HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -98.85 149.36 22.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.921 0.391 . . . . 0.0 110.891 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.593 HD13 ' SG ' ' A' ' 77' ' ' CYS . 39.6 pt -126.99 170.74 16.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.179 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mt -122.83 99.78 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.033 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -99.93 157.5 33.77 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -51.87 160.24 3.09 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.515 2.143 . . . . 0.0 112.282 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.09 -27.42 42.03 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.494 2.129 . . . . 0.0 112.357 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.43 -31.22 71.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.3 -39.16 89.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.088 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.436 HD13 ' CE1' ' A' ' 82' ' ' PHE . 24.1 tp -60.11 -42.3 94.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -74.27 -42.28 59.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.716 ' HG2' HD11 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -61.63 -47.14 86.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.999 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.442 HD11 ' HZ ' ' A' ' 64' ' ' PHE . 13.7 mt -54.12 -26.92 29.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.122 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.96 -27.52 24.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.033 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -97.12 20.05 11.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.268 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.716 HD11 ' HG2' ' A' ' 52' ' ' GLN . 31.1 mt -126.17 20.0 7.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.721 0.296 . . . . 0.0 111.295 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 55.05 30.04 13.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.804 0.335 . . . . 0.0 111.072 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.425 HD12 HD23 ' A' ' 53' ' ' LEU . 28.0 mt -98.24 124.61 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.152 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 t -114.98 169.5 9.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.469 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -70.98 145.17 91.24 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.77 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.7 Cg_endo -76.88 156.24 97.63 Favored 'Cis proline' 0 C--N 1.348 0.503 0 C-N-CA 123.549 -1.438 . . . . 0.0 112.393 0.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.6 mtt -115.76 66.68 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.705 HD22 ' HB2' ' A' ' 148' ' ' CYS . 10.0 mt -84.32 123.47 30.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.442 ' HZ ' HD11 ' A' ' 53' ' ' LEU . 59.9 m-85 -98.31 142.95 29.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -101.03 82.72 2.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.506 HD12 ' SG ' ' A' ' 77' ' ' CYS . 10.6 mt -60.9 94.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -94.46 112.55 24.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.861 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -71.06 103.8 2.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -79.95 61.98 4.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -174.08 -41.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.854 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.24 4.59 26.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.398 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 57.83 49.06 12.66 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.905 0.384 . . . . 0.0 110.904 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.414 ' HB3' HD23 ' A' ' 99' ' ' LEU . 3.4 mmp_? -107.64 168.82 8.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.4 ttm -157.39 128.4 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.679 HG21 HD11 ' A' ' 99' ' ' LEU . 10.3 t -145.81 148.74 33.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.948 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -116.11 95.28 5.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.932 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.593 ' SG ' HD13 ' A' ' 43' ' ' ILE . 30.5 p -107.04 160.98 15.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -118.16 134.91 11.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.531 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.612 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 11.7 p -73.87 151.41 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 111.09 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.547 HD22 ' HG2' ' A' ' 42' ' ' LYS . 63.6 tp -137.55 -59.13 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -102.26 145.34 29.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.612 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 82.4 m-85 -124.89 75.66 1.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.851 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 m -136.57 30.86 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.623 ' HB1' ' O ' ' A' ' 88' ' ' ILE . . . -94.68 155.26 16.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.541 ' HB2' HD12 ' A' ' 88' ' ' ILE . 4.0 m-20 -80.58 160.26 25.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -60.34 113.02 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.5 27.64 32.15 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.58 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.623 ' O ' ' HB1' ' A' ' 84' ' ' ALA . 26.0 mt -148.59 98.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 111.131 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.7 t -103.19 135.12 45.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -103.77 136.78 42.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 mp -136.12 157.55 75.48 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -51.95 179.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.573 2.182 . . . . 0.0 112.321 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.71 -35.54 15.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.734 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 65.3 p-90 -68.06 -43.17 79.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.459 ' HE2' ' CH2' ' A' ' 94' ' ' TRP . 31.0 ttm -66.93 -33.08 74.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.956 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.8 mmt -60.57 -39.83 89.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.811 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -79.34 -33.86 42.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.886 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -60.31 -31.1 69.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.679 HD11 HG21 ' A' ' 75' ' ' THR . 3.8 mt -102.13 0.28 34.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.375 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.4 mt 57.87 30.78 19.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.82 0.343 . . . . 0.0 110.919 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.482 HD11 HG21 ' A' ' 107' ' ' VAL . 38.7 mt -82.42 -178.63 7.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -144.56 -174.19 4.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.789 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -76.82 90.78 3.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.05 50.18 0.74 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.532 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.65 141.91 17.19 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.477 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.482 HD22 ' HB3' ' A' ' 19' ' ' GLN . 59.5 mt -85.65 127.19 34.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.482 HG21 HD11 ' A' ' 101' ' ' LEU . 21.5 t -130.41 139.68 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -80.26 121.77 26.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.412 HG22 HD23 ' A' ' 66' ' ' LEU . 21.5 t -105.27 139.22 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.093 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -143.18 130.03 20.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.3 p -88.77 123.17 32.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.89 140.26 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.134 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -91.96 112.14 23.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.681 HD13 ' O ' ' A' ' 176' ' ' ALA . 11.6 mt -115.76 176.86 4.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -128.01 173.96 9.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.841 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.5 m -59.71 164.67 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.056 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.975 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -96.94 160.74 14.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.103 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 58.3 p -119.58 -41.12 2.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.809 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -133.08 92.4 3.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.807 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.92 143.26 35.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.941 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -117.23 169.76 9.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.828 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.761 ' CD2' HD21 ' A' ' 139' ' ' LEU . 42.9 m-85 -153.75 139.82 18.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -128.57 86.64 57.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.533 ' HA ' HD23 ' A' ' 166' ' ' LEU . 59.4 Cg_exo -51.56 125.44 16.78 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.573 2.182 . . . . 0.0 112.375 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -80.99 -31.22 34.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.5 p -101.01 146.57 32.37 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.595 ' HA ' HD12 ' A' ' 130' ' ' LEU . 62.9 Cg_endo -73.37 -17.14 24.27 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.528 2.152 . . . . 0.0 112.51 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.22 -38.48 68.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.073 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -76.07 -38.28 57.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.595 HD12 ' HA ' ' A' ' 127' ' ' PRO . 21.4 mt -63.48 -32.33 73.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -67.26 -26.1 66.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.061 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.529 HD13 HG21 ' A' ' 138' ' ' VAL . 47.9 mt -64.68 124.49 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.124 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.5 m -59.96 -39.06 84.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.48 77.71 4.47 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.17 -27.79 19.57 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.574 2.183 . . . . 0.0 112.252 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -64.41 -39.77 94.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.0 -51.66 44.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.09 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.529 HG21 HD13 ' A' ' 132' ' ' ILE . 21.4 t -59.73 -30.51 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.761 HD21 ' CD2' ' A' ' 122' ' ' PHE . 6.1 tp -75.98 -44.71 38.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.38 -38.35 77.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -59.63 -31.09 69.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.968 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -86.04 -31.61 21.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.049 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.422 HD22 HD13 ' A' ' 179' ' ' ILE . 28.1 mt -61.35 -28.48 69.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -57.56 -29.71 64.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.067 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -79.07 -31.24 44.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.412 ' CE1' ' HA2' ' A' ' 40' ' ' GLY . 7.4 m-85 -83.6 150.68 25.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -109.87 -29.37 8.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.173 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.705 ' HB2' HD22 ' A' ' 63' ' ' LEU . 17.4 t -141.58 158.69 43.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.6 mt -131.66 178.53 6.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.0 m -158.89 136.63 10.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.5 m -65.41 121.57 15.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.8 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.75 41.34 9.83 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.356 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.77 106.71 9.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.836 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.8 t -66.57 107.02 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.011 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.734 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 4.0 pt -109.1 132.17 57.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.116 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -92.45 129.85 38.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.083 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.455 HG12 HD12 ' A' ' 166' ' ' LEU . 3.0 pt -115.36 140.87 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.155 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -143.01 145.21 32.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -161.3 -48.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.923 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 48.0 p30 -101.66 44.93 0.99 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.976 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.77 30.79 20.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.96 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -139.36 119.04 13.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.425 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.7 mp -88.84 83.99 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.164 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -62.95 179.97 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -132.31 130.72 41.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.888 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 124' ' ' PRO . 20.2 mt -145.63 159.07 43.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.864 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -153.0 114.96 4.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.52 HG22 ' CE1' ' A' ' 122' ' ' PHE . 21.5 t -59.72 135.41 24.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 41.1 mmm -99.97 -46.71 5.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.942 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.38 156.18 44.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.6 p -153.06 157.24 40.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.416 ' O ' HG11 ' A' ' 177' ' ' VAL . 39.2 mttt -143.12 154.9 61.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.3 -31.4 5.31 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 123.298 -1.542 . . . . 0.0 112.434 0.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -108.34 167.67 9.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -35.17 71.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.949 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.681 ' O ' HD13 ' A' ' 114' ' ' LEU . . . -113.61 115.43 27.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.023 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.975 HG21 ' HB2' ' A' ' 117' ' ' ALA . 27.5 m -118.67 154.79 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.438 ' CB ' HD11 ' A' ' 63' ' ' LEU . 1.5 t -99.89 80.01 2.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.422 HD13 HD22 ' A' ' 143' ' ' LEU . 3.1 pt -71.28 81.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.202 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.2 mt -125.19 95.92 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.079 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 61.59 78.38 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.08 148.43 2.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.02 136.57 43.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.946 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.589 ' SD ' ' HB3' ' A' ' 117' ' ' ALA . 4.1 ptt? -143.54 167.45 22.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.1 85.41 5.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.0 108.79 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.108 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.09 179.96 5.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -138.28 140.83 39.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -107.56 99.5 8.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.819 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.255 -0.878 . . . . 0.0 111.057 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.2 t80 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.813 0.34 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.8 p -158.56 85.31 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.415 HG22 ' N ' ' A' ' 19' ' ' GLN . 92.7 m -148.95 160.31 43.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.869 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.415 ' N ' HG22 ' A' ' 18' ' ' THR . 17.9 mt-30 -103.12 121.16 42.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.877 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.66 ' HB2' HG21 ' A' ' 109' ' ' VAL . 2.6 m-85 -122.25 146.87 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.96 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -69.89 169.16 13.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.6 m -131.15 112.77 13.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.52 ' CD2' HG23 ' A' ' 88' ' ' ILE . 82.0 m-85 -122.73 162.46 21.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -83.48 154.21 24.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.5 m -65.25 -29.67 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.112 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.2 p . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.037 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.1 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.755 0.312 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -39.51 76.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.946 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -84.38 94.25 8.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.83 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.18 -134.01 7.41 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.606 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.1 52.3 0.56 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.524 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.9 154.17 26.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 0.0 110.804 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.647 HG21 HD23 ' A' ' 91' ' ' LEU . 40.2 pt -136.85 161.2 36.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.187 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.404 HG23 ' HB3' ' A' ' 81' ' ' GLU . 21.5 mt -110.09 102.13 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.15 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 82.7 mtp -99.55 161.4 24.64 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -55.89 159.52 11.73 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.532 2.155 . . . . 0.0 112.234 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.2 -27.78 23.96 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.625 2.217 . . . . 0.0 112.297 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 p -59.4 -31.75 69.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.23 -36.43 77.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.124 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.79 -44.27 97.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -71.9 -31.18 66.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.942 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.42 -41.5 60.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -61.55 -48.07 82.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.7 p -65.31 -30.82 71.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.876 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.58 -20.35 58.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.2 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.8 mt -94.38 20.03 8.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.295 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.9 t30 56.16 30.59 16.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 111.064 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.3 mt -97.81 141.67 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.129 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 p -134.37 172.1 13.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.454 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.5 t80 -60.6 140.62 92.55 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.855 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.454 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.6 Cg_endo -77.05 163.24 89.82 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 123.501 -1.458 . . . . 0.0 112.345 0.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.4 mtt -130.45 69.42 1.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.454 HD11 ' OG ' ' A' ' 178' ' ' SER . 2.0 mt -90.13 147.56 23.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -113.5 126.75 55.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -82.81 89.09 6.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.413 HD11 HD21 ' A' ' 91' ' ' LEU . 13.6 mt -68.03 77.5 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.857 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -81.92 95.39 7.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.552 ' OD1' HD21 ' A' ' 101' ' ' LEU . 2.9 t-20 -64.38 116.04 5.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.828 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -98.11 29.51 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -119.16 -40.5 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 m -124.28 21.79 8.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.098 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 54.4 37.97 28.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.036 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.416 ' HB3' HD23 ' A' ' 99' ' ' LEU . 8.9 mmp_? -93.09 171.85 8.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.963 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.1 ttp -156.08 125.42 6.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.0 m -144.52 132.25 21.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.888 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.46 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 12.0 m80 -107.35 101.0 10.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.917 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.457 ' SG ' HD13 ' A' ' 43' ' ' ILE . 28.8 p -108.06 172.66 6.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -134.6 137.67 9.45 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.528 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.79 150.91 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.761 0.315 . . . . 0.0 111.091 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.5 tp -133.44 -60.71 0.83 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.404 ' HB3' HG23 ' A' ' 44' ' ' ILE . 1.8 mp0 -99.51 157.24 16.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -130.32 55.46 1.81 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.827 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.14 31.76 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.21 168.46 11.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.415 ' HB3' HD12 ' A' ' 88' ' ' ILE . 3.0 m-20 -83.74 151.8 25.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.861 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -59.9 134.87 57.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.13 24.86 70.66 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.501 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.52 HG23 ' CD2' ' A' ' 23' ' ' PHE . 29.4 mt -145.93 92.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.85 0.357 . . . . 0.0 111.033 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 83.8 m -92.18 126.15 37.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.022 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -92.7 141.3 28.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.777 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.647 HD23 HG21 ' A' ' 43' ' ' ILE . 3.1 mp -141.67 160.21 57.2 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.853 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.504 ' HD3' HG22 ' A' ' 43' ' ' ILE . 55.4 Cg_exo -51.84 177.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.53 2.154 . . . . 0.0 112.365 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -84.32 -46.16 12.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.755 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 70.1 p-90 -60.24 -38.49 83.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.882 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.9 ttm -61.29 -40.81 95.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -41.85 99.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.892 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -71.79 -36.76 70.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -62.25 -39.0 91.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 68' ' ' ASN . 52.0 mt -87.25 -20.68 26.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.4 mt 61.74 42.83 10.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.878 0.37 . . . . 0.0 110.924 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.552 HD21 ' OD1' ' A' ' 68' ' ' ASN . 44.3 mt -87.72 170.01 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.77 179.33 3.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.905 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.92 88.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.886 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.48 47.71 1.38 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.395 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.07 107.95 3.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.457 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 32.3 mt -69.59 132.61 46.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.804 0.335 . . . . 0.0 110.941 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.32 149.52 32.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.073 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -63.26 110.18 1.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.66 HG21 ' HB2' ' A' ' 20' ' ' TYR . 22.4 t -99.58 120.59 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -148.84 142.59 25.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.836 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.1 p -90.15 114.66 26.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.854 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 20.4 m -116.46 152.18 18.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.129 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -108.55 119.11 38.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.1 mt -119.48 179.93 4.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.14 171.61 7.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.915 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.0 m -71.51 133.57 31.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.784 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -65.27 147.42 53.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.149 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.7 p -111.98 -35.53 5.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.431 ' CE1' ' HB2' ' A' ' 187' ' ' ASP . 75.2 t80 -133.23 99.8 4.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.5 p -113.43 111.05 21.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -102.67 136.53 42.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.587 ' CD1' HD21 ' A' ' 139' ' ' LEU . 20.7 m-85 -120.43 155.24 33.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.923 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -133.04 94.62 20.18 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.96 120.4 6.01 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.552 2.168 . . . . 0.0 112.374 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -76.13 -31.48 58.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.965 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.44 149.4 42.1 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.974 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.23 -9.68 26.49 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.536 2.157 . . . . 0.0 112.684 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.417 ' HB3' ' CE2' ' A' ' 164' ' ' TYR . 0.3 OUTLIER -56.41 -35.39 67.74 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.08 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.497 ' CD1' HD11 ' A' ' 166' ' ' LEU . 9.2 t80 -79.61 -34.01 41.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.812 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.8 mt -66.0 -34.77 78.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.29 -26.2 68.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.068 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.488 HD13 HG21 ' A' ' 138' ' ' VAL . 39.1 mt -60.04 139.4 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.002 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.5 m -61.24 -53.35 58.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.39 80.01 29.08 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.875 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.412 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 38.9 Cg_exo -57.15 -35.1 98.83 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.54 2.16 . . . . 0.0 112.194 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -34.08 73.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.962 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.49 -39.06 74.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.114 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.515 HG13 ' OH ' ' A' ' 159' ' ' TYR . 22.1 t -75.43 -30.97 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.587 HD21 ' CD1' ' A' ' 122' ' ' PHE . 9.0 tp -76.71 -30.72 56.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.009 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -80.67 -31.67 36.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.944 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.66 -32.0 70.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.27 -33.5 32.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.104 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.5 ' CD2' HD11 ' A' ' 149' ' ' LEU . 22.7 mt -59.87 -28.93 67.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.043 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -58.29 -33.03 68.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -79.53 -31.14 42.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.725 ' HB3' HD11 ' A' ' 179' ' ' ILE . 4.0 m-85 -71.26 145.56 49.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -108.54 -27.27 9.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.192 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.87 171.61 13.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.537 HD22 HG21 ' A' ' 168' ' ' VAL . 2.7 mt -155.41 136.15 13.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.89 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.22 149.78 47.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.816 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 57.0 m -69.27 100.39 1.31 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.65 28.55 4.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.501 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.89 90.08 4.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.85 0.357 . . . . 0.0 110.867 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.608 HG22 ' HG3' ' A' ' 167' ' ' ARG . 27.7 t -63.37 100.68 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.104 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.755 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 1.2 pt -109.54 161.98 7.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.11 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.688 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -127.28 99.41 5.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.11 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.2 pt -69.41 150.1 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.044 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -158.33 150.3 21.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.515 ' OH ' HG13 ' A' ' 138' ' ' VAL . 30.5 p90 -177.29 -37.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.087 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -103.47 38.94 1.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.944 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 60.86 29.96 19.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -145.87 108.39 4.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.784 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.688 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 2.0 mp -82.48 112.82 20.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.127 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 128' ' ' ASP . 32.5 m-85 -94.13 131.78 39.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.837 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -83.52 107.34 15.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.497 HD11 ' CD1' ' A' ' 129' ' ' PHE . 0.8 OUTLIER -128.68 136.4 50.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.608 ' HG3' HG22 ' A' ' 154' ' ' VAL . 22.7 ttt180 -130.61 131.85 45.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.537 HG21 HD22 ' A' ' 149' ' ' LEU . 21.0 t -70.14 154.41 8.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.406 ' N ' HG12 ' A' ' 168' ' ' VAL . 43.5 mmm -121.35 -57.68 1.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -124.55 141.53 52.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.915 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.426 ' CG2' HG11 ' A' ' 168' ' ' VAL . 40.3 p -145.22 148.29 33.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.566 ' O ' HG11 ' A' ' 177' ' ' VAL . 22.6 mttt -133.94 158.02 76.37 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.21 -41.64 0.92 Allowed 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.222 -1.574 . . . . 0.0 112.427 -0.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.35 178.47 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.843 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -47.49 82.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.46 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -99.06 129.48 45.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.03 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.784 HG21 ' HB2' ' A' ' 117' ' ' ALA . 30.0 m -132.55 135.92 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.201 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.454 ' OG ' HD11 ' A' ' 63' ' ' LEU . 8.0 t -93.04 96.9 10.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.725 HD11 ' HB3' ' A' ' 146' ' ' PHE . 3.6 pt -88.24 82.72 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.132 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.2 mt -109.89 81.02 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.104 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.26 89.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 2.8 t -162.95 166.23 24.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -106.74 121.68 44.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.896 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -134.72 172.1 13.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.951 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.12 111.8 23.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.527 HG11 HD23 ' A' ' 139' ' ' LEU . 21.2 t -96.03 131.77 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.146 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.431 ' HB2' ' CE1' ' A' ' 119' ' ' TYR . 10.6 t70 -114.8 167.19 10.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -127.41 141.67 51.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.974 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -122.5 81.8 1.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.04 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.709 ' N ' ' HG ' ' A' ' 111' ' ' SER . 67.1 t80 . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.878 0.37 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.7 p -141.59 129.16 21.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.1 t -176.5 160.42 2.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -77.76 149.66 34.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -155.02 145.22 21.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.917 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.2 mtt85 -76.5 148.15 37.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 64.3 m -113.52 127.7 56.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.511 ' CD2' HG23 ' A' ' 88' ' ' ILE . 17.4 m-85 -129.01 175.89 8.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.59 156.75 17.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.9 m -67.48 -30.17 48.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.803 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.816 0.341 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -73.5 -37.32 65.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -97.57 76.17 2.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.82 159.24 7.86 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.482 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.92 92.1 1.44 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.533 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.593 ' HG2' HD13 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -153.38 129.26 10.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.327 . . . . 0.0 110.904 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.507 HD13 ' SG ' ' A' ' 77' ' ' CYS . 45.1 pt -123.64 179.91 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.145 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.405 HG22 ' HB2' ' A' ' 84' ' ' ALA . 10.7 mt -130.11 115.65 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.064 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.541 ' C ' ' HB3' ' A' ' 84' ' ' ALA . 25.3 mtp -117.35 158.6 44.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.619 ' N ' ' HB3' ' A' ' 84' ' ' ALA . 50.5 Cg_exo -53.14 163.79 2.09 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.597 2.198 . . . . 0.0 112.234 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.31 -27.76 23.42 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.495 2.13 . . . . 0.0 112.234 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.1 p -59.14 -35.7 73.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.92 -32.56 72.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.8 tp -70.91 -39.51 72.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.19 -33.02 56.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -67.04 -41.55 86.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.572 HD23 HD12 ' A' ' 58' ' ' ILE . 16.4 mt -63.5 -31.6 72.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.9 t -68.88 -42.68 76.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -66.92 -32.19 73.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.4 mt -79.89 -3.26 47.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.461 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 m120 62.2 30.78 17.72 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.733 0.301 . . . . 0.0 110.909 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.572 HD12 HD23 ' A' ' 53' ' ' LEU . 30.5 mt -90.18 106.9 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.109 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.1 p -90.43 171.81 9.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.939 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.488 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -59.25 145.21 81.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.803 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 78.9 Cg_endo -77.41 167.63 78.81 Favored 'Cis proline' 0 C--N 1.347 0.499 0 C-N-CA 123.478 -1.468 . . . . 0.0 112.482 -0.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 4.8 mtt -128.73 62.02 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.419 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -82.85 158.94 22.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.948 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -131.25 126.58 35.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -82.69 106.42 14.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.9 mt -82.41 79.36 8.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.835 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -75.84 93.47 3.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.979 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.52 ' HA ' HG13 ' A' ' 107' ' ' VAL . 5.4 t-20 -68.08 120.04 13.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -97.75 38.07 1.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -128.46 -45.65 1.34 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.8 23.24 7.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.124 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 54.75 39.26 31.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.046 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -89.32 160.43 16.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.964 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 ttm -155.95 124.83 6.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.0 m -153.8 121.38 5.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.854 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -86.01 97.15 10.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.507 ' SG ' HD13 ' A' ' 43' ' ' ILE . 26.4 p -85.19 159.42 20.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -118.26 128.71 7.86 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.521 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.485 HG21 ' CE1' ' A' ' 82' ' ' PHE . 11.4 p -75.45 137.44 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.76 0.314 . . . . 0.0 111.117 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.593 HD13 ' HG2' ' A' ' 42' ' ' LYS . 6.3 tp -124.85 -56.49 1.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -103.39 142.75 33.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.485 ' CE1' HG21 ' A' ' 79' ' ' VAL . 49.9 m-85 -118.01 67.82 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.942 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.04 30.99 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.078 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.619 ' HB3' ' N ' ' A' ' 46' ' ' PRO . . . -86.25 157.92 19.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.658 ' HB2' HD12 ' A' ' 88' ' ' ILE . 3.2 m-20 -81.91 165.28 20.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -63.6 106.86 1.03 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.19 29.93 21.19 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.486 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' A' ' 85' ' ' ASP . 31.9 mt -144.96 117.16 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 0.0 111.132 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 61.7 m -125.29 129.52 50.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -97.82 149.4 22.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 mp -144.34 155.05 57.76 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.957 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.25 170.64 0.23 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.575 2.183 . . . . 0.0 112.307 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -78.02 -44.51 26.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -60.24 -37.28 79.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 50.1 ttm -75.05 -31.62 61.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -42.72 81.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.841 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -75.14 -40.41 59.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.839 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -60.5 -35.92 77.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.495 HD13 HD11 ' A' ' 101' ' ' LEU . 72.6 mt -83.11 -21.99 33.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.15 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 86.3 mt 61.55 38.06 15.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.495 HD11 HD13 ' A' ' 99' ' ' LEU . 8.4 mt -86.51 -178.26 6.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -115.92 168.36 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -65.31 81.39 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.98 41.14 1.86 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.518 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.83 135.73 13.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.555 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.4 mt -81.98 124.6 29.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 0.0 110.935 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 68' ' ' ASN . 21.6 t -130.36 153.37 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.5 143.78 51.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.6 t -124.86 149.4 29.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -157.61 131.47 8.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.709 ' HG ' ' N ' ' A' ' 16' ' ' PHE . 83.9 p -91.86 101.66 14.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.5 m -117.91 144.82 24.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.105 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -102.63 113.04 26.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.6 mt -102.68 171.89 7.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -115.84 171.89 7.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.849 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.1 m -60.41 155.68 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.061 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.896 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -89.59 156.41 18.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.077 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.33 -35.67 4.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -133.94 92.58 2.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.63 110.93 23.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.88 130.4 53.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.607 ' CZ ' HD21 ' A' ' 143' ' ' LEU . 37.6 m-85 -118.26 156.21 29.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.878 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -136.01 87.67 23.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.25 116.64 2.95 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.523 2.149 . . . . 0.0 112.363 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -68.54 -31.3 70.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.963 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -103.74 143.92 27.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.972 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.62 -17.06 20.88 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.585 2.19 . . . . 0.0 112.543 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -33.22 63.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.136 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.598 ' CE2' HD11 ' A' ' 166' ' ' LEU . 7.5 t80 -73.36 -48.48 33.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 70.4 mt -59.29 -30.37 68.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.919 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.85 -25.64 67.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.964 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.594 HG21 HG21 ' A' ' 138' ' ' VAL . 38.7 mt -59.96 138.96 20.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.06 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.7 m -64.0 -42.9 97.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.669 ' O ' HG23 ' A' ' 138' ' ' VAL . 3.2 m120 -117.62 79.97 13.09 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.979 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.46 -28.39 21.96 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.602 2.202 . . . . 0.0 112.247 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -68.5 -38.94 81.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.948 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.77 -38.04 70.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.051 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 134' ' ' ASN . 27.9 t -69.59 -35.51 66.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.019 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.428 HD23 HG11 ' A' ' 186' ' ' VAL . 5.5 tp -78.82 -42.75 26.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.829 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.707 ' HA ' HD12 ' A' ' 143' ' ' LEU . 43.3 mt-10 -66.89 -35.94 81.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -65.24 -34.39 78.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.72 -32.64 27.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.088 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 140' ' ' GLU . 12.4 mt -60.63 -30.12 69.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -58.8 -31.39 68.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -74.4 -33.69 63.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.17 149.95 45.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -110.07 -27.44 9.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.248 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 4.5 t -141.65 163.55 32.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.0 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 149' ' ' LEU . 12.4 mt -137.92 165.02 27.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.781 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.8 145.44 23.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.905 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.3 m -69.34 97.44 0.96 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.19 51.76 0.86 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.472 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.46 120.66 38.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.827 0.346 . . . . 0.0 110.908 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.24 93.2 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.071 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.446 HD12 HG23 ' A' ' 157' ' ' ILE . 1.1 pp -101.35 138.34 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.113 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.672 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -111.9 100.32 8.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.055 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.636 HG12 HD12 ' A' ' 166' ' ' LEU . 2.6 pt -80.0 160.17 4.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.165 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -156.53 147.55 22.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -171.69 -46.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.932 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -96.72 40.31 1.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.92 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 59.71 31.65 20.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -148.5 129.01 13.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.672 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 4.1 mp -87.67 97.51 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.076 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -78.8 120.79 23.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.53 128.99 38.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.981 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.636 HD12 HG12 ' A' ' 157' ' ' ILE . 1.5 mt -145.95 136.25 23.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -136.17 126.12 25.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.16 140.03 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.094 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.6 mmm -107.41 -49.44 3.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -139.17 154.47 48.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.91 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 80.6 p -156.92 125.72 5.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -111.63 158.09 37.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.819 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.01 -40.63 1.12 Allowed 'Cis proline' 0 C--N 1.347 0.459 0 C-N-CA 123.248 -1.563 . . . . 0.0 112.347 0.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.67 174.48 5.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -58.06 -46.71 84.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.912 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -102.62 128.96 49.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.071 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.896 HG21 ' HB2' ' A' ' 117' ' ' ALA . 16.0 m -139.98 153.38 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.167 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.48 101.86 11.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.2 pt -85.24 84.56 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.166 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 29.6 mm -118.51 89.54 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.113 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 60.47 87.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 30.2 t -166.54 154.54 10.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.59 97.07 7.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -102.53 170.27 8.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -93.9 88.27 5.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.866 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.428 HG11 HD23 ' A' ' 139' ' ' LEU . 29.5 t -78.52 120.69 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.43 162.5 16.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.813 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -118.33 162.88 17.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -153.31 96.38 2.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.965 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.117 -179.95 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.2 t80 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.803 0.335 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.7 p -135.47 96.48 3.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.1 t -150.17 160.91 43.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -86.37 161.92 18.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.889 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -159.92 137.83 10.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -70.93 138.49 50.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 75.8 m -100.94 142.03 32.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.865 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -145.34 176.71 9.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.2 p -88.37 167.1 13.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.8 m -102.15 20.03 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.356 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.949 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.802 0.334 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -70.68 -31.73 68.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -99.57 86.75 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.88 -170.98 24.3 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.509 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.23 46.59 1.15 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.541 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -102.21 134.88 44.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.437 HG21 HD23 ' A' ' 91' ' ' LEU . 40.4 pt -127.63 177.15 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.5 mt -128.96 96.04 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.07 159.3 34.57 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.49 ' N ' ' HB3' ' A' ' 84' ' ' ALA . 47.5 Cg_exo -55.94 169.08 1.5 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.585 2.19 . . . . 0.0 112.27 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.25 -26.06 30.34 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.579 2.186 . . . . 0.0 112.369 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.28 -31.15 67.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.015 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . . . -63.32 -43.86 96.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.426 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 3.3 tp -70.82 -32.3 69.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.75 -25.75 44.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.035 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.04 -30.99 13.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.965 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.588 HD23 HD12 ' A' ' 58' ' ' ILE . 13.8 mt -60.47 -49.62 76.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.112 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.53 -31.47 69.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.068 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -70.5 -22.82 62.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.122 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.3 mt -94.78 20.06 9.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.193 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.67 35.58 25.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.863 0.363 . . . . 0.0 110.961 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.588 HD12 HD23 ' A' ' 53' ' ' LEU . 31.1 mt -100.94 124.89 54.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.59 170.4 8.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.808 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.444 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.5 t80 -65.46 140.6 97.69 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.837 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 72.1 Cg_endo -77.15 167.15 80.51 Favored 'Cis proline' 0 C--N 1.349 0.566 0 C-N-CA 123.53 -1.446 . . . . 0.0 112.393 0.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.7 mtt -131.74 69.03 1.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.56 HD11 ' OG ' ' A' ' 178' ' ' SER . 1.4 mt -82.15 148.8 28.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -118.34 142.65 47.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.416 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 10.8 tttt -97.13 107.67 20.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 66' ' ' LEU . 11.4 mt -89.65 99.71 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.0 103.02 12.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.95 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -67.7 129.27 39.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -97.66 38.26 1.3 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.61 -47.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.974 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m -106.31 13.42 28.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.296 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 53.87 30.66 11.83 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.77 0.319 . . . . 0.0 111.13 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.456 ' CB ' HD23 ' A' ' 99' ' ' LEU . 2.9 mmp_? -82.66 161.53 22.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.64 117.98 3.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.0 t -143.68 156.02 44.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.933 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.416 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 13.8 m80 -122.79 112.92 18.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 24.2 p -106.35 168.09 9.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.3 139.04 13.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.583 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.79 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 12.3 p -81.1 151.48 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 0.0 111.051 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.9 tp -129.09 -61.91 1.02 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -113.59 169.45 8.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.79 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 47.6 m-85 -138.75 75.16 1.5 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.852 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 m -142.51 32.48 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.154 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HB3' ' N ' ' A' ' 46' ' ' PRO . . . -92.03 161.9 14.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.054 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.511 ' HB3' HD12 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -82.04 158.26 23.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -60.1 132.77 54.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.24 28.2 73.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.526 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 85' ' ' ASP . 27.5 mt -147.98 127.18 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.835 0.35 . . . . 0.0 111.136 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 83.1 m -132.39 127.34 35.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -94.15 134.12 36.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.437 HD23 HG21 ' A' ' 43' ' ' ILE . 4.1 mp -142.0 159.96 57.19 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.86 -177.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.554 2.169 . . . . 0.0 112.326 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -97.92 -31.64 12.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 45.4 p-90 -67.48 -34.8 77.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.965 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.4 tpp -79.1 -32.0 44.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 44.9 mmm -67.59 -31.35 71.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -37.03 22.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -59.97 -31.73 70.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.456 HD23 ' CB ' ' A' ' 73' ' ' ARG . 8.9 mt -91.62 -16.81 26.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.276 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.3 mt 65.19 33.7 9.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.827 0.346 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.7 mt -79.8 -178.52 6.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.89 175.77 8.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.901 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.9 101.13 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.85 43.03 7.4 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.564 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.85 128.96 9.19 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.54 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.3 mt -79.38 126.87 31.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.93 139.66 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -63.75 110.61 2.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.2 t -101.07 136.9 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.147 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -134.62 164.32 27.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.3 p -123.38 110.88 15.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.89 148.6 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.152 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -104.22 100.03 9.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.804 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.7 mt -96.21 178.44 5.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -120.44 169.65 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.3 m -64.02 146.15 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.033 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.785 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -90.87 149.59 21.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.045 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 75.4 p -114.23 -37.28 4.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -123.65 111.57 16.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.7 m -128.15 122.51 32.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -102.1 132.32 48.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.587 ' CE2' HG22 ' A' ' 168' ' ' VAL . 90.7 m-85 -119.02 161.6 19.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -150.76 93.02 3.79 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.27 117.86 3.51 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.545 2.164 . . . . 0.0 112.34 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -67.09 -33.19 74.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.908 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.73 146.31 33.46 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.61 -14.91 24.67 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.612 2.208 . . . . 0.0 112.541 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -55.05 -34.19 63.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.104 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 135' ' ' PRO . 22.6 t80 -73.68 -36.06 65.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.0 mt -63.27 -31.77 73.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -62.73 -23.09 67.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.071 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.675 HG22 ' H ' ' A' ' 134' ' ' ASN . 48.9 mt -59.94 140.06 18.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.001 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.0 t -69.7 -30.96 68.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.675 ' H ' HG22 ' A' ' 132' ' ' ILE . 2.1 m120 -133.12 67.26 77.09 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.406 ' HB3' ' CE1' ' A' ' 129' ' ' PHE . 37.3 Cg_exo -57.23 -34.0 97.02 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.634 2.223 . . . . 0.0 112.22 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.81 -44.77 92.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.86 -45.03 91.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.079 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.461 HG21 HG21 ' A' ' 132' ' ' ILE . 21.5 t -63.87 -39.89 87.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.442 HD22 ' CZ ' ' A' ' 188' ' ' PHE . 21.5 tp -67.02 -35.91 80.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -76.78 -32.06 57.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -65.42 -33.05 75.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.27 -35.13 28.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.155 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.7 mt -60.26 -30.0 69.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -58.71 -30.48 67.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -83.04 -34.62 26.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.93 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -66.14 136.15 55.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -99.08 -29.2 13.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.153 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.552 ' HB2' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -138.05 164.56 28.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.964 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.6 mt -141.65 154.31 45.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 15.5 m -144.71 141.71 29.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 37.9 m -72.72 119.61 17.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 90.7 43.51 4.81 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.523 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -131.14 122.88 27.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.745 0.307 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.23 84.96 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.055 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.4 pt -77.78 110.45 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.166 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.81 139.56 37.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.083 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 37.0 pt -128.44 144.34 38.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.175 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -138.45 142.68 39.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.792 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -167.45 -48.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.044 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -95.52 41.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 58.11 30.27 19.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.932 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -148.02 122.29 9.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.904 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.503 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.7 mp -81.42 89.12 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.125 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -67.53 166.15 15.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.83 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -117.15 137.82 52.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.27 149.2 29.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -138.73 129.59 26.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.587 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.3 t -74.12 113.24 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.188 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.6 mmt -68.0 -59.93 2.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -144.93 166.07 26.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 77.2 p -154.49 161.12 41.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -138.56 156.8 73.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.33 -18.48 17.88 Favored 'Cis proline' 0 C--N 1.347 0.487 0 C-N-CA 123.312 -1.537 . . . . 0.0 112.589 0.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -133.38 169.88 16.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.902 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -43.48 82.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.934 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -96.55 117.67 31.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' A' ' 117' ' ' ALA . 15.7 m -139.56 151.18 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.214 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.56 ' OG ' HD11 ' A' ' 63' ' ' LEU . 23.3 t -105.54 92.12 4.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.829 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.3 pt -87.48 83.4 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.198 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.2 mt -112.88 96.55 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.042 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.49 81.94 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.823 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 11.0 t -169.5 149.44 3.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.843 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.99 127.85 41.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -132.97 149.43 52.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -78.03 87.87 4.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.843 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.01 136.93 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -114.14 174.11 6.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' PHE . . . . . 0.442 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 15.6 m-85 -139.41 155.48 47.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.955 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -150.55 91.0 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.056 -179.948 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.864 0.364 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.1 p -121.13 109.08 14.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.0 t -174.55 162.3 3.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -91.34 150.17 21.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -145.31 136.59 24.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.6 mtt180 -68.91 141.55 54.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.0 m -101.37 134.62 44.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.539 ' CD2' HG23 ' A' ' 88' ' ' ILE . 8.8 m-85 -146.89 138.49 24.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 76.0 p -66.76 138.32 57.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.498 HG12 ' HB3' ' A' ' 90' ' ' TYR . 17.2 m -59.39 -27.18 36.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.227 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.034 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.762 0.315 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -31.99 71.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -78.31 -46.92 18.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.936 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.59 162.83 19.74 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.438 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.83 30.04 10.73 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.542 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -94.64 174.05 7.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.824 0.345 . . . . 0.0 110.891 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.525 HG22 ' HA ' ' A' ' 91' ' ' LEU . 5.2 pt -146.7 165.51 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.096 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.512 HG22 ' HB2' ' A' ' 84' ' ' ALA . 3.9 mt -116.49 106.04 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.066 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.432 ' C ' ' HB3' ' A' ' 84' ' ' ALA . 71.6 mtp -97.39 160.53 28.61 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.01 162.81 2.44 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.57 2.18 . . . . 0.0 112.301 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.4 -25.94 35.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.582 2.188 . . . . 0.0 112.348 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.4 t -58.86 -30.82 68.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.99 -32.79 73.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.088 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.466 HD13 ' CD2' ' A' ' 82' ' ' PHE . 25.1 tp -60.23 -33.18 71.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -89.1 -30.43 18.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.957 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -41.5 70.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.974 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.422 HD13 ' SD ' ' A' ' 62' ' ' MET . 44.1 mt -54.11 -30.82 50.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.061 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.05 -28.62 17.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -23.17 57.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.7 mt -93.12 17.41 10.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.317 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 54.96 32.46 18.09 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.784 0.326 . . . . 0.0 111.171 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 59' ' ' THR . 38.6 mt -96.27 153.54 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.119 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.402 ' N ' HG22 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -149.19 175.42 11.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.44 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 3.2 t80 -63.36 139.0 97.51 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.9 Cg_endo -76.6 162.1 92.43 Favored 'Cis proline' 0 C--N 1.348 0.55 0 C-N-CA 123.492 -1.462 . . . . 0.0 112.371 -0.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.422 ' SD ' HD13 ' A' ' 53' ' ' LEU . 12.1 mtt -130.48 65.17 1.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.482 HD11 ' OG ' ' A' ' 178' ' ' SER . 15.1 mt -87.69 139.66 30.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -113.1 142.65 45.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.412 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 1.0 OUTLIER -99.01 108.38 21.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.4 mt -95.68 90.63 5.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.4 m -95.8 121.73 37.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -82.01 128.53 34.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.946 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.7 31.4 2.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -120.04 -42.08 2.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.94 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.29 22.47 7.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 54.49 39.83 31.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.093 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.7 159.0 15.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.922 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -150.61 139.69 21.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.562 HG21 HD11 ' A' ' 99' ' ' LEU . 10.2 t -158.03 148.24 20.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.932 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.504 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 66.5 m80 -115.29 115.41 26.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.978 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.8 p -124.74 167.09 15.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.74 165.23 13.44 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.2 141.72 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.859 0.361 . . . . 0.0 111.09 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.5 tp -119.25 -60.63 1.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -107.03 161.94 14.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.971 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.466 ' CD2' HD13 ' A' ' 50' ' ' LEU . 90.0 m-85 -129.7 47.95 2.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.828 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 m -123.38 35.43 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.007 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' A' ' 44' ' ' ILE . . . -92.52 154.86 18.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.051 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.47 149.63 33.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.846 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -59.99 110.51 1.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.97 -22.7 36.78 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.643 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.539 HG23 ' CD2' ' A' ' 23' ' ' PHE . 25.7 mt -99.05 121.82 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 111.139 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 28.5 t -110.41 130.52 55.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.498 ' HB3' HG12 ' A' ' 25' ' ' VAL . 43.6 m-85 -93.23 143.16 26.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.99 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.525 ' HA ' HG22 ' A' ' 43' ' ' ILE . 1.3 mp -144.89 156.54 55.43 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.07 -174.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.538 2.159 . . . . 0.0 112.283 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.69 -37.93 10.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.893 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.664 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 53.7 p-90 -61.36 -39.47 90.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.2 ttp -65.86 -40.01 91.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -37.98 86.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.82 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -74.06 -38.21 64.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.819 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -65.96 -42.01 90.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.562 HD11 HG21 ' A' ' 75' ' ' THR . 8.2 mt -83.23 -16.87 44.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.204 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt 62.31 36.84 14.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.777 0.323 . . . . 0.0 110.9 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.7 mt -84.94 -177.42 6.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -134.42 168.63 18.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.06 91.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.84 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.428 ' HA2' ' CE2' ' A' ' 23' ' ' PHE . . . 106.68 43.74 1.4 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.487 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.08 123.62 7.88 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.531 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.9 mt -72.94 131.21 41.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.809 0.338 . . . . 0.0 110.951 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.72 150.49 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.002 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -72.11 143.37 49.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.36 108.62 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.134 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.49 123.74 34.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.922 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.5 p -81.49 121.78 26.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.4 m -125.94 155.07 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.57 100.81 9.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.776 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.448 HD13 ' C ' ' A' ' 176' ' ' ALA . 2.8 mt -98.6 178.92 4.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -115.71 170.8 8.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 m -70.36 135.03 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.09 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.606 ' HB2' ' CB ' ' A' ' 177' ' ' VAL . . . -74.28 145.45 43.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.8 p -111.53 -31.95 6.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.914 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -129.53 110.3 11.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 93.5 p -122.58 119.0 29.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -106.17 130.87 53.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.68 ' CD1' HD21 ' A' ' 139' ' ' LEU . 87.3 m-85 -117.86 158.81 24.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -143.05 97.93 5.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.57 110.89 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.442 2.094 . . . . 0.0 112.47 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -63.42 -31.4 72.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.1 m -114.33 149.03 41.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.618 ' HA ' HD12 ' A' ' 130' ' ' LEU . 57.4 Cg_endo -70.94 -14.87 32.62 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.618 2.212 . . . . 0.0 112.584 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -55.59 -35.65 66.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.053 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -75.53 -42.98 51.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.916 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 127' ' ' PRO . 13.5 mt -60.07 -31.2 69.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.83 -28.19 69.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.002 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.563 HG22 ' H ' ' A' ' 134' ' ' ASN . 45.8 mt -62.74 137.31 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.093 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.3 t -68.95 -34.28 75.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.706 ' O ' HG23 ' A' ' 138' ' ' VAL . 1.9 m120 -119.51 77.31 19.5 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.86 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.38 -28.31 22.45 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.619 2.212 . . . . 0.0 112.285 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -70.35 -46.67 63.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.15 -31.19 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.157 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 134' ' ' ASN . 26.3 t -78.78 -31.53 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.095 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.68 HD21 ' CD1' ' A' ' 122' ' ' PHE . 11.5 tp -84.5 -34.75 23.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.483 ' OE2' HG21 ' A' ' 186' ' ' VAL . 3.9 mm-40 -70.85 -30.44 66.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.976 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -73.43 -31.63 63.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.17 -31.64 64.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.118 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.498 HD13 ' CE ' ' A' ' 184' ' ' MET . 82.2 mt -59.4 -30.44 68.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.5 mmp_? -62.42 -26.65 68.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -95.97 26.72 3.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.091 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -135.84 152.65 51.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.835 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.13 -34.25 6.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 6.8 t -141.78 158.91 43.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.965 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.93 137.27 36.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.876 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.67 149.4 40.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 43.8 m -69.49 104.8 2.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.82 33.3 3.57 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.552 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.35 111.8 24.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.759 0.314 . . . . 0.0 110.928 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.544 HG22 ' HG3' ' A' ' 167' ' ' ARG . 21.6 t -79.53 79.95 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.075 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.698 HD12 HG23 ' A' ' 157' ' ' ILE . 3.2 pt -63.79 159.07 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.152 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.664 ' HB3' ' HB3' ' A' ' 94' ' ' TRP . . . -125.05 93.0 3.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.085 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.698 HG23 HD12 ' A' ' 155' ' ' ILE . 10.0 pt -85.53 152.72 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.184 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -154.85 140.89 18.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -161.89 -47.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.97 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -93.75 45.19 1.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 55.65 29.48 13.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.086 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -149.34 122.19 8.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.868 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.3 mp -85.12 108.53 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -80.1 173.78 12.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -123.95 110.07 14.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.31 117.52 21.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.826 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.544 ' HG3' HG22 ' A' ' 154' ' ' VAL . 1.8 ttt85 -111.14 133.22 53.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.5 127.16 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.087 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 23.9 mmm -85.6 -54.71 4.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 171' ' ' THR . 0.4 OUTLIER -142.73 160.19 40.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.952 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 170' ' ' GLU . 2.6 p -159.08 146.47 17.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.909 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -129.07 159.86 66.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.95 -41.39 0.97 Allowed 'Cis proline' 0 C--N 1.347 0.48 0 C-N-CA 123.238 -1.567 . . . . 0.0 112.366 -0.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -106.29 172.43 6.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -57.86 -48.71 79.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.061 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.504 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -93.29 110.8 22.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.001 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.606 ' CB ' ' HB2' ' A' ' 117' ' ' ALA . 15.4 m -118.72 133.64 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.167 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.482 ' OG ' HD11 ' A' ' 63' ' ' LEU . 22.2 t -89.73 99.95 12.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.5 pt -94.08 87.26 2.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.249 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.2 mt -118.29 84.59 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.052 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.36 75.35 0.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 49.6 t -153.27 153.99 33.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.903 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.83 129.73 40.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.498 ' CE ' HD13 ' A' ' 143' ' ' LEU . 13.0 ptt? -140.21 179.23 6.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.869 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.45 112.63 25.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.512 HG11 HD23 ' A' ' 139' ' ' LEU . 21.6 t -92.81 127.52 44.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.7 171.81 7.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.878 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -134.74 141.89 46.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -111.75 83.23 1.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.121 179.971 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 t80 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.91 0.386 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.0 p -160.03 112.8 2.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.1 t -176.86 159.46 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.935 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.629 ' HB3' HD22 ' A' ' 106' ' ' LEU . 20.8 mt-30 -95.94 121.85 38.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.814 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -115.48 147.41 40.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -75.17 129.54 37.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.592 ' HB2' HD13 ' A' ' 91' ' ' LEU . 16.6 p -99.01 133.33 43.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.972 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.533 ' CD2' HG23 ' A' ' 88' ' ' ILE . 87.4 m-85 -136.3 178.45 7.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.66 146.07 27.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.695 HG11 HG21 ' A' ' 37' ' ' VAL . 5.1 m -58.41 -26.15 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.257 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.042 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.695 HG21 HG11 ' A' ' 25' ' ' VAL . 19.4 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.866 0.365 . . . . 0.0 111.238 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.429 ' HG3' HG23 ' A' ' 37' ' ' VAL . 4.1 mt-10 -78.03 -31.06 50.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -78.53 -31.22 47.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.67 -178.57 20.14 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.564 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.75 53.24 0.63 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.544 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -114.74 165.04 13.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.851 0.357 . . . . 0.0 110.852 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.1 pt -133.38 174.4 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.543 HG23 ' HB2' ' A' ' 81' ' ' GLU . 2.5 mt -125.51 98.39 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.9 mtm -98.54 155.51 36.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.782 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.71 154.9 40.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.581 2.188 . . . . 0.0 112.211 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.8 -26.42 17.71 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.619 2.213 . . . . 0.0 112.566 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.6 p -58.79 -31.19 68.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.973 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.14 -30.26 69.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.261 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.419 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 33.8 tp -74.69 -30.14 61.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.998 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.18 -33.91 19.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.914 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.73 -38.88 62.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.454 HD13 ' SD ' ' A' ' 62' ' ' MET . 14.0 mt -59.1 -32.84 70.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.043 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -86.98 -30.06 21.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -22.61 62.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.12 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.1 mt -93.93 19.19 9.31 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.244 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 55.12 30.47 14.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.871 0.367 . . . . 0.0 111.14 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.7 mt -99.03 120.81 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.098 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -109.59 168.35 9.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.965 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -60.17 144.58 87.02 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.464 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.89 158.27 96.89 Favored 'Cis proline' 0 C--N 1.348 0.5 0 C-N-CA 123.485 -1.464 . . . . 0.0 112.344 0.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.454 ' SD ' HD13 ' A' ' 53' ' ' LEU . 9.5 mtt -123.7 73.52 1.2 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.789 HD13 HD12 ' A' ' 114' ' ' LEU . 2.0 mt -91.26 134.9 34.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.853 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -102.8 141.3 35.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.404 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 13.5 tttp -94.97 97.6 10.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.4 mt -76.98 76.83 3.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 m -83.16 95.55 8.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -74.79 129.44 37.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.933 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -98.14 35.58 1.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -111.63 -35.66 5.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.841 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.1 t -151.94 29.72 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.973 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 58.72 35.83 24.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.002 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.575 ' HB3' HD23 ' A' ' 99' ' ' LEU . 12.8 mmt180 -81.82 143.31 31.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.929 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -144.22 135.02 25.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.741 HG22 HD21 ' A' ' 99' ' ' LEU . 1.8 t -159.97 95.25 1.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.404 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 62.0 m80 -63.68 115.75 5.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.0 p -121.91 151.31 40.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.37 138.91 15.06 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.519 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.3 146.82 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 111.066 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.9 tp -131.29 -56.65 1.02 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.543 ' HB2' HG23 ' A' ' 44' ' ' ILE . 4.1 mm-40 -91.76 142.85 27.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.841 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CD2' ' HB2' ' A' ' 50' ' ' LEU . 71.8 m-85 -128.3 55.62 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 m -137.07 35.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.177 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.11 161.89 13.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.109 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.62 155.53 38.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.91 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.46 127.37 31.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.948 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.35 27.69 65.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.558 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.533 HG23 ' CD2' ' A' ' 23' ' ' PHE . 29.8 mt -148.75 99.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 111.072 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 13.7 m -100.9 134.85 43.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.32 151.35 22.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 22' ' ' CYS . 5.1 mp -145.29 155.59 54.17 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.41 ' HD2' ' HE2' ' A' ' 95' ' ' MET . 53.6 Cg_exo -52.28 -176.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.528 2.152 . . . . 0.0 112.355 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -87.51 -50.67 6.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.944 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -61.96 -37.53 85.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.856 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.41 ' HE2' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -63.75 -38.26 90.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -47.22 70.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.801 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -38.08 89.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.814 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -59.55 -31.28 69.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.741 HD21 HG22 ' A' ' 75' ' ' THR . 6.3 mt -98.82 -15.25 19.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.234 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.9 mt 61.7 41.25 12.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 0.0 110.872 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.548 HD11 HD13 ' A' ' 99' ' ' LEU . 3.7 mt -79.33 159.04 27.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.828 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -111.13 -178.95 3.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.869 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.53 106.42 1.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.951 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.43 ' HA2' ' CZ ' ' A' ' 23' ' ' PHE . . . 85.8 33.77 14.93 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.545 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.74 136.03 17.48 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.52 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.629 HD22 ' HB3' ' A' ' 19' ' ' GLN . 34.5 mt -88.6 128.86 35.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.866 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.11 146.97 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.156 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -69.16 128.87 38.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.17 99.02 6.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.087 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -124.09 128.48 49.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.4 p -88.78 100.49 13.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 m -103.43 162.09 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.126 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -97.05 116.44 29.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.789 HD12 HD13 ' A' ' 63' ' ' LEU . 65.2 mt -115.4 170.78 8.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -127.4 164.56 21.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.926 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.2 m -62.65 140.47 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.661 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -76.63 148.11 37.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.124 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.9 p -105.0 -36.09 7.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.824 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -127.61 109.63 11.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 m -108.9 126.57 53.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -124.41 134.17 53.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.8 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.494 ' CE2' HG22 ' A' ' 168' ' ' VAL . 91.9 m-85 -127.88 159.32 35.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -137.06 95.31 12.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.62 107.33 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.581 2.188 . . . . 0.0 112.347 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -59.27 -31.22 68.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.0 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.84 146.6 35.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.98 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.53 -16.02 27.37 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.63 2.22 . . . . 0.0 112.515 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.22 -42.6 73.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.009 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -60.21 -40.95 91.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.5 -28.33 69.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -60.68 -24.4 65.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.992 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 134' ' ' ASN . 50.7 mt -62.72 136.9 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.986 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 31.5 m -59.06 -40.2 84.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.481 ' H ' HG22 ' A' ' 132' ' ' ILE . 1.8 m120 -131.63 86.93 47.53 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.77 -28.03 25.7 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.528 2.152 . . . . 0.0 112.272 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -63.34 -31.16 72.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.3 -32.7 49.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.131 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 132' ' ' ILE . 21.4 t -83.37 -30.83 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.179 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.446 HD21 ' HB2' ' A' ' 122' ' ' PHE . 46.5 tp -75.16 -30.39 60.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -85.54 -38.83 18.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.014 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -65.3 -23.98 67.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.25 -33.39 61.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.291 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 23.3 mt -63.65 -22.88 67.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.163 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -29.25 40.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.123 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -87.08 -29.71 21.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.981 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -88.28 140.6 29.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -103.44 -30.37 10.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.653 ' HB2' HD22 ' A' ' 63' ' ' LEU . 4.4 t -131.64 163.56 27.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.8 mt -141.15 164.78 29.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.23 129.09 13.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.409 HG23 ' HA ' ' A' ' 170' ' ' GLU . 52.3 m -59.95 110.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 98.41 51.61 1.42 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.539 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.23 130.25 28.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 110.866 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.5 107.07 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.069 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.3 pt -105.09 106.08 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.144 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.42 127.07 32.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.088 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 36.9 pt -118.8 148.39 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.076 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -146.7 134.56 21.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -149.73 -47.42 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.907 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -100.42 44.31 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.85 30.36 19.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.88 115.93 9.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.9 mp -81.11 86.59 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.09 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -66.9 158.4 30.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.44 136.19 50.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.954 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.3 mt -145.6 154.22 41.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -144.22 125.21 14.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.494 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.6 t -68.7 104.47 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.4 ' O ' HG23 ' A' ' 151' ' ' THR . 0.0 OUTLIER -67.42 -51.5 51.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 171' ' ' THR . 0.1 OUTLIER -151.64 164.23 37.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 170' ' ' GLU . 0.7 OUTLIER -159.97 142.17 13.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 39.4 mttt -118.55 157.48 49.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.2 -27.08 8.82 Favored 'Cis proline' 0 C--N 1.347 0.453 0 C-N-CA 123.268 -1.555 . . . . 0.0 112.355 0.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.98 174.1 8.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.852 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -57.66 -45.23 85.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.51 111.55 23.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.055 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.661 HG21 ' HB2' ' A' ' 117' ' ' ALA . 27.7 m -128.63 140.7 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.619 ' OG ' HD11 ' A' ' 63' ' ' LEU . 3.9 t -97.76 87.69 4.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.1 pt -83.63 82.95 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.1 mt -117.97 89.31 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.161 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.84 88.36 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.07 173.56 12.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.838 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.41 120.09 39.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -135.32 174.04 11.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.837 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -105.24 97.74 7.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.95 145.45 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.04 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -127.38 169.75 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' PHE . . . . . 0.436 ' CE1' HD22 ' A' ' 139' ' ' LEU . 7.0 m-85 -127.42 143.14 51.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.947 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -134.94 97.73 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.916 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.137 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.799 0.333 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.7 p -151.21 110.43 3.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 t -168.55 171.05 9.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.752 ' HB3' HD22 ' A' ' 106' ' ' LEU . 20.9 mt-30 -95.7 126.65 41.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -125.09 143.05 51.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.3 mtt-85 -66.73 144.79 56.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.008 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.6 p -114.92 120.95 41.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.955 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.741 ' CD2' HG23 ' A' ' 88' ' ' ILE . 77.1 m-85 -127.45 177.0 7.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.975 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -91.54 153.36 19.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.24 -28.3 40.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.144 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.088 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.851 0.358 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.81 20.15 10.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -118.22 -38.05 3.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.957 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.34 -154.25 26.33 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.456 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.38 87.73 0.45 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.51 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.0 149.91 31.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.791 0.329 . . . . 0.0 110.843 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.776 HG21 HD23 ' A' ' 91' ' ' LEU . 44.4 pt -138.14 175.52 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.189 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.404 HG23 ' HB2' ' A' ' 81' ' ' GLU . 1.9 mp -129.77 111.22 21.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.092 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 1.4 mtm -105.33 161.0 24.12 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.38 154.01 12.28 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.577 2.185 . . . . 0.0 112.267 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.93 -34.9 68.76 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.563 2.175 . . . . 0.0 112.278 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.81 -29.75 68.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.63 -46.57 86.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.182 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.446 HD13 ' CE2' ' A' ' 82' ' ' PHE . 41.3 tp -61.93 -42.65 99.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.956 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.98 -38.92 76.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -31.62 68.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.811 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.4 mt -63.6 -37.65 88.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.71 10.66 25.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.308 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.5 -25.6 9.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.713 0.292 . . . . 0.0 110.969 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.0 mt -94.48 20.15 8.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.313 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.84 40.12 19.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.889 0.375 . . . . 0.0 111.004 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.1 mm -95.12 127.56 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.097 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.47 158.91 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.909 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.446 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -66.37 143.04 98.08 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.9 Cg_endo -76.81 160.19 95.24 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 123.468 -1.472 . . . . 0.0 112.364 0.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.6 mtt -112.46 53.7 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.452 HD13 ' SG ' ' A' ' 148' ' ' CYS . 17.3 mt -74.68 120.73 20.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.9 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -85.57 168.62 14.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -121.75 102.08 7.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.484 HD22 HG11 ' A' ' 107' ' ' VAL . 65.0 mt -85.76 105.02 15.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.958 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.1 m -104.1 101.84 11.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -77.84 123.32 26.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -98.87 31.56 2.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -129.52 -45.93 1.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.2 m -113.48 15.24 19.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.257 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 53.22 32.29 13.12 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.811 0.338 . . . . 0.0 111.134 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.1 mmt-85 -86.53 151.34 23.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.96 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.47 ' O ' HG21 ' A' ' 150' ' ' THR . 27.3 ttt -149.13 107.46 3.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.815 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.7 t -130.29 163.61 26.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.578 ' CD2' HD11 ' A' ' 114' ' ' LEU . 52.0 m80 -122.14 105.46 10.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.7 p -98.27 175.59 6.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.941 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -137.68 139.27 10.3 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.488 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.503 HG21 ' CE1' ' A' ' 82' ' ' PHE . 9.6 p -82.57 149.97 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 111.03 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.4 tp -136.43 -59.08 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.953 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.404 ' HB2' HG23 ' A' ' 44' ' ' ILE . 4.5 mp0 -92.41 160.57 15.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CE1' HG21 ' A' ' 79' ' ' VAL . 96.6 m-85 -142.18 68.59 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.94 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.9 m -150.96 31.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.156 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.04 179.99 7.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.705 ' HB3' HD12 ' A' ' 88' ' ' ILE . 5.6 t70 -95.39 156.64 16.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -59.93 121.19 11.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.961 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.75 28.06 63.74 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.741 HG23 ' CD2' ' A' ' 23' ' ' PHE . 29.5 mt -146.93 107.79 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 111.165 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 89.0 m -108.35 133.03 53.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -90.67 134.35 34.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.776 HD23 HG21 ' A' ' 43' ' ' ILE . 1.7 mt -136.63 149.94 68.71 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.878 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.48 -172.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.528 2.152 . . . . 0.0 112.34 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -96.73 -41.34 8.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.942 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.444 ' CD2' ' N ' ' A' ' 95' ' ' MET . 65.2 p-90 -61.32 -44.07 97.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.924 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.444 ' N ' ' CD2' ' A' ' 94' ' ' TRP . 31.8 ttm -69.21 -38.19 78.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.982 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -31.39 72.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -85.06 -39.92 17.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -59.91 -34.21 72.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.824 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.1 mt -90.02 -12.93 37.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.219 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.5 mt 62.36 38.7 12.85 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.822 0.344 . . . . 0.0 110.873 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.4 mt -82.89 178.89 7.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -136.24 -179.94 5.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.07 127.51 33.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.406 ' HA2' ' CZ ' ' A' ' 23' ' ' PHE . . . 68.84 28.25 73.23 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.532 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -84.93 131.77 10.64 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.501 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.752 HD22 ' HB3' ' A' ' 19' ' ' GLN . 28.5 mt -84.57 125.15 32.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.772 0.32 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.484 HG11 HD22 ' A' ' 66' ' ' LEU . 21.5 t -122.07 137.02 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.066 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.44 119.36 11.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.72 153.03 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -156.57 159.46 38.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.43 116.74 31.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.58 158.51 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.078 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -113.06 111.55 22.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.578 HD11 ' CD2' ' A' ' 76' ' ' HIS . 4.3 mt -106.49 170.25 8.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -126.44 167.78 15.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.1 m -57.76 159.26 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.259 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.909 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -98.96 153.03 19.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.048 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.0 t -111.08 -30.97 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -143.56 105.66 4.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.849 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 m -111.97 140.64 46.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -119.94 126.75 51.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.964 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.585 ' CE2' HG22 ' A' ' 168' ' ' VAL . 92.1 m-85 -117.73 154.35 31.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -135.5 95.22 14.59 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.86 110.72 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.515 2.143 . . . . 0.0 112.39 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -62.98 -34.57 77.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 m -106.98 147.7 35.59 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.949 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.22 -19.14 26.22 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.572 2.181 . . . . 0.0 112.417 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -55.35 -36.21 66.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.072 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -69.66 -45.34 68.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 25.8 mt -60.59 -32.96 72.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.834 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.82 -27.72 69.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.989 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.463 HD13 HG21 ' A' ' 138' ' ' VAL . 37.0 mt -60.98 131.0 25.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.981 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.2 t -63.03 -42.15 99.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.942 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.44 78.65 3.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.884 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.39 -29.89 16.16 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.593 2.195 . . . . 0.0 112.352 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -65.52 -31.11 72.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.99 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.6 -49.86 17.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.084 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.463 HG21 HD13 ' A' ' 132' ' ' ILE . 21.5 t -62.53 -31.05 50.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.089 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.623 HD23 HG11 ' A' ' 186' ' ' VAL . 42.4 tp -79.8 -37.49 35.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.545 ' HA ' HD12 ' A' ' 143' ' ' LEU . 30.3 mt-10 -80.26 -30.57 38.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -67.18 -30.76 70.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.18 -29.59 20.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 140' ' ' GLU . 16.3 mt -58.49 -29.9 66.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.954 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -59.24 -32.62 70.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -74.74 -31.21 61.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.967 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -81.98 146.63 29.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -106.59 -29.55 9.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.083 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.452 ' SG ' HD13 ' A' ' 63' ' ' LEU . 3.9 t -136.98 164.97 27.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.918 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.3 mt -140.64 173.93 11.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.47 HG21 ' O ' ' A' ' 74' ' ' MET . 63.5 m -155.5 143.65 20.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.7 HG22 ' CB ' ' A' ' 175' ' ' LYS . 8.8 t -81.53 104.52 12.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.98 36.89 2.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.421 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -131.37 146.27 52.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 0.0 110.872 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.61 108.35 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.9 pt -109.41 120.89 61.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.182 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.63 138.95 38.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.2 pt -126.66 137.23 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.073 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -143.99 145.87 32.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.959 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -158.01 -47.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -108.76 43.99 1.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 61.11 31.69 19.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -137.91 99.85 4.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.9 mp -76.51 96.72 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.112 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.76 128.62 34.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.871 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -81.29 131.97 35.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.37 154.0 45.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -149.17 114.58 5.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.585 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.4 t -59.8 151.88 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.101 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.3 mmt -118.05 -43.98 2.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.943 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 171' ' ' THR . 2.2 tp10 -145.81 157.81 43.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 170' ' ' GLU . 11.2 p -157.61 140.24 14.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -119.5 152.51 53.1 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.885 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.56 -27.63 8.37 Favored 'Cis proline' 0 C--N 1.346 0.446 0 C-N-CA 123.343 -1.524 . . . . 0.0 112.453 -0.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.68 173.62 6.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.7 ' CB ' HG22 ' A' ' 151' ' ' THR . 0.2 OUTLIER -58.2 -46.39 85.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.967 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.488 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -98.79 121.46 40.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.066 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.909 HG21 ' HB2' ' A' ' 117' ' ' ALA . 30.5 m -130.38 132.42 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.065 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 24.8 p -82.17 94.83 7.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.806 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.3 pt -81.94 82.46 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.148 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 4.5 mt -114.98 83.62 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.995 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.26 85.08 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 8.0 t -165.03 142.05 5.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.58 116.26 26.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -125.01 177.77 5.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.942 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -102.2 120.06 39.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.623 HG11 HD23 ' A' ' 139' ' ' LEU . 21.5 t -98.32 129.48 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.119 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -108.43 172.05 7.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -141.62 133.86 27.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -117.07 95.52 5.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.084 179.919 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.844 0.355 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.9 p -141.08 114.95 9.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.6 t -176.93 170.13 2.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.831 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -97.25 157.0 16.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.819 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -150.62 147.61 27.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.838 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.0 mtp85 -72.47 124.34 24.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.553 ' HB2' HD13 ' A' ' 91' ' ' LEU . 20.3 p -92.72 127.21 38.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -135.44 143.37 45.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.2 t -59.75 169.23 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.969 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 91' ' ' LEU . 14.5 m -96.03 20.2 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.332 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 C--N 1.331 -0.227 0 CA-C-O 120.807 0.337 . . . . 0.0 110.823 179.935 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.814 0.34 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -70.79 -36.58 73.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -95.26 82.04 3.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.97 142.8 5.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.446 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -66.15 77.76 0.12 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.513 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.683 ' HB3' HD22 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -131.68 117.87 19.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 0.0 110.832 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.484 HD13 ' SG ' ' A' ' 77' ' ' CYS . 43.3 pt -112.5 170.53 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.101 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.51 HG22 ' HB2' ' A' ' 84' ' ' ALA . 5.2 mt -119.5 120.3 63.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.052 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 85.7 mtp -112.88 154.38 44.92 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.11 153.2 16.64 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.57 2.18 . . . . 0.0 112.31 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.92 -28.74 40.69 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.466 2.111 . . . . 0.0 112.304 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.0 p -64.38 -29.11 70.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.995 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.61 -36.4 71.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.249 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.416 HD13 ' CE1' ' A' ' 82' ' ' PHE . 8.2 tp -71.08 -45.78 63.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.938 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -68.94 -31.21 69.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -73.64 -50.64 20.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.976 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.552 ' HA ' HD12 ' A' ' 58' ' ' ILE . 29.4 mt -63.45 -35.38 80.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.2 p -77.21 -29.84 54.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.978 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.49 -20.44 47.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.9 mt -94.46 19.22 9.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.283 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.1 t30 54.88 32.22 17.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.189 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 53' ' ' LEU . 39.7 mt -91.87 112.91 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.15 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.8 p -99.33 169.91 9.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.939 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.457 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -65.07 143.03 98.79 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.457 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 77.1 Cg_endo -77.34 169.02 75.15 Favored 'Cis proline' 0 C--N 1.348 0.502 0 C-N-CA 123.477 -1.468 . . . . 0.0 112.462 0.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.5 mtt -130.08 38.72 3.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.912 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.542 HD22 ' SG ' ' A' ' 148' ' ' CYS . 0.4 OUTLIER -63.15 137.12 58.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.966 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.606 ' CD1' HG12 ' A' ' 109' ' ' VAL . 39.9 m-85 -100.24 160.57 14.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.429 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 13.9 tttt -109.7 84.32 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.88 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.561 HD23 HG22 ' A' ' 109' ' ' VAL . 17.7 mt -69.62 75.18 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.783 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.76 103.39 6.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.981 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.501 ' OD1' HD21 ' A' ' 101' ' ' LEU . 0.9 OUTLIER -70.54 118.22 13.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.915 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.96 33.58 2.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -131.62 -46.1 0.97 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 63.0 m -111.87 15.43 20.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.341 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.61 38.93 29.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.843 0.354 . . . . 0.0 111.084 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.477 ' HB2' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -98.46 163.07 12.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.838 ' O ' HG21 ' A' ' 150' ' ' THR . 27.0 ttp -150.13 114.1 5.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.847 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.5 m -134.9 141.64 46.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.994 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.429 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 42.9 m80 -108.67 118.53 37.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.944 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.494 ' SG ' HD12 ' A' ' 66' ' ' LEU . 28.2 p -128.86 145.97 51.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.928 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.96 138.92 14.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.499 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.37 148.12 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.852 0.358 . . . . 0.0 111.107 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.683 HD22 ' HB3' ' A' ' 42' ' ' LYS . 44.2 tp -113.59 -66.58 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.465 ' OE1' HG13 ' A' ' 83' ' ' VAL . 2.8 mm-40 -114.01 172.34 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.988 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.416 ' CE1' HD13 ' A' ' 50' ' ' LEU . 76.8 m-85 -133.39 66.45 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.853 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.465 HG13 ' OE1' ' A' ' 81' ' ' GLU . 31.4 m -137.2 31.75 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.165 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.51 ' HB2' HG22 ' A' ' 44' ' ' ILE . . . -96.64 178.63 5.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.134 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.703 ' HB2' HD12 ' A' ' 88' ' ' ILE . 4.2 m-20 -96.58 156.46 16.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.931 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -60.9 124.19 19.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.97 28.57 62.3 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.487 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.703 HD12 ' HB2' ' A' ' 85' ' ' ASP . 30.6 mt -146.93 87.99 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 0.0 111.088 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 96.7 m -94.32 120.0 33.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -84.6 146.33 27.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.925 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.553 HD13 ' HB2' ' A' ' 22' ' ' CYS . 1.0 OUTLIER -143.64 160.07 52.03 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.69 -174.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.568 2.179 . . . . 0.0 112.325 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -98.9 -31.46 11.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.986 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 64.1 p-90 -72.31 -38.58 68.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.562 ' HG2' HD12 ' A' ' 99' ' ' LEU . 36.8 ttm -64.52 -35.69 81.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -61.53 -48.77 79.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.873 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -61.83 -42.69 99.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -59.98 -50.24 74.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.568 HD13 HD11 ' A' ' 101' ' ' LEU . 7.2 mt -76.08 -20.62 57.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.5 mt 63.23 44.03 5.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.414 . . . . 0.0 110.815 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.568 HD11 HD13 ' A' ' 99' ' ' LEU . 3.3 mt -86.52 -175.75 5.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.869 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -127.25 172.37 10.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -70.0 78.8 0.49 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.1 35.96 1.07 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.441 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.66 150.17 20.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.451 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.1 mt -92.2 124.6 36.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.938 0.399 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.436 ' CG1' HD22 ' A' ' 66' ' ' LEU . 21.6 t -122.12 132.4 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.97 111.17 2.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.606 HG12 ' CD1' ' A' ' 64' ' ' PHE . 19.7 t -105.56 128.73 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.09 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -145.18 118.52 8.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.7 p -69.86 123.02 20.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.96 168.98 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -131.31 116.17 17.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.85 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 176' ' ' ALA . 1.3 mt -115.76 179.42 3.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.85 174.63 5.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.3 m -64.88 172.36 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.102 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.848 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -105.81 153.2 22.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 38.5 p -113.48 -36.36 4.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -131.98 97.52 4.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.428 ' OG ' HG22 ' A' ' 186' ' ' VAL . 94.9 p -101.43 109.92 21.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.874 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -98.65 119.45 37.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.53 ' CD1' HD21 ' A' ' 139' ' ' LEU . 75.9 m-85 -113.68 147.76 37.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.847 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -126.49 89.86 51.23 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -51.66 102.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.553 2.169 . . . . 0.0 112.288 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 -59.48 -30.78 68.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.969 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.5 m -109.79 145.91 32.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.933 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.8 -16.3 23.53 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.588 2.192 . . . . 0.0 112.555 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -55.17 -33.45 62.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.138 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.401 ' O ' HD12 ' A' ' 132' ' ' ILE . 33.9 t80 -77.11 -40.33 46.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 39.5 mt -64.89 -30.61 71.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.48 -25.13 67.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.026 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.829 HG21 HG21 ' A' ' 138' ' ' VAL . 23.1 mt -60.05 138.25 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.001 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.7 m -65.6 -34.42 78.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.066 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.608 ' H ' HG22 ' A' ' 132' ' ' ILE . 2.0 m120 -128.36 72.55 80.19 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.981 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.62 -32.77 91.45 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.617 2.211 . . . . 0.0 112.275 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -60.01 -47.72 84.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.964 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.4 -45.49 90.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.06 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.829 HG21 HG21 ' A' ' 132' ' ' ILE . 21.4 t -60.66 -39.48 81.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.181 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.592 HD23 HG11 ' A' ' 186' ' ' VAL . 10.1 tp -70.9 -41.91 70.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.913 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -68.01 -31.07 70.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -69.14 -31.36 69.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.406 ' CB ' HG21 ' A' ' 157' ' ' ILE . . . -79.5 -37.8 35.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.138 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.716 HD22 HD11 ' A' ' 149' ' ' LEU . 59.1 mt -61.5 -26.63 68.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.045 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -56.48 -30.37 62.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -82.74 -49.07 10.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.906 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -60.07 152.86 23.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.541 ' HB1' HD21 ' A' ' 63' ' ' LEU . . . -107.07 -29.21 9.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.138 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.542 ' SG ' HD22 ' A' ' 63' ' ' LEU . 1.6 m -146.86 167.87 22.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.953 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.716 HD11 HD22 ' A' ' 143' ' ' LEU . 5.1 mt -142.97 170.19 16.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.838 HG21 ' O ' ' A' ' 74' ' ' MET . 63.4 m -153.6 136.65 15.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.495 HG22 ' CB ' ' A' ' 175' ' ' LYS . 8.8 t -60.67 121.02 11.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 91.54 28.96 12.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.546 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.46 126.57 52.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.942 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.6 t -89.38 91.09 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.089 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.47 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 4.4 pt -87.55 154.63 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.136 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.61 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -129.32 102.36 6.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.406 HG21 ' CB ' ' A' ' 142' ' ' ALA . 7.6 pt -90.93 147.08 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -140.6 145.86 37.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -176.54 -38.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.999 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -99.2 40.3 1.22 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 56.82 29.28 15.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.033 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.31 110.79 2.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.61 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 3.6 mp -68.47 94.43 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -61.68 145.77 51.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -95.41 132.79 40.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.931 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.01 158.22 41.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -156.91 139.01 14.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.855 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.421 HG22 ' CE2' ' A' ' 122' ' ' PHE . 28.6 t -80.9 147.85 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 59.6 mmm -117.41 -40.75 3.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.7 151.38 27.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 64.3 p -151.2 149.35 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -122.22 152.87 61.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.35 -27.32 8.62 Favored 'Cis proline' 0 C--N 1.346 0.435 0 C-N-CA 123.281 -1.55 . . . . 0.0 112.389 -0.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -124.5 168.98 12.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.735 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.495 ' CB ' HG22 ' A' ' 151' ' ' THR . 0.0 OUTLIER -56.59 -49.18 75.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.98 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.52 ' O ' HD22 ' A' ' 114' ' ' LEU . . . -92.85 110.73 22.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.033 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.848 HG21 ' HB2' ' A' ' 117' ' ' ALA . 11.5 m -128.52 148.72 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.19 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.7 95.7 8.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.2 pt -86.97 83.3 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.087 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 28.2 mm -112.73 90.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 61.17 55.29 3.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 6.1 t -135.83 143.27 45.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.19 134.48 41.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.869 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.458 ' SD ' ' HB3' ' A' ' 117' ' ' ALA . 2.1 ptt? -139.65 164.52 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -78.97 76.25 5.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.785 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.592 HG11 HD23 ' A' ' 139' ' ' LEU . 28.6 t -63.3 125.82 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.091 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.32 162.22 16.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' PHE . . . . . 0.416 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 31.0 m-85 -124.17 128.98 50.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -90.97 94.21 9.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.12 179.948 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.1 t80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.819 0.342 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.7 p -154.57 124.34 6.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -175.3 179.34 1.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.952 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.501 ' HB3' HD22 ' A' ' 106' ' ' LEU . 27.9 mt-30 -107.07 155.17 20.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -155.23 152.6 29.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.6 mtt-85 -82.86 134.58 35.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.1 m -102.23 128.14 48.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.496 ' CD2' HG23 ' A' ' 88' ' ' ILE . 52.9 m-85 -138.38 175.19 9.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.949 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.5 t -86.19 -179.98 6.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 91' ' ' LEU . 18.9 m -95.62 20.08 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.347 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.172 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.78 0.324 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -80.45 -31.34 37.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -83.47 91.19 7.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.87 178.27 15.62 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.55 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.73 31.56 8.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.557 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -89.17 135.53 33.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.81 0.338 . . . . 0.0 110.782 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.523 HD13 ' SG ' ' A' ' 77' ' ' CYS . 7.8 pt -128.93 167.75 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.166 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.0 mt -120.3 140.81 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.176 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.484 ' HE1' HG11 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -133.09 158.13 76.58 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.85 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.79 161.42 3.15 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.524 2.149 . . . . 0.0 112.315 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.83 -25.81 32.82 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.648 2.232 . . . . 0.0 112.302 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.7 p -58.95 -38.4 78.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.979 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.471 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -59.32 -33.11 70.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.214 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.5 tp -62.01 -51.58 67.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.82 -31.19 67.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.41 -43.91 63.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.928 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 49' ' ' ALA . 3.8 mt -58.18 -52.25 66.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -65.25 -29.74 70.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -76.58 -26.04 54.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.02 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.9 mt -94.51 20.09 8.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.227 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 m120 58.24 35.51 25.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.866 0.365 . . . . 0.0 111.058 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 53' ' ' LEU . 29.4 mt -102.62 116.74 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 t -114.17 173.56 6.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.468 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -68.1 144.09 96.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.468 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.7 Cg_endo -77.08 159.56 95.53 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 123.446 -1.481 . . . . 0.0 112.327 -0.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 19.1 mtt -125.35 59.0 1.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.983 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.712 HD23 ' HA2' ' A' ' 78' ' ' GLY . 88.8 mt -74.93 114.99 14.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.859 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.429 ' CE2' ' HB ' ' A' ' 79' ' ' VAL . 17.3 m-85 -81.68 133.37 35.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.857 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -85.66 93.23 8.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.037 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.9 mt -78.36 76.85 4.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.6 m -90.02 103.17 15.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.9 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -67.14 127.23 31.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -98.92 32.17 2.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.44 -43.84 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 73.4 m -123.56 23.07 8.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 54.43 31.33 14.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.092 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.531 ' HB3' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -82.33 157.82 23.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.826 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.92 131.91 10.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.607 HG22 HD21 ' A' ' 99' ' ' LEU . 2.7 t -159.95 114.3 2.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.964 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.455 ' CE1' HG21 ' A' ' 112' ' ' VAL . 16.2 m-70 -79.74 122.99 27.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.523 ' SG ' HD13 ' A' ' 43' ' ' ILE . 30.0 p -117.29 150.73 38.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.949 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.712 ' HA2' HD23 ' A' ' 63' ' ' LEU . . . -104.86 129.36 9.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.417 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.429 ' HB ' ' CE2' ' A' ' 64' ' ' PHE . 10.8 p -69.44 147.36 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 111.094 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -130.41 -59.74 1.02 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.818 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -110.11 146.91 34.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.743 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -113.88 49.52 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.06 79.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.147 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -132.31 173.36 11.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.585 ' HB3' HD12 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -76.64 162.93 27.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -66.59 109.92 2.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.02 34.94 54.76 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.483 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.585 HD12 ' HB3' ' A' ' 85' ' ' ASP . 26.8 mt -144.01 91.62 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.81 0.338 . . . . 0.0 111.085 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 97.0 m -80.67 134.52 35.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -99.63 127.38 45.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.404 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -130.19 157.74 76.27 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.849 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.57 -172.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.591 2.194 . . . . 0.0 112.283 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -90.58 -39.02 12.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -69.61 -42.86 73.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.2 ttp -61.08 -31.31 70.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -31.5 61.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.827 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -81.55 -37.13 28.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.894 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -68.62 -45.13 72.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.643 HD13 HD11 ' A' ' 101' ' ' LEU . 7.7 mt -68.83 -23.87 64.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.061 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.8 mt 66.27 48.79 1.57 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.803 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.643 HD11 HD13 ' A' ' 99' ' ' LEU . 5.2 mt -96.36 -176.26 3.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.78 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.31 174.77 10.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -59.85 92.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.02 28.1 7.49 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -70.44 130.0 20.47 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.491 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.501 HD22 ' HB3' ' A' ' 19' ' ' GLN . 64.5 mt -87.82 126.95 35.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.807 0.337 . . . . 0.0 110.927 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 108' ' ' GLN . 21.5 t -129.53 156.42 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.446 ' N ' HG12 ' A' ' 107' ' ' VAL . 19.2 tp60 -79.67 125.01 29.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.484 HG11 ' HE1' ' A' ' 45' ' ' MET . 21.5 t -111.35 105.7 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.097 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -125.45 133.56 52.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.8 p -81.92 108.56 15.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.989 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.455 HG21 ' CE1' ' A' ' 76' ' ' HIS . 6.8 m -111.2 156.21 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -107.57 118.04 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.435 HD13 ' HB1' ' A' ' 176' ' ' ALA . 13.1 mt -118.02 157.15 27.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -109.56 169.83 8.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.7 m -64.85 139.82 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.101 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.842 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -79.75 149.33 31.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.3 p -107.33 -37.85 6.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -128.04 125.22 38.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.8 p -129.74 140.23 51.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.023 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -131.23 125.51 33.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.824 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.787 ' CG ' HD21 ' A' ' 139' ' ' LEU . 17.1 m-85 -113.41 147.62 37.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.982 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -131.06 92.44 33.38 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.779 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.707 ' HA ' HD23 ' A' ' 166' ' ' LEU . 77.1 Cg_exo -50.18 116.58 2.54 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.561 2.174 . . . . 0.0 112.455 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -73.62 -31.45 63.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -106.8 146.93 34.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.27 -14.77 28.5 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.582 2.188 . . . . 0.0 112.461 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.0 -40.07 75.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.011 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -71.87 -38.44 70.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.415 HD21 ' CB ' ' A' ' 190' ' ' ALA . 84.9 mt -64.95 -31.84 73.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.866 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -62.42 -25.62 68.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.449 HG22 ' H ' ' A' ' 134' ' ' ASN . 32.9 mt -66.01 135.38 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.089 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.2 t -66.93 -37.86 85.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.526 ' O ' HG23 ' A' ' 138' ' ' VAL . 3.8 m120 -119.07 75.75 14.73 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.17 -30.27 16.28 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.631 2.221 . . . . 0.0 112.311 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -37.01 84.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.48 -44.33 67.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 134' ' ' ASN . 29.9 t -63.03 -44.73 99.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.012 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.787 HD21 ' CG ' ' A' ' 122' ' ' PHE . 16.0 tp -69.26 -31.58 70.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.819 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.01 -31.43 62.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.914 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -78.79 -34.28 45.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.861 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.23 -35.7 66.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.515 HD22 HD11 ' A' ' 149' ' ' LEU . 14.8 mt -59.73 -25.73 65.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.983 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 -55.4 -30.57 60.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.09 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.24 -31.21 30.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -71.24 140.53 50.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -101.12 -29.59 12.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.105 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 18.3 t -148.76 158.36 44.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.954 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.515 HD11 HD22 ' A' ' 143' ' ' LEU . 11.1 mt -134.34 150.92 50.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.0 m -128.32 148.51 50.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 26.5 m -76.01 101.72 5.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 103.51 48.17 1.23 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.462 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -134.0 115.16 14.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.792 0.329 . . . . 0.0 110.931 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.3 t -72.54 99.25 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 37.3 pt -97.13 143.91 11.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.157 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.597 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -107.97 150.72 26.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.125 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.5 pt -141.15 139.55 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.125 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -127.39 156.66 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -177.43 -47.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -103.02 42.65 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.64 31.04 20.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.915 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.09 126.42 9.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.597 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 3.4 mp -86.9 101.12 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -79.17 123.95 27.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.86 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -87.47 131.48 34.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.707 HD23 ' HA ' ' A' ' 124' ' ' PRO . 1.5 mt -143.69 147.34 34.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.827 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -127.06 127.73 45.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.14 131.91 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 14.2 mmm -87.57 -55.57 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.529 ' O ' HG23 ' A' ' 171' ' ' THR . 0.1 OUTLIER -145.28 160.02 42.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 170' ' ' GLU . 3.0 p -160.07 119.08 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -96.83 155.77 37.27 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.96 -43.18 0.67 Allowed 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.326 -1.531 . . . . 0.0 112.444 0.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.29 174.48 5.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.935 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -59.13 -48.79 80.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.435 ' HB1' HD13 ' A' ' 114' ' ' LEU . . . -92.74 113.02 25.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.084 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.842 HG21 ' HB2' ' A' ' 117' ' ' ALA . 28.2 m -129.54 139.34 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 11.3 t -91.8 98.29 11.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.9 pt -90.91 80.35 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.5 mt -108.41 83.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.08 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 60.94 78.76 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 14.3 t -153.49 148.36 26.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.14 121.91 28.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -144.14 154.04 42.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.16 119.28 19.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.15 109.49 27.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.164 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.8 169.61 9.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' PHE . . . . . 0.6 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 3.1 m-85 -142.12 109.64 5.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -112.01 105.03 13.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.415 ' CB ' HD21 ' A' ' 130' ' ' LEU . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.117 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 CA--C 1.527 0.073 0 CA-C-O 120.789 0.328 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.2 p -159.99 118.4 2.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -176.33 161.22 2.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.972 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -90.11 143.61 26.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.811 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.455 ' HB2' HG21 ' A' ' 109' ' ' VAL . 6.0 m-85 -144.4 136.41 26.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -71.57 157.86 37.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.493 ' SG ' HD13 ' A' ' 101' ' ' LEU . 95.6 m -119.96 130.72 54.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.939 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.613 ' CD2' HG23 ' A' ' 88' ' ' ILE . 70.6 m-85 -136.2 166.79 22.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -79.14 138.58 37.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.946 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 90' ' ' TYR . 26.3 m -63.6 -19.33 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.288 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.412 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.5 t . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.907 0.384 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -71.85 -38.68 70.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.884 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -84.14 79.54 9.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.74 178.8 32.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.411 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.06 37.87 3.6 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.517 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.576 ' HG2' HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -105.5 153.58 21.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.705 0.288 . . . . 0.0 110.872 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.675 HG22 ' HD3' ' A' ' 92' ' ' PRO . 3.0 pt -139.66 179.95 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.041 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.655 HG22 ' HB2' ' A' ' 84' ' ' ALA . 4.5 mt -122.51 136.12 60.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.124 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 71.8 mtp -137.75 161.49 59.85 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.81 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 52.5 Cg_exo -52.79 146.47 35.55 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.506 2.138 . . . . 0.0 112.335 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 46' ' ' PRO . 50.3 Cg_exo -53.83 -26.89 41.21 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.521 2.147 . . . . 0.0 112.384 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.0 t -58.54 -39.01 78.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.035 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.89 -31.08 70.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.102 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.418 HD13 ' CD1' ' A' ' 82' ' ' PHE . 58.3 tp -64.68 -51.31 63.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -72.61 -29.5 63.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -50.34 74.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.947 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.517 HD13 ' SD ' ' A' ' 62' ' ' MET . 1.6 mt -56.56 -38.29 71.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.007 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.8 t -75.52 -27.5 58.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -81.54 -25.04 36.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.03 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.4 mt -95.52 19.77 10.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.18 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 53.98 44.88 28.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.86 0.362 . . . . 0.0 111.173 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.499 HG21 HD23 ' A' ' 53' ' ' LEU . 30.3 mt -107.35 130.37 59.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.182 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 p -113.4 170.84 7.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.444 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.3 t80 -61.15 140.35 94.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.815 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.85 171.34 68.58 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.544 -1.44 . . . . 0.0 112.368 0.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.517 ' SD ' HD13 ' A' ' 53' ' ' LEU . 15.9 mtt -126.31 41.71 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.469 HD22 ' CA ' ' A' ' 78' ' ' GLY . 16.9 mt -68.97 164.0 23.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.935 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -130.34 153.89 48.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.52 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 23.9 tttt -99.82 91.9 5.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.842 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 66' ' ' LEU . 15.1 mt -75.43 78.95 2.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.836 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -81.65 99.17 8.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -71.27 120.23 16.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.829 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -98.46 30.56 3.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.994 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.94 -37.43 4.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.846 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.23 23.54 4.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.128 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.01 39.31 31.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 111.113 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.31 172.46 8.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.0 ttp -157.82 124.93 5.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.834 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.0 m -140.17 155.74 46.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.52 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 65.2 m-70 -129.56 108.86 10.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.1 p -116.59 149.88 38.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.469 ' CA ' HD22 ' A' ' 63' ' ' LEU . . . -104.87 137.68 13.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.545 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.9 p -83.79 134.88 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.782 0.325 . . . . 0.0 111.06 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.576 HD22 ' HG2' ' A' ' 42' ' ' LYS . 57.5 tp -117.94 -58.01 2.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.32 150.75 19.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.418 ' CD1' HD13 ' A' ' 50' ' ' LEU . 65.7 m-85 -132.99 62.83 1.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.3 m -136.15 32.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.164 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.655 ' HB2' HG22 ' A' ' 44' ' ' ILE . . . -95.12 158.78 15.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.071 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.615 ' HB3' HD12 ' A' ' 88' ' ' ILE . 3.9 t70 -68.54 160.31 30.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -66.98 136.12 54.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.19 28.69 73.85 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.452 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.615 HD12 ' HB3' ' A' ' 85' ' ' ASP . 28.8 mt -147.82 112.47 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 111.14 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.7 m -114.85 130.5 56.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.49 ' HB3' HG12 ' A' ' 25' ' ' VAL . 70.1 m-85 -92.42 143.25 26.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.935 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.532 ' CD2' HG21 ' A' ' 43' ' ' ILE . 44.0 mt -139.28 147.67 53.9 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.675 ' HD3' HG22 ' A' ' 43' ' ' ILE . 53.0 Cg_exo -52.52 169.93 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.57 2.18 . . . . 0.0 112.283 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.53 -38.68 77.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.834 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.405 ' CH2' ' CE ' ' A' ' 95' ' ' MET . 51.0 p-90 -72.58 -31.48 65.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.405 ' CE ' ' CH2' ' A' ' 94' ' ' TRP . 7.4 ttm -74.72 -31.16 61.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 37.7 mmm -76.39 -39.06 54.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -76.63 -38.75 54.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.858 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -59.66 -53.49 57.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.41 HD13 HD11 ' A' ' 101' ' ' LEU . 30.8 mt -71.21 -21.79 62.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 mt 66.99 45.6 1.74 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.892 0.377 . . . . 0.0 110.944 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.493 HD13 ' SG ' ' A' ' 22' ' ' CYS . 13.1 mt -96.83 149.24 22.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -103.47 -179.19 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.799 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.34 113.5 2.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.35 42.24 8.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.446 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.86 109.51 3.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.536 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.1 mt -73.27 131.88 42.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 108' ' ' GLN . 21.5 t -137.01 158.83 36.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.079 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.479 ' N ' HG12 ' A' ' 107' ' ' VAL . 16.4 mm100 -74.67 122.5 23.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.455 HG21 ' HB2' ' A' ' 20' ' ' TYR . 21.5 t -117.95 86.9 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.146 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -107.5 135.2 49.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.1 p -75.72 101.49 5.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 65' ' ' LYS . 19.2 m -113.88 149.3 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.105 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -121.84 117.21 25.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.577 HD22 ' O ' ' A' ' 176' ' ' ALA . 6.4 mt -107.81 174.22 5.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.45 164.06 12.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.95 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.1 m -64.69 135.05 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.668 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -77.68 152.87 33.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.076 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.3 t -109.55 -31.77 7.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -134.82 106.7 7.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.6 m -122.92 113.39 19.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.946 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -92.38 142.56 27.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.515 ' CG ' HD21 ' A' ' 139' ' ' LEU . 18.1 m-85 -130.43 150.2 51.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -131.79 95.93 21.72 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.8 109.9 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.536 2.157 . . . . 0.0 112.408 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -59.62 -31.78 69.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.998 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 72.4 p -113.38 146.81 36.11 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.958 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.88 -17.8 25.13 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.544 2.163 . . . . 0.0 112.48 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -55.14 -39.84 69.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.023 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -66.41 -46.91 74.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.7 mt -60.31 -30.67 69.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.968 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.3 -25.07 66.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 134' ' ' ASN . 51.4 mt -62.27 136.92 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.958 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.9 m -58.28 -39.62 79.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.992 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.729 ' O ' HG23 ' A' ' 138' ' ' VAL . 2.3 m120 -125.59 80.67 65.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.0 -28.63 19.05 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.585 2.19 . . . . 0.0 112.363 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.9 mtpm? -66.73 -44.95 80.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.84 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.89 93.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.038 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 134' ' ' ASN . 25.3 t -64.08 -45.25 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.064 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.61 HD22 ' CZ ' ' A' ' 188' ' ' PHE . 21.5 tp -67.91 -43.44 79.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.83 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -62.35 -36.37 82.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.807 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -68.82 -29.83 68.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.35 -33.19 69.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.575 HD22 HD13 ' A' ' 179' ' ' ILE . 65.9 mt -60.49 -25.77 66.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.059 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.6 mtp-105 -55.16 -30.36 59.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.05 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -89.21 -38.7 14.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -69.08 144.67 53.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.423 ' HB1' HD11 ' A' ' 180' ' ' ILE . . . -109.39 -26.15 10.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.22 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -140.25 165.14 28.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.968 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.523 HD11 HD13 ' A' ' 179' ' ' ILE . 20.8 mt -144.33 129.41 18.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.54 145.47 46.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.876 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 169' ' ' MET . 18.7 m -71.47 123.58 22.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.9 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.75 27.69 21.07 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.45 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.82 132.66 53.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.4 t -90.58 89.68 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.084 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 18.4 pt -85.16 132.31 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.081 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -108.05 140.75 40.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.3 pt -125.12 165.26 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.041 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -157.83 150.41 22.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -172.71 -48.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -97.66 41.44 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.94 29.65 19.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.954 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.59 128.12 17.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.801 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.574 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.9 mp -87.83 105.18 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.177 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -82.71 137.44 34.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -90.11 121.73 32.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.001 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.23 141.55 49.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.82 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 -137.24 129.05 28.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.446 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.3 t -76.57 132.46 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.66 ' O ' HG23 ' A' ' 151' ' ' THR . 6.7 mmm -94.0 -68.53 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.95 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -123.8 152.91 41.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.5 p -147.24 150.49 34.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -130.68 153.97 81.66 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.64 -31.96 4.92 Favored 'Cis proline' 0 C--N 1.348 0.522 0 C-N-CA 123.264 -1.557 . . . . 0.0 112.45 -0.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.36 171.53 7.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.835 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -40.75 76.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.022 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.577 ' O ' HD22 ' A' ' 114' ' ' LEU . . . -102.64 124.47 48.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.081 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.668 HG21 ' HB2' ' A' ' 117' ' ' ALA . 15.8 m -137.58 153.71 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.146 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 23.8 t -104.7 98.01 7.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.575 HD13 HD22 ' A' ' 143' ' ' LEU . 2.4 pt -88.68 84.11 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.207 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.423 HD11 ' HB1' ' A' ' 147' ' ' ALA . 26.5 mm -111.65 79.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.089 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 59.14 91.0 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.99 156.16 26.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.967 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.19 103.53 15.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.827 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -126.67 170.84 11.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -94.22 113.54 25.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.39 106.85 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.176 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -87.13 159.33 18.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' PHE . . . . . 0.61 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 13.7 m-85 -133.09 133.24 42.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -121.09 97.37 5.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.087 179.969 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.6 t80 . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.893 0.378 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.0 p -155.23 110.1 2.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.2 t -176.42 168.96 2.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -103.38 146.85 27.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.406 ' HD2' HG21 ' A' ' 109' ' ' VAL . 22.4 m-85 -146.87 147.28 30.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.91 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -84.6 132.08 34.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.9 p -84.82 142.01 30.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.642 ' CD2' HG23 ' A' ' 88' ' ' ILE . 17.2 m-85 -147.0 149.47 33.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.833 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.85 168.51 6.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 m -95.82 20.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.374 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 55.1 m . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.019 179.955 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.791 0.329 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -77.2 -30.14 54.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -97.93 33.72 2.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.6 171.51 25.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.553 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.23 28.66 13.02 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.545 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.83 151.2 20.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.805 0.336 . . . . 0.0 110.913 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.493 HG21 HD23 ' A' ' 91' ' ' LEU . 7.9 pt -133.35 165.67 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.652 HG23 ' HB3' ' A' ' 81' ' ' GLU . 3.0 mt -115.7 96.17 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.138 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.405 ' HG3' HD12 ' A' ' 43' ' ' ILE . 97.1 mtp -88.55 157.8 49.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.8 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -51.83 156.74 6.48 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.571 2.181 . . . . 0.0 112.336 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.71 -27.06 38.57 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.519 2.146 . . . . 0.0 112.318 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.8 p -61.65 -31.67 71.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.87 -31.67 72.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.3 tp -62.27 -34.64 76.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -86.96 -30.54 21.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.0 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.42 -47.25 70.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.5 mt -57.19 -47.48 81.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.077 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 p -64.15 -23.61 67.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.173 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.72 20.11 9.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.355 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -135.83 19.95 3.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.206 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 55.9 33.69 22.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.766 0.317 . . . . 0.0 111.029 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.2 mt -102.78 109.01 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.4 p -104.51 162.96 12.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.471 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -60.14 144.3 87.29 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.775 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.471 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 72.2 Cg_endo -76.71 171.29 68.84 Favored 'Cis proline' 0 C--N 1.347 0.484 0 C-N-CA 123.467 -1.472 . . . . 0.0 112.4 0.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.3 mtt -138.23 78.02 1.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.446 HD22 HD12 ' A' ' 114' ' ' LEU . 1.4 mp -89.55 138.29 31.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -109.78 143.02 40.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.846 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -94.74 99.76 11.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.936 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.714 ' HB2' HG23 ' A' ' 75' ' ' THR . 43.7 mt -84.66 78.44 9.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 53.7 m -77.93 111.59 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.437 ' OD1' HD21 ' A' ' 101' ' ' LEU . 2.8 t30 -74.88 113.96 12.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.956 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -88.92 53.9 2.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -145.22 -53.49 0.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.9 m -120.32 25.37 9.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.067 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 t0 55.19 30.44 14.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.112 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.0 mmt-85 -82.3 146.19 29.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.3 ttm -133.12 140.77 47.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.819 HG21 HD11 ' A' ' 99' ' ' LEU . 4.7 t -157.15 143.0 17.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -120.78 114.6 21.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.2 p -113.46 172.73 6.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.46 124.84 4.83 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.539 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.0 p -64.12 141.65 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 0.0 111.09 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.7 tp -134.9 -54.79 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.652 ' HB3' HG23 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -94.45 152.09 18.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -135.0 73.86 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.6 m -149.93 35.23 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.164 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.69 178.77 5.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.095 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.716 ' CB ' HD12 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -92.69 166.47 12.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.804 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -65.66 90.96 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.807 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 96.73 26.17 10.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.509 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.716 HD12 ' CB ' ' A' ' 85' ' ' ASP . 28.0 mt -136.08 80.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 111.07 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 57.5 m -78.29 134.7 37.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -102.96 130.91 50.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.848 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.493 HD23 HG21 ' A' ' 43' ' ' ILE . 1.3 mp -132.69 162.19 58.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.36 -173.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.628 2.218 . . . . 0.0 112.287 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -94.18 -46.65 7.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.433 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 69.7 p-90 -60.01 -39.63 86.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 37.4 ttm -62.03 -32.79 73.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.893 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -53.17 18.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -61.91 -38.35 88.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -59.96 -40.97 90.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.792 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.819 HD11 HG21 ' A' ' 75' ' ' THR . 10.0 mt -84.86 -14.46 47.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.281 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.7 mt 61.35 32.95 19.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.437 HD21 ' OD1' ' A' ' 68' ' ' ASN . 6.9 mt -82.75 162.88 21.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -108.85 173.52 6.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.898 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -60.14 112.55 1.95 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.83 42.65 10.89 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.465 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.11 119.65 5.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.478 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.9 mt -65.57 129.23 39.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.803 0.335 . . . . 0.0 110.847 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.94 149.78 33.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -75.8 124.28 27.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.406 HG21 ' HD2' ' A' ' 20' ' ' TYR . 21.5 t -111.29 122.87 66.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -144.2 121.87 11.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 71.4 p -72.75 129.35 38.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.4 m -137.69 139.79 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.057 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -101.06 109.37 21.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.446 HD12 HD22 ' A' ' 63' ' ' LEU . 3.9 mt -103.52 172.01 7.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -116.03 164.72 14.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.631 HG21 ' SG ' ' A' ' 182' ' ' CYS . 21.7 m -60.82 144.34 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.094 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.867 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -88.07 153.3 21.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.124 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.1 p -106.35 -31.32 8.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -133.7 112.64 11.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.9 m -123.35 122.1 37.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.23 146.46 38.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.974 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.698 ' CD1' HD21 ' A' ' 139' ' ' LEU . 74.5 m-85 -125.94 143.94 50.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -126.59 90.24 50.26 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.958 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.81 112.08 0.75 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.583 2.189 . . . . 0.0 112.328 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -65.39 -31.25 72.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.1 p -106.57 146.47 33.12 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.931 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.59 -17.03 23.76 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.597 2.198 . . . . 0.0 112.576 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.02 -44.25 74.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.087 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.483 ' CE1' HD11 ' A' ' 157' ' ' ILE . 20.9 t80 -70.49 -44.67 67.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.869 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.3 mt -59.82 -31.81 70.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -64.4 -24.07 67.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.977 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.411 HG22 ' H ' ' A' ' 134' ' ' ASN . 60.5 mt -60.02 139.94 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.924 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.401 HG23 ' N ' ' A' ' 134' ' ' ASN . 9.0 t -59.11 -44.73 92.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.411 ' H ' HG22 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -129.76 86.76 54.32 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.49 -28.61 21.52 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.585 2.19 . . . . 0.0 112.313 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.443 ' HG3' ' CE1' ' A' ' 188' ' ' PHE . 36.8 mttt -65.49 -35.67 81.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.93 -41.85 77.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.076 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.671 HG11 ' CZ ' ' A' ' 159' ' ' TYR . 21.5 t -74.38 -36.8 43.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.075 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.698 HD21 ' CD1' ' A' ' 122' ' ' PHE . 1.3 tp -71.42 -37.59 71.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.22 -31.42 65.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.76 -33.02 68.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.899 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.97 -29.19 32.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.7 mt -57.9 -25.97 61.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.057 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -55.59 -30.0 60.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.034 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -80.02 -35.13 37.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -73.92 132.75 42.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -103.1 -27.21 12.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 7.6 t -123.0 161.12 24.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.433 HD12 HG21 ' A' ' 179' ' ' ILE . 6.1 mt -143.78 113.37 7.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.3 m -117.42 136.37 53.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.08 129.35 39.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.918 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 83.4 47.43 5.72 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.53 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.57 110.85 13.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.738 0.304 . . . . 0.0 110.862 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.59 83.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.193 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.433 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 1.4 pt -81.67 150.58 4.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -114.59 117.4 30.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.023 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.483 HD11 ' CE1' ' A' ' 129' ' ' PHE . 3.4 pt -109.1 145.7 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.227 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -148.77 140.67 23.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.882 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.671 ' CZ ' HG11 ' A' ' 138' ' ' VAL . 1.8 p90 -149.02 -50.17 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -100.81 49.34 0.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 59.05 30.0 19.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.974 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -139.74 105.41 5.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.555 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.8 mp -78.26 88.04 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.144 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -69.58 158.09 35.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.781 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -113.98 135.95 53.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.975 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.462 HD21 ' CD2' ' A' ' 129' ' ' PHE . 3.6 mp -150.4 160.56 43.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.825 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 8.5 ttt-85 -144.77 130.67 19.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.025 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.451 ' CG1' HG23 ' A' ' 171' ' ' THR . 21.5 t -59.56 123.53 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.056 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.17 -61.4 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.06 148.08 44.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.991 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.451 HG23 ' CG1' ' A' ' 168' ' ' VAL . 16.6 p -145.92 138.87 25.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -122.19 154.48 61.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.1 -39.08 1.52 Allowed 'Cis proline' 0 C--N 1.347 0.469 0 C-N-CA 123.267 -1.555 . . . . 0.0 112.324 0.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.49 171.64 7.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.81 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.11 -48.1 82.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -93.2 123.42 36.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.062 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.867 HG21 ' HB2' ' A' ' 117' ' ' ALA . 15.7 m -143.78 152.91 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' SER . . . . . 0.532 ' OG ' HD11 ' A' ' 180' ' ' ILE . 4.7 t -106.45 106.5 17.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.433 HG21 HD12 ' A' ' 149' ' ' LEU . 2.0 pt -92.09 86.6 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.176 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.532 HD11 ' OG ' ' A' ' 178' ' ' SER . 4.8 mt -116.48 81.57 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.015 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 60.36 89.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 116' ' ' VAL . 2.8 t -162.54 153.18 17.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.928 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -80.64 119.57 23.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.5 ptt? -147.83 168.94 20.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -102.07 150.82 22.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.67 106.94 12.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.134 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.16 158.89 15.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.942 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' PHE . . . . . 0.639 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 7.2 m-85 -127.53 148.01 50.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.864 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -139.14 97.26 3.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.139 179.934 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.0 t80 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.759 0.314 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.35 122.69 22.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.405 HG23 ' CE2' ' A' ' 20' ' ' TYR . 11.2 t -177.09 163.75 2.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.913 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -86.14 153.34 22.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.405 ' CE2' HG23 ' A' ' 18' ' ' THR . 13.6 m-85 -154.99 156.74 36.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -82.36 149.8 27.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.905 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.8 m -112.36 119.28 37.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.584 ' CD2' HG23 ' A' ' 88' ' ' ILE . 33.7 m-85 -127.65 163.11 24.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.922 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.8 m -81.22 157.55 25.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.9 m -72.57 -30.61 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.974 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.458 -0.031 0 CA-C-O 120.884 0.373 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -94.03 -31.2 14.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.826 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -97.54 95.42 7.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.888 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.94 -145.98 17.37 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.408 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.11 80.44 0.3 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.557 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.62 ' HG2' HD13 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -142.36 126.62 17.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.826 0.346 . . . . 0.0 110.872 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.401 HG22 ' HD3' ' A' ' 92' ' ' PRO . 13.1 pt -118.17 171.01 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.181 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 mp -128.9 106.7 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.94 160.56 25.7 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.962 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.508 ' N ' ' HB3' ' A' ' 84' ' ' ALA . 51.3 Cg_exo -52.93 161.35 3.32 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.535 2.156 . . . . 0.0 112.28 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.9 -26.39 26.95 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.548 2.165 . . . . 0.0 112.33 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 p -58.86 -31.24 68.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.948 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.45 -36.88 83.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.412 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 44.8 tp -64.86 -38.74 92.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.906 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -77.27 -30.99 54.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.932 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -68.93 -51.3 41.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.9 mt -59.63 -33.13 71.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.5 m -64.24 -30.27 71.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -96.64 20.23 11.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.4 mt -128.57 18.45 6.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.182 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 53.77 30.07 10.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.797 0.332 . . . . 0.0 111.157 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.1 mt -99.59 123.78 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.126 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -119.55 168.79 10.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.462 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -59.93 144.07 86.76 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.89 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.462 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 72.7 Cg_endo -77.27 149.8 90.23 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 123.422 -1.491 . . . . 0.0 112.398 0.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 4.6 mtt -115.74 74.88 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.552 HD21 ' HB1' ' A' ' 147' ' ' ALA . 1.6 mt -88.15 160.37 17.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -127.37 148.28 50.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.837 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.404 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 24.7 tttt -104.11 93.78 5.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.71 80.75 5.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.822 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 m -87.87 95.94 10.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.466 ' ND2' HD21 ' A' ' 101' ' ' LEU . 37.2 t-20 -62.07 123.13 17.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.845 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm -98.31 32.4 2.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -131.93 -46.07 0.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.959 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.0 m -108.66 17.69 21.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.266 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.0 t0 53.16 37.74 25.77 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.848 0.356 . . . . 0.0 111.169 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.488 ' CB ' HD23 ' A' ' 99' ' ' LEU . 3.1 mmt-85 -96.45 152.4 18.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.4 ttp -149.17 123.21 9.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.795 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.452 HG21 HD11 ' A' ' 99' ' ' LEU . 6.5 t -148.96 160.54 43.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.992 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.494 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 15.1 m80 -125.26 107.87 11.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 24.6 p -104.3 161.16 14.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.957 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.53 143.24 17.97 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.661 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 11.1 p -79.53 144.09 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 111.076 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.62 HD13 ' HG2' ' A' ' 42' ' ' LYS . 46.6 tp -116.89 -62.99 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.851 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -122.01 -179.65 4.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.661 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 49.6 m-85 -140.19 80.12 1.74 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.7 m -141.9 31.28 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.129 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.508 ' HB3' ' N ' ' A' ' 46' ' ' PRO . . . -89.85 172.51 8.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.062 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.78 162.37 13.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -60.75 126.1 26.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.89 29.99 76.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.518 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.584 HG23 ' CD2' ' A' ' 23' ' ' PHE . 26.2 mt -148.95 99.25 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.839 0.352 . . . . 0.0 111.169 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 39.0 m -102.68 135.15 44.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -99.53 131.4 45.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 mt -131.27 157.52 77.87 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.401 ' HD3' HG22 ' A' ' 43' ' ' ILE . 52.3 Cg_exo -52.9 -174.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.52 2.147 . . . . 0.0 112.35 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -98.36 -36.04 10.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.895 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 57.0 p-90 -64.97 -31.38 72.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -75.95 -34.16 59.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -37.68 81.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -32.7 52.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -68.58 -38.05 80.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.834 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.488 HD23 ' CB ' ' A' ' 73' ' ' ARG . 7.3 mt -90.73 -21.23 21.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.0 mt 61.26 65.35 0.99 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.898 0.38 . . . . 0.0 110.938 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.466 HD21 ' ND2' ' A' ' 68' ' ' ASN . 8.1 mt -118.84 -177.21 3.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.877 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -126.5 174.59 8.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.881 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -64.85 85.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.26 38.34 1.13 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.426 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.73 134.78 12.68 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.98 123.71 29.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 0.0 110.992 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.93 139.69 51.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.106 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -69.28 102.05 1.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -87.04 142.9 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.96 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -152.95 173.68 15.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.2 p -131.02 108.87 10.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.919 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.5 m -117.9 158.31 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.211 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -110.78 111.4 22.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.475 HD22 ' O ' ' A' ' 176' ' ' ALA . 8.5 mt -110.53 179.94 3.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.935 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.86 168.25 15.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.1 m -59.9 158.09 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.125 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.849 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -97.91 150.7 21.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.045 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.3 t -107.38 -31.28 8.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -132.27 90.76 2.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.2 m -103.69 104.89 14.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.835 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -94.57 146.85 23.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.674 ' CD2' HD21 ' A' ' 139' ' ' LEU . 87.5 m-85 -134.49 152.21 51.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -137.57 93.37 12.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -51.64 121.46 8.61 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.534 2.156 . . . . 0.0 112.297 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -74.14 -31.41 62.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.984 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -107.73 147.36 35.24 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.989 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.43 -15.3 27.93 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.642 2.228 . . . . 0.0 112.52 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.32 -40.22 70.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.103 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.532 ' CE2' HD11 ' A' ' 166' ' ' LEU . 13.6 t80 -70.73 -46.15 63.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.858 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 56.5 mt -59.84 -31.5 69.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -64.53 -25.64 68.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.073 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' ' 134' ' ' ASN . 46.8 mt -61.98 132.68 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.086 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.1 m -61.07 -34.27 74.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.934 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.591 ' H ' HG22 ' A' ' 132' ' ' ILE . 1.0 OUTLIER -120.58 79.97 30.55 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.809 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.64 -30.21 18.52 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.547 2.165 . . . . 0.0 112.295 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -73.72 -31.02 63.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' A' ' 134' ' ' ASN . . . -70.77 -48.71 52.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.15 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.474 HG21 HD13 ' A' ' 132' ' ' ILE . 21.6 t -61.89 -40.37 86.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.674 HD21 ' CD2' ' A' ' 122' ' ' PHE . 9.7 tp -65.41 -46.98 77.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -70.62 -30.91 67.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.966 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -67.58 -27.81 67.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.089 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.5 -26.16 14.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.35 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.3 mt -57.3 -39.47 75.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.117 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -27.62 64.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.05 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -73.54 -30.28 62.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.776 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -78.77 155.6 29.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.552 ' HB1' HD21 ' A' ' 63' ' ' LEU . . . -109.96 -30.51 7.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.536 ' SG ' HD13 ' A' ' 63' ' ' LEU . 1.3 m -145.37 170.77 15.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.932 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.4 mt -137.79 176.25 8.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.5 m -159.67 143.94 14.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.9 m -72.85 123.53 23.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.89 58.49 3.22 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -137.89 130.32 29.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.829 0.347 . . . . 0.0 110.859 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.58 98.52 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.056 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.589 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 14.6 pt -93.68 153.3 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 94' ' ' TRP . . . -119.34 148.31 43.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.067 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 pp -142.13 133.1 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -133.96 141.86 47.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -152.77 -47.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -99.46 45.19 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 61.05 34.34 19.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -152.12 130.43 12.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.804 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.422 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 3.8 mp -95.36 113.25 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.146 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -86.09 157.21 20.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.816 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.23 137.2 46.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.532 HD11 ' CE2' ' A' ' 129' ' ' PHE . 2.9 mt -154.41 134.61 13.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.829 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -126.27 131.39 51.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.503 HG22 ' CE1' ' A' ' 122' ' ' PHE . 27.7 t -72.37 121.1 22.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 18.2 mmm -81.51 -53.56 6.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.0 155.43 41.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.894 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.432 HG23 ' CG1' ' A' ' 168' ' ' VAL . 26.7 p -149.33 158.75 44.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -140.89 157.29 67.76 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.39 -42.24 0.82 Allowed 'Cis proline' 0 C--N 1.346 0.417 0 C-N-CA 123.3 -1.542 . . . . 0.0 112.437 -0.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.84 172.15 7.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.938 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.61 -44.38 89.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.956 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.494 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -102.93 119.04 38.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.849 HG21 ' HB2' ' A' ' 117' ' ' ALA . 16.1 m -127.78 155.68 39.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.16 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.7 t -106.77 95.11 5.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.0 pt -87.83 85.28 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.253 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.7 mm -116.51 86.52 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.102 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 61.4 80.58 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.941 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 9.1 t -159.19 151.08 20.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.811 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.23 127.0 40.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -135.46 173.16 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.83 79.46 5.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.06 138.92 21.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.063 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -137.28 172.3 13.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -134.17 133.85 41.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -117.87 90.31 3.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.069 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 m -139.22 156.85 46.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.7 p -104.51 90.71 3.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.73 -65.27 0.11 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.456 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.0 m 60.42 85.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.761 0.315 . . . . 0.0 110.854 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.56 -49.68 30.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -109.81 14.86 31.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.723 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.9 mt 56.98 73.6 0.78 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.342 . . . . 0.0 111.218 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.86 170.65 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.535 2.157 . . . . 0.0 112.29 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.86 32.43 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 m -109.38 124.01 65.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -134.53 -47.94 0.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -60.93 -177.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.954 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.14 111.79 23.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -173.16 159.82 3.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.428 ' HB2' HD13 ' A' ' 56' ' ' LEU . 10.8 t80 -69.65 120.34 15.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.9 p -151.63 102.11 2.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -165.61 171.61 12.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.86 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.643 ' HB3' HD22 ' A' ' 106' ' ' LEU . 15.8 mt-30 -96.56 156.91 16.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -145.49 148.13 32.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.25 112.11 14.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.507 ' HB3' ' HE3' ' A' ' 96' ' ' MET . 73.0 m -77.61 128.99 35.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.512 ' CD2' HG23 ' A' ' 88' ' ' ILE . 2.0 m-85 -135.41 172.21 13.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.08 163.39 24.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.9 m -81.1 -31.9 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.192 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.8 p -61.72 -30.07 70.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.8 mtt -58.28 -27.16 63.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.109 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.404 HD13 ' CE2' ' A' ' 90' ' ' TYR . 46.0 tp -57.08 156.01 7.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.96 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.05 177.3 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.084 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.78 150.09 12.08 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.534 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.56 -38.92 7.55 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.544 2.163 . . . . 0.0 112.269 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -114.04 169.18 9.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -104.11 128.96 51.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -72.86 132.32 43.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.983 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 79.6 p -107.67 -28.58 9.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.992 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -58.09 -35.1 70.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.022 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.1 t -61.31 -47.28 94.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.064 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.76 -31.2 70.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.902 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.0 mttp -82.65 60.3 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.91 -168.71 41.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.426 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.82 59.8 0.52 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.524 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.82 140.01 50.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.817 0.341 . . . . 0.0 110.853 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.84 HG21 HD23 ' A' ' 91' ' ' LEU . 11.8 pt -126.91 -179.97 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.8 mt -130.49 118.64 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 58.8 mtp -107.89 152.46 41.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.861 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.86 151.87 24.95 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.573 2.182 . . . . 0.0 112.253 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.27 -29.6 58.14 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.576 2.184 . . . . 0.0 112.311 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.1 p -59.76 -30.71 69.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.993 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.51 -39.1 82.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.164 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.483 HD13 ' CD2' ' A' ' 82' ' ' PHE . 12.5 tp -63.9 -43.78 94.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.25 -40.6 94.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.957 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -54.52 27.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.697 ' HA ' HD12 ' A' ' 56' ' ' LEU . 68.3 mt -57.68 -30.17 65.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.0 t -68.5 -29.76 68.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -92.56 -21.21 20.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.164 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.697 HD12 ' HA ' ' A' ' 53' ' ' LEU . 12.8 mt -77.42 -3.34 39.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.513 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.45 31.61 10.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.908 0.385 . . . . 0.0 110.912 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.9 mt -98.79 127.95 50.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.06 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -116.31 178.01 4.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.443 ' CD1' ' HA ' ' A' ' 61' ' ' PRO . 1.3 t80 -66.99 139.89 95.79 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.748 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.443 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.6 166.66 82.13 Favored 'Cis proline' 0 C--N 1.348 0.524 0 C-N-CA 123.517 -1.451 . . . . 0.0 112.411 -0.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 16.1 mtt -134.17 80.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.845 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.41 152.94 19.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.485 ' HB3' HG13 ' A' ' 109' ' ' VAL . 98.2 m-85 -114.5 159.31 20.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -112.4 95.62 5.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.894 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.4 mt -80.7 101.87 9.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -100.75 106.03 17.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.59 ' OD1' HD21 ' A' ' 101' ' ' LEU . 7.5 t30 -76.56 122.89 25.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -98.79 31.27 3.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.86 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.77 -37.08 4.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.803 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.28 25.92 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.016 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t70 56.2 36.82 28.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.114 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.77 153.59 21.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.4 ttp -144.19 131.96 21.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.485 HG21 HD11 ' A' ' 99' ' ' LEU . 2.6 t -150.89 131.89 14.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -107.89 115.59 30.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.5 p -115.88 176.61 5.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.35 135.81 8.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.456 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.1 p -72.34 146.02 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.366 . . . . 0.0 111.102 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.5 tp -118.18 -63.53 1.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -113.68 138.8 49.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.483 ' CD2' HD13 ' A' ' 50' ' ' LEU . 42.5 m-85 -103.51 72.96 1.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 83' ' ' VAL . 15.6 m -148.64 73.36 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.046 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.13 175.12 9.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.07 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -85.01 160.46 20.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.824 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -70.64 132.75 45.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.27 25.61 69.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.657 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.512 HG23 ' CD2' ' A' ' 23' ' ' PHE . 27.1 mt -148.66 82.24 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 111.149 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.53 130.52 35.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.404 ' CE2' HD13 ' A' ' 28' ' ' LEU . 27.4 m-85 -94.89 125.06 39.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.84 HD23 HG21 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -132.58 156.13 80.44 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.918 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.789 ' HD3' HG22 ' A' ' 43' ' ' ILE . 53.5 Cg_exo -52.37 -176.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.547 2.165 . . . . 0.0 112.34 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.13 -33.88 12.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.464 ' CH2' ' HE2' ' A' ' 95' ' ' MET . 66.3 p-90 -63.93 -33.19 75.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.464 ' HE2' ' CH2' ' A' ' 94' ' ' TRP . 17.2 ttm -71.66 -31.29 66.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . 0.507 ' HE3' ' HB3' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -73.21 -47.18 45.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.955 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -64.16 -41.45 97.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -62.69 -42.47 99.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.485 HD11 HG21 ' A' ' 75' ' ' THR . 17.1 mt -83.46 -16.89 43.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.193 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 100' ' ' LEU . 27.6 mt 61.09 34.45 19.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.816 0.341 . . . . 0.0 110.833 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.59 HD21 ' OD1' ' A' ' 68' ' ' ASN . 7.9 mt -84.05 -178.77 7.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.891 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -126.66 169.29 13.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -60.08 111.94 1.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.67 36.0 8.9 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.554 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.09 125.97 8.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.415 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.643 HD22 ' HB3' ' A' ' 19' ' ' GLN . 17.5 mt -77.81 129.24 35.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.9 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.2 135.01 58.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.041 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -60.43 121.93 13.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.485 HG13 ' HB3' ' A' ' 64' ' ' PHE . 21.5 t -116.11 135.81 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -139.17 132.13 29.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.21 96.42 5.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.8 m -109.72 146.16 15.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.18 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -108.58 110.04 21.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 mt -105.71 179.97 4.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.61 171.34 10.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.6 m -59.69 162.06 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.035 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.558 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -102.84 148.56 25.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 80.5 p -104.7 -31.51 9.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.795 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -140.48 111.24 6.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.843 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.1 m -121.65 120.42 34.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.932 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.488 ' O ' HG13 ' A' ' 168' ' ' VAL . 2.5 ttmm -101.72 137.53 39.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -121.17 152.0 39.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.932 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -137.71 93.6 12.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.922 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.65 119.13 4.34 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.556 2.17 . . . . 0.0 112.459 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 40.6 mm-40 -73.64 -33.01 64.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.3 t -104.4 147.38 34.28 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.667 ' HA ' HD12 ' A' ' 130' ' ' LEU . 57.9 Cg_endo -71.19 -17.76 31.03 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.58 2.187 . . . . 0.0 112.503 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.04 -45.0 79.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.006 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -69.33 -45.05 70.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.667 HD12 ' HA ' ' A' ' 127' ' ' PRO . 11.5 mt -59.79 -31.31 69.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.72 -25.91 66.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.986 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.589 HG22 ' H ' ' A' ' 134' ' ' ASN . 52.2 mt -59.97 136.54 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.013 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.0 t -69.34 -32.92 72.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.963 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.589 ' H ' HG22 ' A' ' 132' ' ' ILE . 1.9 m120 -125.1 79.02 66.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.968 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.91 -27.94 20.35 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.569 2.18 . . . . 0.0 112.346 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -65.91 -44.93 83.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.56 -38.78 92.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.123 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 134' ' ' ASN . 26.8 t -72.04 -40.9 67.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.772 HD12 HD13 ' A' ' 166' ' ' LEU . 3.8 tp -72.81 -33.86 66.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.007 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -76.27 -30.23 57.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.986 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -75.37 -30.61 60.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.08 -34.41 17.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.169 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.411 HD22 HD11 ' A' ' 149' ' ' LEU . 14.2 mt -59.53 -27.97 66.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.963 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -57.01 -29.15 63.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.071 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -78.73 -36.63 43.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.976 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.428 ' CZ ' ' HB ' ' A' ' 155' ' ' ILE . 61.3 m-85 -67.48 143.23 56.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.952 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -110.01 -25.34 10.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.178 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 12.2 t -137.46 159.26 42.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.984 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.411 HD11 HD22 ' A' ' 143' ' ' LEU . 25.2 mt -151.32 139.0 19.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.2 m -123.3 160.24 27.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.984 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.8 m -72.97 103.22 3.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 97.83 36.77 4.65 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.54 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -104.5 108.28 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.352 . . . . 0.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 32.6 t -69.59 86.35 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.061 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.428 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 8.2 pt -93.41 131.41 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.136 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -100.06 142.49 31.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.163 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 40.5 pt -127.83 152.74 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -144.19 136.45 26.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.406 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 3.6 p90 -150.71 -50.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -96.78 44.35 1.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 60.29 31.24 20.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -145.12 137.64 26.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.528 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.8 mp -93.82 105.71 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.147 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -91.97 119.38 31.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.02 125.23 28.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.974 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.772 HD13 HD12 ' A' ' 139' ' ' LEU . 1.9 mt -134.14 128.91 35.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.812 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -122.44 133.73 54.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.942 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 121' ' ' LYS . 19.9 t -78.26 139.73 18.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.032 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 56.3 mmm -100.67 -48.3 4.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.987 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.05 153.51 46.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.022 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.444 HG23 HG11 ' A' ' 168' ' ' VAL . 0.9 OUTLIER -148.83 158.18 43.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.805 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -138.1 153.94 73.72 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.04 -34.11 3.55 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 123.204 -1.582 . . . . 0.0 112.448 0.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.52 178.41 4.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -47.67 84.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -99.02 130.55 45.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.558 HG21 ' HB2' ' A' ' 117' ' ' ALA . 31.0 m -134.3 161.58 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.205 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.3 t -119.38 94.57 4.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.8 pt -81.17 83.4 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 35.1 mt -116.01 84.98 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.075 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.37 87.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -159.76 176.56 11.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.802 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.22 107.14 13.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -126.41 179.24 5.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -117.12 121.77 42.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.505 HG11 ' CD2' ' A' ' 139' ' ' LEU . 21.4 t -99.16 122.12 50.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.137 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.76 179.88 4.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.903 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -130.54 157.92 41.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -144.34 87.43 1.88 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.025 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.71 175.27 8.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 0.0 110.891 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.11 -46.37 0.93 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.56 54.32 0.37 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.503 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 92.2 p -135.91 141.01 44.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 110.956 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 m -152.88 163.72 39.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 154.99 149.4 5.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.433 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.9 mt -138.75 95.75 9.71 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.575 0.226 . . . . 0.0 111.136 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.77 123.5 10.8 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.496 2.131 . . . . 0.0 112.329 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.8 ttp85 60.78 92.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.946 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.54 83.97 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.174 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 61.15 100.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 59.18 177.7 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.976 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.43 ' HA ' HD22 ' A' ' 56' ' ' LEU . 2.5 m120 -124.38 45.95 2.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.813 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.81 139.24 34.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.844 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -76.91 104.79 7.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.2 p -137.75 94.97 2.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.91 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.6 t -156.85 174.93 14.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.914 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -102.61 152.79 20.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.945 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -146.98 147.22 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.6 mtt85 -74.68 135.45 41.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.973 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 76.2 m -97.24 132.35 43.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -145.45 157.89 43.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -81.03 161.9 24.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.937 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.6 m -65.41 -31.41 53.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.188 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.7 m -60.15 -31.69 70.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.39 -27.32 68.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.068 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.732 HD13 ' CE2' ' A' ' 90' ' ' TYR . 53.9 tp -56.72 -63.5 1.18 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.979 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.46 -59.79 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.44 149.82 19.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.53 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.84 -45.38 1.02 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.564 2.176 . . . . 0.0 112.282 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -134.4 127.61 31.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -142.92 114.41 7.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.938 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.1 mmm-85 60.39 168.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -112.49 30.45 7.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.946 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.57 -33.78 5.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.051 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.22 -56.68 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.202 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.85 -34.95 51.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.947 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -81.59 100.62 9.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.5 -147.77 19.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.505 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.37 52.69 0.58 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.475 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.76 160.73 20.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.804 0.335 . . . . 0.0 110.917 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.577 HG21 HD23 ' A' ' 91' ' ' LEU . 6.0 pt -145.48 177.51 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.058 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.543 HG22 ' HB2' ' A' ' 84' ' ' ALA . 32.5 mt -122.81 137.86 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.123 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -131.22 160.04 68.87 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.844 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.59 162.68 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.567 2.178 . . . . 0.0 112.321 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.26 -33.48 24.11 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.606 2.204 . . . . 0.0 112.277 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.9 p -60.34 -34.55 73.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.34 -39.62 87.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.424 HD13 ' CE1' ' A' ' 82' ' ' PHE . 39.3 tp -64.24 -42.84 96.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.977 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.3 -30.64 60.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -79.32 -41.77 27.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.059 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.469 HD22 ' SD ' ' A' ' 62' ' ' MET . 3.0 mt -53.52 -49.63 67.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.0 t -72.31 -28.51 63.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.887 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.37 -21.23 62.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 14' ' ' ASN . 70.3 mt -94.07 20.19 8.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.327 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 59.52 30.88 20.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.02 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.438 ' CD1' HD23 ' A' ' 53' ' ' LEU . 35.1 mt -93.07 124.31 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.126 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.444 HG22 ' N ' ' A' ' 60' ' ' TYR . 50.0 m -111.63 162.11 15.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.981 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.479 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -59.51 144.15 84.92 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.79 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.479 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 75.5 Cg_endo -77.23 167.45 79.54 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.539 -1.442 . . . . 0.0 112.409 0.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.469 ' SD ' HD22 ' A' ' 53' ' ' LEU . 63.9 mtt -129.33 66.98 1.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.818 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.668 HD23 ' CA ' ' A' ' 78' ' ' GLY . 2.5 mt -91.07 148.68 22.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.921 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.435 ' HZ ' HD11 ' A' ' 53' ' ' LEU . 60.2 m-85 -113.57 135.64 53.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.804 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -83.49 89.65 7.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.893 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.675 ' HB2' HG23 ' A' ' 75' ' ' THR . 15.6 mt -69.99 76.35 0.48 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -87.36 109.4 19.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.908 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -84.79 117.62 23.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -98.57 33.94 2.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.84 -44.21 1.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.936 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.8 m -120.25 20.99 11.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.175 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.7 t0 53.6 60.0 3.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.944 0.402 . . . . 0.0 111.117 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.502 ' CB ' HD23 ' A' ' 99' ' ' LEU . 4.7 mmt180 -112.11 164.35 13.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.945 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.3 ttp -159.49 130.61 6.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.689 HG21 HD11 ' A' ' 99' ' ' LEU . 5.0 t -158.38 170.77 21.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -138.18 117.01 12.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.923 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 9.4 p -122.36 153.48 38.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.818 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.668 ' CA ' HD23 ' A' ' 63' ' ' LEU . . . -116.98 127.85 7.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.507 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.524 HG21 ' CE2' ' A' ' 82' ' ' PHE . 10.6 p -66.71 130.6 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 0.0 111.064 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.9 tp -106.91 -56.33 2.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -106.77 155.69 19.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.524 ' CE2' HG21 ' A' ' 79' ' ' VAL . 87.1 m-85 -130.43 82.9 2.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 82' ' ' PHE . 16.1 m -157.39 31.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.169 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.543 ' HB2' HG22 ' A' ' 44' ' ' ILE . . . -86.58 167.86 14.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.11 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.525 ' HB3' HD12 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -73.38 159.35 33.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -66.06 107.29 1.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.26 28.32 30.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.426 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 85' ' ' ASP . 27.7 mt -145.81 98.16 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.843 0.354 . . . . 0.0 111.112 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 94.6 m -94.27 132.54 38.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.732 ' CE2' HD13 ' A' ' 28' ' ' LEU . 54.6 m-85 -95.06 127.27 40.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.577 HD23 HG21 ' A' ' 43' ' ' ILE . 1.1 mt -126.27 153.08 74.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.862 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.419 ' HD3' HG22 ' A' ' 43' ' ' ILE . 51.1 Cg_exo -53.41 -173.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.587 2.191 . . . . 0.0 112.244 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -92.57 -40.32 10.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -66.76 -45.43 78.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -33.41 75.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.932 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -39.21 80.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -78.41 -33.98 48.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -60.32 -39.88 88.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.773 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.689 HD11 HG21 ' A' ' 75' ' ' THR . 6.1 mt -87.8 -13.92 40.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.276 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.7 mt 61.93 37.14 15.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.814 0.34 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.3 mt -80.35 -178.53 6.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -130.04 167.85 17.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.86 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -62.73 84.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.944 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.33 33.96 1.4 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.463 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.32 131.73 10.87 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.474 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.1 mt -85.81 129.81 34.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.834 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.28 149.03 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.208 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -64.9 120.44 12.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.47 88.43 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.13 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -102.44 140.98 36.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.98 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.2 p -96.97 106.85 19.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.3 m -118.3 160.78 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -120.9 120.14 34.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.497 HD13 ' C ' ' A' ' 176' ' ' ALA . 10.8 mt -114.49 177.2 4.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.859 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -122.98 170.44 10.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.901 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.15 133.73 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.162 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.874 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -75.91 162.24 28.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.9 p -120.49 -41.42 2.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.946 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -122.02 91.96 3.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.8 m -108.03 120.65 42.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.2 156.26 17.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.964 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.463 ' CE2' HG22 ' A' ' 168' ' ' VAL . 69.9 m-85 -141.56 155.52 45.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -136.76 89.3 17.87 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -51.43 114.59 1.63 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.531 2.154 . . . . 0.0 112.314 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -69.93 -32.01 70.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.0 t -98.85 144.44 28.18 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.59 -19.77 21.2 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.572 2.181 . . . . 0.0 112.484 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -55.13 -36.53 65.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.093 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -71.13 -42.16 69.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 64.3 mt -63.41 -31.46 72.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.12 -23.32 65.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.05 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 134' ' ' ASN . 57.4 mt -59.99 141.59 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.056 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.3 m -67.23 -42.56 83.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.975 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.42 ' H ' HG22 ' A' ' 132' ' ' ILE . 2.5 m120 -125.84 74.91 71.05 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.001 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -57.09 -31.49 90.47 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.613 2.209 . . . . 0.0 112.235 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -43.26 99.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.957 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.66 84.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.19 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.403 HG21 HD13 ' A' ' 132' ' ' ILE . 27.8 t -67.73 -45.12 85.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.762 HD22 ' CZ ' ' A' ' 188' ' ' PHE . 21.0 tp -59.96 -31.25 69.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.016 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -87.24 -30.74 20.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.01 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.52 -31.3 71.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.947 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.26 -33.06 17.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.483 HD22 HD11 ' A' ' 149' ' ' LEU . 14.3 mt -59.3 -25.42 64.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -56.25 -33.64 65.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.031 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -77.73 -34.4 52.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -69.13 137.61 53.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -102.4 -28.07 12.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.191 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 12.9 t -141.61 159.23 42.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.483 HD11 HD22 ' A' ' 143' ' ' LEU . 7.6 mt -141.39 119.58 12.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.7 m -111.17 138.45 47.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.9 m -62.4 123.05 17.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 94.4 49.82 2.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.472 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.35 132.63 35.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.816 0.341 . . . . 0.0 110.825 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.78 89.24 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 29.7 pt -80.21 141.99 14.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.178 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -114.08 98.05 6.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.044 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.8 pt -83.52 148.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.234 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -151.03 151.36 31.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.737 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -176.43 -40.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.989 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -105.28 43.36 1.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.929 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 57.42 30.04 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.057 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -144.98 120.44 10.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.575 ' H ' HD12 ' A' ' 163' ' ' ILE . 4.4 mp -84.65 89.65 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.056 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -70.86 120.5 16.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -74.65 134.47 42.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.43 160.33 41.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.778 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 44.6 ttt-85 -152.12 121.62 6.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.463 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.4 t -62.93 138.07 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.2 mmm -103.82 -56.42 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -137.83 158.49 44.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.978 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 71.4 p -154.51 138.9 16.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -121.73 155.77 59.66 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.71 -26.33 9.52 Favored 'Cis proline' 0 C--N 1.347 0.471 0 C-N-CA 123.324 -1.532 . . . . 0.0 112.428 -0.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -120.74 170.9 9.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -37.35 76.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.963 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.497 ' C ' HD13 ' A' ' 114' ' ' LEU . . . -102.68 117.64 35.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.043 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.874 HG21 ' HB2' ' A' ' 117' ' ' ALA . 15.6 m -137.85 142.87 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 3.8 t -98.2 105.69 17.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.6 pt -95.37 87.84 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.12 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 22.0 mt -116.23 84.35 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.093 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 60.29 88.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.34 175.18 14.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.854 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.16 110.98 20.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.839 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -131.91 179.56 6.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -113.41 110.64 20.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.68 143.69 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.04 177.85 4.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' PHE . . . . . 0.762 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 7.9 m-85 -140.04 141.65 36.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.874 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.3 106.21 14.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.926 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.051 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.3 t 60.35 174.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.916 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.41 90.63 2.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.956 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.84 -164.49 24.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.553 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.4 t -106.56 86.75 2.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.323 . . . . 0.0 110.855 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.93 -31.24 7.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.64 177.2 37.82 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.462 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 9' ' ' PRO . 2.6 pp -67.11 158.74 80.28 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.696 0.284 . . . . 0.0 111.149 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.662 ' O ' HD12 ' A' ' 8' ' ' ILE . 54.0 Cg_exo -52.01 144.09 38.15 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.551 2.167 . . . . 0.0 112.368 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.19 146.0 27.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 m -143.57 48.15 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.082 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 61.24 82.49 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.855 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.76 -46.92 0.49 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.967 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 60.5 99.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.824 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -148.54 109.81 4.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.417 ' CE2' HG22 ' A' ' 18' ' ' THR . 59.9 t80 -59.86 122.52 14.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.96 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.6 p -143.41 115.97 8.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.417 HG22 ' CE2' ' A' ' 16' ' ' PHE . 9.0 t -176.41 162.15 2.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -94.6 150.35 20.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.765 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -142.47 137.93 30.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -72.92 115.05 11.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.467 ' HB2' HD12 ' A' ' 91' ' ' LEU . 24.2 p -85.37 136.18 33.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.967 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.746 ' CD2' HG23 ' A' ' 88' ' ' ILE . 84.7 m-85 -138.99 170.98 15.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.89 146.49 28.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.931 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.1 m -63.47 -26.45 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.225 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.3 t -55.91 -28.64 57.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.079 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -58.05 -27.42 63.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.002 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.3 tp -57.37 -35.52 70.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.948 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.26 -178.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 138.36 147.66 5.21 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.534 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.13 -44.25 50.38 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.623 2.215 . . . . 0.0 112.278 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -97.19 -177.82 3.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.878 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.62 162.36 32.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.421 ' HB3' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -130.09 150.55 51.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 p -115.86 -38.47 3.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -59.59 -28.65 67.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.018 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 34' ' ' ARG . 40.4 t -61.61 -33.69 58.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.056 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -91.73 -32.08 15.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -84.58 92.44 8.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.49 168.6 11.76 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.441 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.02 56.59 3.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.513 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.68 ' HG2' HD13 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -115.86 134.54 54.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.9 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.632 HD13 ' SG ' ' A' ' 77' ' ' CYS . 44.9 pt -128.8 175.31 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.215 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mp -128.98 117.48 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.203 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 14.7 mtp -115.93 163.88 19.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.831 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -51.78 152.89 12.43 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.517 2.145 . . . . 0.0 112.269 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.44 -27.3 40.02 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.541 2.161 . . . . 0.0 112.337 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 95.2 p -63.74 -30.81 71.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.6 -40.43 96.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.742 HD13 ' CD2' ' A' ' 82' ' ' PHE . 23.2 tp -59.7 -40.45 87.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.975 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.35 -30.03 67.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.993 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -84.95 -30.65 24.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.937 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.8 mt -59.39 -30.72 68.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.015 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.5 -30.08 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.044 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -21.95 66.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.23 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.0 mt -93.88 18.37 10.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.392 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 53.94 42.11 31.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.812 0.339 . . . . 0.0 111.167 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.0 mt -107.44 133.59 51.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.126 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.29 169.03 10.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.969 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.47 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -59.92 142.39 88.81 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.7 Cg_endo -77.02 165.82 84.05 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.457 -1.476 . . . . 0.0 112.412 -0.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 65.0 mtt -131.42 51.68 2.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.698 HD22 ' HB2' ' A' ' 148' ' ' CYS . 16.1 mt -68.13 142.08 55.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.918 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' HB3' HG13 ' A' ' 109' ' ' VAL . 97.2 m-85 -109.57 139.06 45.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.769 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.4 ' HD3' ' CE1' ' A' ' 76' ' ' HIS . 0.9 OUTLIER -93.08 96.65 10.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 34.3 mt -80.9 81.38 7.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.978 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.65 108.48 18.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -70.36 123.96 23.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.848 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -98.52 32.19 2.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -124.95 -45.5 1.87 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.943 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.6 t -121.63 17.85 11.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.208 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 52.66 59.9 4.17 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.863 0.364 . . . . 0.0 111.073 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.44 177.66 4.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 37.4 ttp -156.22 129.44 8.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.7 m -150.82 137.46 18.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.427 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 6.8 m80 -112.38 108.7 17.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.632 ' SG ' HD13 ' A' ' 43' ' ' ILE . 31.2 p -109.8 166.66 10.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.98 136.75 11.11 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.428 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.883 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 11.1 p -75.84 148.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.791 0.329 . . . . 0.0 111.168 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.68 HD13 ' HG2' ' A' ' 42' ' ' LYS . 20.2 tp -122.09 -63.47 1.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.871 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -109.66 -179.46 3.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.883 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 57.5 m-85 -150.19 79.97 1.36 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.6 m -148.71 31.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.66 167.08 13.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.143 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.493 ' HB2' HD12 ' A' ' 88' ' ' ILE . 1.2 m-20 -71.06 177.68 3.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -84.82 89.7 7.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 105.74 28.19 5.45 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.519 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.746 HG23 ' CD2' ' A' ' 23' ' ' PHE . 31.8 mt -141.45 82.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.845 0.355 . . . . 0.0 111.057 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 90.6 m -82.77 131.4 35.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.987 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.469 ' O ' HD23 ' A' ' 91' ' ' LEU . 59.3 m-85 -98.55 145.0 27.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 90' ' ' TYR . 17.6 mt -143.29 149.75 49.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.905 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.478 ' HD3' HG22 ' A' ' 43' ' ' ILE . 53.7 Cg_exo -52.13 178.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.574 2.183 . . . . 0.0 112.372 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -85.74 -40.66 15.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 69.3 p-90 -63.25 -35.89 81.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.846 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 37.0 ttm -70.54 -40.86 73.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 4.6 mtt -60.39 -46.58 89.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.942 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -64.64 -33.46 75.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -66.72 -40.55 88.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.825 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.3 mt -84.85 -21.57 29.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.091 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.5 mt 64.4 34.85 10.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 0.0 110.947 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.8 mt -83.87 -179.58 7.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -118.56 -178.02 3.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -71.8 85.04 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.401 ' HA2' ' CZ ' ' A' ' 23' ' ' PHE . . . 112.86 30.51 2.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.549 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.58 145.53 30.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.532 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.4 mt -96.72 123.47 40.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 0.0 110.953 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.77 131.6 72.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.084 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -64.57 100.22 0.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.413 HG13 ' HB3' ' A' ' 64' ' ' PHE . 21.9 t -83.89 126.29 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -134.6 118.35 17.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.2 p -76.92 116.93 18.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.843 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.4 m -121.24 170.15 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.221 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.03 106.38 9.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.795 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mt -106.9 170.68 7.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -115.56 179.96 3.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.2 m -69.48 141.65 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.716 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -83.71 141.68 31.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.088 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 71.5 p -99.75 -31.11 11.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -140.36 107.61 5.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.931 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 96.4 p -120.46 118.33 30.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -103.04 160.06 14.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -141.88 153.49 44.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.91 89.57 29.28 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.008 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.707 ' HG3' HD21 ' A' ' 166' ' ' LEU . 68.5 Cg_exo -50.97 111.06 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.557 2.171 . . . . 0.0 112.401 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -61.49 -31.33 71.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.9 t -98.69 143.21 25.94 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.829 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.82 -20.26 17.48 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.567 2.178 . . . . 0.0 112.395 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.49 -39.65 70.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.042 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.47 ' HE2' HD11 ' A' ' 157' ' ' ILE . 11.0 t80 -64.66 -44.52 90.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.923 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.7 mt -59.71 -30.99 69.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -67.88 -23.74 65.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.024 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.1 mt -59.94 136.59 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.039 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.9 m -61.65 -49.16 77.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.994 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -118.17 82.65 18.42 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.39 -32.37 10.24 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.573 2.182 . . . . 0.0 112.319 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -33.75 75.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.31 -47.56 27.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.103 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.2 t -66.77 -30.57 50.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.146 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 49.8 tp -77.99 -45.59 23.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.937 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.17 -31.31 70.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -64.75 -28.43 69.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.67 -32.42 18.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.106 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.479 HD22 HD11 ' A' ' 149' ' ' LEU . 34.7 mt -59.54 -28.87 67.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.044 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -57.73 -27.16 62.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.094 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -79.0 -41.23 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.921 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.422 ' CZ ' ' HB ' ' A' ' 155' ' ' ILE . 97.0 m-85 -71.32 130.36 41.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -88.79 -33.37 17.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.698 ' HB2' HD22 ' A' ' 63' ' ' LEU . 15.0 t -126.42 158.9 34.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.899 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.479 HD11 HD22 ' A' ' 143' ' ' LEU . 4.2 mt -142.1 125.28 16.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 m -119.0 148.16 43.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 169' ' ' MET . 66.0 m -75.37 128.25 34.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.98 28.08 19.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.555 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -118.81 138.6 52.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.2 t -96.8 104.12 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.126 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 3.1 pt -102.28 89.73 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.153 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.17 134.33 55.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.47 HD11 ' HE2' ' A' ' 129' ' ' PHE . 3.2 pt -121.49 157.43 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.11 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -143.29 155.06 44.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -175.13 -46.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -100.82 43.14 1.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 59.21 30.22 19.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.959 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.37 122.23 9.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.817 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.509 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.8 mp -81.11 88.87 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.099 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -65.79 131.85 47.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.823 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -90.05 113.11 24.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.707 HD21 ' HG3' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -128.55 140.05 51.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.812 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -131.01 134.66 46.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.78 147.36 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.542 ' O ' HG23 ' A' ' 151' ' ' THR . 1.4 mmt -110.12 -61.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.63 152.38 50.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.963 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 43.5 p -150.3 143.64 25.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -120.35 151.95 54.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.19 -38.34 1.8 Allowed 'Cis proline' 0 C--N 1.346 0.427 0 C-N-CA 123.376 -1.51 . . . . 0.0 112.367 0.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -108.64 175.4 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.787 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.52 -47.78 78.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.998 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.427 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -94.18 131.02 40.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.716 HG21 ' HB2' ' A' ' 117' ' ' ALA . 7.8 m -143.33 155.3 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.177 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.451 ' OG ' HD11 ' A' ' 63' ' ' LEU . 2.8 t -112.39 99.82 8.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.827 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.2 pt -88.98 85.72 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.165 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 20.8 mt -116.46 96.06 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 60.75 66.1 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 7.3 t -155.51 154.91 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.93 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -101.71 135.8 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.933 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -137.21 155.47 49.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.7 76.12 7.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.5 125.82 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.144 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.95 167.11 11.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -120.46 127.7 52.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -98.99 96.87 8.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.095 -179.981 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -139.0 165.25 27.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.782 0.325 . . . . 0.0 110.903 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.9 105.08 5.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.85 115.68 3.95 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.451 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -90.3 107.74 19.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.3 p -103.89 105.84 16.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.17 -155.4 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.462 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.423 HG23 ' HD2' ' A' ' 9' ' ' PRO . 8.5 mt -120.19 135.95 24.77 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.62 0.247 . . . . 0.0 110.996 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 8' ' ' ILE . 59.6 Cg_endo -72.23 -167.0 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.5 2.133 . . . . 0.0 112.391 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 64.48 173.2 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.1 m -63.23 178.19 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.3 31.1 6.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.15 124.78 50.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -118.8 160.72 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -151.42 114.18 4.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.966 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -60.47 98.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.8 p -130.53 133.98 46.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.852 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.8 t -177.1 169.41 2.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -99.6 125.31 45.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -123.64 152.4 42.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 -84.66 130.19 34.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.9 m -93.66 130.45 39.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.97 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -133.15 171.12 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -85.12 164.34 18.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.643 HG11 HG11 ' A' ' 37' ' ' VAL . 16.0 m -90.47 11.67 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.473 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.9 p -76.46 -27.76 56.29 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.722 0.296 . . . . 0.0 110.824 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 46.1 mtp -57.89 -48.39 79.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.898 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.31 86.01 6.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.59 -178.16 3.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.1 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -172.75 -164.91 28.96 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.519 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.7 -45.97 1.43 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.593 2.196 . . . . 0.0 112.32 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -86.48 175.62 8.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.947 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -110.77 113.9 26.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.01 125.17 33.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.5 m -137.13 32.14 2.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.83 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -111.33 -29.55 7.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.998 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.643 HG11 HG11 ' A' ' 25' ' ' VAL . 20.8 t -62.03 -29.48 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.275 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.405 ' O ' ' CD1' ' A' ' 94' ' ' TRP . 9.3 mt-10 -82.51 -30.68 29.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.073 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.2 mttm -87.39 -30.62 20.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.009 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.03 -179.93 38.39 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.575 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.12 63.04 0.48 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.528 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.91 153.09 51.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.756 0.312 . . . . 0.0 110.847 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.652 HG21 HD23 ' A' ' 91' ' ' LEU . 10.7 pt -136.89 177.7 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.218 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.9 mt -126.19 114.98 40.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 76.8 mtp -108.74 164.16 15.36 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.819 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 52.6 Cg_exo -54.8 144.94 63.74 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.584 2.189 . . . . 0.0 112.147 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 46' ' ' PRO . 50.9 Cg_exo -54.06 -28.3 49.8 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.448 2.098 . . . . 0.0 112.338 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.0 t -65.44 -29.72 70.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.043 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.13 -48.27 80.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.15 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.701 HD13 ' CE2' ' A' ' 82' ' ' PHE . 25.1 tp -60.49 -43.5 96.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.35 -31.4 69.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -44.58 69.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.999 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 50' ' ' LEU . 5.1 mt -58.19 -30.14 66.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.009 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.3 m -73.84 -26.25 60.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -94.96 20.14 9.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.318 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -134.04 20.02 3.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.219 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 56.18 30.19 16.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.809 0.338 . . . . 0.0 111.013 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.8 mt -100.43 130.28 49.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.77 164.86 15.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.931 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.451 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.6 t80 -64.44 140.81 98.07 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.787 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 76.9 Cg_endo -77.46 164.46 86.41 Favored 'Cis proline' 0 C--N 1.348 0.511 0 C-N-CA 123.487 -1.464 . . . . 0.0 112.473 -0.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 34.2 mtt -135.04 64.65 1.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.803 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.734 HD13 ' SG ' ' A' ' 148' ' ' CYS . 1.1 mt -70.7 165.05 23.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.984 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -132.78 126.23 31.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.409 ' HG3' ' CD2' ' A' ' 76' ' ' HIS . 15.7 ttpt -83.09 112.7 20.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.4 mt -91.71 82.88 5.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.814 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.7 m -86.16 99.6 11.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.481 ' HA ' HG13 ' A' ' 107' ' ' VAL . 26.0 t-20 -62.22 125.18 23.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.5 33.91 2.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.36 -48.27 1.57 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.816 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.2 m -118.18 21.69 12.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.209 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 t0 54.16 35.14 21.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.833 0.349 . . . . 0.0 111.077 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -84.37 162.09 20.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.969 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.78 127.05 13.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.477 ' OG1' HD21 ' A' ' 99' ' ' LEU . 55.8 m -152.93 131.39 12.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.616 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 49.5 m80 -104.48 106.41 16.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.5 p -93.49 174.52 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.25 138.79 10.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.443 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.574 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 10.9 p -84.81 158.41 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.846 0.355 . . . . 0.0 111.055 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.485 ' N ' HG22 ' A' ' 79' ' ' VAL . 16.6 tp -151.56 -58.28 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -104.88 147.36 27.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.701 ' CE2' HD13 ' A' ' 50' ' ' LEU . 97.2 m-85 -125.31 86.72 2.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.2 m -155.91 32.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.109 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.38 165.59 12.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -83.47 165.11 19.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -64.08 121.73 14.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.43 33.7 68.13 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.555 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 26.5 mt -148.46 95.15 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 111.095 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 98.0 m -98.12 126.93 43.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.964 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -89.9 129.45 36.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.652 HD23 HG21 ' A' ' 43' ' ' ILE . 1.4 mp -136.29 155.34 77.34 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.02 -174.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.509 2.139 . . . . 0.0 112.354 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -94.55 -36.05 11.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.608 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 59.1 p-90 -64.34 -37.03 86.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.898 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.45 ' O ' HD12 ' A' ' 99' ' ' LEU . 56.4 ttm -71.24 -39.12 71.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 36.5 mmm -64.57 -45.2 88.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -39.44 68.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -59.61 -31.9 69.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.477 HD21 ' OG1' ' A' ' 75' ' ' THR . 6.4 mt -98.13 -8.84 26.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.342 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.4 mt 63.03 33.6 14.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.849 0.357 . . . . 0.0 110.885 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.6 mt -92.17 130.32 37.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.831 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -84.15 179.07 7.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.79 94.35 0.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.43 41.53 1.48 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.564 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.58 119.92 6.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.569 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.8 mt -73.62 126.57 30.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.838 0.351 . . . . 0.0 110.878 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.481 HG13 ' HA ' ' A' ' 68' ' ' ASN . 21.6 t -127.43 143.62 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.126 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -67.33 104.65 1.55 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.35 136.32 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -141.97 148.2 38.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.3 p -104.68 115.16 29.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.4 m -131.13 173.05 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.078 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.81 100.07 4.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.444 ' CD1' ' HB1' ' A' ' 176' ' ' ALA . 5.0 mt -89.19 -179.95 5.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -123.91 170.23 10.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -64.36 143.96 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.15 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.519 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -83.28 156.37 23.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.181 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.2 p -117.64 -39.94 3.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.943 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -125.22 85.68 2.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.42 ' OG ' HG22 ' A' ' 171' ' ' THR . 35.2 m -100.32 120.43 39.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.859 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -109.53 149.59 29.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 143' ' ' LEU . 89.5 m-85 -134.46 164.03 28.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.84 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -148.43 90.06 5.0 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.13 126.21 19.64 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.486 2.124 . . . . 0.0 112.313 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -73.35 -32.03 64.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.6 m -105.61 148.32 36.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.5 -12.59 27.21 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.586 2.19 . . . . 0.0 112.53 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -55.18 -41.71 72.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.034 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.416 ' CE1' HD11 ' A' ' 166' ' ' LEU . 12.6 t80 -70.67 -35.37 72.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.892 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 26.5 mt -66.68 -29.71 69.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.31 -26.04 68.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.008 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.755 HD13 HG21 ' A' ' 138' ' ' VAL . 47.5 mt -63.13 138.76 22.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.986 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.4 t -66.58 -39.65 88.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.992 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.472 ' H ' HG22 ' A' ' 132' ' ' ILE . 9.2 t30 -126.68 80.49 70.21 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.17 -36.1 92.39 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.542 2.161 . . . . 0.0 112.31 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -59.69 -35.7 75.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.47 -37.34 80.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.2 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.755 HG21 HD13 ' A' ' 132' ' ' ILE . 21.4 t -82.75 -31.69 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.274 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.556 HD21 ' CD1' ' A' ' 122' ' ' PHE . 32.0 tp -75.2 -39.0 60.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.52 -31.35 68.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -66.19 -31.14 71.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.96 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.08 -41.35 13.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.149 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.579 HD11 ' CZ ' ' A' ' 122' ' ' PHE . 15.6 mt -59.41 -27.56 66.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.999 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -56.97 -29.94 63.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.053 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.09 -46.0 18.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.865 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -61.1 134.26 56.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -98.48 -28.63 13.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.734 ' SG ' HD13 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -133.65 166.72 21.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.873 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.573 HD22 HG21 ' A' ' 168' ' ' VAL . 11.8 mt -158.19 147.34 19.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.42 132.08 40.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.0 m -59.99 107.1 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.942 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 112.44 28.87 3.36 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.505 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -122.67 134.28 54.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.774 0.321 . . . . 0.0 110.871 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.13 114.79 29.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.106 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.608 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 7.2 pt -112.87 118.5 58.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.38 141.6 33.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.066 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.6 pt -135.04 147.27 29.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.108 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -143.06 156.46 44.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.439 ' CE2' ' HB2' ' A' ' 160' ' ' ASN . 47.9 p90 -175.29 -44.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.872 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.439 ' HB2' ' CE2' ' A' ' 159' ' ' TYR . 41.0 t30 -101.5 40.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 60.29 31.15 20.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -152.03 134.85 15.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.567 ' H ' HD12 ' A' ' 163' ' ' ILE . 4.0 mp -85.23 105.93 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -89.47 111.52 22.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.2 138.5 57.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.416 HD11 ' CE1' ' A' ' 129' ' ' PHE . 0.5 OUTLIER -156.56 118.05 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -115.79 137.48 52.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.573 HG21 HD22 ' A' ' 149' ' ' LEU . 21.5 t -73.97 109.01 5.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.2 mmm -76.64 -47.01 23.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.13 155.94 43.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.979 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.42 HG22 ' OG ' ' A' ' 120' ' ' SER . 0.5 OUTLIER -160.06 132.9 6.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.763 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -108.88 158.16 34.92 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.69 -26.72 9.1 Favored 'Cis proline' 0 C--N 1.347 0.454 0 C-N-CA 123.31 -1.538 . . . . 0.0 112.414 -0.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -125.74 179.46 5.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -47.83 84.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.616 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -91.04 124.33 35.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.0 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 117' ' ' ALA . 9.2 m -140.74 152.57 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.8 t -113.23 98.95 7.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.2 pt -88.1 85.09 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.184 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.0 mm -113.61 89.19 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.12 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 61.1 77.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.818 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 13.9 t -163.16 149.91 12.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -101.32 131.16 47.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.926 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -136.11 170.98 15.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -91.43 97.73 11.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 29.2 t -84.26 139.69 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.084 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.09 175.24 5.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.844 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -141.56 148.44 39.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -135.87 90.49 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.138 179.939 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m 60.47 -173.84 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.843 0.354 . . . . 0.0 110.896 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 p -159.72 169.96 22.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.941 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.75 -132.81 1.59 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.507 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -63.0 112.76 2.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 0.0 110.863 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -159.12 164.74 35.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 150.88 -170.63 30.66 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.512 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 pt -66.93 150.91 97.55 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.736 0.303 . . . . 0.0 111.105 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.76 167.19 25.14 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.502 2.135 . . . . 0.0 112.389 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.49 118.11 4.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.28 177.4 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -60.24 108.52 0.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.808 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.5 158.85 37.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.969 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.83 116.45 4.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.855 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.39 164.97 17.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.872 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.469 ' CE2' HG22 ' A' ' 18' ' ' THR . 43.7 t80 -94.54 136.57 34.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.9 p -159.04 118.8 3.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.966 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.469 HG22 ' CE2' ' A' ' 16' ' ' PHE . 9.8 t -177.47 150.91 0.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.888 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -75.39 140.02 42.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.436 ' C ' HD23 ' A' ' 106' ' ' LEU . 5.9 m-85 -142.0 144.11 33.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -69.32 176.49 3.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.971 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.1 m -146.38 125.32 12.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.651 ' CD2' HG23 ' A' ' 88' ' ' ILE . 56.7 m-85 -132.64 174.41 10.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 t -93.62 146.94 23.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.28 -27.65 43.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.173 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.5 p -56.62 -28.64 60.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.107 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.7 mtt -58.75 -51.16 71.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.981 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.7 tt -89.22 151.89 21.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -161.6 163.51 29.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.101 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.16 -160.07 9.11 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.432 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.97 -28.24 29.33 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.573 2.182 . . . . 0.0 112.289 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -115.63 151.88 34.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.86 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -80.72 178.77 8.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.4 mtt-85 -167.17 125.92 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.9 t -110.84 -29.49 7.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.961 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -58.93 -29.22 66.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.014 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.9 t -59.79 -40.85 83.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.123 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.87 -31.03 28.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -91.21 56.19 3.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.773 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.33 149.42 6.88 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.423 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.55 72.96 2.73 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.484 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.452 ' HE2' HD13 ' A' ' 80' ' ' LEU . 33.9 mttt -131.28 133.67 45.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.789 0.328 . . . . 0.0 110.842 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.561 HG21 HD23 ' A' ' 91' ' ' LEU . 1.9 pt -120.3 163.67 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.151 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.24 118.3 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.06 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.7 mtm -110.78 164.16 15.53 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 52.2 Cg_exo -55.08 148.23 49.63 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.567 2.178 . . . . 0.0 112.19 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 46' ' ' PRO . 50.7 Cg_exo -53.86 -29.69 54.3 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.513 2.142 . . . . 0.0 112.316 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.7 p -59.0 -30.94 68.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.91 74.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.603 HD13 ' CE2' ' A' ' 82' ' ' PHE . 38.4 tp -70.9 -50.39 35.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.924 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.26 -30.85 69.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.592 ' HG2' HD11 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -77.12 -41.32 42.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.058 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.1 mt -58.23 -31.97 67.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.038 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -82.33 -29.79 30.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.61 -16.08 52.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.216 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.592 HD11 ' HG2' ' A' ' 52' ' ' GLN . 9.2 mt -93.93 19.6 8.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.265 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.3 t30 55.2 30.08 13.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.0 mt -98.18 141.14 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.193 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.8 p -126.45 159.35 33.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.46 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -63.02 145.37 96.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.842 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.46 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.3 Cg_endo -77.1 152.12 94.39 Favored 'Cis proline' 0 C--N 1.348 0.501 0 C-N-CA 123.413 -1.495 . . . . 0.0 112.378 0.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 20.3 mtt -116.17 61.3 0.72 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.651 HD13 HD12 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -78.77 137.95 37.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.826 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.495 ' CD1' HG12 ' A' ' 109' ' ' VAL . 94.7 m-85 -100.73 171.8 7.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.451 ' NZ ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -121.33 86.51 2.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.887 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 mt -66.18 88.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.451 HG23 ' NZ ' ' A' ' 65' ' ' LYS . 3.4 m -88.25 103.08 15.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -85.17 113.69 21.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -96.08 42.93 1.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -124.59 -44.29 1.98 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.85 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 m -128.13 25.65 5.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.085 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 55.92 39.58 30.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.039 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.523 ' HB3' HD23 ' A' ' 99' ' ' LEU . 2.1 mmp_? -89.59 157.39 18.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.962 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.7 ttp -154.72 127.38 8.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.932 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.602 HG21 HD11 ' A' ' 99' ' ' LEU . 4.6 t -157.43 145.22 18.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.965 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -112.14 108.06 17.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.819 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 28.6 p -107.5 147.52 30.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.08 142.47 16.17 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.438 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.41 HG21 ' CE1' ' A' ' 82' ' ' PHE . 11.7 p -70.3 136.12 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.876 0.37 . . . . 0.0 111.066 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.452 HD13 ' HE2' ' A' ' 42' ' ' LYS . 14.7 tp -104.59 -63.25 1.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -127.61 167.49 16.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.934 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.603 ' CE2' HD13 ' A' ' 50' ' ' LEU . 94.8 m-85 -123.27 93.42 3.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 82' ' ' PHE . 22.9 m -156.73 37.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.188 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.91 157.65 19.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.1 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.498 ' HB3' HD12 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -71.41 148.47 46.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -59.81 124.59 20.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.86 -19.15 54.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.594 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.651 HG23 ' CD2' ' A' ' 23' ' ' PHE . 29.0 mt -108.24 132.2 56.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 111.157 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 43.6 m -128.76 126.53 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.56 145.88 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.561 HD23 HG21 ' A' ' 43' ' ' ILE . 4.6 mp -146.57 158.51 46.46 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.03 155.0 9.32 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.605 2.203 . . . . 0.0 112.278 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -69.34 -38.46 78.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.528 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 49.0 p-90 -64.75 -41.17 96.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.446 ' N ' ' CD2' ' A' ' 94' ' ' TRP . 3.3 ttp -66.91 -36.97 83.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.929 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.6 mtp -61.94 -35.69 79.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -77.61 -38.38 48.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -60.33 -31.96 70.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.834 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.602 HD11 HG21 ' A' ' 75' ' ' THR . 9.2 mt -98.13 -14.42 20.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.257 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.7 mt 62.07 39.99 12.51 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.9 0.381 . . . . 0.0 110.88 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 mt -81.23 164.97 21.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.842 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.81 -174.39 2.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -65.01 96.11 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.27 38.12 5.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.06 110.3 3.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.436 HD23 ' C ' ' A' ' 20' ' ' TYR . 26.3 mt -73.76 124.85 26.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.826 0.346 . . . . 0.0 110.945 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -134.34 150.42 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -66.5 136.63 55.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.888 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.495 HG12 ' CD1' ' A' ' 64' ' ' PHE . 21.4 t -123.63 92.3 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -107.79 137.6 45.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 21.7 p -88.49 114.49 25.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.3 m -119.67 131.05 73.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.142 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -82.13 112.42 19.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.651 HD12 HD13 ' A' ' 63' ' ' LEU . 1.9 mt -111.7 175.08 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -133.08 171.83 13.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.06 147.28 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.184 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.589 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -89.65 149.74 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.064 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.1 p -105.55 -28.58 10.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.824 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -134.93 90.78 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.906 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.7 p -98.24 109.03 21.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -101.22 136.46 41.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.845 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.509 ' CZ ' HD21 ' A' ' 143' ' ' LEU . 64.5 m-85 -124.49 156.71 36.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -133.64 94.45 19.21 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.97 108.58 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.52 2.147 . . . . 0.0 112.395 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -61.98 -31.82 72.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.948 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 m -113.87 146.68 36.09 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.002 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.31 -14.6 25.47 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.544 2.163 . . . . 0.0 112.567 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.68 -33.96 61.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.135 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -75.29 -31.38 60.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.9 mt -63.53 -30.72 71.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.71 -27.99 69.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.012 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.648 HD13 HG21 ' A' ' 138' ' ' VAL . 46.8 mt -60.88 135.62 25.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.049 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.6 m -71.07 -30.66 66.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.598 ' H ' HG22 ' A' ' 132' ' ' ILE . 1.1 m120 -127.88 73.32 78.93 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.908 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -56.74 -37.09 98.65 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.629 2.219 . . . . 0.0 112.209 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -60.75 -46.4 90.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.046 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -59.21 -46.02 89.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.055 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.648 HG21 HD13 ' A' ' 132' ' ' ILE . 21.5 t -69.72 -37.54 74.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.485 HD21 ' CD1' ' A' ' 122' ' ' PHE . 4.4 tp -73.5 -34.08 65.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -74.16 -34.49 63.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.906 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.05 -37.07 86.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.3 -33.44 43.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.534 HD22 HD11 ' A' ' 149' ' ' LEU . 12.6 mt -60.03 -28.82 68.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.947 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -57.95 -32.76 68.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.03 -31.56 58.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.83 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -74.71 142.61 44.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -100.79 -30.67 11.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.522 ' SG ' HD13 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -134.56 173.31 11.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.534 HD11 HD22 ' A' ' 143' ' ' LEU . 55.0 mt -149.59 114.38 5.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.824 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.0 m -104.95 144.88 31.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.1 m -71.12 112.72 7.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 99.76 39.3 3.42 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.575 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.18 112.9 20.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 110.883 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.21 82.97 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.116 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.528 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 8.7 pt -79.98 160.52 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.062 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.625 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -121.8 112.91 18.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.3 pt -98.7 152.51 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.208 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -147.72 147.24 29.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 160' ' ' ASN . 52.8 p90 -164.49 -47.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.846 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.45 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 57.0 t-20 -98.93 43.95 1.04 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 60.15 31.02 20.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.17 132.35 19.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.625 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 4.0 mp -90.39 88.49 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.087 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -70.38 123.18 21.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -75.14 133.09 41.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.22 141.38 22.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.877 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -136.94 145.51 44.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.38 153.64 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.177 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 13.2 mmm -121.99 -54.37 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.91 140.13 34.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.7 p -144.43 135.76 25.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -113.49 153.91 45.62 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.69 -37.12 2.22 Favored 'Cis proline' 0 C--N 1.346 0.395 0 C-N-CA 123.337 -1.526 . . . . 0.0 112.4 0.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.39 173.13 6.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -56.58 -43.33 79.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -95.06 127.63 41.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.004 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.589 HG21 ' HB2' ' A' ' 117' ' ' ALA . 16.2 m -138.35 139.61 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.169 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.429 ' HB2' HD11 ' A' ' 180' ' ' ILE . 30.9 p -93.18 102.1 14.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.793 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.0 pt -96.13 88.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.271 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.429 HD11 ' HB2' ' A' ' 178' ' ' SER . 3.5 mp -124.28 82.31 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.005 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 62.19 81.57 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 23.7 t -157.18 158.15 35.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -91.14 129.75 37.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 5.9 ptt? -152.02 174.04 14.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -108.48 117.19 33.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.813 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.477 HG11 HD23 ' A' ' 139' ' ' LEU . 21.4 t -97.91 137.98 23.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.203 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.1 146.56 52.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -105.75 148.13 27.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -114.91 85.16 2.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.931 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.163 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.118 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.1 t -170.98 150.21 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.83 0.347 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.51 -38.36 14.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.816 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.8 28.5 65.82 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.492 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -120.39 97.66 5.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.32 . . . . 0.0 110.924 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.2 p -168.71 -178.4 3.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.86 -159.4 30.25 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.587 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.3 pp -139.9 154.35 70.59 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.731 0.301 . . . . 0.0 111.092 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.51 139.76 41.89 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.605 2.203 . . . . 0.0 112.344 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.5 mmt85 -99.14 30.47 3.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 11' ' ' VAL . 14.9 p -158.95 40.47 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.035 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.75 -58.38 1.24 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.811 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -103.0 30.99 4.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -96.09 168.95 10.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.36 174.13 11.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.426 ' CE2' ' HG ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -68.39 119.7 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.875 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.3 p -159.72 99.5 1.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -160.69 162.39 32.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.747 ' HB3' HD22 ' A' ' 106' ' ' LEU . 12.1 mt-30 -96.06 130.59 43.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.436 ' HD2' HG21 ' A' ' 109' ' ' VAL . 12.7 m-85 -126.15 143.27 51.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -78.08 143.13 37.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.2 p -104.38 130.23 52.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.568 ' CD2' HG23 ' A' ' 88' ' ' ILE . 57.1 m-85 -139.86 154.56 47.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -60.23 162.44 5.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.595 HG12 ' HB3' ' A' ' 90' ' ' TYR . 14.6 m -95.55 20.09 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.331 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 m -88.06 -31.41 19.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.842 0.353 . . . . 0.0 110.911 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.41 -45.95 92.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 31.2 tp -86.47 63.98 8.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.53 123.27 4.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.069 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.47 -155.23 5.04 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.553 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.13 -27.91 31.26 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.616 2.21 . . . . 0.0 112.347 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -102.56 166.79 10.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -126.26 171.21 11.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.964 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -139.24 146.42 40.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.878 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 93.6 p -110.33 -25.15 10.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.026 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -54.02 -29.64 44.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.114 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.93 -54.11 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.129 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.525 ' OE1' HG21 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -73.47 -40.99 63.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.897 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.8 mttm -66.02 79.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.47 -171.9 22.08 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.49 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.7 79.98 0.26 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.453 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.473 ' HE2' HD13 ' A' ' 80' ' ' LEU . 17.0 mttt -140.51 134.25 30.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.813 0.339 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.604 HG21 HD23 ' A' ' 91' ' ' LEU . 24.1 pt -122.53 170.07 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.098 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 4.6 mt -124.46 96.9 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.004 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.9 mmm -90.34 158.55 43.33 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.81 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.64 149.38 32.1 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.51 2.14 . . . . 0.0 112.267 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.54 -30.14 53.03 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.566 2.177 . . . . 0.0 112.276 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.93 -30.19 71.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.43 -30.05 66.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.177 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.421 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 32.2 tp -70.67 -50.6 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.962 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.29 -32.39 73.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -76.78 -44.12 34.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.06 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.426 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 8.1 mt -58.72 -37.02 75.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.953 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.4 t -83.01 -28.76 29.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.79 -19.95 59.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.171 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.6 mt -92.69 15.52 14.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.332 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.83 32.69 20.09 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.735 0.302 . . . . 0.0 111.038 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.419 HD12 HD23 ' A' ' 53' ' ' LEU . 41.2 mt -92.87 144.17 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.107 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.3 p -127.19 179.69 5.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.984 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 16.7 t80 -72.55 138.42 80.65 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.749 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.458 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.4 Cg_endo -77.15 156.57 97.09 Favored 'Cis proline' 0 C--N 1.348 0.537 0 C-N-CA 123.534 -1.444 . . . . 0.0 112.426 0.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 41.8 mtt -119.97 31.34 6.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.809 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.543 HD22 ' HB2' ' A' ' 148' ' ' CYS . 1.3 mt -61.58 149.23 39.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.468 ' HB3' HG13 ' A' ' 109' ' ' VAL . 94.8 m-85 -109.51 145.51 36.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.882 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.57 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 16.8 tttt -92.39 85.97 5.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.949 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.514 HD11 ' SG ' ' A' ' 77' ' ' CYS . 96.2 mt -70.73 90.1 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -98.89 111.64 23.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.927 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -83.86 113.17 20.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.825 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -88.31 54.35 3.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -142.9 -47.48 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.885 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.7 22.5 9.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.157 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 54.52 37.02 27.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.005 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -90.56 147.93 23.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.9 ttt -138.07 142.01 40.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.809 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.5 m -159.98 148.68 17.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.57 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 60.3 m-70 -124.78 114.01 18.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.514 ' SG ' HD11 ' A' ' 66' ' ' LEU . 26.5 p -115.06 155.89 26.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.511 ' CA ' HD23 ' A' ' 63' ' ' LEU . . . -113.23 131.08 9.81 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.449 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.535 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 10.7 p -68.59 140.14 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 111.164 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.473 HD13 ' HE2' ' A' ' 42' ' ' LYS . 12.6 tp -129.65 -56.35 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.832 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -108.54 146.12 33.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.971 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.535 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 76.6 m-85 -120.39 58.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.1 m -125.34 31.2 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.104 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 44' ' ' ILE . . . -85.24 179.24 7.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.076 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.69 169.08 9.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -73.02 107.97 5.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.37 28.21 33.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.493 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.568 HG23 ' CD2' ' A' ' 23' ' ' PHE . 27.0 mt -148.33 95.67 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 111.12 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 15.0 m -91.05 134.2 34.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.595 ' HB3' HG12 ' A' ' 25' ' ' VAL . 34.7 m-85 -97.84 120.64 38.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.604 HD23 HG21 ' A' ' 43' ' ' ILE . 4.8 mt -123.34 150.23 59.96 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.935 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.3 176.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.52 2.147 . . . . 0.0 112.304 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -79.84 -47.4 15.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -59.53 -29.12 67.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.992 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.555 ' SD ' HD22 ' A' ' 91' ' ' LEU . 33.4 ttm -73.45 -30.94 63.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.831 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 6.4 mtp -71.61 -43.59 65.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -68.92 -40.25 79.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.854 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -60.38 -61.51 2.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.819 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 mt -62.88 -20.54 65.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.6 mt 63.25 34.25 13.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.823 0.344 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 mt -81.52 179.27 7.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.827 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -125.79 177.59 6.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -63.97 103.18 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.437 ' CA ' ' CZ ' ' A' ' 23' ' ' PHE . . . 89.41 34.87 8.29 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.521 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.18 117.83 4.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.554 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.747 HD22 ' HB3' ' A' ' 19' ' ' GLN . 12.7 mt -64.71 130.22 42.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 110.884 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.9 t -121.46 138.02 53.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -70.46 112.81 7.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 64' ' ' PHE . 27.0 t -96.44 143.93 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -160.03 138.63 10.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.4 p -91.05 113.91 26.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.6 m -120.86 150.14 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.115 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.74 86.8 2.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.422 ' CD1' ' HB1' ' A' ' 176' ' ' ALA . 4.9 mt -83.01 168.08 17.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.801 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -110.9 175.53 5.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.838 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.14 139.59 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.2 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.944 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -76.39 151.02 36.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.6 t -110.57 -30.93 7.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -138.77 107.72 6.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.938 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 m -114.26 137.99 51.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -129.02 148.63 50.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.496 ' CD1' HD21 ' A' ' 139' ' ' LEU . 67.8 m-85 -133.8 150.84 51.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -131.55 91.33 34.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -51.34 125.02 15.39 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.543 2.162 . . . . 0.0 112.34 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -71.12 -39.77 71.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.1 m -105.57 148.0 35.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.877 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.472 ' HA ' HD12 ' A' ' 130' ' ' LEU . 57.4 Cg_endo -70.73 -11.22 29.25 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.575 2.183 . . . . 0.0 112.576 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -56.37 -39.7 73.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.766 0.317 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -72.32 -38.3 68.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 127' ' ' PRO . 32.4 mt -65.32 -36.94 85.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.824 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.29 -25.3 67.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.652 HG22 ' H ' ' A' ' 134' ' ' ASN . 52.2 mt -59.99 134.57 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.052 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.1 t -59.69 -32.65 70.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.004 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.652 ' H ' HG22 ' A' ' 132' ' ' ILE . 0.5 OUTLIER -137.04 81.01 33.86 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.926 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.34 -30.05 16.11 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.62 2.214 . . . . 0.0 112.318 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -63.51 -37.8 88.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.63 -56.48 17.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.7 -33.94 62.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.164 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.496 HD21 ' CD1' ' A' ' 122' ' ' PHE . 29.7 tp -70.16 -50.92 35.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.943 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.425 ' CD ' HG21 ' A' ' 186' ' ' VAL . 2.2 mt-10 -67.27 -39.07 86.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -60.13 -30.92 69.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.858 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.08 -31.21 61.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.071 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 60.4 mt -57.95 -27.16 63.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.038 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -30.05 62.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.012 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -81.55 -36.25 29.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -77.69 147.14 35.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.962 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -107.96 -28.66 9.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.543 ' HB2' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -128.58 159.56 35.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.402 HD12 HG21 ' A' ' 179' ' ' ILE . 28.4 mt -137.44 118.71 14.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.14 140.77 46.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.86 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.4 m -66.7 125.5 26.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.22 44.69 8.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.438 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -111.01 119.46 39.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.839 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.73 81.22 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 39.9 pt -81.91 178.41 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -152.63 131.32 12.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.039 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 39.8 pt -118.56 138.02 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -136.83 146.01 45.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.425 ' CE2' ' HB2' ' A' ' 160' ' ' ASN . 52.6 p90 -173.98 -44.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.868 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.425 ' HB2' ' CE2' ' A' ' 159' ' ' TYR . 53.1 t30 -97.76 38.5 1.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 60.21 31.12 20.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.21 119.45 8.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.517 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.8 mp -84.09 90.81 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -71.8 138.61 48.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -96.96 124.86 41.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.2 mt -139.33 138.28 36.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -129.85 136.57 49.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.4 t -71.78 130.19 35.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.067 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.2 mmm -91.37 -62.81 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.09 150.45 48.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 31.5 p -144.79 144.22 31.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.849 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -123.84 152.17 65.7 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.96 -38.77 1.62 Allowed 'Cis proline' 0 C--N 1.346 0.436 0 C-N-CA 123.321 -1.533 . . . . 0.0 112.368 0.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -107.63 168.82 8.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -34.87 72.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.947 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.422 ' HB1' ' CD1' ' A' ' 114' ' ' LEU . . . -108.39 124.02 49.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.075 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.944 HG21 ' HB2' ' A' ' 117' ' ' ALA . 6.4 m -135.89 160.04 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 3.7 t -108.93 91.83 3.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.402 HG21 HD12 ' A' ' 149' ' ' LEU . 3.0 pt -80.56 82.76 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.145 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.9 mt -115.2 82.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.089 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 60.0 79.78 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.842 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 2.0 t -156.94 153.93 28.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.85 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -90.7 118.89 30.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -135.11 176.26 8.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.839 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.01 142.06 27.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.425 HG21 ' CD ' ' A' ' 140' ' ' GLU . 21.5 t -129.54 86.6 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.138 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.62 175.39 10.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -134.75 145.34 48.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -141.08 105.09 4.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.092 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.14 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 m -104.25 -66.73 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 110.941 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.56 -69.22 0.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.976 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 58.31 -89.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.494 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.86 147.43 23.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 110.911 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.4 m -109.85 -30.66 7.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.32 -157.37 15.08 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.424 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.4 pt -109.5 134.42 20.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.535 0.207 . . . . 0.0 111.127 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.9 114.97 4.15 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.421 2.081 . . . . 0.0 112.328 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -128.52 101.04 6.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 m -101.34 29.52 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.16 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -113.31 30.65 7.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.805 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -133.51 153.29 51.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -153.84 -59.75 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 62.23 148.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.939 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.15 120.8 16.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.829 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.6 p -158.42 102.85 1.75 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -168.25 177.82 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.45 ' HB3' HD22 ' A' ' 106' ' ' LEU . 57.8 mt-30 -105.38 122.08 45.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -117.73 151.06 38.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 mtt85 -86.4 137.16 32.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.582 ' HB2' HD12 ' A' ' 91' ' ' LEU . 21.5 p -104.16 122.93 46.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.522 ' CD2' HG23 ' A' ' 88' ' ' ILE . 36.7 m-85 -132.05 160.29 36.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 t -77.09 152.72 34.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -64.34 -21.04 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.347 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.4 m -61.17 -18.87 60.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.276 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.1 mtp -94.0 20.06 8.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.428 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.629 HD13 ' N ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -85.32 135.3 33.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.809 0.338 . . . . 0.0 110.745 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.629 ' N ' HD13 ' A' ' 28' ' ' LEU . . . -55.88 134.74 52.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.161 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 140.19 166.07 10.52 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.466 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.48 -28.15 26.94 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.546 2.164 . . . . 0.0 112.278 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.48 145.34 17.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.832 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -84.41 -178.54 6.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.925 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -123.81 144.92 49.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.86 31.64 2.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.898 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -98.31 -31.34 12.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.947 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.36 -31.33 46.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.68 -36.33 65.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.821 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -60.29 -33.29 72.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -110.4 -164.66 19.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.474 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.16 31.63 5.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.55 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.635 ' HE3' HD13 ' A' ' 80' ' ' LEU . 22.0 mmtt -87.66 158.57 18.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.815 0.341 . . . . 0.0 110.973 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.6 pt -135.77 -179.98 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 3.6 mp -130.45 104.45 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.04 157.17 34.21 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.54 ' N ' ' HB3' ' A' ' 84' ' ' ALA . 53.6 Cg_exo -52.34 144.86 38.2 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.541 2.161 . . . . 0.0 112.261 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 46' ' ' PRO . 50.1 Cg_exo -53.66 -30.62 56.61 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.516 2.144 . . . . 0.0 112.279 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.3 p -60.65 -35.45 76.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.94 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.89 -30.98 71.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.144 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.589 HD13 ' CD2' ' A' ' 82' ' ' PHE . 43.3 tp -63.06 -39.38 94.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.56 -32.89 47.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -61.14 -38.79 87.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.53 HD23 HD12 ' A' ' 58' ' ' ILE . 8.8 mt -61.37 -46.21 91.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -60.14 -30.98 69.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.947 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.8 mtt85 -82.1 -26.35 33.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.036 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.1 mt -86.74 6.14 32.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.428 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 t30 59.52 31.34 20.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.81 0.338 . . . . 0.0 110.966 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.53 HD12 HD23 ' A' ' 53' ' ' LEU . 33.1 mt -94.73 125.19 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.128 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.7 p -110.37 170.62 7.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.455 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.8 OUTLIER -64.82 141.18 98.27 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.822 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.9 Cg_endo -77.1 164.61 86.76 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.468 -1.471 . . . . 0.0 112.403 -0.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 20.1 mtt -126.65 72.9 1.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.852 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.665 HD21 ' HB1' ' A' ' 147' ' ' ALA . 4.0 mt -90.96 149.26 21.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.958 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.459 ' HB3' HG13 ' A' ' 109' ' ' VAL . 97.7 m-85 -112.78 142.99 44.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.823 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 59.5 tttt -94.93 103.39 15.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.984 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.5 HD12 ' SG ' ' A' ' 77' ' ' CYS . 7.9 mt -91.69 76.24 5.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.94 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -78.09 97.22 5.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.931 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -66.02 116.92 7.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -92.31 49.71 1.54 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -130.4 -46.13 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.795 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.0 m -133.28 28.82 4.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.958 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 58.02 34.75 24.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.031 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -88.82 156.32 19.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.512 ' O ' HG21 ' A' ' 150' ' ' THR . 13.8 ttm -158.4 137.63 11.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.592 ' CG2' HD11 ' A' ' 99' ' ' LEU . 7.0 t -160.0 108.98 1.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.888 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.436 ' CD2' HD11 ' A' ' 114' ' ' LEU . 37.9 m80 -75.91 118.31 18.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.9 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.5 ' SG ' HD12 ' A' ' 66' ' ' LEU . 24.7 p -111.61 147.16 36.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.95 149.71 19.26 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.499 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.539 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 9.8 p -91.02 154.42 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.853 0.358 . . . . 0.0 111.084 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.635 HD13 ' HE3' ' A' ' 42' ' ' LYS . 53.0 tp -145.96 -55.99 0.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.925 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -101.89 143.96 31.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.894 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.589 ' CD2' HD13 ' A' ' 50' ' ' LEU . 67.4 m-85 -123.54 76.8 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.4 m -150.79 31.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.54 ' HB3' ' N ' ' A' ' 46' ' ' PRO . . . -81.42 150.12 28.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.148 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.481 ' HB3' HD12 ' A' ' 88' ' ' ILE . 0.7 OUTLIER -68.01 173.06 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.85 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -67.95 115.89 7.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.11 29.83 75.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.522 HG23 ' CD2' ' A' ' 23' ' ' PHE . 32.7 mt -142.7 91.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 0.0 111.146 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.5 t -94.66 129.43 41.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.427 ' CE2' HD22 ' A' ' 28' ' ' LEU . 86.3 m-85 -89.01 140.96 28.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 22' ' ' CYS . 4.1 mt -137.47 155.92 75.22 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.2 179.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.603 2.202 . . . . 0.0 112.293 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -87.44 -45.3 10.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.781 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 39.9 p-90 -60.35 -44.89 95.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.4 tpp -60.15 -34.74 73.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -53.36 22.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -60.0 -36.3 76.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.865 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -62.2 -49.08 77.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.781 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.592 HD11 ' CG2' ' A' ' 75' ' ' THR . 4.9 mt -75.36 -17.06 60.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.2 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.4 mt 61.21 35.22 18.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.44 HD13 ' SG ' ' A' ' 22' ' ' CYS . 25.6 mt -80.68 -178.63 6.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.826 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.02 -177.98 4.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 120.75 10.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.8 27.84 70.04 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.504 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -70.71 107.62 2.22 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.439 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' A' ' 19' ' ' GLN . 16.3 mt -69.52 123.52 21.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.839 0.352 . . . . 0.0 110.839 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.2 t -125.59 145.88 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.08 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -73.32 108.72 6.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.459 HG13 ' HB3' ' A' ' 64' ' ' PHE . 21.5 t -95.93 121.54 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.7 114.55 12.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.8 p -77.73 114.86 17.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.985 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.9 m -122.54 144.13 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.071 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.43 102.58 15.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.436 HD11 ' CD2' ' A' ' 76' ' ' HIS . 6.0 mt -99.58 168.93 9.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.63 172.34 7.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.6 m -67.96 140.76 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.122 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.592 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -81.82 148.84 28.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.062 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.7 p -109.63 -31.55 7.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -131.73 93.29 3.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 61.1 m -114.49 94.49 4.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.38 142.5 35.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.823 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.642 ' CE2' HG22 ' A' ' 168' ' ' VAL . 42.7 m-85 -124.68 150.92 45.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.014 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -128.37 93.54 38.13 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.54 104.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.557 2.171 . . . . 0.0 112.373 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -59.51 -30.88 68.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.3 146.31 35.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.821 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.69 -12.76 26.87 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.536 2.157 . . . . 0.0 112.559 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -56.82 -40.69 76.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.067 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.534 ' CD1' HD11 ' A' ' 166' ' ' LEU . 19.2 t80 -67.31 -44.24 79.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.62 -29.98 68.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.947 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -61.99 -26.31 68.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.988 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.564 HG22 ' H ' ' A' ' 134' ' ' ASN . 43.2 mt -61.66 139.68 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.981 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.4 m -65.3 -37.38 86.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.564 ' H ' HG22 ' A' ' 132' ' ' ILE . 2.0 m120 -130.01 71.12 82.28 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.407 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 39.6 Cg_exo -57.0 -29.95 84.78 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.611 2.207 . . . . 0.0 112.241 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -60.31 -49.52 77.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.043 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.45 75.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.139 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.4 HG21 HD13 ' A' ' 132' ' ' ILE . 21.5 t -75.57 -33.27 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.679 HD22 ' CE1' ' A' ' 188' ' ' PHE . 12.6 tp -71.7 -42.87 66.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.14 -37.83 72.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -65.69 -32.76 74.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.58 -31.74 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.136 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.538 HD22 HD11 ' A' ' 149' ' ' LEU . 14.2 mt -63.98 -27.32 69.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.038 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -57.03 -25.2 58.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.101 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -79.74 -49.24 12.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.826 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.431 ' CZ ' ' HB ' ' A' ' 155' ' ' ILE . 84.5 m-85 -60.77 146.72 45.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.665 ' HB1' HD21 ' A' ' 63' ' ' LEU . . . -100.85 -30.33 11.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.24 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.11 167.46 22.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.974 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.538 HD11 HD22 ' A' ' 143' ' ' LEU . 27.6 mt -143.01 137.53 29.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.512 HG21 ' O ' ' A' ' 74' ' ' MET . 2.0 m -114.09 141.64 47.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.0 m -65.83 94.28 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 108.33 30.43 3.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.548 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.03 134.17 46.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.766 0.317 . . . . 0.0 110.854 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 26.1 t -90.2 91.19 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.117 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.781 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 9.3 pt -91.65 134.03 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.494 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -102.05 125.07 48.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.12 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.433 HG12 HD12 ' A' ' 166' ' ' LEU . 5.0 pt -115.88 141.59 32.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.103 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -139.19 142.22 37.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -157.71 -50.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -96.77 44.18 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 60.34 31.47 20.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -148.55 126.21 11.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.494 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 3.8 mp -85.92 95.45 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.188 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -76.66 137.43 39.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -95.46 122.96 38.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.534 HD11 ' CD1' ' A' ' 129' ' ' PHE . 3.2 mt -141.63 100.55 3.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -93.93 127.74 39.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.642 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.2 t -68.94 128.79 32.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.083 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.8 mmm -86.71 -64.16 1.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.014 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -123.14 155.79 36.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 58.2 p -144.98 161.01 40.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.636 ' O ' HG11 ' A' ' 177' ' ' VAL . 25.9 mttt -148.12 155.4 43.47 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.825 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.29 -31.6 5.17 Favored 'Cis proline' 0 C--N 1.348 0.507 0 C-N-CA 123.309 -1.538 . . . . 0.0 112.462 0.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -113.51 176.7 4.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -60.01 -41.94 93.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -98.83 116.94 32.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.018 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.636 HG11 ' O ' ' A' ' 172' ' ' LYS . 17.7 m -133.27 137.66 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.16 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.506 ' OG ' HD11 ' A' ' 63' ' ' LEU . 10.0 t -94.62 97.9 10.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.1 pt -89.63 85.49 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.3 mm -117.83 85.12 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.123 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 60.58 87.26 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 49.9 t -161.65 141.52 10.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.97 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -80.84 108.14 14.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -128.34 179.22 5.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -93.84 89.97 6.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.75 81.33 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.01 172.05 13.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' PHE . . . . . 0.679 ' CE1' HD22 ' A' ' 139' ' ' LEU . 11.8 m-85 -128.52 163.07 25.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.93 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -147.93 101.64 3.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.958 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.048 179.946 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.451 -0.259 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.88 158.55 20.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.921 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.25 -42.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.3 -141.16 3.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.51 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.38 -34.69 61.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 0.0 110.952 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.87 159.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.86 -154.74 29.62 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.479 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 mp -112.88 90.95 16.5 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.674 0.274 . . . . 0.0 111.152 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -51.06 91.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.584 2.189 . . . . 0.0 112.43 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.1 mtt-85 59.55 -178.46 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.977 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 11' ' ' VAL . 10.7 p -155.25 113.74 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.087 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -144.37 -48.38 0.27 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.987 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -170.68 -38.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.082 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 t30 75.59 -68.05 0.22 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.013 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 63.36 135.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.946 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -62.47 89.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.947 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.9 p -118.97 105.34 11.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.831 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.0 t -168.35 160.97 11.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.952 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -95.7 148.57 22.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -139.03 148.5 43.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 -75.84 128.51 35.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.873 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.463 ' HB3' HD13 ' A' ' 91' ' ' LEU . 64.9 m -99.11 125.79 44.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -130.66 175.47 8.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 t -92.28 150.66 20.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.906 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.5 m -68.3 -30.8 48.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.086 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.01 -29.22 66.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -27.78 63.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.046 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.5 tp -57.4 -67.1 0.36 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.023 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -104.93 -68.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.079 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.42 -169.28 23.5 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.465 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.1 -35.74 18.98 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.616 2.211 . . . . 0.0 112.266 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -122.16 121.46 36.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.823 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -165.23 -44.44 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.953 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -131.67 147.7 52.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.4 p -130.83 31.63 4.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -122.03 -43.33 2.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 m -63.11 -32.33 55.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.09 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.17 -31.58 43.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -80.56 -35.17 34.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.78 167.14 26.72 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.476 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.47 40.88 2.57 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.455 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.18 162.4 13.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.356 . . . . 0.0 110.897 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.537 HG22 ' HD3' ' A' ' 92' ' ' PRO . 43.0 pt -141.1 172.55 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.102 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 mt -120.93 86.41 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.174 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.6 mtp -89.11 151.59 47.0 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.773 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.09 156.09 7.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.574 2.183 . . . . 0.0 112.251 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.73 -25.46 61.17 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.625 2.217 . . . . 0.0 112.342 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.5 p -58.87 -30.78 67.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.942 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.79 -47.96 64.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.161 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.733 ' HA ' HD12 ' A' ' 53' ' ' LEU . 56.1 tp -59.51 -39.46 83.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.68 -31.01 64.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.924 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -74.04 -32.6 63.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.733 HD12 ' HA ' ' A' ' 50' ' ' LEU . 23.6 mt -59.84 -30.38 68.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.5 t -80.91 -22.94 39.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.111 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -75.09 -30.57 60.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.018 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.5 mt -95.52 20.05 10.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.243 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 53.58 38.42 28.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.82 0.343 . . . . 0.0 111.265 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 59' ' ' THR . 25.0 mm -77.08 154.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.025 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.408 ' N ' HG22 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -140.91 151.55 44.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.451 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.5 t80 -61.83 140.6 95.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.753 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.75 157.8 97.34 Favored 'Cis proline' 0 C--N 1.349 0.579 0 C-N-CA 123.479 -1.467 . . . . 0.0 112.409 -0.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.626 ' SD ' HD13 ' A' ' 53' ' ' LEU . 45.0 mtt -116.38 56.86 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.91 139.72 45.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.552 ' HB3' HG13 ' A' ' 109' ' ' VAL . 57.6 m-85 -105.81 157.13 17.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.421 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 10.3 tttp -103.55 92.94 4.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.6 mt -75.8 80.64 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.7 m -95.21 117.8 30.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -89.36 129.46 35.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.889 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -98.69 31.11 3.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.32 -41.02 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.847 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m -134.41 21.99 3.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.5 t70 54.4 59.95 3.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.098 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.627 ' HB3' HD23 ' A' ' 99' ' ' LEU . 5.7 mmp_? -106.55 158.98 16.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.1 ttm -159.28 126.64 4.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.712 HG22 HD21 ' A' ' 99' ' ' LEU . 4.4 t -158.96 100.94 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.941 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.421 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 50.4 m80 -65.77 131.98 47.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.926 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.6 p -123.11 166.32 15.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.49 113.24 2.05 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.516 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 80' ' ' LEU . 11.2 p -62.35 154.18 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.102 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.407 ' N ' HG22 ' A' ' 79' ' ' VAL . 23.2 tp -133.33 -62.22 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -95.7 162.76 13.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.51 ' CD2' HD22 ' A' ' 50' ' ' LEU . 51.7 m-85 -140.83 74.02 1.44 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.4 m -143.56 31.44 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.42 158.26 17.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.13 169.1 18.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -73.19 120.79 19.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.82 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.19 26.08 55.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.577 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.3 mt -149.74 113.99 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.834 0.35 . . . . 0.0 111.106 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 86.4 m -117.38 131.29 56.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -97.96 135.87 39.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.465 HD23 HG21 ' A' ' 43' ' ' ILE . 3.3 mp -135.36 160.63 67.25 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.537 ' HD3' HG22 ' A' ' 43' ' ' ILE . 53.6 Cg_exo -52.43 -176.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.582 2.188 . . . . 0.0 112.292 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -93.09 -40.92 10.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.023 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.413 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 65.1 p-90 -61.85 -42.07 98.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.98 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 44.6 ttm -60.43 -44.46 95.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.22 -48.76 80.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -60.57 -36.81 79.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.898 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -65.44 -56.38 12.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.712 HD21 HG22 ' A' ' 75' ' ' THR . 12.2 mt -68.14 -17.68 64.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.184 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.3 mt 62.86 32.35 15.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.844 0.354 . . . . 0.0 110.84 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.84 179.96 7.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -134.08 176.53 8.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -59.91 105.4 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.8 28.45 8.31 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.52 121.58 5.56 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.466 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.6 mt -83.14 123.55 29.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.835 0.35 . . . . 0.0 110.985 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.41 135.55 62.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.085 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -68.28 102.13 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 64' ' ' PHE . 25.4 t -86.86 132.12 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -145.17 133.15 21.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.8 p -90.88 103.06 15.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.1 m -109.19 170.96 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.168 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -114.89 118.69 34.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 176' ' ' ALA . 12.1 mt -119.12 177.31 4.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -123.06 167.53 13.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.2 m -64.85 141.96 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.064 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.638 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -76.53 148.85 36.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.3 p -113.29 -37.05 4.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.926 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -137.6 118.41 14.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.931 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.58 107.2 6.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.07 131.64 34.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.603 ' CG ' HD21 ' A' ' 139' ' ' LEU . 26.4 m-85 -112.29 144.5 41.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -131.57 96.97 19.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.81 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.82 119.91 5.35 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.518 2.145 . . . . 0.0 112.327 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -71.49 -32.22 67.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.033 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.98 147.48 34.56 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.957 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.65 -19.14 28.27 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.571 2.18 . . . . 0.0 112.604 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.52 -48.07 78.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.051 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.457 ' CE1' HD11 ' A' ' 166' ' ' LEU . 13.4 t80 -61.14 -44.96 96.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.88 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.6 mt -59.37 -31.8 69.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -62.77 -26.8 68.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.976 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.629 HG22 ' H ' ' A' ' 134' ' ' ASN . 29.6 mt -61.38 135.56 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.993 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.7 t -64.51 -33.39 75.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.629 ' H ' HG22 ' A' ' 132' ' ' ILE . 0.1 OUTLIER -134.61 81.76 46.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.86 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.12 -27.23 20.42 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.47 2.113 . . . . 0.0 112.321 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -60.14 -35.74 75.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.019 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.3 -39.27 68.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.13 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.54 -30.28 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.275 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.603 HD21 ' CG ' ' A' ' 122' ' ' PHE . 25.5 tp -79.75 -44.51 20.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.04 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -63.64 -31.56 72.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.94 -28.82 67.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.74 -32.63 31.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.124 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.06 -26.63 68.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.076 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -56.41 -30.1 62.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.068 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.86 -42.73 13.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.944 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.597 ' CE2' HD13 ' A' ' 155' ' ' ILE . 37.6 m-85 -62.49 142.42 57.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.547 ' HB1' HD11 ' A' ' 180' ' ' ILE . . . -108.03 -25.67 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.279 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -141.42 165.5 27.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.5 mt -145.83 162.55 37.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.66 143.71 30.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.959 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 169' ' ' MET . 89.0 m -62.98 96.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 110.0 27.47 4.55 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.468 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.93 116.15 28.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.3 t -84.62 89.0 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.069 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.597 HD13 ' CE2' ' A' ' 146' ' ' PHE . 1.1 pt -93.67 142.85 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.111 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.409 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -109.0 131.25 55.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.159 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.8 pt -117.99 154.63 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -144.72 142.06 29.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.908 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.419 ' CE1' ' CD1' ' A' ' 164' ' ' TYR . 16.4 p90 -158.5 -49.75 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.966 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -97.87 44.5 1.04 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.9 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 60.0 30.14 19.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -144.58 142.63 30.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.8 mp -93.67 90.45 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.041 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.419 ' CD1' ' CE1' ' A' ' 159' ' ' TYR . 39.8 m-85 -74.04 120.79 20.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -77.45 139.61 39.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.991 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.475 HD22 HD13 ' A' ' 139' ' ' LEU . 0.7 OUTLIER -153.28 124.78 7.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -124.16 137.67 54.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.929 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.425 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.5 t -76.18 146.96 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.443 ' O ' HG23 ' A' ' 151' ' ' THR . 24.5 mmm -106.23 -56.88 2.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -128.65 149.79 50.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.983 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 17.5 p -145.69 141.17 27.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.869 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -127.43 152.98 77.23 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.99 -28.15 7.94 Favored 'Cis proline' 0 C--N 1.346 0.397 0 C-N-CA 123.38 -1.508 . . . . 0.0 112.366 0.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -124.61 173.25 8.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -47.16 85.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.968 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.487 ' O ' HD22 ' A' ' 114' ' ' LEU . . . -90.88 103.55 16.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.016 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.638 HG21 ' HB2' ' A' ' 117' ' ' ALA . 15.9 m -123.38 132.19 71.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 5.7 t -89.55 85.58 6.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.813 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.8 pt -74.17 81.55 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.213 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.547 HD11 ' HB1' ' A' ' 147' ' ' ALA . 27.9 mm -119.69 103.07 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.977 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.98 79.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.808 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -176.48 144.14 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -101.18 120.48 40.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.969 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.75 172.18 7.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.05 95.06 9.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.414 HG13 ' CD1' ' A' ' 122' ' ' PHE . 21.5 t -86.3 90.34 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.13 175.43 10.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -130.43 151.6 50.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -129.2 80.74 1.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.128 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.561 -0.215 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t -171.99 141.62 1.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.889 0.375 . . . . 0.0 110.917 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 p -118.91 131.68 56.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.94 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.74 134.91 41.11 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.488 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.7 t -167.57 96.24 0.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.857 0.361 . . . . 0.0 110.966 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -118.11 149.62 40.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.88 -162.97 37.13 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.537 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.7 tt -177.56 133.38 0.35 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.587 0.232 . . . . 0.0 111.043 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.11 144.3 38.28 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.4 2.067 . . . . 0.0 112.391 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.89 30.97 3.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.789 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.592 ' O ' HG23 ' A' ' 11' ' ' VAL . 19.3 m -133.16 86.54 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.168 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -146.61 -56.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -126.45 155.61 41.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -129.03 172.1 11.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -137.55 109.62 7.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -61.36 126.9 29.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.858 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.8 p -147.75 107.26 3.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.952 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 t -156.5 178.65 10.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.482 ' HB3' HD22 ' A' ' 106' ' ' LEU . 38.6 mt-30 -107.2 163.29 13.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.861 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -157.36 142.59 17.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.982 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -81.87 118.81 23.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.2 p -84.94 133.43 34.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -138.58 174.52 10.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.21 147.08 23.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.976 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.7 m -68.27 -21.2 26.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.324 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.23 -29.53 33.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.215 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 6.1 mtt -71.94 -41.49 67.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tt -121.46 83.43 2.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -172.46 -178.78 2.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.072 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.6 164.85 13.97 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.87 -45.35 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.603 2.202 . . . . 0.0 112.304 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.7 -31.32 32.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.52 118.97 37.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.45 -40.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.969 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.73 -30.38 71.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.879 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.27 -43.94 92.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.86 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -66.78 -30.93 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.134 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -78.42 -31.37 48.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -71.8 86.46 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.412 ' HA2' ' CE1' ' A' ' 146' ' ' PHE . . . 139.45 -156.83 24.83 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.488 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.22 40.28 1.62 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.552 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HG2' HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -98.85 149.36 22.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.921 0.391 . . . . 0.0 110.891 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.593 HD13 ' SG ' ' A' ' 77' ' ' CYS . 39.6 pt -126.99 170.74 16.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.179 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mt -122.83 99.78 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.033 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -99.93 157.5 33.77 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -51.87 160.24 3.09 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.515 2.143 . . . . 0.0 112.282 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.09 -27.42 42.03 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.494 2.129 . . . . 0.0 112.357 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.43 -31.22 71.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.3 -39.16 89.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.088 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.436 HD13 ' CE1' ' A' ' 82' ' ' PHE . 24.1 tp -60.11 -42.3 94.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -74.27 -42.28 59.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.716 ' HG2' HD11 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -61.63 -47.14 86.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.999 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.442 HD11 ' HZ ' ' A' ' 64' ' ' PHE . 13.7 mt -54.12 -26.92 29.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.122 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.96 -27.52 24.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.033 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -97.12 20.05 11.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.268 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.716 HD11 ' HG2' ' A' ' 52' ' ' GLN . 31.1 mt -126.17 20.0 7.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.721 0.296 . . . . 0.0 111.295 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 55.05 30.04 13.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.804 0.335 . . . . 0.0 111.072 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.425 HD12 HD23 ' A' ' 53' ' ' LEU . 28.0 mt -98.24 124.61 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.152 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 t -114.98 169.5 9.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.469 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -70.98 145.17 91.24 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.77 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.7 Cg_endo -76.88 156.24 97.63 Favored 'Cis proline' 0 C--N 1.348 0.503 0 C-N-CA 123.549 -1.438 . . . . 0.0 112.393 0.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.6 mtt -115.76 66.68 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.705 HD22 ' HB2' ' A' ' 148' ' ' CYS . 10.0 mt -84.32 123.47 30.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.442 ' HZ ' HD11 ' A' ' 53' ' ' LEU . 59.9 m-85 -98.31 142.95 29.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -101.03 82.72 2.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.506 HD12 ' SG ' ' A' ' 77' ' ' CYS . 10.6 mt -60.9 94.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -94.46 112.55 24.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.861 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -71.06 103.8 2.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -79.95 61.98 4.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -174.08 -41.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.854 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.24 4.59 26.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.398 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 57.83 49.06 12.66 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.905 0.384 . . . . 0.0 110.904 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.414 ' HB3' HD23 ' A' ' 99' ' ' LEU . 3.4 mmp_? -107.64 168.82 8.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.4 ttm -157.39 128.4 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.679 HG21 HD11 ' A' ' 99' ' ' LEU . 10.3 t -145.81 148.74 33.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.948 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -116.11 95.28 5.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.932 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.593 ' SG ' HD13 ' A' ' 43' ' ' ILE . 30.5 p -107.04 160.98 15.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -118.16 134.91 11.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.531 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.612 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 11.7 p -73.87 151.41 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 111.09 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.547 HD22 ' HG2' ' A' ' 42' ' ' LYS . 63.6 tp -137.55 -59.13 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -102.26 145.34 29.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.612 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 82.4 m-85 -124.89 75.66 1.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.851 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 m -136.57 30.86 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.623 ' HB1' ' O ' ' A' ' 88' ' ' ILE . . . -94.68 155.26 16.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.541 ' HB2' HD12 ' A' ' 88' ' ' ILE . 4.0 m-20 -80.58 160.26 25.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -60.34 113.02 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.5 27.64 32.15 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.58 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.623 ' O ' ' HB1' ' A' ' 84' ' ' ALA . 26.0 mt -148.59 98.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 111.131 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.7 t -103.19 135.12 45.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -103.77 136.78 42.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 mp -136.12 157.55 75.48 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -51.95 179.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.573 2.182 . . . . 0.0 112.321 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.71 -35.54 15.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.734 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 65.3 p-90 -68.06 -43.17 79.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.459 ' HE2' ' CH2' ' A' ' 94' ' ' TRP . 31.0 ttm -66.93 -33.08 74.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.956 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.8 mmt -60.57 -39.83 89.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.811 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -79.34 -33.86 42.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.886 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -60.31 -31.1 69.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.679 HD11 HG21 ' A' ' 75' ' ' THR . 3.8 mt -102.13 0.28 34.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.375 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.4 mt 57.87 30.78 19.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.82 0.343 . . . . 0.0 110.919 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.482 HD11 HG21 ' A' ' 107' ' ' VAL . 38.7 mt -82.42 -178.63 7.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -144.56 -174.19 4.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.789 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -76.82 90.78 3.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.05 50.18 0.74 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.532 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.65 141.91 17.19 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.477 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.482 HD22 ' HB3' ' A' ' 19' ' ' GLN . 59.5 mt -85.65 127.19 34.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.482 HG21 HD11 ' A' ' 101' ' ' LEU . 21.5 t -130.41 139.68 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -80.26 121.77 26.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.412 HG22 HD23 ' A' ' 66' ' ' LEU . 21.5 t -105.27 139.22 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.093 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -143.18 130.03 20.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.3 p -88.77 123.17 32.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.89 140.26 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.134 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -91.96 112.14 23.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.681 HD13 ' O ' ' A' ' 176' ' ' ALA . 11.6 mt -115.76 176.86 4.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -128.01 173.96 9.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.841 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.5 m -59.71 164.67 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.056 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.975 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -96.94 160.74 14.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.103 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 58.3 p -119.58 -41.12 2.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.809 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -133.08 92.4 3.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.807 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.92 143.26 35.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.941 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -117.23 169.76 9.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.828 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.761 ' CD2' HD21 ' A' ' 139' ' ' LEU . 42.9 m-85 -153.75 139.82 18.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -128.57 86.64 57.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.533 ' HA ' HD23 ' A' ' 166' ' ' LEU . 59.4 Cg_exo -51.56 125.44 16.78 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.573 2.182 . . . . 0.0 112.375 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -80.99 -31.22 34.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.5 p -101.01 146.57 32.37 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.595 ' HA ' HD12 ' A' ' 130' ' ' LEU . 62.9 Cg_endo -73.37 -17.14 24.27 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.528 2.152 . . . . 0.0 112.51 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.22 -38.48 68.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.073 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -76.07 -38.28 57.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.595 HD12 ' HA ' ' A' ' 127' ' ' PRO . 21.4 mt -63.48 -32.33 73.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -67.26 -26.1 66.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.061 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.529 HD13 HG21 ' A' ' 138' ' ' VAL . 47.9 mt -64.68 124.49 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.124 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.5 m -59.96 -39.06 84.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.48 77.71 4.47 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.17 -27.79 19.57 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.574 2.183 . . . . 0.0 112.252 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -64.41 -39.77 94.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.0 -51.66 44.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.09 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.529 HG21 HD13 ' A' ' 132' ' ' ILE . 21.4 t -59.73 -30.51 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.761 HD21 ' CD2' ' A' ' 122' ' ' PHE . 6.1 tp -75.98 -44.71 38.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.38 -38.35 77.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -59.63 -31.09 69.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.968 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -86.04 -31.61 21.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.049 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.422 HD22 HD13 ' A' ' 179' ' ' ILE . 28.1 mt -61.35 -28.48 69.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -57.56 -29.71 64.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.067 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -79.07 -31.24 44.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.412 ' CE1' ' HA2' ' A' ' 40' ' ' GLY . 7.4 m-85 -83.6 150.68 25.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -109.87 -29.37 8.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.173 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.705 ' HB2' HD22 ' A' ' 63' ' ' LEU . 17.4 t -141.58 158.69 43.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.6 mt -131.66 178.53 6.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.0 m -158.89 136.63 10.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.5 m -65.41 121.57 15.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.8 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.75 41.34 9.83 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.356 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.77 106.71 9.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.836 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.8 t -66.57 107.02 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.011 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.734 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 4.0 pt -109.1 132.17 57.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.116 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -92.45 129.85 38.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.083 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.455 HG12 HD12 ' A' ' 166' ' ' LEU . 3.0 pt -115.36 140.87 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.155 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -143.01 145.21 32.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -161.3 -48.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.923 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 48.0 p30 -101.66 44.93 0.99 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.976 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.77 30.79 20.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.96 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -139.36 119.04 13.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.425 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.7 mp -88.84 83.99 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.164 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -62.95 179.97 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -132.31 130.72 41.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.888 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 124' ' ' PRO . 20.2 mt -145.63 159.07 43.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.864 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -153.0 114.96 4.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.52 HG22 ' CE1' ' A' ' 122' ' ' PHE . 21.5 t -59.72 135.41 24.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 41.1 mmm -99.97 -46.71 5.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.942 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.38 156.18 44.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.6 p -153.06 157.24 40.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.416 ' O ' HG11 ' A' ' 177' ' ' VAL . 39.2 mttt -143.12 154.9 61.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.3 -31.4 5.31 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 123.298 -1.542 . . . . 0.0 112.434 0.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -108.34 167.67 9.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -35.17 71.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.949 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.681 ' O ' HD13 ' A' ' 114' ' ' LEU . . . -113.61 115.43 27.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.023 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.975 HG21 ' HB2' ' A' ' 117' ' ' ALA . 27.5 m -118.67 154.79 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.438 ' CB ' HD11 ' A' ' 63' ' ' LEU . 1.5 t -99.89 80.01 2.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.422 HD13 HD22 ' A' ' 143' ' ' LEU . 3.1 pt -71.28 81.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.202 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.2 mt -125.19 95.92 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.079 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 61.59 78.38 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.08 148.43 2.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.02 136.57 43.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.946 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.589 ' SD ' ' HB3' ' A' ' 117' ' ' ALA . 4.1 ptt? -143.54 167.45 22.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.1 85.41 5.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.0 108.79 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.108 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.09 179.96 5.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -138.28 140.83 39.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -107.56 99.5 8.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.819 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.255 -0.878 . . . . 0.0 111.057 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 m 60.71 85.64 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.792 0.33 . . . . 0.0 110.961 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -108.11 152.04 25.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.2 65.91 0.3 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.531 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -73.05 163.48 28.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.798 0.332 . . . . 0.0 110.85 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.1 t 59.87 175.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 61.7 -98.91 0.2 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.491 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.2 mt 68.82 84.28 0.15 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.781 0.324 . . . . 0.0 111.177 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.76 148.5 28.25 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.608 2.205 . . . . 0.0 112.288 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.11 38.94 0.51 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.8 m -116.47 30.69 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.14 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.59 -46.59 65.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -90.29 87.23 6.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -66.43 -64.41 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 60.53 159.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -75.81 138.97 41.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.8 p -158.56 85.31 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.415 HG22 ' N ' ' A' ' 19' ' ' GLN . 92.7 m -148.95 160.31 43.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.869 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.415 ' N ' HG22 ' A' ' 18' ' ' THR . 17.9 mt-30 -103.12 121.16 42.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.877 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.66 ' HB2' HG21 ' A' ' 109' ' ' VAL . 2.6 m-85 -122.25 146.87 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.96 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -69.89 169.16 13.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.6 m -131.15 112.77 13.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.52 ' CD2' HG23 ' A' ' 88' ' ' ILE . 82.0 m-85 -122.73 162.46 21.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -83.48 154.21 24.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.5 m -65.25 -29.67 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.112 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.2 p -57.98 -27.19 63.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.037 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.0 mmt -64.03 -38.05 89.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.97 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 tp -57.87 -36.12 71.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.926 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.97 176.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.138 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 140.54 136.05 3.28 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.431 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.81 -36.17 81.7 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.428 2.085 . . . . 0.0 112.209 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -116.54 120.02 37.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.843 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.73 165.95 10.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.837 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.5 148.06 30.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.09 33.59 4.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.751 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -118.15 -40.94 2.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.96 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.1 t -62.62 -45.81 97.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.084 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -39.51 76.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.946 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -84.38 94.25 8.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.83 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.18 -134.01 7.41 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.606 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.1 52.3 0.56 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.524 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.9 154.17 26.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 0.0 110.804 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.647 HG21 HD23 ' A' ' 91' ' ' LEU . 40.2 pt -136.85 161.2 36.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.187 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.404 HG23 ' HB3' ' A' ' 81' ' ' GLU . 21.5 mt -110.09 102.13 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.15 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 82.7 mtp -99.55 161.4 24.64 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -55.89 159.52 11.73 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.532 2.155 . . . . 0.0 112.234 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.2 -27.78 23.96 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.625 2.217 . . . . 0.0 112.297 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 p -59.4 -31.75 69.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.23 -36.43 77.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.124 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.79 -44.27 97.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -71.9 -31.18 66.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.942 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.42 -41.5 60.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -61.55 -48.07 82.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.7 p -65.31 -30.82 71.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.876 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.58 -20.35 58.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.2 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.8 mt -94.38 20.03 8.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.295 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.9 t30 56.16 30.59 16.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 111.064 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.3 mt -97.81 141.67 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.129 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 p -134.37 172.1 13.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.454 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.5 t80 -60.6 140.62 92.55 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.855 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.454 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.6 Cg_endo -77.05 163.24 89.82 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 123.501 -1.458 . . . . 0.0 112.345 0.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.4 mtt -130.45 69.42 1.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.454 HD11 ' OG ' ' A' ' 178' ' ' SER . 2.0 mt -90.13 147.56 23.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -113.5 126.75 55.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -82.81 89.09 6.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.413 HD11 HD21 ' A' ' 91' ' ' LEU . 13.6 mt -68.03 77.5 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.857 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -81.92 95.39 7.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.552 ' OD1' HD21 ' A' ' 101' ' ' LEU . 2.9 t-20 -64.38 116.04 5.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.828 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -98.11 29.51 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -119.16 -40.5 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 m -124.28 21.79 8.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.098 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 54.4 37.97 28.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.036 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.416 ' HB3' HD23 ' A' ' 99' ' ' LEU . 8.9 mmp_? -93.09 171.85 8.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.963 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.1 ttp -156.08 125.42 6.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.0 m -144.52 132.25 21.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.888 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.46 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 12.0 m80 -107.35 101.0 10.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.917 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.457 ' SG ' HD13 ' A' ' 43' ' ' ILE . 28.8 p -108.06 172.66 6.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -134.6 137.67 9.45 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.528 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.79 150.91 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.761 0.315 . . . . 0.0 111.091 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.5 tp -133.44 -60.71 0.83 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.404 ' HB3' HG23 ' A' ' 44' ' ' ILE . 1.8 mp0 -99.51 157.24 16.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -130.32 55.46 1.81 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.827 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.14 31.76 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.21 168.46 11.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.415 ' HB3' HD12 ' A' ' 88' ' ' ILE . 3.0 m-20 -83.74 151.8 25.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.861 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -59.9 134.87 57.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.13 24.86 70.66 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.501 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.52 HG23 ' CD2' ' A' ' 23' ' ' PHE . 29.4 mt -145.93 92.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.85 0.357 . . . . 0.0 111.033 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 83.8 m -92.18 126.15 37.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.022 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -92.7 141.3 28.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.777 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.647 HD23 HG21 ' A' ' 43' ' ' ILE . 3.1 mp -141.67 160.21 57.2 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.853 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.504 ' HD3' HG22 ' A' ' 43' ' ' ILE . 55.4 Cg_exo -51.84 177.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.53 2.154 . . . . 0.0 112.365 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -84.32 -46.16 12.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.755 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 70.1 p-90 -60.24 -38.49 83.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.882 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.9 ttm -61.29 -40.81 95.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -41.85 99.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.892 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -71.79 -36.76 70.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -62.25 -39.0 91.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 68' ' ' ASN . 52.0 mt -87.25 -20.68 26.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.4 mt 61.74 42.83 10.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.878 0.37 . . . . 0.0 110.924 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.552 HD21 ' OD1' ' A' ' 68' ' ' ASN . 44.3 mt -87.72 170.01 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.77 179.33 3.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.905 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.92 88.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.886 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.48 47.71 1.38 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.395 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.07 107.95 3.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.457 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 32.3 mt -69.59 132.61 46.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.804 0.335 . . . . 0.0 110.941 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.32 149.52 32.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.073 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -63.26 110.18 1.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.66 HG21 ' HB2' ' A' ' 20' ' ' TYR . 22.4 t -99.58 120.59 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -148.84 142.59 25.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.836 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.1 p -90.15 114.66 26.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.854 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 20.4 m -116.46 152.18 18.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.129 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -108.55 119.11 38.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.1 mt -119.48 179.93 4.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.14 171.61 7.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.915 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.0 m -71.51 133.57 31.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.784 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -65.27 147.42 53.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.149 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.7 p -111.98 -35.53 5.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.431 ' CE1' ' HB2' ' A' ' 187' ' ' ASP . 75.2 t80 -133.23 99.8 4.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.5 p -113.43 111.05 21.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -102.67 136.53 42.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.587 ' CD1' HD21 ' A' ' 139' ' ' LEU . 20.7 m-85 -120.43 155.24 33.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.923 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -133.04 94.62 20.18 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.96 120.4 6.01 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.552 2.168 . . . . 0.0 112.374 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -76.13 -31.48 58.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.965 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.44 149.4 42.1 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.974 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.23 -9.68 26.49 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.536 2.157 . . . . 0.0 112.684 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.417 ' HB3' ' CE2' ' A' ' 164' ' ' TYR . 0.3 OUTLIER -56.41 -35.39 67.74 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.08 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.497 ' CD1' HD11 ' A' ' 166' ' ' LEU . 9.2 t80 -79.61 -34.01 41.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.812 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.8 mt -66.0 -34.77 78.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.29 -26.2 68.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.068 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.488 HD13 HG21 ' A' ' 138' ' ' VAL . 39.1 mt -60.04 139.4 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.002 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.5 m -61.24 -53.35 58.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.39 80.01 29.08 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.875 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.412 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 38.9 Cg_exo -57.15 -35.1 98.83 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.54 2.16 . . . . 0.0 112.194 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -34.08 73.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.962 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.49 -39.06 74.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.114 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.515 HG13 ' OH ' ' A' ' 159' ' ' TYR . 22.1 t -75.43 -30.97 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.587 HD21 ' CD1' ' A' ' 122' ' ' PHE . 9.0 tp -76.71 -30.72 56.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.009 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -80.67 -31.67 36.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.944 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.66 -32.0 70.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.27 -33.5 32.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.104 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.5 ' CD2' HD11 ' A' ' 149' ' ' LEU . 22.7 mt -59.87 -28.93 67.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.043 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -58.29 -33.03 68.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -79.53 -31.14 42.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.725 ' HB3' HD11 ' A' ' 179' ' ' ILE . 4.0 m-85 -71.26 145.56 49.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -108.54 -27.27 9.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.192 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.87 171.61 13.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.537 HD22 HG21 ' A' ' 168' ' ' VAL . 2.7 mt -155.41 136.15 13.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.89 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.22 149.78 47.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.816 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 57.0 m -69.27 100.39 1.31 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.65 28.55 4.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.501 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.89 90.08 4.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.85 0.357 . . . . 0.0 110.867 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.608 HG22 ' HG3' ' A' ' 167' ' ' ARG . 27.7 t -63.37 100.68 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.104 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.755 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 1.2 pt -109.54 161.98 7.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.11 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.688 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -127.28 99.41 5.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.11 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.2 pt -69.41 150.1 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.044 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -158.33 150.3 21.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.515 ' OH ' HG13 ' A' ' 138' ' ' VAL . 30.5 p90 -177.29 -37.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.087 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -103.47 38.94 1.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.944 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 60.86 29.96 19.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -145.87 108.39 4.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.784 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.688 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 2.0 mp -82.48 112.82 20.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.127 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 128' ' ' ASP . 32.5 m-85 -94.13 131.78 39.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.837 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -83.52 107.34 15.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.497 HD11 ' CD1' ' A' ' 129' ' ' PHE . 0.8 OUTLIER -128.68 136.4 50.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.608 ' HG3' HG22 ' A' ' 154' ' ' VAL . 22.7 ttt180 -130.61 131.85 45.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.537 HG21 HD22 ' A' ' 149' ' ' LEU . 21.0 t -70.14 154.41 8.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.406 ' N ' HG12 ' A' ' 168' ' ' VAL . 43.5 mmm -121.35 -57.68 1.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -124.55 141.53 52.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.915 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.426 ' CG2' HG11 ' A' ' 168' ' ' VAL . 40.3 p -145.22 148.29 33.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.566 ' O ' HG11 ' A' ' 177' ' ' VAL . 22.6 mttt -133.94 158.02 76.37 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.21 -41.64 0.92 Allowed 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.222 -1.574 . . . . 0.0 112.427 -0.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.35 178.47 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.843 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -47.49 82.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.46 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -99.06 129.48 45.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.03 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.784 HG21 ' HB2' ' A' ' 117' ' ' ALA . 30.0 m -132.55 135.92 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.201 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.454 ' OG ' HD11 ' A' ' 63' ' ' LEU . 8.0 t -93.04 96.9 10.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.725 HD11 ' HB3' ' A' ' 146' ' ' PHE . 3.6 pt -88.24 82.72 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.132 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.2 mt -109.89 81.02 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.104 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.26 89.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 2.8 t -162.95 166.23 24.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -106.74 121.68 44.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.896 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -134.72 172.1 13.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.951 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.12 111.8 23.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.527 HG11 HD23 ' A' ' 139' ' ' LEU . 21.2 t -96.03 131.77 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.146 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.431 ' HB2' ' CE1' ' A' ' 119' ' ' TYR . 10.6 t70 -114.8 167.19 10.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -127.41 141.67 51.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.974 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -122.5 81.8 1.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.04 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.35 102.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.8 0.333 . . . . 0.0 110.866 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.4 p -104.0 36.42 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.65 122.57 6.76 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.508 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.79 -74.23 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.782 0.325 . . . . 0.0 110.899 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.0 t 61.15 35.55 18.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.985 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.02 -110.52 4.04 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.508 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.7 mt -95.69 102.44 10.22 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.646 0.26 . . . . 0.0 111.026 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.02 116.1 4.14 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.334 2.023 . . . . 0.0 112.316 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.22 172.94 12.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.8 m -99.42 29.71 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.113 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 59.88 160.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.929 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -166.7 119.13 0.99 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.814 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -109.13 132.22 54.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.044 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.8 mtm105 -148.94 136.53 20.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -91.1 117.96 30.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.826 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.7 p -141.59 129.16 21.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.1 t -176.5 160.42 2.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -77.76 149.66 34.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -155.02 145.22 21.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.917 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.2 mtt85 -76.5 148.15 37.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 64.3 m -113.52 127.7 56.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.511 ' CD2' HG23 ' A' ' 88' ' ' ILE . 17.4 m-85 -129.01 175.89 8.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.59 156.75 17.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.9 m -67.48 -30.17 48.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -32.1 73.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.803 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.2 mmm -67.89 -18.3 64.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.194 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.2 tp -52.81 -33.2 48.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.836 0.351 . . . . 0.0 111.065 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.9 -175.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.131 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.42 149.08 13.89 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.51 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.82 -61.56 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.539 2.159 . . . . 0.0 112.301 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -66.47 169.25 7.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -144.25 175.05 10.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -138.67 150.57 46.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.919 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.0 30.56 4.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.853 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -119.43 -40.01 2.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.9 m -58.16 -37.95 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -73.5 -37.32 65.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -97.57 76.17 2.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.82 159.24 7.86 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.482 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.92 92.1 1.44 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.533 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.593 ' HG2' HD13 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -153.38 129.26 10.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.327 . . . . 0.0 110.904 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.507 HD13 ' SG ' ' A' ' 77' ' ' CYS . 45.1 pt -123.64 179.91 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.145 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.405 HG22 ' HB2' ' A' ' 84' ' ' ALA . 10.7 mt -130.11 115.65 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.064 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.541 ' C ' ' HB3' ' A' ' 84' ' ' ALA . 25.3 mtp -117.35 158.6 44.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.619 ' N ' ' HB3' ' A' ' 84' ' ' ALA . 50.5 Cg_exo -53.14 163.79 2.09 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.597 2.198 . . . . 0.0 112.234 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.31 -27.76 23.42 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.495 2.13 . . . . 0.0 112.234 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.1 p -59.14 -35.7 73.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.92 -32.56 72.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.8 tp -70.91 -39.51 72.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.19 -33.02 56.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -67.04 -41.55 86.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.572 HD23 HD12 ' A' ' 58' ' ' ILE . 16.4 mt -63.5 -31.6 72.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.9 t -68.88 -42.68 76.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -66.92 -32.19 73.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.4 mt -79.89 -3.26 47.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.461 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 m120 62.2 30.78 17.72 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.733 0.301 . . . . 0.0 110.909 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.572 HD12 HD23 ' A' ' 53' ' ' LEU . 30.5 mt -90.18 106.9 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.109 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.1 p -90.43 171.81 9.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.939 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.488 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -59.25 145.21 81.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.803 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 78.9 Cg_endo -77.41 167.63 78.81 Favored 'Cis proline' 0 C--N 1.347 0.499 0 C-N-CA 123.478 -1.468 . . . . 0.0 112.482 -0.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 4.8 mtt -128.73 62.02 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.419 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -82.85 158.94 22.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.948 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -131.25 126.58 35.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -82.69 106.42 14.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.9 mt -82.41 79.36 8.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.835 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -75.84 93.47 3.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.979 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.52 ' HA ' HG13 ' A' ' 107' ' ' VAL . 5.4 t-20 -68.08 120.04 13.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -97.75 38.07 1.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -128.46 -45.65 1.34 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.8 23.24 7.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.124 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 54.75 39.26 31.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.046 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -89.32 160.43 16.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.964 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 ttm -155.95 124.83 6.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.0 m -153.8 121.38 5.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.854 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -86.01 97.15 10.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.507 ' SG ' HD13 ' A' ' 43' ' ' ILE . 26.4 p -85.19 159.42 20.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -118.26 128.71 7.86 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.521 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.485 HG21 ' CE1' ' A' ' 82' ' ' PHE . 11.4 p -75.45 137.44 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.76 0.314 . . . . 0.0 111.117 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.593 HD13 ' HG2' ' A' ' 42' ' ' LYS . 6.3 tp -124.85 -56.49 1.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -103.39 142.75 33.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.485 ' CE1' HG21 ' A' ' 79' ' ' VAL . 49.9 m-85 -118.01 67.82 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.942 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.04 30.99 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.078 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.619 ' HB3' ' N ' ' A' ' 46' ' ' PRO . . . -86.25 157.92 19.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.658 ' HB2' HD12 ' A' ' 88' ' ' ILE . 3.2 m-20 -81.91 165.28 20.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -63.6 106.86 1.03 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.19 29.93 21.19 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.486 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' A' ' 85' ' ' ASP . 31.9 mt -144.96 117.16 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 0.0 111.132 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 61.7 m -125.29 129.52 50.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -97.82 149.4 22.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 mp -144.34 155.05 57.76 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.957 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.25 170.64 0.23 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.575 2.183 . . . . 0.0 112.307 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -78.02 -44.51 26.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -60.24 -37.28 79.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 50.1 ttm -75.05 -31.62 61.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -42.72 81.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.841 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -75.14 -40.41 59.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.839 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -60.5 -35.92 77.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.495 HD13 HD11 ' A' ' 101' ' ' LEU . 72.6 mt -83.11 -21.99 33.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.15 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 86.3 mt 61.55 38.06 15.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.495 HD11 HD13 ' A' ' 99' ' ' LEU . 8.4 mt -86.51 -178.26 6.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -115.92 168.36 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -65.31 81.39 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.98 41.14 1.86 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.518 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.83 135.73 13.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.555 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.4 mt -81.98 124.6 29.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 0.0 110.935 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 68' ' ' ASN . 21.6 t -130.36 153.37 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.5 143.78 51.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.6 t -124.86 149.4 29.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -157.61 131.47 8.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.9 p -91.86 101.66 14.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.5 m -117.91 144.82 24.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.105 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -102.63 113.04 26.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.6 mt -102.68 171.89 7.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -115.84 171.89 7.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.849 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.1 m -60.41 155.68 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.061 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.896 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -89.59 156.41 18.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.077 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.33 -35.67 4.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -133.94 92.58 2.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.63 110.93 23.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.88 130.4 53.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.607 ' CZ ' HD21 ' A' ' 143' ' ' LEU . 37.6 m-85 -118.26 156.21 29.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.878 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -136.01 87.67 23.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.25 116.64 2.95 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.523 2.149 . . . . 0.0 112.363 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -68.54 -31.3 70.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.963 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -103.74 143.92 27.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.972 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.62 -17.06 20.88 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.585 2.19 . . . . 0.0 112.543 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -33.22 63.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.136 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.598 ' CE2' HD11 ' A' ' 166' ' ' LEU . 7.5 t80 -73.36 -48.48 33.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 70.4 mt -59.29 -30.37 68.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.919 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.85 -25.64 67.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.964 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.594 HG21 HG21 ' A' ' 138' ' ' VAL . 38.7 mt -59.96 138.96 20.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.06 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.7 m -64.0 -42.9 97.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.669 ' O ' HG23 ' A' ' 138' ' ' VAL . 3.2 m120 -117.62 79.97 13.09 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.979 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.46 -28.39 21.96 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.602 2.202 . . . . 0.0 112.247 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -68.5 -38.94 81.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.948 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.77 -38.04 70.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.051 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 134' ' ' ASN . 27.9 t -69.59 -35.51 66.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.019 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.428 HD23 HG11 ' A' ' 186' ' ' VAL . 5.5 tp -78.82 -42.75 26.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.829 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.707 ' HA ' HD12 ' A' ' 143' ' ' LEU . 43.3 mt-10 -66.89 -35.94 81.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -65.24 -34.39 78.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.72 -32.64 27.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.088 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 140' ' ' GLU . 12.4 mt -60.63 -30.12 69.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -58.8 -31.39 68.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -74.4 -33.69 63.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.17 149.95 45.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -110.07 -27.44 9.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.248 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 4.5 t -141.65 163.55 32.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.0 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 149' ' ' LEU . 12.4 mt -137.92 165.02 27.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.781 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.8 145.44 23.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.905 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.3 m -69.34 97.44 0.96 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.19 51.76 0.86 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.472 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.46 120.66 38.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.827 0.346 . . . . 0.0 110.908 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.24 93.2 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.071 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.446 HD12 HG23 ' A' ' 157' ' ' ILE . 1.1 pp -101.35 138.34 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.113 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.672 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -111.9 100.32 8.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.055 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.636 HG12 HD12 ' A' ' 166' ' ' LEU . 2.6 pt -80.0 160.17 4.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.165 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -156.53 147.55 22.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -171.69 -46.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.932 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -96.72 40.31 1.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.92 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 59.71 31.65 20.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -148.5 129.01 13.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.672 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 4.1 mp -87.67 97.51 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.076 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -78.8 120.79 23.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.53 128.99 38.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.981 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.636 HD12 HG12 ' A' ' 157' ' ' ILE . 1.5 mt -145.95 136.25 23.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -136.17 126.12 25.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.16 140.03 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.094 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.6 mmm -107.41 -49.44 3.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -139.17 154.47 48.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.91 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 80.6 p -156.92 125.72 5.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -111.63 158.09 37.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.819 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.01 -40.63 1.12 Allowed 'Cis proline' 0 C--N 1.347 0.459 0 C-N-CA 123.248 -1.563 . . . . 0.0 112.347 0.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.67 174.48 5.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -58.06 -46.71 84.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.912 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -102.62 128.96 49.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.071 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.896 HG21 ' HB2' ' A' ' 117' ' ' ALA . 16.0 m -139.98 153.38 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.167 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.48 101.86 11.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.2 pt -85.24 84.56 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.166 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 29.6 mm -118.51 89.54 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.113 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 60.47 87.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 30.2 t -166.54 154.54 10.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.59 97.07 7.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -102.53 170.27 8.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -93.9 88.27 5.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.866 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.428 HG11 HD23 ' A' ' 139' ' ' LEU . 29.5 t -78.52 120.69 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.43 162.5 16.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.813 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -118.33 162.88 17.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -153.31 96.38 2.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.965 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.117 -179.95 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.43 -178.46 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.937 0.398 . . . . 0.0 110.847 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.1 p -102.85 -71.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.92 174.06 44.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.509 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.9 m -105.68 -69.9 0.8 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.847 0.356 . . . . 0.0 110.936 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.62 105.28 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.54 -168.94 12.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.452 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 pt -128.45 139.03 34.35 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.625 0.25 . . . . 0.0 111.101 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.91 121.27 6.14 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.507 2.138 . . . . 0.0 112.374 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -98.58 139.0 34.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.2 m -101.46 124.28 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.094 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -76.44 -68.24 0.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -113.55 90.79 3.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.957 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.55 119.51 3.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.15 178.71 6.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -99.63 108.92 21.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.7 p -135.47 96.48 3.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.1 t -150.17 160.91 43.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -86.37 161.92 18.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.889 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -159.92 137.83 10.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -70.93 138.49 50.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 75.8 m -100.94 142.03 32.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.865 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -145.34 176.71 9.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.2 p -88.37 167.1 13.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.8 m -102.15 20.03 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.356 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.59 -29.65 9.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.949 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 1.1 mmt -58.61 -27.63 64.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.042 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.437 ' CD1' ' CE2' ' A' ' 90' ' ' TYR . 1.0 OUTLIER -57.42 157.47 6.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.937 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.73 179.86 4.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.088 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 140.67 154.44 6.24 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.475 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.09 -39.51 70.34 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.581 2.187 . . . . 0.0 112.249 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -126.11 170.01 12.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -133.88 147.48 51.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.17 147.74 27.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.944 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 p -108.2 -23.81 11.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.056 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -53.14 -29.88 33.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.107 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -60.51 -41.09 86.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.078 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -70.68 -31.73 68.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -99.57 86.75 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.88 -170.98 24.3 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.509 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.23 46.59 1.15 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.541 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -102.21 134.88 44.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.437 HG21 HD23 ' A' ' 91' ' ' LEU . 40.4 pt -127.63 177.15 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.5 mt -128.96 96.04 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.07 159.3 34.57 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.49 ' N ' ' HB3' ' A' ' 84' ' ' ALA . 47.5 Cg_exo -55.94 169.08 1.5 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.585 2.19 . . . . 0.0 112.27 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.25 -26.06 30.34 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.579 2.186 . . . . 0.0 112.369 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.28 -31.15 67.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.015 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . . . -63.32 -43.86 96.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.426 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 3.3 tp -70.82 -32.3 69.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.75 -25.75 44.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.035 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.04 -30.99 13.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.965 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.588 HD23 HD12 ' A' ' 58' ' ' ILE . 13.8 mt -60.47 -49.62 76.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.112 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.53 -31.47 69.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.068 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -70.5 -22.82 62.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.122 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.3 mt -94.78 20.06 9.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.193 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.67 35.58 25.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.863 0.363 . . . . 0.0 110.961 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.588 HD12 HD23 ' A' ' 53' ' ' LEU . 31.1 mt -100.94 124.89 54.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.59 170.4 8.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.808 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.444 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.5 t80 -65.46 140.6 97.69 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.837 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 72.1 Cg_endo -77.15 167.15 80.51 Favored 'Cis proline' 0 C--N 1.349 0.566 0 C-N-CA 123.53 -1.446 . . . . 0.0 112.393 0.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.7 mtt -131.74 69.03 1.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.56 HD11 ' OG ' ' A' ' 178' ' ' SER . 1.4 mt -82.15 148.8 28.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -118.34 142.65 47.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.416 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 10.8 tttt -97.13 107.67 20.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 66' ' ' LEU . 11.4 mt -89.65 99.71 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.0 103.02 12.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.95 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -67.7 129.27 39.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -97.66 38.26 1.3 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.61 -47.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.974 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m -106.31 13.42 28.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.296 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 53.87 30.66 11.83 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.77 0.319 . . . . 0.0 111.13 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.456 ' CB ' HD23 ' A' ' 99' ' ' LEU . 2.9 mmp_? -82.66 161.53 22.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.64 117.98 3.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.0 t -143.68 156.02 44.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.933 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.416 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 13.8 m80 -122.79 112.92 18.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 24.2 p -106.35 168.09 9.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.3 139.04 13.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.583 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.79 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 12.3 p -81.1 151.48 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 0.0 111.051 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.9 tp -129.09 -61.91 1.02 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -113.59 169.45 8.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.79 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 47.6 m-85 -138.75 75.16 1.5 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.852 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 m -142.51 32.48 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.154 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HB3' ' N ' ' A' ' 46' ' ' PRO . . . -92.03 161.9 14.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.054 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.511 ' HB3' HD12 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -82.04 158.26 23.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -60.1 132.77 54.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.24 28.2 73.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.526 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 85' ' ' ASP . 27.5 mt -147.98 127.18 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.835 0.35 . . . . 0.0 111.136 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 83.1 m -132.39 127.34 35.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.437 ' CE2' ' CD1' ' A' ' 28' ' ' LEU . 35.6 m-85 -94.15 134.12 36.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.437 HD23 HG21 ' A' ' 43' ' ' ILE . 4.1 mp -142.0 159.96 57.19 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.86 -177.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.554 2.169 . . . . 0.0 112.326 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -97.92 -31.64 12.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 45.4 p-90 -67.48 -34.8 77.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.965 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.4 tpp -79.1 -32.0 44.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 44.9 mmm -67.59 -31.35 71.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -37.03 22.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -59.97 -31.73 70.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.456 HD23 ' CB ' ' A' ' 73' ' ' ARG . 8.9 mt -91.62 -16.81 26.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.276 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.3 mt 65.19 33.7 9.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.827 0.346 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.7 mt -79.8 -178.52 6.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.89 175.77 8.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.901 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.9 101.13 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.85 43.03 7.4 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.564 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.85 128.96 9.19 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.54 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.3 mt -79.38 126.87 31.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.93 139.66 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -63.75 110.61 2.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.2 t -101.07 136.9 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.147 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -134.62 164.32 27.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.3 p -123.38 110.88 15.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.89 148.6 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.152 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -104.22 100.03 9.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.804 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.7 mt -96.21 178.44 5.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -120.44 169.65 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.3 m -64.02 146.15 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.033 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.785 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -90.87 149.59 21.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.045 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 75.4 p -114.23 -37.28 4.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -123.65 111.57 16.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.7 m -128.15 122.51 32.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -102.1 132.32 48.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.587 ' CE2' HG22 ' A' ' 168' ' ' VAL . 90.7 m-85 -119.02 161.6 19.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -150.76 93.02 3.79 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.27 117.86 3.51 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.545 2.164 . . . . 0.0 112.34 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -67.09 -33.19 74.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.908 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.73 146.31 33.46 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.61 -14.91 24.67 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.612 2.208 . . . . 0.0 112.541 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -55.05 -34.19 63.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.104 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 135' ' ' PRO . 22.6 t80 -73.68 -36.06 65.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.0 mt -63.27 -31.77 73.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -62.73 -23.09 67.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.071 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.675 HG22 ' H ' ' A' ' 134' ' ' ASN . 48.9 mt -59.94 140.06 18.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.001 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.0 t -69.7 -30.96 68.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.675 ' H ' HG22 ' A' ' 132' ' ' ILE . 2.1 m120 -133.12 67.26 77.09 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.406 ' HB3' ' CE1' ' A' ' 129' ' ' PHE . 37.3 Cg_exo -57.23 -34.0 97.02 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.634 2.223 . . . . 0.0 112.22 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.81 -44.77 92.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.86 -45.03 91.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.079 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.461 HG21 HG21 ' A' ' 132' ' ' ILE . 21.5 t -63.87 -39.89 87.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.442 HD22 ' CZ ' ' A' ' 188' ' ' PHE . 21.5 tp -67.02 -35.91 80.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -76.78 -32.06 57.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -65.42 -33.05 75.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.27 -35.13 28.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.155 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.7 mt -60.26 -30.0 69.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -58.71 -30.48 67.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -83.04 -34.62 26.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.93 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -66.14 136.15 55.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -99.08 -29.2 13.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.153 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.552 ' HB2' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -138.05 164.56 28.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.964 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.6 mt -141.65 154.31 45.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 15.5 m -144.71 141.71 29.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 37.9 m -72.72 119.61 17.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 90.7 43.51 4.81 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.523 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -131.14 122.88 27.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.745 0.307 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.23 84.96 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.055 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.4 pt -77.78 110.45 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.166 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.81 139.56 37.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.083 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 37.0 pt -128.44 144.34 38.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.175 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -138.45 142.68 39.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.792 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -167.45 -48.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.044 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -95.52 41.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 58.11 30.27 19.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.932 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -148.02 122.29 9.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.904 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.503 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.7 mp -81.42 89.12 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.125 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -67.53 166.15 15.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.83 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -117.15 137.82 52.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.27 149.2 29.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -138.73 129.59 26.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.587 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.3 t -74.12 113.24 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.188 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.6 mmt -68.0 -59.93 2.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -144.93 166.07 26.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 77.2 p -154.49 161.12 41.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -138.56 156.8 73.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.33 -18.48 17.88 Favored 'Cis proline' 0 C--N 1.347 0.487 0 C-N-CA 123.312 -1.537 . . . . 0.0 112.589 0.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -133.38 169.88 16.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.902 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -43.48 82.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.934 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -96.55 117.67 31.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' A' ' 117' ' ' ALA . 15.7 m -139.56 151.18 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.214 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.56 ' OG ' HD11 ' A' ' 63' ' ' LEU . 23.3 t -105.54 92.12 4.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.829 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.3 pt -87.48 83.4 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.198 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.2 mt -112.88 96.55 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.042 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.49 81.94 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.823 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 11.0 t -169.5 149.44 3.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.843 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.99 127.85 41.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -132.97 149.43 52.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -78.03 87.87 4.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.843 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.01 136.93 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -114.14 174.11 6.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' PHE . . . . . 0.442 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 15.6 m-85 -139.41 155.48 47.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.955 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -150.55 91.0 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.056 -179.948 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.481 -0.247 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.8 m 62.14 149.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 0.0 110.972 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 m 59.8 96.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.84 -177.18 51.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.425 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 t 60.65 88.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.846 0.355 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -103.23 157.89 16.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.93 -143.97 8.28 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.455 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 8' ' ' ILE . 12.1 tt -144.24 125.29 7.84 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.547 0.213 . . . . 0.0 111.02 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.76 149.55 67.01 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.355 2.037 . . . . 0.0 112.355 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.94 31.33 6.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 m -74.61 149.83 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.156 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -99.46 31.33 3.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -106.99 -60.24 1.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 60.58 178.17 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.6 mtt85 -119.9 -177.21 3.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -83.45 88.3 6.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.1 p -121.13 109.08 14.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.0 t -174.55 162.3 3.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -91.34 150.17 21.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -145.31 136.59 24.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.6 mtt180 -68.91 141.55 54.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.0 m -101.37 134.62 44.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.539 ' CD2' HG23 ' A' ' 88' ' ' ILE . 8.8 m-85 -146.89 138.49 24.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 76.0 p -66.76 138.32 57.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.498 HG12 ' HB3' ' A' ' 90' ' ' TYR . 17.2 m -59.39 -27.18 36.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.227 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.52 -27.5 57.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.034 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 32.4 mmt -57.79 -45.99 85.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.969 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.417 HD13 ' CE2' ' A' ' 90' ' ' TYR . 9.4 tp -60.92 142.61 56.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.821 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.64 174.87 5.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.14 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 144.62 146.92 4.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.419 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.54 -38.85 83.97 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.492 2.128 . . . . 0.0 112.352 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -93.34 126.16 38.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.95 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.95 -53.92 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.791 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.13 145.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.01 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.8 m -111.65 -21.15 11.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.19 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.71 -36.86 62.7 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.141 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.1 t -62.66 -39.31 84.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.016 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -31.99 71.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -78.31 -46.92 18.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.936 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.59 162.83 19.74 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.438 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.83 30.04 10.73 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.542 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -94.64 174.05 7.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.824 0.345 . . . . 0.0 110.891 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.525 HG22 ' HA ' ' A' ' 91' ' ' LEU . 5.2 pt -146.7 165.51 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.096 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.512 HG22 ' HB2' ' A' ' 84' ' ' ALA . 3.9 mt -116.49 106.04 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.066 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.432 ' C ' ' HB3' ' A' ' 84' ' ' ALA . 71.6 mtp -97.39 160.53 28.61 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.01 162.81 2.44 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.57 2.18 . . . . 0.0 112.301 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.4 -25.94 35.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.582 2.188 . . . . 0.0 112.348 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.4 t -58.86 -30.82 68.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.99 -32.79 73.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.088 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.466 HD13 ' CD2' ' A' ' 82' ' ' PHE . 25.1 tp -60.23 -33.18 71.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -89.1 -30.43 18.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.957 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -41.5 70.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.974 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.422 HD13 ' SD ' ' A' ' 62' ' ' MET . 44.1 mt -54.11 -30.82 50.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.061 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.05 -28.62 17.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -23.17 57.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.7 mt -93.12 17.41 10.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.317 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 54.96 32.46 18.09 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.784 0.326 . . . . 0.0 111.171 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 59' ' ' THR . 38.6 mt -96.27 153.54 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.119 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.402 ' N ' HG22 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -149.19 175.42 11.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.44 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 3.2 t80 -63.36 139.0 97.51 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.9 Cg_endo -76.6 162.1 92.43 Favored 'Cis proline' 0 C--N 1.348 0.55 0 C-N-CA 123.492 -1.462 . . . . 0.0 112.371 -0.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.422 ' SD ' HD13 ' A' ' 53' ' ' LEU . 12.1 mtt -130.48 65.17 1.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.482 HD11 ' OG ' ' A' ' 178' ' ' SER . 15.1 mt -87.69 139.66 30.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -113.1 142.65 45.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.412 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 1.0 OUTLIER -99.01 108.38 21.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.4 mt -95.68 90.63 5.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.4 m -95.8 121.73 37.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -82.01 128.53 34.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.946 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.7 31.4 2.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -120.04 -42.08 2.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.94 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.29 22.47 7.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 54.49 39.83 31.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.093 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.7 159.0 15.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.922 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -150.61 139.69 21.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.562 HG21 HD11 ' A' ' 99' ' ' LEU . 10.2 t -158.03 148.24 20.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.932 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.504 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 66.5 m80 -115.29 115.41 26.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.978 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.8 p -124.74 167.09 15.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.74 165.23 13.44 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.2 141.72 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.859 0.361 . . . . 0.0 111.09 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.5 tp -119.25 -60.63 1.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -107.03 161.94 14.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.971 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.466 ' CD2' HD13 ' A' ' 50' ' ' LEU . 90.0 m-85 -129.7 47.95 2.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.828 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 m -123.38 35.43 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.007 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' A' ' 44' ' ' ILE . . . -92.52 154.86 18.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.051 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.47 149.63 33.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.846 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -59.99 110.51 1.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.97 -22.7 36.78 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.643 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.539 HG23 ' CD2' ' A' ' 23' ' ' PHE . 25.7 mt -99.05 121.82 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 111.139 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 28.5 t -110.41 130.52 55.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.498 ' HB3' HG12 ' A' ' 25' ' ' VAL . 43.6 m-85 -93.23 143.16 26.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.99 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.525 ' HA ' HG22 ' A' ' 43' ' ' ILE . 1.3 mp -144.89 156.54 55.43 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.07 -174.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.538 2.159 . . . . 0.0 112.283 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.69 -37.93 10.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.893 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.664 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 53.7 p-90 -61.36 -39.47 90.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.2 ttp -65.86 -40.01 91.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -37.98 86.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.82 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -74.06 -38.21 64.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.819 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -65.96 -42.01 90.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.562 HD11 HG21 ' A' ' 75' ' ' THR . 8.2 mt -83.23 -16.87 44.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.204 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt 62.31 36.84 14.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.777 0.323 . . . . 0.0 110.9 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.7 mt -84.94 -177.42 6.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -134.42 168.63 18.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.06 91.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.84 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.428 ' HA2' ' CE2' ' A' ' 23' ' ' PHE . . . 106.68 43.74 1.4 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.487 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.08 123.62 7.88 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.531 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.9 mt -72.94 131.21 41.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.809 0.338 . . . . 0.0 110.951 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.72 150.49 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.002 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -72.11 143.37 49.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.36 108.62 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.134 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.49 123.74 34.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.922 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.5 p -81.49 121.78 26.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.4 m -125.94 155.07 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.57 100.81 9.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.776 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.448 HD13 ' C ' ' A' ' 176' ' ' ALA . 2.8 mt -98.6 178.92 4.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -115.71 170.8 8.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 m -70.36 135.03 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.09 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.606 ' HB2' ' CB ' ' A' ' 177' ' ' VAL . . . -74.28 145.45 43.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.8 p -111.53 -31.95 6.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.914 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -129.53 110.3 11.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 93.5 p -122.58 119.0 29.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -106.17 130.87 53.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.68 ' CD1' HD21 ' A' ' 139' ' ' LEU . 87.3 m-85 -117.86 158.81 24.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -143.05 97.93 5.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.57 110.89 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.442 2.094 . . . . 0.0 112.47 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -63.42 -31.4 72.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.1 m -114.33 149.03 41.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.618 ' HA ' HD12 ' A' ' 130' ' ' LEU . 57.4 Cg_endo -70.94 -14.87 32.62 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.618 2.212 . . . . 0.0 112.584 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -55.59 -35.65 66.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.053 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -75.53 -42.98 51.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.916 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 127' ' ' PRO . 13.5 mt -60.07 -31.2 69.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.83 -28.19 69.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.002 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.563 HG22 ' H ' ' A' ' 134' ' ' ASN . 45.8 mt -62.74 137.31 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.093 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.3 t -68.95 -34.28 75.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.706 ' O ' HG23 ' A' ' 138' ' ' VAL . 1.9 m120 -119.51 77.31 19.5 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.86 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.38 -28.31 22.45 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.619 2.212 . . . . 0.0 112.285 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -70.35 -46.67 63.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.15 -31.19 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.157 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 134' ' ' ASN . 26.3 t -78.78 -31.53 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.095 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.68 HD21 ' CD1' ' A' ' 122' ' ' PHE . 11.5 tp -84.5 -34.75 23.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.483 ' OE2' HG21 ' A' ' 186' ' ' VAL . 3.9 mm-40 -70.85 -30.44 66.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.976 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -73.43 -31.63 63.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.17 -31.64 64.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.118 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.498 HD13 ' CE ' ' A' ' 184' ' ' MET . 82.2 mt -59.4 -30.44 68.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.5 mmp_? -62.42 -26.65 68.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -95.97 26.72 3.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.091 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -135.84 152.65 51.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.835 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.13 -34.25 6.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 6.8 t -141.78 158.91 43.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.965 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.93 137.27 36.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.876 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.67 149.4 40.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 43.8 m -69.49 104.8 2.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.82 33.3 3.57 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.552 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.35 111.8 24.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.759 0.314 . . . . 0.0 110.928 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.544 HG22 ' HG3' ' A' ' 167' ' ' ARG . 21.6 t -79.53 79.95 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.075 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.698 HD12 HG23 ' A' ' 157' ' ' ILE . 3.2 pt -63.79 159.07 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.152 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.664 ' HB3' ' HB3' ' A' ' 94' ' ' TRP . . . -125.05 93.0 3.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.085 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.698 HG23 HD12 ' A' ' 155' ' ' ILE . 10.0 pt -85.53 152.72 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.184 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -154.85 140.89 18.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -161.89 -47.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.97 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -93.75 45.19 1.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 55.65 29.48 13.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.086 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -149.34 122.19 8.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.868 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.3 mp -85.12 108.53 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -80.1 173.78 12.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -123.95 110.07 14.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.31 117.52 21.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.826 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.544 ' HG3' HG22 ' A' ' 154' ' ' VAL . 1.8 ttt85 -111.14 133.22 53.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.5 127.16 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.087 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 23.9 mmm -85.6 -54.71 4.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 171' ' ' THR . 0.4 OUTLIER -142.73 160.19 40.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.952 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 170' ' ' GLU . 2.6 p -159.08 146.47 17.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.909 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -129.07 159.86 66.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.95 -41.39 0.97 Allowed 'Cis proline' 0 C--N 1.347 0.48 0 C-N-CA 123.238 -1.567 . . . . 0.0 112.366 -0.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -106.29 172.43 6.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -57.86 -48.71 79.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.061 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.504 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -93.29 110.8 22.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.001 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.606 ' CB ' ' HB2' ' A' ' 117' ' ' ALA . 15.4 m -118.72 133.64 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.167 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.482 ' OG ' HD11 ' A' ' 63' ' ' LEU . 22.2 t -89.73 99.95 12.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.5 pt -94.08 87.26 2.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.249 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.2 mt -118.29 84.59 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.052 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.36 75.35 0.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 49.6 t -153.27 153.99 33.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.903 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.83 129.73 40.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.498 ' CE ' HD13 ' A' ' 143' ' ' LEU . 13.0 ptt? -140.21 179.23 6.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.869 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.45 112.63 25.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.512 HG11 HD23 ' A' ' 139' ' ' LEU . 21.6 t -92.81 127.52 44.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.7 171.81 7.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.878 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -134.74 141.89 46.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -111.75 83.23 1.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.121 179.971 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.9 -69.93 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.879 0.371 . . . . 0.0 110.823 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m 59.4 101.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.009 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.7 133.6 1.78 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.532 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.2 p -71.48 -50.32 32.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.828 0.347 . . . . 0.0 110.867 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.3 m 62.29 119.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.939 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.94 176.33 42.28 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.443 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.3 pt -64.77 155.67 81.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.775 0.322 . . . . 0.0 111.072 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.14 58.66 4.32 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.703 2.269 . . . . 0.0 112.507 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.1 mtt85 48.09 -168.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.299 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.3 m -132.77 176.47 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.03 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -106.16 36.44 2.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -110.56 102.37 10.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.803 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -152.19 -169.67 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.937 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.48 ' N ' HD22 ' A' ' 56' ' ' LEU . 6.5 mtp180 61.14 166.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.865 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -102.85 128.39 49.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.0 p -160.03 112.8 2.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.1 t -176.86 159.46 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.935 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.629 ' HB3' HD22 ' A' ' 106' ' ' LEU . 20.8 mt-30 -95.94 121.85 38.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.814 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -115.48 147.41 40.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -75.17 129.54 37.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.592 ' HB2' HD13 ' A' ' 91' ' ' LEU . 16.6 p -99.01 133.33 43.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.972 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.533 ' CD2' HG23 ' A' ' 88' ' ' ILE . 87.4 m-85 -136.3 178.45 7.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.66 146.07 27.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.695 HG11 HG21 ' A' ' 37' ' ' VAL . 5.1 m -58.41 -26.15 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.257 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.73 -30.06 63.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.042 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 10.5 mmm -71.44 -30.46 66.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.965 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tp -58.91 91.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.95 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.38 -76.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.093 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.88 173.68 17.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.507 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.19 -37.64 7.9 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.642 2.228 . . . . 0.0 112.328 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -107.91 129.6 55.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.918 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.67 -68.5 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.2 mmm-85 -111.24 154.96 23.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.53 28.93 5.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.38 -37.34 3.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.994 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.695 HG21 HG11 ' A' ' 25' ' ' VAL . 19.4 m -56.77 -40.18 68.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.238 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.429 ' HG3' HG23 ' A' ' 37' ' ' VAL . 4.1 mt-10 -78.03 -31.06 50.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -78.53 -31.22 47.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.67 -178.57 20.14 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.564 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.75 53.24 0.63 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.544 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -114.74 165.04 13.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.851 0.357 . . . . 0.0 110.852 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.1 pt -133.38 174.4 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.543 HG23 ' HB2' ' A' ' 81' ' ' GLU . 2.5 mt -125.51 98.39 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.9 mtm -98.54 155.51 36.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.782 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.71 154.9 40.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.581 2.188 . . . . 0.0 112.211 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.8 -26.42 17.71 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.619 2.213 . . . . 0.0 112.566 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.6 p -58.79 -31.19 68.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.973 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.14 -30.26 69.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.261 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.419 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 33.8 tp -74.69 -30.14 61.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.998 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.18 -33.91 19.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.914 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.73 -38.88 62.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.454 HD13 ' SD ' ' A' ' 62' ' ' MET . 14.0 mt -59.1 -32.84 70.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.043 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -86.98 -30.06 21.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -22.61 62.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.12 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 15' ' ' ARG . 14.1 mt -93.93 19.19 9.31 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.244 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 55.12 30.47 14.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.871 0.367 . . . . 0.0 111.14 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.7 mt -99.03 120.81 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.098 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -109.59 168.35 9.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.965 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -60.17 144.58 87.02 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.464 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.89 158.27 96.89 Favored 'Cis proline' 0 C--N 1.348 0.5 0 C-N-CA 123.485 -1.464 . . . . 0.0 112.344 0.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.454 ' SD ' HD13 ' A' ' 53' ' ' LEU . 9.5 mtt -123.7 73.52 1.2 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.789 HD13 HD12 ' A' ' 114' ' ' LEU . 2.0 mt -91.26 134.9 34.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.853 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -102.8 141.3 35.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.404 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 13.5 tttp -94.97 97.6 10.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.4 mt -76.98 76.83 3.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 m -83.16 95.55 8.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -74.79 129.44 37.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.933 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -98.14 35.58 1.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -111.63 -35.66 5.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.841 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.1 t -151.94 29.72 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.973 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 58.72 35.83 24.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.002 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.575 ' HB3' HD23 ' A' ' 99' ' ' LEU . 12.8 mmt180 -81.82 143.31 31.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.929 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -144.22 135.02 25.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.741 HG22 HD21 ' A' ' 99' ' ' LEU . 1.8 t -159.97 95.25 1.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.404 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 62.0 m80 -63.68 115.75 5.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.0 p -121.91 151.31 40.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.37 138.91 15.06 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.519 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.3 146.82 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 111.066 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.9 tp -131.29 -56.65 1.02 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.543 ' HB2' HG23 ' A' ' 44' ' ' ILE . 4.1 mm-40 -91.76 142.85 27.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.841 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CD2' ' HB2' ' A' ' 50' ' ' LEU . 71.8 m-85 -128.3 55.62 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 m -137.07 35.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.177 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.11 161.89 13.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.109 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.62 155.53 38.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.91 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.46 127.37 31.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.948 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.35 27.69 65.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.558 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.533 HG23 ' CD2' ' A' ' 23' ' ' PHE . 29.8 mt -148.75 99.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 111.072 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 13.7 m -100.9 134.85 43.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.32 151.35 22.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 22' ' ' CYS . 5.1 mp -145.29 155.59 54.17 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.41 ' HD2' ' HE2' ' A' ' 95' ' ' MET . 53.6 Cg_exo -52.28 -176.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.528 2.152 . . . . 0.0 112.355 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -87.51 -50.67 6.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.944 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -61.96 -37.53 85.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.856 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.41 ' HE2' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -63.75 -38.26 90.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -47.22 70.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.801 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -38.08 89.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.814 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -59.55 -31.28 69.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.741 HD21 HG22 ' A' ' 75' ' ' THR . 6.3 mt -98.82 -15.25 19.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.234 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.9 mt 61.7 41.25 12.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 0.0 110.872 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.548 HD11 HD13 ' A' ' 99' ' ' LEU . 3.7 mt -79.33 159.04 27.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.828 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -111.13 -178.95 3.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.869 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.53 106.42 1.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.951 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.43 ' HA2' ' CZ ' ' A' ' 23' ' ' PHE . . . 85.8 33.77 14.93 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.545 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.74 136.03 17.48 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.52 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.629 HD22 ' HB3' ' A' ' 19' ' ' GLN . 34.5 mt -88.6 128.86 35.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.866 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.11 146.97 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.156 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -69.16 128.87 38.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.17 99.02 6.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.087 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -124.09 128.48 49.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.4 p -88.78 100.49 13.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 m -103.43 162.09 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.126 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -97.05 116.44 29.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.789 HD12 HD13 ' A' ' 63' ' ' LEU . 65.2 mt -115.4 170.78 8.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -127.4 164.56 21.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.926 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.2 m -62.65 140.47 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.661 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -76.63 148.11 37.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.124 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.9 p -105.0 -36.09 7.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.824 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -127.61 109.63 11.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 m -108.9 126.57 53.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -124.41 134.17 53.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.8 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.494 ' CE2' HG22 ' A' ' 168' ' ' VAL . 91.9 m-85 -127.88 159.32 35.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -137.06 95.31 12.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.62 107.33 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.581 2.188 . . . . 0.0 112.347 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -59.27 -31.22 68.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.0 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.84 146.6 35.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.98 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.53 -16.02 27.37 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.63 2.22 . . . . 0.0 112.515 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.22 -42.6 73.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.009 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -60.21 -40.95 91.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.5 -28.33 69.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -60.68 -24.4 65.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.992 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 134' ' ' ASN . 50.7 mt -62.72 136.9 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.986 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 31.5 m -59.06 -40.2 84.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.481 ' H ' HG22 ' A' ' 132' ' ' ILE . 1.8 m120 -131.63 86.93 47.53 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.77 -28.03 25.7 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.528 2.152 . . . . 0.0 112.272 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -63.34 -31.16 72.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.3 -32.7 49.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.131 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 132' ' ' ILE . 21.4 t -83.37 -30.83 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.179 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.446 HD21 ' HB2' ' A' ' 122' ' ' PHE . 46.5 tp -75.16 -30.39 60.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -85.54 -38.83 18.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.014 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -65.3 -23.98 67.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.25 -33.39 61.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.291 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 23.3 mt -63.65 -22.88 67.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.163 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -29.25 40.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.123 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -87.08 -29.71 21.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.981 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -88.28 140.6 29.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -103.44 -30.37 10.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.653 ' HB2' HD22 ' A' ' 63' ' ' LEU . 4.4 t -131.64 163.56 27.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.8 mt -141.15 164.78 29.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.23 129.09 13.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.409 HG23 ' HA ' ' A' ' 170' ' ' GLU . 52.3 m -59.95 110.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 98.41 51.61 1.42 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.539 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.23 130.25 28.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 110.866 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.5 107.07 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.069 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.3 pt -105.09 106.08 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.144 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.42 127.07 32.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.088 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 36.9 pt -118.8 148.39 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.076 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -146.7 134.56 21.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -149.73 -47.42 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.907 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -100.42 44.31 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.85 30.36 19.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.88 115.93 9.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.9 mp -81.11 86.59 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.09 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -66.9 158.4 30.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.44 136.19 50.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.954 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.3 mt -145.6 154.22 41.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -144.22 125.21 14.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.494 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.6 t -68.7 104.47 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.4 ' O ' HG23 ' A' ' 151' ' ' THR . 0.0 OUTLIER -67.42 -51.5 51.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 171' ' ' THR . 0.1 OUTLIER -151.64 164.23 37.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 170' ' ' GLU . 0.7 OUTLIER -159.97 142.17 13.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 39.4 mttt -118.55 157.48 49.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.2 -27.08 8.82 Favored 'Cis proline' 0 C--N 1.347 0.453 0 C-N-CA 123.268 -1.555 . . . . 0.0 112.355 0.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.98 174.1 8.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.852 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -57.66 -45.23 85.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.51 111.55 23.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.055 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.661 HG21 ' HB2' ' A' ' 117' ' ' ALA . 27.7 m -128.63 140.7 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.619 ' OG ' HD11 ' A' ' 63' ' ' LEU . 3.9 t -97.76 87.69 4.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.1 pt -83.63 82.95 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.1 mt -117.97 89.31 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.161 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.84 88.36 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.07 173.56 12.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.838 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.41 120.09 39.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -135.32 174.04 11.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.837 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -105.24 97.74 7.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.95 145.45 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.04 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -127.38 169.75 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' PHE . . . . . 0.436 ' CE1' HD22 ' A' ' 139' ' ' LEU . 7.0 m-85 -127.42 143.14 51.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.947 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -134.94 97.73 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.916 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.137 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.0 m 60.37 106.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 110.949 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.1 p -64.49 -69.45 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.828 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.95 -132.45 17.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.499 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.8 p -134.04 124.59 26.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.329 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.4 m -136.89 178.47 7.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.826 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.53 -169.81 19.54 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.619 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.58 HD12 ' HD3' ' A' ' 10' ' ' ARG . 16.7 pt -150.07 154.24 36.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.704 0.288 . . . . 0.0 111.097 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.27 63.01 2.08 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.587 2.191 . . . . 0.0 112.275 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.58 ' HD3' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -125.38 159.29 32.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.863 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t 55.0 29.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -98.23 139.83 33.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.844 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -177.26 -39.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.838 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -90.23 51.58 2.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.855 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.55 117.38 7.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.11 107.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.002 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.7 p -151.21 110.43 3.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 t -168.55 171.05 9.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.752 ' HB3' HD22 ' A' ' 106' ' ' LEU . 20.9 mt-30 -95.7 126.65 41.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -125.09 143.05 51.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.3 mtt-85 -66.73 144.79 56.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.008 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.6 p -114.92 120.95 41.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.955 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.741 ' CD2' HG23 ' A' ' 88' ' ' ILE . 77.1 m-85 -127.45 177.0 7.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.975 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -91.54 153.36 19.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.24 -28.3 40.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.144 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.02 -29.37 63.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.088 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.22 -31.7 69.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.538 HD13 ' CE2' ' A' ' 90' ' ' TYR . 17.3 tp -79.94 154.66 28.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.2 168.98 11.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.51 161.27 34.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.52 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.24 -40.38 69.85 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.639 2.226 . . . . 0.0 112.259 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -156.88 -74.48 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -163.43 141.8 7.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.8 mmt85 -138.24 104.54 5.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.17 35.77 1.7 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -110.04 -30.23 7.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.9 t -77.16 -28.42 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.197 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.81 20.15 10.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -118.22 -38.05 3.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.957 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.34 -154.25 26.33 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.456 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.38 87.73 0.45 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.51 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.0 149.91 31.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.791 0.329 . . . . 0.0 110.843 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.776 HG21 HD23 ' A' ' 91' ' ' LEU . 44.4 pt -138.14 175.52 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.189 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.404 HG23 ' HB2' ' A' ' 81' ' ' GLU . 1.9 mp -129.77 111.22 21.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.092 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 1.4 mtm -105.33 161.0 24.12 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.38 154.01 12.28 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.577 2.185 . . . . 0.0 112.267 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.93 -34.9 68.76 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.563 2.175 . . . . 0.0 112.278 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.81 -29.75 68.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.63 -46.57 86.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.182 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.446 HD13 ' CE2' ' A' ' 82' ' ' PHE . 41.3 tp -61.93 -42.65 99.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.956 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.98 -38.92 76.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -31.62 68.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.811 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.4 mt -63.6 -37.65 88.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.71 10.66 25.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.308 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.5 -25.6 9.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.713 0.292 . . . . 0.0 110.969 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.0 mt -94.48 20.15 8.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.313 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.84 40.12 19.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.889 0.375 . . . . 0.0 111.004 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.1 mm -95.12 127.56 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.097 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.47 158.91 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.909 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.446 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -66.37 143.04 98.08 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.9 Cg_endo -76.81 160.19 95.24 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 123.468 -1.472 . . . . 0.0 112.364 0.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.6 mtt -112.46 53.7 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.452 HD13 ' SG ' ' A' ' 148' ' ' CYS . 17.3 mt -74.68 120.73 20.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.9 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -85.57 168.62 14.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -121.75 102.08 7.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.484 HD22 HG11 ' A' ' 107' ' ' VAL . 65.0 mt -85.76 105.02 15.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.958 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.1 m -104.1 101.84 11.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -77.84 123.32 26.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -98.87 31.56 2.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -129.52 -45.93 1.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.2 m -113.48 15.24 19.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.257 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 53.22 32.29 13.12 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.811 0.338 . . . . 0.0 111.134 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.1 mmt-85 -86.53 151.34 23.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.96 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.47 ' O ' HG21 ' A' ' 150' ' ' THR . 27.3 ttt -149.13 107.46 3.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.815 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.7 t -130.29 163.61 26.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.578 ' CD2' HD11 ' A' ' 114' ' ' LEU . 52.0 m80 -122.14 105.46 10.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.7 p -98.27 175.59 6.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.941 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -137.68 139.27 10.3 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.488 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.503 HG21 ' CE1' ' A' ' 82' ' ' PHE . 9.6 p -82.57 149.97 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 111.03 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.4 tp -136.43 -59.08 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.953 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.404 ' HB2' HG23 ' A' ' 44' ' ' ILE . 4.5 mp0 -92.41 160.57 15.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CE1' HG21 ' A' ' 79' ' ' VAL . 96.6 m-85 -142.18 68.59 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.94 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.9 m -150.96 31.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.156 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.04 179.99 7.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.705 ' HB3' HD12 ' A' ' 88' ' ' ILE . 5.6 t70 -95.39 156.64 16.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -59.93 121.19 11.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.961 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.75 28.06 63.74 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.741 HG23 ' CD2' ' A' ' 23' ' ' PHE . 29.5 mt -146.93 107.79 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 111.165 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 89.0 m -108.35 133.03 53.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.538 ' CE2' HD13 ' A' ' 28' ' ' LEU . 33.2 m-85 -90.67 134.35 34.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.776 HD23 HG21 ' A' ' 43' ' ' ILE . 1.7 mt -136.63 149.94 68.71 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.878 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.48 -172.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.528 2.152 . . . . 0.0 112.34 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -96.73 -41.34 8.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.942 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.444 ' CD2' ' N ' ' A' ' 95' ' ' MET . 65.2 p-90 -61.32 -44.07 97.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.924 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.444 ' N ' ' CD2' ' A' ' 94' ' ' TRP . 31.8 ttm -69.21 -38.19 78.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.982 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -31.39 72.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -85.06 -39.92 17.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -59.91 -34.21 72.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.824 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.1 mt -90.02 -12.93 37.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.219 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.5 mt 62.36 38.7 12.85 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.822 0.344 . . . . 0.0 110.873 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.4 mt -82.89 178.89 7.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -136.24 -179.94 5.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.07 127.51 33.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.406 ' HA2' ' CZ ' ' A' ' 23' ' ' PHE . . . 68.84 28.25 73.23 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.532 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -84.93 131.77 10.64 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.501 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.752 HD22 ' HB3' ' A' ' 19' ' ' GLN . 28.5 mt -84.57 125.15 32.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.772 0.32 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.484 HG11 HD22 ' A' ' 66' ' ' LEU . 21.5 t -122.07 137.02 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.066 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.44 119.36 11.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.72 153.03 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -156.57 159.46 38.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.43 116.74 31.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.58 158.51 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.078 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -113.06 111.55 22.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.578 HD11 ' CD2' ' A' ' 76' ' ' HIS . 4.3 mt -106.49 170.25 8.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -126.44 167.78 15.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.1 m -57.76 159.26 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.259 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.909 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -98.96 153.03 19.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.048 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.0 t -111.08 -30.97 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -143.56 105.66 4.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.849 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 m -111.97 140.64 46.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -119.94 126.75 51.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.964 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.585 ' CE2' HG22 ' A' ' 168' ' ' VAL . 92.1 m-85 -117.73 154.35 31.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -135.5 95.22 14.59 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.86 110.72 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.515 2.143 . . . . 0.0 112.39 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -62.98 -34.57 77.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 m -106.98 147.7 35.59 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.949 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.22 -19.14 26.22 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.572 2.181 . . . . 0.0 112.417 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -55.35 -36.21 66.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.072 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -69.66 -45.34 68.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 25.8 mt -60.59 -32.96 72.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.834 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.82 -27.72 69.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.989 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.463 HD13 HG21 ' A' ' 138' ' ' VAL . 37.0 mt -60.98 131.0 25.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.981 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.2 t -63.03 -42.15 99.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.942 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.44 78.65 3.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.884 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.39 -29.89 16.16 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.593 2.195 . . . . 0.0 112.352 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -65.52 -31.11 72.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.99 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.6 -49.86 17.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.084 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.463 HG21 HD13 ' A' ' 132' ' ' ILE . 21.5 t -62.53 -31.05 50.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.089 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.623 HD23 HG11 ' A' ' 186' ' ' VAL . 42.4 tp -79.8 -37.49 35.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.545 ' HA ' HD12 ' A' ' 143' ' ' LEU . 30.3 mt-10 -80.26 -30.57 38.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -67.18 -30.76 70.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.18 -29.59 20.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 140' ' ' GLU . 16.3 mt -58.49 -29.9 66.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.954 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -59.24 -32.62 70.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -74.74 -31.21 61.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.967 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -81.98 146.63 29.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -106.59 -29.55 9.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.083 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.452 ' SG ' HD13 ' A' ' 63' ' ' LEU . 3.9 t -136.98 164.97 27.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.918 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.3 mt -140.64 173.93 11.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.47 HG21 ' O ' ' A' ' 74' ' ' MET . 63.5 m -155.5 143.65 20.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.7 HG22 ' CB ' ' A' ' 175' ' ' LYS . 8.8 t -81.53 104.52 12.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.98 36.89 2.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.421 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -131.37 146.27 52.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 0.0 110.872 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.61 108.35 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.9 pt -109.41 120.89 61.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.182 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.63 138.95 38.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.2 pt -126.66 137.23 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.073 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -143.99 145.87 32.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.959 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -158.01 -47.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -108.76 43.99 1.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 61.11 31.69 19.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -137.91 99.85 4.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.9 mp -76.51 96.72 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.112 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.76 128.62 34.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.871 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -81.29 131.97 35.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.37 154.0 45.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -149.17 114.58 5.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.585 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.4 t -59.8 151.88 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.101 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.3 mmt -118.05 -43.98 2.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.943 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 171' ' ' THR . 2.2 tp10 -145.81 157.81 43.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 170' ' ' GLU . 11.2 p -157.61 140.24 14.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -119.5 152.51 53.1 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.885 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.56 -27.63 8.37 Favored 'Cis proline' 0 C--N 1.346 0.446 0 C-N-CA 123.343 -1.524 . . . . 0.0 112.453 -0.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.68 173.62 6.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.7 ' CB ' HG22 ' A' ' 151' ' ' THR . 0.2 OUTLIER -58.2 -46.39 85.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.967 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.488 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -98.79 121.46 40.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.066 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.909 HG21 ' HB2' ' A' ' 117' ' ' ALA . 30.5 m -130.38 132.42 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.065 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 24.8 p -82.17 94.83 7.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.806 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.3 pt -81.94 82.46 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.148 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 4.5 mt -114.98 83.62 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.995 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.26 85.08 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 8.0 t -165.03 142.05 5.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.58 116.26 26.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -125.01 177.77 5.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.942 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -102.2 120.06 39.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.623 HG11 HD23 ' A' ' 139' ' ' LEU . 21.5 t -98.32 129.48 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.119 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -108.43 172.05 7.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -141.62 133.86 27.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -117.07 95.52 5.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.084 179.919 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.526 -0.229 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -95.77 -33.9 12.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.835 0.35 . . . . 0.0 110.909 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 m -112.46 -69.25 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.811 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.68 28.59 5.02 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.512 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.9 p -127.49 -45.32 1.5 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.903 0.382 . . . . 0.0 110.877 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.4 m -120.61 114.47 21.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.72 -126.16 0.98 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.528 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.1 mt -126.67 75.49 74.91 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.83 109.59 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.485 2.124 . . . . 0.0 112.329 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -100.85 88.98 3.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.66 139.08 18.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.103 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -106.21 168.14 9.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.938 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.51 154.2 40.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.967 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -96.11 42.58 1.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.95 150.61 25.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.16 104.58 0.32 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.872 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.9 p -141.08 114.95 9.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.6 t -176.93 170.13 2.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.831 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -97.25 157.0 16.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.819 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -150.62 147.61 27.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.838 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.0 mtp85 -72.47 124.34 24.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.553 ' HB2' HD13 ' A' ' 91' ' ' LEU . 20.3 p -92.72 127.21 38.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -135.44 143.37 45.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.2 t -59.75 169.23 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.969 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 91' ' ' LEU . 14.5 m -96.03 20.2 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.332 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.2 p -89.03 -30.92 18.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.807 0.337 . . . . 0.0 110.823 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -59.64 -39.99 86.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.815 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.8 87.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.38 -174.06 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.131 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.43 153.7 6.56 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.484 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.15 -27.54 29.25 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.59 2.193 . . . . 0.0 112.306 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.64 -47.72 3.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 62.86 120.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -76.5 143.19 40.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.869 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.0 t -118.92 33.68 5.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -110.02 -31.31 7.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.9 m -59.3 -36.61 64.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.196 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -70.79 -36.58 73.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -95.26 82.04 3.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.97 142.8 5.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.446 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -66.15 77.76 0.12 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.513 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.683 ' HB3' HD22 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -131.68 117.87 19.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 0.0 110.832 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.484 HD13 ' SG ' ' A' ' 77' ' ' CYS . 43.3 pt -112.5 170.53 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.101 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.51 HG22 ' HB2' ' A' ' 84' ' ' ALA . 5.2 mt -119.5 120.3 63.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.052 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 85.7 mtp -112.88 154.38 44.92 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.11 153.2 16.64 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.57 2.18 . . . . 0.0 112.31 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.92 -28.74 40.69 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.466 2.111 . . . . 0.0 112.304 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.0 p -64.38 -29.11 70.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.995 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.61 -36.4 71.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.249 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.416 HD13 ' CE1' ' A' ' 82' ' ' PHE . 8.2 tp -71.08 -45.78 63.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.938 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -68.94 -31.21 69.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -73.64 -50.64 20.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.976 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.552 ' HA ' HD12 ' A' ' 58' ' ' ILE . 29.4 mt -63.45 -35.38 80.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.2 p -77.21 -29.84 54.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.978 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.49 -20.44 47.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.9 mt -94.46 19.22 9.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.283 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.1 t30 54.88 32.22 17.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.189 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 53' ' ' LEU . 39.7 mt -91.87 112.91 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.15 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.8 p -99.33 169.91 9.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.939 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.457 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -65.07 143.03 98.79 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.457 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 77.1 Cg_endo -77.34 169.02 75.15 Favored 'Cis proline' 0 C--N 1.348 0.502 0 C-N-CA 123.477 -1.468 . . . . 0.0 112.462 0.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.5 mtt -130.08 38.72 3.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.912 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.542 HD22 ' SG ' ' A' ' 148' ' ' CYS . 0.4 OUTLIER -63.15 137.12 58.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.966 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.606 ' CD1' HG12 ' A' ' 109' ' ' VAL . 39.9 m-85 -100.24 160.57 14.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.429 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 13.9 tttt -109.7 84.32 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.88 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.561 HD23 HG22 ' A' ' 109' ' ' VAL . 17.7 mt -69.62 75.18 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.783 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.76 103.39 6.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.981 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.501 ' OD1' HD21 ' A' ' 101' ' ' LEU . 0.9 OUTLIER -70.54 118.22 13.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.915 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.96 33.58 2.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -131.62 -46.1 0.97 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 63.0 m -111.87 15.43 20.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.341 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.61 38.93 29.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.843 0.354 . . . . 0.0 111.084 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.477 ' HB2' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -98.46 163.07 12.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.838 ' O ' HG21 ' A' ' 150' ' ' THR . 27.0 ttp -150.13 114.1 5.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.847 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.5 m -134.9 141.64 46.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.994 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.429 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 42.9 m80 -108.67 118.53 37.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.944 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.494 ' SG ' HD12 ' A' ' 66' ' ' LEU . 28.2 p -128.86 145.97 51.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.928 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.96 138.92 14.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.499 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.37 148.12 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.852 0.358 . . . . 0.0 111.107 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.683 HD22 ' HB3' ' A' ' 42' ' ' LYS . 44.2 tp -113.59 -66.58 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.465 ' OE1' HG13 ' A' ' 83' ' ' VAL . 2.8 mm-40 -114.01 172.34 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.988 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.416 ' CE1' HD13 ' A' ' 50' ' ' LEU . 76.8 m-85 -133.39 66.45 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.853 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.465 HG13 ' OE1' ' A' ' 81' ' ' GLU . 31.4 m -137.2 31.75 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.165 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.51 ' HB2' HG22 ' A' ' 44' ' ' ILE . . . -96.64 178.63 5.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.134 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.703 ' HB2' HD12 ' A' ' 88' ' ' ILE . 4.2 m-20 -96.58 156.46 16.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.931 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -60.9 124.19 19.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.97 28.57 62.3 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.487 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.703 HD12 ' HB2' ' A' ' 85' ' ' ASP . 30.6 mt -146.93 87.99 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 0.0 111.088 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 96.7 m -94.32 120.0 33.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -84.6 146.33 27.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.925 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.553 HD13 ' HB2' ' A' ' 22' ' ' CYS . 1.0 OUTLIER -143.64 160.07 52.03 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.69 -174.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.568 2.179 . . . . 0.0 112.325 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -98.9 -31.46 11.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.986 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 64.1 p-90 -72.31 -38.58 68.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.562 ' HG2' HD12 ' A' ' 99' ' ' LEU . 36.8 ttm -64.52 -35.69 81.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -61.53 -48.77 79.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.873 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -61.83 -42.69 99.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -59.98 -50.24 74.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.568 HD13 HD11 ' A' ' 101' ' ' LEU . 7.2 mt -76.08 -20.62 57.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.5 mt 63.23 44.03 5.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.414 . . . . 0.0 110.815 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.568 HD11 HD13 ' A' ' 99' ' ' LEU . 3.3 mt -86.52 -175.75 5.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.869 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -127.25 172.37 10.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -70.0 78.8 0.49 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.1 35.96 1.07 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.441 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.66 150.17 20.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.451 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.1 mt -92.2 124.6 36.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.938 0.399 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.436 ' CG1' HD22 ' A' ' 66' ' ' LEU . 21.6 t -122.12 132.4 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.97 111.17 2.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.606 HG12 ' CD1' ' A' ' 64' ' ' PHE . 19.7 t -105.56 128.73 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.09 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -145.18 118.52 8.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.7 p -69.86 123.02 20.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.96 168.98 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -131.31 116.17 17.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.85 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 176' ' ' ALA . 1.3 mt -115.76 179.42 3.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.85 174.63 5.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.3 m -64.88 172.36 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.102 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.848 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -105.81 153.2 22.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 38.5 p -113.48 -36.36 4.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -131.98 97.52 4.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.428 ' OG ' HG22 ' A' ' 186' ' ' VAL . 94.9 p -101.43 109.92 21.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.874 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -98.65 119.45 37.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.53 ' CD1' HD21 ' A' ' 139' ' ' LEU . 75.9 m-85 -113.68 147.76 37.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.847 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -126.49 89.86 51.23 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -51.66 102.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.553 2.169 . . . . 0.0 112.288 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 -59.48 -30.78 68.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.969 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.5 m -109.79 145.91 32.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.933 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.8 -16.3 23.53 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.588 2.192 . . . . 0.0 112.555 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -55.17 -33.45 62.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.138 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.401 ' O ' HD12 ' A' ' 132' ' ' ILE . 33.9 t80 -77.11 -40.33 46.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 39.5 mt -64.89 -30.61 71.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.48 -25.13 67.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.026 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.829 HG21 HG21 ' A' ' 138' ' ' VAL . 23.1 mt -60.05 138.25 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.001 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.7 m -65.6 -34.42 78.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.066 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.608 ' H ' HG22 ' A' ' 132' ' ' ILE . 2.0 m120 -128.36 72.55 80.19 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.981 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.62 -32.77 91.45 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.617 2.211 . . . . 0.0 112.275 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -60.01 -47.72 84.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.964 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.4 -45.49 90.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.06 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.829 HG21 HG21 ' A' ' 132' ' ' ILE . 21.4 t -60.66 -39.48 81.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.181 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.592 HD23 HG11 ' A' ' 186' ' ' VAL . 10.1 tp -70.9 -41.91 70.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.913 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -68.01 -31.07 70.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -69.14 -31.36 69.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.406 ' CB ' HG21 ' A' ' 157' ' ' ILE . . . -79.5 -37.8 35.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.138 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.716 HD22 HD11 ' A' ' 149' ' ' LEU . 59.1 mt -61.5 -26.63 68.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.045 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -56.48 -30.37 62.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -82.74 -49.07 10.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.906 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -60.07 152.86 23.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.541 ' HB1' HD21 ' A' ' 63' ' ' LEU . . . -107.07 -29.21 9.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.138 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.542 ' SG ' HD22 ' A' ' 63' ' ' LEU . 1.6 m -146.86 167.87 22.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.953 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.716 HD11 HD22 ' A' ' 143' ' ' LEU . 5.1 mt -142.97 170.19 16.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.838 HG21 ' O ' ' A' ' 74' ' ' MET . 63.4 m -153.6 136.65 15.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.495 HG22 ' CB ' ' A' ' 175' ' ' LYS . 8.8 t -60.67 121.02 11.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 91.54 28.96 12.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.546 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.46 126.57 52.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.942 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.6 t -89.38 91.09 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.089 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.47 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 4.4 pt -87.55 154.63 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.136 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.61 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -129.32 102.36 6.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.406 HG21 ' CB ' ' A' ' 142' ' ' ALA . 7.6 pt -90.93 147.08 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -140.6 145.86 37.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -176.54 -38.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.999 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -99.2 40.3 1.22 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 56.82 29.28 15.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.033 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.31 110.79 2.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.61 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 3.6 mp -68.47 94.43 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -61.68 145.77 51.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -95.41 132.79 40.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.931 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.01 158.22 41.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -156.91 139.01 14.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.855 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.421 HG22 ' CE2' ' A' ' 122' ' ' PHE . 28.6 t -80.9 147.85 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 59.6 mmm -117.41 -40.75 3.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.7 151.38 27.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 64.3 p -151.2 149.35 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -122.22 152.87 61.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.35 -27.32 8.62 Favored 'Cis proline' 0 C--N 1.346 0.435 0 C-N-CA 123.281 -1.55 . . . . 0.0 112.389 -0.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -124.5 168.98 12.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.735 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.495 ' CB ' HG22 ' A' ' 151' ' ' THR . 0.0 OUTLIER -56.59 -49.18 75.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.98 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.52 ' O ' HD22 ' A' ' 114' ' ' LEU . . . -92.85 110.73 22.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.033 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.848 HG21 ' HB2' ' A' ' 117' ' ' ALA . 11.5 m -128.52 148.72 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.19 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.7 95.7 8.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.2 pt -86.97 83.3 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.087 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 28.2 mm -112.73 90.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 61.17 55.29 3.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 6.1 t -135.83 143.27 45.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.19 134.48 41.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.869 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.458 ' SD ' ' HB3' ' A' ' 117' ' ' ALA . 2.1 ptt? -139.65 164.52 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -78.97 76.25 5.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.785 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.592 HG11 HD23 ' A' ' 139' ' ' LEU . 28.6 t -63.3 125.82 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.091 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.32 162.22 16.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' PHE . . . . . 0.416 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 31.0 m-85 -124.17 128.98 50.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -90.97 94.21 9.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.12 179.948 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m -87.26 -66.49 0.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.0 110.941 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.3 p -65.23 109.11 2.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.5 94.19 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.516 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.47 174.06 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.783 0.325 . . . . 0.0 110.912 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.78 37.9 18.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.958 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.4 146.61 17.88 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.559 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 8' ' ' ILE . 7.6 tp -147.97 74.69 11.02 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.942 0.401 . . . . 0.0 111.037 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.17 148.85 63.35 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.579 2.186 . . . . 0.0 112.309 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.44 144.9 46.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.51 106.82 13.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -157.04 78.06 0.89 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.24 -37.99 3.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.931 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -138.7 166.82 23.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 61.36 113.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -87.62 129.65 35.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.7 p -154.57 124.34 6.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -175.3 179.34 1.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.952 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.501 ' HB3' HD22 ' A' ' 106' ' ' LEU . 27.9 mt-30 -107.07 155.17 20.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -155.23 152.6 29.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.6 mtt-85 -82.86 134.58 35.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.1 m -102.23 128.14 48.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.496 ' CD2' HG23 ' A' ' 88' ' ' ILE . 52.9 m-85 -138.38 175.19 9.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.949 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.5 t -86.19 -179.98 6.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 91' ' ' LEU . 18.9 m -95.62 20.08 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.347 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 m -96.69 -19.45 18.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.172 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 36.1 mtp -93.88 20.06 8.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.282 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.17 -57.03 2.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.847 0.356 . . . . 0.0 110.887 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.93 -174.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.15 174.13 18.02 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.34 -35.29 14.18 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.582 2.188 . . . . 0.0 112.301 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -126.82 122.33 34.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -106.24 150.01 26.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.29 155.46 42.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.9 p -97.89 27.6 4.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.977 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.62 11.81 38.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.161 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.72 -35.11 3.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.78 0.324 . . . . 0.0 111.078 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -80.45 -31.34 37.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -83.47 91.19 7.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.87 178.27 15.62 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.55 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.73 31.56 8.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.557 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -89.17 135.53 33.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.81 0.338 . . . . 0.0 110.782 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.523 HD13 ' SG ' ' A' ' 77' ' ' CYS . 7.8 pt -128.93 167.75 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.166 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.0 mt -120.3 140.81 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.176 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.484 ' HE1' HG11 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -133.09 158.13 76.58 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.85 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.79 161.42 3.15 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.524 2.149 . . . . 0.0 112.315 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.83 -25.81 32.82 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.648 2.232 . . . . 0.0 112.302 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.7 p -58.95 -38.4 78.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.979 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.471 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -59.32 -33.11 70.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.214 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.5 tp -62.01 -51.58 67.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.82 -31.19 67.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.41 -43.91 63.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.928 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 49' ' ' ALA . 3.8 mt -58.18 -52.25 66.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -65.25 -29.74 70.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -76.58 -26.04 54.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.02 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.9 mt -94.51 20.09 8.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.227 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 m120 58.24 35.51 25.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.866 0.365 . . . . 0.0 111.058 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 53' ' ' LEU . 29.4 mt -102.62 116.74 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 t -114.17 173.56 6.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.468 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -68.1 144.09 96.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.468 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.7 Cg_endo -77.08 159.56 95.53 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 123.446 -1.481 . . . . 0.0 112.327 -0.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 19.1 mtt -125.35 59.0 1.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.983 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.712 HD23 ' HA2' ' A' ' 78' ' ' GLY . 88.8 mt -74.93 114.99 14.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.859 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.429 ' CE2' ' HB ' ' A' ' 79' ' ' VAL . 17.3 m-85 -81.68 133.37 35.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.857 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -85.66 93.23 8.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.037 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.9 mt -78.36 76.85 4.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.6 m -90.02 103.17 15.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.9 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -67.14 127.23 31.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -98.92 32.17 2.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.44 -43.84 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 73.4 m -123.56 23.07 8.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 54.43 31.33 14.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.092 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.531 ' HB3' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -82.33 157.82 23.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.826 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.92 131.91 10.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.607 HG22 HD21 ' A' ' 99' ' ' LEU . 2.7 t -159.95 114.3 2.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.964 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.455 ' CE1' HG21 ' A' ' 112' ' ' VAL . 16.2 m-70 -79.74 122.99 27.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.523 ' SG ' HD13 ' A' ' 43' ' ' ILE . 30.0 p -117.29 150.73 38.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.949 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.712 ' HA2' HD23 ' A' ' 63' ' ' LEU . . . -104.86 129.36 9.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.417 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.429 ' HB ' ' CE2' ' A' ' 64' ' ' PHE . 10.8 p -69.44 147.36 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 111.094 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -130.41 -59.74 1.02 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.818 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -110.11 146.91 34.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.743 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -113.88 49.52 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.06 79.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.147 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -132.31 173.36 11.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.585 ' HB3' HD12 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -76.64 162.93 27.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -66.59 109.92 2.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.02 34.94 54.76 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.483 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.585 HD12 ' HB3' ' A' ' 85' ' ' ASP . 26.8 mt -144.01 91.62 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.81 0.338 . . . . 0.0 111.085 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 97.0 m -80.67 134.52 35.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -99.63 127.38 45.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.404 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -130.19 157.74 76.27 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.849 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.57 -172.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.591 2.194 . . . . 0.0 112.283 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -90.58 -39.02 12.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -69.61 -42.86 73.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.2 ttp -61.08 -31.31 70.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -31.5 61.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.827 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -81.55 -37.13 28.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.894 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -68.62 -45.13 72.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.643 HD13 HD11 ' A' ' 101' ' ' LEU . 7.7 mt -68.83 -23.87 64.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.061 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.8 mt 66.27 48.79 1.57 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.803 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.643 HD11 HD13 ' A' ' 99' ' ' LEU . 5.2 mt -96.36 -176.26 3.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.78 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.31 174.77 10.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -59.85 92.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.02 28.1 7.49 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -70.44 130.0 20.47 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.491 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.501 HD22 ' HB3' ' A' ' 19' ' ' GLN . 64.5 mt -87.82 126.95 35.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.807 0.337 . . . . 0.0 110.927 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 108' ' ' GLN . 21.5 t -129.53 156.42 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.446 ' N ' HG12 ' A' ' 107' ' ' VAL . 19.2 tp60 -79.67 125.01 29.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.484 HG11 ' HE1' ' A' ' 45' ' ' MET . 21.5 t -111.35 105.7 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.097 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -125.45 133.56 52.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.8 p -81.92 108.56 15.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.989 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.455 HG21 ' CE1' ' A' ' 76' ' ' HIS . 6.8 m -111.2 156.21 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -107.57 118.04 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.435 HD13 ' HB1' ' A' ' 176' ' ' ALA . 13.1 mt -118.02 157.15 27.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -109.56 169.83 8.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.7 m -64.85 139.82 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.101 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.842 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -79.75 149.33 31.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.3 p -107.33 -37.85 6.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -128.04 125.22 38.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.8 p -129.74 140.23 51.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.023 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -131.23 125.51 33.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.824 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.787 ' CG ' HD21 ' A' ' 139' ' ' LEU . 17.1 m-85 -113.41 147.62 37.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.982 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -131.06 92.44 33.38 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.779 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.707 ' HA ' HD23 ' A' ' 166' ' ' LEU . 77.1 Cg_exo -50.18 116.58 2.54 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.561 2.174 . . . . 0.0 112.455 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -73.62 -31.45 63.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -106.8 146.93 34.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.27 -14.77 28.5 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.582 2.188 . . . . 0.0 112.461 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.0 -40.07 75.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.011 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -71.87 -38.44 70.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.415 HD21 ' CB ' ' A' ' 190' ' ' ALA . 84.9 mt -64.95 -31.84 73.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.866 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -62.42 -25.62 68.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.449 HG22 ' H ' ' A' ' 134' ' ' ASN . 32.9 mt -66.01 135.38 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.089 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.2 t -66.93 -37.86 85.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.526 ' O ' HG23 ' A' ' 138' ' ' VAL . 3.8 m120 -119.07 75.75 14.73 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.17 -30.27 16.28 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.631 2.221 . . . . 0.0 112.311 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -37.01 84.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.48 -44.33 67.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 134' ' ' ASN . 29.9 t -63.03 -44.73 99.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.012 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.787 HD21 ' CG ' ' A' ' 122' ' ' PHE . 16.0 tp -69.26 -31.58 70.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.819 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.01 -31.43 62.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.914 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -78.79 -34.28 45.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.861 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.23 -35.7 66.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.515 HD22 HD11 ' A' ' 149' ' ' LEU . 14.8 mt -59.73 -25.73 65.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.983 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 -55.4 -30.57 60.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.09 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.24 -31.21 30.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -71.24 140.53 50.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -101.12 -29.59 12.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.105 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 18.3 t -148.76 158.36 44.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.954 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.515 HD11 HD22 ' A' ' 143' ' ' LEU . 11.1 mt -134.34 150.92 50.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.0 m -128.32 148.51 50.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 26.5 m -76.01 101.72 5.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 103.51 48.17 1.23 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.462 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -134.0 115.16 14.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.792 0.329 . . . . 0.0 110.931 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.3 t -72.54 99.25 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 37.3 pt -97.13 143.91 11.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.157 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.597 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -107.97 150.72 26.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.125 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.5 pt -141.15 139.55 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.125 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -127.39 156.66 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -177.43 -47.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -103.02 42.65 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.64 31.04 20.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.915 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.09 126.42 9.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.597 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 3.4 mp -86.9 101.12 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -79.17 123.95 27.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.86 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -87.47 131.48 34.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.707 HD23 ' HA ' ' A' ' 124' ' ' PRO . 1.5 mt -143.69 147.34 34.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.827 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -127.06 127.73 45.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.14 131.91 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 14.2 mmm -87.57 -55.57 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.529 ' O ' HG23 ' A' ' 171' ' ' THR . 0.1 OUTLIER -145.28 160.02 42.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 170' ' ' GLU . 3.0 p -160.07 119.08 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -96.83 155.77 37.27 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.96 -43.18 0.67 Allowed 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.326 -1.531 . . . . 0.0 112.444 0.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.29 174.48 5.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.935 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -59.13 -48.79 80.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.435 ' HB1' HD13 ' A' ' 114' ' ' LEU . . . -92.74 113.02 25.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.084 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.842 HG21 ' HB2' ' A' ' 117' ' ' ALA . 28.2 m -129.54 139.34 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 11.3 t -91.8 98.29 11.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.9 pt -90.91 80.35 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.5 mt -108.41 83.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.08 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 60.94 78.76 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 14.3 t -153.49 148.36 26.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.14 121.91 28.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -144.14 154.04 42.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.16 119.28 19.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.15 109.49 27.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.164 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.8 169.61 9.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' PHE . . . . . 0.6 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 3.1 m-85 -142.12 109.64 5.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -112.01 105.03 13.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.415 ' CB ' HD21 ' A' ' 130' ' ' LEU . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.117 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.134 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -115.22 -174.89 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 m 60.24 105.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.13 -121.8 5.73 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.473 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -71.63 178.37 3.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.323 . . . . 0.0 110.888 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.3 121.03 0.85 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.936 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.97 -149.82 51.54 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.549 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.8 pt -140.4 91.78 9.57 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.616 0.246 . . . . 0.0 111.139 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.12 127.98 16.84 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.552 2.168 . . . . 0.0 112.335 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -106.68 114.01 27.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.41 149.25 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.145 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -132.21 -46.79 0.92 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.826 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -94.17 139.47 30.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.93 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -130.55 -178.06 4.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.81 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 63.61 167.23 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.882 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -105.26 141.69 36.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.2 p -159.99 118.4 2.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -176.33 161.22 2.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.972 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -90.11 143.61 26.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.811 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.455 ' HB2' HG21 ' A' ' 109' ' ' VAL . 6.0 m-85 -144.4 136.41 26.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -71.57 157.86 37.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.493 ' SG ' HD13 ' A' ' 101' ' ' LEU . 95.6 m -119.96 130.72 54.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.939 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.613 ' CD2' HG23 ' A' ' 88' ' ' ILE . 70.6 m-85 -136.2 166.79 22.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -79.14 138.58 37.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.946 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 90' ' ' TYR . 26.3 m -63.6 -19.33 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.288 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 m -67.64 -12.49 60.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.412 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 36.4 mtt -91.79 20.13 5.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.624 0.25 . . . . 0.0 111.362 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.585 HD23 ' OH ' ' A' ' 90' ' ' TYR . 1.0 OUTLIER -141.31 74.93 1.48 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.904 0.383 . . . . 0.0 110.881 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.97 -170.63 2.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.067 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.97 -156.45 26.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.505 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.22 -30.04 40.24 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.498 2.132 . . . . 0.0 112.337 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -136.75 167.92 20.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -102.21 -53.53 2.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.5 mmt-85 60.24 109.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.933 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.9 m -96.65 23.48 6.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.092 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -91.17 -29.19 17.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.844 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.5 t -59.28 -36.05 61.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.039 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -71.85 -38.68 70.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.884 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -84.14 79.54 9.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.74 178.8 32.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.411 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.06 37.87 3.6 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.517 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.576 ' HG2' HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -105.5 153.58 21.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.705 0.288 . . . . 0.0 110.872 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.675 HG22 ' HD3' ' A' ' 92' ' ' PRO . 3.0 pt -139.66 179.95 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.041 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.655 HG22 ' HB2' ' A' ' 84' ' ' ALA . 4.5 mt -122.51 136.12 60.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.124 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 71.8 mtp -137.75 161.49 59.85 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.81 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 52.5 Cg_exo -52.79 146.47 35.55 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.506 2.138 . . . . 0.0 112.335 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 46' ' ' PRO . 50.3 Cg_exo -53.83 -26.89 41.21 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.521 2.147 . . . . 0.0 112.384 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.0 t -58.54 -39.01 78.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.035 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.89 -31.08 70.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.102 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.418 HD13 ' CD1' ' A' ' 82' ' ' PHE . 58.3 tp -64.68 -51.31 63.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -72.61 -29.5 63.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -50.34 74.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.947 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.517 HD13 ' SD ' ' A' ' 62' ' ' MET . 1.6 mt -56.56 -38.29 71.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.007 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.8 t -75.52 -27.5 58.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -81.54 -25.04 36.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.03 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.4 mt -95.52 19.77 10.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.18 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 53.98 44.88 28.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.86 0.362 . . . . 0.0 111.173 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.499 HG21 HD23 ' A' ' 53' ' ' LEU . 30.3 mt -107.35 130.37 59.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.182 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 p -113.4 170.84 7.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.444 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.3 t80 -61.15 140.35 94.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.815 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.85 171.34 68.58 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.544 -1.44 . . . . 0.0 112.368 0.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.517 ' SD ' HD13 ' A' ' 53' ' ' LEU . 15.9 mtt -126.31 41.71 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.469 HD22 ' CA ' ' A' ' 78' ' ' GLY . 16.9 mt -68.97 164.0 23.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.935 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -130.34 153.89 48.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.52 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 23.9 tttt -99.82 91.9 5.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.842 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 66' ' ' LEU . 15.1 mt -75.43 78.95 2.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.836 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -81.65 99.17 8.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -71.27 120.23 16.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.829 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -98.46 30.56 3.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.994 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.94 -37.43 4.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.846 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.23 23.54 4.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.128 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.01 39.31 31.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 111.113 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.31 172.46 8.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.0 ttp -157.82 124.93 5.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.834 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.0 m -140.17 155.74 46.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.52 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 65.2 m-70 -129.56 108.86 10.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.1 p -116.59 149.88 38.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.469 ' CA ' HD22 ' A' ' 63' ' ' LEU . . . -104.87 137.68 13.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.545 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.9 p -83.79 134.88 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.782 0.325 . . . . 0.0 111.06 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.576 HD22 ' HG2' ' A' ' 42' ' ' LYS . 57.5 tp -117.94 -58.01 2.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.32 150.75 19.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.418 ' CD1' HD13 ' A' ' 50' ' ' LEU . 65.7 m-85 -132.99 62.83 1.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.3 m -136.15 32.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.164 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.655 ' HB2' HG22 ' A' ' 44' ' ' ILE . . . -95.12 158.78 15.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.071 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.615 ' HB3' HD12 ' A' ' 88' ' ' ILE . 3.9 t70 -68.54 160.31 30.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -66.98 136.12 54.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.19 28.69 73.85 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.452 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.615 HD12 ' HB3' ' A' ' 85' ' ' ASP . 28.8 mt -147.82 112.47 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 111.14 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.7 m -114.85 130.5 56.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.585 ' OH ' HD23 ' A' ' 28' ' ' LEU . 70.1 m-85 -92.42 143.25 26.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.935 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.532 ' CD2' HG21 ' A' ' 43' ' ' ILE . 44.0 mt -139.28 147.67 53.9 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.675 ' HD3' HG22 ' A' ' 43' ' ' ILE . 53.0 Cg_exo -52.52 169.93 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.57 2.18 . . . . 0.0 112.283 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.53 -38.68 77.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.834 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.405 ' CH2' ' CE ' ' A' ' 95' ' ' MET . 51.0 p-90 -72.58 -31.48 65.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.405 ' CE ' ' CH2' ' A' ' 94' ' ' TRP . 7.4 ttm -74.72 -31.16 61.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 37.7 mmm -76.39 -39.06 54.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -76.63 -38.75 54.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.858 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -59.66 -53.49 57.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.41 HD13 HD11 ' A' ' 101' ' ' LEU . 30.8 mt -71.21 -21.79 62.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 mt 66.99 45.6 1.74 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.892 0.377 . . . . 0.0 110.944 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.493 HD13 ' SG ' ' A' ' 22' ' ' CYS . 13.1 mt -96.83 149.24 22.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -103.47 -179.19 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.799 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.34 113.5 2.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.35 42.24 8.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.446 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.86 109.51 3.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.536 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.1 mt -73.27 131.88 42.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 108' ' ' GLN . 21.5 t -137.01 158.83 36.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.079 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.479 ' N ' HG12 ' A' ' 107' ' ' VAL . 16.4 mm100 -74.67 122.5 23.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.455 HG21 ' HB2' ' A' ' 20' ' ' TYR . 21.5 t -117.95 86.9 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.146 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -107.5 135.2 49.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.1 p -75.72 101.49 5.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 65' ' ' LYS . 19.2 m -113.88 149.3 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.105 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -121.84 117.21 25.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.577 HD22 ' O ' ' A' ' 176' ' ' ALA . 6.4 mt -107.81 174.22 5.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.45 164.06 12.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.95 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.1 m -64.69 135.05 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.668 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -77.68 152.87 33.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.076 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.3 t -109.55 -31.77 7.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -134.82 106.7 7.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.6 m -122.92 113.39 19.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.946 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -92.38 142.56 27.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.515 ' CG ' HD21 ' A' ' 139' ' ' LEU . 18.1 m-85 -130.43 150.2 51.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -131.79 95.93 21.72 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.8 109.9 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.536 2.157 . . . . 0.0 112.408 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -59.62 -31.78 69.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.998 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 72.4 p -113.38 146.81 36.11 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.958 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.88 -17.8 25.13 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.544 2.163 . . . . 0.0 112.48 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -55.14 -39.84 69.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.023 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -66.41 -46.91 74.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.7 mt -60.31 -30.67 69.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.968 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.3 -25.07 66.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 134' ' ' ASN . 51.4 mt -62.27 136.92 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.958 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.9 m -58.28 -39.62 79.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.992 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.729 ' O ' HG23 ' A' ' 138' ' ' VAL . 2.3 m120 -125.59 80.67 65.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.0 -28.63 19.05 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.585 2.19 . . . . 0.0 112.363 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.9 mtpm? -66.73 -44.95 80.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.84 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.89 93.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.038 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 134' ' ' ASN . 25.3 t -64.08 -45.25 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.064 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.61 HD22 ' CZ ' ' A' ' 188' ' ' PHE . 21.5 tp -67.91 -43.44 79.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.83 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -62.35 -36.37 82.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.807 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -68.82 -29.83 68.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.35 -33.19 69.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.575 HD22 HD13 ' A' ' 179' ' ' ILE . 65.9 mt -60.49 -25.77 66.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.059 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.6 mtp-105 -55.16 -30.36 59.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.05 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -89.21 -38.7 14.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -69.08 144.67 53.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.423 ' HB1' HD11 ' A' ' 180' ' ' ILE . . . -109.39 -26.15 10.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.22 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -140.25 165.14 28.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.968 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.523 HD11 HD13 ' A' ' 179' ' ' ILE . 20.8 mt -144.33 129.41 18.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.54 145.47 46.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.876 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 169' ' ' MET . 18.7 m -71.47 123.58 22.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.9 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.75 27.69 21.07 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.45 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.82 132.66 53.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.4 t -90.58 89.68 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.084 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 18.4 pt -85.16 132.31 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.081 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -108.05 140.75 40.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.3 pt -125.12 165.26 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.041 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -157.83 150.41 22.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -172.71 -48.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -97.66 41.44 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.94 29.65 19.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.954 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.59 128.12 17.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.801 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.574 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.9 mp -87.83 105.18 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.177 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -82.71 137.44 34.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -90.11 121.73 32.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.001 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.23 141.55 49.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.82 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 -137.24 129.05 28.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.446 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.3 t -76.57 132.46 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.66 ' O ' HG23 ' A' ' 151' ' ' THR . 6.7 mmm -94.0 -68.53 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.95 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -123.8 152.91 41.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.5 p -147.24 150.49 34.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -130.68 153.97 81.66 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.64 -31.96 4.92 Favored 'Cis proline' 0 C--N 1.348 0.522 0 C-N-CA 123.264 -1.557 . . . . 0.0 112.45 -0.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.36 171.53 7.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.835 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -40.75 76.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.022 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.577 ' O ' HD22 ' A' ' 114' ' ' LEU . . . -102.64 124.47 48.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.081 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.668 HG21 ' HB2' ' A' ' 117' ' ' ALA . 15.8 m -137.58 153.71 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.146 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 23.8 t -104.7 98.01 7.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.575 HD13 HD22 ' A' ' 143' ' ' LEU . 2.4 pt -88.68 84.11 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.207 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.423 HD11 ' HB1' ' A' ' 147' ' ' ALA . 26.5 mm -111.65 79.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.089 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 59.14 91.0 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.99 156.16 26.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.967 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.19 103.53 15.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.827 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -126.67 170.84 11.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -94.22 113.54 25.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.39 106.85 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.176 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -87.13 159.33 18.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' PHE . . . . . 0.61 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 13.7 m-85 -133.09 133.24 42.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -121.09 97.37 5.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.087 179.969 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -170.26 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.811 0.339 . . . . 0.0 110.932 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.3 t 60.67 34.8 19.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.25 44.83 2.45 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.519 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.9 m 60.61 172.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.785 0.326 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 m -157.24 37.67 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.7 -166.89 13.73 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.446 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.6 pt -108.34 146.57 33.89 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.676 0.274 . . . . 0.0 111.098 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.08 123.99 9.7 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.572 2.182 . . . . 0.0 112.293 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.78 118.35 21.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.884 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.579 ' O ' HG12 ' A' ' 11' ' ' VAL . 15.5 t -97.88 32.05 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.015 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -166.71 129.33 1.83 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.839 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.77 151.36 51.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -142.72 158.88 43.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.5 158.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.804 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -86.63 123.93 32.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.0 p -155.23 110.1 2.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.2 t -176.42 168.96 2.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -103.38 146.85 27.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.406 ' HD2' HG21 ' A' ' 109' ' ' VAL . 22.4 m-85 -146.87 147.28 30.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.91 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -84.6 132.08 34.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.9 p -84.82 142.01 30.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.642 ' CD2' HG23 ' A' ' 88' ' ' ILE . 17.2 m-85 -147.0 149.47 33.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.833 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.85 168.51 6.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 m -95.82 20.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.374 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 55.1 m -96.38 -25.16 15.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.019 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.7 mmt -54.97 -51.59 65.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.124 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 tp -73.63 142.39 46.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.43 154.84 20.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.06 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -154.95 156.41 26.89 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.498 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.99 -35.78 8.51 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.627 2.218 . . . . 0.0 112.325 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -102.1 -29.92 11.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.947 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 70.85 -62.63 0.44 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.1 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 66.95 133.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.889 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.4 t -104.07 -18.69 14.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.202 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -35.83 44.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.817 0.341 . . . . 0.0 111.116 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.63 -30.29 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.1 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -77.2 -30.14 54.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -97.93 33.72 2.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.6 171.51 25.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.553 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.23 28.66 13.02 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.545 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.83 151.2 20.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.805 0.336 . . . . 0.0 110.913 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.493 HG21 HD23 ' A' ' 91' ' ' LEU . 7.9 pt -133.35 165.67 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.652 HG23 ' HB3' ' A' ' 81' ' ' GLU . 3.0 mt -115.7 96.17 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.138 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.405 ' HG3' HD12 ' A' ' 43' ' ' ILE . 97.1 mtp -88.55 157.8 49.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.8 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -51.83 156.74 6.48 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.571 2.181 . . . . 0.0 112.336 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.71 -27.06 38.57 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.519 2.146 . . . . 0.0 112.318 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.8 p -61.65 -31.67 71.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.87 -31.67 72.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.3 tp -62.27 -34.64 76.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -86.96 -30.54 21.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.0 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.42 -47.25 70.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.5 mt -57.19 -47.48 81.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.077 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 p -64.15 -23.61 67.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.173 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.72 20.11 9.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.355 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -135.83 19.95 3.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.206 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 55.9 33.69 22.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.766 0.317 . . . . 0.0 111.029 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.2 mt -102.78 109.01 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.4 p -104.51 162.96 12.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.471 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -60.14 144.3 87.29 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.775 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.471 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 72.2 Cg_endo -76.71 171.29 68.84 Favored 'Cis proline' 0 C--N 1.347 0.484 0 C-N-CA 123.467 -1.472 . . . . 0.0 112.4 0.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.3 mtt -138.23 78.02 1.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.446 HD22 HD12 ' A' ' 114' ' ' LEU . 1.4 mp -89.55 138.29 31.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -109.78 143.02 40.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.846 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -94.74 99.76 11.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.936 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.714 ' HB2' HG23 ' A' ' 75' ' ' THR . 43.7 mt -84.66 78.44 9.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 53.7 m -77.93 111.59 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.437 ' OD1' HD21 ' A' ' 101' ' ' LEU . 2.8 t30 -74.88 113.96 12.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.956 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -88.92 53.9 2.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -145.22 -53.49 0.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.9 m -120.32 25.37 9.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.067 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 t0 55.19 30.44 14.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.112 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.0 mmt-85 -82.3 146.19 29.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.3 ttm -133.12 140.77 47.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.819 HG21 HD11 ' A' ' 99' ' ' LEU . 4.7 t -157.15 143.0 17.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -120.78 114.6 21.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.2 p -113.46 172.73 6.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.46 124.84 4.83 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.539 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.0 p -64.12 141.65 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 0.0 111.09 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.7 tp -134.9 -54.79 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.652 ' HB3' HG23 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -94.45 152.09 18.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -135.0 73.86 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.6 m -149.93 35.23 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.164 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.69 178.77 5.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.095 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.716 ' CB ' HD12 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -92.69 166.47 12.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.804 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -65.66 90.96 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.807 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 96.73 26.17 10.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.509 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.716 HD12 ' CB ' ' A' ' 85' ' ' ASP . 28.0 mt -136.08 80.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 111.07 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 57.5 m -78.29 134.7 37.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -102.96 130.91 50.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.848 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.493 HD23 HG21 ' A' ' 43' ' ' ILE . 1.3 mp -132.69 162.19 58.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.36 -173.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.628 2.218 . . . . 0.0 112.287 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -94.18 -46.65 7.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.433 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 69.7 p-90 -60.01 -39.63 86.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 37.4 ttm -62.03 -32.79 73.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.893 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -53.17 18.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -61.91 -38.35 88.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -59.96 -40.97 90.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.792 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.819 HD11 HG21 ' A' ' 75' ' ' THR . 10.0 mt -84.86 -14.46 47.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.281 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.7 mt 61.35 32.95 19.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.437 HD21 ' OD1' ' A' ' 68' ' ' ASN . 6.9 mt -82.75 162.88 21.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -108.85 173.52 6.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.898 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -60.14 112.55 1.95 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.83 42.65 10.89 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.465 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.11 119.65 5.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.478 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.9 mt -65.57 129.23 39.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.803 0.335 . . . . 0.0 110.847 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.94 149.78 33.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -75.8 124.28 27.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.406 HG21 ' HD2' ' A' ' 20' ' ' TYR . 21.5 t -111.29 122.87 66.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -144.2 121.87 11.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 71.4 p -72.75 129.35 38.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.4 m -137.69 139.79 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.057 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -101.06 109.37 21.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.446 HD12 HD22 ' A' ' 63' ' ' LEU . 3.9 mt -103.52 172.01 7.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -116.03 164.72 14.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.631 HG21 ' SG ' ' A' ' 182' ' ' CYS . 21.7 m -60.82 144.34 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.094 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.867 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -88.07 153.3 21.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.124 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.1 p -106.35 -31.32 8.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -133.7 112.64 11.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.9 m -123.35 122.1 37.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.23 146.46 38.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.974 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.698 ' CD1' HD21 ' A' ' 139' ' ' LEU . 74.5 m-85 -125.94 143.94 50.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -126.59 90.24 50.26 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.958 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.81 112.08 0.75 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.583 2.189 . . . . 0.0 112.328 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -65.39 -31.25 72.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.1 p -106.57 146.47 33.12 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.931 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.59 -17.03 23.76 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.597 2.198 . . . . 0.0 112.576 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.02 -44.25 74.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.087 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.483 ' CE1' HD11 ' A' ' 157' ' ' ILE . 20.9 t80 -70.49 -44.67 67.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.869 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.3 mt -59.82 -31.81 70.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -64.4 -24.07 67.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.977 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.411 HG22 ' H ' ' A' ' 134' ' ' ASN . 60.5 mt -60.02 139.94 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.924 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.401 HG23 ' N ' ' A' ' 134' ' ' ASN . 9.0 t -59.11 -44.73 92.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.411 ' H ' HG22 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -129.76 86.76 54.32 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.49 -28.61 21.52 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.585 2.19 . . . . 0.0 112.313 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.443 ' HG3' ' CE1' ' A' ' 188' ' ' PHE . 36.8 mttt -65.49 -35.67 81.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.93 -41.85 77.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.076 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.671 HG11 ' CZ ' ' A' ' 159' ' ' TYR . 21.5 t -74.38 -36.8 43.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.075 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.698 HD21 ' CD1' ' A' ' 122' ' ' PHE . 1.3 tp -71.42 -37.59 71.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.22 -31.42 65.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.76 -33.02 68.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.899 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.97 -29.19 32.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.7 mt -57.9 -25.97 61.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.057 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -55.59 -30.0 60.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.034 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -80.02 -35.13 37.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -73.92 132.75 42.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -103.1 -27.21 12.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 7.6 t -123.0 161.12 24.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.433 HD12 HG21 ' A' ' 179' ' ' ILE . 6.1 mt -143.78 113.37 7.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.3 m -117.42 136.37 53.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.08 129.35 39.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.918 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 83.4 47.43 5.72 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.53 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.57 110.85 13.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.738 0.304 . . . . 0.0 110.862 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.59 83.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.193 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.433 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 1.4 pt -81.67 150.58 4.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -114.59 117.4 30.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.023 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.483 HD11 ' CE1' ' A' ' 129' ' ' PHE . 3.4 pt -109.1 145.7 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.227 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -148.77 140.67 23.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.882 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.671 ' CZ ' HG11 ' A' ' 138' ' ' VAL . 1.8 p90 -149.02 -50.17 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -100.81 49.34 0.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 59.05 30.0 19.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.974 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -139.74 105.41 5.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.555 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.8 mp -78.26 88.04 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.144 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -69.58 158.09 35.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.781 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -113.98 135.95 53.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.975 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.462 HD21 ' CD2' ' A' ' 129' ' ' PHE . 3.6 mp -150.4 160.56 43.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.825 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 8.5 ttt-85 -144.77 130.67 19.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.025 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.451 ' CG1' HG23 ' A' ' 171' ' ' THR . 21.5 t -59.56 123.53 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.056 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.17 -61.4 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.06 148.08 44.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.991 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.451 HG23 ' CG1' ' A' ' 168' ' ' VAL . 16.6 p -145.92 138.87 25.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -122.19 154.48 61.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.1 -39.08 1.52 Allowed 'Cis proline' 0 C--N 1.347 0.469 0 C-N-CA 123.267 -1.555 . . . . 0.0 112.324 0.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.49 171.64 7.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.81 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.11 -48.1 82.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -93.2 123.42 36.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.062 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.867 HG21 ' HB2' ' A' ' 117' ' ' ALA . 15.7 m -143.78 152.91 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.532 ' OG ' HD11 ' A' ' 180' ' ' ILE . 4.7 t -106.45 106.5 17.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.433 HG21 HD12 ' A' ' 149' ' ' LEU . 2.0 pt -92.09 86.6 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.176 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.532 HD11 ' OG ' ' A' ' 178' ' ' SER . 4.8 mt -116.48 81.57 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.015 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 60.36 89.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 116' ' ' VAL . 2.8 t -162.54 153.18 17.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.928 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -80.64 119.57 23.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.5 ptt? -147.83 168.94 20.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -102.07 150.82 22.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.67 106.94 12.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.134 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.16 158.89 15.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.942 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' PHE . . . . . 0.639 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 7.2 m-85 -127.53 148.01 50.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.864 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -139.14 97.26 3.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.139 179.934 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 m -124.93 100.72 6.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.823 0.344 . . . . 0.0 110.898 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -98.73 137.84 36.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.87 -73.15 0.52 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.46 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 m -105.88 110.37 22.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.844 0.354 . . . . 0.0 110.92 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 p -164.66 123.88 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.86 129.16 0.73 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.51 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 mt 63.65 88.37 0.12 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.656 0.265 . . . . 0.0 111.04 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.51 152.9 70.64 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.539 2.16 . . . . 0.0 112.267 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -137.32 104.57 5.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.3 m -100.8 35.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 61.76 31.8 18.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -89.79 123.11 33.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.975 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -128.56 -66.85 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 57.99 176.11 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.971 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -94.38 103.11 15.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.35 122.69 22.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.405 HG23 ' CE2' ' A' ' 20' ' ' TYR . 11.2 t -177.09 163.75 2.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.913 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -86.14 153.34 22.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.405 ' CE2' HG23 ' A' ' 18' ' ' THR . 13.6 m-85 -154.99 156.74 36.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -82.36 149.8 27.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.905 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.8 m -112.36 119.28 37.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.584 ' CD2' HG23 ' A' ' 88' ' ' ILE . 33.7 m-85 -127.65 163.11 24.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.922 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.8 m -81.22 157.55 25.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.9 m -72.57 -30.61 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.69 -26.92 68.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.974 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -56.2 -23.01 32.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.254 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.418 HD12 ' CE2' ' A' ' 90' ' ' TYR . 1.5 tp -52.18 108.9 0.33 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.84 0.353 . . . . 0.0 111.066 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.16 -20.53 65.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.432 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.6 155.29 4.02 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.728 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.06 122.14 9.21 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.578 2.185 . . . . 0.0 112.365 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 59.71 173.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -154.61 169.98 22.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.52 163.44 24.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.5 -12.55 17.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.37 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.87 20.04 8.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.678 0.275 . . . . 0.0 111.259 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.1 m -95.72 -34.84 5.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.884 0.373 . . . . 0.0 111.092 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -94.03 -31.2 14.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.826 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -97.54 95.42 7.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.888 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.94 -145.98 17.37 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.408 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.11 80.44 0.3 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.557 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.62 ' HG2' HD13 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -142.36 126.62 17.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.826 0.346 . . . . 0.0 110.872 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.401 HG22 ' HD3' ' A' ' 92' ' ' PRO . 13.1 pt -118.17 171.01 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.181 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 mp -128.9 106.7 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.94 160.56 25.7 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.962 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.508 ' N ' ' HB3' ' A' ' 84' ' ' ALA . 51.3 Cg_exo -52.93 161.35 3.32 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.535 2.156 . . . . 0.0 112.28 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.9 -26.39 26.95 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.548 2.165 . . . . 0.0 112.33 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 p -58.86 -31.24 68.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.948 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.45 -36.88 83.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.412 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 44.8 tp -64.86 -38.74 92.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.906 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -77.27 -30.99 54.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.932 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -68.93 -51.3 41.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.9 mt -59.63 -33.13 71.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.5 m -64.24 -30.27 71.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -96.64 20.23 11.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.4 mt -128.57 18.45 6.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.182 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 53.77 30.07 10.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.797 0.332 . . . . 0.0 111.157 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.1 mt -99.59 123.78 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.126 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -119.55 168.79 10.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.462 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -59.93 144.07 86.76 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.89 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.462 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 72.7 Cg_endo -77.27 149.8 90.23 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 123.422 -1.491 . . . . 0.0 112.398 0.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 4.6 mtt -115.74 74.88 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.552 HD21 ' HB1' ' A' ' 147' ' ' ALA . 1.6 mt -88.15 160.37 17.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -127.37 148.28 50.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.837 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.404 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 24.7 tttt -104.11 93.78 5.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.71 80.75 5.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.822 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 m -87.87 95.94 10.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.466 ' ND2' HD21 ' A' ' 101' ' ' LEU . 37.2 t-20 -62.07 123.13 17.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.845 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm -98.31 32.4 2.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -131.93 -46.07 0.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.959 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.0 m -108.66 17.69 21.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.266 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.0 t0 53.16 37.74 25.77 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.848 0.356 . . . . 0.0 111.169 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.488 ' CB ' HD23 ' A' ' 99' ' ' LEU . 3.1 mmt-85 -96.45 152.4 18.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.4 ttp -149.17 123.21 9.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.795 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.452 HG21 HD11 ' A' ' 99' ' ' LEU . 6.5 t -148.96 160.54 43.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.992 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.494 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 15.1 m80 -125.26 107.87 11.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 24.6 p -104.3 161.16 14.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.957 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.53 143.24 17.97 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.661 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 11.1 p -79.53 144.09 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 111.076 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.62 HD13 ' HG2' ' A' ' 42' ' ' LYS . 46.6 tp -116.89 -62.99 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.851 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -122.01 -179.65 4.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.661 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 49.6 m-85 -140.19 80.12 1.74 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.7 m -141.9 31.28 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.129 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.508 ' HB3' ' N ' ' A' ' 46' ' ' PRO . . . -89.85 172.51 8.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.062 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.78 162.37 13.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -60.75 126.1 26.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.89 29.99 76.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.518 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.584 HG23 ' CD2' ' A' ' 23' ' ' PHE . 26.2 mt -148.95 99.25 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.839 0.352 . . . . 0.0 111.169 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 39.0 m -102.68 135.15 44.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.418 ' CE2' HD12 ' A' ' 28' ' ' LEU . 42.7 m-85 -99.53 131.4 45.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 mt -131.27 157.52 77.87 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.401 ' HD3' HG22 ' A' ' 43' ' ' ILE . 52.3 Cg_exo -52.9 -174.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.52 2.147 . . . . 0.0 112.35 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -98.36 -36.04 10.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.895 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 57.0 p-90 -64.97 -31.38 72.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -75.95 -34.16 59.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -37.68 81.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -32.7 52.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -68.58 -38.05 80.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.834 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.488 HD23 ' CB ' ' A' ' 73' ' ' ARG . 7.3 mt -90.73 -21.23 21.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.0 mt 61.26 65.35 0.99 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.898 0.38 . . . . 0.0 110.938 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.466 HD21 ' ND2' ' A' ' 68' ' ' ASN . 8.1 mt -118.84 -177.21 3.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.877 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -126.5 174.59 8.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.881 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -64.85 85.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.26 38.34 1.13 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.426 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.73 134.78 12.68 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.98 123.71 29.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 0.0 110.992 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.93 139.69 51.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.106 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -69.28 102.05 1.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -87.04 142.9 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.96 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -152.95 173.68 15.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.2 p -131.02 108.87 10.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.919 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.5 m -117.9 158.31 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.211 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -110.78 111.4 22.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.475 HD22 ' O ' ' A' ' 176' ' ' ALA . 8.5 mt -110.53 179.94 3.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.935 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.86 168.25 15.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.1 m -59.9 158.09 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.125 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.849 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -97.91 150.7 21.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.045 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.3 t -107.38 -31.28 8.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -132.27 90.76 2.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.2 m -103.69 104.89 14.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.835 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -94.57 146.85 23.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.674 ' CD2' HD21 ' A' ' 139' ' ' LEU . 87.5 m-85 -134.49 152.21 51.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -137.57 93.37 12.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -51.64 121.46 8.61 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.534 2.156 . . . . 0.0 112.297 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -74.14 -31.41 62.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.984 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -107.73 147.36 35.24 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.989 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.43 -15.3 27.93 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.642 2.228 . . . . 0.0 112.52 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.32 -40.22 70.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.103 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.532 ' CE2' HD11 ' A' ' 166' ' ' LEU . 13.6 t80 -70.73 -46.15 63.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.858 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 56.5 mt -59.84 -31.5 69.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -64.53 -25.64 68.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.073 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' ' 134' ' ' ASN . 46.8 mt -61.98 132.68 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.086 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.1 m -61.07 -34.27 74.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.934 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.591 ' H ' HG22 ' A' ' 132' ' ' ILE . 1.0 OUTLIER -120.58 79.97 30.55 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.809 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.64 -30.21 18.52 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.547 2.165 . . . . 0.0 112.295 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -73.72 -31.02 63.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' A' ' 134' ' ' ASN . . . -70.77 -48.71 52.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.15 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.474 HG21 HD13 ' A' ' 132' ' ' ILE . 21.6 t -61.89 -40.37 86.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.674 HD21 ' CD2' ' A' ' 122' ' ' PHE . 9.7 tp -65.41 -46.98 77.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -70.62 -30.91 67.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.966 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -67.58 -27.81 67.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.089 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.5 -26.16 14.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.35 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.3 mt -57.3 -39.47 75.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.117 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -27.62 64.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.05 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -73.54 -30.28 62.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.776 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -78.77 155.6 29.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.552 ' HB1' HD21 ' A' ' 63' ' ' LEU . . . -109.96 -30.51 7.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.536 ' SG ' HD13 ' A' ' 63' ' ' LEU . 1.3 m -145.37 170.77 15.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.932 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.4 mt -137.79 176.25 8.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.5 m -159.67 143.94 14.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.9 m -72.85 123.53 23.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.89 58.49 3.22 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -137.89 130.32 29.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.829 0.347 . . . . 0.0 110.859 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.58 98.52 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.056 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.589 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 14.6 pt -93.68 153.3 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 94' ' ' TRP . . . -119.34 148.31 43.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.067 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 pp -142.13 133.1 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -133.96 141.86 47.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -152.77 -47.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -99.46 45.19 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 61.05 34.34 19.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -152.12 130.43 12.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.804 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.422 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 3.8 mp -95.36 113.25 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.146 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -86.09 157.21 20.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.816 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.23 137.2 46.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.532 HD11 ' CE2' ' A' ' 129' ' ' PHE . 2.9 mt -154.41 134.61 13.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.829 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -126.27 131.39 51.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.503 HG22 ' CE1' ' A' ' 122' ' ' PHE . 27.7 t -72.37 121.1 22.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 18.2 mmm -81.51 -53.56 6.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.0 155.43 41.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.894 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.432 HG23 ' CG1' ' A' ' 168' ' ' VAL . 26.7 p -149.33 158.75 44.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -140.89 157.29 67.76 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.39 -42.24 0.82 Allowed 'Cis proline' 0 C--N 1.346 0.417 0 C-N-CA 123.3 -1.542 . . . . 0.0 112.437 -0.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.84 172.15 7.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.938 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.61 -44.38 89.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.956 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.494 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -102.93 119.04 38.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.849 HG21 ' HB2' ' A' ' 117' ' ' ALA . 16.1 m -127.78 155.68 39.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.16 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.7 t -106.77 95.11 5.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.0 pt -87.83 85.28 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.253 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.7 mm -116.51 86.52 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.102 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 61.4 80.58 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.941 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 9.1 t -159.19 151.08 20.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.811 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.23 127.0 40.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -135.46 173.16 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.83 79.46 5.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.06 138.92 21.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.063 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -137.28 172.3 13.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -134.17 133.85 41.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -117.87 90.31 3.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.069 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.428 ' HB2' HD13 ' A' ' 56' ' ' LEU . 10.8 t80 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.843 0.354 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.9 p -151.63 102.11 2.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -165.61 171.61 12.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.86 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.643 ' HB3' HD22 ' A' ' 106' ' ' LEU . 15.8 mt-30 -96.56 156.91 16.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -145.49 148.13 32.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.25 112.11 14.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.507 ' HB3' ' HE3' ' A' ' 96' ' ' MET . 73.0 m -77.61 128.99 35.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.512 ' CD2' HG23 ' A' ' 88' ' ' ILE . 2.0 m-85 -135.41 172.21 13.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.08 163.39 24.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.9 m -81.1 -31.9 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.192 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.8 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 180.0 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.824 0.345 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.76 -31.2 70.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.902 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.0 mttp -82.65 60.3 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.91 -168.71 41.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.426 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.82 59.8 0.52 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.524 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.82 140.01 50.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.817 0.341 . . . . 0.0 110.853 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.84 HG21 HD23 ' A' ' 91' ' ' LEU . 11.8 pt -126.91 -179.97 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.8 mt -130.49 118.64 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 58.8 mtp -107.89 152.46 41.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.861 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.86 151.87 24.95 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.573 2.182 . . . . 0.0 112.253 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.27 -29.6 58.14 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.576 2.184 . . . . 0.0 112.311 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.1 p -59.76 -30.71 69.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.993 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.51 -39.1 82.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.164 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.483 HD13 ' CD2' ' A' ' 82' ' ' PHE . 12.5 tp -63.9 -43.78 94.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.25 -40.6 94.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.957 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -54.52 27.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.697 ' HA ' HD12 ' A' ' 56' ' ' LEU . 68.3 mt -57.68 -30.17 65.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.0 t -68.5 -29.76 68.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -92.56 -21.21 20.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.164 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.697 HD12 ' HA ' ' A' ' 53' ' ' LEU . 12.8 mt -77.42 -3.34 39.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.513 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.45 31.61 10.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.908 0.385 . . . . 0.0 110.912 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.9 mt -98.79 127.95 50.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.06 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -116.31 178.01 4.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.443 ' CD1' ' HA ' ' A' ' 61' ' ' PRO . 1.3 t80 -66.99 139.89 95.79 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.748 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.443 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.6 166.66 82.13 Favored 'Cis proline' 0 C--N 1.348 0.524 0 C-N-CA 123.517 -1.451 . . . . 0.0 112.411 -0.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 16.1 mtt -134.17 80.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.845 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.41 152.94 19.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.485 ' HB3' HG13 ' A' ' 109' ' ' VAL . 98.2 m-85 -114.5 159.31 20.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -112.4 95.62 5.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.894 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.4 mt -80.7 101.87 9.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -100.75 106.03 17.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.59 ' OD1' HD21 ' A' ' 101' ' ' LEU . 7.5 t30 -76.56 122.89 25.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -98.79 31.27 3.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.86 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.77 -37.08 4.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.803 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.28 25.92 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.016 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t70 56.2 36.82 28.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.114 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.77 153.59 21.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.4 ttp -144.19 131.96 21.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.485 HG21 HD11 ' A' ' 99' ' ' LEU . 2.6 t -150.89 131.89 14.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -107.89 115.59 30.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.5 p -115.88 176.61 5.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.35 135.81 8.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.456 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.1 p -72.34 146.02 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.366 . . . . 0.0 111.102 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.5 tp -118.18 -63.53 1.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -113.68 138.8 49.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.483 ' CD2' HD13 ' A' ' 50' ' ' LEU . 42.5 m-85 -103.51 72.96 1.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 83' ' ' VAL . 15.6 m -148.64 73.36 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.046 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.13 175.12 9.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.07 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -85.01 160.46 20.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.824 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -70.64 132.75 45.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.27 25.61 69.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.657 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.512 HG23 ' CD2' ' A' ' 23' ' ' PHE . 27.1 mt -148.66 82.24 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 111.149 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.53 130.52 35.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -94.89 125.06 39.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.84 HD23 HG21 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -132.58 156.13 80.44 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.918 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.789 ' HD3' HG22 ' A' ' 43' ' ' ILE . 53.5 Cg_exo -52.37 -176.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.547 2.165 . . . . 0.0 112.34 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.13 -33.88 12.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.464 ' CH2' ' HE2' ' A' ' 95' ' ' MET . 66.3 p-90 -63.93 -33.19 75.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.464 ' HE2' ' CH2' ' A' ' 94' ' ' TRP . 17.2 ttm -71.66 -31.29 66.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . 0.507 ' HE3' ' HB3' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -73.21 -47.18 45.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.955 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -64.16 -41.45 97.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -62.69 -42.47 99.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.485 HD11 HG21 ' A' ' 75' ' ' THR . 17.1 mt -83.46 -16.89 43.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.193 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 100' ' ' LEU . 27.6 mt 61.09 34.45 19.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.816 0.341 . . . . 0.0 110.833 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.59 HD21 ' OD1' ' A' ' 68' ' ' ASN . 7.9 mt -84.05 -178.77 7.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.891 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -126.66 169.29 13.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -60.08 111.94 1.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.67 36.0 8.9 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.554 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.09 125.97 8.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.415 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.643 HD22 ' HB3' ' A' ' 19' ' ' GLN . 17.5 mt -77.81 129.24 35.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.9 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.2 135.01 58.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.041 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -60.43 121.93 13.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.485 HG13 ' HB3' ' A' ' 64' ' ' PHE . 21.5 t -116.11 135.81 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -139.17 132.13 29.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.21 96.42 5.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.8 m -109.72 146.16 15.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.18 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -108.58 110.04 21.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 mt -105.71 179.97 4.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.61 171.34 10.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.6 m -59.69 162.06 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.035 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.558 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -102.84 148.56 25.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 80.5 p -104.7 -31.51 9.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.795 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -140.48 111.24 6.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.843 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.1 m -121.65 120.42 34.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.932 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.488 ' O ' HG13 ' A' ' 168' ' ' VAL . 2.5 ttmm -101.72 137.53 39.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -121.17 152.0 39.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.932 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -137.71 93.6 12.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.922 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.65 119.13 4.34 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.556 2.17 . . . . 0.0 112.459 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 40.6 mm-40 -73.64 -33.01 64.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.3 t -104.4 147.38 34.28 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.667 ' HA ' HD12 ' A' ' 130' ' ' LEU . 57.9 Cg_endo -71.19 -17.76 31.03 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.58 2.187 . . . . 0.0 112.503 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.04 -45.0 79.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.006 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -69.33 -45.05 70.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.667 HD12 ' HA ' ' A' ' 127' ' ' PRO . 11.5 mt -59.79 -31.31 69.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.72 -25.91 66.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.986 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.589 HG22 ' H ' ' A' ' 134' ' ' ASN . 52.2 mt -59.97 136.54 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.013 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.0 t -69.34 -32.92 72.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.963 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.589 ' H ' HG22 ' A' ' 132' ' ' ILE . 1.9 m120 -125.1 79.02 66.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.968 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.91 -27.94 20.35 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.569 2.18 . . . . 0.0 112.346 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -65.91 -44.93 83.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.56 -38.78 92.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.123 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 134' ' ' ASN . 26.8 t -72.04 -40.9 67.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.772 HD12 HD13 ' A' ' 166' ' ' LEU . 3.8 tp -72.81 -33.86 66.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.007 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -76.27 -30.23 57.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.986 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -75.37 -30.61 60.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.08 -34.41 17.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.169 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.411 HD22 HD11 ' A' ' 149' ' ' LEU . 14.2 mt -59.53 -27.97 66.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.963 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -57.01 -29.15 63.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.071 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -78.73 -36.63 43.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.976 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.428 ' CZ ' ' HB ' ' A' ' 155' ' ' ILE . 61.3 m-85 -67.48 143.23 56.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.952 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -110.01 -25.34 10.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.178 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 12.2 t -137.46 159.26 42.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.984 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.411 HD11 HD22 ' A' ' 143' ' ' LEU . 25.2 mt -151.32 139.0 19.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.2 m -123.3 160.24 27.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.984 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.8 m -72.97 103.22 3.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 97.83 36.77 4.65 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.54 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -104.5 108.28 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.352 . . . . 0.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 32.6 t -69.59 86.35 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.061 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.428 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 8.2 pt -93.41 131.41 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.136 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -100.06 142.49 31.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.163 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 40.5 pt -127.83 152.74 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -144.19 136.45 26.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.406 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 3.6 p90 -150.71 -50.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -96.78 44.35 1.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 60.29 31.24 20.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -145.12 137.64 26.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.528 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.8 mp -93.82 105.71 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.147 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -91.97 119.38 31.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.02 125.23 28.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.974 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.772 HD13 HD12 ' A' ' 139' ' ' LEU . 1.9 mt -134.14 128.91 35.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.812 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -122.44 133.73 54.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.942 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 121' ' ' LYS . 19.9 t -78.26 139.73 18.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.032 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 56.3 mmm -100.67 -48.3 4.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.987 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.05 153.51 46.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.022 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.444 HG23 HG11 ' A' ' 168' ' ' VAL . 0.9 OUTLIER -148.83 158.18 43.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.805 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -138.1 153.94 73.72 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.04 -34.11 3.55 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 123.204 -1.582 . . . . 0.0 112.448 0.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.52 178.41 4.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -47.67 84.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -99.02 130.55 45.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.558 HG21 ' HB2' ' A' ' 117' ' ' ALA . 31.0 m -134.3 161.58 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.205 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.3 t -119.38 94.57 4.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.8 pt -81.17 83.4 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 35.1 mt -116.01 84.98 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.075 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.37 87.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -159.76 176.56 11.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.802 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.22 107.14 13.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -126.41 179.24 5.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -117.12 121.77 42.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.505 HG11 ' CD2' ' A' ' 139' ' ' LEU . 21.4 t -99.16 122.12 50.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.137 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.76 179.88 4.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.903 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -130.54 157.92 41.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -144.34 87.43 1.88 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.025 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.434 ' N ' ' HG ' ' A' ' 111' ' ' SER . 4.6 t80 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.741 0.305 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.2 p -137.75 94.97 2.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.91 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.6 t -156.85 174.93 14.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.914 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -102.61 152.79 20.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.945 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -146.98 147.22 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.6 mtt85 -74.68 135.45 41.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.973 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 76.2 m -97.24 132.35 43.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -145.45 157.89 43.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -81.03 161.9 24.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.937 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.6 m -65.41 -31.41 53.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.188 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.7 m . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.746 0.308 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.85 -34.95 51.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.947 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -81.59 100.62 9.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.5 -147.77 19.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.505 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.37 52.69 0.58 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.475 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.76 160.73 20.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.804 0.335 . . . . 0.0 110.917 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.577 HG21 HD23 ' A' ' 91' ' ' LEU . 6.0 pt -145.48 177.51 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.058 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.543 HG22 ' HB2' ' A' ' 84' ' ' ALA . 32.5 mt -122.81 137.86 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.123 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -131.22 160.04 68.87 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.844 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.59 162.68 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.567 2.178 . . . . 0.0 112.321 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.26 -33.48 24.11 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.606 2.204 . . . . 0.0 112.277 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.9 p -60.34 -34.55 73.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.34 -39.62 87.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.424 HD13 ' CE1' ' A' ' 82' ' ' PHE . 39.3 tp -64.24 -42.84 96.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.977 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.3 -30.64 60.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -79.32 -41.77 27.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.059 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.469 HD22 ' SD ' ' A' ' 62' ' ' MET . 3.0 mt -53.52 -49.63 67.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.0 t -72.31 -28.51 63.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.887 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.37 -21.23 62.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.3 mt -94.07 20.19 8.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.327 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 59.52 30.88 20.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.02 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.438 ' CD1' HD23 ' A' ' 53' ' ' LEU . 35.1 mt -93.07 124.31 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.126 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.444 HG22 ' N ' ' A' ' 60' ' ' TYR . 50.0 m -111.63 162.11 15.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.981 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.479 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -59.51 144.15 84.92 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.79 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.479 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 75.5 Cg_endo -77.23 167.45 79.54 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.539 -1.442 . . . . 0.0 112.409 0.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.469 ' SD ' HD22 ' A' ' 53' ' ' LEU . 63.9 mtt -129.33 66.98 1.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.818 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.668 HD23 ' CA ' ' A' ' 78' ' ' GLY . 2.5 mt -91.07 148.68 22.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.921 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.435 ' HZ ' HD11 ' A' ' 53' ' ' LEU . 60.2 m-85 -113.57 135.64 53.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.804 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -83.49 89.65 7.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.893 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.675 ' HB2' HG23 ' A' ' 75' ' ' THR . 15.6 mt -69.99 76.35 0.48 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -87.36 109.4 19.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.908 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -84.79 117.62 23.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -98.57 33.94 2.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.84 -44.21 1.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.936 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.8 m -120.25 20.99 11.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.175 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.7 t0 53.6 60.0 3.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.944 0.402 . . . . 0.0 111.117 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.502 ' CB ' HD23 ' A' ' 99' ' ' LEU . 4.7 mmt180 -112.11 164.35 13.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.945 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.3 ttp -159.49 130.61 6.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.689 HG21 HD11 ' A' ' 99' ' ' LEU . 5.0 t -158.38 170.77 21.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -138.18 117.01 12.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.923 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 9.4 p -122.36 153.48 38.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.818 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.668 ' CA ' HD23 ' A' ' 63' ' ' LEU . . . -116.98 127.85 7.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.507 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.524 HG21 ' CE2' ' A' ' 82' ' ' PHE . 10.6 p -66.71 130.6 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 0.0 111.064 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.9 tp -106.91 -56.33 2.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -106.77 155.69 19.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.524 ' CE2' HG21 ' A' ' 79' ' ' VAL . 87.1 m-85 -130.43 82.9 2.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 82' ' ' PHE . 16.1 m -157.39 31.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.169 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.543 ' HB2' HG22 ' A' ' 44' ' ' ILE . . . -86.58 167.86 14.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.11 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.525 ' HB3' HD12 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -73.38 159.35 33.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -66.06 107.29 1.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.26 28.32 30.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.426 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 85' ' ' ASP . 27.7 mt -145.81 98.16 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.843 0.354 . . . . 0.0 111.112 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 94.6 m -94.27 132.54 38.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -95.06 127.27 40.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.577 HD23 HG21 ' A' ' 43' ' ' ILE . 1.1 mt -126.27 153.08 74.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.862 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.419 ' HD3' HG22 ' A' ' 43' ' ' ILE . 51.1 Cg_exo -53.41 -173.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.587 2.191 . . . . 0.0 112.244 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -92.57 -40.32 10.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -66.76 -45.43 78.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -33.41 75.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.932 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -39.21 80.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -78.41 -33.98 48.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -60.32 -39.88 88.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.773 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.689 HD11 HG21 ' A' ' 75' ' ' THR . 6.1 mt -87.8 -13.92 40.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.276 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.7 mt 61.93 37.14 15.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.814 0.34 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.3 mt -80.35 -178.53 6.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -130.04 167.85 17.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.86 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -62.73 84.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.944 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.33 33.96 1.4 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.463 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.32 131.73 10.87 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.474 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.1 mt -85.81 129.81 34.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.834 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.28 149.03 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.208 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -64.9 120.44 12.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.47 88.43 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.13 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -102.44 140.98 36.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.98 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.434 ' HG ' ' N ' ' A' ' 16' ' ' PHE . 34.2 p -96.97 106.85 19.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.3 m -118.3 160.78 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -120.9 120.14 34.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.497 HD13 ' C ' ' A' ' 176' ' ' ALA . 10.8 mt -114.49 177.2 4.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.859 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -122.98 170.44 10.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.901 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.15 133.73 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.162 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.874 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -75.91 162.24 28.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.9 p -120.49 -41.42 2.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.946 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -122.02 91.96 3.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.8 m -108.03 120.65 42.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.2 156.26 17.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.964 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.463 ' CE2' HG22 ' A' ' 168' ' ' VAL . 69.9 m-85 -141.56 155.52 45.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -136.76 89.3 17.87 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -51.43 114.59 1.63 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.531 2.154 . . . . 0.0 112.314 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -69.93 -32.01 70.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.0 t -98.85 144.44 28.18 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.59 -19.77 21.2 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.572 2.181 . . . . 0.0 112.484 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -55.13 -36.53 65.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.093 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -71.13 -42.16 69.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 64.3 mt -63.41 -31.46 72.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.12 -23.32 65.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.05 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 134' ' ' ASN . 57.4 mt -59.99 141.59 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.056 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.3 m -67.23 -42.56 83.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.975 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.42 ' H ' HG22 ' A' ' 132' ' ' ILE . 2.5 m120 -125.84 74.91 71.05 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.001 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -57.09 -31.49 90.47 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.613 2.209 . . . . 0.0 112.235 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -43.26 99.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.957 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.66 84.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.19 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.403 HG21 HD13 ' A' ' 132' ' ' ILE . 27.8 t -67.73 -45.12 85.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.762 HD22 ' CZ ' ' A' ' 188' ' ' PHE . 21.0 tp -59.96 -31.25 69.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.016 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -87.24 -30.74 20.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.01 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.52 -31.3 71.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.947 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.26 -33.06 17.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.483 HD22 HD11 ' A' ' 149' ' ' LEU . 14.3 mt -59.3 -25.42 64.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -56.25 -33.64 65.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.031 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -77.73 -34.4 52.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -69.13 137.61 53.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -102.4 -28.07 12.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.191 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 12.9 t -141.61 159.23 42.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.483 HD11 HD22 ' A' ' 143' ' ' LEU . 7.6 mt -141.39 119.58 12.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.7 m -111.17 138.45 47.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.9 m -62.4 123.05 17.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 94.4 49.82 2.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.472 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.35 132.63 35.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.816 0.341 . . . . 0.0 110.825 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.78 89.24 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 29.7 pt -80.21 141.99 14.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.178 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -114.08 98.05 6.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.044 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.8 pt -83.52 148.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.234 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -151.03 151.36 31.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.737 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -176.43 -40.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.989 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -105.28 43.36 1.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.929 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 57.42 30.04 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.057 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -144.98 120.44 10.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.575 ' H ' HD12 ' A' ' 163' ' ' ILE . 4.4 mp -84.65 89.65 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.056 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -70.86 120.5 16.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -74.65 134.47 42.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.43 160.33 41.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.778 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 44.6 ttt-85 -152.12 121.62 6.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.463 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.4 t -62.93 138.07 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.2 mmm -103.82 -56.42 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -137.83 158.49 44.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.978 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 71.4 p -154.51 138.9 16.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -121.73 155.77 59.66 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.71 -26.33 9.52 Favored 'Cis proline' 0 C--N 1.347 0.471 0 C-N-CA 123.324 -1.532 . . . . 0.0 112.428 -0.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -120.74 170.9 9.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -37.35 76.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.963 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.497 ' C ' HD13 ' A' ' 114' ' ' LEU . . . -102.68 117.64 35.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.043 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.874 HG21 ' HB2' ' A' ' 117' ' ' ALA . 15.6 m -137.85 142.87 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 3.8 t -98.2 105.69 17.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.6 pt -95.37 87.84 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.12 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 22.0 mt -116.23 84.35 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.093 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 60.29 88.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.34 175.18 14.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.854 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.16 110.98 20.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.839 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -131.91 179.56 6.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.41 110.64 20.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.68 143.69 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.04 177.85 4.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . 0.762 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 7.9 m-85 -140.04 141.65 36.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.874 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.3 106.21 14.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.926 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.051 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.417 ' CE2' HG22 ' A' ' 18' ' ' THR . 59.9 t80 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.6 p -143.41 115.97 8.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.417 HG22 ' CE2' ' A' ' 16' ' ' PHE . 9.0 t -176.41 162.15 2.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -94.6 150.35 20.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.765 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -142.47 137.93 30.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -72.92 115.05 11.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.467 ' HB2' HD12 ' A' ' 91' ' ' LEU . 24.2 p -85.37 136.18 33.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.967 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.746 ' CD2' HG23 ' A' ' 88' ' ' ILE . 84.7 m-85 -138.99 170.98 15.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.89 146.49 28.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.931 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.1 m -63.47 -26.45 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.225 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.3 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.079 179.974 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.787 0.327 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -91.73 -32.08 15.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -84.58 92.44 8.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.49 168.6 11.76 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.441 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.02 56.59 3.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.513 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.68 ' HG2' HD13 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -115.86 134.54 54.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.9 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.632 HD13 ' SG ' ' A' ' 77' ' ' CYS . 44.9 pt -128.8 175.31 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.215 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mp -128.98 117.48 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.203 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 14.7 mtp -115.93 163.88 19.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.831 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -51.78 152.89 12.43 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.517 2.145 . . . . 0.0 112.269 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.44 -27.3 40.02 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.541 2.161 . . . . 0.0 112.337 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 95.2 p -63.74 -30.81 71.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.6 -40.43 96.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.742 HD13 ' CD2' ' A' ' 82' ' ' PHE . 23.2 tp -59.7 -40.45 87.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.975 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.35 -30.03 67.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.993 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -84.95 -30.65 24.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.937 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.8 mt -59.39 -30.72 68.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.015 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.5 -30.08 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.044 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -21.95 66.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.23 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.0 mt -93.88 18.37 10.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.392 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 53.94 42.11 31.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.812 0.339 . . . . 0.0 111.167 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.0 mt -107.44 133.59 51.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.126 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.29 169.03 10.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.969 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.47 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -59.92 142.39 88.81 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.7 Cg_endo -77.02 165.82 84.05 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.457 -1.476 . . . . 0.0 112.412 -0.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 65.0 mtt -131.42 51.68 2.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.698 HD22 ' HB2' ' A' ' 148' ' ' CYS . 16.1 mt -68.13 142.08 55.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.918 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.413 ' HB3' HG13 ' A' ' 109' ' ' VAL . 97.2 m-85 -109.57 139.06 45.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.769 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.4 ' HD3' ' CE1' ' A' ' 76' ' ' HIS . 0.9 OUTLIER -93.08 96.65 10.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 34.3 mt -80.9 81.38 7.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.978 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.65 108.48 18.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -70.36 123.96 23.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.848 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -98.52 32.19 2.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -124.95 -45.5 1.87 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.943 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.6 t -121.63 17.85 11.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.208 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 52.66 59.9 4.17 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.863 0.364 . . . . 0.0 111.073 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.44 177.66 4.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 37.4 ttp -156.22 129.44 8.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.7 m -150.82 137.46 18.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.427 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 6.8 m80 -112.38 108.7 17.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.632 ' SG ' HD13 ' A' ' 43' ' ' ILE . 31.2 p -109.8 166.66 10.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.98 136.75 11.11 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.428 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.883 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 11.1 p -75.84 148.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.791 0.329 . . . . 0.0 111.168 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.68 HD13 ' HG2' ' A' ' 42' ' ' LYS . 20.2 tp -122.09 -63.47 1.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.871 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -109.66 -179.46 3.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.883 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 57.5 m-85 -150.19 79.97 1.36 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.6 m -148.71 31.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.66 167.08 13.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.143 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.493 ' HB2' HD12 ' A' ' 88' ' ' ILE . 1.2 m-20 -71.06 177.68 3.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -84.82 89.7 7.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 105.74 28.19 5.45 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.519 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.746 HG23 ' CD2' ' A' ' 23' ' ' PHE . 31.8 mt -141.45 82.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.845 0.355 . . . . 0.0 111.057 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 90.6 m -82.77 131.4 35.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.987 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.469 ' O ' HD23 ' A' ' 91' ' ' LEU . 59.3 m-85 -98.55 145.0 27.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 90' ' ' TYR . 17.6 mt -143.29 149.75 49.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.905 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.478 ' HD3' HG22 ' A' ' 43' ' ' ILE . 53.7 Cg_exo -52.13 178.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.574 2.183 . . . . 0.0 112.372 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -85.74 -40.66 15.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 69.3 p-90 -63.25 -35.89 81.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.846 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 37.0 ttm -70.54 -40.86 73.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 4.6 mtt -60.39 -46.58 89.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.942 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -64.64 -33.46 75.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -66.72 -40.55 88.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.825 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.3 mt -84.85 -21.57 29.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.091 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.5 mt 64.4 34.85 10.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 0.0 110.947 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.8 mt -83.87 -179.58 7.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -118.56 -178.02 3.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -71.8 85.04 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.401 ' HA2' ' CZ ' ' A' ' 23' ' ' PHE . . . 112.86 30.51 2.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.549 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.58 145.53 30.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.532 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.4 mt -96.72 123.47 40.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 0.0 110.953 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.77 131.6 72.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.084 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -64.57 100.22 0.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.413 HG13 ' HB3' ' A' ' 64' ' ' PHE . 21.9 t -83.89 126.29 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -134.6 118.35 17.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.2 p -76.92 116.93 18.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.843 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.4 m -121.24 170.15 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.221 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.03 106.38 9.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.795 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mt -106.9 170.68 7.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -115.56 179.96 3.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.2 m -69.48 141.65 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.716 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -83.71 141.68 31.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.088 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 71.5 p -99.75 -31.11 11.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -140.36 107.61 5.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.931 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 96.4 p -120.46 118.33 30.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -103.04 160.06 14.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -141.88 153.49 44.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.91 89.57 29.28 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.008 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.707 ' HG3' HD21 ' A' ' 166' ' ' LEU . 68.5 Cg_exo -50.97 111.06 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.557 2.171 . . . . 0.0 112.401 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -61.49 -31.33 71.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.9 t -98.69 143.21 25.94 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.829 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.82 -20.26 17.48 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.567 2.178 . . . . 0.0 112.395 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.49 -39.65 70.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.042 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.47 ' HE2' HD11 ' A' ' 157' ' ' ILE . 11.0 t80 -64.66 -44.52 90.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.923 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.7 mt -59.71 -30.99 69.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -67.88 -23.74 65.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.024 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.1 mt -59.94 136.59 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.039 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.9 m -61.65 -49.16 77.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.994 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -118.17 82.65 18.42 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.39 -32.37 10.24 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.573 2.182 . . . . 0.0 112.319 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -33.75 75.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.31 -47.56 27.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.103 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.2 t -66.77 -30.57 50.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.146 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 49.8 tp -77.99 -45.59 23.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.937 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.17 -31.31 70.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -64.75 -28.43 69.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.67 -32.42 18.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.106 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.479 HD22 HD11 ' A' ' 149' ' ' LEU . 34.7 mt -59.54 -28.87 67.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.044 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -57.73 -27.16 62.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.094 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -79.0 -41.23 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.921 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.422 ' CZ ' ' HB ' ' A' ' 155' ' ' ILE . 97.0 m-85 -71.32 130.36 41.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -88.79 -33.37 17.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.698 ' HB2' HD22 ' A' ' 63' ' ' LEU . 15.0 t -126.42 158.9 34.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.899 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.479 HD11 HD22 ' A' ' 143' ' ' LEU . 4.2 mt -142.1 125.28 16.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 m -119.0 148.16 43.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 169' ' ' MET . 66.0 m -75.37 128.25 34.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.98 28.08 19.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.555 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -118.81 138.6 52.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.2 t -96.8 104.12 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.126 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 3.1 pt -102.28 89.73 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.153 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.17 134.33 55.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.47 HD11 ' HE2' ' A' ' 129' ' ' PHE . 3.2 pt -121.49 157.43 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.11 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -143.29 155.06 44.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -175.13 -46.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -100.82 43.14 1.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 59.21 30.22 19.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.959 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.37 122.23 9.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.817 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.509 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.8 mp -81.11 88.87 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.099 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -65.79 131.85 47.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.823 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -90.05 113.11 24.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.707 HD21 ' HG3' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -128.55 140.05 51.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.812 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -131.01 134.66 46.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.78 147.36 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.542 ' O ' HG23 ' A' ' 151' ' ' THR . 1.4 mmt -110.12 -61.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.63 152.38 50.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.963 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 43.5 p -150.3 143.64 25.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -120.35 151.95 54.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.19 -38.34 1.8 Allowed 'Cis proline' 0 C--N 1.346 0.427 0 C-N-CA 123.376 -1.51 . . . . 0.0 112.367 0.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -108.64 175.4 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.787 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.52 -47.78 78.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.998 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.427 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -94.18 131.02 40.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.716 HG21 ' HB2' ' A' ' 117' ' ' ALA . 7.8 m -143.33 155.3 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.177 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.451 ' OG ' HD11 ' A' ' 63' ' ' LEU . 2.8 t -112.39 99.82 8.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.827 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.2 pt -88.98 85.72 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.165 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 20.8 mt -116.46 96.06 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 60.75 66.1 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 7.3 t -155.51 154.91 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.93 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -101.71 135.8 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.933 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -137.21 155.47 49.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.7 76.12 7.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.5 125.82 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.144 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.95 167.11 11.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -120.46 127.7 52.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -98.99 96.87 8.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.095 -179.981 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.426 ' N ' ' HG ' ' A' ' 111' ' ' SER . 53.9 t80 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.76 0.314 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.8 p -130.53 133.98 46.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.852 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.8 t -177.1 169.41 2.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -99.6 125.31 45.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -123.64 152.4 42.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 -84.66 130.19 34.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.9 m -93.66 130.45 39.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.97 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -133.15 171.12 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -85.12 164.34 18.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.643 HG11 HG11 ' A' ' 37' ' ' VAL . 16.0 m -90.47 11.67 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.473 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.9 p . . . . . 0 C--N 1.331 -0.207 0 CA-C-O 120.722 0.296 . . . . 0.0 110.824 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.643 HG11 HG11 ' A' ' 25' ' ' VAL . 20.8 t . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.826 0.346 . . . . 0.0 111.275 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.405 ' O ' ' CD1' ' A' ' 94' ' ' TRP . 9.3 mt-10 -82.51 -30.68 29.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.073 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.2 mttm -87.39 -30.62 20.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.009 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.03 -179.93 38.39 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.575 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.12 63.04 0.48 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.528 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.91 153.09 51.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.756 0.312 . . . . 0.0 110.847 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.652 HG21 HD23 ' A' ' 91' ' ' LEU . 10.7 pt -136.89 177.7 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.218 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.9 mt -126.19 114.98 40.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 76.8 mtp -108.74 164.16 15.36 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.819 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 52.6 Cg_exo -54.8 144.94 63.74 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.584 2.189 . . . . 0.0 112.147 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 46' ' ' PRO . 50.9 Cg_exo -54.06 -28.3 49.8 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.448 2.098 . . . . 0.0 112.338 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.0 t -65.44 -29.72 70.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.043 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.13 -48.27 80.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.15 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.701 HD13 ' CE2' ' A' ' 82' ' ' PHE . 25.1 tp -60.49 -43.5 96.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.35 -31.4 69.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -44.58 69.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.999 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 50' ' ' LEU . 5.1 mt -58.19 -30.14 66.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.009 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.3 m -73.84 -26.25 60.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -94.96 20.14 9.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.318 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -134.04 20.02 3.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.219 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 56.18 30.19 16.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.809 0.338 . . . . 0.0 111.013 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.8 mt -100.43 130.28 49.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.77 164.86 15.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.931 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.451 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.6 t80 -64.44 140.81 98.07 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.787 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 76.9 Cg_endo -77.46 164.46 86.41 Favored 'Cis proline' 0 C--N 1.348 0.511 0 C-N-CA 123.487 -1.464 . . . . 0.0 112.473 -0.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 34.2 mtt -135.04 64.65 1.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.803 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.734 HD13 ' SG ' ' A' ' 148' ' ' CYS . 1.1 mt -70.7 165.05 23.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.984 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -132.78 126.23 31.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.409 ' HG3' ' CD2' ' A' ' 76' ' ' HIS . 15.7 ttpt -83.09 112.7 20.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.4 mt -91.71 82.88 5.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.814 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.7 m -86.16 99.6 11.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.481 ' HA ' HG13 ' A' ' 107' ' ' VAL . 26.0 t-20 -62.22 125.18 23.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.5 33.91 2.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.36 -48.27 1.57 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.816 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.2 m -118.18 21.69 12.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.209 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 t0 54.16 35.14 21.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.833 0.349 . . . . 0.0 111.077 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -84.37 162.09 20.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.969 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.78 127.05 13.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.477 ' OG1' HD21 ' A' ' 99' ' ' LEU . 55.8 m -152.93 131.39 12.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.616 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 49.5 m80 -104.48 106.41 16.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.5 p -93.49 174.52 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.25 138.79 10.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.443 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.574 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 10.9 p -84.81 158.41 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.846 0.355 . . . . 0.0 111.055 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.485 ' N ' HG22 ' A' ' 79' ' ' VAL . 16.6 tp -151.56 -58.28 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -104.88 147.36 27.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.701 ' CE2' HD13 ' A' ' 50' ' ' LEU . 97.2 m-85 -125.31 86.72 2.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.2 m -155.91 32.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.109 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.38 165.59 12.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -83.47 165.11 19.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -64.08 121.73 14.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.43 33.7 68.13 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.555 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 26.5 mt -148.46 95.15 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 111.095 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 98.0 m -98.12 126.93 43.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.964 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -89.9 129.45 36.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.652 HD23 HG21 ' A' ' 43' ' ' ILE . 1.4 mp -136.29 155.34 77.34 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.02 -174.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.509 2.139 . . . . 0.0 112.354 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -94.55 -36.05 11.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.608 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 59.1 p-90 -64.34 -37.03 86.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.898 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.45 ' O ' HD12 ' A' ' 99' ' ' LEU . 56.4 ttm -71.24 -39.12 71.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 36.5 mmm -64.57 -45.2 88.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -39.44 68.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -59.61 -31.9 69.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.477 HD21 ' OG1' ' A' ' 75' ' ' THR . 6.4 mt -98.13 -8.84 26.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.342 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.4 mt 63.03 33.6 14.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.849 0.357 . . . . 0.0 110.885 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.6 mt -92.17 130.32 37.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.831 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -84.15 179.07 7.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.79 94.35 0.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.43 41.53 1.48 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.564 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.58 119.92 6.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.569 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.8 mt -73.62 126.57 30.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.838 0.351 . . . . 0.0 110.878 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.481 HG13 ' HA ' ' A' ' 68' ' ' ASN . 21.6 t -127.43 143.62 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.126 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -67.33 104.65 1.55 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.35 136.32 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -141.97 148.2 38.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.426 ' HG ' ' N ' ' A' ' 16' ' ' PHE . 53.3 p -104.68 115.16 29.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.4 m -131.13 173.05 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.078 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.81 100.07 4.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.444 ' CD1' ' HB1' ' A' ' 176' ' ' ALA . 5.0 mt -89.19 -179.95 5.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -123.91 170.23 10.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -64.36 143.96 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.15 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.519 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -83.28 156.37 23.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.181 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.2 p -117.64 -39.94 3.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.943 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -125.22 85.68 2.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.42 ' OG ' HG22 ' A' ' 171' ' ' THR . 35.2 m -100.32 120.43 39.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.859 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -109.53 149.59 29.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 143' ' ' LEU . 89.5 m-85 -134.46 164.03 28.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.84 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -148.43 90.06 5.0 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.13 126.21 19.64 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.486 2.124 . . . . 0.0 112.313 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -73.35 -32.03 64.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.6 m -105.61 148.32 36.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.5 -12.59 27.21 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.586 2.19 . . . . 0.0 112.53 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -55.18 -41.71 72.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.034 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.416 ' CE1' HD11 ' A' ' 166' ' ' LEU . 12.6 t80 -70.67 -35.37 72.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.892 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 26.5 mt -66.68 -29.71 69.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.31 -26.04 68.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.008 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.755 HD13 HG21 ' A' ' 138' ' ' VAL . 47.5 mt -63.13 138.76 22.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.986 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.4 t -66.58 -39.65 88.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.992 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.472 ' H ' HG22 ' A' ' 132' ' ' ILE . 9.2 t30 -126.68 80.49 70.21 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.17 -36.1 92.39 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.542 2.161 . . . . 0.0 112.31 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -59.69 -35.7 75.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.47 -37.34 80.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.2 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.755 HG21 HD13 ' A' ' 132' ' ' ILE . 21.4 t -82.75 -31.69 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.274 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.556 HD21 ' CD1' ' A' ' 122' ' ' PHE . 32.0 tp -75.2 -39.0 60.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.52 -31.35 68.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -66.19 -31.14 71.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.96 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.08 -41.35 13.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.149 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.579 HD11 ' CZ ' ' A' ' 122' ' ' PHE . 15.6 mt -59.41 -27.56 66.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.999 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -56.97 -29.94 63.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.053 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.09 -46.0 18.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.865 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -61.1 134.26 56.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -98.48 -28.63 13.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.734 ' SG ' HD13 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -133.65 166.72 21.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.873 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.573 HD22 HG21 ' A' ' 168' ' ' VAL . 11.8 mt -158.19 147.34 19.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.42 132.08 40.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.0 m -59.99 107.1 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.942 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 112.44 28.87 3.36 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.505 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -122.67 134.28 54.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.774 0.321 . . . . 0.0 110.871 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.13 114.79 29.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.106 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.608 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 7.2 pt -112.87 118.5 58.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.38 141.6 33.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.066 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.6 pt -135.04 147.27 29.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.108 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -143.06 156.46 44.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.439 ' CE2' ' HB2' ' A' ' 160' ' ' ASN . 47.9 p90 -175.29 -44.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.872 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.439 ' HB2' ' CE2' ' A' ' 159' ' ' TYR . 41.0 t30 -101.5 40.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 60.29 31.15 20.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -152.03 134.85 15.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.567 ' H ' HD12 ' A' ' 163' ' ' ILE . 4.0 mp -85.23 105.93 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -89.47 111.52 22.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.2 138.5 57.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.416 HD11 ' CE1' ' A' ' 129' ' ' PHE . 0.5 OUTLIER -156.56 118.05 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -115.79 137.48 52.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.573 HG21 HD22 ' A' ' 149' ' ' LEU . 21.5 t -73.97 109.01 5.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.2 mmm -76.64 -47.01 23.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.13 155.94 43.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.979 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.42 HG22 ' OG ' ' A' ' 120' ' ' SER . 0.5 OUTLIER -160.06 132.9 6.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.763 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -108.88 158.16 34.92 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.69 -26.72 9.1 Favored 'Cis proline' 0 C--N 1.347 0.454 0 C-N-CA 123.31 -1.538 . . . . 0.0 112.414 -0.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -125.74 179.46 5.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -47.83 84.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.616 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -91.04 124.33 35.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.0 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 117' ' ' ALA . 9.2 m -140.74 152.57 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.8 t -113.23 98.95 7.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.2 pt -88.1 85.09 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.184 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.0 mm -113.61 89.19 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.12 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 61.1 77.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.818 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 13.9 t -163.16 149.91 12.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -101.32 131.16 47.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.926 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -136.11 170.98 15.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.43 97.73 11.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 29.2 t -84.26 139.69 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.084 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.09 175.24 5.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.844 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -141.56 148.44 39.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -135.87 90.49 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.138 179.939 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.469 ' CE2' HG22 ' A' ' 18' ' ' THR . 43.7 t80 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.789 0.328 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.9 p -159.04 118.8 3.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.966 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.469 HG22 ' CE2' ' A' ' 16' ' ' PHE . 9.8 t -177.47 150.91 0.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.888 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -75.39 140.02 42.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.436 ' C ' HD23 ' A' ' 106' ' ' LEU . 5.9 m-85 -142.0 144.11 33.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -69.32 176.49 3.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.971 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.1 m -146.38 125.32 12.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.651 ' CD2' HG23 ' A' ' 88' ' ' ILE . 56.7 m-85 -132.64 174.41 10.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 t -93.62 146.94 23.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.28 -27.65 43.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.173 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.5 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.107 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.89 0.376 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.87 -31.03 28.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -91.21 56.19 3.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.773 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.33 149.42 6.88 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.423 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.55 72.96 2.73 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.484 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.452 ' HE2' HD13 ' A' ' 80' ' ' LEU . 33.9 mttt -131.28 133.67 45.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.789 0.328 . . . . 0.0 110.842 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.561 HG21 HD23 ' A' ' 91' ' ' LEU . 1.9 pt -120.3 163.67 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.151 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.24 118.3 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.06 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.7 mtm -110.78 164.16 15.53 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 52.2 Cg_exo -55.08 148.23 49.63 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.567 2.178 . . . . 0.0 112.19 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 46' ' ' PRO . 50.7 Cg_exo -53.86 -29.69 54.3 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.513 2.142 . . . . 0.0 112.316 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.7 p -59.0 -30.94 68.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.91 74.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.603 HD13 ' CE2' ' A' ' 82' ' ' PHE . 38.4 tp -70.9 -50.39 35.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.924 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.26 -30.85 69.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.592 ' HG2' HD11 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -77.12 -41.32 42.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.058 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.1 mt -58.23 -31.97 67.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.038 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -82.33 -29.79 30.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.61 -16.08 52.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.216 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.592 HD11 ' HG2' ' A' ' 52' ' ' GLN . 9.2 mt -93.93 19.6 8.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.265 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.3 t30 55.2 30.08 13.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.0 mt -98.18 141.14 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.193 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.8 p -126.45 159.35 33.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.46 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -63.02 145.37 96.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.842 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.46 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.3 Cg_endo -77.1 152.12 94.39 Favored 'Cis proline' 0 C--N 1.348 0.501 0 C-N-CA 123.413 -1.495 . . . . 0.0 112.378 0.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 20.3 mtt -116.17 61.3 0.72 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.651 HD13 HD12 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -78.77 137.95 37.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.826 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.495 ' CD1' HG12 ' A' ' 109' ' ' VAL . 94.7 m-85 -100.73 171.8 7.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.451 ' NZ ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -121.33 86.51 2.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.887 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 mt -66.18 88.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.451 HG23 ' NZ ' ' A' ' 65' ' ' LYS . 3.4 m -88.25 103.08 15.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -85.17 113.69 21.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -96.08 42.93 1.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -124.59 -44.29 1.98 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.85 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 m -128.13 25.65 5.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.085 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 55.92 39.58 30.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.039 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.523 ' HB3' HD23 ' A' ' 99' ' ' LEU . 2.1 mmp_? -89.59 157.39 18.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.962 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.7 ttp -154.72 127.38 8.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.932 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.602 HG21 HD11 ' A' ' 99' ' ' LEU . 4.6 t -157.43 145.22 18.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.965 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -112.14 108.06 17.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.819 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 28.6 p -107.5 147.52 30.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.08 142.47 16.17 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.438 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.41 HG21 ' CE1' ' A' ' 82' ' ' PHE . 11.7 p -70.3 136.12 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.876 0.37 . . . . 0.0 111.066 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.452 HD13 ' HE2' ' A' ' 42' ' ' LYS . 14.7 tp -104.59 -63.25 1.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -127.61 167.49 16.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.934 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.603 ' CE2' HD13 ' A' ' 50' ' ' LEU . 94.8 m-85 -123.27 93.42 3.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 82' ' ' PHE . 22.9 m -156.73 37.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.188 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.91 157.65 19.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.1 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.498 ' HB3' HD12 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -71.41 148.47 46.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -59.81 124.59 20.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.86 -19.15 54.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.594 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.651 HG23 ' CD2' ' A' ' 23' ' ' PHE . 29.0 mt -108.24 132.2 56.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 111.157 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 43.6 m -128.76 126.53 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.56 145.88 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.561 HD23 HG21 ' A' ' 43' ' ' ILE . 4.6 mp -146.57 158.51 46.46 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.03 155.0 9.32 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.605 2.203 . . . . 0.0 112.278 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -69.34 -38.46 78.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.528 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 49.0 p-90 -64.75 -41.17 96.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.446 ' N ' ' CD2' ' A' ' 94' ' ' TRP . 3.3 ttp -66.91 -36.97 83.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.929 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.6 mtp -61.94 -35.69 79.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -77.61 -38.38 48.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -60.33 -31.96 70.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.834 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.602 HD11 HG21 ' A' ' 75' ' ' THR . 9.2 mt -98.13 -14.42 20.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.257 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.7 mt 62.07 39.99 12.51 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.9 0.381 . . . . 0.0 110.88 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 mt -81.23 164.97 21.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.842 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.81 -174.39 2.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -65.01 96.11 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.27 38.12 5.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.06 110.3 3.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.436 HD23 ' C ' ' A' ' 20' ' ' TYR . 26.3 mt -73.76 124.85 26.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.826 0.346 . . . . 0.0 110.945 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -134.34 150.42 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -66.5 136.63 55.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.888 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.495 HG12 ' CD1' ' A' ' 64' ' ' PHE . 21.4 t -123.63 92.3 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -107.79 137.6 45.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.431 ' HG ' ' N ' ' A' ' 16' ' ' PHE . 21.7 p -88.49 114.49 25.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.3 m -119.67 131.05 73.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.142 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -82.13 112.42 19.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.651 HD12 HD13 ' A' ' 63' ' ' LEU . 1.9 mt -111.7 175.08 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -133.08 171.83 13.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.06 147.28 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.184 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.589 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -89.65 149.74 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.064 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.1 p -105.55 -28.58 10.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.824 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -134.93 90.78 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.906 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.7 p -98.24 109.03 21.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -101.22 136.46 41.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.845 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.509 ' CZ ' HD21 ' A' ' 143' ' ' LEU . 64.5 m-85 -124.49 156.71 36.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -133.64 94.45 19.21 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.97 108.58 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.52 2.147 . . . . 0.0 112.395 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -61.98 -31.82 72.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.948 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 m -113.87 146.68 36.09 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.002 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.31 -14.6 25.47 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.544 2.163 . . . . 0.0 112.567 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.68 -33.96 61.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.135 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -75.29 -31.38 60.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.9 mt -63.53 -30.72 71.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.71 -27.99 69.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.012 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.648 HD13 HG21 ' A' ' 138' ' ' VAL . 46.8 mt -60.88 135.62 25.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.049 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.6 m -71.07 -30.66 66.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.598 ' H ' HG22 ' A' ' 132' ' ' ILE . 1.1 m120 -127.88 73.32 78.93 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.908 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -56.74 -37.09 98.65 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.629 2.219 . . . . 0.0 112.209 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -60.75 -46.4 90.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.046 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -59.21 -46.02 89.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.055 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.648 HG21 HD13 ' A' ' 132' ' ' ILE . 21.5 t -69.72 -37.54 74.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.485 HD21 ' CD1' ' A' ' 122' ' ' PHE . 4.4 tp -73.5 -34.08 65.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -74.16 -34.49 63.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.906 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.05 -37.07 86.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.3 -33.44 43.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.534 HD22 HD11 ' A' ' 149' ' ' LEU . 12.6 mt -60.03 -28.82 68.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.947 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -57.95 -32.76 68.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.03 -31.56 58.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.83 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -74.71 142.61 44.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -100.79 -30.67 11.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.522 ' SG ' HD13 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -134.56 173.31 11.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.534 HD11 HD22 ' A' ' 143' ' ' LEU . 55.0 mt -149.59 114.38 5.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.824 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.0 m -104.95 144.88 31.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.1 m -71.12 112.72 7.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 99.76 39.3 3.42 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.575 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.18 112.9 20.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 110.883 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.21 82.97 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.116 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.528 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 8.7 pt -79.98 160.52 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.062 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.625 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -121.8 112.91 18.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.3 pt -98.7 152.51 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.208 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -147.72 147.24 29.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 160' ' ' ASN . 52.8 p90 -164.49 -47.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.846 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.45 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 57.0 t-20 -98.93 43.95 1.04 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 60.15 31.02 20.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.17 132.35 19.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.625 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 4.0 mp -90.39 88.49 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.087 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -70.38 123.18 21.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -75.14 133.09 41.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.22 141.38 22.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.877 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -136.94 145.51 44.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.38 153.64 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.177 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 13.2 mmm -121.99 -54.37 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.91 140.13 34.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.7 p -144.43 135.76 25.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -113.49 153.91 45.62 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.69 -37.12 2.22 Favored 'Cis proline' 0 C--N 1.346 0.395 0 C-N-CA 123.337 -1.526 . . . . 0.0 112.4 0.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.39 173.13 6.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -56.58 -43.33 79.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -95.06 127.63 41.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.004 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.589 HG21 ' HB2' ' A' ' 117' ' ' ALA . 16.2 m -138.35 139.61 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.169 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.429 ' HB2' HD11 ' A' ' 180' ' ' ILE . 30.9 p -93.18 102.1 14.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.793 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.0 pt -96.13 88.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.271 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.429 HD11 ' HB2' ' A' ' 178' ' ' SER . 3.5 mp -124.28 82.31 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.005 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 62.19 81.57 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 23.7 t -157.18 158.15 35.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -91.14 129.75 37.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 5.9 ptt? -152.02 174.04 14.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -108.48 117.19 33.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.813 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.477 HG11 HD23 ' A' ' 139' ' ' LEU . 21.4 t -97.91 137.98 23.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.203 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.1 146.56 52.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -105.75 148.13 27.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -114.91 85.16 2.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.931 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.163 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.426 ' CE2' ' HG ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.791 0.329 . . . . 0.0 110.875 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.3 p -159.72 99.5 1.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -160.69 162.39 32.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.747 ' HB3' HD22 ' A' ' 106' ' ' LEU . 12.1 mt-30 -96.06 130.59 43.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.436 ' HD2' HG21 ' A' ' 109' ' ' VAL . 12.7 m-85 -126.15 143.27 51.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -78.08 143.13 37.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.2 p -104.38 130.23 52.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.568 ' CD2' HG23 ' A' ' 88' ' ' ILE . 57.1 m-85 -139.86 154.56 47.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -60.23 162.44 5.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.595 HG12 ' HB3' ' A' ' 90' ' ' TYR . 14.6 m -95.55 20.09 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.331 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-O 120.842 0.353 . . . . 0.0 110.911 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.745 0.307 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.525 ' OE1' HG21 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -73.47 -40.99 63.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.897 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.8 mttm -66.02 79.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.47 -171.9 22.08 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.49 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.7 79.98 0.26 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.453 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.473 ' HE2' HD13 ' A' ' 80' ' ' LEU . 17.0 mttt -140.51 134.25 30.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.813 0.339 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.604 HG21 HD23 ' A' ' 91' ' ' LEU . 24.1 pt -122.53 170.07 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.098 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 4.6 mt -124.46 96.9 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.004 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.9 mmm -90.34 158.55 43.33 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.81 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.64 149.38 32.1 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.51 2.14 . . . . 0.0 112.267 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.54 -30.14 53.03 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.566 2.177 . . . . 0.0 112.276 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.93 -30.19 71.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.43 -30.05 66.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.177 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.421 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 32.2 tp -70.67 -50.6 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.962 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.29 -32.39 73.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -76.78 -44.12 34.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.06 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.426 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 8.1 mt -58.72 -37.02 75.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.953 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.4 t -83.01 -28.76 29.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.79 -19.95 59.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.171 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.6 mt -92.69 15.52 14.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.332 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.83 32.69 20.09 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.735 0.302 . . . . 0.0 111.038 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.419 HD12 HD23 ' A' ' 53' ' ' LEU . 41.2 mt -92.87 144.17 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.107 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.3 p -127.19 179.69 5.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.984 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 16.7 t80 -72.55 138.42 80.65 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.749 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.458 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.4 Cg_endo -77.15 156.57 97.09 Favored 'Cis proline' 0 C--N 1.348 0.537 0 C-N-CA 123.534 -1.444 . . . . 0.0 112.426 0.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 41.8 mtt -119.97 31.34 6.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.809 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.543 HD22 ' HB2' ' A' ' 148' ' ' CYS . 1.3 mt -61.58 149.23 39.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.468 ' HB3' HG13 ' A' ' 109' ' ' VAL . 94.8 m-85 -109.51 145.51 36.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.882 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -92.39 85.97 5.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.949 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.514 HD11 ' SG ' ' A' ' 77' ' ' CYS . 96.2 mt -70.73 90.1 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -98.89 111.64 23.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.927 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -83.86 113.17 20.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.825 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -88.31 54.35 3.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -142.9 -47.48 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.885 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.7 22.5 9.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.157 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 54.52 37.02 27.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.005 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -90.56 147.93 23.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.9 ttt -138.07 142.01 40.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.809 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.5 m -159.98 148.68 17.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.47 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 72.9 m80 -124.78 114.01 18.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.514 ' SG ' HD11 ' A' ' 66' ' ' LEU . 26.5 p -115.06 155.89 26.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.511 ' CA ' HD23 ' A' ' 63' ' ' LEU . . . -113.23 131.08 9.81 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.449 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.535 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 10.7 p -68.59 140.14 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 111.164 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.473 HD13 ' HE2' ' A' ' 42' ' ' LYS . 12.6 tp -129.65 -56.35 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.832 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -108.54 146.12 33.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.971 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.535 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 76.6 m-85 -120.39 58.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.1 m -125.34 31.2 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.104 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 44' ' ' ILE . . . -85.24 179.24 7.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.076 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.69 169.08 9.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -73.02 107.97 5.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.37 28.21 33.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.493 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.568 HG23 ' CD2' ' A' ' 23' ' ' PHE . 27.0 mt -148.33 95.67 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 111.12 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 15.0 m -91.05 134.2 34.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.595 ' HB3' HG12 ' A' ' 25' ' ' VAL . 34.7 m-85 -97.84 120.64 38.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.604 HD23 HG21 ' A' ' 43' ' ' ILE . 4.8 mt -123.34 150.23 59.96 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.935 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.3 176.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.52 2.147 . . . . 0.0 112.304 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -79.84 -47.4 15.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -59.53 -29.12 67.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.992 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.555 ' SD ' HD22 ' A' ' 91' ' ' LEU . 33.4 ttm -73.45 -30.94 63.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.831 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 6.4 mtp -71.61 -43.59 65.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -68.92 -40.25 79.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.854 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -60.38 -61.51 2.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.819 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 mt -62.88 -20.54 65.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.6 mt 63.25 34.25 13.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.823 0.344 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 mt -81.52 179.27 7.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.827 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -125.79 177.59 6.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -63.97 103.18 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.437 ' CA ' ' CZ ' ' A' ' 23' ' ' PHE . . . 89.41 34.87 8.29 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.521 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.18 117.83 4.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.554 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.747 HD22 ' HB3' ' A' ' 19' ' ' GLN . 12.7 mt -64.71 130.22 42.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 110.884 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.9 t -121.46 138.02 53.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -70.46 112.81 7.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 64' ' ' PHE . 27.0 t -96.44 143.93 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -160.03 138.63 10.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.4 p -91.05 113.91 26.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.6 m -120.86 150.14 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.115 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.74 86.8 2.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.422 ' CD1' ' HB1' ' A' ' 176' ' ' ALA . 4.9 mt -83.01 168.08 17.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.801 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -110.9 175.53 5.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.838 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.14 139.59 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.2 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.944 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -76.39 151.02 36.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.6 t -110.57 -30.93 7.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -138.77 107.72 6.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.938 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 m -114.26 137.99 51.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -129.02 148.63 50.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.496 ' CD1' HD21 ' A' ' 139' ' ' LEU . 67.8 m-85 -133.8 150.84 51.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -131.55 91.33 34.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -51.34 125.02 15.39 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.543 2.162 . . . . 0.0 112.34 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -71.12 -39.77 71.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.1 m -105.57 148.0 35.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.877 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.472 ' HA ' HD12 ' A' ' 130' ' ' LEU . 57.4 Cg_endo -70.73 -11.22 29.25 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.575 2.183 . . . . 0.0 112.576 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -56.37 -39.7 73.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.766 0.317 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -72.32 -38.3 68.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 127' ' ' PRO . 32.4 mt -65.32 -36.94 85.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.824 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.29 -25.3 67.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.652 HG22 ' H ' ' A' ' 134' ' ' ASN . 52.2 mt -59.99 134.57 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.052 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.1 t -59.69 -32.65 70.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.004 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.652 ' H ' HG22 ' A' ' 132' ' ' ILE . 0.5 OUTLIER -137.04 81.01 33.86 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.926 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.34 -30.05 16.11 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.62 2.214 . . . . 0.0 112.318 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -63.51 -37.8 88.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.63 -56.48 17.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.7 -33.94 62.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.164 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.496 HD21 ' CD1' ' A' ' 122' ' ' PHE . 29.7 tp -70.16 -50.92 35.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.943 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.425 ' CD ' HG21 ' A' ' 186' ' ' VAL . 2.2 mt-10 -67.27 -39.07 86.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -60.13 -30.92 69.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.858 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.08 -31.21 61.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.071 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 60.4 mt -57.95 -27.16 63.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.038 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -30.05 62.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.012 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -81.55 -36.25 29.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -77.69 147.14 35.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.962 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -107.96 -28.66 9.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.543 ' HB2' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -128.58 159.56 35.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.402 HD12 HG21 ' A' ' 179' ' ' ILE . 28.4 mt -137.44 118.71 14.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.14 140.77 46.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.86 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.4 m -66.7 125.5 26.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.22 44.69 8.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.438 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -111.01 119.46 39.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.839 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.73 81.22 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 39.9 pt -81.91 178.41 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -152.63 131.32 12.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.039 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 39.8 pt -118.56 138.02 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -136.83 146.01 45.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.425 ' CE2' ' HB2' ' A' ' 160' ' ' ASN . 52.6 p90 -173.98 -44.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.868 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.425 ' HB2' ' CE2' ' A' ' 159' ' ' TYR . 53.1 t30 -97.76 38.5 1.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 60.21 31.12 20.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.21 119.45 8.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.517 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.8 mp -84.09 90.81 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -71.8 138.61 48.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -96.96 124.86 41.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.2 mt -139.33 138.28 36.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -129.85 136.57 49.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.4 t -71.78 130.19 35.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.067 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.2 mmm -91.37 -62.81 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.09 150.45 48.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 31.5 p -144.79 144.22 31.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.849 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -123.84 152.17 65.7 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.96 -38.77 1.62 Allowed 'Cis proline' 0 C--N 1.346 0.436 0 C-N-CA 123.321 -1.533 . . . . 0.0 112.368 0.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -107.63 168.82 8.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -34.87 72.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.947 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.47 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -108.39 124.02 49.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.075 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.944 HG21 ' HB2' ' A' ' 117' ' ' ALA . 6.4 m -135.89 160.04 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 3.7 t -108.93 91.83 3.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.402 HG21 HD12 ' A' ' 149' ' ' LEU . 3.0 pt -80.56 82.76 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.145 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.9 mt -115.2 82.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.089 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 60.0 79.78 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.842 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 2.0 t -156.94 153.93 28.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.85 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -90.7 118.89 30.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -135.11 176.26 8.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.839 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.01 142.06 27.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.425 HG21 ' CD ' ' A' ' 140' ' ' GLU . 21.5 t -129.54 86.6 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.138 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.62 175.39 10.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -134.75 145.34 48.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -141.08 105.09 4.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.092 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.78 0.324 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.6 p -158.42 102.85 1.75 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -168.25 177.82 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.45 ' HB3' HD22 ' A' ' 106' ' ' LEU . 57.8 mt-30 -105.38 122.08 45.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -117.73 151.06 38.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 mtt85 -86.4 137.16 32.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.582 ' HB2' HD12 ' A' ' 91' ' ' LEU . 21.5 p -104.16 122.93 46.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.522 ' CD2' HG23 ' A' ' 88' ' ' ILE . 36.7 m-85 -132.05 160.29 36.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 t -77.09 152.72 34.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -64.34 -21.04 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.347 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.276 -179.956 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.749 0.309 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.68 -36.33 65.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.821 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -60.29 -33.29 72.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -110.4 -164.66 19.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.474 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.16 31.63 5.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.55 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.635 ' HE3' HD13 ' A' ' 80' ' ' LEU . 22.0 mmtt -87.66 158.57 18.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.815 0.341 . . . . 0.0 110.973 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.6 pt -135.77 -179.98 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 3.6 mp -130.45 104.45 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.04 157.17 34.21 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.54 ' N ' ' HB3' ' A' ' 84' ' ' ALA . 53.6 Cg_exo -52.34 144.86 38.2 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.541 2.161 . . . . 0.0 112.261 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 46' ' ' PRO . 50.1 Cg_exo -53.66 -30.62 56.61 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.516 2.144 . . . . 0.0 112.279 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.3 p -60.65 -35.45 76.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.94 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.89 -30.98 71.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.144 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.589 HD13 ' CD2' ' A' ' 82' ' ' PHE . 43.3 tp -63.06 -39.38 94.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.56 -32.89 47.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -61.14 -38.79 87.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.53 HD23 HD12 ' A' ' 58' ' ' ILE . 8.8 mt -61.37 -46.21 91.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -60.14 -30.98 69.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.947 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.8 mtt85 -82.1 -26.35 33.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.036 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.1 mt -86.74 6.14 32.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.428 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 t30 59.52 31.34 20.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.81 0.338 . . . . 0.0 110.966 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.53 HD12 HD23 ' A' ' 53' ' ' LEU . 33.1 mt -94.73 125.19 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.128 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.7 p -110.37 170.62 7.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.455 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.8 OUTLIER -64.82 141.18 98.27 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.822 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.9 Cg_endo -77.1 164.61 86.76 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.468 -1.471 . . . . 0.0 112.403 -0.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 20.1 mtt -126.65 72.9 1.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.852 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.665 HD21 ' HB1' ' A' ' 147' ' ' ALA . 4.0 mt -90.96 149.26 21.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.958 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.459 ' HB3' HG13 ' A' ' 109' ' ' VAL . 97.7 m-85 -112.78 142.99 44.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.823 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 59.5 tttt -94.93 103.39 15.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.984 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.5 HD12 ' SG ' ' A' ' 77' ' ' CYS . 7.9 mt -91.69 76.24 5.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.94 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -78.09 97.22 5.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.931 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -66.02 116.92 7.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -92.31 49.71 1.54 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -130.4 -46.13 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.795 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.0 m -133.28 28.82 4.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.958 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 58.02 34.75 24.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.031 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -88.82 156.32 19.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.512 ' O ' HG21 ' A' ' 150' ' ' THR . 13.8 ttm -158.4 137.63 11.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.592 ' CG2' HD11 ' A' ' 99' ' ' LEU . 7.0 t -160.0 108.98 1.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.888 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.436 ' CD2' HD11 ' A' ' 114' ' ' LEU . 37.9 m80 -75.91 118.31 18.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.9 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.5 ' SG ' HD12 ' A' ' 66' ' ' LEU . 24.7 p -111.61 147.16 36.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.95 149.71 19.26 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.499 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.539 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 9.8 p -91.02 154.42 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.853 0.358 . . . . 0.0 111.084 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.635 HD13 ' HE3' ' A' ' 42' ' ' LYS . 53.0 tp -145.96 -55.99 0.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.925 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -101.89 143.96 31.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.894 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.589 ' CD2' HD13 ' A' ' 50' ' ' LEU . 67.4 m-85 -123.54 76.8 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.4 m -150.79 31.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.54 ' HB3' ' N ' ' A' ' 46' ' ' PRO . . . -81.42 150.12 28.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.148 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.481 ' HB3' HD12 ' A' ' 88' ' ' ILE . 0.7 OUTLIER -68.01 173.06 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.85 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -67.95 115.89 7.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.11 29.83 75.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.522 HG23 ' CD2' ' A' ' 23' ' ' PHE . 32.7 mt -142.7 91.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 0.0 111.146 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.5 t -94.66 129.43 41.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -89.01 140.96 28.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 22' ' ' CYS . 4.1 mt -137.47 155.92 75.22 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.2 179.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.603 2.202 . . . . 0.0 112.293 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -87.44 -45.3 10.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.781 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 39.9 p-90 -60.35 -44.89 95.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.4 tpp -60.15 -34.74 73.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -53.36 22.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -60.0 -36.3 76.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.865 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -62.2 -49.08 77.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.781 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.592 HD11 ' CG2' ' A' ' 75' ' ' THR . 4.9 mt -75.36 -17.06 60.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.2 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.4 mt 61.21 35.22 18.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.44 HD13 ' SG ' ' A' ' 22' ' ' CYS . 25.6 mt -80.68 -178.63 6.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.826 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.02 -177.98 4.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 120.75 10.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.8 27.84 70.04 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.504 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -70.71 107.62 2.22 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.439 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' A' ' 19' ' ' GLN . 16.3 mt -69.52 123.52 21.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.839 0.352 . . . . 0.0 110.839 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.2 t -125.59 145.88 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.08 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -73.32 108.72 6.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.459 HG13 ' HB3' ' A' ' 64' ' ' PHE . 21.5 t -95.93 121.54 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.7 114.55 12.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.8 p -77.73 114.86 17.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.985 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.9 m -122.54 144.13 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.071 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.43 102.58 15.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.436 HD11 ' CD2' ' A' ' 76' ' ' HIS . 6.0 mt -99.58 168.93 9.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.63 172.34 7.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.6 m -67.96 140.76 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.122 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.592 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -81.82 148.84 28.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.062 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.7 p -109.63 -31.55 7.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -131.73 93.29 3.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 61.1 m -114.49 94.49 4.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.38 142.5 35.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.823 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.642 ' CE2' HG22 ' A' ' 168' ' ' VAL . 42.7 m-85 -124.68 150.92 45.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.014 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -128.37 93.54 38.13 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.54 104.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.557 2.171 . . . . 0.0 112.373 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -59.51 -30.88 68.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.3 146.31 35.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.821 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.69 -12.76 26.87 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.536 2.157 . . . . 0.0 112.559 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -56.82 -40.69 76.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.067 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.534 ' CD1' HD11 ' A' ' 166' ' ' LEU . 19.2 t80 -67.31 -44.24 79.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.62 -29.98 68.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.947 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -61.99 -26.31 68.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.988 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.564 HG22 ' H ' ' A' ' 134' ' ' ASN . 43.2 mt -61.66 139.68 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.981 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.4 m -65.3 -37.38 86.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.564 ' H ' HG22 ' A' ' 132' ' ' ILE . 2.0 m120 -130.01 71.12 82.28 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.407 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 39.6 Cg_exo -57.0 -29.95 84.78 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.611 2.207 . . . . 0.0 112.241 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -60.31 -49.52 77.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.043 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.45 75.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.139 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.4 HG21 HD13 ' A' ' 132' ' ' ILE . 21.5 t -75.57 -33.27 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.679 HD22 ' CE1' ' A' ' 188' ' ' PHE . 12.6 tp -71.7 -42.87 66.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.14 -37.83 72.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -65.69 -32.76 74.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.58 -31.74 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.136 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.538 HD22 HD11 ' A' ' 149' ' ' LEU . 14.2 mt -63.98 -27.32 69.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.038 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -57.03 -25.2 58.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.101 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -79.74 -49.24 12.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.826 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.431 ' CZ ' ' HB ' ' A' ' 155' ' ' ILE . 84.5 m-85 -60.77 146.72 45.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.665 ' HB1' HD21 ' A' ' 63' ' ' LEU . . . -100.85 -30.33 11.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.24 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.11 167.46 22.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.974 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.538 HD11 HD22 ' A' ' 143' ' ' LEU . 27.6 mt -143.01 137.53 29.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.512 HG21 ' O ' ' A' ' 74' ' ' MET . 2.0 m -114.09 141.64 47.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.0 m -65.83 94.28 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 108.33 30.43 3.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.548 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.03 134.17 46.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.766 0.317 . . . . 0.0 110.854 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 26.1 t -90.2 91.19 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.117 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.781 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 9.3 pt -91.65 134.03 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.494 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -102.05 125.07 48.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.12 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.433 HG12 HD12 ' A' ' 166' ' ' LEU . 5.0 pt -115.88 141.59 32.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.103 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -139.19 142.22 37.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -157.71 -50.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -96.77 44.18 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 60.34 31.47 20.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -148.55 126.21 11.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.494 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 3.8 mp -85.92 95.45 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.188 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -76.66 137.43 39.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -95.46 122.96 38.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.534 HD11 ' CD1' ' A' ' 129' ' ' PHE . 3.2 mt -141.63 100.55 3.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -93.93 127.74 39.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.642 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.2 t -68.94 128.79 32.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.083 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.8 mmm -86.71 -64.16 1.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.014 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -123.14 155.79 36.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 58.2 p -144.98 161.01 40.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.636 ' O ' HG11 ' A' ' 177' ' ' VAL . 25.9 mttt -148.12 155.4 43.47 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.825 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.29 -31.6 5.17 Favored 'Cis proline' 0 C--N 1.348 0.507 0 C-N-CA 123.309 -1.538 . . . . 0.0 112.462 0.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -113.51 176.7 4.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -60.01 -41.94 93.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -98.83 116.94 32.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.018 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.636 HG11 ' O ' ' A' ' 172' ' ' LYS . 17.7 m -133.27 137.66 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.16 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.506 ' OG ' HD11 ' A' ' 63' ' ' LEU . 10.0 t -94.62 97.9 10.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.1 pt -89.63 85.49 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.3 mm -117.83 85.12 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.123 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 60.58 87.26 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 49.9 t -161.65 141.52 10.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.97 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -80.84 108.14 14.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -128.34 179.22 5.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -93.84 89.97 6.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.75 81.33 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.01 172.05 13.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . 0.679 ' CE1' HD22 ' A' ' 139' ' ' LEU . 11.8 m-85 -128.52 163.07 25.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.93 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -147.93 101.64 3.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.958 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.048 179.946 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.3 t80 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.889 0.376 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.9 p -118.97 105.34 11.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.831 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.0 t -168.35 160.97 11.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.952 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -95.7 148.57 22.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -139.03 148.5 43.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 -75.84 128.51 35.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.873 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.463 ' HB3' HD13 ' A' ' 91' ' ' LEU . 64.9 m -99.11 125.79 44.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -130.66 175.47 8.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 t -92.28 150.66 20.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.906 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.5 m -68.3 -30.8 48.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.086 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.869 0.366 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.17 -31.58 43.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -80.56 -35.17 34.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.78 167.14 26.72 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.476 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.47 40.88 2.57 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.455 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.18 162.4 13.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.356 . . . . 0.0 110.897 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.537 HG22 ' HD3' ' A' ' 92' ' ' PRO . 43.0 pt -141.1 172.55 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.102 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 mt -120.93 86.41 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.174 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.6 mtp -89.11 151.59 47.0 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.773 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.09 156.09 7.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.574 2.183 . . . . 0.0 112.251 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.73 -25.46 61.17 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.625 2.217 . . . . 0.0 112.342 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.5 p -58.87 -30.78 67.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.942 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.79 -47.96 64.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.161 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.733 ' HA ' HD12 ' A' ' 53' ' ' LEU . 56.1 tp -59.51 -39.46 83.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.68 -31.01 64.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.924 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -74.04 -32.6 63.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.733 HD12 ' HA ' ' A' ' 50' ' ' LEU . 23.6 mt -59.84 -30.38 68.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.5 t -80.91 -22.94 39.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.111 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -75.09 -30.57 60.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.018 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.5 mt -95.52 20.05 10.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.243 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 53.58 38.42 28.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.82 0.343 . . . . 0.0 111.265 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 59' ' ' THR . 25.0 mm -77.08 154.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.025 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.408 ' N ' HG22 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -140.91 151.55 44.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.451 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.5 t80 -61.83 140.6 95.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.753 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.75 157.8 97.34 Favored 'Cis proline' 0 C--N 1.349 0.579 0 C-N-CA 123.479 -1.467 . . . . 0.0 112.409 -0.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.626 ' SD ' HD13 ' A' ' 53' ' ' LEU . 45.0 mtt -116.38 56.86 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.91 139.72 45.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.552 ' HB3' HG13 ' A' ' 109' ' ' VAL . 57.6 m-85 -105.81 157.13 17.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.421 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 10.3 tttp -103.55 92.94 4.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.6 mt -75.8 80.64 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.7 m -95.21 117.8 30.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -89.36 129.46 35.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.889 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -98.69 31.11 3.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.32 -41.02 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.847 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m -134.41 21.99 3.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.5 t70 54.4 59.95 3.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.098 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.627 ' HB3' HD23 ' A' ' 99' ' ' LEU . 5.7 mmp_? -106.55 158.98 16.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.1 ttm -159.28 126.64 4.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.712 HG22 HD21 ' A' ' 99' ' ' LEU . 4.4 t -158.96 100.94 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.941 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.421 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 50.4 m80 -65.77 131.98 47.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.926 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.6 p -123.11 166.32 15.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.49 113.24 2.05 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.516 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 80' ' ' LEU . 11.2 p -62.35 154.18 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.102 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.407 ' N ' HG22 ' A' ' 79' ' ' VAL . 23.2 tp -133.33 -62.22 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -95.7 162.76 13.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.51 ' CD2' HD22 ' A' ' 50' ' ' LEU . 51.7 m-85 -140.83 74.02 1.44 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.4 m -143.56 31.44 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.42 158.26 17.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.13 169.1 18.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -73.19 120.79 19.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.82 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.19 26.08 55.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.577 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.3 mt -149.74 113.99 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.834 0.35 . . . . 0.0 111.106 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 86.4 m -117.38 131.29 56.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -97.96 135.87 39.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.465 HD23 HG21 ' A' ' 43' ' ' ILE . 3.3 mp -135.36 160.63 67.25 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.537 ' HD3' HG22 ' A' ' 43' ' ' ILE . 53.6 Cg_exo -52.43 -176.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.582 2.188 . . . . 0.0 112.292 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -93.09 -40.92 10.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.023 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.413 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 65.1 p-90 -61.85 -42.07 98.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.98 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 44.6 ttm -60.43 -44.46 95.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.22 -48.76 80.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -60.57 -36.81 79.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.898 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -65.44 -56.38 12.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.712 HD21 HG22 ' A' ' 75' ' ' THR . 12.2 mt -68.14 -17.68 64.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.184 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.3 mt 62.86 32.35 15.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.844 0.354 . . . . 0.0 110.84 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.84 179.96 7.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -134.08 176.53 8.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -59.91 105.4 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.8 28.45 8.31 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.52 121.58 5.56 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.466 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.6 mt -83.14 123.55 29.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.835 0.35 . . . . 0.0 110.985 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.41 135.55 62.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.085 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -68.28 102.13 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 64' ' ' PHE . 25.4 t -86.86 132.12 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -145.17 133.15 21.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.8 p -90.88 103.06 15.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.1 m -109.19 170.96 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.168 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -114.89 118.69 34.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 176' ' ' ALA . 12.1 mt -119.12 177.31 4.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -123.06 167.53 13.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.2 m -64.85 141.96 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.064 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.638 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -76.53 148.85 36.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.3 p -113.29 -37.05 4.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.926 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -137.6 118.41 14.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.931 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.58 107.2 6.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.07 131.64 34.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.603 ' CG ' HD21 ' A' ' 139' ' ' LEU . 26.4 m-85 -112.29 144.5 41.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -131.57 96.97 19.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.81 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.82 119.91 5.35 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.518 2.145 . . . . 0.0 112.327 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -71.49 -32.22 67.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.033 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.98 147.48 34.56 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.957 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.65 -19.14 28.27 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.571 2.18 . . . . 0.0 112.604 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.52 -48.07 78.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.051 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.457 ' CE1' HD11 ' A' ' 166' ' ' LEU . 13.4 t80 -61.14 -44.96 96.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.88 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.6 mt -59.37 -31.8 69.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -62.77 -26.8 68.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.976 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.629 HG22 ' H ' ' A' ' 134' ' ' ASN . 29.6 mt -61.38 135.56 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.993 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.7 t -64.51 -33.39 75.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.629 ' H ' HG22 ' A' ' 132' ' ' ILE . 0.1 OUTLIER -134.61 81.76 46.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.86 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.12 -27.23 20.42 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.47 2.113 . . . . 0.0 112.321 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -60.14 -35.74 75.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.019 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.3 -39.27 68.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.13 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.54 -30.28 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.275 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.603 HD21 ' CG ' ' A' ' 122' ' ' PHE . 25.5 tp -79.75 -44.51 20.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.04 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -63.64 -31.56 72.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.94 -28.82 67.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.74 -32.63 31.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.124 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.06 -26.63 68.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.076 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -56.41 -30.1 62.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.068 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -85.86 -42.73 13.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.944 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.597 ' CE2' HD13 ' A' ' 155' ' ' ILE . 37.6 m-85 -62.49 142.42 57.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.547 ' HB1' HD11 ' A' ' 180' ' ' ILE . . . -108.03 -25.67 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.279 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -141.42 165.5 27.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.5 mt -145.83 162.55 37.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.66 143.71 30.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.959 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 169' ' ' MET . 89.0 m -62.98 96.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 110.0 27.47 4.55 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.468 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.93 116.15 28.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.3 t -84.62 89.0 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.069 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.597 HD13 ' CE2' ' A' ' 146' ' ' PHE . 1.1 pt -93.67 142.85 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.111 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.409 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -109.0 131.25 55.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.159 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.8 pt -117.99 154.63 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -144.72 142.06 29.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.908 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.419 ' CE1' ' CD1' ' A' ' 164' ' ' TYR . 16.4 p90 -158.5 -49.75 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.966 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -97.87 44.5 1.04 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.9 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 60.0 30.14 19.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -144.58 142.63 30.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.8 mp -93.67 90.45 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.041 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.419 ' CD1' ' CE1' ' A' ' 159' ' ' TYR . 39.8 m-85 -74.04 120.79 20.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -77.45 139.61 39.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.991 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.475 HD22 HD13 ' A' ' 139' ' ' LEU . 0.7 OUTLIER -153.28 124.78 7.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -124.16 137.67 54.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.929 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.425 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.5 t -76.18 146.96 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.443 ' O ' HG23 ' A' ' 151' ' ' THR . 24.5 mmm -106.23 -56.88 2.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -128.65 149.79 50.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.983 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 17.5 p -145.69 141.17 27.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.869 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -127.43 152.98 77.23 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.99 -28.15 7.94 Favored 'Cis proline' 0 C--N 1.346 0.397 0 C-N-CA 123.38 -1.508 . . . . 0.0 112.366 0.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -124.61 173.25 8.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -47.16 85.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.968 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.487 ' O ' HD22 ' A' ' 114' ' ' LEU . . . -90.88 103.55 16.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.016 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.638 HG21 ' HB2' ' A' ' 117' ' ' ALA . 15.9 m -123.38 132.19 71.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 5.7 t -89.55 85.58 6.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.813 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.8 pt -74.17 81.55 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.213 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.547 HD11 ' HB1' ' A' ' 147' ' ' ALA . 27.9 mm -119.69 103.07 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.977 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.98 79.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.808 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -176.48 144.14 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -101.18 120.48 40.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.969 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.75 172.18 7.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.05 95.06 9.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.414 HG13 ' CD1' ' A' ' 122' ' ' PHE . 21.5 t -86.3 90.34 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.13 175.43 10.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -130.43 151.6 50.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -129.2 80.74 1.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.128 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.1 t80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.856 0.36 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.8 p -147.75 107.26 3.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.952 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 t -156.5 178.65 10.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.482 ' HB3' HD22 ' A' ' 106' ' ' LEU . 38.6 mt-30 -107.2 163.29 13.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.861 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -157.36 142.59 17.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.982 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -81.87 118.81 23.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.2 p -84.94 133.43 34.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -138.58 174.52 10.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.21 147.08 23.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.976 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.7 m -68.27 -21.2 26.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.324 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.215 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.819 0.342 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -78.42 -31.37 48.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -71.8 86.46 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.412 ' HA2' ' CE1' ' A' ' 146' ' ' PHE . . . 139.45 -156.83 24.83 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.488 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.22 40.28 1.62 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.552 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HG2' HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -98.85 149.36 22.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.921 0.391 . . . . 0.0 110.891 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.593 HD13 ' SG ' ' A' ' 77' ' ' CYS . 39.6 pt -126.99 170.74 16.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.179 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mt -122.83 99.78 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.033 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -99.93 157.5 33.77 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -51.87 160.24 3.09 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.515 2.143 . . . . 0.0 112.282 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.09 -27.42 42.03 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.494 2.129 . . . . 0.0 112.357 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.43 -31.22 71.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.3 -39.16 89.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.088 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.436 HD13 ' CE1' ' A' ' 82' ' ' PHE . 24.1 tp -60.11 -42.3 94.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -74.27 -42.28 59.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.716 ' HG2' HD11 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -61.63 -47.14 86.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.999 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.442 HD11 ' HZ ' ' A' ' 64' ' ' PHE . 13.7 mt -54.12 -26.92 29.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.122 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.96 -27.52 24.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.033 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -97.12 20.05 11.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.268 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.716 HD11 ' HG2' ' A' ' 52' ' ' GLN . 31.1 mt -126.17 20.0 7.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.721 0.296 . . . . 0.0 111.295 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 55.05 30.04 13.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.804 0.335 . . . . 0.0 111.072 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.425 HD12 HD23 ' A' ' 53' ' ' LEU . 28.0 mt -98.24 124.61 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.152 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 t -114.98 169.5 9.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.469 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -70.98 145.17 91.24 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.77 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.7 Cg_endo -76.88 156.24 97.63 Favored 'Cis proline' 0 C--N 1.348 0.503 0 C-N-CA 123.549 -1.438 . . . . 0.0 112.393 0.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.6 mtt -115.76 66.68 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.705 HD22 ' HB2' ' A' ' 148' ' ' CYS . 10.0 mt -84.32 123.47 30.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.442 ' HZ ' HD11 ' A' ' 53' ' ' LEU . 59.9 m-85 -98.31 142.95 29.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -101.03 82.72 2.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.506 HD12 ' SG ' ' A' ' 77' ' ' CYS . 10.6 mt -60.9 94.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -94.46 112.55 24.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.861 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -71.06 103.8 2.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -79.95 61.98 4.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -174.08 -41.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.854 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.24 4.59 26.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.398 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 57.83 49.06 12.66 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.905 0.384 . . . . 0.0 110.904 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.414 ' HB3' HD23 ' A' ' 99' ' ' LEU . 3.4 mmp_? -107.64 168.82 8.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.4 ttm -157.39 128.4 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.679 HG21 HD11 ' A' ' 99' ' ' LEU . 10.3 t -145.81 148.74 33.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.948 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -116.11 95.28 5.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.932 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.593 ' SG ' HD13 ' A' ' 43' ' ' ILE . 30.5 p -107.04 160.98 15.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -118.16 134.91 11.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.531 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.612 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 11.7 p -73.87 151.41 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 111.09 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.547 HD22 ' HG2' ' A' ' 42' ' ' LYS . 63.6 tp -137.55 -59.13 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -102.26 145.34 29.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.612 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 82.4 m-85 -124.89 75.66 1.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.851 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 m -136.57 30.86 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.623 ' HB1' ' O ' ' A' ' 88' ' ' ILE . . . -94.68 155.26 16.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.541 ' HB2' HD12 ' A' ' 88' ' ' ILE . 4.0 m-20 -80.58 160.26 25.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -60.34 113.02 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.5 27.64 32.15 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.58 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.623 ' O ' ' HB1' ' A' ' 84' ' ' ALA . 26.0 mt -148.59 98.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 111.131 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.7 t -103.19 135.12 45.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -103.77 136.78 42.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 mp -136.12 157.55 75.48 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -51.95 179.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.573 2.182 . . . . 0.0 112.321 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.71 -35.54 15.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.734 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 65.3 p-90 -68.06 -43.17 79.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.459 ' HE2' ' CH2' ' A' ' 94' ' ' TRP . 31.0 ttm -66.93 -33.08 74.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.956 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.8 mmt -60.57 -39.83 89.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.811 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -79.34 -33.86 42.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.886 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -60.31 -31.1 69.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.679 HD11 HG21 ' A' ' 75' ' ' THR . 3.8 mt -102.13 0.28 34.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.375 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.4 mt 57.87 30.78 19.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.82 0.343 . . . . 0.0 110.919 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.482 HD11 HG21 ' A' ' 107' ' ' VAL . 38.7 mt -82.42 -178.63 7.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -144.56 -174.19 4.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.789 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -76.82 90.78 3.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.05 50.18 0.74 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.532 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.65 141.91 17.19 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.477 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.482 HD22 ' HB3' ' A' ' 19' ' ' GLN . 59.5 mt -85.65 127.19 34.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.482 HG21 HD11 ' A' ' 101' ' ' LEU . 21.5 t -130.41 139.68 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -80.26 121.77 26.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.412 HG22 HD23 ' A' ' 66' ' ' LEU . 21.5 t -105.27 139.22 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.093 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -143.18 130.03 20.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.3 p -88.77 123.17 32.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.89 140.26 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.134 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -91.96 112.14 23.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.681 HD13 ' O ' ' A' ' 176' ' ' ALA . 11.6 mt -115.76 176.86 4.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -128.01 173.96 9.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.841 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.5 m -59.71 164.67 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.056 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.975 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -96.94 160.74 14.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.103 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 58.3 p -119.58 -41.12 2.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.809 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -133.08 92.4 3.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.807 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.92 143.26 35.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.941 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -117.23 169.76 9.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.828 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.761 ' CD2' HD21 ' A' ' 139' ' ' LEU . 42.9 m-85 -153.75 139.82 18.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -128.57 86.64 57.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.533 ' HA ' HD23 ' A' ' 166' ' ' LEU . 59.4 Cg_exo -51.56 125.44 16.78 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.573 2.182 . . . . 0.0 112.375 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -80.99 -31.22 34.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.5 p -101.01 146.57 32.37 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.595 ' HA ' HD12 ' A' ' 130' ' ' LEU . 62.9 Cg_endo -73.37 -17.14 24.27 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.528 2.152 . . . . 0.0 112.51 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.22 -38.48 68.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.073 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -76.07 -38.28 57.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.595 HD12 ' HA ' ' A' ' 127' ' ' PRO . 21.4 mt -63.48 -32.33 73.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -67.26 -26.1 66.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.061 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.529 HD13 HG21 ' A' ' 138' ' ' VAL . 47.9 mt -64.68 124.49 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.124 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.5 m -59.96 -39.06 84.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.48 77.71 4.47 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.17 -27.79 19.57 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.574 2.183 . . . . 0.0 112.252 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -64.41 -39.77 94.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.0 -51.66 44.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.09 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.529 HG21 HD13 ' A' ' 132' ' ' ILE . 21.4 t -59.73 -30.51 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.761 HD21 ' CD2' ' A' ' 122' ' ' PHE . 6.1 tp -75.98 -44.71 38.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.38 -38.35 77.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -59.63 -31.09 69.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.968 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -86.04 -31.61 21.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.049 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.422 HD22 HD13 ' A' ' 179' ' ' ILE . 28.1 mt -61.35 -28.48 69.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -57.56 -29.71 64.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.067 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -79.07 -31.24 44.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.412 ' CE1' ' HA2' ' A' ' 40' ' ' GLY . 7.4 m-85 -83.6 150.68 25.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -109.87 -29.37 8.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.173 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.705 ' HB2' HD22 ' A' ' 63' ' ' LEU . 17.4 t -141.58 158.69 43.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.6 mt -131.66 178.53 6.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.0 m -158.89 136.63 10.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.5 m -65.41 121.57 15.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.8 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.75 41.34 9.83 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.356 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.77 106.71 9.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.836 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.8 t -66.57 107.02 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.011 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.734 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 4.0 pt -109.1 132.17 57.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.116 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -92.45 129.85 38.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.083 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.455 HG12 HD12 ' A' ' 166' ' ' LEU . 3.0 pt -115.36 140.87 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.155 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -143.01 145.21 32.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -161.3 -48.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.923 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 48.0 p30 -101.66 44.93 0.99 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.976 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.77 30.79 20.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.96 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -139.36 119.04 13.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.425 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.7 mp -88.84 83.99 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.164 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -62.95 179.97 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -132.31 130.72 41.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.888 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 124' ' ' PRO . 20.2 mt -145.63 159.07 43.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.864 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -153.0 114.96 4.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.52 HG22 ' CE1' ' A' ' 122' ' ' PHE . 21.5 t -59.72 135.41 24.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 41.1 mmm -99.97 -46.71 5.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.942 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.38 156.18 44.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.6 p -153.06 157.24 40.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.416 ' O ' HG11 ' A' ' 177' ' ' VAL . 39.2 mttt -143.12 154.9 61.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.3 -31.4 5.31 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 123.298 -1.542 . . . . 0.0 112.434 0.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -108.34 167.67 9.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -35.17 71.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.949 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.681 ' O ' HD13 ' A' ' 114' ' ' LEU . . . -113.61 115.43 27.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.023 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.975 HG21 ' HB2' ' A' ' 117' ' ' ALA . 27.5 m -118.67 154.79 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.438 ' CB ' HD11 ' A' ' 63' ' ' LEU . 1.5 t -99.89 80.01 2.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.422 HD13 HD22 ' A' ' 143' ' ' LEU . 3.1 pt -71.28 81.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.202 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.2 mt -125.19 95.92 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.079 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 61.59 78.38 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.08 148.43 2.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.02 136.57 43.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.946 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.589 ' SD ' ' HB3' ' A' ' 117' ' ' ALA . 4.1 ptt? -143.54 167.45 22.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.1 85.41 5.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.0 108.79 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.108 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.09 179.96 5.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -138.28 140.83 39.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -107.56 99.5 8.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.819 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.255 -0.878 . . . . 0.0 111.057 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.2 t80 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.813 0.34 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.8 p -158.56 85.31 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.415 HG22 ' N ' ' A' ' 19' ' ' GLN . 92.7 m -148.95 160.31 43.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.869 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.415 ' N ' HG22 ' A' ' 18' ' ' THR . 17.9 mt-30 -103.12 121.16 42.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.877 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.66 ' HB2' HG21 ' A' ' 109' ' ' VAL . 2.6 m-85 -122.25 146.87 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.96 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -69.89 169.16 13.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.6 m -131.15 112.77 13.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.52 ' CD2' HG23 ' A' ' 88' ' ' ILE . 82.0 m-85 -122.73 162.46 21.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -83.48 154.21 24.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.5 m -65.25 -29.67 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.112 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.2 p . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.037 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.1 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.755 0.312 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -39.51 76.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.946 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -84.38 94.25 8.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.83 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.18 -134.01 7.41 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.606 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.1 52.3 0.56 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.524 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.9 154.17 26.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 0.0 110.804 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.647 HG21 HD23 ' A' ' 91' ' ' LEU . 40.2 pt -136.85 161.2 36.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.187 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.404 HG23 ' HB3' ' A' ' 81' ' ' GLU . 21.5 mt -110.09 102.13 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.15 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 82.7 mtp -99.55 161.4 24.64 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -55.89 159.52 11.73 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.532 2.155 . . . . 0.0 112.234 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.2 -27.78 23.96 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.625 2.217 . . . . 0.0 112.297 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 p -59.4 -31.75 69.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.23 -36.43 77.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.124 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.79 -44.27 97.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -71.9 -31.18 66.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.942 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.42 -41.5 60.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -61.55 -48.07 82.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.7 p -65.31 -30.82 71.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.876 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.58 -20.35 58.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.2 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.8 mt -94.38 20.03 8.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.295 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.9 t30 56.16 30.59 16.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 111.064 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.3 mt -97.81 141.67 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.129 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 p -134.37 172.1 13.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.454 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.5 t80 -60.6 140.62 92.55 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.855 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.454 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.6 Cg_endo -77.05 163.24 89.82 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 123.501 -1.458 . . . . 0.0 112.345 0.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.4 mtt -130.45 69.42 1.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.454 HD11 ' OG ' ' A' ' 178' ' ' SER . 2.0 mt -90.13 147.56 23.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -113.5 126.75 55.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -82.81 89.09 6.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.413 HD11 HD21 ' A' ' 91' ' ' LEU . 13.6 mt -68.03 77.5 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.857 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -81.92 95.39 7.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.552 ' OD1' HD21 ' A' ' 101' ' ' LEU . 2.9 t-20 -64.38 116.04 5.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.828 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -98.11 29.51 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -119.16 -40.5 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 m -124.28 21.79 8.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.098 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 54.4 37.97 28.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.036 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.416 ' HB3' HD23 ' A' ' 99' ' ' LEU . 8.9 mmp_? -93.09 171.85 8.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.963 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.1 ttp -156.08 125.42 6.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.0 m -144.52 132.25 21.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.888 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.46 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 12.0 m80 -107.35 101.0 10.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.917 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.457 ' SG ' HD13 ' A' ' 43' ' ' ILE . 28.8 p -108.06 172.66 6.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -134.6 137.67 9.45 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.528 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.79 150.91 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.761 0.315 . . . . 0.0 111.091 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.5 tp -133.44 -60.71 0.83 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.404 ' HB3' HG23 ' A' ' 44' ' ' ILE . 1.8 mp0 -99.51 157.24 16.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -130.32 55.46 1.81 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.827 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.14 31.76 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.21 168.46 11.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.415 ' HB3' HD12 ' A' ' 88' ' ' ILE . 3.0 m-20 -83.74 151.8 25.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.861 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -59.9 134.87 57.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.13 24.86 70.66 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.501 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.52 HG23 ' CD2' ' A' ' 23' ' ' PHE . 29.4 mt -145.93 92.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.85 0.357 . . . . 0.0 111.033 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 83.8 m -92.18 126.15 37.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.022 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -92.7 141.3 28.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.777 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.647 HD23 HG21 ' A' ' 43' ' ' ILE . 3.1 mp -141.67 160.21 57.2 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.853 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.504 ' HD3' HG22 ' A' ' 43' ' ' ILE . 55.4 Cg_exo -51.84 177.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.53 2.154 . . . . 0.0 112.365 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -84.32 -46.16 12.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.755 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 70.1 p-90 -60.24 -38.49 83.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.882 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.9 ttm -61.29 -40.81 95.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -41.85 99.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.892 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -71.79 -36.76 70.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -62.25 -39.0 91.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 68' ' ' ASN . 52.0 mt -87.25 -20.68 26.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.4 mt 61.74 42.83 10.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.878 0.37 . . . . 0.0 110.924 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.552 HD21 ' OD1' ' A' ' 68' ' ' ASN . 44.3 mt -87.72 170.01 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.77 179.33 3.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.905 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.92 88.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.886 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.48 47.71 1.38 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.395 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.07 107.95 3.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.457 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 32.3 mt -69.59 132.61 46.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.804 0.335 . . . . 0.0 110.941 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.32 149.52 32.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.073 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -63.26 110.18 1.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.66 HG21 ' HB2' ' A' ' 20' ' ' TYR . 22.4 t -99.58 120.59 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -148.84 142.59 25.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.836 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.1 p -90.15 114.66 26.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.854 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 20.4 m -116.46 152.18 18.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.129 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -108.55 119.11 38.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.1 mt -119.48 179.93 4.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.14 171.61 7.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.915 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.0 m -71.51 133.57 31.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.784 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -65.27 147.42 53.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.149 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.7 p -111.98 -35.53 5.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.431 ' CE1' ' HB2' ' A' ' 187' ' ' ASP . 75.2 t80 -133.23 99.8 4.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.5 p -113.43 111.05 21.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -102.67 136.53 42.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.587 ' CD1' HD21 ' A' ' 139' ' ' LEU . 20.7 m-85 -120.43 155.24 33.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.923 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -133.04 94.62 20.18 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.96 120.4 6.01 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.552 2.168 . . . . 0.0 112.374 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -76.13 -31.48 58.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.965 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.44 149.4 42.1 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.974 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.23 -9.68 26.49 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.536 2.157 . . . . 0.0 112.684 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.417 ' HB3' ' CE2' ' A' ' 164' ' ' TYR . 0.3 OUTLIER -56.41 -35.39 67.74 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.08 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.497 ' CD1' HD11 ' A' ' 166' ' ' LEU . 9.2 t80 -79.61 -34.01 41.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.812 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.8 mt -66.0 -34.77 78.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.29 -26.2 68.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.068 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.488 HD13 HG21 ' A' ' 138' ' ' VAL . 39.1 mt -60.04 139.4 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.002 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.5 m -61.24 -53.35 58.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.39 80.01 29.08 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.875 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.412 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 38.9 Cg_exo -57.15 -35.1 98.83 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.54 2.16 . . . . 0.0 112.194 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -34.08 73.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.962 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.49 -39.06 74.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.114 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.515 HG13 ' OH ' ' A' ' 159' ' ' TYR . 22.1 t -75.43 -30.97 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.587 HD21 ' CD1' ' A' ' 122' ' ' PHE . 9.0 tp -76.71 -30.72 56.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.009 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -80.67 -31.67 36.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.944 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.66 -32.0 70.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.27 -33.5 32.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.104 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.5 ' CD2' HD11 ' A' ' 149' ' ' LEU . 22.7 mt -59.87 -28.93 67.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.043 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -58.29 -33.03 68.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -79.53 -31.14 42.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.725 ' HB3' HD11 ' A' ' 179' ' ' ILE . 4.0 m-85 -71.26 145.56 49.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -108.54 -27.27 9.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.192 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.87 171.61 13.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.537 HD22 HG21 ' A' ' 168' ' ' VAL . 2.7 mt -155.41 136.15 13.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.89 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.22 149.78 47.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.816 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 57.0 m -69.27 100.39 1.31 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.65 28.55 4.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.501 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.89 90.08 4.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.85 0.357 . . . . 0.0 110.867 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.608 HG22 ' HG3' ' A' ' 167' ' ' ARG . 27.7 t -63.37 100.68 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.104 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.755 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 1.2 pt -109.54 161.98 7.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.11 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.688 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -127.28 99.41 5.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.11 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.2 pt -69.41 150.1 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.044 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -158.33 150.3 21.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.515 ' OH ' HG13 ' A' ' 138' ' ' VAL . 30.5 p90 -177.29 -37.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.087 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -103.47 38.94 1.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.944 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 60.86 29.96 19.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -145.87 108.39 4.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.784 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.688 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 2.0 mp -82.48 112.82 20.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.127 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 128' ' ' ASP . 32.5 m-85 -94.13 131.78 39.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.837 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -83.52 107.34 15.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.497 HD11 ' CD1' ' A' ' 129' ' ' PHE . 0.8 OUTLIER -128.68 136.4 50.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.608 ' HG3' HG22 ' A' ' 154' ' ' VAL . 22.7 ttt180 -130.61 131.85 45.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.537 HG21 HD22 ' A' ' 149' ' ' LEU . 21.0 t -70.14 154.41 8.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.406 ' N ' HG12 ' A' ' 168' ' ' VAL . 43.5 mmm -121.35 -57.68 1.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -124.55 141.53 52.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.915 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.426 ' CG2' HG11 ' A' ' 168' ' ' VAL . 40.3 p -145.22 148.29 33.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.566 ' O ' HG11 ' A' ' 177' ' ' VAL . 22.6 mttt -133.94 158.02 76.37 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.21 -41.64 0.92 Allowed 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.222 -1.574 . . . . 0.0 112.427 -0.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.35 178.47 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.843 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -47.49 82.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.46 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -99.06 129.48 45.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.03 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.784 HG21 ' HB2' ' A' ' 117' ' ' ALA . 30.0 m -132.55 135.92 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.201 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.454 ' OG ' HD11 ' A' ' 63' ' ' LEU . 8.0 t -93.04 96.9 10.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.725 HD11 ' HB3' ' A' ' 146' ' ' PHE . 3.6 pt -88.24 82.72 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.132 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.2 mt -109.89 81.02 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.104 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.26 89.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 2.8 t -162.95 166.23 24.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -106.74 121.68 44.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.896 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -134.72 172.1 13.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.951 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.12 111.8 23.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.527 HG11 HD23 ' A' ' 139' ' ' LEU . 21.2 t -96.03 131.77 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.146 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.431 ' HB2' ' CE1' ' A' ' 119' ' ' TYR . 10.6 t70 -114.8 167.19 10.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -127.41 141.67 51.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.974 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -122.5 81.8 1.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.04 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.709 ' N ' ' HG ' ' A' ' 111' ' ' SER . 67.1 t80 . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.878 0.37 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.7 p -141.59 129.16 21.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.1 t -176.5 160.42 2.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -77.76 149.66 34.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -155.02 145.22 21.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.917 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.2 mtt85 -76.5 148.15 37.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 64.3 m -113.52 127.7 56.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.511 ' CD2' HG23 ' A' ' 88' ' ' ILE . 17.4 m-85 -129.01 175.89 8.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.59 156.75 17.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.9 m -67.48 -30.17 48.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.803 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.816 0.341 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -73.5 -37.32 65.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -97.57 76.17 2.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.82 159.24 7.86 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.482 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.92 92.1 1.44 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.533 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.593 ' HG2' HD13 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -153.38 129.26 10.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.327 . . . . 0.0 110.904 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.507 HD13 ' SG ' ' A' ' 77' ' ' CYS . 45.1 pt -123.64 179.91 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.145 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.405 HG22 ' HB2' ' A' ' 84' ' ' ALA . 10.7 mt -130.11 115.65 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.064 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.541 ' C ' ' HB3' ' A' ' 84' ' ' ALA . 25.3 mtp -117.35 158.6 44.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.619 ' N ' ' HB3' ' A' ' 84' ' ' ALA . 50.5 Cg_exo -53.14 163.79 2.09 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.597 2.198 . . . . 0.0 112.234 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.31 -27.76 23.42 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.495 2.13 . . . . 0.0 112.234 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.1 p -59.14 -35.7 73.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.92 -32.56 72.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.8 tp -70.91 -39.51 72.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.19 -33.02 56.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -67.04 -41.55 86.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.572 HD23 HD12 ' A' ' 58' ' ' ILE . 16.4 mt -63.5 -31.6 72.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.9 t -68.88 -42.68 76.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -66.92 -32.19 73.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.4 mt -79.89 -3.26 47.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.461 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 m120 62.2 30.78 17.72 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.733 0.301 . . . . 0.0 110.909 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.572 HD12 HD23 ' A' ' 53' ' ' LEU . 30.5 mt -90.18 106.9 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.109 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.1 p -90.43 171.81 9.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.939 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.488 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -59.25 145.21 81.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.803 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 78.9 Cg_endo -77.41 167.63 78.81 Favored 'Cis proline' 0 C--N 1.347 0.499 0 C-N-CA 123.478 -1.468 . . . . 0.0 112.482 -0.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 4.8 mtt -128.73 62.02 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.419 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -82.85 158.94 22.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.948 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -131.25 126.58 35.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -82.69 106.42 14.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.9 mt -82.41 79.36 8.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.835 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -75.84 93.47 3.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.979 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.52 ' HA ' HG13 ' A' ' 107' ' ' VAL . 5.4 t-20 -68.08 120.04 13.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -97.75 38.07 1.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -128.46 -45.65 1.34 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.8 23.24 7.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.124 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 54.75 39.26 31.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.046 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -89.32 160.43 16.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.964 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 ttm -155.95 124.83 6.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.0 m -153.8 121.38 5.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.854 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -86.01 97.15 10.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.507 ' SG ' HD13 ' A' ' 43' ' ' ILE . 26.4 p -85.19 159.42 20.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -118.26 128.71 7.86 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.521 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.485 HG21 ' CE1' ' A' ' 82' ' ' PHE . 11.4 p -75.45 137.44 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.76 0.314 . . . . 0.0 111.117 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.593 HD13 ' HG2' ' A' ' 42' ' ' LYS . 6.3 tp -124.85 -56.49 1.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -103.39 142.75 33.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.485 ' CE1' HG21 ' A' ' 79' ' ' VAL . 49.9 m-85 -118.01 67.82 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.942 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.04 30.99 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.078 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.619 ' HB3' ' N ' ' A' ' 46' ' ' PRO . . . -86.25 157.92 19.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.658 ' HB2' HD12 ' A' ' 88' ' ' ILE . 3.2 m-20 -81.91 165.28 20.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -63.6 106.86 1.03 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.19 29.93 21.19 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.486 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' A' ' 85' ' ' ASP . 31.9 mt -144.96 117.16 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 0.0 111.132 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 61.7 m -125.29 129.52 50.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -97.82 149.4 22.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 mp -144.34 155.05 57.76 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.957 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.25 170.64 0.23 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.575 2.183 . . . . 0.0 112.307 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -78.02 -44.51 26.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -60.24 -37.28 79.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 50.1 ttm -75.05 -31.62 61.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -42.72 81.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.841 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -75.14 -40.41 59.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.839 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -60.5 -35.92 77.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.495 HD13 HD11 ' A' ' 101' ' ' LEU . 72.6 mt -83.11 -21.99 33.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.15 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 86.3 mt 61.55 38.06 15.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.495 HD11 HD13 ' A' ' 99' ' ' LEU . 8.4 mt -86.51 -178.26 6.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -115.92 168.36 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -65.31 81.39 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.98 41.14 1.86 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.518 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.83 135.73 13.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.555 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.4 mt -81.98 124.6 29.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 0.0 110.935 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 68' ' ' ASN . 21.6 t -130.36 153.37 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.5 143.78 51.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.6 t -124.86 149.4 29.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -157.61 131.47 8.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.709 ' HG ' ' N ' ' A' ' 16' ' ' PHE . 83.9 p -91.86 101.66 14.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.5 m -117.91 144.82 24.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.105 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -102.63 113.04 26.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.6 mt -102.68 171.89 7.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -115.84 171.89 7.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.849 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.1 m -60.41 155.68 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.061 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.896 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -89.59 156.41 18.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.077 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.33 -35.67 4.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -133.94 92.58 2.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.63 110.93 23.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.88 130.4 53.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.607 ' CZ ' HD21 ' A' ' 143' ' ' LEU . 37.6 m-85 -118.26 156.21 29.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.878 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -136.01 87.67 23.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.25 116.64 2.95 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.523 2.149 . . . . 0.0 112.363 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -68.54 -31.3 70.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.963 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -103.74 143.92 27.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.972 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.62 -17.06 20.88 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.585 2.19 . . . . 0.0 112.543 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -33.22 63.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.136 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.598 ' CE2' HD11 ' A' ' 166' ' ' LEU . 7.5 t80 -73.36 -48.48 33.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 70.4 mt -59.29 -30.37 68.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.919 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.85 -25.64 67.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.964 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.594 HG21 HG21 ' A' ' 138' ' ' VAL . 38.7 mt -59.96 138.96 20.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.06 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.7 m -64.0 -42.9 97.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.669 ' O ' HG23 ' A' ' 138' ' ' VAL . 3.2 m120 -117.62 79.97 13.09 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.979 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.46 -28.39 21.96 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.602 2.202 . . . . 0.0 112.247 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -68.5 -38.94 81.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.948 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.77 -38.04 70.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.051 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 134' ' ' ASN . 27.9 t -69.59 -35.51 66.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.019 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.428 HD23 HG11 ' A' ' 186' ' ' VAL . 5.5 tp -78.82 -42.75 26.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.829 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.707 ' HA ' HD12 ' A' ' 143' ' ' LEU . 43.3 mt-10 -66.89 -35.94 81.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -65.24 -34.39 78.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.72 -32.64 27.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.088 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 140' ' ' GLU . 12.4 mt -60.63 -30.12 69.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -58.8 -31.39 68.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -74.4 -33.69 63.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.17 149.95 45.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -110.07 -27.44 9.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.248 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 4.5 t -141.65 163.55 32.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.0 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 149' ' ' LEU . 12.4 mt -137.92 165.02 27.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.781 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.8 145.44 23.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.905 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.3 m -69.34 97.44 0.96 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.19 51.76 0.86 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.472 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.46 120.66 38.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.827 0.346 . . . . 0.0 110.908 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.24 93.2 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.071 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.446 HD12 HG23 ' A' ' 157' ' ' ILE . 1.1 pp -101.35 138.34 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.113 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.672 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -111.9 100.32 8.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.055 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.636 HG12 HD12 ' A' ' 166' ' ' LEU . 2.6 pt -80.0 160.17 4.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.165 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -156.53 147.55 22.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -171.69 -46.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.932 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -96.72 40.31 1.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.92 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 59.71 31.65 20.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -148.5 129.01 13.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.672 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 4.1 mp -87.67 97.51 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.076 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -78.8 120.79 23.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.53 128.99 38.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.981 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.636 HD12 HG12 ' A' ' 157' ' ' ILE . 1.5 mt -145.95 136.25 23.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -136.17 126.12 25.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.16 140.03 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.094 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.6 mmm -107.41 -49.44 3.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -139.17 154.47 48.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.91 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 80.6 p -156.92 125.72 5.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -111.63 158.09 37.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.819 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.01 -40.63 1.12 Allowed 'Cis proline' 0 C--N 1.347 0.459 0 C-N-CA 123.248 -1.563 . . . . 0.0 112.347 0.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.67 174.48 5.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -58.06 -46.71 84.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.912 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -102.62 128.96 49.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.071 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.896 HG21 ' HB2' ' A' ' 117' ' ' ALA . 16.0 m -139.98 153.38 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.167 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.48 101.86 11.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.2 pt -85.24 84.56 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.166 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 29.6 mm -118.51 89.54 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.113 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 60.47 87.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 30.2 t -166.54 154.54 10.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.59 97.07 7.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -102.53 170.27 8.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -93.9 88.27 5.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.866 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.428 HG11 HD23 ' A' ' 139' ' ' LEU . 29.5 t -78.52 120.69 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.43 162.5 16.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.813 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -118.33 162.88 17.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -153.31 96.38 2.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.965 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.117 -179.95 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.2 t80 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.803 0.335 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.7 p -135.47 96.48 3.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.1 t -150.17 160.91 43.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -86.37 161.92 18.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.889 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -159.92 137.83 10.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -70.93 138.49 50.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 75.8 m -100.94 142.03 32.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.865 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -145.34 176.71 9.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.2 p -88.37 167.1 13.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.8 m -102.15 20.03 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.356 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.949 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.802 0.334 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -70.68 -31.73 68.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -99.57 86.75 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.88 -170.98 24.3 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.509 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.23 46.59 1.15 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.541 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -102.21 134.88 44.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.437 HG21 HD23 ' A' ' 91' ' ' LEU . 40.4 pt -127.63 177.15 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.5 mt -128.96 96.04 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.07 159.3 34.57 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.49 ' N ' ' HB3' ' A' ' 84' ' ' ALA . 47.5 Cg_exo -55.94 169.08 1.5 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.585 2.19 . . . . 0.0 112.27 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.25 -26.06 30.34 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.579 2.186 . . . . 0.0 112.369 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.28 -31.15 67.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.015 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . . . -63.32 -43.86 96.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.426 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 3.3 tp -70.82 -32.3 69.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.75 -25.75 44.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.035 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.04 -30.99 13.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.965 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.588 HD23 HD12 ' A' ' 58' ' ' ILE . 13.8 mt -60.47 -49.62 76.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.112 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.53 -31.47 69.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.068 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -70.5 -22.82 62.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.122 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.3 mt -94.78 20.06 9.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.193 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.67 35.58 25.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.863 0.363 . . . . 0.0 110.961 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.588 HD12 HD23 ' A' ' 53' ' ' LEU . 31.1 mt -100.94 124.89 54.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.59 170.4 8.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.808 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.444 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.5 t80 -65.46 140.6 97.69 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.837 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 72.1 Cg_endo -77.15 167.15 80.51 Favored 'Cis proline' 0 C--N 1.349 0.566 0 C-N-CA 123.53 -1.446 . . . . 0.0 112.393 0.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.7 mtt -131.74 69.03 1.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.56 HD11 ' OG ' ' A' ' 178' ' ' SER . 1.4 mt -82.15 148.8 28.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -118.34 142.65 47.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.416 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 10.8 tttt -97.13 107.67 20.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 66' ' ' LEU . 11.4 mt -89.65 99.71 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.0 103.02 12.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.95 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -67.7 129.27 39.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -97.66 38.26 1.3 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.61 -47.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.974 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m -106.31 13.42 28.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.296 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 53.87 30.66 11.83 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.77 0.319 . . . . 0.0 111.13 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.456 ' CB ' HD23 ' A' ' 99' ' ' LEU . 2.9 mmp_? -82.66 161.53 22.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.64 117.98 3.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.0 t -143.68 156.02 44.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.933 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.416 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 13.8 m80 -122.79 112.92 18.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 24.2 p -106.35 168.09 9.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.3 139.04 13.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.583 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.79 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 12.3 p -81.1 151.48 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 0.0 111.051 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.9 tp -129.09 -61.91 1.02 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -113.59 169.45 8.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.79 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 47.6 m-85 -138.75 75.16 1.5 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.852 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 m -142.51 32.48 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.154 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HB3' ' N ' ' A' ' 46' ' ' PRO . . . -92.03 161.9 14.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.054 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.511 ' HB3' HD12 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -82.04 158.26 23.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -60.1 132.77 54.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.24 28.2 73.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.526 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 85' ' ' ASP . 27.5 mt -147.98 127.18 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.835 0.35 . . . . 0.0 111.136 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 83.1 m -132.39 127.34 35.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -94.15 134.12 36.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.437 HD23 HG21 ' A' ' 43' ' ' ILE . 4.1 mp -142.0 159.96 57.19 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.86 -177.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.554 2.169 . . . . 0.0 112.326 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -97.92 -31.64 12.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 45.4 p-90 -67.48 -34.8 77.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.965 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.4 tpp -79.1 -32.0 44.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 44.9 mmm -67.59 -31.35 71.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -37.03 22.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -59.97 -31.73 70.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.456 HD23 ' CB ' ' A' ' 73' ' ' ARG . 8.9 mt -91.62 -16.81 26.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.276 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.3 mt 65.19 33.7 9.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.827 0.346 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.7 mt -79.8 -178.52 6.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.89 175.77 8.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.901 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.9 101.13 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.85 43.03 7.4 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.564 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.85 128.96 9.19 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.54 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.3 mt -79.38 126.87 31.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.93 139.66 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -63.75 110.61 2.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.2 t -101.07 136.9 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.147 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -134.62 164.32 27.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.3 p -123.38 110.88 15.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.89 148.6 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.152 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -104.22 100.03 9.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.804 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.7 mt -96.21 178.44 5.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -120.44 169.65 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.3 m -64.02 146.15 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.033 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.785 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -90.87 149.59 21.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.045 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 75.4 p -114.23 -37.28 4.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -123.65 111.57 16.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.7 m -128.15 122.51 32.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -102.1 132.32 48.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.587 ' CE2' HG22 ' A' ' 168' ' ' VAL . 90.7 m-85 -119.02 161.6 19.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -150.76 93.02 3.79 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.27 117.86 3.51 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.545 2.164 . . . . 0.0 112.34 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -67.09 -33.19 74.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.908 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.73 146.31 33.46 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.61 -14.91 24.67 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.612 2.208 . . . . 0.0 112.541 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -55.05 -34.19 63.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.104 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 135' ' ' PRO . 22.6 t80 -73.68 -36.06 65.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.0 mt -63.27 -31.77 73.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -62.73 -23.09 67.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.071 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.675 HG22 ' H ' ' A' ' 134' ' ' ASN . 48.9 mt -59.94 140.06 18.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.001 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.0 t -69.7 -30.96 68.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.675 ' H ' HG22 ' A' ' 132' ' ' ILE . 2.1 m120 -133.12 67.26 77.09 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.406 ' HB3' ' CE1' ' A' ' 129' ' ' PHE . 37.3 Cg_exo -57.23 -34.0 97.02 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.634 2.223 . . . . 0.0 112.22 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.81 -44.77 92.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.86 -45.03 91.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.079 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.461 HG21 HG21 ' A' ' 132' ' ' ILE . 21.5 t -63.87 -39.89 87.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.442 HD22 ' CZ ' ' A' ' 188' ' ' PHE . 21.5 tp -67.02 -35.91 80.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -76.78 -32.06 57.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -65.42 -33.05 75.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.27 -35.13 28.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.155 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.7 mt -60.26 -30.0 69.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -58.71 -30.48 67.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -83.04 -34.62 26.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.93 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -66.14 136.15 55.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -99.08 -29.2 13.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.153 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.552 ' HB2' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -138.05 164.56 28.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.964 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.6 mt -141.65 154.31 45.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 15.5 m -144.71 141.71 29.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 37.9 m -72.72 119.61 17.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 90.7 43.51 4.81 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.523 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -131.14 122.88 27.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.745 0.307 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.23 84.96 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.055 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.4 pt -77.78 110.45 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.166 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.81 139.56 37.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.083 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 37.0 pt -128.44 144.34 38.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.175 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -138.45 142.68 39.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.792 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -167.45 -48.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.044 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -95.52 41.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 58.11 30.27 19.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.932 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -148.02 122.29 9.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.904 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.503 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.7 mp -81.42 89.12 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.125 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -67.53 166.15 15.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.83 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -117.15 137.82 52.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.27 149.2 29.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -138.73 129.59 26.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.587 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.3 t -74.12 113.24 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.188 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.6 mmt -68.0 -59.93 2.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -144.93 166.07 26.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 77.2 p -154.49 161.12 41.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -138.56 156.8 73.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.33 -18.48 17.88 Favored 'Cis proline' 0 C--N 1.347 0.487 0 C-N-CA 123.312 -1.537 . . . . 0.0 112.589 0.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -133.38 169.88 16.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.902 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -43.48 82.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.934 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -96.55 117.67 31.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' A' ' 117' ' ' ALA . 15.7 m -139.56 151.18 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.214 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.56 ' OG ' HD11 ' A' ' 63' ' ' LEU . 23.3 t -105.54 92.12 4.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.829 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.3 pt -87.48 83.4 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.198 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.2 mt -112.88 96.55 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.042 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.49 81.94 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.823 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 11.0 t -169.5 149.44 3.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.843 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.99 127.85 41.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -132.97 149.43 52.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -78.03 87.87 4.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.843 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.01 136.93 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -114.14 174.11 6.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . 0.442 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 15.6 m-85 -139.41 155.48 47.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.955 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -150.55 91.0 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.056 -179.948 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.2 t80 . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.864 0.364 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.1 p -121.13 109.08 14.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.0 t -174.55 162.3 3.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -91.34 150.17 21.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -145.31 136.59 24.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.6 mtt180 -68.91 141.55 54.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.0 m -101.37 134.62 44.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.539 ' CD2' HG23 ' A' ' 88' ' ' ILE . 8.8 m-85 -146.89 138.49 24.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 76.0 p -66.76 138.32 57.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.498 HG12 ' HB3' ' A' ' 90' ' ' TYR . 17.2 m -59.39 -27.18 36.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.227 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.034 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.762 0.315 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -31.99 71.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -78.31 -46.92 18.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.936 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.59 162.83 19.74 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.438 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.83 30.04 10.73 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.542 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -94.64 174.05 7.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.824 0.345 . . . . 0.0 110.891 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.525 HG22 ' HA ' ' A' ' 91' ' ' LEU . 5.2 pt -146.7 165.51 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.096 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.512 HG22 ' HB2' ' A' ' 84' ' ' ALA . 3.9 mt -116.49 106.04 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.066 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.432 ' C ' ' HB3' ' A' ' 84' ' ' ALA . 71.6 mtp -97.39 160.53 28.61 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.01 162.81 2.44 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.57 2.18 . . . . 0.0 112.301 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.4 -25.94 35.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.582 2.188 . . . . 0.0 112.348 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.4 t -58.86 -30.82 68.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.99 -32.79 73.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.088 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.466 HD13 ' CD2' ' A' ' 82' ' ' PHE . 25.1 tp -60.23 -33.18 71.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -89.1 -30.43 18.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.957 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -41.5 70.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.974 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.422 HD13 ' SD ' ' A' ' 62' ' ' MET . 44.1 mt -54.11 -30.82 50.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.061 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.05 -28.62 17.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -23.17 57.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.7 mt -93.12 17.41 10.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.317 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 54.96 32.46 18.09 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.784 0.326 . . . . 0.0 111.171 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 59' ' ' THR . 38.6 mt -96.27 153.54 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.119 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.402 ' N ' HG22 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -149.19 175.42 11.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.44 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 3.2 t80 -63.36 139.0 97.51 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.9 Cg_endo -76.6 162.1 92.43 Favored 'Cis proline' 0 C--N 1.348 0.55 0 C-N-CA 123.492 -1.462 . . . . 0.0 112.371 -0.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.422 ' SD ' HD13 ' A' ' 53' ' ' LEU . 12.1 mtt -130.48 65.17 1.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.482 HD11 ' OG ' ' A' ' 178' ' ' SER . 15.1 mt -87.69 139.66 30.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -113.1 142.65 45.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.412 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 1.0 OUTLIER -99.01 108.38 21.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.4 mt -95.68 90.63 5.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.4 m -95.8 121.73 37.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -82.01 128.53 34.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.946 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.7 31.4 2.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -120.04 -42.08 2.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.94 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.29 22.47 7.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 54.49 39.83 31.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.093 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.7 159.0 15.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.922 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -150.61 139.69 21.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.562 HG21 HD11 ' A' ' 99' ' ' LEU . 10.2 t -158.03 148.24 20.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.932 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.504 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 66.5 m80 -115.29 115.41 26.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.978 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.8 p -124.74 167.09 15.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.74 165.23 13.44 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.2 141.72 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.859 0.361 . . . . 0.0 111.09 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.5 tp -119.25 -60.63 1.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -107.03 161.94 14.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.971 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.466 ' CD2' HD13 ' A' ' 50' ' ' LEU . 90.0 m-85 -129.7 47.95 2.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.828 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 m -123.38 35.43 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.007 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' A' ' 44' ' ' ILE . . . -92.52 154.86 18.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.051 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.47 149.63 33.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.846 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -59.99 110.51 1.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.97 -22.7 36.78 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.643 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.539 HG23 ' CD2' ' A' ' 23' ' ' PHE . 25.7 mt -99.05 121.82 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 111.139 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 28.5 t -110.41 130.52 55.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.498 ' HB3' HG12 ' A' ' 25' ' ' VAL . 43.6 m-85 -93.23 143.16 26.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.99 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.525 ' HA ' HG22 ' A' ' 43' ' ' ILE . 1.3 mp -144.89 156.54 55.43 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.07 -174.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.538 2.159 . . . . 0.0 112.283 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.69 -37.93 10.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.893 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.664 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 53.7 p-90 -61.36 -39.47 90.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.2 ttp -65.86 -40.01 91.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -37.98 86.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.82 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -74.06 -38.21 64.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.819 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -65.96 -42.01 90.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.562 HD11 HG21 ' A' ' 75' ' ' THR . 8.2 mt -83.23 -16.87 44.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.204 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt 62.31 36.84 14.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.777 0.323 . . . . 0.0 110.9 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.7 mt -84.94 -177.42 6.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -134.42 168.63 18.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.06 91.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.84 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.428 ' HA2' ' CE2' ' A' ' 23' ' ' PHE . . . 106.68 43.74 1.4 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.487 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.08 123.62 7.88 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.531 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.9 mt -72.94 131.21 41.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.809 0.338 . . . . 0.0 110.951 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.72 150.49 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.002 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -72.11 143.37 49.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.36 108.62 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.134 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.49 123.74 34.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.922 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.5 p -81.49 121.78 26.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.4 m -125.94 155.07 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.57 100.81 9.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.776 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.448 HD13 ' C ' ' A' ' 176' ' ' ALA . 2.8 mt -98.6 178.92 4.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -115.71 170.8 8.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 m -70.36 135.03 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.09 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.606 ' HB2' ' CB ' ' A' ' 177' ' ' VAL . . . -74.28 145.45 43.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.8 p -111.53 -31.95 6.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.914 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -129.53 110.3 11.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 93.5 p -122.58 119.0 29.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -106.17 130.87 53.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.68 ' CD1' HD21 ' A' ' 139' ' ' LEU . 87.3 m-85 -117.86 158.81 24.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -143.05 97.93 5.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.57 110.89 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.442 2.094 . . . . 0.0 112.47 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -63.42 -31.4 72.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.1 m -114.33 149.03 41.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.618 ' HA ' HD12 ' A' ' 130' ' ' LEU . 57.4 Cg_endo -70.94 -14.87 32.62 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.618 2.212 . . . . 0.0 112.584 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -55.59 -35.65 66.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.053 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -75.53 -42.98 51.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.916 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 127' ' ' PRO . 13.5 mt -60.07 -31.2 69.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.83 -28.19 69.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.002 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.563 HG22 ' H ' ' A' ' 134' ' ' ASN . 45.8 mt -62.74 137.31 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.093 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.3 t -68.95 -34.28 75.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.706 ' O ' HG23 ' A' ' 138' ' ' VAL . 1.9 m120 -119.51 77.31 19.5 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.86 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.38 -28.31 22.45 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.619 2.212 . . . . 0.0 112.285 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -70.35 -46.67 63.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.15 -31.19 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.157 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 134' ' ' ASN . 26.3 t -78.78 -31.53 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.095 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.68 HD21 ' CD1' ' A' ' 122' ' ' PHE . 11.5 tp -84.5 -34.75 23.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.483 ' OE2' HG21 ' A' ' 186' ' ' VAL . 3.9 mm-40 -70.85 -30.44 66.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.976 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -73.43 -31.63 63.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.17 -31.64 64.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.118 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.498 HD13 ' CE ' ' A' ' 184' ' ' MET . 82.2 mt -59.4 -30.44 68.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.5 mmp_? -62.42 -26.65 68.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -95.97 26.72 3.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.091 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -135.84 152.65 51.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.835 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.13 -34.25 6.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 6.8 t -141.78 158.91 43.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.965 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.93 137.27 36.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.876 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.67 149.4 40.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 43.8 m -69.49 104.8 2.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.82 33.3 3.57 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.552 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.35 111.8 24.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.759 0.314 . . . . 0.0 110.928 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.544 HG22 ' HG3' ' A' ' 167' ' ' ARG . 21.6 t -79.53 79.95 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.075 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.698 HD12 HG23 ' A' ' 157' ' ' ILE . 3.2 pt -63.79 159.07 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.152 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.664 ' HB3' ' HB3' ' A' ' 94' ' ' TRP . . . -125.05 93.0 3.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.085 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.698 HG23 HD12 ' A' ' 155' ' ' ILE . 10.0 pt -85.53 152.72 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.184 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -154.85 140.89 18.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -161.89 -47.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.97 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -93.75 45.19 1.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 55.65 29.48 13.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.086 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -149.34 122.19 8.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.868 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.3 mp -85.12 108.53 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -80.1 173.78 12.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -123.95 110.07 14.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.31 117.52 21.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.826 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.544 ' HG3' HG22 ' A' ' 154' ' ' VAL . 1.8 ttt85 -111.14 133.22 53.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.5 127.16 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.087 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 23.9 mmm -85.6 -54.71 4.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 171' ' ' THR . 0.4 OUTLIER -142.73 160.19 40.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.952 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 170' ' ' GLU . 2.6 p -159.08 146.47 17.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.909 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -129.07 159.86 66.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.95 -41.39 0.97 Allowed 'Cis proline' 0 C--N 1.347 0.48 0 C-N-CA 123.238 -1.567 . . . . 0.0 112.366 -0.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -106.29 172.43 6.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -57.86 -48.71 79.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.061 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.504 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -93.29 110.8 22.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.001 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.606 ' CB ' ' HB2' ' A' ' 117' ' ' ALA . 15.4 m -118.72 133.64 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.167 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.482 ' OG ' HD11 ' A' ' 63' ' ' LEU . 22.2 t -89.73 99.95 12.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.5 pt -94.08 87.26 2.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.249 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.2 mt -118.29 84.59 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.052 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.36 75.35 0.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 49.6 t -153.27 153.99 33.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.903 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.83 129.73 40.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.498 ' CE ' HD13 ' A' ' 143' ' ' LEU . 13.0 ptt? -140.21 179.23 6.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.869 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.45 112.63 25.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.512 HG11 HD23 ' A' ' 139' ' ' LEU . 21.6 t -92.81 127.52 44.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.7 171.81 7.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.878 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -134.74 141.89 46.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -111.75 83.23 1.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.121 179.971 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 t80 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.91 0.386 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.0 p -160.03 112.8 2.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.1 t -176.86 159.46 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.935 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.629 ' HB3' HD22 ' A' ' 106' ' ' LEU . 20.8 mt-30 -95.94 121.85 38.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.814 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -115.48 147.41 40.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -75.17 129.54 37.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.592 ' HB2' HD13 ' A' ' 91' ' ' LEU . 16.6 p -99.01 133.33 43.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.972 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.533 ' CD2' HG23 ' A' ' 88' ' ' ILE . 87.4 m-85 -136.3 178.45 7.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.66 146.07 27.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.695 HG11 HG21 ' A' ' 37' ' ' VAL . 5.1 m -58.41 -26.15 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.257 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.042 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.695 HG21 HG11 ' A' ' 25' ' ' VAL . 19.4 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.866 0.365 . . . . 0.0 111.238 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.429 ' HG3' HG23 ' A' ' 37' ' ' VAL . 4.1 mt-10 -78.03 -31.06 50.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -78.53 -31.22 47.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.67 -178.57 20.14 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.564 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.75 53.24 0.63 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.544 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -114.74 165.04 13.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.851 0.357 . . . . 0.0 110.852 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.1 pt -133.38 174.4 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.543 HG23 ' HB2' ' A' ' 81' ' ' GLU . 2.5 mt -125.51 98.39 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.9 mtm -98.54 155.51 36.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.782 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.71 154.9 40.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.581 2.188 . . . . 0.0 112.211 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.8 -26.42 17.71 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.619 2.213 . . . . 0.0 112.566 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.6 p -58.79 -31.19 68.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.973 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.14 -30.26 69.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.261 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.419 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 33.8 tp -74.69 -30.14 61.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.998 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.18 -33.91 19.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.914 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.73 -38.88 62.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.454 HD13 ' SD ' ' A' ' 62' ' ' MET . 14.0 mt -59.1 -32.84 70.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.043 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -86.98 -30.06 21.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -22.61 62.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.12 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.1 mt -93.93 19.19 9.31 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.244 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 55.12 30.47 14.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.871 0.367 . . . . 0.0 111.14 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.7 mt -99.03 120.81 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.098 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -109.59 168.35 9.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.965 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -60.17 144.58 87.02 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.464 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.89 158.27 96.89 Favored 'Cis proline' 0 C--N 1.348 0.5 0 C-N-CA 123.485 -1.464 . . . . 0.0 112.344 0.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.454 ' SD ' HD13 ' A' ' 53' ' ' LEU . 9.5 mtt -123.7 73.52 1.2 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.789 HD13 HD12 ' A' ' 114' ' ' LEU . 2.0 mt -91.26 134.9 34.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.853 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -102.8 141.3 35.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.404 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 13.5 tttp -94.97 97.6 10.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.4 mt -76.98 76.83 3.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 m -83.16 95.55 8.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -74.79 129.44 37.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.933 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -98.14 35.58 1.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -111.63 -35.66 5.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.841 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.1 t -151.94 29.72 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.973 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 58.72 35.83 24.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.002 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.575 ' HB3' HD23 ' A' ' 99' ' ' LEU . 12.8 mmt180 -81.82 143.31 31.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.929 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -144.22 135.02 25.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.741 HG22 HD21 ' A' ' 99' ' ' LEU . 1.8 t -159.97 95.25 1.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.404 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 62.0 m80 -63.68 115.75 5.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.0 p -121.91 151.31 40.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.37 138.91 15.06 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.519 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.3 146.82 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 111.066 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.9 tp -131.29 -56.65 1.02 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.543 ' HB2' HG23 ' A' ' 44' ' ' ILE . 4.1 mm-40 -91.76 142.85 27.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.841 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CD2' ' HB2' ' A' ' 50' ' ' LEU . 71.8 m-85 -128.3 55.62 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 m -137.07 35.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.177 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.11 161.89 13.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.109 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.62 155.53 38.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.91 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.46 127.37 31.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.948 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.35 27.69 65.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.558 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.533 HG23 ' CD2' ' A' ' 23' ' ' PHE . 29.8 mt -148.75 99.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 111.072 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 13.7 m -100.9 134.85 43.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.32 151.35 22.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 22' ' ' CYS . 5.1 mp -145.29 155.59 54.17 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.41 ' HD2' ' HE2' ' A' ' 95' ' ' MET . 53.6 Cg_exo -52.28 -176.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.528 2.152 . . . . 0.0 112.355 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -87.51 -50.67 6.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.944 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -61.96 -37.53 85.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.856 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.41 ' HE2' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -63.75 -38.26 90.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -47.22 70.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.801 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -38.08 89.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.814 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -59.55 -31.28 69.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.741 HD21 HG22 ' A' ' 75' ' ' THR . 6.3 mt -98.82 -15.25 19.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.234 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.9 mt 61.7 41.25 12.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 0.0 110.872 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.548 HD11 HD13 ' A' ' 99' ' ' LEU . 3.7 mt -79.33 159.04 27.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.828 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -111.13 -178.95 3.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.869 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.53 106.42 1.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.951 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.43 ' HA2' ' CZ ' ' A' ' 23' ' ' PHE . . . 85.8 33.77 14.93 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.545 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.74 136.03 17.48 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.52 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.629 HD22 ' HB3' ' A' ' 19' ' ' GLN . 34.5 mt -88.6 128.86 35.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.866 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.11 146.97 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.156 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -69.16 128.87 38.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.17 99.02 6.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.087 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -124.09 128.48 49.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.4 p -88.78 100.49 13.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 m -103.43 162.09 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.126 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -97.05 116.44 29.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.789 HD12 HD13 ' A' ' 63' ' ' LEU . 65.2 mt -115.4 170.78 8.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -127.4 164.56 21.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.926 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.2 m -62.65 140.47 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.661 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -76.63 148.11 37.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.124 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.9 p -105.0 -36.09 7.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.824 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -127.61 109.63 11.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 m -108.9 126.57 53.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -124.41 134.17 53.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.8 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.494 ' CE2' HG22 ' A' ' 168' ' ' VAL . 91.9 m-85 -127.88 159.32 35.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -137.06 95.31 12.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.62 107.33 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.581 2.188 . . . . 0.0 112.347 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -59.27 -31.22 68.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.0 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.84 146.6 35.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.98 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.53 -16.02 27.37 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.63 2.22 . . . . 0.0 112.515 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.22 -42.6 73.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.009 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -60.21 -40.95 91.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.5 -28.33 69.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -60.68 -24.4 65.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.992 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 134' ' ' ASN . 50.7 mt -62.72 136.9 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.986 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 31.5 m -59.06 -40.2 84.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.481 ' H ' HG22 ' A' ' 132' ' ' ILE . 1.8 m120 -131.63 86.93 47.53 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.77 -28.03 25.7 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.528 2.152 . . . . 0.0 112.272 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -63.34 -31.16 72.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.3 -32.7 49.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.131 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 132' ' ' ILE . 21.4 t -83.37 -30.83 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.179 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.446 HD21 ' HB2' ' A' ' 122' ' ' PHE . 46.5 tp -75.16 -30.39 60.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -85.54 -38.83 18.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.014 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -65.3 -23.98 67.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.25 -33.39 61.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.291 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 23.3 mt -63.65 -22.88 67.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.163 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -29.25 40.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.123 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -87.08 -29.71 21.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.981 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -88.28 140.6 29.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -103.44 -30.37 10.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.653 ' HB2' HD22 ' A' ' 63' ' ' LEU . 4.4 t -131.64 163.56 27.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.8 mt -141.15 164.78 29.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.23 129.09 13.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.409 HG23 ' HA ' ' A' ' 170' ' ' GLU . 52.3 m -59.95 110.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 98.41 51.61 1.42 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.539 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.23 130.25 28.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 110.866 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.5 107.07 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.069 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.3 pt -105.09 106.08 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.144 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.42 127.07 32.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.088 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 36.9 pt -118.8 148.39 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.076 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -146.7 134.56 21.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -149.73 -47.42 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.907 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -100.42 44.31 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.85 30.36 19.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.88 115.93 9.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.9 mp -81.11 86.59 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.09 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -66.9 158.4 30.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.44 136.19 50.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.954 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.3 mt -145.6 154.22 41.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -144.22 125.21 14.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.494 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.6 t -68.7 104.47 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.4 ' O ' HG23 ' A' ' 151' ' ' THR . 0.0 OUTLIER -67.42 -51.5 51.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 171' ' ' THR . 0.1 OUTLIER -151.64 164.23 37.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 170' ' ' GLU . 0.7 OUTLIER -159.97 142.17 13.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 39.4 mttt -118.55 157.48 49.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.2 -27.08 8.82 Favored 'Cis proline' 0 C--N 1.347 0.453 0 C-N-CA 123.268 -1.555 . . . . 0.0 112.355 0.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.98 174.1 8.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.852 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -57.66 -45.23 85.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.51 111.55 23.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.055 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.661 HG21 ' HB2' ' A' ' 117' ' ' ALA . 27.7 m -128.63 140.7 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.619 ' OG ' HD11 ' A' ' 63' ' ' LEU . 3.9 t -97.76 87.69 4.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.1 pt -83.63 82.95 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.1 mt -117.97 89.31 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.161 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.84 88.36 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.07 173.56 12.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.838 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.41 120.09 39.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -135.32 174.04 11.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.837 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -105.24 97.74 7.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.947 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.95 145.45 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.04 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -127.38 169.75 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . 0.436 ' CE1' HD22 ' A' ' 139' ' ' LEU . 7.0 m-85 -127.42 143.14 51.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.947 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -134.94 97.73 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.916 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.137 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.799 0.333 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.7 p -151.21 110.43 3.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 t -168.55 171.05 9.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.752 ' HB3' HD22 ' A' ' 106' ' ' LEU . 20.9 mt-30 -95.7 126.65 41.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -125.09 143.05 51.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.3 mtt-85 -66.73 144.79 56.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.008 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.6 p -114.92 120.95 41.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.955 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.741 ' CD2' HG23 ' A' ' 88' ' ' ILE . 77.1 m-85 -127.45 177.0 7.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.975 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -91.54 153.36 19.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.24 -28.3 40.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.144 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.088 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.851 0.358 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.81 20.15 10.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -118.22 -38.05 3.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.957 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.34 -154.25 26.33 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.456 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.38 87.73 0.45 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.51 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.0 149.91 31.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.791 0.329 . . . . 0.0 110.843 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.776 HG21 HD23 ' A' ' 91' ' ' LEU . 44.4 pt -138.14 175.52 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.189 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.404 HG23 ' HB2' ' A' ' 81' ' ' GLU . 1.9 mp -129.77 111.22 21.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.092 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 1.4 mtm -105.33 161.0 24.12 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.38 154.01 12.28 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.577 2.185 . . . . 0.0 112.267 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.93 -34.9 68.76 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.563 2.175 . . . . 0.0 112.278 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.81 -29.75 68.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.63 -46.57 86.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.182 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.446 HD13 ' CE2' ' A' ' 82' ' ' PHE . 41.3 tp -61.93 -42.65 99.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.956 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.98 -38.92 76.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -31.62 68.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.811 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.4 mt -63.6 -37.65 88.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.71 10.66 25.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.308 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.5 -25.6 9.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.713 0.292 . . . . 0.0 110.969 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.0 mt -94.48 20.15 8.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.313 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.84 40.12 19.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.889 0.375 . . . . 0.0 111.004 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.1 mm -95.12 127.56 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.097 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.47 158.91 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.909 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.446 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -66.37 143.04 98.08 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.9 Cg_endo -76.81 160.19 95.24 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 123.468 -1.472 . . . . 0.0 112.364 0.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.6 mtt -112.46 53.7 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.452 HD13 ' SG ' ' A' ' 148' ' ' CYS . 17.3 mt -74.68 120.73 20.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.9 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -85.57 168.62 14.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -121.75 102.08 7.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.484 HD22 HG11 ' A' ' 107' ' ' VAL . 65.0 mt -85.76 105.02 15.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.958 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.1 m -104.1 101.84 11.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -77.84 123.32 26.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -98.87 31.56 2.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -129.52 -45.93 1.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.2 m -113.48 15.24 19.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.257 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 53.22 32.29 13.12 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.811 0.338 . . . . 0.0 111.134 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.1 mmt-85 -86.53 151.34 23.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.96 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.47 ' O ' HG21 ' A' ' 150' ' ' THR . 27.3 ttt -149.13 107.46 3.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.815 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.7 t -130.29 163.61 26.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.578 ' CD2' HD11 ' A' ' 114' ' ' LEU . 52.0 m80 -122.14 105.46 10.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.7 p -98.27 175.59 6.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.941 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -137.68 139.27 10.3 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.488 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.503 HG21 ' CE1' ' A' ' 82' ' ' PHE . 9.6 p -82.57 149.97 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 111.03 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.4 tp -136.43 -59.08 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.953 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.404 ' HB2' HG23 ' A' ' 44' ' ' ILE . 4.5 mp0 -92.41 160.57 15.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CE1' HG21 ' A' ' 79' ' ' VAL . 96.6 m-85 -142.18 68.59 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.94 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.9 m -150.96 31.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.156 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.04 179.99 7.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.705 ' HB3' HD12 ' A' ' 88' ' ' ILE . 5.6 t70 -95.39 156.64 16.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -59.93 121.19 11.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.961 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.75 28.06 63.74 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.741 HG23 ' CD2' ' A' ' 23' ' ' PHE . 29.5 mt -146.93 107.79 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 111.165 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 89.0 m -108.35 133.03 53.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -90.67 134.35 34.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.776 HD23 HG21 ' A' ' 43' ' ' ILE . 1.7 mt -136.63 149.94 68.71 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.878 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.48 -172.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.528 2.152 . . . . 0.0 112.34 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -96.73 -41.34 8.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.942 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.444 ' CD2' ' N ' ' A' ' 95' ' ' MET . 65.2 p-90 -61.32 -44.07 97.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.924 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.444 ' N ' ' CD2' ' A' ' 94' ' ' TRP . 31.8 ttm -69.21 -38.19 78.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.982 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -31.39 72.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -85.06 -39.92 17.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -59.91 -34.21 72.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.824 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.1 mt -90.02 -12.93 37.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.219 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.5 mt 62.36 38.7 12.85 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.822 0.344 . . . . 0.0 110.873 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.4 mt -82.89 178.89 7.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -136.24 -179.94 5.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.07 127.51 33.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.406 ' HA2' ' CZ ' ' A' ' 23' ' ' PHE . . . 68.84 28.25 73.23 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.532 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -84.93 131.77 10.64 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.501 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.752 HD22 ' HB3' ' A' ' 19' ' ' GLN . 28.5 mt -84.57 125.15 32.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.772 0.32 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.484 HG11 HD22 ' A' ' 66' ' ' LEU . 21.5 t -122.07 137.02 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.066 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.44 119.36 11.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.72 153.03 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -156.57 159.46 38.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.43 116.74 31.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.58 158.51 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.078 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -113.06 111.55 22.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.578 HD11 ' CD2' ' A' ' 76' ' ' HIS . 4.3 mt -106.49 170.25 8.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -126.44 167.78 15.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.1 m -57.76 159.26 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.259 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.909 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -98.96 153.03 19.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.048 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.0 t -111.08 -30.97 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -143.56 105.66 4.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.849 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 m -111.97 140.64 46.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -119.94 126.75 51.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.964 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.585 ' CE2' HG22 ' A' ' 168' ' ' VAL . 92.1 m-85 -117.73 154.35 31.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -135.5 95.22 14.59 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.86 110.72 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.515 2.143 . . . . 0.0 112.39 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -62.98 -34.57 77.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 m -106.98 147.7 35.59 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.949 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.22 -19.14 26.22 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.572 2.181 . . . . 0.0 112.417 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -55.35 -36.21 66.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.072 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -69.66 -45.34 68.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 25.8 mt -60.59 -32.96 72.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.834 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.82 -27.72 69.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.989 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.463 HD13 HG21 ' A' ' 138' ' ' VAL . 37.0 mt -60.98 131.0 25.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.981 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.2 t -63.03 -42.15 99.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.942 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.44 78.65 3.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.884 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.39 -29.89 16.16 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.593 2.195 . . . . 0.0 112.352 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -65.52 -31.11 72.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.99 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.6 -49.86 17.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.084 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.463 HG21 HD13 ' A' ' 132' ' ' ILE . 21.5 t -62.53 -31.05 50.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.089 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.623 HD23 HG11 ' A' ' 186' ' ' VAL . 42.4 tp -79.8 -37.49 35.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.545 ' HA ' HD12 ' A' ' 143' ' ' LEU . 30.3 mt-10 -80.26 -30.57 38.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -67.18 -30.76 70.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.18 -29.59 20.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 140' ' ' GLU . 16.3 mt -58.49 -29.9 66.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.954 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -59.24 -32.62 70.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -74.74 -31.21 61.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.967 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -81.98 146.63 29.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -106.59 -29.55 9.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.083 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.452 ' SG ' HD13 ' A' ' 63' ' ' LEU . 3.9 t -136.98 164.97 27.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.918 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.3 mt -140.64 173.93 11.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.47 HG21 ' O ' ' A' ' 74' ' ' MET . 63.5 m -155.5 143.65 20.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.7 HG22 ' CB ' ' A' ' 175' ' ' LYS . 8.8 t -81.53 104.52 12.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.98 36.89 2.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.421 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -131.37 146.27 52.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 0.0 110.872 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.61 108.35 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.9 pt -109.41 120.89 61.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.182 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.63 138.95 38.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.2 pt -126.66 137.23 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.073 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -143.99 145.87 32.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.959 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -158.01 -47.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -108.76 43.99 1.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 61.11 31.69 19.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -137.91 99.85 4.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.9 mp -76.51 96.72 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.112 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.76 128.62 34.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.871 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -81.29 131.97 35.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.37 154.0 45.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -149.17 114.58 5.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.585 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.4 t -59.8 151.88 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.101 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.3 mmt -118.05 -43.98 2.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.943 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 171' ' ' THR . 2.2 tp10 -145.81 157.81 43.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 170' ' ' GLU . 11.2 p -157.61 140.24 14.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -119.5 152.51 53.1 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.885 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.56 -27.63 8.37 Favored 'Cis proline' 0 C--N 1.346 0.446 0 C-N-CA 123.343 -1.524 . . . . 0.0 112.453 -0.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.68 173.62 6.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.7 ' CB ' HG22 ' A' ' 151' ' ' THR . 0.2 OUTLIER -58.2 -46.39 85.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.967 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.488 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -98.79 121.46 40.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.066 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.909 HG21 ' HB2' ' A' ' 117' ' ' ALA . 30.5 m -130.38 132.42 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.065 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 24.8 p -82.17 94.83 7.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.806 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.3 pt -81.94 82.46 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.148 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 4.5 mt -114.98 83.62 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.995 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.26 85.08 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 8.0 t -165.03 142.05 5.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.58 116.26 26.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -125.01 177.77 5.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.942 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -102.2 120.06 39.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.623 HG11 HD23 ' A' ' 139' ' ' LEU . 21.5 t -98.32 129.48 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.119 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -108.43 172.05 7.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -141.62 133.86 27.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -117.07 95.52 5.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.084 179.919 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.844 0.355 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.9 p -141.08 114.95 9.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.6 t -176.93 170.13 2.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.831 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -97.25 157.0 16.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.819 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -150.62 147.61 27.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.838 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.0 mtp85 -72.47 124.34 24.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.553 ' HB2' HD13 ' A' ' 91' ' ' LEU . 20.3 p -92.72 127.21 38.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -135.44 143.37 45.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.2 t -59.75 169.23 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.969 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 91' ' ' LEU . 14.5 m -96.03 20.2 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.332 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 C--N 1.331 -0.227 0 CA-C-O 120.807 0.337 . . . . 0.0 110.823 179.935 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.814 0.34 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -70.79 -36.58 73.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -95.26 82.04 3.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.97 142.8 5.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.446 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -66.15 77.76 0.12 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.513 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.683 ' HB3' HD22 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -131.68 117.87 19.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 0.0 110.832 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.484 HD13 ' SG ' ' A' ' 77' ' ' CYS . 43.3 pt -112.5 170.53 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.101 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.51 HG22 ' HB2' ' A' ' 84' ' ' ALA . 5.2 mt -119.5 120.3 63.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.052 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 85.7 mtp -112.88 154.38 44.92 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.11 153.2 16.64 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.57 2.18 . . . . 0.0 112.31 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.92 -28.74 40.69 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.466 2.111 . . . . 0.0 112.304 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.0 p -64.38 -29.11 70.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.995 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.61 -36.4 71.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.249 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.416 HD13 ' CE1' ' A' ' 82' ' ' PHE . 8.2 tp -71.08 -45.78 63.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.938 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -68.94 -31.21 69.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -73.64 -50.64 20.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.976 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.552 ' HA ' HD12 ' A' ' 58' ' ' ILE . 29.4 mt -63.45 -35.38 80.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.2 p -77.21 -29.84 54.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.978 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.49 -20.44 47.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.9 mt -94.46 19.22 9.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.283 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.1 t30 54.88 32.22 17.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.189 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 53' ' ' LEU . 39.7 mt -91.87 112.91 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.15 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.8 p -99.33 169.91 9.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.939 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.457 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -65.07 143.03 98.79 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.457 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 77.1 Cg_endo -77.34 169.02 75.15 Favored 'Cis proline' 0 C--N 1.348 0.502 0 C-N-CA 123.477 -1.468 . . . . 0.0 112.462 0.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.5 mtt -130.08 38.72 3.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.912 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.542 HD22 ' SG ' ' A' ' 148' ' ' CYS . 0.4 OUTLIER -63.15 137.12 58.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.966 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.606 ' CD1' HG12 ' A' ' 109' ' ' VAL . 39.9 m-85 -100.24 160.57 14.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.429 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 13.9 tttt -109.7 84.32 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.88 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.561 HD23 HG22 ' A' ' 109' ' ' VAL . 17.7 mt -69.62 75.18 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.783 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.76 103.39 6.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.981 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.501 ' OD1' HD21 ' A' ' 101' ' ' LEU . 0.9 OUTLIER -70.54 118.22 13.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.915 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.96 33.58 2.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -131.62 -46.1 0.97 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 63.0 m -111.87 15.43 20.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.341 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.61 38.93 29.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.843 0.354 . . . . 0.0 111.084 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.477 ' HB2' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -98.46 163.07 12.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.838 ' O ' HG21 ' A' ' 150' ' ' THR . 27.0 ttp -150.13 114.1 5.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.847 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.5 m -134.9 141.64 46.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.994 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.429 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 42.9 m80 -108.67 118.53 37.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.944 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.494 ' SG ' HD12 ' A' ' 66' ' ' LEU . 28.2 p -128.86 145.97 51.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.928 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.96 138.92 14.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.499 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.37 148.12 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.852 0.358 . . . . 0.0 111.107 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.683 HD22 ' HB3' ' A' ' 42' ' ' LYS . 44.2 tp -113.59 -66.58 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.465 ' OE1' HG13 ' A' ' 83' ' ' VAL . 2.8 mm-40 -114.01 172.34 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.988 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.416 ' CE1' HD13 ' A' ' 50' ' ' LEU . 76.8 m-85 -133.39 66.45 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.853 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.465 HG13 ' OE1' ' A' ' 81' ' ' GLU . 31.4 m -137.2 31.75 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.165 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.51 ' HB2' HG22 ' A' ' 44' ' ' ILE . . . -96.64 178.63 5.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.134 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.703 ' HB2' HD12 ' A' ' 88' ' ' ILE . 4.2 m-20 -96.58 156.46 16.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.931 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -60.9 124.19 19.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.97 28.57 62.3 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.487 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.703 HD12 ' HB2' ' A' ' 85' ' ' ASP . 30.6 mt -146.93 87.99 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 0.0 111.088 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 96.7 m -94.32 120.0 33.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -84.6 146.33 27.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.925 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.553 HD13 ' HB2' ' A' ' 22' ' ' CYS . 1.0 OUTLIER -143.64 160.07 52.03 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.69 -174.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.568 2.179 . . . . 0.0 112.325 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -98.9 -31.46 11.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.986 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 64.1 p-90 -72.31 -38.58 68.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.562 ' HG2' HD12 ' A' ' 99' ' ' LEU . 36.8 ttm -64.52 -35.69 81.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -61.53 -48.77 79.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.873 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -61.83 -42.69 99.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -59.98 -50.24 74.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.568 HD13 HD11 ' A' ' 101' ' ' LEU . 7.2 mt -76.08 -20.62 57.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.5 mt 63.23 44.03 5.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.414 . . . . 0.0 110.815 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.568 HD11 HD13 ' A' ' 99' ' ' LEU . 3.3 mt -86.52 -175.75 5.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.869 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -127.25 172.37 10.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -70.0 78.8 0.49 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.1 35.96 1.07 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.441 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.66 150.17 20.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.451 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.1 mt -92.2 124.6 36.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.938 0.399 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.436 ' CG1' HD22 ' A' ' 66' ' ' LEU . 21.6 t -122.12 132.4 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.97 111.17 2.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.606 HG12 ' CD1' ' A' ' 64' ' ' PHE . 19.7 t -105.56 128.73 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.09 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -145.18 118.52 8.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.7 p -69.86 123.02 20.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.96 168.98 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -131.31 116.17 17.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.85 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 176' ' ' ALA . 1.3 mt -115.76 179.42 3.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.85 174.63 5.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.3 m -64.88 172.36 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.102 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.848 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -105.81 153.2 22.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 38.5 p -113.48 -36.36 4.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -131.98 97.52 4.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.428 ' OG ' HG22 ' A' ' 186' ' ' VAL . 94.9 p -101.43 109.92 21.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.874 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -98.65 119.45 37.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.53 ' CD1' HD21 ' A' ' 139' ' ' LEU . 75.9 m-85 -113.68 147.76 37.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.847 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.49 89.86 51.23 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -51.66 102.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.553 2.169 . . . . 0.0 112.288 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -59.48 -30.78 68.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.969 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.5 m -109.79 145.91 32.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.933 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.8 -16.3 23.53 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.588 2.192 . . . . 0.0 112.555 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -55.17 -33.45 62.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.138 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.401 ' O ' HD12 ' A' ' 132' ' ' ILE . 33.9 t80 -77.11 -40.33 46.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 39.5 mt -64.89 -30.61 71.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.48 -25.13 67.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.026 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.829 HG21 HG21 ' A' ' 138' ' ' VAL . 23.1 mt -60.05 138.25 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.001 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.7 m -65.6 -34.42 78.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.066 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.608 ' H ' HG22 ' A' ' 132' ' ' ILE . 2.0 m120 -128.36 72.55 80.19 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.981 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.62 -32.77 91.45 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.617 2.211 . . . . 0.0 112.275 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -60.01 -47.72 84.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.964 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.4 -45.49 90.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.06 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.829 HG21 HG21 ' A' ' 132' ' ' ILE . 21.4 t -60.66 -39.48 81.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.181 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.592 HD23 HG11 ' A' ' 186' ' ' VAL . 10.1 tp -70.9 -41.91 70.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.913 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -68.01 -31.07 70.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -69.14 -31.36 69.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.406 ' CB ' HG21 ' A' ' 157' ' ' ILE . . . -79.5 -37.8 35.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.138 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.716 HD22 HD11 ' A' ' 149' ' ' LEU . 59.1 mt -61.5 -26.63 68.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.045 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -56.48 -30.37 62.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -82.74 -49.07 10.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.906 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -60.07 152.86 23.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.541 ' HB1' HD21 ' A' ' 63' ' ' LEU . . . -107.07 -29.21 9.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.138 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.542 ' SG ' HD22 ' A' ' 63' ' ' LEU . 1.6 m -146.86 167.87 22.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.953 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.716 HD11 HD22 ' A' ' 143' ' ' LEU . 5.1 mt -142.97 170.19 16.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.838 HG21 ' O ' ' A' ' 74' ' ' MET . 63.4 m -153.6 136.65 15.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.495 HG22 ' CB ' ' A' ' 175' ' ' LYS . 8.8 t -60.67 121.02 11.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 91.54 28.96 12.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.546 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.46 126.57 52.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.942 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.6 t -89.38 91.09 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.089 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.47 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 4.4 pt -87.55 154.63 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.136 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.61 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -129.32 102.36 6.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.406 HG21 ' CB ' ' A' ' 142' ' ' ALA . 7.6 pt -90.93 147.08 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -140.6 145.86 37.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -176.54 -38.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.999 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -99.2 40.3 1.22 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 56.82 29.28 15.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.033 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.31 110.79 2.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.61 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 3.6 mp -68.47 94.43 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -61.68 145.77 51.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -95.41 132.79 40.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.931 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.01 158.22 41.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -156.91 139.01 14.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.855 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.421 HG22 ' CE2' ' A' ' 122' ' ' PHE . 28.6 t -80.9 147.85 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 59.6 mmm -117.41 -40.75 3.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.7 151.38 27.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 64.3 p -151.2 149.35 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -122.22 152.87 61.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.35 -27.32 8.62 Favored 'Cis proline' 0 C--N 1.346 0.435 0 C-N-CA 123.281 -1.55 . . . . 0.0 112.389 -0.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -124.5 168.98 12.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.735 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.495 ' CB ' HG22 ' A' ' 151' ' ' THR . 0.0 OUTLIER -56.59 -49.18 75.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.98 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.52 ' O ' HD22 ' A' ' 114' ' ' LEU . . . -92.85 110.73 22.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.033 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.848 HG21 ' HB2' ' A' ' 117' ' ' ALA . 11.5 m -128.52 148.72 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.19 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.7 95.7 8.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.2 pt -86.97 83.3 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.087 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 28.2 mm -112.73 90.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 61.17 55.29 3.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 6.1 t -135.83 143.27 45.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.19 134.48 41.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.869 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.458 ' SD ' ' HB3' ' A' ' 117' ' ' ALA . 2.1 ptt? -139.65 164.52 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -78.97 76.25 5.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.785 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.592 HG11 HD23 ' A' ' 139' ' ' LEU . 28.6 t -63.3 125.82 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.091 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.32 162.22 16.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . 0.416 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 31.0 m-85 -124.17 128.98 50.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -90.97 94.21 9.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.12 179.948 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.1 t80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.819 0.342 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.7 p -154.57 124.34 6.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -175.3 179.34 1.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.952 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.501 ' HB3' HD22 ' A' ' 106' ' ' LEU . 27.9 mt-30 -107.07 155.17 20.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -155.23 152.6 29.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.6 mtt-85 -82.86 134.58 35.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.1 m -102.23 128.14 48.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.496 ' CD2' HG23 ' A' ' 88' ' ' ILE . 52.9 m-85 -138.38 175.19 9.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.949 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.5 t -86.19 -179.98 6.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 91' ' ' LEU . 18.9 m -95.62 20.08 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.347 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.172 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.78 0.324 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -80.45 -31.34 37.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -83.47 91.19 7.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.87 178.27 15.62 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.55 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.73 31.56 8.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.557 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -89.17 135.53 33.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.81 0.338 . . . . 0.0 110.782 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.523 HD13 ' SG ' ' A' ' 77' ' ' CYS . 7.8 pt -128.93 167.75 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.166 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.0 mt -120.3 140.81 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.176 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.484 ' HE1' HG11 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -133.09 158.13 76.58 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.85 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.79 161.42 3.15 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.524 2.149 . . . . 0.0 112.315 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.83 -25.81 32.82 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.648 2.232 . . . . 0.0 112.302 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.7 p -58.95 -38.4 78.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.979 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.471 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -59.32 -33.11 70.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.214 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.5 tp -62.01 -51.58 67.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.82 -31.19 67.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.41 -43.91 63.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.928 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 49' ' ' ALA . 3.8 mt -58.18 -52.25 66.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -65.25 -29.74 70.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -76.58 -26.04 54.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.02 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.9 mt -94.51 20.09 8.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.227 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 m120 58.24 35.51 25.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.866 0.365 . . . . 0.0 111.058 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 53' ' ' LEU . 29.4 mt -102.62 116.74 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 t -114.17 173.56 6.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.468 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -68.1 144.09 96.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.468 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.7 Cg_endo -77.08 159.56 95.53 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 123.446 -1.481 . . . . 0.0 112.327 -0.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 19.1 mtt -125.35 59.0 1.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.983 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.712 HD23 ' HA2' ' A' ' 78' ' ' GLY . 88.8 mt -74.93 114.99 14.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.859 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.429 ' CE2' ' HB ' ' A' ' 79' ' ' VAL . 17.3 m-85 -81.68 133.37 35.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.857 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -85.66 93.23 8.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.037 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.9 mt -78.36 76.85 4.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.6 m -90.02 103.17 15.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.9 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -67.14 127.23 31.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -98.92 32.17 2.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.44 -43.84 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 73.4 m -123.56 23.07 8.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 54.43 31.33 14.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.092 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.531 ' HB3' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -82.33 157.82 23.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.826 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.92 131.91 10.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.607 HG22 HD21 ' A' ' 99' ' ' LEU . 2.7 t -159.95 114.3 2.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.964 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.551 ' CD2' HD11 ' A' ' 114' ' ' LEU . 12.0 m80 -79.74 122.99 27.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.523 ' SG ' HD13 ' A' ' 43' ' ' ILE . 30.0 p -117.29 150.73 38.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.949 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.712 ' HA2' HD23 ' A' ' 63' ' ' LEU . . . -104.86 129.36 9.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.417 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.429 ' HB ' ' CE2' ' A' ' 64' ' ' PHE . 10.8 p -69.44 147.36 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 111.094 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -130.41 -59.74 1.02 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.818 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -110.11 146.91 34.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.743 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -113.88 49.52 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.06 79.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.147 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -132.31 173.36 11.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.585 ' HB3' HD12 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -76.64 162.93 27.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -66.59 109.92 2.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.02 34.94 54.76 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.483 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.585 HD12 ' HB3' ' A' ' 85' ' ' ASP . 26.8 mt -144.01 91.62 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.81 0.338 . . . . 0.0 111.085 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 97.0 m -80.67 134.52 35.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -99.63 127.38 45.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.404 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -130.19 157.74 76.27 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.849 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.57 -172.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.591 2.194 . . . . 0.0 112.283 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -90.58 -39.02 12.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -69.61 -42.86 73.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.2 ttp -61.08 -31.31 70.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -31.5 61.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.827 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -81.55 -37.13 28.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.894 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -68.62 -45.13 72.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.643 HD13 HD11 ' A' ' 101' ' ' LEU . 7.7 mt -68.83 -23.87 64.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.061 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.8 mt 66.27 48.79 1.57 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.803 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.643 HD11 HD13 ' A' ' 99' ' ' LEU . 5.2 mt -96.36 -176.26 3.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.78 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.31 174.77 10.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -59.85 92.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.02 28.1 7.49 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -70.44 130.0 20.47 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.491 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.501 HD22 ' HB3' ' A' ' 19' ' ' GLN . 64.5 mt -87.82 126.95 35.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.807 0.337 . . . . 0.0 110.927 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 108' ' ' GLN . 21.5 t -129.53 156.42 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.446 ' N ' HG12 ' A' ' 107' ' ' VAL . 19.2 tp60 -79.67 125.01 29.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.484 HG11 ' HE1' ' A' ' 45' ' ' MET . 21.5 t -111.35 105.7 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.097 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -125.45 133.56 52.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.8 p -81.92 108.56 15.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.989 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.414 HG21 ' CD2' ' A' ' 76' ' ' HIS . 6.8 m -111.2 156.21 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -107.57 118.04 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.551 HD11 ' CD2' ' A' ' 76' ' ' HIS . 13.1 mt -118.02 157.15 27.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -109.56 169.83 8.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.7 m -64.85 139.82 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.101 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.842 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -79.75 149.33 31.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.3 p -107.33 -37.85 6.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -128.04 125.22 38.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.8 p -129.74 140.23 51.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.023 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -131.23 125.51 33.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.824 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.787 ' CG ' HD21 ' A' ' 139' ' ' LEU . 17.1 m-85 -113.41 147.62 37.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.982 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -131.06 92.44 33.38 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.779 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.707 ' HA ' HD23 ' A' ' 166' ' ' LEU . 77.1 Cg_exo -50.18 116.58 2.54 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.561 2.174 . . . . 0.0 112.455 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -73.62 -31.45 63.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -106.8 146.93 34.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.27 -14.77 28.5 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.582 2.188 . . . . 0.0 112.461 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.0 -40.07 75.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.011 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -71.87 -38.44 70.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.415 HD21 ' CB ' ' A' ' 190' ' ' ALA . 84.9 mt -64.95 -31.84 73.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.866 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -62.42 -25.62 68.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.449 HG22 ' H ' ' A' ' 134' ' ' ASN . 32.9 mt -66.01 135.38 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.089 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.2 t -66.93 -37.86 85.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.526 ' O ' HG23 ' A' ' 138' ' ' VAL . 3.8 m120 -119.07 75.75 14.73 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.17 -30.27 16.28 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.631 2.221 . . . . 0.0 112.311 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -37.01 84.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.48 -44.33 67.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 134' ' ' ASN . 29.9 t -63.03 -44.73 99.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.012 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.787 HD21 ' CG ' ' A' ' 122' ' ' PHE . 16.0 tp -69.26 -31.58 70.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.819 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.01 -31.43 62.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.914 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -78.79 -34.28 45.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.861 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.23 -35.7 66.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.515 HD22 HD11 ' A' ' 149' ' ' LEU . 14.8 mt -59.73 -25.73 65.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.983 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 -55.4 -30.57 60.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.09 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.24 -31.21 30.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -71.24 140.53 50.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -101.12 -29.59 12.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.105 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 18.3 t -148.76 158.36 44.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.954 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.515 HD11 HD22 ' A' ' 143' ' ' LEU . 11.1 mt -134.34 150.92 50.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.0 m -128.32 148.51 50.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 26.5 m -76.01 101.72 5.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 103.51 48.17 1.23 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.462 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -134.0 115.16 14.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.792 0.329 . . . . 0.0 110.931 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.3 t -72.54 99.25 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 37.3 pt -97.13 143.91 11.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.157 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.597 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -107.97 150.72 26.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.125 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.5 pt -141.15 139.55 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.125 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -127.39 156.66 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -177.43 -47.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -103.02 42.65 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.64 31.04 20.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.915 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.09 126.42 9.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.597 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 3.4 mp -86.9 101.12 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -79.17 123.95 27.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.86 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -87.47 131.48 34.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.707 HD23 ' HA ' ' A' ' 124' ' ' PRO . 1.5 mt -143.69 147.34 34.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.827 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -127.06 127.73 45.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.14 131.91 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 14.2 mmm -87.57 -55.57 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.529 ' O ' HG23 ' A' ' 171' ' ' THR . 0.1 OUTLIER -145.28 160.02 42.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 170' ' ' GLU . 3.0 p -160.07 119.08 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -96.83 155.77 37.27 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.96 -43.18 0.67 Allowed 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.326 -1.531 . . . . 0.0 112.444 0.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.29 174.48 5.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.935 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -59.13 -48.79 80.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.435 ' HB1' HD13 ' A' ' 114' ' ' LEU . . . -92.74 113.02 25.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.084 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.842 HG21 ' HB2' ' A' ' 117' ' ' ALA . 28.2 m -129.54 139.34 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 11.3 t -91.8 98.29 11.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.9 pt -90.91 80.35 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.5 mt -108.41 83.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.08 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 60.94 78.76 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 14.3 t -153.49 148.36 26.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.14 121.91 28.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -144.14 154.04 42.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.16 119.28 19.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.15 109.49 27.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.164 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.8 169.61 9.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . 0.6 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 3.1 m-85 -142.12 109.64 5.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -112.01 105.03 13.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.415 ' CB ' HD21 ' A' ' 130' ' ' LEU . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.117 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.3 t80 . . . . . 0 CA--C 1.527 0.073 0 CA-C-O 120.789 0.328 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.2 p -159.99 118.4 2.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -176.33 161.22 2.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.972 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -90.11 143.61 26.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.811 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.455 ' HB2' HG21 ' A' ' 109' ' ' VAL . 6.0 m-85 -144.4 136.41 26.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -71.57 157.86 37.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.493 ' SG ' HD13 ' A' ' 101' ' ' LEU . 95.6 m -119.96 130.72 54.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.939 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.613 ' CD2' HG23 ' A' ' 88' ' ' ILE . 70.6 m-85 -136.2 166.79 22.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -79.14 138.58 37.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.946 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 90' ' ' TYR . 26.3 m -63.6 -19.33 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.288 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.412 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.5 t . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.907 0.384 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -71.85 -38.68 70.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.884 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -84.14 79.54 9.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.74 178.8 32.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.411 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.06 37.87 3.6 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.517 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.576 ' HG2' HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -105.5 153.58 21.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.705 0.288 . . . . 0.0 110.872 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.675 HG22 ' HD3' ' A' ' 92' ' ' PRO . 3.0 pt -139.66 179.95 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.041 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.655 HG22 ' HB2' ' A' ' 84' ' ' ALA . 4.5 mt -122.51 136.12 60.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.124 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 71.8 mtp -137.75 161.49 59.85 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.81 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 52.5 Cg_exo -52.79 146.47 35.55 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.506 2.138 . . . . 0.0 112.335 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 46' ' ' PRO . 50.3 Cg_exo -53.83 -26.89 41.21 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.521 2.147 . . . . 0.0 112.384 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.0 t -58.54 -39.01 78.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.035 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.89 -31.08 70.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.102 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.418 HD13 ' CD1' ' A' ' 82' ' ' PHE . 58.3 tp -64.68 -51.31 63.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -72.61 -29.5 63.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -50.34 74.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.947 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.517 HD13 ' SD ' ' A' ' 62' ' ' MET . 1.6 mt -56.56 -38.29 71.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.007 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.8 t -75.52 -27.5 58.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -81.54 -25.04 36.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.03 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.4 mt -95.52 19.77 10.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.18 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 53.98 44.88 28.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.86 0.362 . . . . 0.0 111.173 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.499 HG21 HD23 ' A' ' 53' ' ' LEU . 30.3 mt -107.35 130.37 59.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.182 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 p -113.4 170.84 7.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.444 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.3 t80 -61.15 140.35 94.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.815 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.85 171.34 68.58 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.544 -1.44 . . . . 0.0 112.368 0.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.517 ' SD ' HD13 ' A' ' 53' ' ' LEU . 15.9 mtt -126.31 41.71 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.469 HD22 ' CA ' ' A' ' 78' ' ' GLY . 16.9 mt -68.97 164.0 23.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.935 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -130.34 153.89 48.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HB2' HG21 ' A' ' 112' ' ' VAL . 23.9 tttt -99.82 91.9 5.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.842 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 66' ' ' LEU . 15.1 mt -75.43 78.95 2.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.836 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -81.65 99.17 8.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -71.27 120.23 16.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.829 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -98.46 30.56 3.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.994 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.94 -37.43 4.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.846 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.23 23.54 4.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.128 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.01 39.31 31.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 111.113 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.31 172.46 8.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.0 ttp -157.82 124.93 5.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.834 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.0 m -140.17 155.74 46.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -129.56 108.86 10.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.1 p -116.59 149.88 38.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.469 ' CA ' HD22 ' A' ' 63' ' ' LEU . . . -104.87 137.68 13.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.545 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.9 p -83.79 134.88 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.782 0.325 . . . . 0.0 111.06 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.576 HD22 ' HG2' ' A' ' 42' ' ' LYS . 57.5 tp -117.94 -58.01 2.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.32 150.75 19.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.418 ' CD1' HD13 ' A' ' 50' ' ' LEU . 65.7 m-85 -132.99 62.83 1.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.3 m -136.15 32.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.164 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.655 ' HB2' HG22 ' A' ' 44' ' ' ILE . . . -95.12 158.78 15.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.071 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.615 ' HB3' HD12 ' A' ' 88' ' ' ILE . 3.9 t70 -68.54 160.31 30.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -66.98 136.12 54.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.19 28.69 73.85 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.452 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.615 HD12 ' HB3' ' A' ' 85' ' ' ASP . 28.8 mt -147.82 112.47 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 111.14 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.7 m -114.85 130.5 56.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.49 ' HB3' HG12 ' A' ' 25' ' ' VAL . 70.1 m-85 -92.42 143.25 26.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.935 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.532 ' CD2' HG21 ' A' ' 43' ' ' ILE . 44.0 mt -139.28 147.67 53.9 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.675 ' HD3' HG22 ' A' ' 43' ' ' ILE . 53.0 Cg_exo -52.52 169.93 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.57 2.18 . . . . 0.0 112.283 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.53 -38.68 77.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.834 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.405 ' CH2' ' CE ' ' A' ' 95' ' ' MET . 51.0 p-90 -72.58 -31.48 65.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.405 ' CE ' ' CH2' ' A' ' 94' ' ' TRP . 7.4 ttm -74.72 -31.16 61.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 37.7 mmm -76.39 -39.06 54.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -76.63 -38.75 54.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.858 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -59.66 -53.49 57.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.41 HD13 HD11 ' A' ' 101' ' ' LEU . 30.8 mt -71.21 -21.79 62.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 mt 66.99 45.6 1.74 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.892 0.377 . . . . 0.0 110.944 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.493 HD13 ' SG ' ' A' ' 22' ' ' CYS . 13.1 mt -96.83 149.24 22.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -103.47 -179.19 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.799 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.34 113.5 2.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.35 42.24 8.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.446 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.86 109.51 3.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.536 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.1 mt -73.27 131.88 42.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 108' ' ' GLN . 21.5 t -137.01 158.83 36.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.079 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.479 ' N ' HG12 ' A' ' 107' ' ' VAL . 62.7 mm-40 -74.67 122.5 23.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.455 HG21 ' HB2' ' A' ' 20' ' ' TYR . 21.5 t -117.95 86.9 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.146 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -107.5 135.2 49.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.1 p -75.72 101.49 5.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 65' ' ' LYS . 19.2 m -113.88 149.3 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.105 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -121.84 117.21 25.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.577 HD22 ' O ' ' A' ' 176' ' ' ALA . 6.4 mt -107.81 174.22 5.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.45 164.06 12.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.95 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.1 m -64.69 135.05 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.668 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -77.68 152.87 33.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.076 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.3 t -109.55 -31.77 7.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -134.82 106.7 7.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.6 m -122.92 113.39 19.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.946 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -92.38 142.56 27.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.515 ' CG ' HD21 ' A' ' 139' ' ' LEU . 18.1 m-85 -130.43 150.2 51.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -131.79 95.93 21.72 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.8 109.9 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.536 2.157 . . . . 0.0 112.408 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -59.62 -31.78 69.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.998 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 72.4 p -113.38 146.81 36.11 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.958 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.88 -17.8 25.13 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.544 2.163 . . . . 0.0 112.48 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -55.14 -39.84 69.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.023 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -66.41 -46.91 74.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.7 mt -60.31 -30.67 69.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.968 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.3 -25.07 66.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 134' ' ' ASN . 51.4 mt -62.27 136.92 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.958 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.9 m -58.28 -39.62 79.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.992 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.729 ' O ' HG23 ' A' ' 138' ' ' VAL . 2.3 m120 -125.59 80.67 65.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.0 -28.63 19.05 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.585 2.19 . . . . 0.0 112.363 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.9 mtpm? -66.73 -44.95 80.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.84 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.89 93.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.038 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 134' ' ' ASN . 25.3 t -64.08 -45.25 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.064 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.61 HD22 ' CZ ' ' A' ' 188' ' ' PHE . 21.5 tp -67.91 -43.44 79.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.83 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -62.35 -36.37 82.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.807 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -68.82 -29.83 68.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.35 -33.19 69.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.575 HD22 HD13 ' A' ' 179' ' ' ILE . 65.9 mt -60.49 -25.77 66.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.059 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.6 mtp-105 -55.16 -30.36 59.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.05 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -89.21 -38.7 14.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -69.08 144.67 53.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.423 ' HB1' HD11 ' A' ' 180' ' ' ILE . . . -109.39 -26.15 10.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.22 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -140.25 165.14 28.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.968 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.523 HD11 HD13 ' A' ' 179' ' ' ILE . 20.8 mt -144.33 129.41 18.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.54 145.47 46.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.876 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 169' ' ' MET . 18.7 m -71.47 123.58 22.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.9 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.75 27.69 21.07 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.45 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.82 132.66 53.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.4 t -90.58 89.68 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.084 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 18.4 pt -85.16 132.31 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.081 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -108.05 140.75 40.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.3 pt -125.12 165.26 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.041 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -157.83 150.41 22.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -172.71 -48.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -97.66 41.44 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.94 29.65 19.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.954 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.59 128.12 17.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.801 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.574 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.9 mp -87.83 105.18 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.177 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -82.71 137.44 34.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -90.11 121.73 32.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.001 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.23 141.55 49.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.82 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 -137.24 129.05 28.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.446 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.3 t -76.57 132.46 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.66 ' O ' HG23 ' A' ' 151' ' ' THR . 6.7 mmm -94.0 -68.53 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.95 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -123.8 152.91 41.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.5 p -147.24 150.49 34.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -130.68 153.97 81.66 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.64 -31.96 4.92 Favored 'Cis proline' 0 C--N 1.348 0.522 0 C-N-CA 123.264 -1.557 . . . . 0.0 112.45 -0.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.36 171.53 7.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.835 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -40.75 76.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.022 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.577 ' O ' HD22 ' A' ' 114' ' ' LEU . . . -102.64 124.47 48.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.081 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.668 HG21 ' HB2' ' A' ' 117' ' ' ALA . 15.8 m -137.58 153.71 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.146 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 23.8 t -104.7 98.01 7.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.575 HD13 HD22 ' A' ' 143' ' ' LEU . 2.4 pt -88.68 84.11 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.207 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.423 HD11 ' HB1' ' A' ' 147' ' ' ALA . 26.5 mm -111.65 79.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.089 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 59.14 91.0 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.99 156.16 26.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.967 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.19 103.53 15.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.827 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -126.67 170.84 11.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -94.22 113.54 25.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.39 106.85 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.176 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -87.13 159.33 18.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . 0.61 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 13.7 m-85 -133.09 133.24 42.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -121.09 97.37 5.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.087 179.969 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.6 t80 . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.893 0.378 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.0 p -155.23 110.1 2.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.2 t -176.42 168.96 2.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -103.38 146.85 27.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.406 ' HD2' HG21 ' A' ' 109' ' ' VAL . 22.4 m-85 -146.87 147.28 30.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.91 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -84.6 132.08 34.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.9 p -84.82 142.01 30.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.642 ' CD2' HG23 ' A' ' 88' ' ' ILE . 17.2 m-85 -147.0 149.47 33.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.833 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.85 168.51 6.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 m -95.82 20.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.374 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 55.1 m . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.019 179.955 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.791 0.329 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -77.2 -30.14 54.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -97.93 33.72 2.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.6 171.51 25.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.553 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.23 28.66 13.02 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.545 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.83 151.2 20.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.805 0.336 . . . . 0.0 110.913 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.493 HG21 HD23 ' A' ' 91' ' ' LEU . 7.9 pt -133.35 165.67 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.652 HG23 ' HB3' ' A' ' 81' ' ' GLU . 3.0 mt -115.7 96.17 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.138 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.405 ' HG3' HD12 ' A' ' 43' ' ' ILE . 97.1 mtp -88.55 157.8 49.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.8 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -51.83 156.74 6.48 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.571 2.181 . . . . 0.0 112.336 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.71 -27.06 38.57 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.519 2.146 . . . . 0.0 112.318 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.8 p -61.65 -31.67 71.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.87 -31.67 72.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.3 tp -62.27 -34.64 76.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -86.96 -30.54 21.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.0 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.42 -47.25 70.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.5 mt -57.19 -47.48 81.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.077 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 p -64.15 -23.61 67.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.173 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.72 20.11 9.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.355 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -135.83 19.95 3.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.206 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 55.9 33.69 22.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.766 0.317 . . . . 0.0 111.029 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.2 mt -102.78 109.01 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.4 p -104.51 162.96 12.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.471 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -60.14 144.3 87.29 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.775 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.471 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 72.2 Cg_endo -76.71 171.29 68.84 Favored 'Cis proline' 0 C--N 1.347 0.484 0 C-N-CA 123.467 -1.472 . . . . 0.0 112.4 0.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.3 mtt -138.23 78.02 1.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.446 HD22 HD12 ' A' ' 114' ' ' LEU . 1.4 mp -89.55 138.29 31.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -109.78 143.02 40.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.846 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -94.74 99.76 11.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.936 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.714 ' HB2' HG23 ' A' ' 75' ' ' THR . 43.7 mt -84.66 78.44 9.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 53.7 m -77.93 111.59 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.437 ' OD1' HD21 ' A' ' 101' ' ' LEU . 2.8 t30 -74.88 113.96 12.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.956 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -88.92 53.9 2.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -145.22 -53.49 0.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.9 m -120.32 25.37 9.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.067 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 t0 55.19 30.44 14.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.112 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.0 mmt-85 -82.3 146.19 29.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.3 ttm -133.12 140.77 47.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.819 HG21 HD11 ' A' ' 99' ' ' LEU . 4.7 t -157.15 143.0 17.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -120.78 114.6 21.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.2 p -113.46 172.73 6.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.46 124.84 4.83 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.539 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.0 p -64.12 141.65 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 0.0 111.09 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.7 tp -134.9 -54.79 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.652 ' HB3' HG23 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -94.45 152.09 18.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -135.0 73.86 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.6 m -149.93 35.23 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.164 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.69 178.77 5.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.095 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.716 ' CB ' HD12 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -92.69 166.47 12.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.804 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -65.66 90.96 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.807 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 96.73 26.17 10.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.509 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.716 HD12 ' CB ' ' A' ' 85' ' ' ASP . 28.0 mt -136.08 80.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 111.07 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 57.5 m -78.29 134.7 37.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -102.96 130.91 50.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.848 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.493 HD23 HG21 ' A' ' 43' ' ' ILE . 1.3 mp -132.69 162.19 58.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.36 -173.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.628 2.218 . . . . 0.0 112.287 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -94.18 -46.65 7.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.433 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 69.7 p-90 -60.01 -39.63 86.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 37.4 ttm -62.03 -32.79 73.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.893 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -53.17 18.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -61.91 -38.35 88.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -59.96 -40.97 90.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.792 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.819 HD11 HG21 ' A' ' 75' ' ' THR . 10.0 mt -84.86 -14.46 47.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.281 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.7 mt 61.35 32.95 19.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.437 HD21 ' OD1' ' A' ' 68' ' ' ASN . 6.9 mt -82.75 162.88 21.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -108.85 173.52 6.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.898 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -60.14 112.55 1.95 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.83 42.65 10.89 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.465 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.11 119.65 5.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.478 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.9 mt -65.57 129.23 39.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.803 0.335 . . . . 0.0 110.847 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.94 149.78 33.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -75.8 124.28 27.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.406 HG21 ' HD2' ' A' ' 20' ' ' TYR . 21.5 t -111.29 122.87 66.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -144.2 121.87 11.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 71.4 p -72.75 129.35 38.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.4 m -137.69 139.79 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.057 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -101.06 109.37 21.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.446 HD12 HD22 ' A' ' 63' ' ' LEU . 3.9 mt -103.52 172.01 7.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -116.03 164.72 14.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.631 HG21 ' SG ' ' A' ' 182' ' ' CYS . 21.7 m -60.82 144.34 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.094 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.867 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -88.07 153.3 21.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.124 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.1 p -106.35 -31.32 8.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -133.7 112.64 11.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.9 m -123.35 122.1 37.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.23 146.46 38.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.974 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.698 ' CD1' HD21 ' A' ' 139' ' ' LEU . 74.5 m-85 -125.94 143.94 50.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -126.59 90.24 50.26 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.958 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.81 112.08 0.75 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.583 2.189 . . . . 0.0 112.328 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -65.39 -31.25 72.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.1 p -106.57 146.47 33.12 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.931 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.59 -17.03 23.76 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.597 2.198 . . . . 0.0 112.576 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.02 -44.25 74.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.087 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.483 ' CE1' HD11 ' A' ' 157' ' ' ILE . 20.9 t80 -70.49 -44.67 67.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.869 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.3 mt -59.82 -31.81 70.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -64.4 -24.07 67.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.977 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.411 HG22 ' H ' ' A' ' 134' ' ' ASN . 60.5 mt -60.02 139.94 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.924 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.401 HG23 ' N ' ' A' ' 134' ' ' ASN . 9.0 t -59.11 -44.73 92.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.411 ' H ' HG22 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -129.76 86.76 54.32 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.49 -28.61 21.52 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.585 2.19 . . . . 0.0 112.313 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.443 ' HG3' ' CE1' ' A' ' 188' ' ' PHE . 36.8 mttt -65.49 -35.67 81.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.93 -41.85 77.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.076 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.671 HG11 ' CZ ' ' A' ' 159' ' ' TYR . 21.5 t -74.38 -36.8 43.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.075 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.698 HD21 ' CD1' ' A' ' 122' ' ' PHE . 1.3 tp -71.42 -37.59 71.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.22 -31.42 65.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.76 -33.02 68.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.899 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.97 -29.19 32.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.7 mt -57.9 -25.97 61.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.057 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -55.59 -30.0 60.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.034 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -80.02 -35.13 37.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -73.92 132.75 42.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -103.1 -27.21 12.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 7.6 t -123.0 161.12 24.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.433 HD12 HG21 ' A' ' 179' ' ' ILE . 6.1 mt -143.78 113.37 7.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.3 m -117.42 136.37 53.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.08 129.35 39.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.918 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 83.4 47.43 5.72 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.53 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.57 110.85 13.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.738 0.304 . . . . 0.0 110.862 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.59 83.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.193 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.433 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 1.4 pt -81.67 150.58 4.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -114.59 117.4 30.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.023 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.483 HD11 ' CE1' ' A' ' 129' ' ' PHE . 3.4 pt -109.1 145.7 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.227 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -148.77 140.67 23.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.882 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.671 ' CZ ' HG11 ' A' ' 138' ' ' VAL . 1.8 p90 -149.02 -50.17 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -100.81 49.34 0.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 59.05 30.0 19.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.974 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -139.74 105.41 5.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.555 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.8 mp -78.26 88.04 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.144 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -69.58 158.09 35.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.781 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -113.98 135.95 53.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.975 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.462 HD21 ' CD2' ' A' ' 129' ' ' PHE . 3.6 mp -150.4 160.56 43.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.825 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 8.5 ttt-85 -144.77 130.67 19.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.025 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.451 ' CG1' HG23 ' A' ' 171' ' ' THR . 21.5 t -59.56 123.53 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.056 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.17 -61.4 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.06 148.08 44.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.991 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.451 HG23 ' CG1' ' A' ' 168' ' ' VAL . 16.6 p -145.92 138.87 25.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -122.19 154.48 61.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.1 -39.08 1.52 Allowed 'Cis proline' 0 C--N 1.347 0.469 0 C-N-CA 123.267 -1.555 . . . . 0.0 112.324 0.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.49 171.64 7.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.81 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.11 -48.1 82.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -93.2 123.42 36.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.062 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.867 HG21 ' HB2' ' A' ' 117' ' ' ALA . 15.7 m -143.78 152.91 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . 0.532 ' OG ' HD11 ' A' ' 180' ' ' ILE . 4.7 t -106.45 106.5 17.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.433 HG21 HD12 ' A' ' 149' ' ' LEU . 2.0 pt -92.09 86.6 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.176 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.532 HD11 ' OG ' ' A' ' 178' ' ' SER . 4.8 mt -116.48 81.57 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.015 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 60.36 89.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 116' ' ' VAL . 2.8 t -162.54 153.18 17.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.928 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -80.64 119.57 23.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.5 ptt? -147.83 168.94 20.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -102.07 150.82 22.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.67 106.94 12.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.134 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.16 158.89 15.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.942 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . 0.639 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 7.2 m-85 -127.53 148.01 50.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.864 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -139.14 97.26 3.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.139 179.934 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.0 t80 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.759 0.314 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.35 122.69 22.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.405 HG23 ' CE2' ' A' ' 20' ' ' TYR . 11.2 t -177.09 163.75 2.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.913 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -86.14 153.34 22.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.405 ' CE2' HG23 ' A' ' 18' ' ' THR . 13.6 m-85 -154.99 156.74 36.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -82.36 149.8 27.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.905 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.8 m -112.36 119.28 37.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.584 ' CD2' HG23 ' A' ' 88' ' ' ILE . 33.7 m-85 -127.65 163.11 24.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.922 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.8 m -81.22 157.55 25.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.9 m -72.57 -30.61 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.974 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.458 -0.031 0 CA-C-O 120.884 0.373 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -94.03 -31.2 14.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.826 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -97.54 95.42 7.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.888 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.94 -145.98 17.37 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.408 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.11 80.44 0.3 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.557 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.62 ' HG2' HD13 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -142.36 126.62 17.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.826 0.346 . . . . 0.0 110.872 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.401 HG22 ' HD3' ' A' ' 92' ' ' PRO . 13.1 pt -118.17 171.01 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.181 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 mp -128.9 106.7 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.94 160.56 25.7 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.962 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.508 ' N ' ' HB3' ' A' ' 84' ' ' ALA . 51.3 Cg_exo -52.93 161.35 3.32 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.535 2.156 . . . . 0.0 112.28 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.9 -26.39 26.95 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.548 2.165 . . . . 0.0 112.33 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 p -58.86 -31.24 68.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.948 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.45 -36.88 83.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.412 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 44.8 tp -64.86 -38.74 92.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.906 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -77.27 -30.99 54.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.932 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -68.93 -51.3 41.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.9 mt -59.63 -33.13 71.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.5 m -64.24 -30.27 71.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -96.64 20.23 11.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.4 mt -128.57 18.45 6.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.182 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 53.77 30.07 10.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.797 0.332 . . . . 0.0 111.157 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.1 mt -99.59 123.78 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.126 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -119.55 168.79 10.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.462 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -59.93 144.07 86.76 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.89 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.462 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 72.7 Cg_endo -77.27 149.8 90.23 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 123.422 -1.491 . . . . 0.0 112.398 0.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 4.6 mtt -115.74 74.88 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.552 HD21 ' HB1' ' A' ' 147' ' ' ALA . 1.6 mt -88.15 160.37 17.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -127.37 148.28 50.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.837 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.404 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 24.7 tttt -104.11 93.78 5.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.71 80.75 5.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.822 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 m -87.87 95.94 10.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.466 ' ND2' HD21 ' A' ' 101' ' ' LEU . 37.2 t-20 -62.07 123.13 17.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.845 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm -98.31 32.4 2.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -131.93 -46.07 0.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.959 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.0 m -108.66 17.69 21.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.266 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.0 t0 53.16 37.74 25.77 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.848 0.356 . . . . 0.0 111.169 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.488 ' CB ' HD23 ' A' ' 99' ' ' LEU . 3.1 mmt-85 -96.45 152.4 18.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.4 ttp -149.17 123.21 9.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.795 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.452 HG21 HD11 ' A' ' 99' ' ' LEU . 6.5 t -148.96 160.54 43.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.992 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.494 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 15.1 m80 -125.26 107.87 11.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 24.6 p -104.3 161.16 14.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.957 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.53 143.24 17.97 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.661 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 11.1 p -79.53 144.09 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 111.076 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.62 HD13 ' HG2' ' A' ' 42' ' ' LYS . 46.6 tp -116.89 -62.99 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.851 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -122.01 -179.65 4.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.661 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 49.6 m-85 -140.19 80.12 1.74 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.7 m -141.9 31.28 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.129 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.508 ' HB3' ' N ' ' A' ' 46' ' ' PRO . . . -89.85 172.51 8.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.062 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.78 162.37 13.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -60.75 126.1 26.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.89 29.99 76.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.518 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.584 HG23 ' CD2' ' A' ' 23' ' ' PHE . 26.2 mt -148.95 99.25 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.839 0.352 . . . . 0.0 111.169 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 39.0 m -102.68 135.15 44.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -99.53 131.4 45.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 mt -131.27 157.52 77.87 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.401 ' HD3' HG22 ' A' ' 43' ' ' ILE . 52.3 Cg_exo -52.9 -174.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.52 2.147 . . . . 0.0 112.35 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -98.36 -36.04 10.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.895 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 57.0 p-90 -64.97 -31.38 72.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -75.95 -34.16 59.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -37.68 81.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -32.7 52.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -68.58 -38.05 80.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.834 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.488 HD23 ' CB ' ' A' ' 73' ' ' ARG . 7.3 mt -90.73 -21.23 21.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.0 mt 61.26 65.35 0.99 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.898 0.38 . . . . 0.0 110.938 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.466 HD21 ' ND2' ' A' ' 68' ' ' ASN . 8.1 mt -118.84 -177.21 3.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.877 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -126.5 174.59 8.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.881 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -64.85 85.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.26 38.34 1.13 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.426 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.73 134.78 12.68 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.98 123.71 29.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 0.0 110.992 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.93 139.69 51.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.106 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -69.28 102.05 1.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -87.04 142.9 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.96 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -152.95 173.68 15.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.2 p -131.02 108.87 10.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.919 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.5 m -117.9 158.31 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.211 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -110.78 111.4 22.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.475 HD22 ' O ' ' A' ' 176' ' ' ALA . 8.5 mt -110.53 179.94 3.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.935 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.86 168.25 15.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.1 m -59.9 158.09 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.125 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.849 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -97.91 150.7 21.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.045 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.3 t -107.38 -31.28 8.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -132.27 90.76 2.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.2 m -103.69 104.89 14.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.835 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -94.57 146.85 23.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.674 ' CD2' HD21 ' A' ' 139' ' ' LEU . 87.5 m-85 -134.49 152.21 51.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -137.57 93.37 12.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -51.64 121.46 8.61 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.534 2.156 . . . . 0.0 112.297 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -74.14 -31.41 62.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.984 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -107.73 147.36 35.24 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.989 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.43 -15.3 27.93 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.642 2.228 . . . . 0.0 112.52 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.32 -40.22 70.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.103 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.532 ' CE2' HD11 ' A' ' 166' ' ' LEU . 13.6 t80 -70.73 -46.15 63.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.858 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 56.5 mt -59.84 -31.5 69.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -64.53 -25.64 68.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.073 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' ' 134' ' ' ASN . 46.8 mt -61.98 132.68 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.086 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.1 m -61.07 -34.27 74.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.934 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.591 ' H ' HG22 ' A' ' 132' ' ' ILE . 1.0 OUTLIER -120.58 79.97 30.55 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.809 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.64 -30.21 18.52 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.547 2.165 . . . . 0.0 112.295 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -73.72 -31.02 63.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' A' ' 134' ' ' ASN . . . -70.77 -48.71 52.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.15 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.474 HG21 HD13 ' A' ' 132' ' ' ILE . 21.6 t -61.89 -40.37 86.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.674 HD21 ' CD2' ' A' ' 122' ' ' PHE . 9.7 tp -65.41 -46.98 77.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -70.62 -30.91 67.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.966 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -67.58 -27.81 67.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.089 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.5 -26.16 14.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.35 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.3 mt -57.3 -39.47 75.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.117 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -27.62 64.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.05 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -73.54 -30.28 62.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.776 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -78.77 155.6 29.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.552 ' HB1' HD21 ' A' ' 63' ' ' LEU . . . -109.96 -30.51 7.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.536 ' SG ' HD13 ' A' ' 63' ' ' LEU . 1.3 m -145.37 170.77 15.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.932 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.4 mt -137.79 176.25 8.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.5 m -159.67 143.94 14.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.9 m -72.85 123.53 23.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.89 58.49 3.22 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -137.89 130.32 29.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.829 0.347 . . . . 0.0 110.859 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.58 98.52 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.056 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.589 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 14.6 pt -93.68 153.3 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 94' ' ' TRP . . . -119.34 148.31 43.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.067 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 pp -142.13 133.1 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -133.96 141.86 47.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -152.77 -47.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -99.46 45.19 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 61.05 34.34 19.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -152.12 130.43 12.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.804 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.422 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 3.8 mp -95.36 113.25 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.146 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -86.09 157.21 20.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.816 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.23 137.2 46.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.532 HD11 ' CE2' ' A' ' 129' ' ' PHE . 2.9 mt -154.41 134.61 13.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.829 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -126.27 131.39 51.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.503 HG22 ' CE1' ' A' ' 122' ' ' PHE . 27.7 t -72.37 121.1 22.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 18.2 mmm -81.51 -53.56 6.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.0 155.43 41.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.894 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.432 HG23 ' CG1' ' A' ' 168' ' ' VAL . 26.7 p -149.33 158.75 44.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -140.89 157.29 67.76 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.39 -42.24 0.82 Allowed 'Cis proline' 0 C--N 1.346 0.417 0 C-N-CA 123.3 -1.542 . . . . 0.0 112.437 -0.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.84 172.15 7.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.938 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.61 -44.38 89.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.956 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.494 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -102.93 119.04 38.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.849 HG21 ' HB2' ' A' ' 117' ' ' ALA . 16.1 m -127.78 155.68 39.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.16 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.7 t -106.77 95.11 5.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.0 pt -87.83 85.28 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.253 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.7 mm -116.51 86.52 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.102 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 61.4 80.58 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.941 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 9.1 t -159.19 151.08 20.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.811 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.23 127.0 40.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -135.46 173.16 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.83 79.46 5.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.06 138.92 21.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.063 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -137.28 172.3 13.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -134.17 133.85 41.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -117.87 90.31 3.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.069 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 m -139.22 156.85 46.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.7 p -104.51 90.71 3.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.73 -65.27 0.11 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.456 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.0 m 60.42 85.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.761 0.315 . . . . 0.0 110.854 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.56 -49.68 30.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.905 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -109.81 14.86 31.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.723 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.9 mt 56.98 73.6 0.78 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.342 . . . . 0.0 111.218 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.86 170.65 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.535 2.157 . . . . 0.0 112.29 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.86 32.43 0.06 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 m -109.38 124.01 65.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -134.53 -47.94 0.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -60.93 -177.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.954 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.14 111.79 23.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -173.16 159.82 3.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.428 ' HB2' HD13 ' A' ' 56' ' ' LEU . 10.8 t80 -69.65 120.34 15.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.9 p -151.63 102.11 2.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -165.61 171.61 12.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.86 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.643 ' HB3' HD22 ' A' ' 106' ' ' LEU . 15.8 mt-30 -96.56 156.91 16.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -145.49 148.13 32.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.25 112.11 14.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.507 ' HB3' ' HE3' ' A' ' 96' ' ' MET . 73.0 m -77.61 128.99 35.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.512 ' CD2' HG23 ' A' ' 88' ' ' ILE . 2.0 m-85 -135.41 172.21 13.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.08 163.39 24.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.9 m -81.1 -31.9 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.192 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.8 p -61.72 -30.07 70.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.8 mtt -58.28 -27.16 63.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.109 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.404 HD13 ' CE2' ' A' ' 90' ' ' TYR . 46.0 tp -57.08 156.01 7.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.96 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.05 177.3 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.084 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.78 150.09 12.08 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.534 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.56 -38.92 7.55 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.544 2.163 . . . . 0.0 112.269 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -114.04 169.18 9.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -104.11 128.96 51.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -72.86 132.32 43.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.983 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 79.6 p -107.67 -28.58 9.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.992 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -58.09 -35.1 70.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.022 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.1 t -61.31 -47.28 94.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.064 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.76 -31.2 70.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.902 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.0 mttp -82.65 60.3 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.91 -168.71 41.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.426 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.82 59.8 0.52 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.524 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.82 140.01 50.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.817 0.341 . . . . 0.0 110.853 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.84 HG21 HD23 ' A' ' 91' ' ' LEU . 11.8 pt -126.91 -179.97 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.8 mt -130.49 118.64 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.076 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 58.8 mtp -107.89 152.46 41.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.861 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.86 151.87 24.95 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.573 2.182 . . . . 0.0 112.253 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.27 -29.6 58.14 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.576 2.184 . . . . 0.0 112.311 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.1 p -59.76 -30.71 69.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.993 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -59.51 -39.1 82.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.164 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.483 HD13 ' CD2' ' A' ' 82' ' ' PHE . 12.5 tp -63.9 -43.78 94.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.25 -40.6 94.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.957 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -54.52 27.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.697 ' HA ' HD12 ' A' ' 56' ' ' LEU . 68.3 mt -57.68 -30.17 65.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.0 t -68.5 -29.76 68.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.867 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -92.56 -21.21 20.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.164 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.697 HD12 ' HA ' ' A' ' 53' ' ' LEU . 12.8 mt -77.42 -3.34 39.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.513 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.45 31.61 10.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.908 0.385 . . . . 0.0 110.912 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.9 mt -98.79 127.95 50.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.06 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -116.31 178.01 4.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.921 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.443 ' CD1' ' HA ' ' A' ' 61' ' ' PRO . 1.3 t80 -66.99 139.89 95.79 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.748 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.443 ' HA ' ' CD1' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.6 166.66 82.13 Favored 'Cis proline' 0 C--N 1.348 0.524 0 C-N-CA 123.517 -1.451 . . . . 0.0 112.411 -0.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 16.1 mtt -134.17 80.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.845 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.41 152.94 19.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.485 ' HB3' HG13 ' A' ' 109' ' ' VAL . 98.2 m-85 -114.5 159.31 20.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -112.4 95.62 5.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.894 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.4 mt -80.7 101.87 9.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.5 m -100.75 106.03 17.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.59 ' OD1' HD21 ' A' ' 101' ' ' LEU . 7.5 t30 -76.56 122.89 25.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -98.79 31.27 3.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.86 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.77 -37.08 4.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.803 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.28 25.92 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.016 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 t70 56.2 36.82 28.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.114 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.77 153.59 21.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.4 ttp -144.19 131.96 21.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.485 HG21 HD11 ' A' ' 99' ' ' LEU . 2.6 t -150.89 131.89 14.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -107.89 115.59 30.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.946 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.5 p -115.88 176.61 5.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.35 135.81 8.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.456 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.1 p -72.34 146.02 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.366 . . . . 0.0 111.102 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.5 tp -118.18 -63.53 1.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -113.68 138.8 49.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.483 ' CD2' HD13 ' A' ' 50' ' ' LEU . 42.5 m-85 -103.51 72.96 1.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 83' ' ' VAL . 15.6 m -148.64 73.36 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.046 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.13 175.12 9.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.07 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -85.01 160.46 20.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.824 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -70.64 132.75 45.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.27 25.61 69.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.657 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.512 HG23 ' CD2' ' A' ' 23' ' ' PHE . 27.1 mt -148.66 82.24 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 111.149 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.7 m -79.53 130.52 35.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.404 ' CE2' HD13 ' A' ' 28' ' ' LEU . 27.4 m-85 -94.89 125.06 39.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.84 HD23 HG21 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -132.58 156.13 80.44 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.918 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.789 ' HD3' HG22 ' A' ' 43' ' ' ILE . 53.5 Cg_exo -52.37 -176.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.547 2.165 . . . . 0.0 112.34 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -95.13 -33.88 12.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.464 ' CH2' ' HE2' ' A' ' 95' ' ' MET . 66.3 p-90 -63.93 -33.19 75.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.464 ' HE2' ' CH2' ' A' ' 94' ' ' TRP . 17.2 ttm -71.66 -31.29 66.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . 0.507 ' HE3' ' HB3' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -73.21 -47.18 45.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.955 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -64.16 -41.45 97.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -62.69 -42.47 99.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.485 HD11 HG21 ' A' ' 75' ' ' THR . 17.1 mt -83.46 -16.89 43.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.193 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 100' ' ' LEU . 27.6 mt 61.09 34.45 19.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.816 0.341 . . . . 0.0 110.833 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.59 HD21 ' OD1' ' A' ' 68' ' ' ASN . 7.9 mt -84.05 -178.77 7.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.891 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -126.66 169.29 13.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -60.08 111.94 1.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.67 36.0 8.9 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.554 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.09 125.97 8.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.415 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.643 HD22 ' HB3' ' A' ' 19' ' ' GLN . 17.5 mt -77.81 129.24 35.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.9 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.2 135.01 58.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.041 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -60.43 121.93 13.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.485 HG13 ' HB3' ' A' ' 64' ' ' PHE . 21.5 t -116.11 135.81 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -139.17 132.13 29.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.21 96.42 5.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.8 m -109.72 146.16 15.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.18 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -108.58 110.04 21.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 mt -105.71 179.97 4.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.61 171.34 10.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.6 m -59.69 162.06 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.035 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.558 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -102.84 148.56 25.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 80.5 p -104.7 -31.51 9.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.795 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -140.48 111.24 6.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.843 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.1 m -121.65 120.42 34.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.932 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.488 ' O ' HG13 ' A' ' 168' ' ' VAL . 2.5 ttmm -101.72 137.53 39.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -121.17 152.0 39.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.932 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -137.71 93.6 12.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.922 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.65 119.13 4.34 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.556 2.17 . . . . 0.0 112.459 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 40.6 mm-40 -73.64 -33.01 64.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.3 t -104.4 147.38 34.28 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.667 ' HA ' HD12 ' A' ' 130' ' ' LEU . 57.9 Cg_endo -71.19 -17.76 31.03 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.58 2.187 . . . . 0.0 112.503 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.04 -45.0 79.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.006 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -69.33 -45.05 70.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.667 HD12 ' HA ' ' A' ' 127' ' ' PRO . 11.5 mt -59.79 -31.31 69.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.72 -25.91 66.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.986 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.589 HG22 ' H ' ' A' ' 134' ' ' ASN . 52.2 mt -59.97 136.54 23.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.013 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.0 t -69.34 -32.92 72.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.963 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.589 ' H ' HG22 ' A' ' 132' ' ' ILE . 1.9 m120 -125.1 79.02 66.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.968 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.91 -27.94 20.35 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.569 2.18 . . . . 0.0 112.346 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -65.91 -44.93 83.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.56 -38.78 92.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.123 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 134' ' ' ASN . 26.8 t -72.04 -40.9 67.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.128 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.772 HD12 HD13 ' A' ' 166' ' ' LEU . 3.8 tp -72.81 -33.86 66.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.007 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -76.27 -30.23 57.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.986 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -75.37 -30.61 60.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.08 -34.41 17.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.169 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.411 HD22 HD11 ' A' ' 149' ' ' LEU . 14.2 mt -59.53 -27.97 66.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.963 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -57.01 -29.15 63.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.071 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -78.73 -36.63 43.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.976 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.428 ' CZ ' ' HB ' ' A' ' 155' ' ' ILE . 61.3 m-85 -67.48 143.23 56.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.952 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -110.01 -25.34 10.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.178 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 12.2 t -137.46 159.26 42.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.984 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.411 HD11 HD22 ' A' ' 143' ' ' LEU . 25.2 mt -151.32 139.0 19.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.2 m -123.3 160.24 27.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.984 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.8 m -72.97 103.22 3.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 97.83 36.77 4.65 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.54 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -104.5 108.28 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.352 . . . . 0.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 32.6 t -69.59 86.35 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.061 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.428 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 8.2 pt -93.41 131.41 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.136 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -100.06 142.49 31.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.163 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 40.5 pt -127.83 152.74 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -144.19 136.45 26.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.877 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.406 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 3.6 p90 -150.71 -50.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -96.78 44.35 1.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 60.29 31.24 20.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -145.12 137.64 26.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.528 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.8 mp -93.82 105.71 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.147 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -91.97 119.38 31.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.02 125.23 28.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.974 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.772 HD13 HD12 ' A' ' 139' ' ' LEU . 1.9 mt -134.14 128.91 35.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.812 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -122.44 133.73 54.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.942 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 121' ' ' LYS . 19.9 t -78.26 139.73 18.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.032 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 56.3 mmm -100.67 -48.3 4.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.987 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.05 153.51 46.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.022 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.444 HG23 HG11 ' A' ' 168' ' ' VAL . 0.9 OUTLIER -148.83 158.18 43.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.805 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -138.1 153.94 73.72 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.04 -34.11 3.55 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 123.204 -1.582 . . . . 0.0 112.448 0.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.52 178.41 4.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -47.67 84.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -99.02 130.55 45.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.558 HG21 ' HB2' ' A' ' 117' ' ' ALA . 31.0 m -134.3 161.58 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.205 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.3 t -119.38 94.57 4.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.8 pt -81.17 83.4 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 35.1 mt -116.01 84.98 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.075 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.37 87.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -159.76 176.56 11.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.802 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.22 107.14 13.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -126.41 179.24 5.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -117.12 121.77 42.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.505 HG11 ' CD2' ' A' ' 139' ' ' LEU . 21.4 t -99.16 122.12 50.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.137 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.76 179.88 4.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.903 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -130.54 157.92 41.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -144.34 87.43 1.88 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.025 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.71 175.27 8.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 0.0 110.891 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.11 -46.37 0.93 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.56 54.32 0.37 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.503 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 92.2 p -135.91 141.01 44.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 110.956 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 m -152.88 163.72 39.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 154.99 149.4 5.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.433 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.9 mt -138.75 95.75 9.71 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.575 0.226 . . . . 0.0 111.136 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.77 123.5 10.8 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.496 2.131 . . . . 0.0 112.329 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.8 ttp85 60.78 92.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.946 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.54 83.97 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.174 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 61.15 100.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 59.18 177.7 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.976 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.43 ' HA ' HD22 ' A' ' 56' ' ' LEU . 2.5 m120 -124.38 45.95 2.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.813 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.81 139.24 34.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.844 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -76.91 104.79 7.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.2 p -137.75 94.97 2.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.91 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.6 t -156.85 174.93 14.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.914 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -102.61 152.79 20.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.945 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -146.98 147.22 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.6 mtt85 -74.68 135.45 41.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.973 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 76.2 m -97.24 132.35 43.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -145.45 157.89 43.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -81.03 161.9 24.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.937 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.6 m -65.41 -31.41 53.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.188 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.7 m -60.15 -31.69 70.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.95 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.39 -27.32 68.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.068 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.732 HD13 ' CE2' ' A' ' 90' ' ' TYR . 53.9 tp -56.72 -63.5 1.18 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.979 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.46 -59.79 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.44 149.82 19.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.53 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.84 -45.38 1.02 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.564 2.176 . . . . 0.0 112.282 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -134.4 127.61 31.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -142.92 114.41 7.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.938 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.1 mmm-85 60.39 168.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -112.49 30.45 7.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.946 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.57 -33.78 5.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.051 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.22 -56.68 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.202 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.85 -34.95 51.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.947 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -81.59 100.62 9.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.5 -147.77 19.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.505 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.37 52.69 0.58 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.475 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.76 160.73 20.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.804 0.335 . . . . 0.0 110.917 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.577 HG21 HD23 ' A' ' 91' ' ' LEU . 6.0 pt -145.48 177.51 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.058 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.543 HG22 ' HB2' ' A' ' 84' ' ' ALA . 32.5 mt -122.81 137.86 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.123 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -131.22 160.04 68.87 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.844 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.59 162.68 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.567 2.178 . . . . 0.0 112.321 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.26 -33.48 24.11 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.606 2.204 . . . . 0.0 112.277 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.9 p -60.34 -34.55 73.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.34 -39.62 87.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.424 HD13 ' CE1' ' A' ' 82' ' ' PHE . 39.3 tp -64.24 -42.84 96.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.977 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -75.3 -30.64 60.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -79.32 -41.77 27.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.059 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.469 HD22 ' SD ' ' A' ' 62' ' ' MET . 3.0 mt -53.52 -49.63 67.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.039 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.0 t -72.31 -28.51 63.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.887 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.37 -21.23 62.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 14' ' ' ASN . 70.3 mt -94.07 20.19 8.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.327 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 59.52 30.88 20.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.02 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.438 ' CD1' HD23 ' A' ' 53' ' ' LEU . 35.1 mt -93.07 124.31 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.126 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.444 HG22 ' N ' ' A' ' 60' ' ' TYR . 50.0 m -111.63 162.11 15.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.981 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.479 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -59.51 144.15 84.92 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.79 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.479 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 75.5 Cg_endo -77.23 167.45 79.54 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.539 -1.442 . . . . 0.0 112.409 0.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.469 ' SD ' HD22 ' A' ' 53' ' ' LEU . 63.9 mtt -129.33 66.98 1.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.818 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.668 HD23 ' CA ' ' A' ' 78' ' ' GLY . 2.5 mt -91.07 148.68 22.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.921 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.435 ' HZ ' HD11 ' A' ' 53' ' ' LEU . 60.2 m-85 -113.57 135.64 53.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.804 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -83.49 89.65 7.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.893 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.675 ' HB2' HG23 ' A' ' 75' ' ' THR . 15.6 mt -69.99 76.35 0.48 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -87.36 109.4 19.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.908 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -84.79 117.62 23.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -98.57 33.94 2.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.84 -44.21 1.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.936 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.8 m -120.25 20.99 11.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.175 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.7 t0 53.6 60.0 3.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.944 0.402 . . . . 0.0 111.117 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.502 ' CB ' HD23 ' A' ' 99' ' ' LEU . 4.7 mmt180 -112.11 164.35 13.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.945 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.3 ttp -159.49 130.61 6.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.689 HG21 HD11 ' A' ' 99' ' ' LEU . 5.0 t -158.38 170.77 21.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -138.18 117.01 12.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.923 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 9.4 p -122.36 153.48 38.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.818 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.668 ' CA ' HD23 ' A' ' 63' ' ' LEU . . . -116.98 127.85 7.61 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.507 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.524 HG21 ' CE2' ' A' ' 82' ' ' PHE . 10.6 p -66.71 130.6 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 0.0 111.064 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.9 tp -106.91 -56.33 2.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -106.77 155.69 19.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.524 ' CE2' HG21 ' A' ' 79' ' ' VAL . 87.1 m-85 -130.43 82.9 2.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.841 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 82' ' ' PHE . 16.1 m -157.39 31.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.169 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.543 ' HB2' HG22 ' A' ' 44' ' ' ILE . . . -86.58 167.86 14.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.11 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.525 ' HB3' HD12 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -73.38 159.35 33.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -66.06 107.29 1.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.26 28.32 30.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.426 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 85' ' ' ASP . 27.7 mt -145.81 98.16 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.843 0.354 . . . . 0.0 111.112 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 94.6 m -94.27 132.54 38.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.732 ' CE2' HD13 ' A' ' 28' ' ' LEU . 54.6 m-85 -95.06 127.27 40.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.577 HD23 HG21 ' A' ' 43' ' ' ILE . 1.1 mt -126.27 153.08 74.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.862 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.419 ' HD3' HG22 ' A' ' 43' ' ' ILE . 51.1 Cg_exo -53.41 -173.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.587 2.191 . . . . 0.0 112.244 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -92.57 -40.32 10.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 57.5 p-90 -66.76 -45.43 78.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -33.41 75.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.932 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -39.21 80.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.884 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -78.41 -33.98 48.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -60.32 -39.88 88.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.773 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.689 HD11 HG21 ' A' ' 75' ' ' THR . 6.1 mt -87.8 -13.92 40.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.276 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.7 mt 61.93 37.14 15.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.814 0.34 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.3 mt -80.35 -178.53 6.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -130.04 167.85 17.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.86 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -62.73 84.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.944 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.33 33.96 1.4 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.463 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.32 131.73 10.87 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.474 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.1 mt -85.81 129.81 34.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.834 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.28 149.03 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.208 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -64.9 120.44 12.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.47 88.43 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.13 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -102.44 140.98 36.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.98 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.2 p -96.97 106.85 19.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.3 m -118.3 160.78 17.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -120.9 120.14 34.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.497 HD13 ' C ' ' A' ' 176' ' ' ALA . 10.8 mt -114.49 177.2 4.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.859 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -122.98 170.44 10.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.901 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.15 133.73 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.162 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.874 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -75.91 162.24 28.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.9 p -120.49 -41.42 2.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.946 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -122.02 91.96 3.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.8 m -108.03 120.65 42.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.2 156.26 17.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.964 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.463 ' CE2' HG22 ' A' ' 168' ' ' VAL . 69.9 m-85 -141.56 155.52 45.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -136.76 89.3 17.87 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -51.43 114.59 1.63 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.531 2.154 . . . . 0.0 112.314 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -69.93 -32.01 70.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.0 t -98.85 144.44 28.18 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.916 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.59 -19.77 21.2 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.572 2.181 . . . . 0.0 112.484 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -55.13 -36.53 65.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.093 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -71.13 -42.16 69.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 64.3 mt -63.41 -31.46 72.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.12 -23.32 65.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.05 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 134' ' ' ASN . 57.4 mt -59.99 141.59 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.056 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.3 m -67.23 -42.56 83.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.975 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.42 ' H ' HG22 ' A' ' 132' ' ' ILE . 2.5 m120 -125.84 74.91 71.05 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.001 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -57.09 -31.49 90.47 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.613 2.209 . . . . 0.0 112.235 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -43.26 99.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.957 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.66 84.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.19 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.403 HG21 HD13 ' A' ' 132' ' ' ILE . 27.8 t -67.73 -45.12 85.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.762 HD22 ' CZ ' ' A' ' 188' ' ' PHE . 21.0 tp -59.96 -31.25 69.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.016 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -87.24 -30.74 20.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.01 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.52 -31.3 71.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.947 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.26 -33.06 17.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.483 HD22 HD11 ' A' ' 149' ' ' LEU . 14.3 mt -59.3 -25.42 64.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -56.25 -33.64 65.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.031 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -77.73 -34.4 52.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -69.13 137.61 53.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.905 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -102.4 -28.07 12.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.191 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 12.9 t -141.61 159.23 42.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.483 HD11 HD22 ' A' ' 143' ' ' LEU . 7.6 mt -141.39 119.58 12.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.7 m -111.17 138.45 47.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.9 m -62.4 123.05 17.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 94.4 49.82 2.31 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.472 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.35 132.63 35.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.816 0.341 . . . . 0.0 110.825 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.78 89.24 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.17 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 29.7 pt -80.21 141.99 14.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.178 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -114.08 98.05 6.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.044 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 3.8 pt -83.52 148.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.234 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -151.03 151.36 31.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.737 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -176.43 -40.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.989 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -105.28 43.36 1.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.929 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 57.42 30.04 17.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.057 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -144.98 120.44 10.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.575 ' H ' HD12 ' A' ' 163' ' ' ILE . 4.4 mp -84.65 89.65 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.056 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -70.86 120.5 16.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -74.65 134.47 42.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.43 160.33 41.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.778 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 44.6 ttt-85 -152.12 121.62 6.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.463 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.4 t -62.93 138.07 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.2 mmm -103.82 -56.42 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -137.83 158.49 44.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.978 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 71.4 p -154.51 138.9 16.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -121.73 155.77 59.66 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.71 -26.33 9.52 Favored 'Cis proline' 0 C--N 1.347 0.471 0 C-N-CA 123.324 -1.532 . . . . 0.0 112.428 -0.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -120.74 170.9 9.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -37.35 76.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.963 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.497 ' C ' HD13 ' A' ' 114' ' ' LEU . . . -102.68 117.64 35.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.043 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.874 HG21 ' HB2' ' A' ' 117' ' ' ALA . 15.6 m -137.85 142.87 34.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 3.8 t -98.2 105.69 17.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.6 pt -95.37 87.84 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.12 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 22.0 mt -116.23 84.35 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.093 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 60.29 88.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.34 175.18 14.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.854 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.16 110.98 20.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.839 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -131.91 179.56 6.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.41 110.64 20.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.68 143.69 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.163 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.04 177.85 4.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . 0.762 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 7.9 m-85 -140.04 141.65 36.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.874 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.3 106.21 14.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.926 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.051 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.3 t 60.35 174.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.916 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.41 90.63 2.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.956 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.84 -164.49 24.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.553 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.4 t -106.56 86.75 2.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.323 . . . . 0.0 110.855 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.93 -31.24 7.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.64 177.2 37.82 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.462 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 9' ' ' PRO . 2.6 pp -67.11 158.74 80.28 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.696 0.284 . . . . 0.0 111.149 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.662 ' O ' HD12 ' A' ' 8' ' ' ILE . 54.0 Cg_exo -52.01 144.09 38.15 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.551 2.167 . . . . 0.0 112.368 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.19 146.0 27.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.6 m -143.57 48.15 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.082 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 61.24 82.49 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.855 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.76 -46.92 0.49 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.967 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.529 ' ND2' HD22 ' A' ' 56' ' ' LEU . 1.3 m120 60.5 99.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.824 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -148.54 109.81 4.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.417 ' CE2' HG22 ' A' ' 18' ' ' THR . 59.9 t80 -59.86 122.52 14.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.96 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.6 p -143.41 115.97 8.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.956 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.417 HG22 ' CE2' ' A' ' 16' ' ' PHE . 9.0 t -176.41 162.15 2.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -94.6 150.35 20.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.765 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -142.47 137.93 30.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.3 mtp85 -72.92 115.05 11.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.467 ' HB2' HD12 ' A' ' 91' ' ' LEU . 24.2 p -85.37 136.18 33.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.967 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.746 ' CD2' HG23 ' A' ' 88' ' ' ILE . 84.7 m-85 -138.99 170.98 15.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.89 146.49 28.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.931 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.1 m -63.47 -26.45 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.225 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.3 t -55.91 -28.64 57.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.079 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -58.05 -27.42 63.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.002 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.3 tp -57.37 -35.52 70.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.948 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.26 -178.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 138.36 147.66 5.21 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.534 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.13 -44.25 50.38 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.623 2.215 . . . . 0.0 112.278 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -97.19 -177.82 3.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.878 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.62 162.36 32.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.421 ' HB3' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -130.09 150.55 51.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.1 p -115.86 -38.47 3.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -59.59 -28.65 67.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.018 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 34' ' ' ARG . 40.4 t -61.61 -33.69 58.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.056 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -91.73 -32.08 15.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -84.58 92.44 8.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.49 168.6 11.76 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.441 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.02 56.59 3.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.513 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.68 ' HG2' HD13 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -115.86 134.54 54.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.9 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.632 HD13 ' SG ' ' A' ' 77' ' ' CYS . 44.9 pt -128.8 175.31 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.215 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mp -128.98 117.48 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.203 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 14.7 mtp -115.93 163.88 19.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.831 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -51.78 152.89 12.43 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.517 2.145 . . . . 0.0 112.269 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.44 -27.3 40.02 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.541 2.161 . . . . 0.0 112.337 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 95.2 p -63.74 -30.81 71.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.6 -40.43 96.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.742 HD13 ' CD2' ' A' ' 82' ' ' PHE . 23.2 tp -59.7 -40.45 87.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.975 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.35 -30.03 67.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.993 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -84.95 -30.65 24.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.937 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.8 mt -59.39 -30.72 68.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.015 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.5 -30.08 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.044 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -21.95 66.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.23 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.529 HD22 ' ND2' ' A' ' 14' ' ' ASN . 62.0 mt -93.88 18.37 10.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.392 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 53.94 42.11 31.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.812 0.339 . . . . 0.0 111.167 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.0 mt -107.44 133.59 51.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.126 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.29 169.03 10.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.969 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.47 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -59.92 142.39 88.81 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.7 Cg_endo -77.02 165.82 84.05 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.457 -1.476 . . . . 0.0 112.412 -0.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 65.0 mtt -131.42 51.68 2.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.698 HD22 ' HB2' ' A' ' 148' ' ' CYS . 16.1 mt -68.13 142.08 55.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.918 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' HB3' HG13 ' A' ' 109' ' ' VAL . 97.2 m-85 -109.57 139.06 45.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.769 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.4 ' HD3' ' CE1' ' A' ' 76' ' ' HIS . 0.9 OUTLIER -93.08 96.65 10.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 34.3 mt -80.9 81.38 7.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.978 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.65 108.48 18.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.846 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -70.36 123.96 23.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.848 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -98.52 32.19 2.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -124.95 -45.5 1.87 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.943 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.6 t -121.63 17.85 11.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.208 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 52.66 59.9 4.17 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.863 0.364 . . . . 0.0 111.073 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.44 177.66 4.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 37.4 ttp -156.22 129.44 8.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.7 m -150.82 137.46 18.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.427 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 6.8 m80 -112.38 108.7 17.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.632 ' SG ' HD13 ' A' ' 43' ' ' ILE . 31.2 p -109.8 166.66 10.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.98 136.75 11.11 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.428 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.883 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 11.1 p -75.84 148.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.791 0.329 . . . . 0.0 111.168 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.68 HD13 ' HG2' ' A' ' 42' ' ' LYS . 20.2 tp -122.09 -63.47 1.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.871 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -109.66 -179.46 3.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.883 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 57.5 m-85 -150.19 79.97 1.36 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.6 m -148.71 31.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.66 167.08 13.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.143 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.493 ' HB2' HD12 ' A' ' 88' ' ' ILE . 1.2 m-20 -71.06 177.68 3.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -84.82 89.7 7.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 105.74 28.19 5.45 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.519 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.746 HG23 ' CD2' ' A' ' 23' ' ' PHE . 31.8 mt -141.45 82.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.845 0.355 . . . . 0.0 111.057 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 90.6 m -82.77 131.4 35.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.987 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.469 ' O ' HD23 ' A' ' 91' ' ' LEU . 59.3 m-85 -98.55 145.0 27.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 90' ' ' TYR . 17.6 mt -143.29 149.75 49.36 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.905 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.478 ' HD3' HG22 ' A' ' 43' ' ' ILE . 53.7 Cg_exo -52.13 178.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.574 2.183 . . . . 0.0 112.372 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -85.74 -40.66 15.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 69.3 p-90 -63.25 -35.89 81.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.846 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 37.0 ttm -70.54 -40.86 73.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 4.6 mtt -60.39 -46.58 89.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.942 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -64.64 -33.46 75.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -66.72 -40.55 88.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.825 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.3 mt -84.85 -21.57 29.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.091 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.5 mt 64.4 34.85 10.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.818 0.342 . . . . 0.0 110.947 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.8 mt -83.87 -179.58 7.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -118.56 -178.02 3.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -71.8 85.04 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.401 ' HA2' ' CZ ' ' A' ' 23' ' ' PHE . . . 112.86 30.51 2.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.549 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.58 145.53 30.37 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.532 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.4 mt -96.72 123.47 40.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.816 0.341 . . . . 0.0 110.953 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.77 131.6 72.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.084 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -64.57 100.22 0.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.413 HG13 ' HB3' ' A' ' 64' ' ' PHE . 21.9 t -83.89 126.29 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -134.6 118.35 17.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.2 p -76.92 116.93 18.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.843 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.4 m -121.24 170.15 11.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.221 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.03 106.38 9.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.795 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.1 mt -106.9 170.68 7.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -115.56 179.96 3.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.2 m -69.48 141.65 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.716 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -83.71 141.68 31.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.088 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 71.5 p -99.75 -31.11 11.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -140.36 107.61 5.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.931 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 96.4 p -120.46 118.33 30.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -103.04 160.06 14.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -141.88 153.49 44.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.91 89.57 29.28 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.008 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.707 ' HG3' HD21 ' A' ' 166' ' ' LEU . 68.5 Cg_exo -50.97 111.06 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.557 2.171 . . . . 0.0 112.401 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -61.49 -31.33 71.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.9 t -98.69 143.21 25.94 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.829 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.82 -20.26 17.48 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.567 2.178 . . . . 0.0 112.395 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.49 -39.65 70.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.042 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.47 ' HE2' HD11 ' A' ' 157' ' ' ILE . 11.0 t80 -64.66 -44.52 90.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.923 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.7 mt -59.71 -30.99 69.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.964 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -67.88 -23.74 65.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.024 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.1 mt -59.94 136.59 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.039 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.9 m -61.65 -49.16 77.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.994 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -118.17 82.65 18.42 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.39 -32.37 10.24 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.573 2.182 . . . . 0.0 112.319 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -33.75 75.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.31 -47.56 27.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.103 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.2 t -66.77 -30.57 50.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.146 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 49.8 tp -77.99 -45.59 23.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.937 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.17 -31.31 70.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.935 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -64.75 -28.43 69.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.67 -32.42 18.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.106 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.479 HD22 HD11 ' A' ' 149' ' ' LEU . 34.7 mt -59.54 -28.87 67.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.044 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -57.73 -27.16 62.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.094 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -79.0 -41.23 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.921 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.422 ' CZ ' ' HB ' ' A' ' 155' ' ' ILE . 97.0 m-85 -71.32 130.36 41.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -88.79 -33.37 17.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.161 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.698 ' HB2' HD22 ' A' ' 63' ' ' LEU . 15.0 t -126.42 158.9 34.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.899 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.479 HD11 HD22 ' A' ' 143' ' ' LEU . 4.2 mt -142.1 125.28 16.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 m -119.0 148.16 43.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 169' ' ' MET . 66.0 m -75.37 128.25 34.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.98 28.08 19.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.555 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -118.81 138.6 52.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.368 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.2 t -96.8 104.12 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.126 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 3.1 pt -102.28 89.73 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.153 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.17 134.33 55.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.47 HD11 ' HE2' ' A' ' 129' ' ' PHE . 3.2 pt -121.49 157.43 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.11 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -143.29 155.06 44.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -175.13 -46.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -100.82 43.14 1.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 59.21 30.22 19.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.959 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.37 122.23 9.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.817 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.509 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.8 mp -81.11 88.87 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.099 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -65.79 131.85 47.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.823 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -90.05 113.11 24.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.707 HD21 ' HG3' ' A' ' 124' ' ' PRO . 0.3 OUTLIER -128.55 140.05 51.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.812 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -131.01 134.66 46.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.78 147.36 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.542 ' O ' HG23 ' A' ' 151' ' ' THR . 1.4 mmt -110.12 -61.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.63 152.38 50.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.963 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 43.5 p -150.3 143.64 25.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -120.35 151.95 54.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.19 -38.34 1.8 Allowed 'Cis proline' 0 C--N 1.346 0.427 0 C-N-CA 123.376 -1.51 . . . . 0.0 112.367 0.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -108.64 175.4 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.787 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.52 -47.78 78.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.998 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.427 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -94.18 131.02 40.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.716 HG21 ' HB2' ' A' ' 117' ' ' ALA . 7.8 m -143.33 155.3 16.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.177 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.451 ' OG ' HD11 ' A' ' 63' ' ' LEU . 2.8 t -112.39 99.82 8.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.827 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.2 pt -88.98 85.72 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.165 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 20.8 mt -116.46 96.06 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 60.75 66.1 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 7.3 t -155.51 154.91 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.93 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -101.71 135.8 42.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.933 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -137.21 155.47 49.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.7 76.12 7.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -64.5 125.82 22.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.144 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.95 167.11 11.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -120.46 127.7 52.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -98.99 96.87 8.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.175 -0.917 . . . . 0.0 111.095 -179.981 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -139.0 165.25 27.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.782 0.325 . . . . 0.0 110.903 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.9 105.08 5.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.85 115.68 3.95 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.451 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -90.3 107.74 19.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.3 p -103.89 105.84 16.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.17 -155.4 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.462 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.423 HG23 ' HD2' ' A' ' 9' ' ' PRO . 8.5 mt -120.19 135.95 24.77 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.62 0.247 . . . . 0.0 110.996 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 8' ' ' ILE . 59.6 Cg_endo -72.23 -167.0 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.5 2.133 . . . . 0.0 112.391 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 64.48 173.2 0.19 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.1 m -63.23 178.19 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.3 31.1 6.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.15 124.78 50.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -118.8 160.72 21.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -151.42 114.18 4.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.966 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -60.47 98.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.8 p -130.53 133.98 46.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.852 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.8 t -177.1 169.41 2.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -99.6 125.31 45.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -123.64 152.4 42.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 -84.66 130.19 34.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.9 m -93.66 130.45 39.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.97 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -133.15 171.12 14.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -85.12 164.34 18.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.643 HG11 HG11 ' A' ' 37' ' ' VAL . 16.0 m -90.47 11.67 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.473 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.9 p -76.46 -27.76 56.29 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.722 0.296 . . . . 0.0 110.824 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 46.1 mtp -57.89 -48.39 79.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.898 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.31 86.01 6.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.892 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -101.59 -178.16 3.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.1 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -172.75 -164.91 28.96 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.519 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.7 -45.97 1.43 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.593 2.196 . . . . 0.0 112.32 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -86.48 175.62 8.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.947 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -110.77 113.9 26.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.01 125.17 33.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.5 m -137.13 32.14 2.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.83 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -111.33 -29.55 7.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.998 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.643 HG11 HG11 ' A' ' 25' ' ' VAL . 20.8 t -62.03 -29.48 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.275 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.405 ' O ' ' CD1' ' A' ' 94' ' ' TRP . 9.3 mt-10 -82.51 -30.68 29.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.073 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.2 mttm -87.39 -30.62 20.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.009 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.03 -179.93 38.39 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.575 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.12 63.04 0.48 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.528 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.91 153.09 51.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.756 0.312 . . . . 0.0 110.847 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.652 HG21 HD23 ' A' ' 91' ' ' LEU . 10.7 pt -136.89 177.7 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.218 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.9 mt -126.19 114.98 40.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 76.8 mtp -108.74 164.16 15.36 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.819 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 52.6 Cg_exo -54.8 144.94 63.74 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.584 2.189 . . . . 0.0 112.147 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 46' ' ' PRO . 50.9 Cg_exo -54.06 -28.3 49.8 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.448 2.098 . . . . 0.0 112.338 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.0 t -65.44 -29.72 70.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.043 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.13 -48.27 80.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.15 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.701 HD13 ' CE2' ' A' ' 82' ' ' PHE . 25.1 tp -60.49 -43.5 96.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.35 -31.4 69.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -44.58 69.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.999 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 50' ' ' LEU . 5.1 mt -58.19 -30.14 66.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.009 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.3 m -73.84 -26.25 60.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -94.96 20.14 9.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.318 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.0 mt -134.04 20.02 3.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.219 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 56.18 30.19 16.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.809 0.338 . . . . 0.0 111.013 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.8 mt -100.43 130.28 49.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.77 164.86 15.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.931 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.451 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.6 t80 -64.44 140.81 98.07 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.787 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 76.9 Cg_endo -77.46 164.46 86.41 Favored 'Cis proline' 0 C--N 1.348 0.511 0 C-N-CA 123.487 -1.464 . . . . 0.0 112.473 -0.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 34.2 mtt -135.04 64.65 1.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.803 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.734 HD13 ' SG ' ' A' ' 148' ' ' CYS . 1.1 mt -70.7 165.05 23.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.984 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -132.78 126.23 31.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.409 ' HG3' ' CD2' ' A' ' 76' ' ' HIS . 15.7 ttpt -83.09 112.7 20.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 48.4 mt -91.71 82.88 5.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.814 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.7 m -86.16 99.6 11.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.481 ' HA ' HG13 ' A' ' 107' ' ' VAL . 26.0 t-20 -62.22 125.18 23.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.5 33.91 2.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.36 -48.27 1.57 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.816 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.2 m -118.18 21.69 12.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.209 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 t0 54.16 35.14 21.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.833 0.349 . . . . 0.0 111.077 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -84.37 162.09 20.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.969 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.78 127.05 13.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.477 ' OG1' HD21 ' A' ' 99' ' ' LEU . 55.8 m -152.93 131.39 12.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.616 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 49.5 m80 -104.48 106.41 16.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.945 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.5 p -93.49 174.52 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.25 138.79 10.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.443 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.574 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 10.9 p -84.81 158.41 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.846 0.355 . . . . 0.0 111.055 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.485 ' N ' HG22 ' A' ' 79' ' ' VAL . 16.6 tp -151.56 -58.28 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -104.88 147.36 27.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.701 ' CE2' HD13 ' A' ' 50' ' ' LEU . 97.2 m-85 -125.31 86.72 2.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.2 m -155.91 32.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.109 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.38 165.59 12.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -83.47 165.11 19.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -64.08 121.73 14.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.43 33.7 68.13 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.555 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 26.5 mt -148.46 95.15 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.805 0.336 . . . . 0.0 111.095 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 98.0 m -98.12 126.93 43.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.964 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -89.9 129.45 36.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.652 HD23 HG21 ' A' ' 43' ' ' ILE . 1.4 mp -136.29 155.34 77.34 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.981 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.02 -174.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.509 2.139 . . . . 0.0 112.354 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -94.55 -36.05 11.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.608 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 59.1 p-90 -64.34 -37.03 86.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.898 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.45 ' O ' HD12 ' A' ' 99' ' ' LEU . 56.4 ttm -71.24 -39.12 71.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 36.5 mmm -64.57 -45.2 88.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -39.44 68.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -59.61 -31.9 69.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.477 HD21 ' OG1' ' A' ' 75' ' ' THR . 6.4 mt -98.13 -8.84 26.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.342 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 22.4 mt 63.03 33.6 14.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.849 0.357 . . . . 0.0 110.885 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.6 mt -92.17 130.32 37.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.831 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -84.15 179.07 7.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.79 94.35 0.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.43 41.53 1.48 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.564 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.58 119.92 6.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.569 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.8 mt -73.62 126.57 30.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.838 0.351 . . . . 0.0 110.878 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.481 HG13 ' HA ' ' A' ' 68' ' ' ASN . 21.6 t -127.43 143.62 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.126 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -67.33 104.65 1.55 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.35 136.32 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -141.97 148.2 38.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.3 p -104.68 115.16 29.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.4 m -131.13 173.05 15.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.078 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.81 100.07 4.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.444 ' CD1' ' HB1' ' A' ' 176' ' ' ALA . 5.0 mt -89.19 -179.95 5.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -123.91 170.23 10.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.0 m -64.36 143.96 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.15 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.519 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -83.28 156.37 23.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.181 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.2 p -117.64 -39.94 3.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.943 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -125.22 85.68 2.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.42 ' OG ' HG22 ' A' ' 171' ' ' THR . 35.2 m -100.32 120.43 39.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.859 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -109.53 149.59 29.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.579 ' CZ ' HD11 ' A' ' 143' ' ' LEU . 89.5 m-85 -134.46 164.03 28.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.84 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -148.43 90.06 5.0 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.13 126.21 19.64 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.486 2.124 . . . . 0.0 112.313 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -73.35 -32.03 64.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.6 m -105.61 148.32 36.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.5 -12.59 27.21 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.586 2.19 . . . . 0.0 112.53 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -55.18 -41.71 72.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.034 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.416 ' CE1' HD11 ' A' ' 166' ' ' LEU . 12.6 t80 -70.67 -35.37 72.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.892 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 26.5 mt -66.68 -29.71 69.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.31 -26.04 68.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.008 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.755 HD13 HG21 ' A' ' 138' ' ' VAL . 47.5 mt -63.13 138.76 22.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.986 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.4 t -66.58 -39.65 88.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.992 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.472 ' H ' HG22 ' A' ' 132' ' ' ILE . 9.2 t30 -126.68 80.49 70.21 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.896 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.17 -36.1 92.39 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.542 2.161 . . . . 0.0 112.31 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -59.69 -35.7 75.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.47 -37.34 80.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.2 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.755 HG21 HD13 ' A' ' 132' ' ' ILE . 21.4 t -82.75 -31.69 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.274 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.556 HD21 ' CD1' ' A' ' 122' ' ' PHE . 32.0 tp -75.2 -39.0 60.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.52 -31.35 68.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.929 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -66.19 -31.14 71.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.96 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.08 -41.35 13.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.149 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.579 HD11 ' CZ ' ' A' ' 122' ' ' PHE . 15.6 mt -59.41 -27.56 66.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.999 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -56.97 -29.94 63.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.053 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.09 -46.0 18.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.865 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -61.1 134.26 56.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -98.48 -28.63 13.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.734 ' SG ' HD13 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -133.65 166.72 21.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.873 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.573 HD22 HG21 ' A' ' 168' ' ' VAL . 11.8 mt -158.19 147.34 19.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.42 132.08 40.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.0 m -59.99 107.1 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.942 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 112.44 28.87 3.36 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.505 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -122.67 134.28 54.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.774 0.321 . . . . 0.0 110.871 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.13 114.79 29.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.106 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.608 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 7.2 pt -112.87 118.5 58.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.38 141.6 33.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.066 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.6 pt -135.04 147.27 29.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.108 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -143.06 156.46 44.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.881 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.439 ' CE2' ' HB2' ' A' ' 160' ' ' ASN . 47.9 p90 -175.29 -44.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.872 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.439 ' HB2' ' CE2' ' A' ' 159' ' ' TYR . 41.0 t30 -101.5 40.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.864 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 60.29 31.15 20.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -152.03 134.85 15.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.567 ' H ' HD12 ' A' ' 163' ' ' ILE . 4.0 mp -85.23 105.93 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -89.47 111.52 22.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -66.2 138.5 57.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.416 HD11 ' CE1' ' A' ' 129' ' ' PHE . 0.5 OUTLIER -156.56 118.05 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -115.79 137.48 52.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.573 HG21 HD22 ' A' ' 149' ' ' LEU . 21.5 t -73.97 109.01 5.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.2 mmm -76.64 -47.01 23.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -145.13 155.94 43.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.979 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.42 HG22 ' OG ' ' A' ' 120' ' ' SER . 0.5 OUTLIER -160.06 132.9 6.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.763 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -108.88 158.16 34.92 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.69 -26.72 9.1 Favored 'Cis proline' 0 C--N 1.347 0.454 0 C-N-CA 123.31 -1.538 . . . . 0.0 112.414 -0.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -125.74 179.46 5.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -47.83 84.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.861 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.616 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -91.04 124.33 35.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.0 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 117' ' ' ALA . 9.2 m -140.74 152.57 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.8 t -113.23 98.95 7.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.2 pt -88.1 85.09 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.184 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.0 mm -113.61 89.19 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.12 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 61.1 77.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.818 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 13.9 t -163.16 149.91 12.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -101.32 131.16 47.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.926 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -136.11 170.98 15.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.43 97.73 11.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.858 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 29.2 t -84.26 139.69 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.084 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.09 175.24 5.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.844 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -141.56 148.44 39.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -135.87 90.49 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.138 179.939 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m 60.47 -173.84 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.843 0.354 . . . . 0.0 110.896 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 p -159.72 169.96 22.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.941 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.75 -132.81 1.59 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.507 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -63.0 112.76 2.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 0.0 110.863 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -159.12 164.74 35.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 150.88 -170.63 30.66 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.512 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 pt -66.93 150.91 97.55 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.736 0.303 . . . . 0.0 111.105 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.76 167.19 25.14 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.502 2.135 . . . . 0.0 112.389 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.49 118.11 4.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.9 m -134.28 177.4 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -60.24 108.52 0.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.808 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.5 158.85 37.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.969 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.83 116.45 4.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.855 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.39 164.97 17.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.872 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.469 ' CE2' HG22 ' A' ' 18' ' ' THR . 43.7 t80 -94.54 136.57 34.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.9 p -159.04 118.8 3.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.966 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.469 HG22 ' CE2' ' A' ' 16' ' ' PHE . 9.8 t -177.47 150.91 0.72 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.888 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -75.39 140.02 42.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.436 ' C ' HD23 ' A' ' 106' ' ' LEU . 5.9 m-85 -142.0 144.11 33.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -69.32 176.49 3.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.971 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.1 m -146.38 125.32 12.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.651 ' CD2' HG23 ' A' ' 88' ' ' ILE . 56.7 m-85 -132.64 174.41 10.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 t -93.62 146.94 23.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.28 -27.65 43.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.173 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.5 p -56.62 -28.64 60.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.107 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.7 mtt -58.75 -51.16 71.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.981 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.7 tt -89.22 151.89 21.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -161.6 163.51 29.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.101 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -134.16 -160.07 9.11 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.432 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.97 -28.24 29.33 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.573 2.182 . . . . 0.0 112.289 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -115.63 151.88 34.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.86 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -80.72 178.77 8.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.4 mtt-85 -167.17 125.92 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.9 t -110.84 -29.49 7.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.961 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -58.93 -29.22 66.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.014 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.9 t -59.79 -40.85 83.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.123 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.87 -31.03 28.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -91.21 56.19 3.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.773 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.33 149.42 6.88 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.423 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.55 72.96 2.73 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.484 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.452 ' HE2' HD13 ' A' ' 80' ' ' LEU . 33.9 mttt -131.28 133.67 45.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.789 0.328 . . . . 0.0 110.842 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.561 HG21 HD23 ' A' ' 91' ' ' LEU . 1.9 pt -120.3 163.67 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.151 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -127.24 118.3 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.06 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.7 mtm -110.78 164.16 15.53 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 52.2 Cg_exo -55.08 148.23 49.63 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.567 2.178 . . . . 0.0 112.19 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 46' ' ' PRO . 50.7 Cg_exo -53.86 -29.69 54.3 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.513 2.142 . . . . 0.0 112.316 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.7 p -59.0 -30.94 68.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 -32.91 74.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.603 HD13 ' CE2' ' A' ' 82' ' ' PHE . 38.4 tp -70.9 -50.39 35.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.924 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.26 -30.85 69.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.592 ' HG2' HD11 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -77.12 -41.32 42.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.058 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.1 mt -58.23 -31.97 67.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.038 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -82.33 -29.79 30.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.61 -16.08 52.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.216 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.592 HD11 ' HG2' ' A' ' 52' ' ' GLN . 9.2 mt -93.93 19.6 8.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.265 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.3 t30 55.2 30.08 13.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.0 mt -98.18 141.14 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.193 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.8 p -126.45 159.35 33.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.46 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -63.02 145.37 96.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.842 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.46 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.3 Cg_endo -77.1 152.12 94.39 Favored 'Cis proline' 0 C--N 1.348 0.501 0 C-N-CA 123.413 -1.495 . . . . 0.0 112.378 0.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 20.3 mtt -116.17 61.3 0.72 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.651 HD13 HD12 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -78.77 137.95 37.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.826 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.495 ' CD1' HG12 ' A' ' 109' ' ' VAL . 94.7 m-85 -100.73 171.8 7.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.451 ' NZ ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -121.33 86.51 2.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.887 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 mt -66.18 88.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.451 HG23 ' NZ ' ' A' ' 65' ' ' LYS . 3.4 m -88.25 103.08 15.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -85.17 113.69 21.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -96.08 42.93 1.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -124.59 -44.29 1.98 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.85 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 m -128.13 25.65 5.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.085 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 55.92 39.58 30.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.039 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.523 ' HB3' HD23 ' A' ' 99' ' ' LEU . 2.1 mmp_? -89.59 157.39 18.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.962 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 41.7 ttp -154.72 127.38 8.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.932 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.602 HG21 HD11 ' A' ' 99' ' ' LEU . 4.6 t -157.43 145.22 18.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.965 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -112.14 108.06 17.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.819 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 28.6 p -107.5 147.52 30.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.08 142.47 16.17 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.438 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.41 HG21 ' CE1' ' A' ' 82' ' ' PHE . 11.7 p -70.3 136.12 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.876 0.37 . . . . 0.0 111.066 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.452 HD13 ' HE2' ' A' ' 42' ' ' LYS . 14.7 tp -104.59 -63.25 1.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -127.61 167.49 16.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.934 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.603 ' CE2' HD13 ' A' ' 50' ' ' LEU . 94.8 m-85 -123.27 93.42 3.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 82' ' ' PHE . 22.9 m -156.73 37.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.188 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.91 157.65 19.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.1 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.498 ' HB3' HD12 ' A' ' 88' ' ' ILE . 0.2 OUTLIER -71.41 148.47 46.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.835 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -59.81 124.59 20.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.86 -19.15 54.65 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.594 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.651 HG23 ' CD2' ' A' ' 23' ' ' PHE . 29.0 mt -108.24 132.2 56.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 111.157 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 43.6 m -128.76 126.53 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.56 145.88 24.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.561 HD23 HG21 ' A' ' 43' ' ' ILE . 4.6 mp -146.57 158.51 46.46 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.03 155.0 9.32 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.605 2.203 . . . . 0.0 112.278 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -69.34 -38.46 78.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.528 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 49.0 p-90 -64.75 -41.17 96.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.446 ' N ' ' CD2' ' A' ' 94' ' ' TRP . 3.3 ttp -66.91 -36.97 83.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.929 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.6 mtp -61.94 -35.69 79.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -77.61 -38.38 48.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -60.33 -31.96 70.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.834 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.602 HD11 HG21 ' A' ' 75' ' ' THR . 9.2 mt -98.13 -14.42 20.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.257 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.7 mt 62.07 39.99 12.51 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.9 0.381 . . . . 0.0 110.88 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 mt -81.23 164.97 21.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.842 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.81 -174.39 2.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -65.01 96.11 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.27 38.12 5.17 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.478 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.06 110.3 3.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.436 HD23 ' C ' ' A' ' 20' ' ' TYR . 26.3 mt -73.76 124.85 26.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.826 0.346 . . . . 0.0 110.945 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -134.34 150.42 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -66.5 136.63 55.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.888 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.495 HG12 ' CD1' ' A' ' 64' ' ' PHE . 21.4 t -123.63 92.3 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.119 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -107.79 137.6 45.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 21.7 p -88.49 114.49 25.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.3 m -119.67 131.05 73.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.142 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -82.13 112.42 19.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.651 HD12 HD13 ' A' ' 63' ' ' LEU . 1.9 mt -111.7 175.08 5.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -133.08 171.83 13.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.06 147.28 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.184 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.589 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -89.65 149.74 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.064 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.1 p -105.55 -28.58 10.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.824 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -134.93 90.78 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.906 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.7 p -98.24 109.03 21.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.858 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -101.22 136.46 41.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.845 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.509 ' CZ ' HD21 ' A' ' 143' ' ' LEU . 64.5 m-85 -124.49 156.71 36.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -133.64 94.45 19.21 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.97 108.58 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.52 2.147 . . . . 0.0 112.395 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -61.98 -31.82 72.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.948 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.3 m -113.87 146.68 36.09 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.002 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.31 -14.6 25.47 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.544 2.163 . . . . 0.0 112.567 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.68 -33.96 61.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.135 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -75.29 -31.38 60.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 37.9 mt -63.53 -30.72 71.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.71 -27.99 69.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.012 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.648 HD13 HG21 ' A' ' 138' ' ' VAL . 46.8 mt -60.88 135.62 25.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.049 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.6 m -71.07 -30.66 66.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.598 ' H ' HG22 ' A' ' 132' ' ' ILE . 1.1 m120 -127.88 73.32 78.93 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.908 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -56.74 -37.09 98.65 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.629 2.219 . . . . 0.0 112.209 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -60.75 -46.4 90.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.046 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -59.21 -46.02 89.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.055 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.648 HG21 HD13 ' A' ' 132' ' ' ILE . 21.5 t -69.72 -37.54 74.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.485 HD21 ' CD1' ' A' ' 122' ' ' PHE . 4.4 tp -73.5 -34.08 65.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -74.16 -34.49 63.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.906 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.05 -37.07 86.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.913 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.3 -33.44 43.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.534 HD22 HD11 ' A' ' 149' ' ' LEU . 12.6 mt -60.03 -28.82 68.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.947 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -57.95 -32.76 68.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.03 -31.56 58.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.83 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -74.71 142.61 44.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.942 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -100.79 -30.67 11.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.522 ' SG ' HD13 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -134.56 173.31 11.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.534 HD11 HD22 ' A' ' 143' ' ' LEU . 55.0 mt -149.59 114.38 5.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.824 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.0 m -104.95 144.88 31.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.1 m -71.12 112.72 7.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 99.76 39.3 3.42 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.575 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.18 112.9 20.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 110.883 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.21 82.97 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.116 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.528 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 8.7 pt -79.98 160.52 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.062 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.625 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -121.8 112.91 18.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.3 pt -98.7 152.51 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.208 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 37.6 t-20 -147.72 147.24 29.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 160' ' ' ASN . 52.8 p90 -164.49 -47.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.846 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.45 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 57.0 t-20 -98.93 43.95 1.04 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 60.15 31.02 20.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.17 132.35 19.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.625 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 4.0 mp -90.39 88.49 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.087 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -70.38 123.18 21.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -75.14 133.09 41.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.22 141.38 22.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.877 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -136.94 145.51 44.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.38 153.64 6.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.177 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 13.2 mmm -121.99 -54.37 1.92 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.91 140.13 34.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 6.7 p -144.43 135.76 25.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -113.49 153.91 45.62 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.69 -37.12 2.22 Favored 'Cis proline' 0 C--N 1.346 0.395 0 C-N-CA 123.337 -1.526 . . . . 0.0 112.4 0.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.39 173.13 6.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -56.58 -43.33 79.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -95.06 127.63 41.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.004 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.589 HG21 ' HB2' ' A' ' 117' ' ' ALA . 16.2 m -138.35 139.61 41.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.169 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.429 ' HB2' HD11 ' A' ' 180' ' ' ILE . 30.9 p -93.18 102.1 14.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.793 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.0 pt -96.13 88.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.271 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.429 HD11 ' HB2' ' A' ' 178' ' ' SER . 3.5 mp -124.28 82.31 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.005 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 62.19 81.57 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 23.7 t -157.18 158.15 35.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -91.14 129.75 37.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 5.9 ptt? -152.02 174.04 14.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -108.48 117.19 33.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.813 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.477 HG11 HD23 ' A' ' 139' ' ' LEU . 21.4 t -97.91 137.98 23.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.203 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.1 146.56 52.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -105.75 148.13 27.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -114.91 85.16 2.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.931 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.163 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.118 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.1 t -170.98 150.21 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.83 0.347 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.51 -38.36 14.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.816 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.8 28.5 65.82 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.492 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -120.39 97.66 5.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.773 0.32 . . . . 0.0 110.924 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.2 p -168.71 -178.4 3.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.86 -159.4 30.25 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.587 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.3 pp -139.9 154.35 70.59 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.731 0.301 . . . . 0.0 111.092 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.51 139.76 41.89 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.605 2.203 . . . . 0.0 112.344 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.5 mmt85 -99.14 30.47 3.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 11' ' ' VAL . 14.9 p -158.95 40.47 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.035 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.75 -58.38 1.24 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.811 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -103.0 30.99 4.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -96.09 168.95 10.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.968 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.36 174.13 11.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.426 ' CE2' ' HG ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -68.39 119.7 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.875 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.3 p -159.72 99.5 1.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -160.69 162.39 32.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.747 ' HB3' HD22 ' A' ' 106' ' ' LEU . 12.1 mt-30 -96.06 130.59 43.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.92 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.436 ' HD2' HG21 ' A' ' 109' ' ' VAL . 12.7 m-85 -126.15 143.27 51.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -78.08 143.13 37.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.2 p -104.38 130.23 52.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.568 ' CD2' HG23 ' A' ' 88' ' ' ILE . 57.1 m-85 -139.86 154.56 47.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -60.23 162.44 5.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.904 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.595 HG12 ' HB3' ' A' ' 90' ' ' TYR . 14.6 m -95.55 20.09 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.331 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 m -88.06 -31.41 19.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.842 0.353 . . . . 0.0 110.911 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.41 -45.95 92.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 31.2 tp -86.47 63.98 8.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.884 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.53 123.27 4.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.069 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.47 -155.23 5.04 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.553 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.13 -27.91 31.26 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.616 2.21 . . . . 0.0 112.347 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -102.56 166.79 10.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -126.26 171.21 11.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.964 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -139.24 146.42 40.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.878 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 93.6 p -110.33 -25.15 10.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.026 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -54.02 -29.64 44.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.114 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.93 -54.11 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.129 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.525 ' OE1' HG21 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -73.47 -40.99 63.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.897 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.8 mttm -66.02 79.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.47 -171.9 22.08 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.49 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.7 79.98 0.26 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.453 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.473 ' HE2' HD13 ' A' ' 80' ' ' LEU . 17.0 mttt -140.51 134.25 30.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.813 0.339 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.604 HG21 HD23 ' A' ' 91' ' ' LEU . 24.1 pt -122.53 170.07 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.098 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 4.6 mt -124.46 96.9 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.004 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.9 mmm -90.34 158.55 43.33 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.81 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.64 149.38 32.1 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.51 2.14 . . . . 0.0 112.267 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.54 -30.14 53.03 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.566 2.177 . . . . 0.0 112.276 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.93 -30.19 71.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.43 -30.05 66.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.177 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.421 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 32.2 tp -70.67 -50.6 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.962 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.29 -32.39 73.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -76.78 -44.12 34.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.06 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.426 ' HG ' ' CE2' ' A' ' 16' ' ' PHE . 8.1 mt -58.72 -37.02 75.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.953 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.4 t -83.01 -28.76 29.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.959 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.79 -19.95 59.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.171 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.6 mt -92.69 15.52 14.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.332 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.83 32.69 20.09 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.735 0.302 . . . . 0.0 111.038 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.419 HD12 HD23 ' A' ' 53' ' ' LEU . 41.2 mt -92.87 144.17 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.107 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.3 p -127.19 179.69 5.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.984 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 16.7 t80 -72.55 138.42 80.65 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.749 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.458 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.4 Cg_endo -77.15 156.57 97.09 Favored 'Cis proline' 0 C--N 1.348 0.537 0 C-N-CA 123.534 -1.444 . . . . 0.0 112.426 0.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 41.8 mtt -119.97 31.34 6.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.809 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.543 HD22 ' HB2' ' A' ' 148' ' ' CYS . 1.3 mt -61.58 149.23 39.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.468 ' HB3' HG13 ' A' ' 109' ' ' VAL . 94.8 m-85 -109.51 145.51 36.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.882 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -92.39 85.97 5.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.949 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.514 HD11 ' SG ' ' A' ' 77' ' ' CYS . 96.2 mt -70.73 90.1 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -98.89 111.64 23.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.927 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -83.86 113.17 20.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.825 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -88.31 54.35 3.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -142.9 -47.48 0.32 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.885 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.7 22.5 9.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.157 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 54.52 37.02 27.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.005 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -90.56 147.93 23.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.9 ttt -138.07 142.01 40.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.809 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.5 m -159.98 148.68 17.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.47 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 72.9 m80 -124.78 114.01 18.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.514 ' SG ' HD11 ' A' ' 66' ' ' LEU . 26.5 p -115.06 155.89 26.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.511 ' CA ' HD23 ' A' ' 63' ' ' LEU . . . -113.23 131.08 9.81 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.449 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.535 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 10.7 p -68.59 140.14 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 111.164 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.473 HD13 ' HE2' ' A' ' 42' ' ' LYS . 12.6 tp -129.65 -56.35 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.832 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -108.54 146.12 33.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.971 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.535 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 76.6 m-85 -120.39 58.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.1 m -125.34 31.2 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.104 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 44' ' ' ILE . . . -85.24 179.24 7.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.076 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.69 169.08 9.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -73.02 107.97 5.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.37 28.21 33.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.493 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.568 HG23 ' CD2' ' A' ' 23' ' ' PHE . 27.0 mt -148.33 95.67 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 111.12 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 15.0 m -91.05 134.2 34.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.595 ' HB3' HG12 ' A' ' 25' ' ' VAL . 34.7 m-85 -97.84 120.64 38.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.604 HD23 HG21 ' A' ' 43' ' ' ILE . 4.8 mt -123.34 150.23 59.96 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.935 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.3 176.18 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.52 2.147 . . . . 0.0 112.304 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -79.84 -47.4 15.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.928 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -59.53 -29.12 67.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.992 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.555 ' SD ' HD22 ' A' ' 91' ' ' LEU . 33.4 ttm -73.45 -30.94 63.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.831 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 6.4 mtp -71.61 -43.59 65.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -68.92 -40.25 79.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.854 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -60.38 -61.51 2.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.819 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 mt -62.88 -20.54 65.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.6 mt 63.25 34.25 13.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.823 0.344 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 mt -81.52 179.27 7.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.827 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -125.79 177.59 6.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -63.97 103.18 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.437 ' CA ' ' CZ ' ' A' ' 23' ' ' PHE . . . 89.41 34.87 8.29 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.521 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.18 117.83 4.91 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.554 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.747 HD22 ' HB3' ' A' ' 19' ' ' GLN . 12.7 mt -64.71 130.22 42.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 110.884 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.9 t -121.46 138.02 53.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -70.46 112.81 7.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 64' ' ' PHE . 27.0 t -96.44 143.93 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -160.03 138.63 10.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 33.4 p -91.05 113.91 26.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.6 m -120.86 150.14 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.115 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.74 86.8 2.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.422 ' CD1' ' HB1' ' A' ' 176' ' ' ALA . 4.9 mt -83.01 168.08 17.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.801 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -110.9 175.53 5.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.838 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.14 139.59 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.2 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.944 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -76.39 151.02 36.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.6 t -110.57 -30.93 7.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -138.77 107.72 6.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.938 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 m -114.26 137.99 51.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -129.02 148.63 50.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.496 ' CD1' HD21 ' A' ' 139' ' ' LEU . 67.8 m-85 -133.8 150.84 51.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -131.55 91.33 34.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -51.34 125.02 15.39 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.543 2.162 . . . . 0.0 112.34 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -71.12 -39.77 71.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.1 m -105.57 148.0 35.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.877 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.472 ' HA ' HD12 ' A' ' 130' ' ' LEU . 57.4 Cg_endo -70.73 -11.22 29.25 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.575 2.183 . . . . 0.0 112.576 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -56.37 -39.7 73.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.766 0.317 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -72.32 -38.3 68.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 127' ' ' PRO . 32.4 mt -65.32 -36.94 85.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.824 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.29 -25.3 67.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.652 HG22 ' H ' ' A' ' 134' ' ' ASN . 52.2 mt -59.99 134.57 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.052 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.1 t -59.69 -32.65 70.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.004 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.652 ' H ' HG22 ' A' ' 132' ' ' ILE . 0.5 OUTLIER -137.04 81.01 33.86 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.926 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.34 -30.05 16.11 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.62 2.214 . . . . 0.0 112.318 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -63.51 -37.8 88.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.916 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.63 -56.48 17.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.7 -33.94 62.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.164 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.496 HD21 ' CD1' ' A' ' 122' ' ' PHE . 29.7 tp -70.16 -50.92 35.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.943 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.425 ' CD ' HG21 ' A' ' 186' ' ' VAL . 2.2 mt-10 -67.27 -39.07 86.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -60.13 -30.92 69.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.858 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.08 -31.21 61.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.071 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 60.4 mt -57.95 -27.16 63.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.038 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.58 -30.05 62.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.012 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -81.55 -36.25 29.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -77.69 147.14 35.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.962 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -107.96 -28.66 9.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.543 ' HB2' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -128.58 159.56 35.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.402 HD12 HG21 ' A' ' 179' ' ' ILE . 28.4 mt -137.44 118.71 14.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.14 140.77 46.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.86 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.4 m -66.7 125.5 26.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.22 44.69 8.66 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.438 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -111.01 119.46 39.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.839 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.73 81.22 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 39.9 pt -81.91 178.41 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.087 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -152.63 131.32 12.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.039 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 39.8 pt -118.56 138.02 50.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -136.83 146.01 45.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.425 ' CE2' ' HB2' ' A' ' 160' ' ' ASN . 52.6 p90 -173.98 -44.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.868 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.425 ' HB2' ' CE2' ' A' ' 159' ' ' TYR . 53.1 t30 -97.76 38.5 1.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 60.21 31.12 20.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.21 119.45 8.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.517 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.8 mp -84.09 90.81 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -71.8 138.61 48.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -96.96 124.86 41.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.2 mt -139.33 138.28 36.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.926 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -129.85 136.57 49.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.4 t -71.78 130.19 35.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.067 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.2 mmm -91.37 -62.81 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.09 150.45 48.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 31.5 p -144.79 144.22 31.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.849 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.3 mttt -123.84 152.17 65.7 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.96 -38.77 1.62 Allowed 'Cis proline' 0 C--N 1.346 0.436 0 C-N-CA 123.321 -1.533 . . . . 0.0 112.368 0.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -107.63 168.82 8.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -34.87 72.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.947 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.47 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -108.39 124.02 49.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.075 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.944 HG21 ' HB2' ' A' ' 117' ' ' ALA . 6.4 m -135.89 160.04 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 3.7 t -108.93 91.83 3.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.402 HG21 HD12 ' A' ' 149' ' ' LEU . 3.0 pt -80.56 82.76 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.145 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 19.9 mt -115.2 82.8 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.089 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 60.0 79.78 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.842 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 2.0 t -156.94 153.93 28.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.85 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -90.7 118.89 30.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -135.11 176.26 8.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.839 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.01 142.06 27.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.425 HG21 ' CD ' ' A' ' 140' ' ' GLU . 21.5 t -129.54 86.6 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.138 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.62 175.39 10.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -134.75 145.34 48.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -141.08 105.09 4.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.092 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.14 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 m -104.25 -66.73 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 110.941 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.56 -69.22 0.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.976 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 58.31 -89.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.494 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.86 147.43 23.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 110.911 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.4 m -109.85 -30.66 7.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.32 -157.37 15.08 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.424 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.4 pt -109.5 134.42 20.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.535 0.207 . . . . 0.0 111.127 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.9 114.97 4.15 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.421 2.081 . . . . 0.0 112.328 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -128.52 101.04 6.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 m -101.34 29.52 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.16 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -113.31 30.65 7.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.805 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -133.51 153.29 51.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -153.84 -59.75 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 62.23 148.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.939 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.15 120.8 16.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.829 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.6 p -158.42 102.85 1.75 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -168.25 177.82 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.45 ' HB3' HD22 ' A' ' 106' ' ' LEU . 57.8 mt-30 -105.38 122.08 45.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -117.73 151.06 38.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.2 mtt85 -86.4 137.16 32.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.582 ' HB2' HD12 ' A' ' 91' ' ' LEU . 21.5 p -104.16 122.93 46.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.522 ' CD2' HG23 ' A' ' 88' ' ' ILE . 36.7 m-85 -132.05 160.29 36.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.891 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 t -77.09 152.72 34.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -64.34 -21.04 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.347 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.4 m -61.17 -18.87 60.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.276 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.1 mtp -94.0 20.06 8.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.428 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.629 HD13 ' N ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -85.32 135.3 33.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.809 0.338 . . . . 0.0 110.745 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.629 ' N ' HD13 ' A' ' 28' ' ' LEU . . . -55.88 134.74 52.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.161 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 140.19 166.07 10.52 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.466 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.48 -28.15 26.94 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.546 2.164 . . . . 0.0 112.278 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.48 145.34 17.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.832 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -84.41 -178.54 6.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.925 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -123.81 144.92 49.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.86 31.64 2.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.898 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -98.31 -31.34 12.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.947 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.36 -31.33 46.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.68 -36.33 65.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.821 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -60.29 -33.29 72.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -110.4 -164.66 19.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.474 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.16 31.63 5.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.55 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.635 ' HE3' HD13 ' A' ' 80' ' ' LEU . 22.0 mmtt -87.66 158.57 18.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.815 0.341 . . . . 0.0 110.973 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.6 pt -135.77 -179.98 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 3.6 mp -130.45 104.45 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.04 157.17 34.21 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.54 ' N ' ' HB3' ' A' ' 84' ' ' ALA . 53.6 Cg_exo -52.34 144.86 38.2 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.541 2.161 . . . . 0.0 112.261 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 46' ' ' PRO . 50.1 Cg_exo -53.66 -30.62 56.61 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.516 2.144 . . . . 0.0 112.279 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.3 p -60.65 -35.45 76.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.94 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.89 -30.98 71.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.144 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.589 HD13 ' CD2' ' A' ' 82' ' ' PHE . 43.3 tp -63.06 -39.38 94.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.56 -32.89 47.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -61.14 -38.79 87.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.53 HD23 HD12 ' A' ' 58' ' ' ILE . 8.8 mt -61.37 -46.21 91.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -60.14 -30.98 69.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.947 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.8 mtt85 -82.1 -26.35 33.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.036 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.1 mt -86.74 6.14 32.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.428 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 t30 59.52 31.34 20.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.81 0.338 . . . . 0.0 110.966 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.53 HD12 HD23 ' A' ' 53' ' ' LEU . 33.1 mt -94.73 125.19 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.128 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.7 p -110.37 170.62 7.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.455 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.8 OUTLIER -64.82 141.18 98.27 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.822 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.9 Cg_endo -77.1 164.61 86.76 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.468 -1.471 . . . . 0.0 112.403 -0.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 20.1 mtt -126.65 72.9 1.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.852 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.665 HD21 ' HB1' ' A' ' 147' ' ' ALA . 4.0 mt -90.96 149.26 21.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.958 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.459 ' HB3' HG13 ' A' ' 109' ' ' VAL . 97.7 m-85 -112.78 142.99 44.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.823 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.408 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 59.5 tttt -94.93 103.39 15.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.984 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.5 HD12 ' SG ' ' A' ' 77' ' ' CYS . 7.9 mt -91.69 76.24 5.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.94 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -78.09 97.22 5.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.931 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -66.02 116.92 7.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -92.31 49.71 1.54 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -130.4 -46.13 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.795 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.0 m -133.28 28.82 4.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.958 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 58.02 34.75 24.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.031 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -88.82 156.32 19.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.934 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.512 ' O ' HG21 ' A' ' 150' ' ' THR . 13.8 ttm -158.4 137.63 11.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.592 ' CG2' HD11 ' A' ' 99' ' ' LEU . 7.0 t -160.0 108.98 1.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.888 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.436 ' CD2' HD11 ' A' ' 114' ' ' LEU . 37.9 m80 -75.91 118.31 18.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.9 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.5 ' SG ' HD12 ' A' ' 66' ' ' LEU . 24.7 p -111.61 147.16 36.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.95 149.71 19.26 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.499 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.539 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 9.8 p -91.02 154.42 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.853 0.358 . . . . 0.0 111.084 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.635 HD13 ' HE3' ' A' ' 42' ' ' LYS . 53.0 tp -145.96 -55.99 0.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.925 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -101.89 143.96 31.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.894 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.589 ' CD2' HD13 ' A' ' 50' ' ' LEU . 67.4 m-85 -123.54 76.8 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.4 m -150.79 31.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.54 ' HB3' ' N ' ' A' ' 46' ' ' PRO . . . -81.42 150.12 28.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.148 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.481 ' HB3' HD12 ' A' ' 88' ' ' ILE . 0.7 OUTLIER -68.01 173.06 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.85 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -67.95 115.89 7.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.11 29.83 75.0 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.522 HG23 ' CD2' ' A' ' 23' ' ' PHE . 32.7 mt -142.7 91.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 0.0 111.146 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 47.5 t -94.66 129.43 41.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.427 ' CE2' HD22 ' A' ' 28' ' ' LEU . 86.3 m-85 -89.01 140.96 28.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 22' ' ' CYS . 4.1 mt -137.47 155.92 75.22 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.2 179.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.603 2.202 . . . . 0.0 112.293 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -87.44 -45.3 10.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.781 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 39.9 p-90 -60.35 -44.89 95.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.4 tpp -60.15 -34.74 73.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -53.36 22.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.845 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -60.0 -36.3 76.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.865 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -62.2 -49.08 77.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.781 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.592 HD11 ' CG2' ' A' ' 75' ' ' THR . 4.9 mt -75.36 -17.06 60.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.2 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.4 mt 61.21 35.22 18.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.44 HD13 ' SG ' ' A' ' 22' ' ' CYS . 25.6 mt -80.68 -178.63 6.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.826 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.02 -177.98 4.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.929 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 120.75 10.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.8 27.84 70.04 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.504 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -70.71 107.62 2.22 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.439 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' A' ' 19' ' ' GLN . 16.3 mt -69.52 123.52 21.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.839 0.352 . . . . 0.0 110.839 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.2 t -125.59 145.88 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.08 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -73.32 108.72 6.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.459 HG13 ' HB3' ' A' ' 64' ' ' PHE . 21.5 t -95.93 121.54 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.7 114.55 12.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.8 p -77.73 114.86 17.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.985 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.9 m -122.54 144.13 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.071 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.43 102.58 15.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.436 HD11 ' CD2' ' A' ' 76' ' ' HIS . 6.0 mt -99.58 168.93 9.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.63 172.34 7.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.6 m -67.96 140.76 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.122 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.592 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -81.82 148.84 28.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.062 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.7 p -109.63 -31.55 7.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -131.73 93.29 3.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 61.1 m -114.49 94.49 4.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.38 142.5 35.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.823 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.642 ' CE2' HG22 ' A' ' 168' ' ' VAL . 42.7 m-85 -124.68 150.92 45.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.014 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -128.37 93.54 38.13 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.54 104.76 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.557 2.171 . . . . 0.0 112.373 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -59.51 -30.88 68.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.863 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.3 146.31 35.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.821 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.69 -12.76 26.87 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.536 2.157 . . . . 0.0 112.559 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -56.82 -40.69 76.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.067 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.534 ' CD1' HD11 ' A' ' 166' ' ' LEU . 19.2 t80 -67.31 -44.24 79.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.62 -29.98 68.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.947 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -61.99 -26.31 68.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.988 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.564 HG22 ' H ' ' A' ' 134' ' ' ASN . 43.2 mt -61.66 139.68 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.981 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.4 m -65.3 -37.38 86.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.564 ' H ' HG22 ' A' ' 132' ' ' ILE . 2.0 m120 -130.01 71.12 82.28 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.407 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 39.6 Cg_exo -57.0 -29.95 84.78 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.611 2.207 . . . . 0.0 112.241 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -60.31 -49.52 77.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.043 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.22 -35.45 75.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.139 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.4 HG21 HD13 ' A' ' 132' ' ' ILE . 21.5 t -75.57 -33.27 26.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.679 HD22 ' CE1' ' A' ' 188' ' ' PHE . 12.6 tp -71.7 -42.87 66.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.14 -37.83 72.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -65.69 -32.76 74.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.58 -31.74 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.136 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.538 HD22 HD11 ' A' ' 149' ' ' LEU . 14.2 mt -63.98 -27.32 69.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.038 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -57.03 -25.2 58.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.101 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -79.74 -49.24 12.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.826 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.431 ' CZ ' ' HB ' ' A' ' 155' ' ' ILE . 84.5 m-85 -60.77 146.72 45.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.665 ' HB1' HD21 ' A' ' 63' ' ' LEU . . . -100.85 -30.33 11.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.24 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -142.11 167.46 22.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.974 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.538 HD11 HD22 ' A' ' 143' ' ' LEU . 27.6 mt -143.01 137.53 29.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.512 HG21 ' O ' ' A' ' 74' ' ' MET . 2.0 m -114.09 141.64 47.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.0 m -65.83 94.28 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 108.33 30.43 3.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.548 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.03 134.17 46.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.766 0.317 . . . . 0.0 110.854 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 26.1 t -90.2 91.19 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.117 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.781 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 9.3 pt -91.65 134.03 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.494 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -102.05 125.07 48.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.12 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.433 HG12 HD12 ' A' ' 166' ' ' LEU . 5.0 pt -115.88 141.59 32.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.103 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -139.19 142.22 37.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -157.71 -50.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -96.77 44.18 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 60.34 31.47 20.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.878 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -148.55 126.21 11.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.494 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 3.8 mp -85.92 95.45 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.188 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -76.66 137.43 39.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -95.46 122.96 38.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.534 HD11 ' CD1' ' A' ' 129' ' ' PHE . 3.2 mt -141.63 100.55 3.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -93.93 127.74 39.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.642 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.2 t -68.94 128.79 32.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.083 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 3.8 mmm -86.71 -64.16 1.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.014 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -123.14 155.79 36.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 58.2 p -144.98 161.01 40.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.636 ' O ' HG11 ' A' ' 177' ' ' VAL . 25.9 mttt -148.12 155.4 43.47 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.825 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.29 -31.6 5.17 Favored 'Cis proline' 0 C--N 1.348 0.507 0 C-N-CA 123.309 -1.538 . . . . 0.0 112.462 0.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -113.51 176.7 4.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.95 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -60.01 -41.94 93.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -98.83 116.94 32.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.018 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.636 HG11 ' O ' ' A' ' 172' ' ' LYS . 17.7 m -133.27 137.66 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.16 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.506 ' OG ' HD11 ' A' ' 63' ' ' LEU . 10.0 t -94.62 97.9 10.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.1 pt -89.63 85.49 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.3 mm -117.83 85.12 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.123 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 60.58 87.26 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 49.9 t -161.65 141.52 10.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.97 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -80.84 108.14 14.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -128.34 179.22 5.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -93.84 89.97 6.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.75 81.33 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.01 172.05 13.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . 0.679 ' CE1' HD22 ' A' ' 139' ' ' LEU . 11.8 m-85 -128.52 163.07 25.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.93 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -147.93 101.64 3.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.958 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.048 179.946 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.451 -0.259 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.88 158.55 20.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.921 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.25 -42.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.3 -141.16 3.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.51 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.38 -34.69 61.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 0.0 110.952 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.87 159.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.883 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.86 -154.74 29.62 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.479 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.4 mp -112.88 90.95 16.5 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.674 0.274 . . . . 0.0 111.152 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -51.06 91.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.584 2.189 . . . . 0.0 112.43 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.1 mtt-85 59.55 -178.46 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.977 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 11' ' ' VAL . 10.7 p -155.25 113.74 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.087 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -144.37 -48.38 0.27 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.987 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -170.68 -38.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.082 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 t30 75.59 -68.05 0.22 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.013 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 63.36 135.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.946 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -62.47 89.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.947 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.9 p -118.97 105.34 11.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.831 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.0 t -168.35 160.97 11.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.952 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -95.7 148.57 22.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -139.03 148.5 43.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 -75.84 128.51 35.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.873 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.463 ' HB3' HD13 ' A' ' 91' ' ' LEU . 64.9 m -99.11 125.79 44.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -130.66 175.47 8.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 t -92.28 150.66 20.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.906 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.5 m -68.3 -30.8 48.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.086 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.01 -29.22 66.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.93 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -27.78 63.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.046 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.5 tp -57.4 -67.1 0.36 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.023 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -104.93 -68.43 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.079 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.42 -169.28 23.5 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.465 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.1 -35.74 18.98 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.616 2.211 . . . . 0.0 112.266 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -122.16 121.46 36.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.823 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -165.23 -44.44 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.953 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -131.67 147.7 52.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.4 p -130.83 31.63 4.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -122.03 -43.33 2.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 m -63.11 -32.33 55.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.09 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.17 -31.58 43.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -80.56 -35.17 34.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.949 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.78 167.14 26.72 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.476 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.47 40.88 2.57 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.455 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.18 162.4 13.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.356 . . . . 0.0 110.897 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.537 HG22 ' HD3' ' A' ' 92' ' ' PRO . 43.0 pt -141.1 172.55 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.102 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.0 mt -120.93 86.41 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.174 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.6 mtp -89.11 151.59 47.0 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.773 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.09 156.09 7.98 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.574 2.183 . . . . 0.0 112.251 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.73 -25.46 61.17 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.625 2.217 . . . . 0.0 112.342 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.5 p -58.87 -30.78 67.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.942 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.79 -47.96 64.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.161 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.733 ' HA ' HD12 ' A' ' 53' ' ' LEU . 56.1 tp -59.51 -39.46 83.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.68 -31.01 64.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.924 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -74.04 -32.6 63.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.733 HD12 ' HA ' ' A' ' 50' ' ' LEU . 23.6 mt -59.84 -30.38 68.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.5 t -80.91 -22.94 39.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.111 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -75.09 -30.57 60.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.018 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.5 mt -95.52 20.05 10.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.243 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 53.58 38.42 28.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.82 0.343 . . . . 0.0 111.265 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 59' ' ' THR . 25.0 mm -77.08 154.61 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.025 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.408 ' N ' HG22 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -140.91 151.55 44.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.451 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.5 t80 -61.83 140.6 95.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.753 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.75 157.8 97.34 Favored 'Cis proline' 0 C--N 1.349 0.579 0 C-N-CA 123.479 -1.467 . . . . 0.0 112.409 -0.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.626 ' SD ' HD13 ' A' ' 53' ' ' LEU . 45.0 mtt -116.38 56.86 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.91 139.72 45.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.552 ' HB3' HG13 ' A' ' 109' ' ' VAL . 57.6 m-85 -105.81 157.13 17.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.935 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.421 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 10.3 tttp -103.55 92.94 4.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.6 mt -75.8 80.64 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.7 m -95.21 117.8 30.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -89.36 129.46 35.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.889 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -98.69 31.11 3.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.32 -41.02 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.847 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m -134.41 21.99 3.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.5 t70 54.4 59.95 3.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.098 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.627 ' HB3' HD23 ' A' ' 99' ' ' LEU . 5.7 mmp_? -106.55 158.98 16.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.1 ttm -159.28 126.64 4.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.712 HG22 HD21 ' A' ' 99' ' ' LEU . 4.4 t -158.96 100.94 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.941 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.421 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 50.4 m80 -65.77 131.98 47.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.926 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.6 p -123.11 166.32 15.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -123.49 113.24 2.05 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.516 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.407 HG22 ' N ' ' A' ' 80' ' ' LEU . 11.2 p -62.35 154.18 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.813 0.34 . . . . 0.0 111.102 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.407 ' N ' HG22 ' A' ' 79' ' ' VAL . 23.2 tp -133.33 -62.22 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -95.7 162.76 13.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.51 ' CD2' HD22 ' A' ' 50' ' ' LEU . 51.7 m-85 -140.83 74.02 1.44 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.4 m -143.56 31.44 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.42 158.26 17.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.098 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.13 169.1 18.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -73.19 120.79 19.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.82 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.19 26.08 55.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.577 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.3 mt -149.74 113.99 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.834 0.35 . . . . 0.0 111.106 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 86.4 m -117.38 131.29 56.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -97.96 135.87 39.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.465 HD23 HG21 ' A' ' 43' ' ' ILE . 3.3 mp -135.36 160.63 67.25 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.935 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.537 ' HD3' HG22 ' A' ' 43' ' ' ILE . 53.6 Cg_exo -52.43 -176.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.582 2.188 . . . . 0.0 112.292 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -93.09 -40.92 10.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.023 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.413 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 65.1 p-90 -61.85 -42.07 98.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.98 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 44.6 ttm -60.43 -44.46 95.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.22 -48.76 80.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -60.57 -36.81 79.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.898 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -65.44 -56.38 12.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.712 HD21 HG22 ' A' ' 75' ' ' THR . 12.2 mt -68.14 -17.68 64.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.184 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.3 mt 62.86 32.35 15.86 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.844 0.354 . . . . 0.0 110.84 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.84 179.96 7.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -134.08 176.53 8.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -59.91 105.4 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.8 28.45 8.31 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.52 121.58 5.56 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.466 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.6 mt -83.14 123.55 29.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.835 0.35 . . . . 0.0 110.985 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.41 135.55 62.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.085 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -68.28 102.13 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 64' ' ' PHE . 25.4 t -86.86 132.12 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -145.17 133.15 21.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.8 p -90.88 103.06 15.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.1 m -109.19 170.96 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.168 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -114.89 118.69 34.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.487 HD22 ' O ' ' A' ' 176' ' ' ALA . 12.1 mt -119.12 177.31 4.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -123.06 167.53 13.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.89 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.2 m -64.85 141.96 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.064 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.638 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -76.53 148.85 36.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.3 p -113.29 -37.05 4.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.926 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -137.6 118.41 14.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.931 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.58 107.2 6.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.07 131.64 34.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.603 ' CG ' HD21 ' A' ' 139' ' ' LEU . 26.4 m-85 -112.29 144.5 41.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -131.57 96.97 19.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.81 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.82 119.91 5.35 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.518 2.145 . . . . 0.0 112.327 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -71.49 -32.22 67.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.033 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.98 147.48 34.56 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.957 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.65 -19.14 28.27 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.571 2.18 . . . . 0.0 112.604 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.52 -48.07 78.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.051 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.457 ' CE1' HD11 ' A' ' 166' ' ' LEU . 13.4 t80 -61.14 -44.96 96.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.88 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 54.6 mt -59.37 -31.8 69.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -62.77 -26.8 68.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.976 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.629 HG22 ' H ' ' A' ' 134' ' ' ASN . 29.6 mt -61.38 135.56 25.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.993 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.7 t -64.51 -33.39 75.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.629 ' H ' HG22 ' A' ' 132' ' ' ILE . 0.1 OUTLIER -134.61 81.76 46.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.86 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.12 -27.23 20.42 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.47 2.113 . . . . 0.0 112.321 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -60.14 -35.74 75.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.019 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.3 -39.27 68.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.13 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.54 -30.28 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.275 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.603 HD21 ' CG ' ' A' ' 122' ' ' PHE . 25.5 tp -79.75 -44.51 20.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.04 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -63.64 -31.56 72.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.94 -28.82 67.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.74 -32.63 31.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.124 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.06 -26.63 68.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.076 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -56.41 -30.1 62.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.068 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -85.86 -42.73 13.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.944 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.597 ' CE2' HD13 ' A' ' 155' ' ' ILE . 37.6 m-85 -62.49 142.42 57.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.547 ' HB1' HD11 ' A' ' 180' ' ' ILE . . . -108.03 -25.67 11.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.279 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -141.42 165.5 27.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.5 mt -145.83 162.55 37.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -144.66 143.71 30.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.959 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 169' ' ' MET . 89.0 m -62.98 96.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 110.0 27.47 4.55 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.468 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.93 116.15 28.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.3 t -84.62 89.0 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.069 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.597 HD13 ' CE2' ' A' ' 146' ' ' PHE . 1.1 pt -93.67 142.85 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.111 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.409 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -109.0 131.25 55.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.159 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.8 pt -117.99 154.63 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -144.72 142.06 29.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.908 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.419 ' CE1' ' CD1' ' A' ' 164' ' ' TYR . 16.4 p90 -158.5 -49.75 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.966 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -97.87 44.5 1.04 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.9 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 60.0 30.14 19.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.4 mtpp -144.58 142.63 30.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.8 mp -93.67 90.45 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.041 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.419 ' CD1' ' CE1' ' A' ' 159' ' ' TYR . 39.8 m-85 -74.04 120.79 20.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -77.45 139.61 39.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.991 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.475 HD22 HD13 ' A' ' 139' ' ' LEU . 0.7 OUTLIER -153.28 124.78 7.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -124.16 137.67 54.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.929 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.425 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.5 t -76.18 146.96 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.146 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.443 ' O ' HG23 ' A' ' 151' ' ' THR . 24.5 mmm -106.23 -56.88 2.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -128.65 149.79 50.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.983 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 17.5 p -145.69 141.17 27.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.869 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -127.43 152.98 77.23 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.826 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.99 -28.15 7.94 Favored 'Cis proline' 0 C--N 1.346 0.397 0 C-N-CA 123.38 -1.508 . . . . 0.0 112.366 0.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -124.61 173.25 8.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -47.16 85.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.968 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.487 ' O ' HD22 ' A' ' 114' ' ' LEU . . . -90.88 103.55 16.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.016 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.638 HG21 ' HB2' ' A' ' 117' ' ' ALA . 15.9 m -123.38 132.19 71.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 5.7 t -89.55 85.58 6.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.813 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 3.8 pt -74.17 81.55 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.213 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.547 HD11 ' HB1' ' A' ' 147' ' ' ALA . 27.9 mm -119.69 103.07 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.977 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.98 79.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.808 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -176.48 144.14 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -101.18 120.48 40.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.969 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.75 172.18 7.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.05 95.06 9.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.414 HG13 ' CD1' ' A' ' 122' ' ' PHE . 21.5 t -86.3 90.34 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.13 175.43 10.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -130.43 151.6 50.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -129.2 80.74 1.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.128 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.561 -0.215 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t -171.99 141.62 1.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.889 0.375 . . . . 0.0 110.917 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 p -118.91 131.68 56.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.94 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.74 134.91 41.11 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.488 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.7 t -167.57 96.24 0.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.857 0.361 . . . . 0.0 110.966 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -118.11 149.62 40.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.88 -162.97 37.13 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.537 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.7 tt -177.56 133.38 0.35 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.587 0.232 . . . . 0.0 111.043 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.11 144.3 38.28 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.4 2.067 . . . . 0.0 112.391 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.89 30.97 3.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.789 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 11' ' ' VAL . 19.3 m -133.16 86.54 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.168 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -146.61 -56.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -126.45 155.61 41.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -129.03 172.1 11.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -137.55 109.62 7.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -61.36 126.9 29.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.858 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.8 p -147.75 107.26 3.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.952 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 t -156.5 178.65 10.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.482 ' HB3' HD22 ' A' ' 106' ' ' LEU . 38.6 mt-30 -107.2 163.29 13.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.861 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -157.36 142.59 17.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.982 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -81.87 118.81 23.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.2 p -84.94 133.43 34.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -138.58 174.52 10.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.21 147.08 23.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.976 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.7 m -68.27 -21.2 26.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.324 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.23 -29.53 33.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.215 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 6.1 mtt -71.94 -41.49 67.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 tt -121.46 83.43 2.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -172.46 -178.78 2.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.072 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.6 164.85 13.97 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.495 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.87 -45.35 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.603 2.202 . . . . 0.0 112.304 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.7 -31.32 32.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.52 118.97 37.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.45 -40.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.969 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.73 -30.38 71.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.879 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.27 -43.94 92.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.86 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -66.78 -30.93 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.134 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -78.42 -31.37 48.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -71.8 86.46 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.412 ' HA2' ' CE1' ' A' ' 146' ' ' PHE . . . 139.45 -156.83 24.83 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.488 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.22 40.28 1.62 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.552 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HG2' HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -98.85 149.36 22.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.921 0.391 . . . . 0.0 110.891 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.593 HD13 ' SG ' ' A' ' 77' ' ' CYS . 39.6 pt -126.99 170.74 16.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.179 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mt -122.83 99.78 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.033 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -99.93 157.5 33.77 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -51.87 160.24 3.09 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.515 2.143 . . . . 0.0 112.282 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.09 -27.42 42.03 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.494 2.129 . . . . 0.0 112.357 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.43 -31.22 71.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.3 -39.16 89.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.088 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.436 HD13 ' CE1' ' A' ' 82' ' ' PHE . 24.1 tp -60.11 -42.3 94.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -74.27 -42.28 59.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.716 ' HG2' HD11 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -61.63 -47.14 86.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.999 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.442 HD11 ' HZ ' ' A' ' 64' ' ' PHE . 13.7 mt -54.12 -26.92 29.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.122 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.96 -27.52 24.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.033 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -97.12 20.05 11.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.268 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.716 HD11 ' HG2' ' A' ' 52' ' ' GLN . 31.1 mt -126.17 20.0 7.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.721 0.296 . . . . 0.0 111.295 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 55.05 30.04 13.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.804 0.335 . . . . 0.0 111.072 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.425 HD12 HD23 ' A' ' 53' ' ' LEU . 28.0 mt -98.24 124.61 51.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.152 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 t -114.98 169.5 9.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.469 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -70.98 145.17 91.24 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.77 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.7 Cg_endo -76.88 156.24 97.63 Favored 'Cis proline' 0 C--N 1.348 0.503 0 C-N-CA 123.549 -1.438 . . . . 0.0 112.393 0.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 64.6 mtt -115.76 66.68 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.705 HD22 ' HB2' ' A' ' 148' ' ' CYS . 10.0 mt -84.32 123.47 30.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.442 ' HZ ' HD11 ' A' ' 53' ' ' LEU . 59.9 m-85 -98.31 142.95 29.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -101.03 82.72 2.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.506 HD12 ' SG ' ' A' ' 77' ' ' CYS . 10.6 mt -60.9 94.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -94.46 112.55 24.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.861 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -71.06 103.8 2.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -79.95 61.98 4.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -174.08 -41.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.854 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.24 4.59 26.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.398 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 57.83 49.06 12.66 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.905 0.384 . . . . 0.0 110.904 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.414 ' HB3' HD23 ' A' ' 99' ' ' LEU . 3.4 mmp_? -107.64 168.82 8.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.4 ttm -157.39 128.4 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.679 HG21 HD11 ' A' ' 99' ' ' LEU . 10.3 t -145.81 148.74 33.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.948 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -116.11 95.28 5.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.932 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.593 ' SG ' HD13 ' A' ' 43' ' ' ILE . 30.5 p -107.04 160.98 15.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -118.16 134.91 11.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.531 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.612 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 11.7 p -73.87 151.41 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.846 0.355 . . . . 0.0 111.09 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.547 HD22 ' HG2' ' A' ' 42' ' ' LYS . 63.6 tp -137.55 -59.13 0.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -102.26 145.34 29.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.612 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 82.4 m-85 -124.89 75.66 1.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.851 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 m -136.57 30.86 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.623 ' HB1' ' O ' ' A' ' 88' ' ' ILE . . . -94.68 155.26 16.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.048 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.541 ' HB2' HD12 ' A' ' 88' ' ' ILE . 4.0 m-20 -80.58 160.26 25.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -60.34 113.02 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.5 27.64 32.15 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.58 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.623 ' O ' ' HB1' ' A' ' 84' ' ' ALA . 26.0 mt -148.59 98.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 111.131 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.7 t -103.19 135.12 45.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -103.77 136.78 42.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 mp -136.12 157.55 75.48 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -51.95 179.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.573 2.182 . . . . 0.0 112.321 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.71 -35.54 15.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.734 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 65.3 p-90 -68.06 -43.17 79.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.459 ' HE2' ' CH2' ' A' ' 94' ' ' TRP . 31.0 ttm -66.93 -33.08 74.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.956 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 1.8 mmt -60.57 -39.83 89.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.811 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -79.34 -33.86 42.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.886 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -60.31 -31.1 69.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.679 HD11 HG21 ' A' ' 75' ' ' THR . 3.8 mt -102.13 0.28 34.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.375 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.4 mt 57.87 30.78 19.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.82 0.343 . . . . 0.0 110.919 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.482 HD11 HG21 ' A' ' 107' ' ' VAL . 38.7 mt -82.42 -178.63 7.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -144.56 -174.19 4.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.789 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -76.82 90.78 3.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.871 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.05 50.18 0.74 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.532 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -113.65 141.91 17.19 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.477 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.482 HD22 ' HB3' ' A' ' 19' ' ' GLN . 59.5 mt -85.65 127.19 34.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.891 0.377 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.482 HG21 HD11 ' A' ' 101' ' ' LEU . 21.5 t -130.41 139.68 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -80.26 121.77 26.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.412 HG22 HD23 ' A' ' 66' ' ' LEU . 21.5 t -105.27 139.22 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.093 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -143.18 130.03 20.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.3 p -88.77 123.17 32.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.915 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.89 140.26 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.134 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -91.96 112.14 23.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.681 HD13 ' O ' ' A' ' 176' ' ' ALA . 11.6 mt -115.76 176.86 4.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -128.01 173.96 9.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.841 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.5 m -59.71 164.67 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.056 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.975 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -96.94 160.74 14.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.103 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 58.3 p -119.58 -41.12 2.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.809 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -133.08 92.4 3.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.807 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.92 143.26 35.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.941 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -117.23 169.76 9.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.828 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.761 ' CD2' HD21 ' A' ' 139' ' ' LEU . 42.9 m-85 -153.75 139.82 18.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -128.57 86.64 57.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.924 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.533 ' HA ' HD23 ' A' ' 166' ' ' LEU . 59.4 Cg_exo -51.56 125.44 16.78 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.573 2.182 . . . . 0.0 112.375 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -80.99 -31.22 34.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.5 p -101.01 146.57 32.37 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.595 ' HA ' HD12 ' A' ' 130' ' ' LEU . 62.9 Cg_endo -73.37 -17.14 24.27 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.528 2.152 . . . . 0.0 112.51 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.22 -38.48 68.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.073 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -76.07 -38.28 57.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.595 HD12 ' HA ' ' A' ' 127' ' ' PRO . 21.4 mt -63.48 -32.33 73.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -67.26 -26.1 66.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.061 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.529 HD13 HG21 ' A' ' 138' ' ' VAL . 47.9 mt -64.68 124.49 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.124 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.5 m -59.96 -39.06 84.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.48 77.71 4.47 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.17 -27.79 19.57 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.574 2.183 . . . . 0.0 112.252 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -64.41 -39.77 94.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.0 -51.66 44.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.09 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.529 HG21 HD13 ' A' ' 132' ' ' ILE . 21.4 t -59.73 -30.51 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.761 HD21 ' CD2' ' A' ' 122' ' ' PHE . 6.1 tp -75.98 -44.71 38.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.38 -38.35 77.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -59.63 -31.09 69.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.968 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -86.04 -31.61 21.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.049 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.422 HD22 HD13 ' A' ' 179' ' ' ILE . 28.1 mt -61.35 -28.48 69.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -57.56 -29.71 64.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.067 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -79.07 -31.24 44.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.412 ' CE1' ' HA2' ' A' ' 40' ' ' GLY . 7.4 m-85 -83.6 150.68 25.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -109.87 -29.37 8.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.173 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.705 ' HB2' HD22 ' A' ' 63' ' ' LEU . 17.4 t -141.58 158.69 43.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.6 mt -131.66 178.53 6.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.0 m -158.89 136.63 10.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 28.5 m -65.41 121.57 15.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.8 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.75 41.34 9.83 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.356 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.77 106.71 9.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.836 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.8 t -66.57 107.02 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.011 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.734 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 4.0 pt -109.1 132.17 57.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.116 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -92.45 129.85 38.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.083 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.455 HG12 HD12 ' A' ' 166' ' ' LEU . 3.0 pt -115.36 140.87 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.155 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -143.01 145.21 32.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -161.3 -48.15 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.923 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 48.0 p30 -101.66 44.93 0.99 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.976 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.77 30.79 20.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.96 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -139.36 119.04 13.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.425 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.7 mp -88.84 83.99 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.164 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -62.95 179.97 0.33 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -132.31 130.72 41.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.888 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 124' ' ' PRO . 20.2 mt -145.63 159.07 43.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.864 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -153.0 114.96 4.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.865 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.52 HG22 ' CE1' ' A' ' 122' ' ' PHE . 21.5 t -59.72 135.41 24.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 41.1 mmm -99.97 -46.71 5.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.942 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.38 156.18 44.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.6 p -153.06 157.24 40.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.416 ' O ' HG11 ' A' ' 177' ' ' VAL . 39.2 mttt -143.12 154.9 61.97 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.3 -31.4 5.31 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 123.298 -1.542 . . . . 0.0 112.434 0.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -108.34 167.67 9.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -35.17 71.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.949 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.681 ' O ' HD13 ' A' ' 114' ' ' LEU . . . -113.61 115.43 27.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.023 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.975 HG21 ' HB2' ' A' ' 117' ' ' ALA . 27.5 m -118.67 154.79 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.438 ' CB ' HD11 ' A' ' 63' ' ' LEU . 1.5 t -99.89 80.01 2.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.422 HD13 HD22 ' A' ' 143' ' ' LEU . 3.1 pt -71.28 81.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.202 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.2 mt -125.19 95.92 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.079 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 61.59 78.38 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.08 148.43 2.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.02 136.57 43.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.946 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.589 ' SD ' ' HB3' ' A' ' 117' ' ' ALA . 4.1 ptt? -143.54 167.45 22.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.1 85.41 5.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.0 108.79 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.108 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.09 179.96 5.82 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -138.28 140.83 39.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -107.56 99.5 8.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.819 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.255 -0.878 . . . . 0.0 111.057 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 m 60.71 85.64 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.792 0.33 . . . . 0.0 110.961 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -108.11 152.04 25.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.2 65.91 0.3 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.531 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -73.05 163.48 28.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.798 0.332 . . . . 0.0 110.85 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.1 t 59.87 175.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 61.7 -98.91 0.2 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.491 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.2 mt 68.82 84.28 0.15 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.781 0.324 . . . . 0.0 111.177 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.76 148.5 28.25 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.608 2.205 . . . . 0.0 112.288 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.11 38.94 0.51 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.8 m -116.47 30.69 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.14 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.59 -46.59 65.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -90.29 87.23 6.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -66.43 -64.41 0.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 60.53 159.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -75.81 138.97 41.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.8 p -158.56 85.31 0.84 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.415 HG22 ' N ' ' A' ' 19' ' ' GLN . 92.7 m -148.95 160.31 43.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.869 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.415 ' N ' HG22 ' A' ' 18' ' ' THR . 17.9 mt-30 -103.12 121.16 42.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.877 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.66 ' HB2' HG21 ' A' ' 109' ' ' VAL . 2.6 m-85 -122.25 146.87 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.96 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -69.89 169.16 13.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.6 m -131.15 112.77 13.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.52 ' CD2' HG23 ' A' ' 88' ' ' ILE . 82.0 m-85 -122.73 162.46 21.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -83.48 154.21 24.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.5 m -65.25 -29.67 47.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.112 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.2 p -57.98 -27.19 63.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.037 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.0 mmt -64.03 -38.05 89.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.97 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 tp -57.87 -36.12 71.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.926 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.97 176.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.138 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 140.54 136.05 3.28 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.431 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.81 -36.17 81.7 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.428 2.085 . . . . 0.0 112.209 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -116.54 120.02 37.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.843 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.73 165.95 10.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.837 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.5 148.06 30.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.009 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.09 33.59 4.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.751 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -118.15 -40.94 2.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.96 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.1 t -62.62 -45.81 97.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.084 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -39.51 76.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.946 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -84.38 94.25 8.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.83 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.18 -134.01 7.41 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.606 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.1 52.3 0.56 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.524 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.9 154.17 26.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 0.0 110.804 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.647 HG21 HD23 ' A' ' 91' ' ' LEU . 40.2 pt -136.85 161.2 36.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.187 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.404 HG23 ' HB3' ' A' ' 81' ' ' GLU . 21.5 mt -110.09 102.13 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.15 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 82.7 mtp -99.55 161.4 24.64 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -55.89 159.52 11.73 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.532 2.155 . . . . 0.0 112.234 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.2 -27.78 23.96 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.625 2.217 . . . . 0.0 112.297 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.2 p -59.4 -31.75 69.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.23 -36.43 77.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.124 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 tp -61.79 -44.27 97.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -71.9 -31.18 66.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.942 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.42 -41.5 60.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -61.55 -48.07 82.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.7 p -65.31 -30.82 71.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.876 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.58 -20.35 58.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.2 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.8 mt -94.38 20.03 8.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.295 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.9 t30 56.16 30.59 16.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.812 0.339 . . . . 0.0 111.064 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.3 mt -97.81 141.67 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.129 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 p -134.37 172.1 13.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.454 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.5 t80 -60.6 140.62 92.55 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.855 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.454 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 73.6 Cg_endo -77.05 163.24 89.82 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 123.501 -1.458 . . . . 0.0 112.345 0.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 46.4 mtt -130.45 69.42 1.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.454 HD11 ' OG ' ' A' ' 178' ' ' SER . 2.0 mt -90.13 147.56 23.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -113.5 126.75 55.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -82.81 89.09 6.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.413 HD11 HD21 ' A' ' 91' ' ' LEU . 13.6 mt -68.03 77.5 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.857 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -81.92 95.39 7.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.552 ' OD1' HD21 ' A' ' 101' ' ' LEU . 2.9 t-20 -64.38 116.04 5.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.828 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -98.11 29.51 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -119.16 -40.5 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 m -124.28 21.79 8.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.098 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 54.4 37.97 28.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.036 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.416 ' HB3' HD23 ' A' ' 99' ' ' LEU . 8.9 mmp_? -93.09 171.85 8.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.963 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 40.1 ttp -156.08 125.42 6.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.0 m -144.52 132.25 21.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.888 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.46 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 12.0 m80 -107.35 101.0 10.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.917 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.457 ' SG ' HD13 ' A' ' 43' ' ' ILE . 28.8 p -108.06 172.66 6.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -134.6 137.67 9.45 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.528 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.79 150.91 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.761 0.315 . . . . 0.0 111.091 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.5 tp -133.44 -60.71 0.83 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.404 ' HB3' HG23 ' A' ' 44' ' ' ILE . 1.8 mp0 -99.51 157.24 16.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -130.32 55.46 1.81 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.827 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.14 31.76 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.21 168.46 11.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.415 ' HB3' HD12 ' A' ' 88' ' ' ILE . 3.0 m-20 -83.74 151.8 25.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.861 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -59.9 134.87 57.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.13 24.86 70.66 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.501 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.52 HG23 ' CD2' ' A' ' 23' ' ' PHE . 29.4 mt -145.93 92.08 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.85 0.357 . . . . 0.0 111.033 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 83.8 m -92.18 126.15 37.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.022 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -92.7 141.3 28.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.777 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.647 HD23 HG21 ' A' ' 43' ' ' ILE . 3.1 mp -141.67 160.21 57.2 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.853 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.504 ' HD3' HG22 ' A' ' 43' ' ' ILE . 55.4 Cg_exo -51.84 177.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.53 2.154 . . . . 0.0 112.365 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -84.32 -46.16 12.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.755 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 70.1 p-90 -60.24 -38.49 83.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.882 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.9 ttm -61.29 -40.81 95.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -41.85 99.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.892 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -71.79 -36.76 70.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -62.25 -39.0 91.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 68' ' ' ASN . 52.0 mt -87.25 -20.68 26.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.4 mt 61.74 42.83 10.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.878 0.37 . . . . 0.0 110.924 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.552 HD21 ' OD1' ' A' ' 68' ' ' ASN . 44.3 mt -87.72 170.01 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.77 179.33 3.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.905 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.92 88.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.886 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.48 47.71 1.38 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.395 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.07 107.95 3.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.457 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 32.3 mt -69.59 132.61 46.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.804 0.335 . . . . 0.0 110.941 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.32 149.52 32.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.073 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -63.26 110.18 1.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.66 HG21 ' HB2' ' A' ' 20' ' ' TYR . 22.4 t -99.58 120.59 49.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -148.84 142.59 25.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.836 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.1 p -90.15 114.66 26.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.854 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 20.4 m -116.46 152.18 18.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.129 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -108.55 119.11 38.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.1 mt -119.48 179.93 4.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.14 171.61 7.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.915 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.0 m -71.51 133.57 31.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.784 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -65.27 147.42 53.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.149 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.7 p -111.98 -35.53 5.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.431 ' CE1' ' HB2' ' A' ' 187' ' ' ASP . 75.2 t80 -133.23 99.8 4.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.5 p -113.43 111.05 21.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -102.67 136.53 42.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.587 ' CD1' HD21 ' A' ' 139' ' ' LEU . 20.7 m-85 -120.43 155.24 33.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.923 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -133.04 94.62 20.18 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.96 120.4 6.01 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.552 2.168 . . . . 0.0 112.374 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -76.13 -31.48 58.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.965 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.44 149.4 42.1 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.974 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.23 -9.68 26.49 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.536 2.157 . . . . 0.0 112.684 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.417 ' HB3' ' CE2' ' A' ' 164' ' ' TYR . 0.3 OUTLIER -56.41 -35.39 67.74 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.08 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.497 ' CD1' HD11 ' A' ' 166' ' ' LEU . 9.2 t80 -79.61 -34.01 41.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.812 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 34.8 mt -66.0 -34.77 78.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.29 -26.2 68.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.068 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.488 HD13 HG21 ' A' ' 138' ' ' VAL . 39.1 mt -60.04 139.4 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.002 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.5 m -61.24 -53.35 58.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.39 80.01 29.08 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.875 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.412 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 38.9 Cg_exo -57.15 -35.1 98.83 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.54 2.16 . . . . 0.0 112.194 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -34.08 73.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.962 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.49 -39.06 74.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.114 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.515 HG13 ' OH ' ' A' ' 159' ' ' TYR . 22.1 t -75.43 -30.97 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.587 HD21 ' CD1' ' A' ' 122' ' ' PHE . 9.0 tp -76.71 -30.72 56.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.009 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -80.67 -31.67 36.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.944 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.66 -32.0 70.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.27 -33.5 32.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.104 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.5 ' CD2' HD11 ' A' ' 149' ' ' LEU . 22.7 mt -59.87 -28.93 67.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.043 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -58.29 -33.03 68.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -79.53 -31.14 42.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.725 ' HB3' HD11 ' A' ' 179' ' ' ILE . 4.0 m-85 -71.26 145.56 49.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -108.54 -27.27 9.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.192 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.87 171.61 13.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.537 HD22 HG21 ' A' ' 168' ' ' VAL . 2.7 mt -155.41 136.15 13.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.89 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.22 149.78 47.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.816 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 57.0 m -69.27 100.39 1.31 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.65 28.55 4.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.501 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.89 90.08 4.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.85 0.357 . . . . 0.0 110.867 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.608 HG22 ' HG3' ' A' ' 167' ' ' ARG . 27.7 t -63.37 100.68 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.104 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.755 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 1.2 pt -109.54 161.98 7.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.11 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.688 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -127.28 99.41 5.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.11 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.2 pt -69.41 150.1 10.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.044 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -158.33 150.3 21.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.515 ' OH ' HG13 ' A' ' 138' ' ' VAL . 30.5 p90 -177.29 -37.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.087 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -103.47 38.94 1.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 110.944 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 60.86 29.96 19.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -145.87 108.39 4.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.784 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.688 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 2.0 mp -82.48 112.82 20.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.127 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 128' ' ' ASP . 32.5 m-85 -94.13 131.78 39.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.837 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -83.52 107.34 15.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.497 HD11 ' CD1' ' A' ' 129' ' ' PHE . 0.8 OUTLIER -128.68 136.4 50.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.608 ' HG3' HG22 ' A' ' 154' ' ' VAL . 22.7 ttt180 -130.61 131.85 45.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.537 HG21 HD22 ' A' ' 149' ' ' LEU . 21.0 t -70.14 154.41 8.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.406 ' N ' HG12 ' A' ' 168' ' ' VAL . 43.5 mmm -121.35 -57.68 1.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -124.55 141.53 52.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.915 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.426 ' CG2' HG11 ' A' ' 168' ' ' VAL . 40.3 p -145.22 148.29 33.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.566 ' O ' HG11 ' A' ' 177' ' ' VAL . 22.6 mttt -133.94 158.02 76.37 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.916 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.21 -41.64 0.92 Allowed 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.222 -1.574 . . . . 0.0 112.427 -0.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.35 178.47 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.843 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -47.49 82.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.46 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -99.06 129.48 45.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.03 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.784 HG21 ' HB2' ' A' ' 117' ' ' ALA . 30.0 m -132.55 135.92 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.201 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.454 ' OG ' HD11 ' A' ' 63' ' ' LEU . 8.0 t -93.04 96.9 10.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.725 HD11 ' HB3' ' A' ' 146' ' ' PHE . 3.6 pt -88.24 82.72 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.132 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.2 mt -109.89 81.02 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.104 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.26 89.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 2.8 t -162.95 166.23 24.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -106.74 121.68 44.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.896 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -134.72 172.1 13.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.951 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.12 111.8 23.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.527 HG11 HD23 ' A' ' 139' ' ' LEU . 21.2 t -96.03 131.77 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.146 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.431 ' HB2' ' CE1' ' A' ' 119' ' ' TYR . 10.6 t70 -114.8 167.19 10.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -127.41 141.67 51.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.974 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -122.5 81.8 1.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.04 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.35 102.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.8 0.333 . . . . 0.0 110.866 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.4 p -104.0 36.42 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.65 122.57 6.76 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.508 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.79 -74.23 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.782 0.325 . . . . 0.0 110.899 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.0 t 61.15 35.55 18.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.985 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.02 -110.52 4.04 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.508 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.7 mt -95.69 102.44 10.22 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.646 0.26 . . . . 0.0 111.026 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.02 116.1 4.14 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.334 2.023 . . . . 0.0 112.316 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.22 172.94 12.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.8 m -99.42 29.71 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.113 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 59.88 160.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.929 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -166.7 119.13 0.99 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.814 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -109.13 132.22 54.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.044 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.8 mtm105 -148.94 136.53 20.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -91.1 117.96 30.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.826 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.7 p -141.59 129.16 21.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.1 t -176.5 160.42 2.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -77.76 149.66 34.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -155.02 145.22 21.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.917 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.2 mtt85 -76.5 148.15 37.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 64.3 m -113.52 127.7 56.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.511 ' CD2' HG23 ' A' ' 88' ' ' ILE . 17.4 m-85 -129.01 175.89 8.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.59 156.75 17.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.9 m -67.48 -30.17 48.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.45 -32.1 73.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.803 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.2 mmm -67.89 -18.3 64.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.194 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.2 tp -52.81 -33.2 48.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.836 0.351 . . . . 0.0 111.065 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.9 -175.33 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.131 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.42 149.08 13.89 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.51 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.82 -61.56 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.539 2.159 . . . . 0.0 112.301 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -66.47 169.25 7.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -144.25 175.05 10.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -138.67 150.57 46.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.919 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.0 30.56 4.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.853 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -119.43 -40.01 2.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.9 m -58.16 -37.95 65.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.159 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -73.5 -37.32 65.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -97.57 76.17 2.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.82 159.24 7.86 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.482 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.92 92.1 1.44 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.533 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.593 ' HG2' HD13 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -153.38 129.26 10.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.788 0.327 . . . . 0.0 110.904 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.507 HD13 ' SG ' ' A' ' 77' ' ' CYS . 45.1 pt -123.64 179.91 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.145 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.405 HG22 ' HB2' ' A' ' 84' ' ' ALA . 10.7 mt -130.11 115.65 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.064 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.541 ' C ' ' HB3' ' A' ' 84' ' ' ALA . 25.3 mtp -117.35 158.6 44.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.619 ' N ' ' HB3' ' A' ' 84' ' ' ALA . 50.5 Cg_exo -53.14 163.79 2.09 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.597 2.198 . . . . 0.0 112.234 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.31 -27.76 23.42 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.495 2.13 . . . . 0.0 112.234 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.1 p -59.14 -35.7 73.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.92 -32.56 72.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.8 tp -70.91 -39.51 72.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.19 -33.02 56.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -67.04 -41.55 86.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.572 HD23 HD12 ' A' ' 58' ' ' ILE . 16.4 mt -63.5 -31.6 72.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.9 t -68.88 -42.68 76.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -66.92 -32.19 73.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.4 mt -79.89 -3.26 47.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.461 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 m120 62.2 30.78 17.72 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.733 0.301 . . . . 0.0 110.909 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.572 HD12 HD23 ' A' ' 53' ' ' LEU . 30.5 mt -90.18 106.9 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.109 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.1 p -90.43 171.81 9.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.939 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.488 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -59.25 145.21 81.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.803 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 78.9 Cg_endo -77.41 167.63 78.81 Favored 'Cis proline' 0 C--N 1.347 0.499 0 C-N-CA 123.478 -1.468 . . . . 0.0 112.482 -0.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 4.8 mtt -128.73 62.02 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.419 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -82.85 158.94 22.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.948 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -131.25 126.58 35.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -82.69 106.42 14.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.9 mt -82.41 79.36 8.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.835 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -75.84 93.47 3.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.979 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.52 ' HA ' HG13 ' A' ' 107' ' ' VAL . 5.4 t-20 -68.08 120.04 13.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -97.75 38.07 1.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -128.46 -45.65 1.34 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.8 23.24 7.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.124 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 54.75 39.26 31.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.046 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -89.32 160.43 16.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.964 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 ttm -155.95 124.83 6.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.0 m -153.8 121.38 5.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.854 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -86.01 97.15 10.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.507 ' SG ' HD13 ' A' ' 43' ' ' ILE . 26.4 p -85.19 159.42 20.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -118.26 128.71 7.86 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.521 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.485 HG21 ' CE1' ' A' ' 82' ' ' PHE . 11.4 p -75.45 137.44 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.76 0.314 . . . . 0.0 111.117 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.593 HD13 ' HG2' ' A' ' 42' ' ' LYS . 6.3 tp -124.85 -56.49 1.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.911 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -103.39 142.75 33.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.485 ' CE1' HG21 ' A' ' 79' ' ' VAL . 49.9 m-85 -118.01 67.82 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.942 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.2 m -137.04 30.99 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.078 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.619 ' HB3' ' N ' ' A' ' 46' ' ' PRO . . . -86.25 157.92 19.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.658 ' HB2' HD12 ' A' ' 88' ' ' ILE . 3.2 m-20 -81.91 165.28 20.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -63.6 106.86 1.03 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.19 29.93 21.19 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.486 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' A' ' 85' ' ' ASP . 31.9 mt -144.96 117.16 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.793 0.33 . . . . 0.0 111.132 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 61.7 m -125.29 129.52 50.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.928 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -97.82 149.4 22.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 mp -144.34 155.05 57.76 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.957 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.25 170.64 0.23 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.575 2.183 . . . . 0.0 112.307 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -78.02 -44.51 26.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -60.24 -37.28 79.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 50.1 ttm -75.05 -31.62 61.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -42.72 81.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.841 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -75.14 -40.41 59.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.839 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -60.5 -35.92 77.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.495 HD13 HD11 ' A' ' 101' ' ' LEU . 72.6 mt -83.11 -21.99 33.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.15 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 86.3 mt 61.55 38.06 15.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.86 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.495 HD11 HD13 ' A' ' 99' ' ' LEU . 8.4 mt -86.51 -178.26 6.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -115.92 168.36 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -65.31 81.39 0.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.98 41.14 1.86 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.518 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -88.83 135.73 13.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.555 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.4 mt -81.98 124.6 29.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 0.0 110.935 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 68' ' ' ASN . 21.6 t -130.36 153.37 38.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.5 143.78 51.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.6 t -124.86 149.4 29.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -157.61 131.47 8.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 83.9 p -91.86 101.66 14.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.5 m -117.91 144.82 24.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.105 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -102.63 113.04 26.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.6 mt -102.68 171.89 7.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -115.84 171.89 7.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.849 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 31.1 m -60.41 155.68 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.061 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.896 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -89.59 156.41 18.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.077 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.33 -35.67 4.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -133.94 92.58 2.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.63 110.93 23.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.813 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.88 130.4 53.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.607 ' CZ ' HD21 ' A' ' 143' ' ' LEU . 37.6 m-85 -118.26 156.21 29.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.878 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -136.01 87.67 23.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.25 116.64 2.95 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.523 2.149 . . . . 0.0 112.363 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -68.54 -31.3 70.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.963 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -103.74 143.92 27.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.972 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.62 -17.06 20.88 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.585 2.19 . . . . 0.0 112.543 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -33.22 63.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.136 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.598 ' CE2' HD11 ' A' ' 166' ' ' LEU . 7.5 t80 -73.36 -48.48 33.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 70.4 mt -59.29 -30.37 68.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.919 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.85 -25.64 67.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.964 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.594 HG21 HG21 ' A' ' 138' ' ' VAL . 38.7 mt -59.96 138.96 20.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.06 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.7 m -64.0 -42.9 97.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.669 ' O ' HG23 ' A' ' 138' ' ' VAL . 3.2 m120 -117.62 79.97 13.09 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.979 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.46 -28.39 21.96 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.602 2.202 . . . . 0.0 112.247 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -68.5 -38.94 81.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.948 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.77 -38.04 70.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.051 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 134' ' ' ASN . 27.9 t -69.59 -35.51 66.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.019 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.428 HD23 HG11 ' A' ' 186' ' ' VAL . 5.5 tp -78.82 -42.75 26.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.829 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.707 ' HA ' HD12 ' A' ' 143' ' ' LEU . 43.3 mt-10 -66.89 -35.94 81.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -65.24 -34.39 78.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.72 -32.64 27.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.088 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.707 HD12 ' HA ' ' A' ' 140' ' ' GLU . 12.4 mt -60.63 -30.12 69.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -58.8 -31.39 68.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -74.4 -33.69 63.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.17 149.95 45.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -110.07 -27.44 9.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.248 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 4.5 t -141.65 163.55 32.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.0 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 149' ' ' LEU . 12.4 mt -137.92 165.02 27.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.781 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.8 145.44 23.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.905 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.3 m -69.34 97.44 0.96 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.19 51.76 0.86 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.472 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.46 120.66 38.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.827 0.346 . . . . 0.0 110.908 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.24 93.2 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.071 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.446 HD12 HG23 ' A' ' 157' ' ' ILE . 1.1 pp -101.35 138.34 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.113 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.672 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -111.9 100.32 8.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.055 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.636 HG12 HD12 ' A' ' 166' ' ' LEU . 2.6 pt -80.0 160.17 4.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.165 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -156.53 147.55 22.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -171.69 -46.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.932 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 32.3 p30 -96.72 40.31 1.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.92 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 59.71 31.65 20.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -148.5 129.01 13.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.672 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 4.1 mp -87.67 97.51 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.076 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -78.8 120.79 23.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.859 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.53 128.99 38.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.981 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.636 HD12 HG12 ' A' ' 157' ' ' ILE . 1.5 mt -145.95 136.25 23.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -136.17 126.12 25.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.3 t -62.16 140.03 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.094 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 4.6 mmm -107.41 -49.44 3.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -139.17 154.47 48.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.91 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 80.6 p -156.92 125.72 5.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -111.63 158.09 37.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.819 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.01 -40.63 1.12 Allowed 'Cis proline' 0 C--N 1.347 0.459 0 C-N-CA 123.248 -1.563 . . . . 0.0 112.347 0.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.67 174.48 5.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -58.06 -46.71 84.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.912 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -102.62 128.96 49.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.071 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.896 HG21 ' HB2' ' A' ' 117' ' ' ALA . 16.0 m -139.98 153.38 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.167 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.48 101.86 11.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.2 pt -85.24 84.56 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.166 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 29.6 mm -118.51 89.54 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.113 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 60.47 87.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 30.2 t -166.54 154.54 10.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.59 97.07 7.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -102.53 170.27 8.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -93.9 88.27 5.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.866 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.428 HG11 HD23 ' A' ' 139' ' ' LEU . 29.5 t -78.52 120.69 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.43 162.5 16.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.813 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -118.33 162.88 17.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -153.31 96.38 2.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.965 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.117 -179.95 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.43 -178.46 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.937 0.398 . . . . 0.0 110.847 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.1 p -102.85 -71.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.92 174.06 44.52 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.509 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.9 m -105.68 -69.9 0.8 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.847 0.356 . . . . 0.0 110.936 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.62 105.28 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.54 -168.94 12.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.452 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 pt -128.45 139.03 34.35 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.625 0.25 . . . . 0.0 111.101 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.91 121.27 6.14 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.507 2.138 . . . . 0.0 112.374 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -98.58 139.0 34.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.2 m -101.46 124.28 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.094 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -76.44 -68.24 0.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -113.55 90.79 3.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.957 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.55 119.51 3.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.15 178.71 6.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -99.63 108.92 21.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.7 p -135.47 96.48 3.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.1 t -150.17 160.91 43.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -86.37 161.92 18.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.889 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -159.92 137.83 10.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -70.93 138.49 50.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 75.8 m -100.94 142.03 32.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.865 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -145.34 176.71 9.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.2 p -88.37 167.1 13.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.8 m -102.15 20.03 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.356 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.59 -29.65 9.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.949 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 1.1 mmt -58.61 -27.63 64.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.042 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.437 ' CD1' ' CE2' ' A' ' 90' ' ' TYR . 1.0 OUTLIER -57.42 157.47 6.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.937 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.73 179.86 4.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.088 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 140.67 154.44 6.24 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.475 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.09 -39.51 70.34 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.581 2.187 . . . . 0.0 112.249 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -126.11 170.01 12.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -133.88 147.48 51.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.17 147.74 27.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.944 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 p -108.2 -23.81 11.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.056 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -53.14 -29.88 33.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.107 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -60.51 -41.09 86.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.078 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -70.68 -31.73 68.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -99.57 86.75 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.88 -170.98 24.3 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.509 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.23 46.59 1.15 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.541 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -102.21 134.88 44.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 110.893 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.437 HG21 HD23 ' A' ' 91' ' ' LEU . 40.4 pt -127.63 177.15 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.5 mt -128.96 96.04 3.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.07 159.3 34.57 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.49 ' N ' ' HB3' ' A' ' 84' ' ' ALA . 47.5 Cg_exo -55.94 169.08 1.5 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.585 2.19 . . . . 0.0 112.27 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.25 -26.06 30.34 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.579 2.186 . . . . 0.0 112.369 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.28 -31.15 67.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.015 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . . . -63.32 -43.86 96.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.154 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.426 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 3.3 tp -70.82 -32.3 69.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.75 -25.75 44.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.035 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.04 -30.99 13.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.965 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.588 HD23 HD12 ' A' ' 58' ' ' ILE . 13.8 mt -60.47 -49.62 76.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.112 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.53 -31.47 69.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.068 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -70.5 -22.82 62.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.122 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.3 mt -94.78 20.06 9.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.193 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.67 35.58 25.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.863 0.363 . . . . 0.0 110.961 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.588 HD12 HD23 ' A' ' 53' ' ' LEU . 31.1 mt -100.94 124.89 54.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.59 170.4 8.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.808 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.444 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.5 t80 -65.46 140.6 97.69 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.837 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 72.1 Cg_endo -77.15 167.15 80.51 Favored 'Cis proline' 0 C--N 1.349 0.566 0 C-N-CA 123.53 -1.446 . . . . 0.0 112.393 0.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.7 mtt -131.74 69.03 1.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.56 HD11 ' OG ' ' A' ' 178' ' ' SER . 1.4 mt -82.15 148.8 28.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -118.34 142.65 47.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.416 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 10.8 tttt -97.13 107.67 20.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 66' ' ' LEU . 11.4 mt -89.65 99.71 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.0 103.02 12.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.95 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -67.7 129.27 39.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -97.66 38.26 1.3 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -142.61 -47.5 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.974 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.8 m -106.31 13.42 28.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.296 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 53.87 30.66 11.83 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.77 0.319 . . . . 0.0 111.13 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.456 ' CB ' HD23 ' A' ' 99' ' ' LEU . 2.9 mmp_? -82.66 161.53 22.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.64 117.98 3.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.0 t -143.68 156.02 44.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.933 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.416 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 13.8 m80 -122.79 112.92 18.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 24.2 p -106.35 168.09 9.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.3 139.04 13.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.583 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.79 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 12.3 p -81.1 151.48 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 0.0 111.051 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.9 tp -129.09 -61.91 1.02 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -113.59 169.45 8.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.79 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 47.6 m-85 -138.75 75.16 1.5 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.852 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.1 m -142.51 32.48 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.154 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HB3' ' N ' ' A' ' 46' ' ' PRO . . . -92.03 161.9 14.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.054 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.511 ' HB3' HD12 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -82.04 158.26 23.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -60.1 132.77 54.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 68.24 28.2 73.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.526 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 85' ' ' ASP . 27.5 mt -147.98 127.18 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.835 0.35 . . . . 0.0 111.136 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 83.1 m -132.39 127.34 35.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.437 ' CE2' ' CD1' ' A' ' 28' ' ' LEU . 35.6 m-85 -94.15 134.12 36.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.437 HD23 HG21 ' A' ' 43' ' ' ILE . 4.1 mp -142.0 159.96 57.19 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -51.86 -177.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.554 2.169 . . . . 0.0 112.326 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -97.92 -31.64 12.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.952 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 45.4 p-90 -67.48 -34.8 77.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.965 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.4 tpp -79.1 -32.0 44.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 44.9 mmm -67.59 -31.35 71.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -37.03 22.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -59.97 -31.73 70.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.456 HD23 ' CB ' ' A' ' 73' ' ' ARG . 8.9 mt -91.62 -16.81 26.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.276 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.3 mt 65.19 33.7 9.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.827 0.346 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.7 mt -79.8 -178.52 6.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.89 175.77 8.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.901 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.9 101.13 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.85 43.03 7.4 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.564 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.85 128.96 9.19 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.54 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.3 mt -79.38 126.87 31.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.93 139.66 49.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -63.75 110.61 2.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.2 t -101.07 136.9 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.147 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -134.62 164.32 27.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.3 p -123.38 110.88 15.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.89 148.6 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.152 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -104.22 100.03 9.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.804 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.7 mt -96.21 178.44 5.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -120.44 169.65 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 20.3 m -64.02 146.15 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.033 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.785 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -90.87 149.59 21.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.045 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 75.4 p -114.23 -37.28 4.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -123.65 111.57 16.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 9.7 m -128.15 122.51 32.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.865 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -102.1 132.32 48.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.587 ' CE2' HG22 ' A' ' 168' ' ' VAL . 90.7 m-85 -119.02 161.6 19.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -150.76 93.02 3.79 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.27 117.86 3.51 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.545 2.164 . . . . 0.0 112.34 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -67.09 -33.19 74.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.908 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.73 146.31 33.46 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.61 -14.91 24.67 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.612 2.208 . . . . 0.0 112.541 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -55.05 -34.19 63.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.104 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 135' ' ' PRO . 22.6 t80 -73.68 -36.06 65.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.0 mt -63.27 -31.77 73.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -62.73 -23.09 67.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.071 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.675 HG22 ' H ' ' A' ' 134' ' ' ASN . 48.9 mt -59.94 140.06 18.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.001 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.0 t -69.7 -30.96 68.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.675 ' H ' HG22 ' A' ' 132' ' ' ILE . 2.1 m120 -133.12 67.26 77.09 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.989 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.406 ' HB3' ' CE1' ' A' ' 129' ' ' PHE . 37.3 Cg_exo -57.23 -34.0 97.02 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.634 2.223 . . . . 0.0 112.22 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.81 -44.77 92.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.86 -45.03 91.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.079 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.461 HG21 HG21 ' A' ' 132' ' ' ILE . 21.5 t -63.87 -39.89 87.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.442 HD22 ' CZ ' ' A' ' 188' ' ' PHE . 21.5 tp -67.02 -35.91 80.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -76.78 -32.06 57.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -65.42 -33.05 75.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -82.27 -35.13 28.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.155 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.7 mt -60.26 -30.0 69.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -58.71 -30.48 67.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -83.04 -34.62 26.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.93 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -66.14 136.15 55.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -99.08 -29.2 13.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.153 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.552 ' HB2' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -138.05 164.56 28.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.964 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.6 mt -141.65 154.31 45.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 15.5 m -144.71 141.71 29.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 37.9 m -72.72 119.61 17.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 90.7 43.51 4.81 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.523 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -131.14 122.88 27.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.745 0.307 . . . . 0.0 110.911 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.23 84.96 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.055 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.4 pt -77.78 110.45 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.166 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.81 139.56 37.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.083 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 37.0 pt -128.44 144.34 38.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.175 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -138.45 142.68 39.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.792 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -167.45 -48.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.044 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -95.52 41.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 58.11 30.27 19.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.932 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -148.02 122.29 9.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.904 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.503 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.7 mp -81.42 89.12 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.125 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -67.53 166.15 15.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.83 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -117.15 137.82 52.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.27 149.2 29.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -138.73 129.59 26.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.587 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.3 t -74.12 113.24 12.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.188 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.6 mmt -68.0 -59.93 2.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -144.93 166.07 26.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 77.2 p -154.49 161.12 41.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -138.56 156.8 73.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.33 -18.48 17.88 Favored 'Cis proline' 0 C--N 1.347 0.487 0 C-N-CA 123.312 -1.537 . . . . 0.0 112.589 0.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -133.38 169.88 16.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.902 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -43.48 82.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.934 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -96.55 117.67 31.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' A' ' 117' ' ' ALA . 15.7 m -139.56 151.18 22.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.214 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.56 ' OG ' HD11 ' A' ' 63' ' ' LEU . 23.3 t -105.54 92.12 4.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.829 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.3 pt -87.48 83.4 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.198 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.2 mt -112.88 96.55 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.042 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.49 81.94 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.823 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 11.0 t -169.5 149.44 3.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.843 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.99 127.85 41.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -132.97 149.43 52.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -78.03 87.87 4.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.843 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.01 136.93 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -114.14 174.11 6.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . 0.442 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 15.6 m-85 -139.41 155.48 47.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.955 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -150.55 91.0 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.056 -179.948 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.481 -0.247 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.8 m 62.14 149.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 0.0 110.972 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 m 59.8 96.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.84 -177.18 51.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.425 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 t 60.65 88.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.846 0.355 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -103.23 157.89 16.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.93 -143.97 8.28 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.455 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 8' ' ' ILE . 12.1 tt -144.24 125.29 7.84 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.547 0.213 . . . . 0.0 111.02 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.76 149.55 67.01 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.355 2.037 . . . . 0.0 112.355 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.94 31.33 6.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.6 m -74.61 149.83 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.156 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -99.46 31.33 3.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -106.99 -60.24 1.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 60.58 178.17 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.6 mtt85 -119.9 -177.21 3.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -83.45 88.3 6.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.1 p -121.13 109.08 14.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.0 t -174.55 162.3 3.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -91.34 150.17 21.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -145.31 136.59 24.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.6 mtt180 -68.91 141.55 54.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.0 m -101.37 134.62 44.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.958 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.539 ' CD2' HG23 ' A' ' 88' ' ' ILE . 8.8 m-85 -146.89 138.49 24.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 76.0 p -66.76 138.32 57.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.498 HG12 ' HB3' ' A' ' 90' ' ' TYR . 17.2 m -59.39 -27.18 36.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.227 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.52 -27.5 57.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.034 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 32.4 mmt -57.79 -45.99 85.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.969 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.417 HD13 ' CE2' ' A' ' 90' ' ' TYR . 9.4 tp -60.92 142.61 56.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.821 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.64 174.87 5.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.14 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 144.62 146.92 4.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.419 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.54 -38.85 83.97 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.492 2.128 . . . . 0.0 112.352 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -93.34 126.16 38.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.95 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.95 -53.92 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.791 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.13 145.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.01 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.8 m -111.65 -21.15 11.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.19 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.71 -36.86 62.7 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.141 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.1 t -62.66 -39.31 84.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.016 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -31.99 71.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -78.31 -46.92 18.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.936 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -60.59 162.83 19.74 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.438 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.83 30.04 10.73 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.542 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -94.64 174.05 7.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.824 0.345 . . . . 0.0 110.891 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.525 HG22 ' HA ' ' A' ' 91' ' ' LEU . 5.2 pt -146.7 165.51 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.096 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.512 HG22 ' HB2' ' A' ' 84' ' ' ALA . 3.9 mt -116.49 106.04 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.066 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.432 ' C ' ' HB3' ' A' ' 84' ' ' ALA . 71.6 mtp -97.39 160.53 28.61 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.01 162.81 2.44 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.57 2.18 . . . . 0.0 112.301 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.4 -25.94 35.3 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.582 2.188 . . . . 0.0 112.348 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.4 t -58.86 -30.82 68.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.99 -32.79 73.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.088 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.466 HD13 ' CD2' ' A' ' 82' ' ' PHE . 25.1 tp -60.23 -33.18 71.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -89.1 -30.43 18.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.957 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -41.5 70.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.974 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.422 HD13 ' SD ' ' A' ' 62' ' ' MET . 44.1 mt -54.11 -30.82 50.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.061 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.05 -28.62 17.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -23.17 57.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.17 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.7 mt -93.12 17.41 10.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.317 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 54.96 32.46 18.09 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.784 0.326 . . . . 0.0 111.171 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 59' ' ' THR . 38.6 mt -96.27 153.54 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.119 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.402 ' N ' HG22 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -149.19 175.42 11.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.44 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 3.2 t80 -63.36 139.0 97.51 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.9 Cg_endo -76.6 162.1 92.43 Favored 'Cis proline' 0 C--N 1.348 0.55 0 C-N-CA 123.492 -1.462 . . . . 0.0 112.371 -0.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.422 ' SD ' HD13 ' A' ' 53' ' ' LEU . 12.1 mtt -130.48 65.17 1.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.482 HD11 ' OG ' ' A' ' 178' ' ' SER . 15.1 mt -87.69 139.66 30.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -113.1 142.65 45.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.412 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 1.0 OUTLIER -99.01 108.38 21.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.4 mt -95.68 90.63 5.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.4 m -95.8 121.73 37.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 -82.01 128.53 34.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.946 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.7 31.4 2.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -120.04 -42.08 2.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.94 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.29 22.47 7.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 54.49 39.83 31.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.093 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.7 159.0 15.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.922 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -150.61 139.69 21.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.562 HG21 HD11 ' A' ' 99' ' ' LEU . 10.2 t -158.03 148.24 20.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.932 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.504 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 66.5 m80 -115.29 115.41 26.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.978 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.8 p -124.74 167.09 15.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.933 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.74 165.23 13.44 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.2 141.72 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.859 0.361 . . . . 0.0 111.09 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.5 tp -119.25 -60.63 1.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -107.03 161.94 14.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.971 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.466 ' CD2' HD13 ' A' ' 50' ' ' LEU . 90.0 m-85 -129.7 47.95 2.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.828 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 m -123.38 35.43 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.007 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' A' ' 44' ' ' ILE . . . -92.52 154.86 18.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.051 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.47 149.63 33.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.846 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -59.99 110.51 1.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.97 -22.7 36.78 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.643 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.539 HG23 ' CD2' ' A' ' 23' ' ' PHE . 25.7 mt -99.05 121.82 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.0 111.139 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 28.5 t -110.41 130.52 55.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.498 ' HB3' HG12 ' A' ' 25' ' ' VAL . 43.6 m-85 -93.23 143.16 26.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.99 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.525 ' HA ' HG22 ' A' ' 43' ' ' ILE . 1.3 mp -144.89 156.54 55.43 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.07 -174.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.538 2.159 . . . . 0.0 112.283 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.69 -37.93 10.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.893 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.664 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 53.7 p-90 -61.36 -39.47 90.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.2 ttp -65.86 -40.01 91.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -37.98 86.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.82 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -74.06 -38.21 64.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.819 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -65.96 -42.01 90.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.816 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.562 HD11 HG21 ' A' ' 75' ' ' THR . 8.2 mt -83.23 -16.87 44.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.204 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt 62.31 36.84 14.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.777 0.323 . . . . 0.0 110.9 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.7 mt -84.94 -177.42 6.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -134.42 168.63 18.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.904 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.06 91.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.84 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.428 ' HA2' ' CE2' ' A' ' 23' ' ' PHE . . . 106.68 43.74 1.4 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.487 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.08 123.62 7.88 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.531 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.9 mt -72.94 131.21 41.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.809 0.338 . . . . 0.0 110.951 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.72 150.49 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.002 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -72.11 143.37 49.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.36 108.62 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.134 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.49 123.74 34.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.922 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.5 p -81.49 121.78 26.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.4 m -125.94 155.07 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.57 100.81 9.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.776 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.448 HD13 ' C ' ' A' ' 176' ' ' ALA . 2.8 mt -98.6 178.92 4.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -115.71 170.8 8.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.9 m -70.36 135.03 29.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.09 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.606 ' HB2' ' CB ' ' A' ' 177' ' ' VAL . . . -74.28 145.45 43.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.8 p -111.53 -31.95 6.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.914 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -129.53 110.3 11.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 93.5 p -122.58 119.0 29.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -106.17 130.87 53.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.68 ' CD1' HD21 ' A' ' 139' ' ' LEU . 87.3 m-85 -117.86 158.81 24.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -143.05 97.93 5.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.57 110.89 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.442 2.094 . . . . 0.0 112.47 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -63.42 -31.4 72.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.1 m -114.33 149.03 41.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.618 ' HA ' HD12 ' A' ' 130' ' ' LEU . 57.4 Cg_endo -70.94 -14.87 32.62 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.618 2.212 . . . . 0.0 112.584 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -55.59 -35.65 66.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.053 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -75.53 -42.98 51.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.916 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 127' ' ' PRO . 13.5 mt -60.07 -31.2 69.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.83 -28.19 69.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.002 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.563 HG22 ' H ' ' A' ' 134' ' ' ASN . 45.8 mt -62.74 137.31 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.093 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.3 t -68.95 -34.28 75.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.706 ' O ' HG23 ' A' ' 138' ' ' VAL . 1.9 m120 -119.51 77.31 19.5 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.86 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.38 -28.31 22.45 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.619 2.212 . . . . 0.0 112.285 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -70.35 -46.67 63.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.15 -31.19 71.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.157 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 134' ' ' ASN . 26.3 t -78.78 -31.53 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.095 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.68 HD21 ' CD1' ' A' ' 122' ' ' PHE . 11.5 tp -84.5 -34.75 23.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.483 ' OE2' HG21 ' A' ' 186' ' ' VAL . 3.9 mm-40 -70.85 -30.44 66.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.976 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -73.43 -31.63 63.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.17 -31.64 64.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.118 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.498 HD13 ' CE ' ' A' ' 184' ' ' MET . 82.2 mt -59.4 -30.44 68.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.5 mmp_? -62.42 -26.65 68.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -95.97 26.72 3.97 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.091 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -135.84 152.65 51.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.835 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -111.13 -34.25 6.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 6.8 t -141.78 158.91 43.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.965 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.93 137.27 36.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.876 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.67 149.4 40.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 43.8 m -69.49 104.8 2.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.82 33.3 3.57 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.552 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.35 111.8 24.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.759 0.314 . . . . 0.0 110.928 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.544 HG22 ' HG3' ' A' ' 167' ' ' ARG . 21.6 t -79.53 79.95 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.075 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.698 HD12 HG23 ' A' ' 157' ' ' ILE . 3.2 pt -63.79 159.07 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.152 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.664 ' HB3' ' HB3' ' A' ' 94' ' ' TRP . . . -125.05 93.0 3.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.085 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.698 HG23 HD12 ' A' ' 155' ' ' ILE . 10.0 pt -85.53 152.72 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.184 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -154.85 140.89 18.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -161.89 -47.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.97 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -93.75 45.19 1.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 55.65 29.48 13.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.086 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -149.34 122.19 8.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.868 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 3.3 mp -85.12 108.53 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -80.1 173.78 12.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -123.95 110.07 14.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.31 117.52 21.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.826 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.544 ' HG3' HG22 ' A' ' 154' ' ' VAL . 1.8 ttt85 -111.14 133.22 53.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.5 127.16 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.087 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 23.9 mmm -85.6 -54.71 4.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.485 ' O ' HG23 ' A' ' 171' ' ' THR . 0.4 OUTLIER -142.73 160.19 40.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.952 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.485 HG23 ' O ' ' A' ' 170' ' ' GLU . 2.6 p -159.08 146.47 17.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.909 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -129.07 159.86 66.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.95 -41.39 0.97 Allowed 'Cis proline' 0 C--N 1.347 0.48 0 C-N-CA 123.238 -1.567 . . . . 0.0 112.366 -0.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -106.29 172.43 6.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -57.86 -48.71 79.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.061 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.504 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -93.29 110.8 22.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.001 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.606 ' CB ' ' HB2' ' A' ' 117' ' ' ALA . 15.4 m -118.72 133.64 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.167 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.482 ' OG ' HD11 ' A' ' 63' ' ' LEU . 22.2 t -89.73 99.95 12.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.5 pt -94.08 87.26 2.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.249 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.2 mt -118.29 84.59 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.052 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.36 75.35 0.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 49.6 t -153.27 153.99 33.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.903 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.83 129.73 40.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.498 ' CE ' HD13 ' A' ' 143' ' ' LEU . 13.0 ptt? -140.21 179.23 6.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.869 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.45 112.63 25.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.512 HG11 HD23 ' A' ' 139' ' ' LEU . 21.6 t -92.81 127.52 44.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.058 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -117.7 171.81 7.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.878 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -134.74 141.89 46.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -111.75 83.23 1.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.121 179.971 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.9 -69.93 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.879 0.371 . . . . 0.0 110.823 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m 59.4 101.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.009 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.7 133.6 1.78 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.532 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.2 p -71.48 -50.32 32.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.828 0.347 . . . . 0.0 110.867 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.3 m 62.29 119.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.939 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.94 176.33 42.28 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.443 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.3 pt -64.77 155.67 81.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.775 0.322 . . . . 0.0 111.072 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.14 58.66 4.32 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.703 2.269 . . . . 0.0 112.507 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.1 mtt85 48.09 -168.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.299 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.3 m -132.77 176.47 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.03 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -106.16 36.44 2.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -110.56 102.37 10.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.803 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -152.19 -169.67 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.937 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.48 ' N ' HD22 ' A' ' 56' ' ' LEU . 6.5 mtp180 61.14 166.82 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.865 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -102.85 128.39 49.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.0 p -160.03 112.8 2.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.1 t -176.86 159.46 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.935 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.629 ' HB3' HD22 ' A' ' 106' ' ' LEU . 20.8 mt-30 -95.94 121.85 38.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.814 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -115.48 147.41 40.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.847 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -75.17 129.54 37.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.592 ' HB2' HD13 ' A' ' 91' ' ' LEU . 16.6 p -99.01 133.33 43.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.972 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.533 ' CD2' HG23 ' A' ' 88' ' ' ILE . 87.4 m-85 -136.3 178.45 7.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.66 146.07 27.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.695 HG11 HG21 ' A' ' 37' ' ' VAL . 5.1 m -58.41 -26.15 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.257 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.73 -30.06 63.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.042 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 10.5 mmm -71.44 -30.46 66.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.965 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tp -58.91 91.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.95 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 65.38 -76.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.093 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.88 173.68 17.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.507 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.19 -37.64 7.9 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.642 2.228 . . . . 0.0 112.328 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -107.91 129.6 55.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.918 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -155.67 -68.5 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.2 mmm-85 -111.24 154.96 23.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.53 28.93 5.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.38 -37.34 3.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.994 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.695 HG21 HG11 ' A' ' 25' ' ' VAL . 19.4 m -56.77 -40.18 68.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.238 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.429 ' HG3' HG23 ' A' ' 37' ' ' VAL . 4.1 mt-10 -78.03 -31.06 50.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -78.53 -31.22 47.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.67 -178.57 20.14 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.564 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.75 53.24 0.63 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.544 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -114.74 165.04 13.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.851 0.357 . . . . 0.0 110.852 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.1 pt -133.38 174.4 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.543 HG23 ' HB2' ' A' ' 81' ' ' GLU . 2.5 mt -125.51 98.39 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.9 mtm -98.54 155.51 36.71 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.782 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.71 154.9 40.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.581 2.188 . . . . 0.0 112.211 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.8 -26.42 17.71 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.619 2.213 . . . . 0.0 112.566 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.6 p -58.79 -31.19 68.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.973 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.14 -30.26 69.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.261 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.419 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 33.8 tp -74.69 -30.14 61.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.998 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.18 -33.91 19.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.914 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.73 -38.88 62.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.454 HD13 ' SD ' ' A' ' 62' ' ' MET . 14.0 mt -59.1 -32.84 70.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.043 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -86.98 -30.06 21.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -22.61 62.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.12 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 15' ' ' ARG . 14.1 mt -93.93 19.19 9.31 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.244 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 55.12 30.47 14.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.871 0.367 . . . . 0.0 111.14 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.7 mt -99.03 120.81 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.098 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -109.59 168.35 9.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.965 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -60.17 144.58 87.02 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.839 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.464 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.89 158.27 96.89 Favored 'Cis proline' 0 C--N 1.348 0.5 0 C-N-CA 123.485 -1.464 . . . . 0.0 112.344 0.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.454 ' SD ' HD13 ' A' ' 53' ' ' LEU . 9.5 mtt -123.7 73.52 1.2 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.789 HD13 HD12 ' A' ' 114' ' ' LEU . 2.0 mt -91.26 134.9 34.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.853 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -102.8 141.3 35.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.404 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 13.5 tttp -94.97 97.6 10.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.872 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.4 mt -76.98 76.83 3.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 m -83.16 95.55 8.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -74.79 129.44 37.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.933 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -98.14 35.58 1.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.909 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -111.63 -35.66 5.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.841 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.1 t -151.94 29.72 0.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.973 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 58.72 35.83 24.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.002 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.575 ' HB3' HD23 ' A' ' 99' ' ' LEU . 12.8 mmt180 -81.82 143.31 31.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.929 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -144.22 135.02 25.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.741 HG22 HD21 ' A' ' 99' ' ' LEU . 1.8 t -159.97 95.25 1.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.404 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 62.0 m80 -63.68 115.75 5.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.0 p -121.91 151.31 40.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.37 138.91 15.06 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.519 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.3 146.82 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.808 0.337 . . . . 0.0 111.066 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.9 tp -131.29 -56.65 1.02 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.543 ' HB2' HG23 ' A' ' 44' ' ' ILE . 4.1 mm-40 -91.76 142.85 27.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.841 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CD2' ' HB2' ' A' ' 50' ' ' LEU . 71.8 m-85 -128.3 55.62 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.884 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 m -137.07 35.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.177 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.11 161.89 13.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.109 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.62 155.53 38.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.91 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.46 127.37 31.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.948 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.35 27.69 65.3 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.558 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.533 HG23 ' CD2' ' A' ' 23' ' ' PHE . 29.8 mt -148.75 99.15 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 111.072 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 13.7 m -100.9 134.85 43.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -101.32 151.35 22.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 22' ' ' CYS . 5.1 mp -145.29 155.59 54.17 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.41 ' HD2' ' HE2' ' A' ' 95' ' ' MET . 53.6 Cg_exo -52.28 -176.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.528 2.152 . . . . 0.0 112.355 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -87.51 -50.67 6.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.944 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -61.96 -37.53 85.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.856 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.41 ' HE2' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -63.75 -38.26 90.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.854 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -47.22 70.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.801 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -38.08 89.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.814 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -59.55 -31.28 69.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.741 HD21 HG22 ' A' ' 75' ' ' THR . 6.3 mt -98.82 -15.25 19.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.234 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.9 mt 61.7 41.25 12.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 0.0 110.872 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.548 HD11 HD13 ' A' ' 99' ' ' LEU . 3.7 mt -79.33 159.04 27.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.828 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -111.13 -178.95 3.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.869 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.53 106.42 1.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.951 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.43 ' HA2' ' CZ ' ' A' ' 23' ' ' PHE . . . 85.8 33.77 14.93 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.545 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.74 136.03 17.48 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.52 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.629 HD22 ' HB3' ' A' ' 19' ' ' GLN . 34.5 mt -88.6 128.86 35.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 0.0 110.866 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.11 146.97 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.156 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -69.16 128.87 38.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.17 99.02 6.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.087 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -124.09 128.48 49.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.849 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.4 p -88.78 100.49 13.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 m -103.43 162.09 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.126 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -97.05 116.44 29.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.789 HD12 HD13 ' A' ' 63' ' ' LEU . 65.2 mt -115.4 170.78 8.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -127.4 164.56 21.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.926 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.2 m -62.65 140.47 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.661 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -76.63 148.11 37.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.124 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.9 p -105.0 -36.09 7.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.824 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -127.61 109.63 11.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 m -108.9 126.57 53.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.2 ttpt -124.41 134.17 53.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.8 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.494 ' CE2' HG22 ' A' ' 168' ' ' VAL . 91.9 m-85 -127.88 159.32 35.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -137.06 95.31 12.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.62 107.33 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.581 2.188 . . . . 0.0 112.347 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -59.27 -31.22 68.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.0 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.84 146.6 35.43 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.98 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.53 -16.02 27.37 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.63 2.22 . . . . 0.0 112.515 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.22 -42.6 73.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.009 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -60.21 -40.95 91.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.5 -28.33 69.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -60.68 -24.4 65.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.992 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 134' ' ' ASN . 50.7 mt -62.72 136.9 25.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.986 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 31.5 m -59.06 -40.2 84.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.481 ' H ' HG22 ' A' ' 132' ' ' ILE . 1.8 m120 -131.63 86.93 47.53 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.904 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.77 -28.03 25.7 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.528 2.152 . . . . 0.0 112.272 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -63.34 -31.16 72.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.3 -32.7 49.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.131 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 132' ' ' ILE . 21.4 t -83.37 -30.83 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.179 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.446 HD21 ' HB2' ' A' ' 122' ' ' PHE . 46.5 tp -75.16 -30.39 60.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.92 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -85.54 -38.83 18.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.014 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -65.3 -23.98 67.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.25 -33.39 61.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.291 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 23.3 mt -63.65 -22.88 67.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.163 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.89 -29.25 40.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.123 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -87.08 -29.71 21.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.981 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -88.28 140.6 29.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -103.44 -30.37 10.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.653 ' HB2' HD22 ' A' ' 63' ' ' LEU . 4.4 t -131.64 163.56 27.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.8 mt -141.15 164.78 29.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.23 129.09 13.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.409 HG23 ' HA ' ' A' ' 170' ' ' GLU . 52.3 m -59.95 110.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 98.41 51.61 1.42 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.539 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.23 130.25 28.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 110.866 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.5 107.07 13.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.069 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 2.3 pt -105.09 106.08 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.144 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -81.42 127.07 32.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.088 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 36.9 pt -118.8 148.39 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.076 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -146.7 134.56 21.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -149.73 -47.42 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.907 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -100.42 44.31 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.85 30.36 19.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.88 115.93 9.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.579 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.9 mp -81.11 86.59 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.09 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -66.9 158.4 30.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.44 136.19 50.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.954 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.3 mt -145.6 154.22 41.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -144.22 125.21 14.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.935 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.494 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.6 t -68.7 104.47 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.4 ' O ' HG23 ' A' ' 151' ' ' THR . 0.0 OUTLIER -67.42 -51.5 51.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 171' ' ' THR . 0.1 OUTLIER -151.64 164.23 37.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 170' ' ' GLU . 0.7 OUTLIER -159.97 142.17 13.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 39.4 mttt -118.55 157.48 49.54 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.2 -27.08 8.82 Favored 'Cis proline' 0 C--N 1.347 0.453 0 C-N-CA 123.268 -1.555 . . . . 0.0 112.355 0.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.98 174.1 8.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.852 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -57.66 -45.23 85.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.51 111.55 23.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.055 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.661 HG21 ' HB2' ' A' ' 117' ' ' ALA . 27.7 m -128.63 140.7 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.159 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.619 ' OG ' HD11 ' A' ' 63' ' ' LEU . 3.9 t -97.76 87.69 4.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.1 pt -83.63 82.95 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.1 mt -117.97 89.31 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.161 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.84 88.36 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -164.07 173.56 12.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.838 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -114.41 120.09 39.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -135.32 174.04 11.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.837 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -105.24 97.74 7.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.947 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.95 145.45 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.04 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -127.38 169.75 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . 0.436 ' CE1' HD22 ' A' ' 139' ' ' LEU . 7.0 m-85 -127.42 143.14 51.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.947 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -134.94 97.73 3.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.916 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.137 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.0 m 60.37 106.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 110.949 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.1 p -64.49 -69.45 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.828 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.95 -132.45 17.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.499 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.8 p -134.04 124.59 26.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.329 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.4 m -136.89 178.47 7.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.826 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.53 -169.81 19.54 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.619 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.58 HD12 ' HD3' ' A' ' 10' ' ' ARG . 16.7 pt -150.07 154.24 36.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.704 0.288 . . . . 0.0 111.097 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.27 63.01 2.08 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.587 2.191 . . . . 0.0 112.275 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.58 ' HD3' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -125.38 159.29 32.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.863 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t 55.0 29.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -98.23 139.83 33.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.844 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -177.26 -39.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.838 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -90.23 51.58 2.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.855 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.55 117.38 7.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -60.11 107.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.002 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.7 p -151.21 110.43 3.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 t -168.55 171.05 9.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.752 ' HB3' HD22 ' A' ' 106' ' ' LEU . 20.9 mt-30 -95.7 126.65 41.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -125.09 143.05 51.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.3 mtt-85 -66.73 144.79 56.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.008 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.6 p -114.92 120.95 41.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.955 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.741 ' CD2' HG23 ' A' ' 88' ' ' ILE . 77.1 m-85 -127.45 177.0 7.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.975 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.6 m -91.54 153.36 19.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.5 m -68.24 -28.3 40.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.144 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.02 -29.37 63.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.088 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.22 -31.7 69.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.538 HD13 ' CE2' ' A' ' 90' ' ' TYR . 17.3 tp -79.94 154.66 28.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.2 168.98 11.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.51 161.27 34.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.52 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.24 -40.38 69.85 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.639 2.226 . . . . 0.0 112.259 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -156.88 -74.48 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -163.43 141.8 7.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.8 mmt85 -138.24 104.54 5.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.17 35.77 1.7 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -110.04 -30.23 7.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.9 t -77.16 -28.42 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.197 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.81 20.15 10.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -118.22 -38.05 3.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.784 0.326 . . . . 0.0 110.957 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.34 -154.25 26.33 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.456 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.38 87.73 0.45 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.51 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.0 149.91 31.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.791 0.329 . . . . 0.0 110.843 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.776 HG21 HD23 ' A' ' 91' ' ' LEU . 44.4 pt -138.14 175.52 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.189 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.404 HG23 ' HB2' ' A' ' 81' ' ' GLU . 1.9 mp -129.77 111.22 21.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.092 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 1.4 mtm -105.33 161.0 24.12 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.38 154.01 12.28 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.577 2.185 . . . . 0.0 112.267 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.93 -34.9 68.76 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.563 2.175 . . . . 0.0 112.278 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.81 -29.75 68.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.63 -46.57 86.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.182 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.446 HD13 ' CE2' ' A' ' 82' ' ' PHE . 41.3 tp -61.93 -42.65 99.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.956 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.98 -38.92 76.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.65 -31.62 68.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.811 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.4 mt -63.6 -37.65 88.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.71 10.66 25.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.308 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.5 -25.6 9.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.713 0.292 . . . . 0.0 110.969 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.0 mt -94.48 20.15 8.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.313 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.84 40.12 19.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.889 0.375 . . . . 0.0 111.004 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.1 mm -95.12 127.56 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.097 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.47 158.91 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.909 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.446 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -66.37 143.04 98.08 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.9 Cg_endo -76.81 160.19 95.24 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 123.468 -1.472 . . . . 0.0 112.364 0.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.6 mtt -112.46 53.7 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.452 HD13 ' SG ' ' A' ' 148' ' ' CYS . 17.3 mt -74.68 120.73 20.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.9 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -85.57 168.62 14.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -121.75 102.08 7.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.484 HD22 HG11 ' A' ' 107' ' ' VAL . 65.0 mt -85.76 105.02 15.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.958 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.1 m -104.1 101.84 11.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -77.84 123.32 26.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.883 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -98.87 31.56 2.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.84 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -129.52 -45.93 1.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.2 m -113.48 15.24 19.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.257 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 53.22 32.29 13.12 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.811 0.338 . . . . 0.0 111.134 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.1 mmt-85 -86.53 151.34 23.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.96 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.47 ' O ' HG21 ' A' ' 150' ' ' THR . 27.3 ttt -149.13 107.46 3.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.815 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.7 t -130.29 163.61 26.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.578 ' CD2' HD11 ' A' ' 114' ' ' LEU . 52.0 m80 -122.14 105.46 10.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.7 p -98.27 175.59 6.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.941 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -137.68 139.27 10.3 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.488 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.503 HG21 ' CE1' ' A' ' 82' ' ' PHE . 9.6 p -82.57 149.97 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 111.03 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.4 tp -136.43 -59.08 0.73 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.953 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.404 ' HB2' HG23 ' A' ' 44' ' ' ILE . 4.5 mp0 -92.41 160.57 15.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CE1' HG21 ' A' ' 79' ' ' VAL . 96.6 m-85 -142.18 68.59 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.94 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.9 m -150.96 31.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.156 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.04 179.99 7.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.705 ' HB3' HD12 ' A' ' 88' ' ' ILE . 5.6 t70 -95.39 156.64 16.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -59.93 121.19 11.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.961 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.75 28.06 63.74 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.741 HG23 ' CD2' ' A' ' 23' ' ' PHE . 29.5 mt -146.93 107.79 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 111.165 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 89.0 m -108.35 133.03 53.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.538 ' CE2' HD13 ' A' ' 28' ' ' LEU . 33.2 m-85 -90.67 134.35 34.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.776 HD23 HG21 ' A' ' 43' ' ' ILE . 1.7 mt -136.63 149.94 68.71 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.878 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.48 -172.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.528 2.152 . . . . 0.0 112.34 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -96.73 -41.34 8.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.942 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.444 ' CD2' ' N ' ' A' ' 95' ' ' MET . 65.2 p-90 -61.32 -44.07 97.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.924 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.444 ' N ' ' CD2' ' A' ' 94' ' ' TRP . 31.8 ttm -69.21 -38.19 78.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.982 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -31.39 72.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -85.06 -39.92 17.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -59.91 -34.21 72.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.824 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.1 mt -90.02 -12.93 37.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.219 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.5 mt 62.36 38.7 12.85 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.822 0.344 . . . . 0.0 110.873 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.4 mt -82.89 178.89 7.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -136.24 -179.94 5.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.07 127.51 33.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.406 ' HA2' ' CZ ' ' A' ' 23' ' ' PHE . . . 68.84 28.25 73.23 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.532 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -84.93 131.77 10.64 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.501 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.752 HD22 ' HB3' ' A' ' 19' ' ' GLN . 28.5 mt -84.57 125.15 32.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.772 0.32 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.484 HG11 HD22 ' A' ' 66' ' ' LEU . 21.5 t -122.07 137.02 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.066 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.44 119.36 11.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.72 153.03 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.117 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -156.57 159.46 38.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.43 116.74 31.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.58 158.51 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.078 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -113.06 111.55 22.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.578 HD11 ' CD2' ' A' ' 76' ' ' HIS . 4.3 mt -106.49 170.25 8.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.877 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -126.44 167.78 15.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.1 m -57.76 159.26 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.259 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.909 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -98.96 153.03 19.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.048 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.0 t -111.08 -30.97 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -143.56 105.66 4.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.849 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 m -111.97 140.64 46.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -119.94 126.75 51.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.964 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.585 ' CE2' HG22 ' A' ' 168' ' ' VAL . 92.1 m-85 -117.73 154.35 31.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -135.5 95.22 14.59 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.86 110.72 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.515 2.143 . . . . 0.0 112.39 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -62.98 -34.57 77.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.7 m -106.98 147.7 35.59 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.949 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.22 -19.14 26.22 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.572 2.181 . . . . 0.0 112.417 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -55.35 -36.21 66.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.072 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -69.66 -45.34 68.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 25.8 mt -60.59 -32.96 72.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.834 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.82 -27.72 69.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.989 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.463 HD13 HG21 ' A' ' 138' ' ' VAL . 37.0 mt -60.98 131.0 25.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.981 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.2 t -63.03 -42.15 99.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.942 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.44 78.65 3.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.884 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.39 -29.89 16.16 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.593 2.195 . . . . 0.0 112.352 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -65.52 -31.11 72.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.99 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.6 -49.86 17.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.084 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.463 HG21 HD13 ' A' ' 132' ' ' ILE . 21.5 t -62.53 -31.05 50.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.089 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.623 HD23 HG11 ' A' ' 186' ' ' VAL . 42.4 tp -79.8 -37.49 35.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.545 ' HA ' HD12 ' A' ' 143' ' ' LEU . 30.3 mt-10 -80.26 -30.57 38.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -67.18 -30.76 70.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.18 -29.59 20.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 140' ' ' GLU . 16.3 mt -58.49 -29.9 66.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.954 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -59.24 -32.62 70.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -74.74 -31.21 61.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.967 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -81.98 146.63 29.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -106.59 -29.55 9.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.083 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.452 ' SG ' HD13 ' A' ' 63' ' ' LEU . 3.9 t -136.98 164.97 27.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.918 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.3 mt -140.64 173.93 11.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.47 HG21 ' O ' ' A' ' 74' ' ' MET . 63.5 m -155.5 143.65 20.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.7 HG22 ' CB ' ' A' ' 175' ' ' LYS . 8.8 t -81.53 104.52 12.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 107.98 36.89 2.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.421 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -131.37 146.27 52.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 0.0 110.872 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.61 108.35 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.122 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.9 pt -109.41 120.89 61.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.182 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.63 138.95 38.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.2 pt -126.66 137.23 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.073 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -143.99 145.87 32.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.959 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -158.01 -47.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -108.76 43.99 1.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 61.11 31.69 19.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -137.91 99.85 4.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.9 mp -76.51 96.72 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.112 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -83.76 128.62 34.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.871 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -81.29 131.97 35.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.37 154.0 45.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -149.17 114.58 5.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.585 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.4 t -59.8 151.88 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.101 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.3 mmt -118.05 -43.98 2.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.943 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 171' ' ' THR . 2.2 tp10 -145.81 157.81 43.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 170' ' ' GLU . 11.2 p -157.61 140.24 14.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.799 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -119.5 152.51 53.1 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.885 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.56 -27.63 8.37 Favored 'Cis proline' 0 C--N 1.346 0.446 0 C-N-CA 123.343 -1.524 . . . . 0.0 112.453 -0.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.68 173.62 6.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.7 ' CB ' HG22 ' A' ' 151' ' ' THR . 0.2 OUTLIER -58.2 -46.39 85.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.967 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.488 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -98.79 121.46 40.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.066 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.909 HG21 ' HB2' ' A' ' 117' ' ' ALA . 30.5 m -130.38 132.42 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.065 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 24.8 p -82.17 94.83 7.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.806 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.3 pt -81.94 82.46 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.148 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 4.5 mt -114.98 83.62 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.995 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.26 85.08 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 8.0 t -165.03 142.05 5.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.58 116.26 26.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -125.01 177.77 5.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.942 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -102.2 120.06 39.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.623 HG11 HD23 ' A' ' 139' ' ' LEU . 21.5 t -98.32 129.48 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.119 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -108.43 172.05 7.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -141.62 133.86 27.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -117.07 95.52 5.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.084 179.919 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.526 -0.229 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -95.77 -33.9 12.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.835 0.35 . . . . 0.0 110.909 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 m -112.46 -69.25 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.811 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.68 28.59 5.02 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.512 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.9 p -127.49 -45.32 1.5 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.903 0.382 . . . . 0.0 110.877 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.4 m -120.61 114.47 21.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.72 -126.16 0.98 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.528 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.1 mt -126.67 75.49 74.91 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 111.154 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.83 109.59 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.485 2.124 . . . . 0.0 112.329 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -100.85 88.98 3.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.66 139.08 18.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.103 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -106.21 168.14 9.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.938 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.51 154.2 40.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.967 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -96.11 42.58 1.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.95 150.61 25.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.16 104.58 0.32 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.872 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.9 p -141.08 114.95 9.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.6 t -176.93 170.13 2.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.831 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -97.25 157.0 16.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.819 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -150.62 147.61 27.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.838 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.0 mtp85 -72.47 124.34 24.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.553 ' HB2' HD13 ' A' ' 91' ' ' LEU . 20.3 p -92.72 127.21 38.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -135.44 143.37 45.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.2 t -59.75 169.23 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.969 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 91' ' ' LEU . 14.5 m -96.03 20.2 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.332 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.2 p -89.03 -30.92 18.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.807 0.337 . . . . 0.0 110.823 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -59.64 -39.99 86.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.815 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.8 87.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.38 -174.06 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.131 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.43 153.7 6.56 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.484 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.15 -27.54 29.25 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.59 2.193 . . . . 0.0 112.306 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.64 -47.72 3.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 62.86 120.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.91 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -76.5 143.19 40.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.869 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.0 t -118.92 33.68 5.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -110.02 -31.31 7.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.9 m -59.3 -36.61 64.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.196 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -70.79 -36.58 73.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -95.26 82.04 3.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.97 142.8 5.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.446 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -66.15 77.76 0.12 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.513 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.683 ' HB3' HD22 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -131.68 117.87 19.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.825 0.345 . . . . 0.0 110.832 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.484 HD13 ' SG ' ' A' ' 77' ' ' CYS . 43.3 pt -112.5 170.53 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.101 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.51 HG22 ' HB2' ' A' ' 84' ' ' ALA . 5.2 mt -119.5 120.3 63.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.052 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 85.7 mtp -112.88 154.38 44.92 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.11 153.2 16.64 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.57 2.18 . . . . 0.0 112.31 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.92 -28.74 40.69 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.466 2.111 . . . . 0.0 112.304 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.0 p -64.38 -29.11 70.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.995 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.61 -36.4 71.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.249 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.416 HD13 ' CE1' ' A' ' 82' ' ' PHE . 8.2 tp -71.08 -45.78 63.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.938 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -68.94 -31.21 69.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -73.64 -50.64 20.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.976 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.552 ' HA ' HD12 ' A' ' 58' ' ' ILE . 29.4 mt -63.45 -35.38 80.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.948 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.2 p -77.21 -29.84 54.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.978 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.49 -20.44 47.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.179 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.9 mt -94.46 19.22 9.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.283 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.1 t30 54.88 32.22 17.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.189 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 53' ' ' LEU . 39.7 mt -91.87 112.91 26.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.15 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.8 p -99.33 169.91 9.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.939 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.457 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -65.07 143.03 98.79 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.457 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 77.1 Cg_endo -77.34 169.02 75.15 Favored 'Cis proline' 0 C--N 1.348 0.502 0 C-N-CA 123.477 -1.468 . . . . 0.0 112.462 0.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 27.5 mtt -130.08 38.72 3.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.912 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.542 HD22 ' SG ' ' A' ' 148' ' ' CYS . 0.4 OUTLIER -63.15 137.12 58.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.966 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.606 ' CD1' HG12 ' A' ' 109' ' ' VAL . 39.9 m-85 -100.24 160.57 14.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.429 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 13.9 tttt -109.7 84.32 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.88 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.561 HD23 HG22 ' A' ' 109' ' ' VAL . 17.7 mt -69.62 75.18 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.783 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -76.76 103.39 6.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.981 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.501 ' OD1' HD21 ' A' ' 101' ' ' LEU . 0.9 OUTLIER -70.54 118.22 13.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.915 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.96 33.58 2.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -131.62 -46.1 0.97 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 63.0 m -111.87 15.43 20.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.341 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.61 38.93 29.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.843 0.354 . . . . 0.0 111.084 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.477 ' HB2' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -98.46 163.07 12.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.838 ' O ' HG21 ' A' ' 150' ' ' THR . 27.0 ttp -150.13 114.1 5.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.847 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.5 m -134.9 141.64 46.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.994 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.429 ' CE1' ' HG3' ' A' ' 65' ' ' LYS . 42.9 m80 -108.67 118.53 37.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.944 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.494 ' SG ' HD12 ' A' ' 66' ' ' LEU . 28.2 p -128.86 145.97 51.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.928 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -107.96 138.92 14.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.499 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.37 148.12 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.852 0.358 . . . . 0.0 111.107 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.683 HD22 ' HB3' ' A' ' 42' ' ' LYS . 44.2 tp -113.59 -66.58 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.465 ' OE1' HG13 ' A' ' 83' ' ' VAL . 2.8 mm-40 -114.01 172.34 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.988 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.416 ' CE1' HD13 ' A' ' 50' ' ' LEU . 76.8 m-85 -133.39 66.45 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.853 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.465 HG13 ' OE1' ' A' ' 81' ' ' GLU . 31.4 m -137.2 31.75 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.165 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.51 ' HB2' HG22 ' A' ' 44' ' ' ILE . . . -96.64 178.63 5.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.134 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.703 ' HB2' HD12 ' A' ' 88' ' ' ILE . 4.2 m-20 -96.58 156.46 16.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.931 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -60.9 124.19 19.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.97 28.57 62.3 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.487 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.703 HD12 ' HB2' ' A' ' 85' ' ' ASP . 30.6 mt -146.93 87.99 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 0.0 111.088 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 96.7 m -94.32 120.0 33.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -84.6 146.33 27.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.925 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.553 HD13 ' HB2' ' A' ' 22' ' ' CYS . 1.0 OUTLIER -143.64 160.07 52.03 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.69 -174.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.568 2.179 . . . . 0.0 112.325 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -98.9 -31.46 11.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.986 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 64.1 p-90 -72.31 -38.58 68.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.562 ' HG2' HD12 ' A' ' 99' ' ' LEU . 36.8 ttm -64.52 -35.69 81.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.916 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -61.53 -48.77 79.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.873 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -61.83 -42.69 99.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -59.98 -50.24 74.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.568 HD13 HD11 ' A' ' 101' ' ' LEU . 7.2 mt -76.08 -20.62 57.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.5 mt 63.23 44.03 5.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.97 0.414 . . . . 0.0 110.815 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.568 HD11 HD13 ' A' ' 99' ' ' LEU . 3.3 mt -86.52 -175.75 5.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.869 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -127.25 172.37 10.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -70.0 78.8 0.49 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.1 35.96 1.07 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.441 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.66 150.17 20.19 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.451 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.1 mt -92.2 124.6 36.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.938 0.399 . . . . 0.0 110.853 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.436 ' CG1' HD22 ' A' ' 66' ' ' LEU . 21.6 t -122.12 132.4 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.97 111.17 2.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.606 HG12 ' CD1' ' A' ' 64' ' ' PHE . 19.7 t -105.56 128.73 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.09 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -145.18 118.52 8.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 24.7 p -69.86 123.02 20.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.96 168.98 22.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.199 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -131.31 116.17 17.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.85 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 176' ' ' ALA . 1.3 mt -115.76 179.42 3.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.85 174.63 5.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.3 m -64.88 172.36 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.102 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.848 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -105.81 153.2 22.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 38.5 p -113.48 -36.36 4.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -131.98 97.52 4.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.428 ' OG ' HG22 ' A' ' 186' ' ' VAL . 94.9 p -101.43 109.92 21.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.874 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -98.65 119.45 37.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.53 ' CD1' HD21 ' A' ' 139' ' ' LEU . 75.9 m-85 -113.68 147.76 37.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.847 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.49 89.86 51.23 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -51.66 102.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.553 2.169 . . . . 0.0 112.288 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -59.48 -30.78 68.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.969 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.5 m -109.79 145.91 32.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.933 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.8 -16.3 23.53 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.588 2.192 . . . . 0.0 112.555 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -55.17 -33.45 62.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.138 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.401 ' O ' HD12 ' A' ' 132' ' ' ILE . 33.9 t80 -77.11 -40.33 46.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 39.5 mt -64.89 -30.61 71.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.916 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.48 -25.13 67.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.026 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.829 HG21 HG21 ' A' ' 138' ' ' VAL . 23.1 mt -60.05 138.25 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.001 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.7 m -65.6 -34.42 78.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.066 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.608 ' H ' HG22 ' A' ' 132' ' ' ILE . 2.0 m120 -128.36 72.55 80.19 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.981 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.62 -32.77 91.45 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.617 2.211 . . . . 0.0 112.275 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -60.01 -47.72 84.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.964 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.4 -45.49 90.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.06 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.829 HG21 HG21 ' A' ' 132' ' ' ILE . 21.4 t -60.66 -39.48 81.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.181 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.592 HD23 HG11 ' A' ' 186' ' ' VAL . 10.1 tp -70.9 -41.91 70.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.913 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -68.01 -31.07 70.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.934 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -69.14 -31.36 69.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.406 ' CB ' HG21 ' A' ' 157' ' ' ILE . . . -79.5 -37.8 35.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.138 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.716 HD22 HD11 ' A' ' 149' ' ' LEU . 59.1 mt -61.5 -26.63 68.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.045 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.2 mtt-85 -56.48 -30.37 62.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -82.74 -49.07 10.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.906 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -60.07 152.86 23.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.541 ' HB1' HD21 ' A' ' 63' ' ' LEU . . . -107.07 -29.21 9.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.138 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.542 ' SG ' HD22 ' A' ' 63' ' ' LEU . 1.6 m -146.86 167.87 22.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.953 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.716 HD11 HD22 ' A' ' 143' ' ' LEU . 5.1 mt -142.97 170.19 16.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.838 HG21 ' O ' ' A' ' 74' ' ' MET . 63.4 m -153.6 136.65 15.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.495 HG22 ' CB ' ' A' ' 175' ' ' LYS . 8.8 t -60.67 121.02 11.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 91.54 28.96 12.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.546 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.46 126.57 52.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.942 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.6 t -89.38 91.09 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.089 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.47 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 4.4 pt -87.55 154.63 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.136 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.61 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -129.32 102.36 6.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.406 HG21 ' CB ' ' A' ' 142' ' ' ALA . 7.6 pt -90.93 147.08 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -140.6 145.86 37.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -176.54 -38.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.999 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -99.2 40.3 1.22 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 56.82 29.28 15.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.033 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.31 110.79 2.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.61 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 3.6 mp -68.47 94.43 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -61.68 145.77 51.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -95.41 132.79 40.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.931 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.01 158.22 41.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -156.91 139.01 14.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.855 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.421 HG22 ' CE2' ' A' ' 122' ' ' PHE . 28.6 t -80.9 147.85 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 59.6 mmm -117.41 -40.75 3.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.7 151.38 27.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 64.3 p -151.2 149.35 29.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -122.22 152.87 61.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.35 -27.32 8.62 Favored 'Cis proline' 0 C--N 1.346 0.435 0 C-N-CA 123.281 -1.55 . . . . 0.0 112.389 -0.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -124.5 168.98 12.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.735 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.495 ' CB ' HG22 ' A' ' 151' ' ' THR . 0.0 OUTLIER -56.59 -49.18 75.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.98 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.52 ' O ' HD22 ' A' ' 114' ' ' LEU . . . -92.85 110.73 22.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.033 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.848 HG21 ' HB2' ' A' ' 117' ' ' ALA . 11.5 m -128.52 148.72 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.19 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.7 95.7 8.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.2 pt -86.97 83.3 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.087 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 28.2 mm -112.73 90.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 61.17 55.29 3.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 6.1 t -135.83 143.27 45.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.19 134.48 41.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.869 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.458 ' SD ' ' HB3' ' A' ' 117' ' ' ALA . 2.1 ptt? -139.65 164.52 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -78.97 76.25 5.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.785 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.592 HG11 HD23 ' A' ' 139' ' ' LEU . 28.6 t -63.3 125.82 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.091 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.32 162.22 16.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . 0.416 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 31.0 m-85 -124.17 128.98 50.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -90.97 94.21 9.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.12 179.948 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m -87.26 -66.49 0.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.858 0.361 . . . . 0.0 110.941 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.3 p -65.23 109.11 2.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.5 94.19 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.516 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.47 174.06 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.783 0.325 . . . . 0.0 110.912 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.78 37.9 18.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.958 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -141.4 146.61 17.88 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.559 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 8' ' ' ILE . 7.6 tp -147.97 74.69 11.02 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.942 0.401 . . . . 0.0 111.037 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.17 148.85 63.35 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.579 2.186 . . . . 0.0 112.309 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.44 144.9 46.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.51 106.82 13.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.147 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -157.04 78.06 0.89 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.24 -37.99 3.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.931 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -138.7 166.82 23.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 61.36 113.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -87.62 129.65 35.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.7 p -154.57 124.34 6.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -175.3 179.34 1.53 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.952 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.501 ' HB3' HD22 ' A' ' 106' ' ' LEU . 27.9 mt-30 -107.07 155.17 20.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -155.23 152.6 29.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.894 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.6 mtt-85 -82.86 134.58 35.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.1 m -102.23 128.14 48.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.933 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.496 ' CD2' HG23 ' A' ' 88' ' ' ILE . 52.9 m-85 -138.38 175.19 9.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.949 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.5 t -86.19 -179.98 6.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 91' ' ' LEU . 18.9 m -95.62 20.08 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.347 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 m -96.69 -19.45 18.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.172 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 36.1 mtp -93.88 20.06 8.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.282 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.17 -57.03 2.64 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.847 0.356 . . . . 0.0 110.887 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.93 -174.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.15 174.13 18.02 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.511 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.34 -35.29 14.18 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.582 2.188 . . . . 0.0 112.301 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -126.82 122.33 34.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -106.24 150.01 26.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.29 155.46 42.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.9 p -97.89 27.6 4.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.977 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.62 11.81 38.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.161 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.72 -35.11 3.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.78 0.324 . . . . 0.0 111.078 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -80.45 -31.34 37.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -83.47 91.19 7.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.87 178.27 15.62 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.55 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.73 31.56 8.58 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.557 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -89.17 135.53 33.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.81 0.338 . . . . 0.0 110.782 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.523 HD13 ' SG ' ' A' ' 77' ' ' CYS . 7.8 pt -128.93 167.75 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.166 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.0 mt -120.3 140.81 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.176 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.484 ' HE1' HG11 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -133.09 158.13 76.58 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.85 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.79 161.42 3.15 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.524 2.149 . . . . 0.0 112.315 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.83 -25.81 32.82 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.648 2.232 . . . . 0.0 112.302 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.7 p -58.95 -38.4 78.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.979 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.471 ' O ' HD12 ' A' ' 53' ' ' LEU . . . -59.32 -33.11 70.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.214 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.5 tp -62.01 -51.58 67.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.82 -31.19 67.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.41 -43.91 63.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.928 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 49' ' ' ALA . 3.8 mt -58.18 -52.25 66.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -65.25 -29.74 70.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -76.58 -26.04 54.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.02 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.9 mt -94.51 20.09 8.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.227 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.0 m120 58.24 35.51 25.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.866 0.365 . . . . 0.0 111.058 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 53' ' ' LEU . 29.4 mt -102.62 116.74 46.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.148 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 t -114.17 173.56 6.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.468 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -68.1 144.09 96.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.468 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.7 Cg_endo -77.08 159.56 95.53 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 123.446 -1.481 . . . . 0.0 112.327 -0.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 19.1 mtt -125.35 59.0 1.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.983 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.712 HD23 ' HA2' ' A' ' 78' ' ' GLY . 88.8 mt -74.93 114.99 14.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.859 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.429 ' CE2' ' HB ' ' A' ' 79' ' ' VAL . 17.3 m-85 -81.68 133.37 35.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.857 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -85.66 93.23 8.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.037 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.9 mt -78.36 76.85 4.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.6 m -90.02 103.17 15.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.9 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -67.14 127.23 31.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -98.92 32.17 2.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -123.44 -43.84 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 73.4 m -123.56 23.07 8.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 54.43 31.33 14.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.092 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.531 ' HB3' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -82.33 157.82 23.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.826 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.92 131.91 10.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.607 HG22 HD21 ' A' ' 99' ' ' LEU . 2.7 t -159.95 114.3 2.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.964 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.551 ' CD2' HD11 ' A' ' 114' ' ' LEU . 12.0 m80 -79.74 122.99 27.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.523 ' SG ' HD13 ' A' ' 43' ' ' ILE . 30.0 p -117.29 150.73 38.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.949 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.712 ' HA2' HD23 ' A' ' 63' ' ' LEU . . . -104.86 129.36 9.8 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.417 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.429 ' HB ' ' CE2' ' A' ' 64' ' ' PHE . 10.8 p -69.44 147.36 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 111.094 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -130.41 -59.74 1.02 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.818 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -110.11 146.91 34.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.743 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -113.88 49.52 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.888 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.06 79.0 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.147 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -132.31 173.36 11.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.585 ' HB3' HD12 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -76.64 162.93 27.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -66.59 109.92 2.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.02 34.94 54.76 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.483 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.585 HD12 ' HB3' ' A' ' 85' ' ' ASP . 26.8 mt -144.01 91.62 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.81 0.338 . . . . 0.0 111.085 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 97.0 m -80.67 134.52 35.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -99.63 127.38 45.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.404 ' O ' HG13 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -130.19 157.74 76.27 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.849 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.57 -172.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.591 2.194 . . . . 0.0 112.283 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -90.58 -39.02 12.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -69.61 -42.86 73.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.2 ttp -61.08 -31.31 70.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -31.5 61.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.827 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -81.55 -37.13 28.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.894 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -68.62 -45.13 72.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.643 HD13 HD11 ' A' ' 101' ' ' LEU . 7.7 mt -68.83 -23.87 64.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.061 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.8 mt 66.27 48.79 1.57 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.803 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.643 HD11 HD13 ' A' ' 99' ' ' LEU . 5.2 mt -96.36 -176.26 3.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.78 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.31 174.77 10.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.914 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -59.85 92.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.02 28.1 7.49 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.461 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -70.44 130.0 20.47 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.491 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.501 HD22 ' HB3' ' A' ' 19' ' ' GLN . 64.5 mt -87.82 126.95 35.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.807 0.337 . . . . 0.0 110.927 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 108' ' ' GLN . 21.5 t -129.53 156.42 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.446 ' N ' HG12 ' A' ' 107' ' ' VAL . 19.2 tp60 -79.67 125.01 29.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.484 HG11 ' HE1' ' A' ' 45' ' ' MET . 21.5 t -111.35 105.7 19.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.097 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -125.45 133.56 52.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.8 p -81.92 108.56 15.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.989 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.414 HG21 ' CD2' ' A' ' 76' ' ' HIS . 6.8 m -111.2 156.21 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -107.57 118.04 35.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.551 HD11 ' CD2' ' A' ' 76' ' ' HIS . 13.1 mt -118.02 157.15 27.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -109.56 169.83 8.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.7 m -64.85 139.82 20.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.101 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.842 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -79.75 149.33 31.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.134 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.3 p -107.33 -37.85 6.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -128.04 125.22 38.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.8 p -129.74 140.23 51.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.023 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -131.23 125.51 33.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.824 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.787 ' CG ' HD21 ' A' ' 139' ' ' LEU . 17.1 m-85 -113.41 147.62 37.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.982 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -131.06 92.44 33.38 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.779 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.707 ' HA ' HD23 ' A' ' 166' ' ' LEU . 77.1 Cg_exo -50.18 116.58 2.54 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.561 2.174 . . . . 0.0 112.455 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -73.62 -31.45 63.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -106.8 146.93 34.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.27 -14.77 28.5 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.582 2.188 . . . . 0.0 112.461 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.0 -40.07 75.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.011 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -71.87 -38.44 70.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.415 HD21 ' CB ' ' A' ' 190' ' ' ALA . 84.9 mt -64.95 -31.84 73.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.866 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -62.42 -25.62 68.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.449 HG22 ' H ' ' A' ' 134' ' ' ASN . 32.9 mt -66.01 135.38 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.089 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.2 t -66.93 -37.86 85.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.526 ' O ' HG23 ' A' ' 138' ' ' VAL . 3.8 m120 -119.07 75.75 14.73 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.954 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.17 -30.27 16.28 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.631 2.221 . . . . 0.0 112.311 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -37.01 84.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.48 -44.33 67.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 134' ' ' ASN . 29.9 t -63.03 -44.73 99.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.012 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.787 HD21 ' CG ' ' A' ' 122' ' ' PHE . 16.0 tp -69.26 -31.58 70.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.819 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.01 -31.43 62.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.914 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -78.79 -34.28 45.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.861 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.23 -35.7 66.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.515 HD22 HD11 ' A' ' 149' ' ' LEU . 14.8 mt -59.73 -25.73 65.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.983 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 -55.4 -30.57 60.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.09 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.24 -31.21 30.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -71.24 140.53 50.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -101.12 -29.59 12.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.105 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 18.3 t -148.76 158.36 44.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.954 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.515 HD11 HD22 ' A' ' 143' ' ' LEU . 11.1 mt -134.34 150.92 50.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.0 m -128.32 148.51 50.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 26.5 m -76.01 101.72 5.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 103.51 48.17 1.23 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.462 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -134.0 115.16 14.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.792 0.329 . . . . 0.0 110.931 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.3 t -72.54 99.25 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 37.3 pt -97.13 143.91 11.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.157 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.597 ' HB1' ' CG2' ' A' ' 163' ' ' ILE . . . -107.97 150.72 26.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.125 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.5 pt -141.15 139.55 33.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.125 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -127.39 156.66 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -177.43 -47.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -103.02 42.65 1.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.942 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.64 31.04 20.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.915 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.09 126.42 9.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.597 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 3.4 mp -86.9 101.12 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.137 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -79.17 123.95 27.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.86 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -87.47 131.48 34.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.95 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.707 HD23 ' HA ' ' A' ' 124' ' ' PRO . 1.5 mt -143.69 147.34 34.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.827 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -127.06 127.73 45.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.14 131.91 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.045 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 14.2 mmm -87.57 -55.57 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.994 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.529 ' O ' HG23 ' A' ' 171' ' ' THR . 0.1 OUTLIER -145.28 160.02 42.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.926 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 170' ' ' GLU . 3.0 p -160.07 119.08 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -96.83 155.77 37.27 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.96 -43.18 0.67 Allowed 'Cis proline' 0 C--N 1.347 0.457 0 C-N-CA 123.326 -1.531 . . . . 0.0 112.444 0.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.29 174.48 5.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.935 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -59.13 -48.79 80.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.93 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.435 ' HB1' HD13 ' A' ' 114' ' ' LEU . . . -92.74 113.02 25.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.084 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.842 HG21 ' HB2' ' A' ' 117' ' ' ALA . 28.2 m -129.54 139.34 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 11.3 t -91.8 98.29 11.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.9 pt -90.91 80.35 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 32.5 mt -108.41 83.69 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.08 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 60.94 78.76 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 14.3 t -153.49 148.36 26.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.14 121.91 28.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -144.14 154.04 42.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.16 119.28 19.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.15 109.49 27.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.164 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.8 169.61 9.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . 0.6 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 3.1 m-85 -142.12 109.64 5.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -112.01 105.03 13.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.885 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.415 ' CB ' HD21 ' A' ' 130' ' ' LEU . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.117 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.134 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -115.22 -174.89 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.791 0.329 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.1 m 60.24 105.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.13 -121.8 5.73 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.473 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.1 m -71.63 178.37 3.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.777 0.323 . . . . 0.0 110.888 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.3 121.03 0.85 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.936 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.97 -149.82 51.54 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.549 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.8 pt -140.4 91.78 9.57 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.616 0.246 . . . . 0.0 111.139 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.12 127.98 16.84 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.552 2.168 . . . . 0.0 112.335 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -106.68 114.01 27.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.41 149.25 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.145 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -132.21 -46.79 0.92 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.826 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -94.17 139.47 30.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.93 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -130.55 -178.06 4.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.81 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 63.61 167.23 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.882 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -105.26 141.69 36.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.2 p -159.99 118.4 2.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -176.33 161.22 2.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.972 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -90.11 143.61 26.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.811 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.455 ' HB2' HG21 ' A' ' 109' ' ' VAL . 6.0 m-85 -144.4 136.41 26.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -71.57 157.86 37.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.493 ' SG ' HD13 ' A' ' 101' ' ' LEU . 95.6 m -119.96 130.72 54.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.939 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.613 ' CD2' HG23 ' A' ' 88' ' ' ILE . 70.6 m-85 -136.2 166.79 22.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -79.14 138.58 37.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.946 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 90' ' ' TYR . 26.3 m -63.6 -19.33 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.288 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 m -67.64 -12.49 60.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.412 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 36.4 mtt -91.79 20.13 5.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.624 0.25 . . . . 0.0 111.362 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.585 HD23 ' OH ' ' A' ' 90' ' ' TYR . 1.0 OUTLIER -141.31 74.93 1.48 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.904 0.383 . . . . 0.0 110.881 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.97 -170.63 2.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.067 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.97 -156.45 26.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.505 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.22 -30.04 40.24 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.498 2.132 . . . . 0.0 112.337 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -136.75 167.92 20.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -102.21 -53.53 2.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.5 mmt-85 60.24 109.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.933 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.9 m -96.65 23.48 6.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.092 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -91.17 -29.19 17.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.844 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.5 t -59.28 -36.05 61.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.039 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -71.85 -38.68 70.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.884 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -84.14 79.54 9.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.74 178.8 32.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.411 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.06 37.87 3.6 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.517 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.576 ' HG2' HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -105.5 153.58 21.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.705 0.288 . . . . 0.0 110.872 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.675 HG22 ' HD3' ' A' ' 92' ' ' PRO . 3.0 pt -139.66 179.95 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.041 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.655 HG22 ' HB2' ' A' ' 84' ' ' ALA . 4.5 mt -122.51 136.12 60.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.124 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 71.8 mtp -137.75 161.49 59.85 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.81 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 52.5 Cg_exo -52.79 146.47 35.55 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.506 2.138 . . . . 0.0 112.335 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 46' ' ' PRO . 50.3 Cg_exo -53.83 -26.89 41.21 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.521 2.147 . . . . 0.0 112.384 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.0 t -58.54 -39.01 78.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.035 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.89 -31.08 70.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.102 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.418 HD13 ' CD1' ' A' ' 82' ' ' PHE . 58.3 tp -64.68 -51.31 63.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -72.61 -29.5 63.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -50.34 74.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.947 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.517 HD13 ' SD ' ' A' ' 62' ' ' MET . 1.6 mt -56.56 -38.29 71.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.007 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.8 t -75.52 -27.5 58.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -81.54 -25.04 36.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.03 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.4 mt -95.52 19.77 10.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.18 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 53.98 44.88 28.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.86 0.362 . . . . 0.0 111.173 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.499 HG21 HD23 ' A' ' 53' ' ' LEU . 30.3 mt -107.35 130.37 59.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.182 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 p -113.4 170.84 7.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.444 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 1.3 t80 -61.15 140.35 94.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.815 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.444 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 71.6 Cg_endo -76.85 171.34 68.58 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.544 -1.44 . . . . 0.0 112.368 0.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.517 ' SD ' HD13 ' A' ' 53' ' ' LEU . 15.9 mtt -126.31 41.71 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.469 HD22 ' CA ' ' A' ' 78' ' ' GLY . 16.9 mt -68.97 164.0 23.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.935 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -130.34 153.89 48.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HB2' HG21 ' A' ' 112' ' ' VAL . 23.9 tttt -99.82 91.9 5.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.842 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 66' ' ' LEU . 15.1 mt -75.43 78.95 2.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.836 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 m -81.65 99.17 8.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -71.27 120.23 16.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.829 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.0 mtmt -98.46 30.56 3.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.994 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.94 -37.43 4.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.846 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.23 23.54 4.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.128 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 55.01 39.31 31.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 111.113 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.31 172.46 8.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.0 ttp -157.82 124.93 5.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.834 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.0 m -140.17 155.74 46.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -129.56 108.86 10.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.1 p -116.59 149.88 38.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.469 ' CA ' HD22 ' A' ' 63' ' ' LEU . . . -104.87 137.68 13.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.545 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.9 p -83.79 134.88 25.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.782 0.325 . . . . 0.0 111.06 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.576 HD22 ' HG2' ' A' ' 42' ' ' LYS . 57.5 tp -117.94 -58.01 2.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.32 150.75 19.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.418 ' CD1' HD13 ' A' ' 50' ' ' LEU . 65.7 m-85 -132.99 62.83 1.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.3 m -136.15 32.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.164 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.655 ' HB2' HG22 ' A' ' 44' ' ' ILE . . . -95.12 158.78 15.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.071 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.615 ' HB3' HD12 ' A' ' 88' ' ' ILE . 3.9 t70 -68.54 160.31 30.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -66.98 136.12 54.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.19 28.69 73.85 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.452 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.615 HD12 ' HB3' ' A' ' 85' ' ' ASP . 28.8 mt -147.82 112.47 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 111.14 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 85.7 m -114.85 130.5 56.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.585 ' OH ' HD23 ' A' ' 28' ' ' LEU . 70.1 m-85 -92.42 143.25 26.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.935 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.532 ' CD2' HG21 ' A' ' 43' ' ' ILE . 44.0 mt -139.28 147.67 53.9 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.675 ' HD3' HG22 ' A' ' 43' ' ' ILE . 53.0 Cg_exo -52.52 169.93 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.57 2.18 . . . . 0.0 112.283 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.53 -38.68 77.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.834 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.405 ' CH2' ' CE ' ' A' ' 95' ' ' MET . 51.0 p-90 -72.58 -31.48 65.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.405 ' CE ' ' CH2' ' A' ' 94' ' ' TRP . 7.4 ttm -74.72 -31.16 61.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 37.7 mmm -76.39 -39.06 54.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.847 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -76.63 -38.75 54.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.858 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -59.66 -53.49 57.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.41 HD13 HD11 ' A' ' 101' ' ' LEU . 30.8 mt -71.21 -21.79 62.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.115 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 mt 66.99 45.6 1.74 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.892 0.377 . . . . 0.0 110.944 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.493 HD13 ' SG ' ' A' ' 22' ' ' CYS . 13.1 mt -96.83 149.24 22.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -103.47 -179.19 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.799 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.34 113.5 2.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.35 42.24 8.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.446 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.86 109.51 3.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.536 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.1 mt -73.27 131.88 42.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 108' ' ' GLN . 21.5 t -137.01 158.83 36.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.079 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.479 ' N ' HG12 ' A' ' 107' ' ' VAL . 62.7 mm-40 -74.67 122.5 23.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.455 HG21 ' HB2' ' A' ' 20' ' ' TYR . 21.5 t -117.95 86.9 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.146 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -107.5 135.2 49.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 68.1 p -75.72 101.49 5.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.441 HG21 ' HB2' ' A' ' 65' ' ' LYS . 19.2 m -113.88 149.3 16.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.105 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -121.84 117.21 25.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.577 HD22 ' O ' ' A' ' 176' ' ' ALA . 6.4 mt -107.81 174.22 5.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.45 164.06 12.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.95 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.1 m -64.69 135.05 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.121 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.668 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -77.68 152.87 33.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.076 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.3 t -109.55 -31.77 7.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -134.82 106.7 7.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.6 m -122.92 113.39 19.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.946 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -92.38 142.56 27.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.515 ' CG ' HD21 ' A' ' 139' ' ' LEU . 18.1 m-85 -130.43 150.2 51.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -131.79 95.93 21.72 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.8 109.9 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.536 2.157 . . . . 0.0 112.408 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -59.62 -31.78 69.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.998 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 72.4 p -113.38 146.81 36.11 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.958 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.88 -17.8 25.13 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.544 2.163 . . . . 0.0 112.48 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -55.14 -39.84 69.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.023 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -66.41 -46.91 74.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.7 mt -60.31 -30.67 69.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.968 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.3 -25.07 66.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.938 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 134' ' ' ASN . 51.4 mt -62.27 136.92 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.958 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.9 m -58.28 -39.62 79.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.992 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.729 ' O ' HG23 ' A' ' 138' ' ' VAL . 2.3 m120 -125.59 80.67 65.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.0 -28.63 19.05 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.585 2.19 . . . . 0.0 112.363 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.9 mtpm? -66.73 -44.95 80.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.84 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.89 93.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.038 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 134' ' ' ASN . 25.3 t -64.08 -45.25 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.064 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.61 HD22 ' CZ ' ' A' ' 188' ' ' PHE . 21.5 tp -67.91 -43.44 79.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.83 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -62.35 -36.37 82.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.807 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -68.82 -29.83 68.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.35 -33.19 69.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.575 HD22 HD13 ' A' ' 179' ' ' ILE . 65.9 mt -60.49 -25.77 66.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.059 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.6 mtp-105 -55.16 -30.36 59.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.05 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -89.21 -38.7 14.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -69.08 144.67 53.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.423 ' HB1' HD11 ' A' ' 180' ' ' ILE . . . -109.39 -26.15 10.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.22 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -140.25 165.14 28.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.968 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.523 HD11 HD13 ' A' ' 179' ' ' ILE . 20.8 mt -144.33 129.41 18.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.54 145.47 46.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.876 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.66 HG23 ' O ' ' A' ' 169' ' ' MET . 18.7 m -71.47 123.58 22.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.9 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.75 27.69 21.07 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.45 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.82 132.66 53.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 27.4 t -90.58 89.68 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.084 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 18.4 pt -85.16 132.31 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.081 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -108.05 140.75 40.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 43.3 pt -125.12 165.26 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.041 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -157.83 150.41 22.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -172.71 -48.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -97.66 41.44 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.94 29.65 19.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.954 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.59 128.12 17.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.801 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.574 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.9 mp -87.83 105.18 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.177 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -82.71 137.44 34.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -90.11 121.73 32.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.001 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.23 141.55 49.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.82 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 -137.24 129.05 28.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.446 HG22 ' CE2' ' A' ' 122' ' ' PHE . 21.3 t -76.57 132.46 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.66 ' O ' HG23 ' A' ' 151' ' ' THR . 6.7 mmm -94.0 -68.53 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.95 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -123.8 152.91 41.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.039 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.5 p -147.24 150.49 34.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -130.68 153.97 81.66 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.64 -31.96 4.92 Favored 'Cis proline' 0 C--N 1.348 0.522 0 C-N-CA 123.264 -1.557 . . . . 0.0 112.45 -0.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.36 171.53 7.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.835 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -40.75 76.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.022 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.577 ' O ' HD22 ' A' ' 114' ' ' LEU . . . -102.64 124.47 48.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.081 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.668 HG21 ' HB2' ' A' ' 117' ' ' ALA . 15.8 m -137.58 153.71 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.146 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 23.8 t -104.7 98.01 7.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.575 HD13 HD22 ' A' ' 143' ' ' LEU . 2.4 pt -88.68 84.11 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.207 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.423 HD11 ' HB1' ' A' ' 147' ' ' ALA . 26.5 mm -111.65 79.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.089 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 59.14 91.0 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.99 156.16 26.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.967 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.19 103.53 15.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.827 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -126.67 170.84 11.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -94.22 113.54 25.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.39 106.85 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.176 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -87.13 159.33 18.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . 0.61 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 13.7 m-85 -133.09 133.24 42.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -121.09 97.37 5.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.087 179.969 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -170.26 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.811 0.339 . . . . 0.0 110.932 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.3 t 60.67 34.8 19.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.25 44.83 2.45 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.519 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.9 m 60.61 172.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.785 0.326 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.0 m -157.24 37.67 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.7 -166.89 13.73 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.446 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.6 pt -108.34 146.57 33.89 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.676 0.274 . . . . 0.0 111.098 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.08 123.99 9.7 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.572 2.182 . . . . 0.0 112.293 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.78 118.35 21.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.884 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.579 ' O ' HG12 ' A' ' 11' ' ' VAL . 15.5 t -97.88 32.05 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.015 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -166.71 129.33 1.83 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.839 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.77 151.36 51.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -142.72 158.88 43.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.5 158.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.804 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -86.63 123.93 32.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.0 p -155.23 110.1 2.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.2 t -176.42 168.96 2.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -103.38 146.85 27.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.406 ' HD2' HG21 ' A' ' 109' ' ' VAL . 22.4 m-85 -146.87 147.28 30.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.91 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -84.6 132.08 34.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.9 p -84.82 142.01 30.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.642 ' CD2' HG23 ' A' ' 88' ' ' ILE . 17.2 m-85 -147.0 149.47 33.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.833 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.85 168.51 6.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.4 m -95.82 20.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.374 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 55.1 m -96.38 -25.16 15.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.019 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 3.7 mmt -54.97 -51.59 65.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.124 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 tp -73.63 142.39 46.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.43 154.84 20.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.06 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -154.95 156.41 26.89 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.498 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.99 -35.78 8.51 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.627 2.218 . . . . 0.0 112.325 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -102.1 -29.92 11.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.947 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 70.85 -62.63 0.44 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.1 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 66.95 133.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.889 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.4 t -104.07 -18.69 14.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.202 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -35.83 44.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.817 0.341 . . . . 0.0 111.116 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.63 -30.29 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.1 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -77.2 -30.14 54.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -97.93 33.72 2.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.6 171.51 25.26 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.553 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.23 28.66 13.02 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.545 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.83 151.2 20.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.805 0.336 . . . . 0.0 110.913 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.493 HG21 HD23 ' A' ' 91' ' ' LEU . 7.9 pt -133.35 165.67 31.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.141 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.652 HG23 ' HB3' ' A' ' 81' ' ' GLU . 3.0 mt -115.7 96.17 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.138 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.405 ' HG3' HD12 ' A' ' 43' ' ' ILE . 97.1 mtp -88.55 157.8 49.28 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.8 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -51.83 156.74 6.48 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.571 2.181 . . . . 0.0 112.336 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.71 -27.06 38.57 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.519 2.146 . . . . 0.0 112.318 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.8 p -61.65 -31.67 71.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.87 -31.67 72.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.3 tp -62.27 -34.64 76.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -86.96 -30.54 21.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.0 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.42 -47.25 70.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 58.5 mt -57.19 -47.48 81.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.077 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 p -64.15 -23.61 67.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.173 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.72 20.11 9.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.355 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -135.83 19.95 3.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.206 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 55.9 33.69 22.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.766 0.317 . . . . 0.0 111.029 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.2 mt -102.78 109.01 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.4 p -104.51 162.96 12.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.88 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.471 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -60.14 144.3 87.29 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.775 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.471 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 72.2 Cg_endo -76.71 171.29 68.84 Favored 'Cis proline' 0 C--N 1.347 0.484 0 C-N-CA 123.467 -1.472 . . . . 0.0 112.4 0.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.3 mtt -138.23 78.02 1.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.446 HD22 HD12 ' A' ' 114' ' ' LEU . 1.4 mp -89.55 138.29 31.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -109.78 143.02 40.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.846 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -94.74 99.76 11.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.936 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.714 ' HB2' HG23 ' A' ' 75' ' ' THR . 43.7 mt -84.66 78.44 9.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 53.7 m -77.93 111.59 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.831 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.437 ' OD1' HD21 ' A' ' 101' ' ' LEU . 2.8 t30 -74.88 113.96 12.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.956 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -88.92 53.9 2.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -145.22 -53.49 0.29 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.9 m -120.32 25.37 9.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.067 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 t0 55.19 30.44 14.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.112 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.0 mmt-85 -82.3 146.19 29.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.3 ttm -133.12 140.77 47.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.819 HG21 HD11 ' A' ' 99' ' ' LEU . 4.7 t -157.15 143.0 17.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.932 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -120.78 114.6 21.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 30.2 p -113.46 172.73 6.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.46 124.84 4.83 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.539 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.0 p -64.12 141.65 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.784 0.326 . . . . 0.0 111.09 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.7 tp -134.9 -54.79 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.652 ' HB3' HG23 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -94.45 152.09 18.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.824 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -135.0 73.86 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.6 m -149.93 35.23 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.164 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.69 178.77 5.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.095 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.716 ' CB ' HD12 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -92.69 166.47 12.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.804 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -65.66 90.96 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.807 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 96.73 26.17 10.94 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.509 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.716 HD12 ' CB ' ' A' ' 85' ' ' ASP . 28.0 mt -136.08 80.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 111.07 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 57.5 m -78.29 134.7 37.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.974 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -102.96 130.91 50.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.848 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.493 HD23 HG21 ' A' ' 43' ' ' ILE . 1.3 mp -132.69 162.19 58.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.36 -173.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.628 2.218 . . . . 0.0 112.287 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -94.18 -46.65 7.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.929 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.433 ' CZ3' HG22 ' A' ' 155' ' ' ILE . 69.7 p-90 -60.01 -39.63 86.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 37.4 ttm -62.03 -32.79 73.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.893 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -53.17 18.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -61.91 -38.35 88.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -59.96 -40.97 90.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.792 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.819 HD11 HG21 ' A' ' 75' ' ' THR . 10.0 mt -84.86 -14.46 47.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.281 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 56.7 mt 61.35 32.95 19.08 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.437 HD21 ' OD1' ' A' ' 68' ' ' ASN . 6.9 mt -82.75 162.88 21.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -108.85 173.52 6.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.898 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -60.14 112.55 1.95 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.83 42.65 10.89 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.465 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.11 119.65 5.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.478 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.9 mt -65.57 129.23 39.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.803 0.335 . . . . 0.0 110.847 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.94 149.78 33.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -75.8 124.28 27.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.406 HG21 ' HD2' ' A' ' 20' ' ' TYR . 21.5 t -111.29 122.87 66.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -144.2 121.87 11.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 71.4 p -72.75 129.35 38.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.4 m -137.69 139.79 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.057 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -101.06 109.37 21.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.446 HD12 HD22 ' A' ' 63' ' ' LEU . 3.9 mt -103.52 172.01 7.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.896 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -116.03 164.72 14.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.631 HG21 ' SG ' ' A' ' 182' ' ' CYS . 21.7 m -60.82 144.34 13.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.094 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.867 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -88.07 153.3 21.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.124 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.1 p -106.35 -31.32 8.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -133.7 112.64 11.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.9 m -123.35 122.1 37.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.859 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.23 146.46 38.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.974 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.698 ' CD1' HD21 ' A' ' 139' ' ' LEU . 74.5 m-85 -125.94 143.94 50.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -126.59 90.24 50.26 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.958 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.81 112.08 0.75 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.583 2.189 . . . . 0.0 112.328 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -65.39 -31.25 72.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.1 p -106.57 146.47 33.12 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.931 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.59 -17.03 23.76 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.597 2.198 . . . . 0.0 112.576 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.02 -44.25 74.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.087 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.483 ' CE1' HD11 ' A' ' 157' ' ' ILE . 20.9 t80 -70.49 -44.67 67.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.869 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 38.3 mt -59.82 -31.81 70.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -64.4 -24.07 67.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.977 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.411 HG22 ' H ' ' A' ' 134' ' ' ASN . 60.5 mt -60.02 139.94 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.924 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.401 HG23 ' N ' ' A' ' 134' ' ' ASN . 9.0 t -59.11 -44.73 92.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.411 ' H ' HG22 ' A' ' 132' ' ' ILE . 0.8 OUTLIER -129.76 86.76 54.32 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.49 -28.61 21.52 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.585 2.19 . . . . 0.0 112.313 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.443 ' HG3' ' CE1' ' A' ' 188' ' ' PHE . 36.8 mttt -65.49 -35.67 81.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.93 -41.85 77.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.076 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.671 HG11 ' CZ ' ' A' ' 159' ' ' TYR . 21.5 t -74.38 -36.8 43.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.075 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.698 HD21 ' CD1' ' A' ' 122' ' ' PHE . 1.3 tp -71.42 -37.59 71.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.22 -31.42 65.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.76 -33.02 68.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.899 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.97 -29.19 32.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.7 mt -57.9 -25.97 61.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.057 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -55.59 -30.0 60.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.034 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -80.02 -35.13 37.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -73.92 132.75 42.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -103.1 -27.21 12.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 7.6 t -123.0 161.12 24.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.433 HD12 HG21 ' A' ' 179' ' ' ILE . 6.1 mt -143.78 113.37 7.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.3 m -117.42 136.37 53.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.08 129.35 39.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.918 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 83.4 47.43 5.72 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.53 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.57 110.85 13.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.738 0.304 . . . . 0.0 110.862 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.59 83.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.193 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.433 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 1.4 pt -81.67 150.58 4.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -114.59 117.4 30.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.023 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.483 HD11 ' CE1' ' A' ' 129' ' ' PHE . 3.4 pt -109.1 145.7 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.227 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -148.77 140.67 23.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.882 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.671 ' CZ ' HG11 ' A' ' 138' ' ' VAL . 1.8 p90 -149.02 -50.17 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -100.81 49.34 0.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 59.05 30.0 19.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.974 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -139.74 105.41 5.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.555 ' H ' HD12 ' A' ' 163' ' ' ILE . 3.8 mp -78.26 88.04 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.144 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -69.58 158.09 35.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.781 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -113.98 135.95 53.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.975 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.462 HD21 ' CD2' ' A' ' 129' ' ' PHE . 3.6 mp -150.4 160.56 43.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.825 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 8.5 ttt-85 -144.77 130.67 19.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.025 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.451 ' CG1' HG23 ' A' ' 171' ' ' THR . 21.5 t -59.56 123.53 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.056 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.17 -61.4 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.06 148.08 44.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.991 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.451 HG23 ' CG1' ' A' ' 168' ' ' VAL . 16.6 p -145.92 138.87 25.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -122.19 154.48 61.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.1 -39.08 1.52 Allowed 'Cis proline' 0 C--N 1.347 0.469 0 C-N-CA 123.267 -1.555 . . . . 0.0 112.324 0.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.49 171.64 7.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.81 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.11 -48.1 82.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -93.2 123.42 36.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.062 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.867 HG21 ' HB2' ' A' ' 117' ' ' ALA . 15.7 m -143.78 152.91 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.532 ' OG ' HD11 ' A' ' 180' ' ' ILE . 4.7 t -106.45 106.5 17.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.433 HG21 HD12 ' A' ' 149' ' ' LEU . 2.0 pt -92.09 86.6 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.176 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.532 HD11 ' OG ' ' A' ' 178' ' ' SER . 4.8 mt -116.48 81.57 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.015 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 60.36 89.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 116' ' ' VAL . 2.8 t -162.54 153.18 17.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.928 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -80.64 119.57 23.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.5 ptt? -147.83 168.94 20.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -102.07 150.82 22.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.67 106.94 12.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.134 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.16 158.89 15.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.942 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . 0.639 ' CZ ' HD22 ' A' ' 139' ' ' LEU . 7.2 m-85 -127.53 148.01 50.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.864 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -139.14 97.26 3.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.182 -0.913 . . . . 0.0 111.139 179.934 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 m -124.93 100.72 6.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.823 0.344 . . . . 0.0 110.898 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -98.73 137.84 36.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.87 -73.15 0.52 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.46 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 m -105.88 110.37 22.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.844 0.354 . . . . 0.0 110.92 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 p -164.66 123.88 1.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.86 129.16 0.73 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.51 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 mt 63.65 88.37 0.12 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.656 0.265 . . . . 0.0 111.04 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.51 152.9 70.64 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.539 2.16 . . . . 0.0 112.267 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -137.32 104.57 5.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.3 m -100.8 35.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.121 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 61.76 31.8 18.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -89.79 123.11 33.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.975 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -128.56 -66.85 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 57.99 176.11 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.971 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -94.38 103.11 15.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.35 122.69 22.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.405 HG23 ' CE2' ' A' ' 20' ' ' TYR . 11.2 t -177.09 163.75 2.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.913 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -86.14 153.34 22.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.405 ' CE2' HG23 ' A' ' 18' ' ' THR . 13.6 m-85 -154.99 156.74 36.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -82.36 149.8 27.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.905 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.8 m -112.36 119.28 37.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.584 ' CD2' HG23 ' A' ' 88' ' ' ILE . 33.7 m-85 -127.65 163.11 24.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.922 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.8 m -81.22 157.55 25.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.9 m -72.57 -30.61 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.69 -26.92 68.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.974 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -56.2 -23.01 32.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.254 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.418 HD12 ' CE2' ' A' ' 90' ' ' TYR . 1.5 tp -52.18 108.9 0.33 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.84 0.353 . . . . 0.0 111.066 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.16 -20.53 65.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.432 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.6 155.29 4.02 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.728 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.06 122.14 9.21 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.578 2.185 . . . . 0.0 112.365 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 59.71 173.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -154.61 169.98 22.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.52 163.44 24.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.5 -12.55 17.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.37 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.87 20.04 8.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.678 0.275 . . . . 0.0 111.259 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.1 m -95.72 -34.84 5.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.884 0.373 . . . . 0.0 111.092 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -94.03 -31.2 14.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.826 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -97.54 95.42 7.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.888 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.94 -145.98 17.37 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.408 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.11 80.44 0.3 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.557 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.62 ' HG2' HD13 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -142.36 126.62 17.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.826 0.346 . . . . 0.0 110.872 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.401 HG22 ' HD3' ' A' ' 92' ' ' PRO . 13.1 pt -118.17 171.01 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.181 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 mp -128.9 106.7 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.94 160.56 25.7 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.962 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.508 ' N ' ' HB3' ' A' ' 84' ' ' ALA . 51.3 Cg_exo -52.93 161.35 3.32 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.535 2.156 . . . . 0.0 112.28 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.9 -26.39 26.95 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.548 2.165 . . . . 0.0 112.33 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 p -58.86 -31.24 68.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.948 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.45 -36.88 83.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.096 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.412 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 44.8 tp -64.86 -38.74 92.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.906 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -77.27 -30.99 54.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.932 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -68.93 -51.3 41.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.9 mt -59.63 -33.13 71.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.5 m -64.24 -30.27 71.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -96.64 20.23 11.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.4 mt -128.57 18.45 6.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.182 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 53.77 30.07 10.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.797 0.332 . . . . 0.0 111.157 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.1 mt -99.59 123.78 52.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.126 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 t -119.55 168.79 10.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.462 ' CG ' ' HA ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -59.93 144.07 86.76 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.89 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.462 ' HA ' ' CG ' ' A' ' 60' ' ' TYR . 72.7 Cg_endo -77.27 149.8 90.23 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 123.422 -1.491 . . . . 0.0 112.398 0.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 4.6 mtt -115.74 74.88 0.91 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.552 HD21 ' HB1' ' A' ' 147' ' ' ALA . 1.6 mt -88.15 160.37 17.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -127.37 148.28 50.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.837 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.404 ' HG3' ' CE1' ' A' ' 76' ' ' HIS . 24.7 tttt -104.11 93.78 5.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.71 80.75 5.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.822 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 m -87.87 95.94 10.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.466 ' ND2' HD21 ' A' ' 101' ' ' LEU . 37.2 t-20 -62.07 123.13 17.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.845 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm -98.31 32.4 2.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -131.93 -46.07 0.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.959 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.0 m -108.66 17.69 21.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.266 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.0 t0 53.16 37.74 25.77 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.848 0.356 . . . . 0.0 111.169 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.488 ' CB ' HD23 ' A' ' 99' ' ' LEU . 3.1 mmt-85 -96.45 152.4 18.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.4 ttp -149.17 123.21 9.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.795 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.452 HG21 HD11 ' A' ' 99' ' ' LEU . 6.5 t -148.96 160.54 43.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.992 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.494 ' CE1' ' HB2' ' A' ' 176' ' ' ALA . 15.1 m80 -125.26 107.87 11.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 24.6 p -104.3 161.16 14.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.957 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.53 143.24 17.97 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.661 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 11.1 p -79.53 144.09 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.815 0.341 . . . . 0.0 111.076 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.62 HD13 ' HG2' ' A' ' 42' ' ' LYS . 46.6 tp -116.89 -62.99 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.851 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -122.01 -179.65 4.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.661 ' CZ ' HG21 ' A' ' 79' ' ' VAL . 49.6 m-85 -140.19 80.12 1.74 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.7 m -141.9 31.28 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.129 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.508 ' HB3' ' N ' ' A' ' 46' ' ' PRO . . . -89.85 172.51 8.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.062 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.78 162.37 13.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -60.75 126.1 26.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.89 29.99 76.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.518 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.584 HG23 ' CD2' ' A' ' 23' ' ' PHE . 26.2 mt -148.95 99.25 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.839 0.352 . . . . 0.0 111.169 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 39.0 m -102.68 135.15 44.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.939 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.418 ' CE2' HD12 ' A' ' 28' ' ' LEU . 42.7 m-85 -99.53 131.4 45.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.6 mt -131.27 157.52 77.87 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.401 ' HD3' HG22 ' A' ' 43' ' ' ILE . 52.3 Cg_exo -52.9 -174.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.52 2.147 . . . . 0.0 112.35 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -98.36 -36.04 10.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.895 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 156' ' ' ALA . 57.0 p-90 -64.97 -31.38 72.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.924 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -75.95 -34.16 59.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -37.68 81.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -32.7 52.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -68.58 -38.05 80.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.834 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.488 HD23 ' CB ' ' A' ' 73' ' ' ARG . 7.3 mt -90.73 -21.23 21.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.172 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.0 mt 61.26 65.35 0.99 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.898 0.38 . . . . 0.0 110.938 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.466 HD21 ' ND2' ' A' ' 68' ' ' ASN . 8.1 mt -118.84 -177.21 3.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.877 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -126.5 174.59 8.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.881 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -64.85 85.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.26 38.34 1.13 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.426 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.73 134.78 12.68 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 82.9 mt -81.98 123.71 29.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 0.0 110.992 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.93 139.69 51.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.106 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -69.28 102.05 1.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -87.04 142.9 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.96 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -152.95 173.68 15.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.2 p -131.02 108.87 10.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.919 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.5 m -117.9 158.31 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.211 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -110.78 111.4 22.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.931 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.475 HD22 ' O ' ' A' ' 176' ' ' ALA . 8.5 mt -110.53 179.94 3.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.935 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.86 168.25 15.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.1 m -59.9 158.09 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.125 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.849 ' HB2' HG21 ' A' ' 177' ' ' VAL . . . -97.91 150.7 21.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.045 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.3 t -107.38 -31.28 8.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -132.27 90.76 2.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.2 m -103.69 104.89 14.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.835 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -94.57 146.85 23.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.674 ' CD2' HD21 ' A' ' 139' ' ' LEU . 87.5 m-85 -134.49 152.21 51.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -137.57 93.37 12.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -51.64 121.46 8.61 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.534 2.156 . . . . 0.0 112.297 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -74.14 -31.41 62.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.984 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -107.73 147.36 35.24 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.989 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.43 -15.3 27.93 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.642 2.228 . . . . 0.0 112.52 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.32 -40.22 70.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.103 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.532 ' CE2' HD11 ' A' ' 166' ' ' LEU . 13.6 t80 -70.73 -46.15 63.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.858 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 56.5 mt -59.84 -31.5 69.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -64.53 -25.64 68.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.073 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' ' 134' ' ' ASN . 46.8 mt -61.98 132.68 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.086 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.1 m -61.07 -34.27 74.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.934 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.591 ' H ' HG22 ' A' ' 132' ' ' ILE . 1.0 OUTLIER -120.58 79.97 30.55 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.809 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.64 -30.21 18.52 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.547 2.165 . . . . 0.0 112.295 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -73.72 -31.02 63.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' A' ' 134' ' ' ASN . . . -70.77 -48.71 52.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.15 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.474 HG21 HD13 ' A' ' 132' ' ' ILE . 21.6 t -61.89 -40.37 86.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.674 HD21 ' CD2' ' A' ' 122' ' ' PHE . 9.7 tp -65.41 -46.98 77.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -70.62 -30.91 67.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.966 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -67.58 -27.81 67.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.089 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.5 -26.16 14.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.35 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.3 mt -57.3 -39.47 75.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.117 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.6 -27.62 64.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.05 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -73.54 -30.28 62.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.776 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -78.77 155.6 29.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.552 ' HB1' HD21 ' A' ' 63' ' ' LEU . . . -109.96 -30.51 7.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.536 ' SG ' HD13 ' A' ' 63' ' ' LEU . 1.3 m -145.37 170.77 15.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.932 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.4 mt -137.79 176.25 8.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 7.5 m -159.67 143.94 14.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.9 m -72.85 123.53 23.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.89 58.49 3.22 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -137.89 130.32 29.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.829 0.347 . . . . 0.0 110.859 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.58 98.52 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.056 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.589 HG22 ' CZ3' ' A' ' 94' ' ' TRP . 14.6 pt -93.68 153.3 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 94' ' ' TRP . . . -119.34 148.31 43.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.067 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.1 pp -142.13 133.1 25.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -133.96 141.86 47.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -152.77 -47.47 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 39.8 p-10 -99.46 45.19 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 61.05 34.34 19.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -152.12 130.43 12.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.804 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.422 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 3.8 mp -95.36 113.25 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.146 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -86.09 157.21 20.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.816 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -108.23 137.2 46.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.532 HD11 ' CE2' ' A' ' 129' ' ' PHE . 2.9 mt -154.41 134.61 13.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.829 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -126.27 131.39 51.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.503 HG22 ' CE1' ' A' ' 122' ' ' PHE . 27.7 t -72.37 121.1 22.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 18.2 mmm -81.51 -53.56 6.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.0 155.43 41.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.894 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.432 HG23 ' CG1' ' A' ' 168' ' ' VAL . 26.7 p -149.33 158.75 44.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.883 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -140.89 157.29 67.76 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.39 -42.24 0.82 Allowed 'Cis proline' 0 C--N 1.346 0.417 0 C-N-CA 123.3 -1.542 . . . . 0.0 112.437 -0.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.84 172.15 7.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.938 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.61 -44.38 89.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.956 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.494 ' HB2' ' CE1' ' A' ' 76' ' ' HIS . . . -102.93 119.04 38.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.075 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.849 HG21 ' HB2' ' A' ' 117' ' ' ALA . 16.1 m -127.78 155.68 39.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.16 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.7 t -106.77 95.11 5.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 2.0 pt -87.83 85.28 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.253 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.7 mm -116.51 86.52 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.102 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 61.4 80.58 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.941 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' CYS . . . . . . . . . . . . . 9.1 t -159.19 151.08 20.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.811 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.23 127.0 40.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -135.46 173.16 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.83 79.46 5.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.06 138.92 21.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.063 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -137.28 172.3 13.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -134.17 133.85 41.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -117.87 90.31 3.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.069 -179.977 . . . . . . . . 0 0 . 1 stop_ save_